Citrus Sinensis ID: 006772
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 632 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FY48 | 1625 | E3 ubiquitin-protein liga | no | no | 0.417 | 0.162 | 0.309 | 4e-30 | |
| Q54XJ4 | 1495 | Probable serine/threonine | yes | no | 0.280 | 0.118 | 0.327 | 5e-18 | |
| P08103 | 524 | Tyrosine-protein kinase H | yes | no | 0.428 | 0.517 | 0.252 | 5e-17 | |
| P08631 | 526 | Tyrosine-protein kinase H | yes | no | 0.411 | 0.494 | 0.261 | 9e-17 | |
| O14299 | 1401 | MAP kinase kinase kinase | yes | no | 0.384 | 0.173 | 0.286 | 2e-16 | |
| Q95M30 | 504 | Tyrosine-protein kinase H | N/A | no | 0.411 | 0.515 | 0.261 | 2e-16 | |
| Q6P6U0 | 517 | Tyrosine-protein kinase F | yes | no | 0.417 | 0.510 | 0.277 | 2e-16 | |
| P50545 | 524 | Tyrosine-protein kinase H | no | no | 0.428 | 0.517 | 0.249 | 2e-16 | |
| Q9GM70 | 397 | Serine/threonine-protein | no | no | 0.367 | 0.584 | 0.28 | 3e-16 | |
| P14234 | 517 | Tyrosine-protein kinase F | no | no | 0.417 | 0.510 | 0.270 | 5e-16 |
| >sp|Q9FY48|KEG_ARATH E3 ubiquitin-protein ligase KEG OS=Arabidopsis thaliana GN=KEG PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 133 bits (335), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 90/291 (30%), Positives = 141/291 (48%), Gaps = 27/291 (9%)
Query: 45 LKLKHRIGR----GPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL 100
+KL +IG G FG V + + H +AVK + ++ + + E L
Sbjct: 137 MKLVRQIGEESSSGGFGGVEMWDATVAGGGGRCKHRVAVKKMTLTEDMDVEWMQGQLESL 196
Query: 101 FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
++VC HG+ ++G +C+ M GSV + Q+ G+L L ILRYG +A+
Sbjct: 197 RRASMWCRNVCTFHGVVKMDGSLCLLMDRCFGSVQSEM-QRNEGRLTLEQILRYGADVAR 255
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI------PYLLLGRSLSDSDMALRLG 214
G+++LH+ G++ +N+KPSNLLL V+ D+G+ P R DS
Sbjct: 256 GVAELHAAGVICMNIKPSNLLLDASGNAVVSDYGLAPILKKPTCQKTRPEFDSSKVTLYT 315
Query: 215 -----TPNYMAPEQWEP------EVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263
+P+Y APE W P E +S E+D W FGC+++EM TG PW G S EEI
Sbjct: 316 DCVTLSPHYTAPEAWGPVKKLFWEDASGVSPESDAWSFGCTLVEMCTGSTPWDGLSREEI 375
Query: 264 YHSVVIKKEKP-----CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
+ +VV ++ P + G+P + +I C ++ RP +L F
Sbjct: 376 FQAVVKARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRPTFNAMLATF 426
|
Mediates E2-dependent protein ubiquitination. Acts as a negative regulator of abscisic acid signaling. Required for ABI5 degradation. Arabidopsis thaliana (taxid: 3702) EC: 6EC: .EC: 3EC: .EC: 2EC: .EC: - |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 93.6 bits (231), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 60/183 (32%), Positives = 99/183 (54%), Gaps = 6/183 (3%)
Query: 125 IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184
I M+F E ++I + R G LP + Y Q+ G+ LH G++ ++K +NLL+S
Sbjct: 99 IVMEFIENGSLEKIIK-RHGLLPESLVTVYIAQVLNGLEYLHRQGVIHRDIKAANLLIST 157
Query: 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCS 244
+ L DFG+ + S + D GTP +MAPE + ++G IS D W GC+
Sbjct: 158 DGSIKLADFGVATKVSDLSSDNPDDTFA-GTPYWMAPEVIQ--MQG-ISTACDVWSLGCT 213
Query: 245 IMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMAD 304
I+E+LTG P+FG + + +V +++ P IP G+ A+++ ++ CF+ D R
Sbjct: 214 IIELLTGTPPYFGLAPAAALYKIV-QEDHPPIPPGISAALKDFLLNCFKKDENIRSSAKQ 272
Query: 305 ILH 307
+LH
Sbjct: 273 LLH 275
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P08103|HCK_MOUSE Tyrosine-protein kinase HCK OS=Mus musculus GN=Hck PE=1 SV=4 | Back alignment and function description |
|---|
Score = 90.1 bits (222), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 78/309 (25%), Positives = 143/309 (46%), Gaps = 38/309 (12%)
Query: 26 LRTVVATPTQTRPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
L +P +PW I SL+++ ++G G FG+VW+AT ++++ ++AV
Sbjct: 235 LSVPCVSPKPQKPWEKDAWEIPRESLQMEKKLGAGQFGEVWMAT-------YNKHTKVAV 287
Query: 80 KMLLPLKEDCAKVFVNKF--EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGD 136
K + P + V F E K + + LH + V I I +F +GS+ D
Sbjct: 288 KTMKP-----GSMSVEAFLAEANLMKSLQHDKLVKLHAV-VSQEPIFIVTEFMAKGSLLD 341
Query: 137 RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196
+ + G K PLP ++ + Q+++G++ + + +L+ +N+L+S + DFG
Sbjct: 342 FLKSEEGSKQPLPKLIDFSAQISEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-- 399
Query: 197 YLLLGRSLSDSDMALRLGTP---NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GI 252
L R + D++ R G + APE G + ++D W FG +ME++T G
Sbjct: 400 ---LARIIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGR 453
Query: 253 QPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAF 309
P+ G S E+ ++ P P P + N++I C++ RP + +L F
Sbjct: 454 IPYPGMSNPEVIRALEHGYRMP-RPDNCPEELYNIMIRCWKNRPEERPTFEYIQSVLDDF 512
Query: 310 ESSQNAVYN 318
++ + Y
Sbjct: 513 YTATESQYQ 521
|
Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P08631|HCK_HUMAN Tyrosine-protein kinase HCK OS=Homo sapiens GN=HCK PE=1 SV=5 | Back alignment and function description |
|---|
Score = 89.4 bits (220), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 78/298 (26%), Positives = 139/298 (46%), Gaps = 38/298 (12%)
Query: 37 RPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA 90
+PW I SLKL+ ++G G FG+VW+AT ++++ ++AVK + P
Sbjct: 248 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-------YNKHTKVAVKTMKP-----G 295
Query: 91 KVFVNKF--EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLP 147
+ V F E K + + LH + V I I +F +GS+ D + G K P
Sbjct: 296 SMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQP 354
Query: 148 LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207
LP ++ + Q+A+G++ + + +L+ +N+L+S + DFG L R + D+
Sbjct: 355 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-----LARVIEDN 409
Query: 208 DMALRLGTP---NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263
+ R G + APE G + ++D W FG +ME++T G P+ G S E+
Sbjct: 410 EYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 466
Query: 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAFESSQNAVYN 318
++ P P P + N+++ C++ RP + +L F ++ + Y
Sbjct: 467 IRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQ 523
|
Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|O14299|WIS4_SCHPO MAP kinase kinase kinase wis4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=wis4 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 88.6 bits (218), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 33/276 (11%)
Query: 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ 108
H + G FGDV+ + ++ D LAVK +K ++ F + +++ + +
Sbjct: 1041 HFVRSGMFGDVYTGVNMETGD------LLAVK---EIKLQDSRTFRSTVDQIHNEMTVLE 1091
Query: 109 -----SVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILR-YGIQLAKG 161
+V +G+ V K+ I M+F +G S+ D +A G++ ++L+ Y +QL +G
Sbjct: 1092 RLNHPNVVTYYGVEVHREKVYIFMEFCQGGSLADLLAH---GRIEDENVLKVYVVQLLEG 1148
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL---LGRSLSDSDMALRL----G 214
++ +HS +L ++KP+N+LL + DFG + + D+ L G
Sbjct: 1149 LAYIHSQHILHRDIKPANILLDHRGMIKYSDFGSALYVSPPTDPEVRYEDIQPELQHLAG 1208
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE--EIYHSVVIKKE 272
TP YMAPE +G D W GC I+EM+TG PW E +YH V
Sbjct: 1209 TPMYMAPEIILGTKKGDFG-AMDIWSLGCVILEMMTGSTPWSEMDNEWAIMYH--VAAMH 1265
Query: 273 KPCIPSG--LPPAVENVIIGCFEYDLRNRPLMADIL 306
P IP + + I CFE D RP D+L
Sbjct: 1266 TPSIPQNEKISSLARDFIEQCFERDPEQRPRAVDLL 1301
|
Involved in a signal transduction pathway that is activated in under conditions of heat shock, oxidative stress or limited nutrition. Unlike win1, it is not activated by changes in the osmolarity of the extracellular environment. Activates the wis1 MAP kinase kinase by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q95M30|HCK_MACFA Tyrosine-protein kinase HCK OS=Macaca fascicularis GN=HCK PE=2 SV=3 | Back alignment and function description |
|---|
Score = 88.6 bits (218), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 78/298 (26%), Positives = 139/298 (46%), Gaps = 38/298 (12%)
Query: 37 RPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA 90
+PW I SLKL+ ++G G FG+VW+AT ++++ ++AVK + P
Sbjct: 226 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-------YNKHTKVAVKTMKP-----G 273
Query: 91 KVFVNKF--EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLP 147
+ V F E K + + LH + V I I +F +GS+ D + G K P
Sbjct: 274 SMSVEAFLAEANLMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQP 332
Query: 148 LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207
LP ++ + Q+A+G++ + + +L+ +N+L+S + DFG L R + D+
Sbjct: 333 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-----LARIIEDN 387
Query: 208 DMALRLGTP---NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263
+ R G + APE G + ++D W FG +ME++T G P+ G S E+
Sbjct: 388 EYTAREGAKFPIKWTAPEAIN---FGSSTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 444
Query: 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAFESSQNAVYN 318
++ P P P + N+++ C++ RP + +L F ++ + Y
Sbjct: 445 IRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQ 501
|
Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS. Macaca fascicularis (taxid: 9541) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q6P6U0|FGR_RAT Tyrosine-protein kinase Fgr OS=Rattus norvegicus GN=Fgr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 88.6 bits (218), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 81/292 (27%), Positives = 133/292 (45%), Gaps = 28/292 (9%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
ID S+ L R+G G FGDVWL T + S ++AVK L P K F+ E
Sbjct: 246 IDRNSIALDRRLGTGCFGDVWLGTWNCST-------KVAVKTLKP-GTMSPKAFLE--EA 295
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQL 158
K + L+ + V I I +F GS+ D + ++G L LP+++ Q+
Sbjct: 296 QIMKLLRHDKLVQLYAV-VSEEPIYIVTEFMCYGSLLDFLKDRKGHNLMLPNLVDMAAQV 354
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
A+G++ + + + +L+ +N+L+ EH + DFG L R + D + + GT
Sbjct: 355 AEGMAYMERMNYIHRDLRAANILVGEHLICKIADFG-----LARLIVDDEYNPQQGTK-- 407
Query: 219 MAPEQW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274
P +W E + G + ++D W FG + E++T G P+ G + E+ V P
Sbjct: 408 -FPIKWTAPEAALFGRFTVKSDVWSFGILLTELITKGRVPYPGMNNREVLEQVEHGYHMP 466
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAFESSQNAVYNDGEWT 323
C P G P ++ V+ + D RP + L + +S Y G+ T
Sbjct: 467 C-PPGCPVSLYEVMEQTWRLDPEERPTFEYLQSFLEDYFTSTEPQYQPGDQT 517
|
Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as MS4A2/FCER1B, FCER1G and FCGR2. Acts downstream of ITGB1 and ITGB2, and regulates actin cytoskeleton reorganization, cell spreading and adhesion. Depending on the context, activates or inhibits cellular responses. Functions as negative regulator of ITGB2 signaling, phagocytosis and SYK activity in monocytes. Required for normal ITGB1 and ITGB2 signaling, normal cell spreading and adhesion in neutrophils and macrophages. Functions as positive regulator of cell migration and regulates cytoskeleton reorganization via RAC1 activation. Phosphorylates SYK (in vitro) and promotes SYK-dependent activation of AKT1 and MAP kinase signaling. Phosphorylates PLD2 in antigen-stimulated mast cells, leading to PLD2 activation and the production of the signaling molecules lysophosphatidic acid and diacylglycerol. Promotes activation of PIK3R1. Phosphorylates FASLG, and thereby regulates its ubiquitination and subsequent internalization. Phosphorylates ABL1. Promotes phosphorylation of CBL, CTTN, PIK3R1, PTK2/FAK1, PTK2B/PYK2 and VAV2 (By similarity). Phosphorylates HCLS1 that has already been phosphorylated by SYK, but not unphosphorylated HCLS1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P50545|HCK_RAT Tyrosine-protein kinase HCK OS=Rattus norvegicus GN=Hck PE=1 SV=4 | Back alignment and function description |
|---|
Score = 88.2 bits (217), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 77/309 (24%), Positives = 143/309 (46%), Gaps = 38/309 (12%)
Query: 26 LRTVVATPTQTRPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
L +P +PW I SL+++ ++G G FG+VW+AT ++++ ++AV
Sbjct: 235 LSVPCVSPKPQKPWEKDAWEIPRESLQMEKKLGAGQFGEVWMAT-------YNKHTKVAV 287
Query: 80 KMLLPLKEDCAKVFVNKF--EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGD 136
K + P + V F E K + + LH + V I I +F +GS+ D
Sbjct: 288 KTMKP-----GSMSVEAFLAEANLMKTLQHDKLVKLHAV-VSQEPIFIVTEFMAKGSLLD 341
Query: 137 RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196
+ + G K PLP ++ + Q+++G++ + + +L+ +N+L+S + DFG
Sbjct: 342 FLKSEEGSKQPLPKLIDFSAQISEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-- 399
Query: 197 YLLLGRSLSDSDMALRLGTP---NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GI 252
L R + D++ R G + APE G + ++D W FG +ME++T G
Sbjct: 400 ---LARIIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGR 453
Query: 253 QPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAF 309
P+ G S E+ ++ P P P + +++I C++ RP + +L F
Sbjct: 454 IPYPGMSNPEVIRALEHGYRMP-RPDNCPEELYSIMIRCWKNRPEERPTFEYIQSVLDDF 512
Query: 310 ESSQNAVYN 318
++ + Y
Sbjct: 513 YTATESQYQ 521
|
Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus GN=STK17A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 87.4 bits (215), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 23 PDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML 82
P L T + T +T P+ D SL +GRG F V S +F A K +
Sbjct: 22 PGGLLTEIRTAIRTEPFQDCYSLSPGRELGRGKFAVVRKCIQKDSGKEF------AAKFM 75
Query: 83 LPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIA 139
+ +DC +++ + +++ V LH + + ++ + +++ G + D+
Sbjct: 76 RKRRKGQDCRMEIIHEIA-VLELAQDNPWVINLHEVYETSSEMILVLEYAAGGEISDQCV 134
Query: 140 QQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199
R D+ R Q+ +G+ LH+ ++ L+LKP N+LL+ L GD I
Sbjct: 135 ADRDEAFNEKDVQRLMRQILEGVHFLHTHDVVHLDLKPQNILLTSESPL--GDIKIVDFG 192
Query: 200 LGRSLSDSDMALR--LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257
L R + +S+ LR +GTP Y+APE + PIS TD W G MLTGI P+ G
Sbjct: 193 LSRIVKNSE-ELREIMGTPEYVAPEILSYD---PISMATDMWSIGVLTYVMLTGISPFLG 248
Query: 258 KSVEEIYHSV 267
+ +E + ++
Sbjct: 249 DNKQETFLNI 258
|
Acts as a positive regulator of apoptosis. May also act as a regulator of cellular reactive oxygen species. Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P14234|FGR_MOUSE Tyrosine-protein kinase Fgr OS=Mus musculus GN=Fgr PE=1 SV=2 | Back alignment and function description |
|---|
Score = 86.7 bits (213), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 28/292 (9%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
ID S+ L+ R+G G FGDVWL T + S ++AVK L P K F+ + +
Sbjct: 246 IDRNSIALERRLGTGCFGDVWLGTWNCST-------KVAVKTLKP-GTMSPKAFLEEAQI 297
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQL 158
+ K + L+ + V I I +F GS+ D + + G L LP ++ Q+
Sbjct: 298 M--KLLRHDKLVQLYAV-VSEEPIYIVTEFMCYGSLLDFLKDREGQNLMLPHLVDMAAQV 354
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
A+G++ + + + +L+ +N+L+ E+ + DFG L R + D++ + GT
Sbjct: 355 AEGMAYMERMNYIHRDLRAANILVGEYLICKIADFG-----LARLIEDNEYNPQQGTK-- 407
Query: 219 MAPEQW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274
P +W E + G + ++D W FG + E++T G P+ G + E+ V P
Sbjct: 408 -FPIKWTAPEAALFGRFTVKSDVWSFGILLTELITKGRVPYPGMNNREVLEQVEHGYHMP 466
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAFESSQNAVYNDGEWT 323
C P G P ++ V+ + D RP + L + +S Y G+ T
Sbjct: 467 C-PPGCPASLYEVMEQAWRLDPEERPTFEYLQSFLEDYFTSTEPQYQPGDQT 517
|
Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as MS4A2/FCER1B, FCER1G and FCGR2. Acts downstream of ITGB1 and ITGB2, and regulates actin cytoskeleton reorganization, cell spreading and adhesion. Depending on the context, activates or inhibits cellular responses. Functions as negative regulator of ITGB2 signaling, phagocytosis and SYK activity in monocytes (PubMed:11672534). Required for normal ITGB1 and ITGB2 signaling, normal cell spreading and adhesion in neutrophils and macrophages (PubMed:8666673 and PubMed:9687507). Functions as positive regulator of cell migration and regulates cytoskeleton reorganization via RAC1 activation (PubMed:15561106). Phosphorylates SYK (in vitro) and promotes SYK-dependent activation of AKT1 and MAP kinase signaling (PubMed:21746961). Phosphorylates PLD2 in antigen-stimulated mast cells, leading to PLD2 activation and the production of the signaling molecules lysophosphatidic acid and diacylglycerol. Promotes activation of PIK3R1. Phosphorylates FASLG, and thereby regulates its ubiquitination and subsequent internalization. Phosphorylates ABL1. Promotes phosphorylation of CBL, CTTN, PIK3R1, PTK2/FAK1, PTK2B/PYK2 and VAV2. Phosphorylates HCLS1 that has already been phosphorylated by SYK, but not unphosphorylated HCLS1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 632 | ||||||
| 255553227 | 658 | protein kinase, putative [Ricinus commun | 0.988 | 0.949 | 0.730 | 0.0 | |
| 225442924 | 630 | PREDICTED: uncharacterized protein LOC10 | 0.996 | 1.0 | 0.718 | 0.0 | |
| 297743474 | 946 | unnamed protein product [Vitis vinifera] | 0.919 | 0.614 | 0.734 | 0.0 | |
| 296082051 | 750 | unnamed protein product [Vitis vinifera] | 0.974 | 0.821 | 0.654 | 0.0 | |
| 225430314 | 638 | PREDICTED: uncharacterized protein LOC10 | 0.974 | 0.965 | 0.654 | 0.0 | |
| 255548886 | 632 | protein kinase, putative [Ricinus commun | 0.992 | 0.992 | 0.631 | 0.0 | |
| 224089274 | 583 | predicted protein [Populus trichocarpa] | 0.919 | 0.996 | 0.664 | 0.0 | |
| 224141907 | 562 | predicted protein [Populus trichocarpa] | 0.887 | 0.998 | 0.656 | 0.0 | |
| 449437150 | 626 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.998 | 0.573 | 0.0 | |
| 357123184 | 631 | PREDICTED: E3 ubiquitin-protein ligase K | 0.984 | 0.985 | 0.574 | 0.0 |
| >gi|255553227|ref|XP_002517656.1| protein kinase, putative [Ricinus communis] gi|223543288|gb|EEF44820.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2444), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/630 (73%), Positives = 527/630 (83%), Gaps = 5/630 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MAE+IR +PA SFEY LFEGDPDHLRTVVATPTQ PWI+P LKLKHRIGRG FGDVW
Sbjct: 33 MAEKIRVPEPATSFEYMLFEGDPDHLRTVVATPTQISPWIEPAELKLKHRIGRGIFGDVW 92
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHHQS+DDFDEYHE+AVKML PLKED ++FV+KFE+LF K RE V WLHGIS++N
Sbjct: 93 LATHHQSSDDFDEYHEVAVKMLHPLKEDLTQIFVDKFEKLFLKCREILGVGWLHGISIMN 152
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
G+ICIAMKFY+GS+ DRIA +GGKL L DILRYGI LAKGI +LHSIGLLVLNLKPSN
Sbjct: 153 GQICIAMKFYKGSIADRIALVKGGKLQLSDILRYGIDLAKGIQELHSIGLLVLNLKPSNF 212
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
L++EHD VLGDFGI +LL G L +S+MALRLGTPNYMAPEQWEPEVRGPISFETD+WG
Sbjct: 213 LINEHDHAVLGDFGISFLLHGIPLLNSEMALRLGTPNYMAPEQWEPEVRGPISFETDSWG 272
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCSI+EMLTG+QP+FGKS+EEIY SVVIK+E P IP+GLPPAVENV+ GCF+YDLRNRP
Sbjct: 273 FGCSIVEMLTGVQPFFGKSIEEIYQSVVIKQETPQIPNGLPPAVENVLGGCFQYDLRNRP 332
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM D+LHAF SSQNAV + W GL SRAL+ SS YTAWY +D+LQ+GDTVRSRKP
Sbjct: 333 LMEDVLHAFHSSQNAVNSGEGWVGLESRALSGKSS-GSYTAWYLSRDNLQLGDTVRSRKP 391
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
LNA KPQT+DVP GT+VG D++ DRN VLVK+ GLHNPLRVQES+LERVTFG A GDWV
Sbjct: 392 LNACKPQTMDVPKGTLVGPDSNDDRNGFVLVKVAGLHNPLRVQESTLERVTFGFAEGDWV 451
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
LK+E S HS VG+LHSVQRDG V+VGF+GLETLW G YS++QMAKAYYVGQFVR+ AN+
Sbjct: 452 YLKEETSMHSPVGILHSVQRDGGVAVGFVGLETLWMGTYSDLQMAKAYYVGQFVRLKANL 511
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
T RF+WPRKRGG WATG+I QVL NGCL+V FPGR G S + LADP+EVE+VSFDT
Sbjct: 512 VTARFKWPRKRGGGWATGRISQVLSNGCLIVSFPGRLVFGDESNTFLADPAEVEVVSFDT 571
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVGGRLKKGQGNSKRGGNNCQ 600
CPGV+EKY+H+ED+HWSVRPLAIALGLF AMKL VGRS+ +L+KG+ K G + Q
Sbjct: 572 CPGVMEKYQHVEDFHWSVRPLAIALGLFTAMKLTLSVGRSISTKLRKGR---KSGEGHSQ 628
Query: 601 DGQAAGGNGAWLRSPVANIIFREGVPATAA 630
DGQ GGN AWL PVANI+F+EGVPA
Sbjct: 629 DGQ-GGGNAAWLPPPVANILFKEGVPAATV 657
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442924|ref|XP_002265172.1| PREDICTED: uncharacterized protein LOC100268161 isoform 1 [Vitis vinifera] gi|359482371|ref|XP_003632763.1| PREDICTED: uncharacterized protein LOC100268161 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2406), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/632 (71%), Positives = 515/632 (81%), Gaps = 2/632 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MAE+I A P ASFEYELFEGDPDHLRTV AT TQ PWIDP SLKLKHRIGRG FGDVW
Sbjct: 1 MAEKIGAAPPPASFEYELFEGDPDHLRTVAATSTQLSPWIDPASLKLKHRIGRGLFGDVW 60
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHHQSADD+DEYHE+AVKML ++ED ++F++KF +F K R+ + VCWLHGIS+
Sbjct: 61 LATHHQSADDYDEYHEVAVKMLHTIREDHMQMFLDKFAGIFLKCRQLKGVCWLHGISIKT 120
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GK+CIAMKFYEGSVGDR+A +GGKLPL D+LRYGI+LAKGI +LHS G+LVLNLKPSN
Sbjct: 121 GKVCIAMKFYEGSVGDRMAHLKGGKLPLSDVLRYGIELAKGIMELHSTGVLVLNLKPSNF 180
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL+EHDQ+VLGD GIPYLLLG L + DM LRLGTPNYMAPEQWEPEVRGPIS ETDTWG
Sbjct: 181 LLNEHDQVVLGDMGIPYLLLGIPLPNPDMVLRLGTPNYMAPEQWEPEVRGPISCETDTWG 240
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCSI+EMLTG+QPW G+S+EEIY SVVIK+EKP IPSGLPP VENV+ GCFEYDLRNRP
Sbjct: 241 FGCSIVEMLTGVQPWCGRSIEEIYQSVVIKQEKPHIPSGLPPEVENVLNGCFEYDLRNRP 300
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM DIL AFESSQNAVY+DG W GL SR T+ S+ +GYT+W+ KD L VGD VRSRKP
Sbjct: 301 LMVDILQAFESSQNAVYSDGGWIGLESRTCTERSNSRGYTSWFLSKDSLHVGDIVRSRKP 360
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
LNA KPQ +DVP GTVVG D D DR+ VLVKI G HNPLRV S+LERVT GL DWV
Sbjct: 361 LNACKPQIMDVPEGTVVGFDGDNDRDGFVLVKIRGKHNPLRVHVSTLERVTSGLVVTDWV 420
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
LK+ N +HS+VG+LHSVQRDGSV+VGF+GLETLWRG+ SE+QMA+ YYVGQFVR+ NV
Sbjct: 421 RLKEPNRKHSTVGILHSVQRDGSVAVGFLGLETLWRGHSSELQMAETYYVGQFVRLKTNV 480
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
FTPRF+WPRK+GG W TG+I QVLPNGCLVV FPGRF G S S LADP+EVELVSFD
Sbjct: 481 FTPRFDWPRKKGGAWVTGRIAQVLPNGCLVVRFPGRFVFGVESNSFLADPAEVELVSFDK 540
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVGGRLKKGQGNSKRGGNNCQ 600
C GVVEKY HIED+HW+VRPL IA G+F +KLG VG +V R++K N CQ
Sbjct: 541 CHGVVEKYHHIEDFHWAVRPLVIAFGVFTTLKLGVFVGGNVCVRMRKSPRNLTPNDGQCQ 600
Query: 601 DGQAAGGNGAWLRSPVANIIFREGVPATAAAR 632
DGQ AGGN AW+ VANI+FREG P TA AR
Sbjct: 601 DGQ-AGGNPAWIPPTVANILFREG-PPTATAR 630
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743474|emb|CBI36341.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/581 (73%), Positives = 484/581 (83%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MAE+I A P ASFEYELFEGDPDHLRTV AT TQ PWIDP SLKLKHRIGRG FGDVW
Sbjct: 74 MAEKIGAAPPPASFEYELFEGDPDHLRTVAATSTQLSPWIDPASLKLKHRIGRGLFGDVW 133
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHHQSADD+DEYHE+AVKML ++ED ++F++KF +F K R+ + VCWLHGIS+
Sbjct: 134 LATHHQSADDYDEYHEVAVKMLHTIREDHMQMFLDKFAGIFLKCRQLKGVCWLHGISIKT 193
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GK+CIAMKFYEGSVGDR+A +GGKLPL D+LRYGI+LAKGI +LHS G+LVLNLKPSN
Sbjct: 194 GKVCIAMKFYEGSVGDRMAHLKGGKLPLSDVLRYGIELAKGIMELHSTGVLVLNLKPSNF 253
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL+EHDQ+VLGD GIPYLLLG L + DM LRLGTPNYMAPEQWEPEVRGPIS ETDTWG
Sbjct: 254 LLNEHDQVVLGDMGIPYLLLGIPLPNPDMVLRLGTPNYMAPEQWEPEVRGPISCETDTWG 313
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCSI+EMLTG+QPW G+S+EEIY SVVIK+EKP IPSGLPP VENV+ GCFEYDLRNRP
Sbjct: 314 FGCSIVEMLTGVQPWCGRSIEEIYQSVVIKQEKPHIPSGLPPEVENVLNGCFEYDLRNRP 373
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM DIL AFESSQNAVY+DG W GL SR T+ S+ +GYT+W+ KD L VGD VRSRKP
Sbjct: 374 LMVDILQAFESSQNAVYSDGGWIGLESRTCTERSNSRGYTSWFLSKDSLHVGDIVRSRKP 433
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
LNA KPQ +DVP GTVVG D D DR+ VLVKI G HNPLRV S+LERVT GL DWV
Sbjct: 434 LNACKPQIMDVPEGTVVGFDGDNDRDGFVLVKIRGKHNPLRVHVSTLERVTSGLVVTDWV 493
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
LK+ N +HS+VG+LHSVQRDGSV+VGF+GLETLWRG+ SE+QMA+ YYVGQFVR+ NV
Sbjct: 494 RLKEPNRKHSTVGILHSVQRDGSVAVGFLGLETLWRGHSSELQMAETYYVGQFVRLKTNV 553
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
FTPRF+WPRK+GG W TG+I QVLPNGCLVV FPGRF G S S LADP+EVELVSFD
Sbjct: 554 FTPRFDWPRKKGGAWVTGRIAQVLPNGCLVVRFPGRFVFGVESNSFLADPAEVELVSFDK 613
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSV 581
C GVVEKY HIED+HW+VRPL IA G+F +KLG VG +V
Sbjct: 614 CHGVVEKYHHIEDFHWAVRPLVIAFGVFTTLKLGVFVGGNV 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082051|emb|CBI21056.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 836 bits (2160), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/620 (65%), Positives = 495/620 (79%), Gaps = 4/620 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MA + A + AA+FE+ELFEGDPDHLRTVVATP PWIDP +LKL+HRIGRGPFGDVW
Sbjct: 113 MAGKAAATQSAAAFEFELFEGDPDHLRTVVATPNLISPWIDPATLKLRHRIGRGPFGDVW 172
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LAT H A+D+DEYHE+A+KML P+KED KV ++K E LF K + + VCWLHGISVI+
Sbjct: 173 LATQHLFAEDYDEYHEVAIKMLHPIKEDLMKVVLDKLENLFSKCQGLKGVCWLHGISVIS 232
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GKICI MKFYEGS+GD++A +GGKL L DILRYGI LA+ I +LHS +LVLNLKP N
Sbjct: 233 GKICIIMKFYEGSLGDKMAHLKGGKLSLRDILRYGIDLAQAILELHSKEILVLNLKPYNF 292
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL ++D+ +LGD GIPYLLL L SD+A RLGTPNYMAPEQW+PEVRGP+S ETD+WG
Sbjct: 293 LLDQNDEAILGDLGIPYLLLQIPLPSSDIARRLGTPNYMAPEQWQPEVRGPLSLETDSWG 352
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCSI+EMLTG+QPW GKSVEE++ SVV K+EKP IPSGLPPAVE VIIGCF YD R+RP
Sbjct: 353 FGCSIVEMLTGVQPWCGKSVEEVHDSVVRKQEKPFIPSGLPPAVERVIIGCFAYDFRSRP 412
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
M +IL AF+SS+NAVY+DG WTGLGSR +TD V GY+ W+ K++ VGD VRSRKP
Sbjct: 413 SMKNILEAFKSSENAVYSDGGWTGLGSRTITDNFIVNGYSEWFLSKENFLVGDLVRSRKP 472
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
++ KP+ +DVP GTVVGL+ D+D++ VLV++ G+H+PLRV + +LERVT GLAAGDWV
Sbjct: 473 PHSCKPENMDVPGGTVVGLERDSDQDGYVLVRVLGIHDPLRVHKYTLERVTSGLAAGDWV 532
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
L+ E+ R+S VG+LHS+ RDGSV VGFIG+ETLW+G+ + +QMA++Y GQFVR+ ANV
Sbjct: 533 RLETEDRRNSRVGILHSISRDGSVDVGFIGMETLWKGSCTNLQMAESYCKGQFVRLKANV 592
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
+PRFEWPRKRGG WATG+I QVLPNGCLVV FPGR P+G S LADP+EVELVSF+T
Sbjct: 593 LSPRFEWPRKRGGAWATGRIWQVLPNGCLVVNFPGRLPIGDECSSFLADPAEVELVSFNT 652
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVG-GRLKKGQGNSKRGGNNC 599
PG+V+KY+H+ED+HW+VRPL IALGLF+AMK G VG+ +G GR K+ +G S N
Sbjct: 653 SPGLVKKYQHLEDFHWAVRPLLIALGLFSAMKFGIFVGKKIGIGRSKEKRGQSTMTQNES 712
Query: 600 Q--DGQAAGGNGAWLRSPVA 617
Q D Q A GN AWL VA
Sbjct: 713 QRLDNQTA-GNAAWLPQTVA 731
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430314|ref|XP_002282747.1| PREDICTED: uncharacterized protein LOC100268069 [Vitis vinifera] gi|147822641|emb|CAN70648.1| hypothetical protein VITISV_025237 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/620 (65%), Positives = 495/620 (79%), Gaps = 4/620 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MA + A + AA+FE+ELFEGDPDHLRTVVATP PWIDP +LKL+HRIGRGPFGDVW
Sbjct: 1 MAGKAAATQSAAAFEFELFEGDPDHLRTVVATPNLISPWIDPATLKLRHRIGRGPFGDVW 60
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LAT H A+D+DEYHE+A+KML P+KED KV ++K E LF K + + VCWLHGISVI+
Sbjct: 61 LATQHLFAEDYDEYHEVAIKMLHPIKEDLMKVVLDKLENLFSKCQGLKGVCWLHGISVIS 120
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GKICI MKFYEGS+GD++A +GGKL L DILRYGI LA+ I +LHS +LVLNLKP N
Sbjct: 121 GKICIIMKFYEGSLGDKMAHLKGGKLSLRDILRYGIDLAQAILELHSKEILVLNLKPYNF 180
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL ++D+ +LGD GIPYLLL L SD+A RLGTPNYMAPEQW+PEVRGP+S ETD+WG
Sbjct: 181 LLDQNDEAILGDLGIPYLLLQIPLPSSDIARRLGTPNYMAPEQWQPEVRGPLSLETDSWG 240
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCSI+EMLTG+QPW GKSVEE++ SVV K+EKP IPSGLPPAVE VIIGCF YD R+RP
Sbjct: 241 FGCSIVEMLTGVQPWCGKSVEEVHDSVVRKQEKPFIPSGLPPAVERVIIGCFAYDFRSRP 300
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
M +IL AF+SS+NAVY+DG WTGLGSR +TD V GY+ W+ K++ VGD VRSRKP
Sbjct: 301 SMKNILEAFKSSENAVYSDGGWTGLGSRTITDNFIVNGYSEWFLSKENFLVGDLVRSRKP 360
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
++ KP+ +DVP GTVVGL+ D+D++ VLV++ G+H+PLRV + +LERVT GLAAGDWV
Sbjct: 361 PHSCKPENMDVPGGTVVGLERDSDQDGYVLVRVLGIHDPLRVHKYTLERVTSGLAAGDWV 420
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
L+ E+ R+S VG+LHS+ RDGSV VGFIG+ETLW+G+ + +QMA++Y GQFVR+ ANV
Sbjct: 421 RLETEDRRNSRVGILHSISRDGSVDVGFIGMETLWKGSCTNLQMAESYCKGQFVRLKANV 480
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
+PRFEWPRKRGG WATG+I QVLPNGCLVV FPGR P+G S LADP+EVELVSF+T
Sbjct: 481 LSPRFEWPRKRGGAWATGRIWQVLPNGCLVVNFPGRLPIGDECSSFLADPAEVELVSFNT 540
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVG-GRLKKGQGNSKRGGNNC 599
PG+V+KY+H+ED+HW+VRPL IALGLF+AMK G VG+ +G GR K+ +G S N
Sbjct: 541 SPGLVKKYQHLEDFHWAVRPLLIALGLFSAMKFGIFVGKKIGIGRSKEKRGQSTMTQNES 600
Query: 600 Q--DGQAAGGNGAWLRSPVA 617
Q D Q A GN AWL VA
Sbjct: 601 QRLDNQTA-GNAAWLPQTVA 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548886|ref|XP_002515499.1| protein kinase, putative [Ricinus communis] gi|223545443|gb|EEF46948.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/632 (63%), Positives = 493/632 (78%), Gaps = 5/632 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MA ++ +PA SFEYELFEGD D LRTVVA+ Q+ PWIDP +LKL+HRIGRGPFGDVW
Sbjct: 1 MAGKVVPAQPATSFEYELFEGDYDRLRTVVASSNQSTPWIDPENLKLRHRIGRGPFGDVW 60
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHH S +D+DEYHE+A+KML P+KED +V ++KF++LF K + VC + GIS+IN
Sbjct: 61 LATHHHSTEDYDEYHEVALKMLHPVKEDHVRVLLDKFDDLFLKCGGIEGVCLIRGISIIN 120
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GKICI M+FYEGS+GD++A+++GGK+ L D+LRYGI+LA+G+ +LH+ LLVLNLK SN
Sbjct: 121 GKICIIMRFYEGSIGDKMARRKGGKISLADVLRYGIELAQGVLELHAKDLLVLNLKSSNF 180
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL+E+DQ +LGD GIPYLLLG L SDM+ LGTPNYMAPEQW+PEVRGP+S ETD+WG
Sbjct: 181 LLNENDQAILGDVGIPYLLLGIPLRSSDMSYMLGTPNYMAPEQWQPEVRGPLSAETDSWG 240
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
F C ++EMLTGIQPW G+SVEEIY VV K+EKP IP GLPP VENV+ CFEYD RNRP
Sbjct: 241 FACGVVEMLTGIQPWSGRSVEEIYDLVVRKQEKPRIPEGLPPPVENVLHSCFEYDFRNRP 300
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM DIL F+SSQNAVY DG W LGSR + D S GY+ W+ LKDHLQVGDTVRSRKP
Sbjct: 301 LMKDILRIFKSSQNAVYGDGGWRELGSRTILDKSGGTGYSKWFLLKDHLQVGDTVRSRKP 360
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
LN+ K + +DVP VVGL+ D D++ +LV++ G+H+PLRV +LERVTFGLAAGDWV
Sbjct: 361 LNSSKSENMDVPEAIVVGLERDADQDGFLLVRVLGIHDPLRVPILTLERVTFGLAAGDWV 420
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
LK+EN RHS VG+LHS+ RDGSV+VGFIG+ET W+GN SE+QMAK+Y+VGQFVR+ A +
Sbjct: 421 RLKEENKRHSPVGILHSINRDGSVAVGFIGVETFWKGNSSELQMAKSYFVGQFVRLKAKI 480
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
+PRFEWPRKR G WATGKI +LPNGCLVV FPGR G + LADP EVE VSF+T
Sbjct: 481 LSPRFEWPRKRQGAWATGKIRHILPNGCLVVNFPGRLTFGEEHNTFLADPGEVEEVSFNT 540
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVG-GRLKKGQGNSKRGGNNC 599
CPG+V+KY+H+ED HW+VRPL IALGLF AMK+G VG+ +G + +K + N + +
Sbjct: 541 CPGMVKKYQHLEDIHWAVRPLLIALGLFTAMKVGVFVGKKMGRSKGRKLESNVVQNDDQP 600
Query: 600 QDGQAAGGNG-AWLRSPVANIIFREGVPATAA 630
G ++G +G AW VANI+ GV AA
Sbjct: 601 MAGPSSGHSGQAWFPPSVANIL---GVTTAAA 629
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224089274|ref|XP_002308671.1| predicted protein [Populus trichocarpa] gi|222854647|gb|EEE92194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/582 (66%), Positives = 481/582 (82%), Gaps = 1/582 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MA ++ +P FE+EL+E DPDHLRTVVA+ +Q P IDP LKL+HRIGRGPFGDVW
Sbjct: 1 MASKVVPAQPVTPFEFELYE-DPDHLRTVVASSSQPTPRIDPAKLKLRHRIGRGPFGDVW 59
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHHQS +D+DE HE+AVKML P+KE+ +V ++KF+ LF K + ++VC+LHGISVIN
Sbjct: 60 LATHHQSTEDYDECHEVAVKMLHPIKEEHMRVVLDKFDNLFSKCQGIENVCFLHGISVIN 119
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GKICI MKFYEGSVGD++A+ +GGKL LPD+LRYGI LA+GI+ LH+ +LV NLKP +
Sbjct: 120 GKICIVMKFYEGSVGDKMARLKGGKLSLPDVLRYGIVLAQGIAQLHAKEILVFNLKPCSF 179
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL+E+DQ VLGD GIP+LL G L +DM+ RLGTPNYMAPEQW+PE+RGP+SFETD+WG
Sbjct: 180 LLNENDQAVLGDVGIPFLLFGIPLPSADMSRRLGTPNYMAPEQWQPEIRGPVSFETDSWG 239
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCS++EMLTG+QPW GKSVEEIY SVV K+EKP IP GLPP VENV++GCFEYDLR+RP
Sbjct: 240 FGCSVVEMLTGVQPWRGKSVEEIYESVVRKQEKPRIPEGLPPPVENVLLGCFEYDLRSRP 299
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM DI+ F+SSQNAV+ DG WTG GSR + S GYT W+ KDHLQVGD VRSR+P
Sbjct: 300 LMTDIVRVFKSSQNAVFVDGGWTGFGSRTTLEKFSGTGYTEWFLSKDHLQVGDMVRSRRP 359
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
N+ KP+ +DVP GTVVGL+ D DR+ VLV++ G+H+PLR+ S+LERVTFGLAAGDWV
Sbjct: 360 PNSCKPENMDVPEGTVVGLERDPDRDGFVLVRVHGIHDPLRLPVSTLERVTFGLAAGDWV 419
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
LK+E+ RHS VG+LHS++RDGSV+VGFIG+ETLW+GN SE+QMA+ Y+VGQFVR ANV
Sbjct: 420 HLKEEDRRHSPVGILHSIKRDGSVAVGFIGVETLWKGNSSELQMAEPYFVGQFVRPRANV 479
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
+PRFEWPRK GG WATG+I +LPNGCL+V FPGR +G + S LADP+EVE+VSF++
Sbjct: 480 LSPRFEWPRKTGGAWATGRIWWILPNGCLIVKFPGRLTIGQENSSFLADPAEVEVVSFNS 539
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVG 582
CPGVV+KY+H ED+HW+VRPL IALG+F AMK+G+ VG+ +G
Sbjct: 540 CPGVVKKYQHFEDFHWAVRPLVIALGIFTAMKVGFFVGKKIG 581
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141907|ref|XP_002324302.1| predicted protein [Populus trichocarpa] gi|222865736|gb|EEF02867.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2055), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/562 (65%), Positives = 466/562 (82%), Gaps = 1/562 (0%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF 104
LKL+HRIGRGPFGDVWLATHHQS +D+DEYHE+AVKML PLKE+ ++ ++KF+ LF K
Sbjct: 1 LKLRHRIGRGPFGDVWLATHHQSTEDYDEYHEVAVKMLQPLKEEHMRLVLDKFDGLFSKC 60
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
+ ++VC+LHGISV+NGKICI MKFYEGS+GD++A +GGKL LPD+LRYGI+LA+GI++
Sbjct: 61 QGVENVCFLHGISVMNGKICIVMKFYEGSIGDKMALLKGGKLTLPDVLRYGIELAQGIAE 120
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW 224
LH+ +LVLNLKP + LL+E+DQ VLGD GIPYLL G L+ SDM RLGTPNYMAPEQW
Sbjct: 121 LHAKEILVLNLKPCSFLLNENDQAVLGDIGIPYLLFGIPLTSSDMPWRLGTPNYMAPEQW 180
Query: 225 EPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284
+PE+RGPIS ETD+WGFGCSI+EMLTG+ PW GKS+EEIY SVV K+EKP IP GLPP V
Sbjct: 181 QPEIRGPISSETDSWGFGCSIVEMLTGVLPWCGKSIEEIYDSVVRKQEKPHIPEGLPPPV 240
Query: 285 ENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYP 344
EN+++GCFEYDLR+RPLM DIL F+SSQNAV+ DG WTG GSR + + SS GYT W+
Sbjct: 241 ENILLGCFEYDLRSRPLMTDILRVFKSSQNAVFVDGGWTGFGSRTILEKSSGAGYTEWFL 300
Query: 345 LKDHLQVGDTVRSRKPLNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQE 404
KDHLQVGD VRSR+P N+ KP+ +DVP GTVVGL+ + DR+ VLV + G+H+PLR+
Sbjct: 301 SKDHLQVGDMVRSRRPPNSCKPENMDVPEGTVVGLERNPDRDGFVLVSVHGIHDPLRLPV 360
Query: 405 SSLERVTFGLAAGDWVSLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQM 464
S+LE+V+FGLAAGDWV LK+EN++HS VG+LHS+ RDGSV+VGFIG+ETLW+G YSE+QM
Sbjct: 361 STLEKVSFGLAAGDWVHLKEENNKHSPVGILHSINRDGSVAVGFIGVETLWKGKYSELQM 420
Query: 465 AKAYYVGQFVRVGANVFTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSG 524
A++Y+VGQFVR+ NV +PRFEWPRK GG WATGKI +LPNGCL+V FPGRF +G +
Sbjct: 421 AESYFVGQFVRLKTNVLSPRFEWPRKTGGAWATGKIWWILPNGCLIVKFPGRFTIGQENS 480
Query: 525 SSLADPSEVELVSFDTCPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSV-GG 583
S LADP+EVE+VSF+TCPGVV+KY+H+ED+HW+VRPL IALG+F AMK+G+ G+ +
Sbjct: 481 SFLADPAEVEVVSFNTCPGVVKKYQHLEDFHWAVRPLVIALGIFTAMKVGFFTGKKIRRS 540
Query: 584 RLKKGQGNSKRGGNNCQDGQAA 605
R+ + +GN+ + DGQ +
Sbjct: 541 RVNRPRGNAVQSNGQYTDGQTS 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437150|ref|XP_004136355.1| PREDICTED: uncharacterized protein LOC101208616 [Cucumis sativus] gi|449525714|ref|XP_004169861.1| PREDICTED: uncharacterized LOC101208616 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/629 (57%), Positives = 481/629 (76%), Gaps = 4/629 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
M+ Q A +P SFEYEL +GD DH+RTVVA+ + P I+P+ +KL+HRIGRG FGDVW
Sbjct: 1 MSTQEAASQPVPSFEYELLDGDTDHVRTVVASSNYSSPRIEPSKVKLRHRIGRGVFGDVW 60
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHHQS D+DEYHE+AVKML P+KED +V ++K E+ F K + ++ VC L+G+S+I
Sbjct: 61 LATHHQSTKDYDEYHEVAVKMLNPVKEDHMRVVLDKLEDRFYKCQAAKGVCRLYGVSIIG 120
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
GK+CI MKFYEGS+ D++A+ + GKL PD+LRYGI LA+GI +LHS +LVLN+KPSN+
Sbjct: 121 GKLCIIMKFYEGSIADKMARLKDGKLSPPDVLRYGINLAQGIFELHSKEILVLNMKPSNM 180
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL+ DQ +LGD GIP+LL + +SD+ RLGTPNYMAPEQW+PEVRGPIS+ETD+WG
Sbjct: 181 LLTTKDQAILGDIGIPFLLHSVPIPNSDIVQRLGTPNYMAPEQWQPEVRGPISYETDSWG 240
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
F C I+EMLTG+QPW GKSV+EI+HSVV K+EKPCIPSGLPP +ENV++GCFEYDLR+RP
Sbjct: 241 FACCIIEMLTGVQPWRGKSVDEIFHSVVRKQEKPCIPSGLPPLIENVLLGCFEYDLRSRP 300
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM DIL+ F+S Q+ +G+W +GS + + SS G+T W+ KDHLQV D VRSRKP
Sbjct: 301 LMTDILNVFQSFQHV---NGDWQAIGSSKVLNKSSATGHTEWFLSKDHLQVNDLVRSRKP 357
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
LN+ K +++P G +VGL+ +T++++ VLV++ G+H+P+RV S+LERV+FGLAAGDW+
Sbjct: 358 LNSCKSDNMNIPEGKIVGLEGETEKDAFVLVRVRGIHDPVRVYASTLERVSFGLAAGDWI 417
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
LK+ + +HS VG+LHS+ R G+V+V FIG+ETLW+GN S+ QMA+++ VGQFVR+ A++
Sbjct: 418 RLKEADKKHSPVGILHSIDRVGNVAVAFIGVETLWKGNSSQFQMAESFCVGQFVRIKASI 477
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
PRFEW RK+G WATGKI +LPNGCL+V FPG S +ADP+EVE+V+F T
Sbjct: 478 LRPRFEWLRKKGSVWATGKIWWILPNGCLMVKFPGILSFKEECNSYMADPAEVEVVNFST 537
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVGGRLKKGQGNSKRGGNNCQ 600
CPG+V+KY+H+ED+HWSVRP+ IA G+F AMKLG G+ ++KKGQ N +
Sbjct: 538 CPGMVKKYQHLEDFHWSVRPILIAFGMFTAMKLGIAFGKVGRSKVKKGQSNLVYCESQHV 597
Query: 601 DGQAAGGNGAWLRSPVANIIFREGVPATA 629
+GQ N AW+ PV NI+F + V A
Sbjct: 598 EGQNT-NNPAWIPPPVKNILFGDSVNTVA 625
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357123184|ref|XP_003563292.1| PREDICTED: E3 ubiquitin-protein ligase KEG-like isoform 1 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/628 (57%), Positives = 468/628 (74%), Gaps = 6/628 (0%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MA Q +PA FEY L E DPDH RTV + P+Q PWIDP+ L LKHRIGRGPFGDVW
Sbjct: 1 MAGQSSDPQPAELFEYMLLEKDPDHYRTVFSGPSQISPWIDPSVLSLKHRIGRGPFGDVW 60
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
+ATHHQ +D+D YHE+AVKML P+K+D +VF +F+E+F K + SVC+LHGIS N
Sbjct: 61 IATHHQRTEDYDRYHEVAVKMLHPVKDDQLQVFSARFDEIFGKCQGLGSVCFLHGISTQN 120
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180
G+ICIAMKFYEGS+GD++A+ +GG+LPL D+LRYG LA+G+ DLHS G+L+LNLKP N
Sbjct: 121 GRICIAMKFYEGSIGDKMARHKGGRLPLSDVLRYGADLARGVLDLHSRGILILNLKPCNF 180
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
LL +HD VLGDFGIP LL G SL + D+ RLGT NYMAPEQW+P +RGPIS+ETD+WG
Sbjct: 181 LLDDHDHAVLGDFGIPSLLFGLSLPNPDLIQRLGTANYMAPEQWQPGIRGPISYETDSWG 240
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
F CSI+EM +GIQPW GKS +EIY VV+KKEKP P LPP V+NV+ GCFEYD R+RP
Sbjct: 241 FACSILEMFSGIQPWRGKSPDEIYQLVVLKKEKPIFPYNLPPEVKNVLSGCFEYDFRDRP 300
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
LM DILHAFES+++ Y++ W + + + T W KD LQVGD VRSRK
Sbjct: 301 LMTDILHAFESAKDVDYDNAGWNS-SEHLMAERPTQPSCTNWSLFKDKLQVGDKVRSRKL 359
Query: 361 LNARKPQTVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWV 420
N+ P+T+++P GT+VGL+ D + + +LV++ G H+PL+V+ S++ERVT+G AAGDWV
Sbjct: 360 KNSCTPETMEIPDGTIVGLEKDGECDGYILVRVHGRHDPLKVRSSTVERVTYGFAAGDWV 419
Query: 421 SLKDENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGANV 480
L++E+ + S VG+LHS+ R+G+V VG IG++TLW+G Y+++QMA+AY VGQFV + N+
Sbjct: 420 RLREEDKKRSQVGILHSIDRNGTVHVGLIGMDTLWKGEYADLQMAEAYCVGQFVMLRTNI 479
Query: 481 FTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSFDT 540
+PRFEW RKRGG +ATG+I Q+LPNGCLVV FPG+F LG S LADPSEVE VSFD
Sbjct: 480 SSPRFEWQRKRGGGFATGRISQILPNGCLVVKFPGKFNLGEVC-SCLADPSEVEAVSFDK 538
Query: 541 CPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVGG-RLKKGQGNSKRGGNNC 599
C G+V+KY+H+ED+HW+VRPL IA+G F AMKLG VG+ + R +K S + G++
Sbjct: 539 CEGIVKKYEHLEDFHWAVRPLFIAIGFFTAMKLGIFVGKGIARPRSRKVASVSDQSGDHQ 598
Query: 600 QDGQAAGGN---GAWLRSPVANIIFREG 624
+ Q N AWL PVAN++F +G
Sbjct: 599 KFQQQEVQNSASAAWLPPPVANMLFGDG 626
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 632 | ||||||
| TAIR|locus:2116545 | 611 | AT4G32250 [Arabidopsis thalian | 0.954 | 0.986 | 0.573 | 4.9e-188 | |
| TAIR|locus:2185061 | 1625 | KEG "AT5G13530" [Arabidopsis t | 0.150 | 0.058 | 0.349 | 4.9e-29 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.466 | 0.513 | 0.271 | 1.2e-15 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.454 | 0.525 | 0.251 | 1.2e-13 | |
| WB|WBGene00003472 | 1420 | mtk-1 [Caenorhabditis elegans | 0.417 | 0.185 | 0.252 | 2.8e-13 | |
| UNIPROTKB|E1BXA3 | 494 | HCK "Uncharacterized protein" | 0.420 | 0.538 | 0.260 | 5.1e-13 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.287 | 0.465 | 0.269 | 6.6e-13 | |
| RGD|621319 | 517 | Fgr "Gardner-Rasheed feline sa | 0.419 | 0.512 | 0.268 | 9.3e-13 | |
| MGI|MGI:95527 | 517 | Fgr "Gardner-Rasheed feline sa | 0.419 | 0.512 | 0.265 | 2e-12 | |
| UNIPROTKB|A8K4G3 | 506 | HCK "cDNA FLJ78472, highly sim | 0.419 | 0.523 | 0.248 | 2.5e-12 |
| TAIR|locus:2116545 AT4G32250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1823 (646.8 bits), Expect = 4.9e-188, P = 4.9e-188
Identities = 354/617 (57%), Positives = 449/617 (72%)
Query: 1 MAEQIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVW 60
MA +I A KP + EYE+ EG+ + A T PW++ ++LKL+HRIGRGPFGDVW
Sbjct: 1 MASKIIAGKPDDT-EYEIIEGESES-----ALAAGTSPWMNSSTLKLRHRIGRGPFGDVW 54
Query: 61 LATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120
LATHHQS +D+DE+HE+A+KML P+KED +V V+KFE+LF K + ++VC L G+S IN
Sbjct: 55 LATHHQSTEDYDEHHEVAIKMLYPIKEDQRRVVVDKFEDLFSKCQGLENVCLLRGVSSIN 114
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGXXXXXXXXXXX 180
GKIC+ MKFYEGS+GD++A+ +GGKL LPD+LRYG+ LA GI +LHS G
Sbjct: 115 GKICVVMKFYEGSLGDKMARLKGGKLSLPDVLRYGVDLATGILELHSKGFLILNLKPSNF 174
Query: 181 XXXEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240
++D+ +LGD GIPYLLL L SDM RLGTPNYMAPEQW+P+VRGP+SFETD+WG
Sbjct: 175 LLSDNDKAILGDVGIPYLLLSIPLPSSDMTERLGTPNYMAPEQWQPDVRGPMSFETDSWG 234
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
FGCSI+EMLTG+QPW G+S +EIY VV K+EK IPS +PP +EN++ GCF YDLR+RP
Sbjct: 235 FGCSIVEMLTGVQPWSGRSADEIYDLVVRKQEKLSIPSSIPPPLENLLRGCFMYDLRSRP 294
Query: 301 LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKP 360
M DIL +S QN+ G+ SR + +S+ GYT W+ KDHLQV DTVRSRKP
Sbjct: 295 SMTDILLVLKSLQNSEEEQVR-RGIDSREIRKSSATLGYTEWFLSKDHLQVRDTVRSRKP 353
Query: 361 LNARKPQTVDVPAGTVVGLDAD-TDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDW 419
N+ K + +DVP G VVGL+ D TD + VLVK+ G+H+PLRV S LERVT GLA+GDW
Sbjct: 354 ANSCKHENMDVPEGMVVGLERDSTDPDGFVLVKVHGVHDPLRVHVSVLERVTNGLASGDW 413
Query: 420 VSLK-DENSRHSSVGVLHSVQRDGSVSVGFIGLETLWRGNYSEIQMAKAYYVGQFVRVGA 478
V LK ++ RHS VGVLHS+ R+G+V+VGFIGL TLW+G S++QMAK Y VGQFV++ A
Sbjct: 414 VRLKVRKDKRHSPVGVLHSIDREGNVAVGFIGLPTLWKGTSSQLQMAKVYSVGQFVKLKA 473
Query: 479 NVFTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSLADPSEVELVSF 538
NV PRF+W RK G WATG+I QVLPNGCL V FPG P G GS LADP+EVE+V+F
Sbjct: 474 NVVIPRFKWMRKGRGIWATGRISQVLPNGCLEVDFPGMLPFGEEHGSYLADPAEVEIVNF 533
Query: 539 DTCPGVVEKYKHIEDYHWSVRPLAIALGLFAAMKLGWLVGRSVGGRLKKG-QGNSKRGGN 597
+TC G VEKY+H+ED+HW+VRPL IA+GL AMKLG V + +G R K G Q + G
Sbjct: 534 NTCQGAVEKYQHLEDFHWAVRPLLIAMGLLTAMKLGICVRKKIG-RSKDGKQRDGSTGQG 592
Query: 598 NCQ--DGQAAGGNGAWL 612
+C+ DG+ + WL
Sbjct: 593 DCKIPDGKGSD-KSKWL 608
|
|
| TAIR|locus:2185061 KEG "AT5G13530" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 159 (61.0 bits), Expect = 4.9e-29, Sum P(3) = 4.9e-29
Identities = 37/106 (34%), Positives = 55/106 (51%)
Query: 215 TPNYMAPEQWEP------EVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
+P+Y APE W P E +S E+D W FGC+++EM TG PW G S EEI+ +VV
Sbjct: 321 SPHYTAPEAWGPVKKLFWEDASGVSPESDAWSFGCTLVEMCTGSTPWDGLSREEIFQAVV 380
Query: 269 IKKEKP-----CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
++ P + G+P + +I C ++ RP +L F
Sbjct: 381 KARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRPTFNAMLATF 426
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 228 (85.3 bits), Expect = 1.2e-15, P = 1.2e-15
Identities = 88/324 (27%), Positives = 138/324 (42%)
Query: 13 SFEYELFEGDPDHLRTVVATPTQ-TRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADD 70
SF E G RT V P T W I+ LK H+I G +GD++ T+
Sbjct: 257 SFSPEKENGQTG-ARTHVPIPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQ--- 312
Query: 71 FDEYHELAVKMLLP--LKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128
E+A+K+L P L D K F + + K R V ++ G +CI +
Sbjct: 313 -----EVAIKVLKPERLDSDLEKEFAQEVF-IMRKVRHKNVVQFI-GACTKPPHLCIVTE 365
Query: 129 FYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGXXXXXXXXXXXXXXEHDQ 187
F G SV D + +Q+G LP + + I + KG+S LH E++
Sbjct: 366 FMPGGSVYDYLHKQKG-VFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEV 424
Query: 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIME 247
+ + DFG+ + + M GT +MAPE E + P + D + +G + E
Sbjct: 425 VKVADFGVARVKAQTGV----MTAETGTYRWMAPEVIEHK---PYDHKADVFSYGIVLWE 477
Query: 248 MLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+LTG P+ + + VV K +P IP P + ++ +E+D RP ++I+
Sbjct: 478 LLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFSEIIE 537
Query: 308 AFESSQNAVYNDGEW-----TGLG 326
+ V +GE TGLG
Sbjct: 538 QLQEIAKEVGEEGEEKKKSSTGLG 561
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 217 (81.4 bits), Expect = 1.2e-13, Sum P(2) = 1.2e-13
Identities = 79/314 (25%), Positives = 138/314 (43%)
Query: 9 KPAASFEYELFEGDPDHLRTVVATPTQ-TRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQ 66
K + FE++ + + + + PT T W ID T LK++ ++ G +GD+ T+
Sbjct: 250 KSISFFEHD--KSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCS 307
Query: 67 SADDFDEYHELAVKMLLPLKEDCAKVFVNKF-EELF--PKFRESQSVCWLHGISVINGKI 123
E+A+K L P + + + +F +E+F K R V +L G + +
Sbjct: 308 Q--------EVAIKFLKPDRVN--NEMLREFSQEVFIMRKVRHKNVVQFL-GACTRSPTL 356
Query: 124 CIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGXXXXXXXXXXXXX 182
CI +F GS+ D + +Q+ L +L+ + +AKG+S LH
Sbjct: 357 CIVTEFMARGSIYDFLHKQKCA-FKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLM 415
Query: 183 XEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFG 242
EH + + DFG+ + + M GT +MAPE E + P + + D + +
Sbjct: 416 DEHGLVKVADFGVARV----QIESGVMTAETGTYRWMAPEVIEHK---PYNHKADVFSYA 468
Query: 243 CSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM 302
+ E+LTG P+ + + VV K +P IP P V+ ++ C+ D RPL
Sbjct: 469 IVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLF 528
Query: 303 ADILHAFESSQNAV 316
+I+ + V
Sbjct: 529 EEIIEMLQQIMKEV 542
|
|
| WB|WBGene00003472 mtk-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 212 (79.7 bits), Expect = 2.8e-13, P = 2.8e-13
Identities = 73/289 (25%), Positives = 125/289 (43%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF--VNKFEE 99
P L I G FG V H+ A D D + +A K++ +E+ + +N F +
Sbjct: 1122 PFQWALLDHIASGSFGSV-----HR-AMDIDSHRVIAAKVMRIQRENHKAIESEINIFRQ 1175
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
L +++ +G+ V + + I M++ +RI GK+ L + +Y L
Sbjct: 1176 LI-----HENLVKYYGVQVEDSDVIIFMEYCSQGTLERICH---GKMDLKMVRQYTNSLL 1227
Query: 160 KGISDLHSIGXXXXXXXXXXXXXXEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
+ + LHS + L LGDFG L+ S + GTP +M
Sbjct: 1228 RAVQYLHSHKIIHRDIKPANIFLDKCTVLKLGDFGCSSRLVESSTVYGEFQTTAGTPQFM 1287
Query: 220 APEQW----EPEVRGPISF---ETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
APE + + E G S D W G +++ M+TG P+ G++ +I ++ +K+
Sbjct: 1288 APEIYSYGEKDETTGSYSGYGRSVDIWALGATVVNMMTGKVPFEGQTRHQIAFALCFRKQ 1347
Query: 273 KPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319
KP P + P V+ CFE+ +RP A++L ++ N + D
Sbjct: 1348 KPTYPDIADKRPDVKRFFDNCFEFLPNDRPTAAELLQTTFANVNITFQD 1396
|
|
| UNIPROTKB|E1BXA3 HCK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 203 (76.5 bits), Expect = 5.1e-13, P = 5.1e-13
Identities = 79/303 (26%), Positives = 133/303 (43%)
Query: 31 ATPTQTRPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP 84
+ P +PW I SLKL+ ++G G FG+VW+AT ++++ ++AVK + P
Sbjct: 209 SVPRPQKPWEKDAWEIPRASLKLEKKLGAGQFGEVWMAT-------YNKHTKVAVKTMKP 261
Query: 85 LKEDCAKVFVNKF-EEL-FPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQ 141
+ V+ F EE K + + LH + I I +F E GS+ D + +
Sbjct: 262 -----GSMSVSAFLEEANLMKSLQHDKLVRLHAVVTREEPIYIITEFMEKGSLLDFLKSE 316
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGXXXXXXXXXXXXXXEHDQLVLGDFGIPYLLLG 201
G K PLP ++ + Q+A+G++ + + DFG L
Sbjct: 317 EGNKQPLPKLIDFSAQIAEGMAYIEKRNYIHRDLRAANILVSAMLVCKIADFG-----LA 371
Query: 202 RSLSDSDMALRLGT--P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFG 257
R + D++ R G P + APE G + ++D W FG + E++T G P+ G
Sbjct: 372 RIIEDNEYVAREGAKFPIKWTAPEAIN---YGSFTIKSDVWSFGILLTEIVTYGRIPYPG 428
Query: 258 KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQN 314
S E+ ++ P S P + +V+I C++ +RP M IL F ++
Sbjct: 429 MSSAEVIRALEHGYRMPRTES-CPEELYDVMIRCWKTKPEDRPTFEYMQSILEDFFTATE 487
Query: 315 AVY 317
Y
Sbjct: 488 GQY 490
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 196 (74.1 bits), Expect = 6.6e-13, Sum P(2) = 6.6e-13
Identities = 51/189 (26%), Positives = 91/189 (48%)
Query: 124 CIAMKFYEGSVGDR-IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGXXXXXXXXXXXXX 182
C+ +++ G + + ++ KLP+ D+++ + LA+G+S LHS
Sbjct: 182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241
Query: 183 XEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFG 242
+ L + DFG+ + + + DM GT YMAPE E + P + + D + FG
Sbjct: 242 QPNKTLKIADFGVARV---EAQNPQDMTGETGTLGYMAPEVLEGK---PYNRKCDVYSFG 295
Query: 243 CSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM 302
+ E+ P+ S EI H+VV + +P IP P AV N++ C++ + RP M
Sbjct: 296 VCLWEIYCCDMPYADCSFAEISHAVVHRNLRPEIPKCCPHAVANIMKRCWDPNPDRRPEM 355
Query: 303 ADILHAFES 311
+++ E+
Sbjct: 356 EEVVKLLEA 364
|
|
| RGD|621319 Fgr "Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 201 (75.8 bits), Expect = 9.3e-13, P = 9.3e-13
Identities = 79/294 (26%), Positives = 128/294 (43%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W ID S+ L R+G G FGDVWL T + S ++AVK L P K F+ +
Sbjct: 244 WEIDRNSIALDRRLGTGCFGDVWLGTWNCST-------KVAVKTLKPGTMS-PKAFLEEA 295
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGI 156
+ + K + L+ + V I I +F GS+ D + ++G L LP+++
Sbjct: 296 QIM--KLLRHDKLVQLYAV-VSEEPIYIVTEFMCYGSLLDFLKDRKGHNLMLPNLVDMAA 352
Query: 157 QLAKGISDLHSIGXXXXXXXXXXXXXXEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT- 215
Q+A+G++ + + EH + DFG L R + D + + GT
Sbjct: 353 QVAEGMAYMERMNYIHRDLRAANILVGEHLICKIADFG-----LARLIVDDEYNPQQGTK 407
Query: 216 -P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P + APE + G + ++D W FG + E++T G P+ G + E+ V
Sbjct: 408 FPIKWTAPEA---ALFGRFTVKSDVWSFGILLTELITKGRVPYPGMNNREVLEQVEHGYH 464
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQNAVYNDGEWT 323
PC P G P ++ V+ + D RP + L + +S Y G+ T
Sbjct: 465 MPC-PPGCPVSLYEVMEQTWRLDPEERPTFEYLQSFLEDYFTSTEPQYQPGDQT 517
|
|
| MGI|MGI:95527 Fgr "Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homolog" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 198 (74.8 bits), Expect = 2.0e-12, P = 2.0e-12
Identities = 78/294 (26%), Positives = 128/294 (43%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W ID S+ L+ R+G G FGDVWL T + S ++AVK L P K F+ +
Sbjct: 244 WEIDRNSIALERRLGTGCFGDVWLGTWNCST-------KVAVKTLKPGTMS-PKAFLEEA 295
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGI 156
+ + K + L+ + V I I +F GS+ D + + G L LP ++
Sbjct: 296 QIM--KLLRHDKLVQLYAV-VSEEPIYIVTEFMCYGSLLDFLKDREGQNLMLPHLVDMAA 352
Query: 157 QLAKGISDLHSIGXXXXXXXXXXXXXXEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT- 215
Q+A+G++ + + E+ + DFG L R + D++ + GT
Sbjct: 353 QVAEGMAYMERMNYIHRDLRAANILVGEYLICKIADFG-----LARLIEDNEYNPQQGTK 407
Query: 216 -P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P + APE + G + ++D W FG + E++T G P+ G + E+ V
Sbjct: 408 FPIKWTAPEA---ALFGRFTVKSDVWSFGILLTELITKGRVPYPGMNNREVLEQVEHGYH 464
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQNAVYNDGEWT 323
PC P G P ++ V+ + D RP + L + +S Y G+ T
Sbjct: 465 MPC-PPGCPASLYEVMEQAWRLDPEERPTFEYLQSFLEDYFTSTEPQYQPGDQT 517
|
|
| UNIPROTKB|A8K4G3 HCK "cDNA FLJ78472, highly similar to Human hemopoietic cell protein-tyrosine kinase (HCK) gene" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 197 (74.4 bits), Expect = 2.5e-12, P = 2.5e-12
Identities = 73/294 (24%), Positives = 131/294 (44%)
Query: 33 PTQTRPWIDPT-SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
P + W P SLKL+ ++G G FG+VW+AT ++++ ++AVK + P +
Sbjct: 229 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-------YNKHTKVAVKTMKPGSMS-VE 280
Query: 92 VFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPD 150
F+ + + K + + LH + V I I +F +GS+ D + G K PLP
Sbjct: 281 AFLAEANVM--KTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 337
Query: 151 ILRYGIQLAKGISDLHSIGXXXXXXXXXXXXXXEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
++ + Q+A+G++ + + DFG L R + D++
Sbjct: 338 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-----LARVIEDNEYT 392
Query: 211 LRLGT--P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266
R G P + APE G + ++D W FG +ME++T G P+ G S E+ +
Sbjct: 393 AREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 449
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQNAVY 317
+ P P P + N+++ C++ RP + +L F ++ + Y
Sbjct: 450 LERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY 502
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 632 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.002 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.003 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.003 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 9e-36
Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 42/279 (15%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
++ ++G G FG V+LA ++ +A+K++ K + K E R
Sbjct: 2 EILEKLGEGSFGKVYLARDKKT------GKLVAIKVIK-------KKKIKKDRERI--LR 46
Query: 106 E--------SQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
E ++ L+ + K+ + M++ E G + D + ++ G+L + Y
Sbjct: 47 EIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLR 104
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL-RLGT 215
Q+ + LHS G++ +LKP N+LL E + L DFG L R L + +GT
Sbjct: 105 QILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG-----LARQLDPGEKLTTFVGT 159
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKP 274
P YMAPE D W G + E+LTG P+ G + E++ I K KP
Sbjct: 160 PEYMAPEVLL---GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK--KIGKPKP 214
Query: 275 CIPS---GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P + P +++I D R + L H F
Sbjct: 215 PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 64/258 (24%), Positives = 115/258 (44%), Gaps = 48/258 (18%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+G G FG V+LA ++ ++A+K++ + + E+ K ++
Sbjct: 1 LGEGGFGTVYLARDKKTG------KKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNI 53
Query: 111 CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG 169
L+G+ + + M++ E GS+ D + ++ GKL +ILR +Q+ +G+ LHS G
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 170 LLVLNLKPSNLLLSE-HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV 228
++ +LKP N+LL + ++ L DFG+ LL + S + +GTP YMAPE +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLL---TSDKSLLKTIVGTPAYMAPEVLLGK- 168
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVI 288
G S ++D W G + E+ P ++++I
Sbjct: 169 -GYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 289 IGCFEYDLRNRPLMADIL 306
+ D RP +IL
Sbjct: 195 RKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-33
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 31/297 (10%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---EL 100
S ++ ++G G FG+V+LA + +A+K+L E +K V +F ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---------LVALKVLAKKLESKSK-EVERFLREIQI 50
Query: 101 FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRG--GKLPLPDILRYGIQL 158
++ L+ G + + M++ +G + + ++ G G L + L Q+
Sbjct: 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYLL---LGRSLSDSDMALRLG 214
+ LHS G++ ++KP N+LL + L DFG+ LL S + + +G
Sbjct: 111 LSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW-----------FGKSVEEI 263
TP YMAPE S +D W G ++ E+LTG+ P+ K + E+
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230
Query: 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMA-DILHAFESSQNAVYND 319
+ P P + A +++ D +NR + D+ H + +D
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
|
Length = 384 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 43/281 (15%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF 104
+L ++G G FG V+ A H +AVK+L E ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHK------GTGKIVAVKILKKRSEKS--------KKDQTAR 46
Query: 105 RESQS--------VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
RE + + L + + M++ E G + D ++ RGG L + +
Sbjct: 47 REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIA 104
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+Q+ +G+ LHS G++ +LKP N+LL E+ + + DFG L S S + +GT
Sbjct: 105 LQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFG---LAKKLLKSSSSLTTFVGT 161
Query: 216 PNYMAPEQWEPEVRG--PISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
P YMAPE + G + D W G + E+LTG P+ G+++ + +I++
Sbjct: 162 PWYMAPEV----LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ--LIRRIL 215
Query: 274 PCIPSG-------LPPAVENVIIGCFEYDLRNRPLMADILH 307
+++I C D RP +IL
Sbjct: 216 GPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 1e-31
Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 40/271 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL-------FP- 102
IG+G FG V+L +L V + L K + E+ P
Sbjct: 8 IGKGSFGKVYLVRRKSDG-------KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 103 --KFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD--ILRYGIQ 157
K+ ES + GK+CI M++ + G + +I +Q+ P P+ IL + +Q
Sbjct: 61 IIKYYES----FEE-----KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL-SDSDMAL-RLGT 215
L + LHS +L ++KP N+ L+ + + LGDFGI + L S D+A +GT
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI-----SKVLSSTVDLAKTVVGT 166
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275
P Y++PE + P ++++D W GC + E+ T P+ G+++ E+ ++K + P
Sbjct: 167 PYYLSPELCQ---NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK-ILKGQYPP 222
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
IPS + N++ + D RP +A IL
Sbjct: 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 41/278 (14%)
Query: 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVK--MLLPLKEDCAKVFVNKFEELFPKFRE 106
+GRG FG V+LA + + +AVK L E+ + + L
Sbjct: 6 ELLGRGSFGSVYLALDKDTGE------LMAVKSVELSGDSEEELEALEREIRIL----SS 55
Query: 107 SQSV----CWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
Q + + I +++ GS+ + ++ GKLP P I +Y Q+ +G
Sbjct: 56 LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEG 113
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPN 217
++ LHS G++ ++K +N+L+ + L DFG + L D + GTP
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDGVVKLADFG-----CAKRLGDIETGEGTGSVRGTPY 168
Query: 218 YMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPW--FGKSVEEIYHSVVIKKEK 273
+MA PEV D W GC+++EM TG PW G + +Y + E
Sbjct: 169 WMA-----PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-IGSSGEP 222
Query: 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL--HAF 309
P IP L ++ + C D + RP AD L H F
Sbjct: 223 PEIPEHLSEEAKDFLRKCLRRDPKKRP-TADELLQHPF 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 24/273 (8%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELF 101
L L ++G G FG+V+ E+AVK L KED ++ + +F +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKV--EVAVKTL---KEDASEQQIEEFLREARIM 55
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
K +V L G+ + I M++ E G + + ++ KL L D+L + +Q+A+
Sbjct: 56 RKLDH-PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIAR 113
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP---N 217
G+ L S + +L N L+ E+ + + DFG L R L D D + G
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFG-----LSRDLYDDDYYRKRGGKLPIR 168
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276
+MAPE + G + ++D W FG + E+ T G QP+ G S EE+ + +
Sbjct: 169 WMAPESLK---EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE-YLKNGYRLPQ 224
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
P PP + ++++ C+ D +RP ++++
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 23/273 (8%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELF 101
L L ++G G FG+V+ T D + E+AVK L KED ++ + +F +
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEV--EVAVKTL---KEDASEQQIEEFLREARIM 55
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
K ++ L G+ + I M++ G + D + + R +L L D+L + +Q+A+
Sbjct: 56 RKLDH-PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP---N 217
G+ L S + +L N L+ E+ + + DFG L R L D D G
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFG-----LSRDLYDDDYYKVKGGKLPIR 169
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276
+MAPE + G + ++D W FG + E+ T G +P+ G S E+ + K +
Sbjct: 170 WMAPESLK---EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE-YLKKGYRLPK 225
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
P PP + +++ C+ D +RP ++++
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 107 SQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD--ILRYGIQLAKGIS 163
++ + K+CI M++ G + I++++ + +P+ I R IQL +G+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA-LRLGTPNYMAPE 222
LH +L +LK +N+LL +D + +GD GI +L MA ++GTP+YMAPE
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN------MAKTQIGTPHYMAPE 171
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
W+ P S+++D W GC + EM T P+ +S++++ + V + + P IP
Sbjct: 172 VWK---GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-VQRGKYPPIPPIYSQ 227
Query: 283 AVENVIIGCFEYDLRNRPLMADIL 306
++N I + + RP IL
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 25/274 (9%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE---LF 101
L+L ++G G FG+V+ T + + ++AVK L KE ++ +F E +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTET--KVAVKTL---KEGASEEEREEFLEEASIM 55
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
K V L G+ + I ++ G + D + ++ G KL L D+L+ +Q+AK
Sbjct: 56 KKLSHPNIVR-LLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAK 113
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT----P 216
G+ L S + +L N L++E+ + + DFG L R + + D + G
Sbjct: 114 GMEYLESKNFVHRDLAARNCLVTENLVVKISDFG-----LSRDIYEDDYYRKRGGGKLPI 168
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275
+MAPE + G + ++D W FG + E+ T G QP+ G S EE+ + +
Sbjct: 169 KWMAPESLK---DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-LEDGYRLP 224
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
P P + +++ C+ YD +RP ++++
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 18/274 (6%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFE-- 98
PT+ + +G+G FG V+L D D ELAVK + + K VN E
Sbjct: 1 PTNWRRGKLLGQGAFGRVYLCY------DVDTGRELAVKQVPFDPDSPETKKEVNALECE 54
Query: 99 -ELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGI 156
+L + + V + G + + I M++ G SV D++ G L +Y
Sbjct: 55 IQLLKNLQHERIVQYY-GCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTR 111
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ LHS ++ ++K +N+L + LGDFG L S + M GTP
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276
+M+PE E G + D W GC+++EMLT PW + + P +
Sbjct: 172 YWMSPEVISGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL 228
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
PS + P N + F + + RP ++L H F
Sbjct: 229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 120 NGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178
K+ + +++ G G+ + + G+ Y ++ + LHS+G++ +LKP
Sbjct: 65 EEKLYLVLEYAPG--GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPE 122
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDT 238
N+LL + L DFG+ L + GTP Y+APE D
Sbjct: 123 NILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLL---GKGYGKAVDW 176
Query: 239 WGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRN 298
W G + EMLTG P++ + +EIY I K+ P L P ++I G + D
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEK--ILKDPLRFPEFLSPEARDLISGLLQKDPTK 234
Query: 299 R 299
R
Sbjct: 235 R 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179
GK+ I M++ E G + + QRG LP + R+ IQ+ G++ LHS +L ++K N
Sbjct: 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLN 131
Query: 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR--LGTPNYMAPEQWEPEVRGPISFETD 237
L L +D + +GD G+ + LSD+ +GTP Y++PE E + P + ++D
Sbjct: 132 LFLDAYDNVKIGDLGV-----AKLLSDNTNFANTIVGTPYYLSPELCEDK---PYNEKSD 183
Query: 238 TWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLR 297
W G + E TG P+ + + ++ P + + +I C D R
Sbjct: 184 VWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYR 242
Query: 298 NRPLMADIL 306
RP +L
Sbjct: 243 QRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 63/275 (22%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
++ +IG+G FG+V+ A H ++ E+A+K++ L+ K + ++ K +
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGK------EVAIKVI-KLESKEKKEKIINEIQILKKCK 55
Query: 106 ESQSV----CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
V +L ++ I M+F GS+ D + + L I +L K
Sbjct: 56 HPNIVKYYGSYLK-----KDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLK 109
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
G+ LHS G++ ++K +N+LL+ ++ L DFG+ L ++ +GTP +MA
Sbjct: 110 GLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWMA 165
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--VEEIYHSVVIKKEKPC--- 275
PE P ++ D W G + +E+ G +P + + ++ ++ I P
Sbjct: 166 PEVIN---GKPYDYKADIWSLGITAIELAEG-KPPYSELPPMKALFK---IATNGPPGLR 218
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P ++ + C + + RP +L H F
Sbjct: 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 78/277 (28%), Positives = 128/277 (46%), Gaps = 35/277 (12%)
Query: 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL--FPKFRE 106
++IG G FG V+ A + D +AVK + ++++ K +E+ +
Sbjct: 6 NKIGGGTFGKVYTAV------NLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKH 58
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH 166
V + +G+ V K+ I M++ G + + + G L I Y +QL +G++ LH
Sbjct: 59 PNLVKY-YGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLH 116
Query: 167 SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWE 225
S G++ ++KP+N+ L + + LGDFG L + + + L GTP YMAPE
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV-- 174
Query: 226 PEVRGPISFET--------DTWGFGCSIMEMLTGIQPWFGKSVEE--IYHSVVIKKEKPC 275
I+ D W GC ++EM TG +PW E ++H V KP
Sbjct: 175 ------ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPP 226
Query: 276 IPS--GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
IP L P ++ + C E D + RP +++L H F
Sbjct: 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 28/267 (10%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVF---VNKFEELFPKFR 105
++G G FG V S +AVK L K D F L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV---IPVAVKCLKSDKLSDIMDDFLKEAAIMHSL----- 53
Query: 106 ESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
+ +++ L+G+ V+ + + + GS+ DR+ + G + + Y +Q+A G+
Sbjct: 54 DHENLIRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD----MALRLGTP-NYM 219
L S + +L N+LL+ D++ +GDFG L R+L ++ M L P +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFG-----LMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
APE S +D W FG ++ EM T G +PW G S +I + + E+ P
Sbjct: 168 APESLR---TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADI 305
P + NV++ C+ ++ +RP A +
Sbjct: 225 ACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 46/283 (16%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEY-HELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
+G G FG+V+ D E+AVK L KED ++ F +E++
Sbjct: 3 LGEGAFGEVYKGK----LKGKDGKTTEVAVKTL---KEDASEEERKDF------LKEARV 49
Query: 110 VCWLH--------GISVINGKICIAMKFYEG--------SVGDRIAQQRGGKLPLPDILR 153
+ L G+ + + +++ EG L L D+L
Sbjct: 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ IQ+AKG+ L S + +L N L+ E + + DFG L R + D D +
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFG-----LSRDVYDDDYYRKK 164
Query: 214 GT---PN-YMAPEQWEPEVRGPI-SFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSV 267
P +MAPE ++ I + ++D W FG + E+ T G P+ G S EE+ +
Sbjct: 165 TGGKLPIRWMAPES----LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220
Query: 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
K + P P + +++ C++ D +RP ++++ E
Sbjct: 221 -RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 25/267 (9%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEE---LFPKFRE 106
+G G FG V+ + D F AVK + + + V + E+ L K +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFF------AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 107 SQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
V +L G + I ++ GS+ + ++ G P P I Y Q+ G+ L
Sbjct: 62 PNIVQYL-GTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYL 118
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQW 224
H + ++K +N+L+ + + L DFG + + + + A G+P +MAPE
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFG-----MAKQVVEFSFAKSFKGSPYWMAPEVI 173
Query: 225 EPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCIPSGLPPA 283
+ G D W GC+++EM TG PW + V ++ + KE P IP L
Sbjct: 174 AQQ--GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDE 230
Query: 284 VENVIIGCFEYDLRNRPLMADIL-HAF 309
++ I+ C + D RP A++L H F
Sbjct: 231 AKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 70/258 (27%), Positives = 126/258 (48%), Gaps = 20/258 (7%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM--LLPLKEDCAKVFVNKFEELFPK 103
+L IGRG FG V+ + DF +A+K L +KE+ K + + + L K
Sbjct: 3 QLGDLIGRGAFGVVYKGLN-LETGDF-----VAIKQISLEKIKEEALKSIMQEIDLL--K 54
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
+ ++ G + + I +++ E GS+ I ++ G P + Y Q+ +G+
Sbjct: 55 NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGL 112
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+ LH G++ ++K +N+L ++ + L DFG+ L S D+ + GTP +MAPE
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV---GTPYWMAPE 169
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
E S +D W GC+++E+LTG P++ + +V P +P G+ P
Sbjct: 170 VIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP-LPEGISP 225
Query: 283 AVENVIIGCFEYDLRNRP 300
+++ ++ CF+ D RP
Sbjct: 226 ELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 65/261 (24%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+G+G +G+V L H + + K+ L + + +L + + V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQY-----VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 111 CWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGISDLHS 167
+ +G + I M F EG GD ++ +Q+G LP ++ + +Q+A + LH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEG--GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEP 226
+L +LK N+ L+ + + +GD GI +L + DMA L GTP YM+PE +
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL----ENQCDMASTLIGTPYYMSPELFSN 176
Query: 227 EVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286
+ P ++++D W GC + EM T + K + + + +I+ + P +P P +
Sbjct: 177 K---PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-IIEGKLPPMPKDYSPELGE 232
Query: 287 VIIGCFEYDLRNRPLMADILH 307
+I RP + IL
Sbjct: 233 LIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF-- 97
I SLKL+ ++G G FG+VW+AT ++++ ++AVK + P + V F
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMAT-------YNKHTKVAVKTMKP-----GSMSVEAFLA 50
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
E K + + LH + V I I +F GS+ D + G K PLP ++ +
Sbjct: 51 EANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+A+G++ + + +L+ +N+L+S + DFG L R + D++ R G
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-----LARVIEDNEYTAREGAK 164
Query: 217 NYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P +W PE G + ++D W FG +ME++T G P+ G S E+ ++
Sbjct: 165 ---FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 221
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHAF 309
P + P + N+++ C++ RP + +L F
Sbjct: 222 MPRPEN-CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 38/231 (16%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
I +G +G V+LA + D + A+K++ + + N+ +++ E +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIY------AIKVI----KKADMIRKNQVDQVL---TERDIL 47
Query: 111 CWLHGISVIN--------GKICIAMKFYEGSVGD--RIAQQRGGKLPLP-DILR-YGIQL 158
V+ + + M++ G GD + + G L D+ R Y ++
Sbjct: 48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPG--GDLASLLENVGS---LDEDVARIYIAEI 102
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL-LLGRSLSDSDMALR----L 213
+ LHS G++ +LKP N+L+ + L L DFG+ + L+ R ++ +D +
Sbjct: 103 VLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
GTP+Y+APE + S D W GC + E L GI P+ G++ EEI+
Sbjct: 163 GTPDYIAPEVI---LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 36/279 (12%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
I + L IG G FGDV+ + +E +AVK K + KF +
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYM---SPENEKIAVAVKTC---KNCTSPSVREKFLQ 56
Query: 100 ---LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
+ +F V L G+ N + I M+ G + + Q L L ++ Y
Sbjct: 57 EAYIMRQFDHPHIV-KLIGVITEN-PVWIVMELAPLGELRSYL-QVNKYSLDLASLILYS 113
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM--ALRL 213
QL+ ++ L S + ++ N+L+S D + LGDFG L R L D A +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG-----LSRYLEDESYYKASKG 168
Query: 214 GTP-NYMAPEQWEPEVRGPISFE-----TDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266
P +MAPE I+F +D W FG + E+L G++P+ G ++
Sbjct: 169 KLPIKWMAPES--------INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-G 219
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
+ E+ +P PP + +++ C+ YD RP ++
Sbjct: 220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYH----ELAV-KMLLPLKEDCAKVFVNKFEELFPKFR 105
IG G FG ++LA D H E+ + KM + KE K + L K +
Sbjct: 8 IGEGSFGKIYLAK-----AKSDSEHCVIKEIDLTKMPVKEKEASKKEVI-----LLAKMK 57
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGI 162
V + NG++ I M++ +G GD RI +QRG IL + +Q++ G+
Sbjct: 58 HPNIVTFFASFQE-NGRLFIVMEYCDG--GDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALR--LGTPNYM 219
+H +L ++K N+ LS++ + LGDFGI R L+DS +GTP Y+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGI-----ARQLNDSMELAYTCVGTPYYL 169
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279
+PE + P + +TD W GC + E+ T P+ G ++ ++ + P P
Sbjct: 170 SPEICQNR---PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-N 225
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADIL 306
+ ++I F+ R+RP + IL
Sbjct: 226 FSRDLRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 20/266 (7%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKF 104
L+ R+G+G FG V+L ++ L V +P+ E V N+ +L K
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKA----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKG 161
+ ++ H + CI ++ EG D + G L + + IQL G
Sbjct: 60 -DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMA 220
+ +H +L +LK N+ L +++ L +GDFG+ LL+G D+A GTP YM+
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMG----SCDLATTFTGTPYYMS 173
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280
PE + + G S ++D W GC + EM + G++ + +V + P +P
Sbjct: 174 PEALKHQ--GYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETY 229
Query: 281 PPAVENVIIGCFEYDLRNRPLMADIL 306
+ +++ D RP A+IL
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF--VNKFE- 98
P + +L +GRG FG+V+L D D ELAVK + P D + VN E
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCY------DADTGRELAVKQV-PFDPDSQETSKEVNALEC 53
Query: 99 --ELFPKFRESQSVCWLHGI-SVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRY 154
+L R + V + + K+ I +++ G S+ D++ G L RY
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRY 111
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
Q+ +G+S LHS ++ ++K +N+L + LGDFG + +S + + G
Sbjct: 112 TRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
TP +M+PE E G + D W C+++EMLT PW + + KP
Sbjct: 172 TPYWMSPEVISGEGYGR---KADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+P G+ A + + F + + RP +L H F
Sbjct: 229 MLPDGVSDACRDFLKQIF-VEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 10/189 (5%)
Query: 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178
+ + I M++ G ++ D+I +Q+G +L Y Q+ +S +H G+L ++K
Sbjct: 71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTL 130
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR-LGTPNYMAPEQWEPEVRGPISFETD 237
N+ L++ + LGDFGI +L S+ MA +GTP YM+PE + +F++D
Sbjct: 131 NIFLTKAGLIKLGDFGISKIL----GSEYSMAETVVGTPYYMSPELCQGV---KYNFKSD 183
Query: 238 TWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLR 297
W GC + E+LT + + + + +V P + S + +++ + D
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPE 242
Query: 298 NRPLMADIL 306
RP ++L
Sbjct: 243 KRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 59/266 (22%), Positives = 101/266 (37%), Gaps = 49/266 (18%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IG G F V LA + + E A+K+ K + K +++ E + +
Sbjct: 9 IGEGSFSTVVLAK------EKETNKEYAIKI-------LDKRQLIKEKKVKYVKIEKEVL 55
Query: 111 CWLHGISVI---------NGKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLA 159
L+G I + +++ G+ + Q + G L Y ++
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPN--GE-LLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG---------IPYLLLGRSLSDSDMA 210
+ LHS G++ +LKP N+LL + + + DFG P G + +
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 211 LRL--------GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262
+ GT Y++PE P +D W GC I +MLTG P+ G +
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLN---EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 263 IYHSVVIKKEKPCIPSGLPPAVENVI 288
+ I K + P PP +++I
Sbjct: 230 TFQK--ILKLEYSFPPNFPPDAKDLI 253
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFEELFPKFRESQ 108
RIG G G V+ A ++ + +A+K + L E + E + +
Sbjct: 7 RIGEGAHGIVFKAKDRETGE------TVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59
Query: 109 SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI 168
V L + + M++ + + + + LP + Y L KG++ +H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL---RLGTPNYMAPE--- 222
G++ +LKP+NLL+S L + DFG L R S+ + L ++ T Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFG-----LARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 223 ---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256
+++P V D W GC E+L G P F
Sbjct: 174 GARKYDPGV--------DLWAVGCIFAELLNG-SPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 132 GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191
GS+G + + G+ + + Q+ +G++ LHS G+L +LK NLL+ +
Sbjct: 93 GSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKIS 150
Query: 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG 251
DFGI +D +M+++ G+ +MAPE +G S + D W GC ++EM G
Sbjct: 151 DFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIHSYSQG-YSAKVDIWSLGCVVLEMFAG 208
Query: 252 IQPWFGKSVEEIYHSVV---IKKEKPCIPSGLPPAVENVII----GCFEYDLRNRPLMAD 304
+PW S EE ++ K+ P IP + + V + CF + NRP +
Sbjct: 209 RRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265
Query: 305 IL-HAF 309
+L H F
Sbjct: 266 LLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE--LFPKFRESQ 108
I +G FG V+LA + D F A+K+L N E + ES
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYF------AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 109 SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI 168
V L+ + + M++ G + + GG LP +Y ++ G+ DLH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQR 116
Query: 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL-LLGRSLSDSDMALRLGTPNYMAPEQWEPE 227
G++ ++KP NLL+ + L L DFG+ L + GTP+Y+APE
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV--------GTPDYLAPETILGV 168
Query: 228 VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
+D W GC I E L G P+ ++ + ++ +++
Sbjct: 169 ---GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 25/267 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
K+K +IG G FG L + + E+ + + P + + ++ V + +
Sbjct: 4 KVK-KIGEGSFGKAILVKSKEDGKQY-VIKEINISKMSPKEREESRKEV----AVLSNMK 57
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGI 162
V + NG + I M + EG GD +I QRG P IL + +Q+ +
Sbjct: 58 HPNIVQYQESFEE-NGNLYIVMDYCEG--GDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTPNYM 219
+H +L ++K N+ L++ + LGDFGI +L +S + L +GTP Y+
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIGTPYYL 168
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279
+PE E P + ++D W GC + EM T + +++ + +I+ P + S
Sbjct: 169 SPEICENR---PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK-IIRGSYPPVSSH 224
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADIL 306
+ N++ F+ + R+RP + IL
Sbjct: 225 YSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHEL-AVKML-LPLKEDCAKVFVNKFEELF 101
L+ +G+G G V+ H ++ A+K + + E+ K + + + L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRH-------KPTGKIYALKKIHVDGDEEFRKQLLRELKTLR 54
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
ES V +G G+I I +++ + GS+ D + + GK+P P + Q+ K
Sbjct: 55 SC--ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILK 110
Query: 161 GISDLHSIGLLV-LNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTP 216
G+ LH+ ++ ++KPSNLL++ ++ + DFGI + L ++ + +GT
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI-----SKVLENT-LDQCNTFVGTV 164
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF----GKSVEEIYHSVVIKKE 272
YM+PE+ + E S+ D W G +++E G P+ E + +
Sbjct: 165 TYMSPERIQGE---SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--ICDGP 219
Query: 273 KPCIPSGL-PPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P +P+ P + I C + D + RP A++L H F
Sbjct: 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 67/262 (25%), Positives = 126/262 (48%), Gaps = 25/262 (9%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK 103
SL+L ++G G FG+VW+ T + + ++AVK L P + F+ + ++ K
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNGNT-------KVAVKTLKP-GTMSPESFLEE-AQIMKK 57
Query: 104 FRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
R + V L+ + V I I ++ +GS+ D + G L LP+++ Q+A G+
Sbjct: 58 LRHDKLV-QLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+ + + + +L+ +N+L+ + + DFG L R + D++ R G P
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFG-----LARLIEDNEYTARQGAK---FPI 167
Query: 223 QW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+W E + G + ++D W FG + E++T G P+ G + E+ V PC P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-PQ 226
Query: 279 GLPPAVENVIIGCFEYDLRNRP 300
P ++ +++ C++ D RP
Sbjct: 227 DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 32/266 (12%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+GRG FG V L +L + +P+++ + K E L + E Q +
Sbjct: 8 VGRGAFGIVHLCRRKAD-------QKLVIIKQIPVEQ------MTKDERLAAQ-NECQVL 53
Query: 111 CWLHGISVI--------NGKICIAMKFYEGSVGDRIAQQRGGK-LPLPDILRYGIQLAKG 161
L ++I + + I M++ G Q+R L IL + +Q+
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
+ +H+ +L +LK N+LL +H +V +GDFGI +L S S +GTP Y++
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCYIS 169
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280
PE E + P + ++D W GC + E+ + + + ++ + ++ P I
Sbjct: 170 PELCEGK---PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRY 225
Query: 281 PPAVENVIIGCFEYDLRNRPLMADIL 306
P + +I+ D RP ++ I+
Sbjct: 226 SPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 68/262 (25%), Positives = 127/262 (48%), Gaps = 25/262 (9%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK 103
SL+L ++G+G FG+VW+ T + + ++A+K L P + F+ + ++ K
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTT-------KVAIKTLKP-GTMMPEAFLQE-AQIMKK 57
Query: 104 FRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
R + V L+ + V I I +F +GS+ D + + G L LP ++ Q+A G+
Sbjct: 58 LRHDKLVP-LYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM 115
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+ + + + +L+ +N+L+ ++ + DFG L R + D++ R G P
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFG-----LARLIEDNEYTARQGAK---FPI 167
Query: 223 QW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+W E + G + ++D W FG + E++T G P+ G E+ V PC P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-PQ 226
Query: 279 GLPPAVENVIIGCFEYDLRNRP 300
G P ++ ++ C++ D RP
Sbjct: 227 GCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 28/268 (10%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF-- 97
I S+KL ++G G FG+VW+ ++ S ++AVK L P + V F
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNST-------KVAVKTLKP-----GTMSVQAFLE 50
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGI 156
E K + + L+ + I I ++ +GS+ D + GGK+ LP ++ +
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+A+G++ + + +L+ +N+L+SE + DFG L R + D++ R G
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG-----LARVIEDNEYTAREGAK 165
Query: 217 NYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P +W PE G + ++D W FG + E++T G P+ G S ++ ++
Sbjct: 166 ---FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR 222
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP 300
P P + +++ C++ RP
Sbjct: 223 MP-RMENCPDELYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 19/259 (7%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+G G FG L H S + A+K + K A K L K + V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKY------AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 111 CWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGISDLHS 167
+ +G + I M++ +G GD +I QRG P IL++ +Q+ G+ +H
Sbjct: 62 AFKESFEA-DGHLYIVMEYCDG--GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE 227
+L ++K N+ L+++ ++ LGDFG LL + + +GTP Y+ PE WE
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL---TSPGAYACTYVGTPYYVPPEIWE-- 173
Query: 228 VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENV 287
P + ++D W GC + E+ T P+ S + + V KP +PS + ++
Sbjct: 174 -NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSL 231
Query: 288 IIGCFEYDLRNRPLMADIL 306
I F+ + R+RP IL
Sbjct: 232 IKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 72/273 (26%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+G+G FG V+LA + F A+K L K+D V ++ E + S+
Sbjct: 3 LGKGSFGKVFLAELKGTNQFF------AIKAL---KKDV--VLMDDDVECTMVEKRVLSL 51
Query: 111 CWLHGISV-------INGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGI 162
W H + M++ G GD + Q K LP Y ++ G+
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNG--GDLMFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
LHS G++ +LK N+LL + + DFG + L D+ GTP+Y+APE
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDGHIKIADFG---MCKENMLGDAKTCTFCGTPDYIAPE 166
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
+ D W FG + EML G P+ G EE++ S I+ + PC P L
Sbjct: 167 ILLGQKYN---TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS--IRMDNPCYPRWLTR 221
Query: 283 AVENVIIGCF----------EYDLRNRPLMADI 305
+++++ F + D+R P +I
Sbjct: 222 EAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFEELFPKFRESQS 109
+G G G V H + +AVK + L + E K + + + L + S
Sbjct: 9 LGAGNSGVVSKVLHRPTG------KIMAVKTIRLEINEAIQKQILRELDIL----HKCNS 58
Query: 110 --VCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS 167
+ +G NG I I M++ +G D+I ++ G++P + + + + KG++ LH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 168 -IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEP 226
++ ++KPSN+L++ Q+ L DFG+ L+ SL+ + +GT +YMAPE+ +
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTF----VGTSSYMAPERIQG 173
Query: 227 EVRGPISFETDTWGFGCSIMEMLTGIQPWFG-----KSVEEIYHSVVIKKEKPCIPSG-L 280
S D W G S++E+ TG P+ + E+ +V + P +PSG
Sbjct: 174 NDYSVKS---DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKF 229
Query: 281 PPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P ++ + C D R RP ++L H F
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPF 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 69/271 (25%), Positives = 129/271 (47%), Gaps = 26/271 (9%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK 103
SL+L+ ++G+G FG+VW+ T + + +A+K L P + F+ + ++ K
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKP-GTMSPEAFLQE-AQVMKK 57
Query: 104 FRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
R + V L+ + V I I ++ +GS+ D + + G L LP ++ Q+A G+
Sbjct: 58 LRHEKLV-QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+ + + + +L+ +N+L+ E+ + DFG L R + D++ R G P
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLVCKVADFG-----LARLIEDNEYTARQGAK---FPI 167
Query: 223 QW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+W E + G + ++D W FG + E+ T G P+ G E+ V PC P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PP 226
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
P ++ +++ C+ + RP + L AF
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTF-EYLQAF 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 25/200 (12%)
Query: 120 NGKICIAMKFYEGSVGD-----RIAQQRGGKLPLPDILRYGIQLAKGISDLH---SIGLL 171
N + I M++ EG GD + ++ + I R QL + + H G
Sbjct: 73 NQTLYIVMEYCEG--GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT 130
Query: 172 VL--NLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR--LGTPNYMAPEQWEPE 227
VL +LKP+N+ L ++ + LGDFG L + L + +GTP YM+PEQ
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFG-----LAKILGHDSSFAKTYVGTPYYMSPEQLN-- 183
Query: 228 VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-PCIPSGLPPAVEN 286
++D W GC I E+ P+ ++ ++ + IK+ K IP +
Sbjct: 184 -HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--ASKIKEGKFRRIPYRYSSELNE 240
Query: 287 VIIGCFEYDLRNRPLMADIL 306
VI D RP ++L
Sbjct: 241 VIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE--------LFP 102
IG+G FG V LA + AVK+L K+ +N+ E+ +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCY------AVKVLQ------KKIVLNRKEQKHIMAERNVLL 50
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKG 161
K + + LH K+ + F G G+ QR P P Y ++A
Sbjct: 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNG--GELFFHLQRERSFPEPRARFYAAEIASA 108
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMA 220
+ LHSI ++ +LKP N+LL +VL DFG L ++ SD GTP Y+A
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFG----LCKEGIAQSDTTTTFCGTPEYLA 164
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270
PE + P D W G + EML G+ P++ + V E+Y +++ K
Sbjct: 165 PEVIRKQ---PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 36/270 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML--------LPLKEDCAKVFVNKFEELFP 102
+G+G +G V+ +A D +A+K + PL E+ A L
Sbjct: 16 LGKGTYGIVY------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIA---------LHS 60
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPD----ILRYGIQL 158
+ V +L S NG I M+ G + + + G PL D I+ Y Q+
Sbjct: 61 YLKHRNIVQYLGSDSE-NGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQI 117
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALRLGTPN 217
+G+ LH ++ ++K N+L++ + +V + DFG L G + GT
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQ 174
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCI 276
YMAPE + RG D W GC+I+EM TG P+ + V + K P I
Sbjct: 175 YMAPEVIDKGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
P L +N I+ CFE D R D+L
Sbjct: 234 PESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 19/237 (8%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IG+G FG V LA H++ + F L K +L KE+ K +++ L + V
Sbjct: 3 IGKGSFGKVLLA-RHKAEEKFYAVKVLQKKAILKKKEE--KHIMSERNVLLKNVKHPFLV 59
Query: 111 CWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIG 169
LH K+ + + G G+ QR P Y ++A + LHS+
Sbjct: 60 -GLHFSFQTADKLYFVLDYING--GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 170 LLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVR 229
++ +LKP N+LL +VL DFG+ + + + S GTP Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---GTPEYLAPEVLHKQ-- 171
Query: 230 GPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286
P D W G + EML G+ P++ ++ E+Y +++ K P L P + N
Sbjct: 172 -PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITN 221
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 75/287 (26%), Positives = 126/287 (43%), Gaps = 41/287 (14%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--------LKEDC 89
W I SLKL+ ++G G FG+VW+ T + + ++AVK L P L+E
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTT-------KVAVKTLKPGTMSPEAFLQE-- 51
Query: 90 AKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPL 148
++ K R + V L+ + I I ++ GS+ D + G KL L
Sbjct: 52 --------AQIMKKLRHDKLV-QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL 102
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD 208
P ++ Q+A+G++ L S + +L N+L+ E+ + DFG L R + D +
Sbjct: 103 PQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFG-----LARLIEDDE 157
Query: 209 MALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIY 264
R G P +W PE G + ++D W FG + E++T G P+ G + E+
Sbjct: 158 YTAREGAK---FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
Query: 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
V P P P + ++++ C++ D RP + E
Sbjct: 215 EQVERGYRMPR-PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 18/185 (9%)
Query: 122 KICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178
+C+ M G GD I P + Y Q+ G+ LH ++ +LKP
Sbjct: 67 DLCLVMTLMNG--GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPE 124
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDT 238
N+LL +H + + D G+ L G R GTP YMAPE + EV F D
Sbjct: 125 NVLLDDHGNVRISDLGLAVELKGGKKIKG----RAGTPGYMAPEVLQGEV---YDFSVDW 177
Query: 239 WGFGCSIMEMLTGIQPW--FGKSV--EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEY 294
+ GC++ EM+ G P+ + V EE+ + + P P +++ +
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE--YPDKFSPEAKDLCEALLQK 235
Query: 295 DLRNR 299
D R
Sbjct: 236 DPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 38/285 (13%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W ID TS++L ++G G FG+VW + + +AVK L P D K F+ +
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTT-------PVAVKTLKPGTMD-PKDFLAEA 52
Query: 98 EEL----FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILR 153
+ + PK + +VC L I + MK+ GS+ + + G L LP ++
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYI---VTELMKY--GSLLEYLQGGAGRALKLPQLID 107
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Q+A G++ L + + +L N+L+ E++ + DFG L R + + R
Sbjct: 108 MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFG-----LARVIKEDIYEARE 162
Query: 214 GTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269
G P +W PE S ++D W FG + E++T G P+ G + E+ V
Sbjct: 163 GAK---FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314
PC P G P + ++++ C++ D +RP FE+ Q
Sbjct: 220 GYRMPC-PPGCPKELYDIMLDCWKEDPDDRP-------TFETLQW 256
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 58/182 (31%), Positives = 86/182 (47%), Gaps = 11/182 (6%)
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
D+ Y +LA + LHS+G++ +LKP N+LL E + L DFG L S+
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHEKK 154
Query: 210 ALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
A GT YMAPE R + D W FG + EMLTG P+ GK +E +
Sbjct: 155 AYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT--M 209
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSR 328
I K K +P L P ++++ F+ + NR L A E ++ ++ +W L R
Sbjct: 210 ILKAKLGMPQFLSPEAQSLLRALFKRNPANR-LGAGPDGVEEIKRHPFFSTIDWNKLYRR 268
Query: 329 AL 330
+
Sbjct: 269 EI 270
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 23/254 (9%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---LKEDCAKVFVNKFEELFPKFRES 107
IG+G FG V LA H + AVK+L LK+ K + + L +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFY------AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 108 QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLH 166
V LH K+ + + G G+ QR P P Y ++A + LH
Sbjct: 57 FLVG-LHYSFQTADKLYFVLDYVNG--GELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 167 SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEP 226
S+ ++ +LKP N+LL +VL DFG+ + S + S GTP Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRK 170
Query: 227 EVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC-IPSGLPPAVE 285
+ P D W G + EML G+ P++ + E+Y +++ KP + + +
Sbjct: 171 Q---PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL---NKPLRLKPNISVSAR 224
Query: 286 NVIIGCFEYDLRNR 299
+++ G + D R
Sbjct: 225 HLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+L RIG G +GDV+ A + + +A+K++ L+ + + + + R
Sbjct: 6 ELIQRIGSGTYGDVYKARDIATGE------LVAIKVI-KLEPGDDFEIIQQEISMLKECR 58
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
V + G + K+ I M++ G S+ D I Q G L I + KG++
Sbjct: 59 HPNIVAY-FGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTPNYMAP 221
LH G + ++K +N+LL+E + L DFG+ L + +A R +GTP +MAP
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAP 170
Query: 222 EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257
E E +G + D W G + +E+ P F
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 56/177 (31%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 80 KMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIA 139
KM L KE KV L F +C + +S++NG +K++ +VG
Sbjct: 38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV--MSLMNGG---DLKYHIYNVG---- 88
Query: 140 QQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199
+RG L + ++ Y Q+ GI LHS+ ++ ++KP N+LL + L D G+ L
Sbjct: 89 -ERG--LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145
Query: 200 L-GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
G++++ R GT YMAPE + E P S+ D + GCSI EM+ G P+
Sbjct: 146 KDGKTITQ-----RAGTNGYMAPEILKEE---PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 122 KICIAMKFYEGSVGD---RIAQQRGGKLPLPD----ILRYGIQLAKGISDLHSIGLLVLN 174
K+ + M++ GS GD +I Q+ LP + +L Y I LA + ++HS ++ +
Sbjct: 139 KLLLIMEY--GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRD 194
Query: 175 LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS---DMALRL-GTPNYMAPEQWEPEVRG 230
LK +N+ L + LGDFG + SDS D+A GTP Y+APE WE R
Sbjct: 195 LKSANIFLMPTGIIKLGDFG-----FSKQYSDSVSLDVASSFCGTPYYLAPELWE---RK 246
Query: 231 PISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIG 290
S + D W G + E+LT +P+ G S EI V+ K P P + ++ ++
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF-PCPVSSGMKALLDP 305
Query: 291 CFEYDLRNRPLMADILH 307
+ RP +LH
Sbjct: 306 LLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 45/255 (17%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL----FPKFRE 106
IGRG FG+V + + + A+K+L NK+E L FRE
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVY------AMKIL------------NKWEMLKRAETACFRE 50
Query: 107 SQSVC------W---LHGISVINGKICIAMKFYEGSVGDRIA--QQRGGKLPLPDILRYG 155
+ V W LH + + M +Y G GD + + +LP D+ R+
Sbjct: 51 ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG--GDLLTLLSKFEDRLP-EDMARFY 107
Query: 156 I-QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
+ ++ I +H +G + ++KP N+LL ++ + L DFG LL S++A+ G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--G 165
Query: 215 TPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
TP+Y++PE Q + +G E D W G + EML G P++ +S+ E Y ++ KE
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 273 KPCIPSGLPPAVENV 287
PP V +V
Sbjct: 226 H----FQFPPDVTDV 236
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 41/167 (24%), Positives = 67/167 (40%), Gaps = 17/167 (10%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ ++ + LHS G++ ++KP N+LL E + + DF I + +L+ S
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS----TS 160
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---VEEIYHSVVIK 270
GTP YMAPE + S D W G + E L G +P+ G S ++I
Sbjct: 161 GTPGYMAPEVLCRQGY---SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
Query: 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVY 317
P+ + I E D + R + + +N Y
Sbjct: 218 DVL--YPATWSTEAIDAINKLLERDPQKR-----LGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 10/228 (4%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IGRG FG+V L H S + +L K + + D A + E F S V
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYA--MKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWV 105
Query: 111 CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGL 170
L + + + M++ G GD + +P Y ++ + +HS+GL
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPG--GDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-VR 229
+ ++KP N+LL +H L L DFG + + D A +GTP+Y++PE + +
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGD 221
Query: 230 GPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277
G E D W G + EML G P++ S+ Y ++ K P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 36/268 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IGRG +G V+ H + +A+K++ D + + L + R+SQ
Sbjct: 9 IGRGAYGAVYRGKHVPTG------RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 111 -------CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+L G + I M++ EG G + G + I ++ +
Sbjct: 63 NITKYYGSYLKGPRL-----WIIMEYAEG--GSVRTLMKAGPIAEKYISVIIREVLVALK 115
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
+H +G++ ++K +N+L++ + L DFG+ LL S S GTP +MAPE
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GTPYWMAPEV 172
Query: 224 WEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV--VIKKEKPCIP-S 278
+ ++T D W G +I EM TG P+ S + + ++ + K + P + +
Sbjct: 173 ----ITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDN 225
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADIL 306
G + + C + + + R L A+ L
Sbjct: 226 GYSKLLREFVAACLDEEPKER-LSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 30/273 (10%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKM--LLPLKEDCAKVFVNKFEE---LFPKFR 105
+G+G +G V+ +Q +AVK L A+ K +E L +
Sbjct: 8 LGKGAYGTVYCGLTNQG-------QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ--QRGGKLPLPDILRYGIQLAKGIS 163
V +L G + + I I M+F G I+ R G LP P +Y Q+ G++
Sbjct: 61 HVNIVQYL-GTCLDDNTISIFMEFVPGG---SISSILNRFGPLPEPVFCKYTKQILDGVA 116
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL--LGRSLSDSDMALRL-GTPNYMA 220
LH+ ++ ++K +N++L + + L DFG L +G + S+M + GTP +MA
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK---PCIP 277
PE G S D W GC++ EM TG P S++ + I + P +P
Sbjct: 177 PEVINESGYGRKS---DIWSIGCTVFEMATGKPPL--ASMDRLAAMFYIGAHRGLMPRLP 231
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
A + + C D RP +L H F
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y ++A I LHS+ ++ +LKP N+LL +VL DFG L + +
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG----LCKEGVEPEETTSTF 156
Query: 214 -GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
GTP Y+APE E P D W G + EML G+ P++ + V ++Y +++ K
Sbjct: 157 CGTPEYLAPEVLRKE---PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ +P G A ++++G D R R
Sbjct: 214 Q--LPGGKTVAACDLLVGLLHKDQRRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 71/266 (26%), Positives = 111/266 (41%), Gaps = 51/266 (19%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE--------L-- 100
+G G FG V L H S + A+K+L AK+ K E L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYY------ALKIL-----SKAKIVKLKQVEHVLNEKRILQS 57
Query: 101 --FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQ 157
P F + L+G + + + M++ G G+ + ++ G+ P P Y Q
Sbjct: 58 IRHP-F-----LVNLYGSFQDDSNLYLVMEYVPG--GELFSHLRKSGRFPEPVARFYAAQ 109
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR--SLSDSDMALRLGT 215
+ + LHS+ ++ +LKP NLLL + + DFG + GR +L GT
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--------GT 161
Query: 216 PNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
P Y+APE + + D W G I EML G P+F + +IY ++ K +
Sbjct: 162 PEYLAPEIILSKGYGKA-----VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR 216
Query: 274 PCIPSGLPPAVENVIIGCFEYDLRNR 299
PS P +++I + DL R
Sbjct: 217 --FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 23/277 (8%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKFE- 98
P + + +G+G FG V+L D D ELA K + P + +K V+ E
Sbjct: 1 PINWRRGKLLGQGAFGRVYLCY------DVDTGRELAAKQVQFDPESPETSKE-VSALEC 53
Query: 99 --ELFPKFRESQSVCWLHGISVINGK--ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILR 153
+L + + V + +G + + I M++ G SV D++ G L +
Sbjct: 54 EIQLLKNLQHERIVQY-YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRK 110
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y Q+ +G+S LHS ++ ++K +N+L + LGDFG L +S + +
Sbjct: 111 YTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
GTP +M+PE E G + D W GC+++EMLT PW + +
Sbjct: 171 GTPYWMSPEVISGEGYGR---KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
Query: 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P +PS + + +GC + R+RP ++L H F
Sbjct: 228 PQLPSHISEHARD-FLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 28/274 (10%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK 103
+LKL ++G G FG+VW+ ++ + ++A+K LK+ E K
Sbjct: 7 TLKLVKKLGAGQFGEVWMGY-------YNGHTKVAIK---SLKQGSMSPEAFLAEANLMK 56
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
+ + L+ + V I I ++ E GS+ D + G KL + ++ Q+A+G+
Sbjct: 57 QLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+ + + +L+ +N+L+SE + DFG L R + D++ R G P
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFG-----LARLIEDNEYTAREGAK---FPI 167
Query: 223 QW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+W PE G + ++D W FG + E++T G P+ G + E+ ++ P P
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-PD 226
Query: 279 GLPPAVENVIIGCFEYDLRNRP---LMADILHAF 309
P + ++ C++ RP + +L F
Sbjct: 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 79/299 (26%), Positives = 124/299 (41%), Gaps = 46/299 (15%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
D L+ IG G G V+ ++ H +AVK + + NK EE
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTG------HVMAVKQMR--RTG------NK-EE 56
Query: 100 LFPKFRESQSVCWLH---------GISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPD 150
+ V H G + + + I M+ + D++ ++ G +P D
Sbjct: 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIP-ED 114
Query: 151 ILRYGIQLAKGISDLHSI----GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206
IL G + LH + G++ ++KPSN+LL + L DFGI GR L D
Sbjct: 115 IL--GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS----GR-LVD 167
Query: 207 SDMALR-LGTPNYMAPEQWEPEVRGP-ISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
S R G YMAPE+ +P P D W G S++E+ TG P+ E
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227
Query: 265 HSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF----ESSQNAV 316
+ ++++E P +P G P + + C D R RP ++L H F E+++ V
Sbjct: 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKFE- 98
PT+ +L +G+G FG V+L D D ELAVK + P + +K VN E
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCY------DADTGRELAVKQVQFDPESPETSKE-VNALEC 53
Query: 99 --ELFPKFRESQSVCWLHGI-SVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRY 154
+L + V + + + + I M+ GS+ D++ G L +Y
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKY 111
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
Q+ +G+S LHS ++ ++K +N+L + LGDFG L LS + M G
Sbjct: 112 TRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
TP +M+PE E G + D W GC+++EMLT PW
Sbjct: 172 TPYWMSPEVISGEGYGR---KADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 73/281 (25%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+G G FG+V+ T +AVK L D K K L F V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 111 CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGK--------LPLPDILRYGIQLAKGI 162
L G+ ++N I M+ EG GD ++ R + L L ++L + +AKG
Sbjct: 63 KLL-GVCLLNEPQYIIMELMEG--GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQ-----LVLGDFGIPYLLLGRSLSDSDMALRLGTP- 216
L + + +L N L+SE + +GDFG L R + SD + G
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG-----LARDIYKSDYYRKEGEGL 174
Query: 217 ---NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI--K 270
+MAPE + G + ++D W FG + E+LT G QP+ + +E+ V +
Sbjct: 175 LPVRWMAPESL---LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRP---LMADILHA 308
+K P P + ++ C+ D RP + +IL
Sbjct: 232 LQK---PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 45/296 (15%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKV-----FV 94
+ + L +G+G FG V+ + +A+K + + A + F+
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKG-EPETRVAIKTV----NENASMRERIEFL 57
Query: 95 NKFEELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQR--------GGK 145
N E K V L G+ + M+ +G + + +R G
Sbjct: 58 N--EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L ++ ++A G++ L + + +L N +++E + +GDFG + R +
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG-----MTRDIY 170
Query: 206 DSD---------MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPW 255
++D + +R +MAPE + G + ++D W FG + EM T QP+
Sbjct: 171 ETDYYRKGGKGLLPVR-----WMAPESLKD---GVFTTKSDVWSFGVVLWEMATLAEQPY 222
Query: 256 FGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
G S EE+ VI +P P + ++ C++Y+ + RP +I+ + +
Sbjct: 223 QGLSNEEVL-KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
LK +G G FG V+LA H + D+ +AVK L E + F + E L +
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKML-VAVKALKEASESARQDFQREAELL--TVLQ 65
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRG--------------GKLPLPDIL 152
Q + +G+ + + ++ +R + G G+L L +L
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
Q+A G+ L S+ + +L N L+ + + +GDFG + R + +D R
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFG-----MSRDIYSTDY-YR 179
Query: 213 LGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268
+G M P +W P + + E+D W FG + E+ T G QPW+ S E +
Sbjct: 180 VGG-RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
+E P PP V ++ GC++ + + R ++ DI
Sbjct: 239 QGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 67/252 (26%), Positives = 111/252 (44%), Gaps = 37/252 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK----FRE 106
IGRG FG+V + + F A+K+L NK+E L FRE
Sbjct: 9 IGRGAFGEVAVVKLKNADKVF------AMKIL------------NKWEMLKRAETACFRE 50
Query: 107 SQSVC------W---LHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILR-YGI 156
+ V W LH + + M +Y G + + +LP D+ R Y
Sbjct: 51 ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLA 109
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
++ I +H + + ++KP N+L+ + + L DFG L+ S +A+ GTP
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTP 167
Query: 217 NYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
+Y++PE Q + +G E D W G + EML G P++ +S+ E Y ++ KE+
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 227
Query: 275 CIPSGLPPAVEN 286
P+ + E+
Sbjct: 228 QFPAQVTDVSED 239
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y ++ + LHS ++ +LKP N+LL + + L DFG + L D L
Sbjct: 106 YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFG-----FAKKLRDRTWTL-C 159
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
GTP Y+APE + + D W G I EML G P+F + IY ++ K +
Sbjct: 160 GTPEYLAPEVIQSKGHNK---AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE 216
Query: 274 PCIPSGLPPAVENVI 288
P L +++I
Sbjct: 217 --FPRHLDLYAKDLI 229
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 77/296 (26%), Positives = 120/296 (40%), Gaps = 41/296 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKEDCAKVFVNKFEELFPKFRE 106
I G +G V+L H ++ F A+K + L L+ +VFV E F E
Sbjct: 9 ISNGAYGAVYLVRHKETRQRF------AMKKINKQNLILRNQIQQVFV---ERDILTFAE 59
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDL 165
+ V + +C+ M++ EG GD + G LP+ Y + + L
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEG--GDCATLLKNIGALPVDMARMYFAETVLALEYL 117
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL---------------GRSLSDSDMA 210
H+ G++ +LKP NLL++ + L DFG+ + L R D +
Sbjct: 118 HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270
GTP Y+APE +R D W G + E L G P+FG + EE++ V+
Sbjct: 178 ---GTPEYIAPEVI---LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231
Query: 271 K-EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGL 325
E P LP +++I + R AFE Q+ + +W GL
Sbjct: 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGG---AFEVKQHRFFLGLDWNGL 284
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-------MLLPLKEDCAKVFVN 95
+ +++ +IGRG F +V+ AT + +A+K M ++DC K
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLL------DRKPVALKKVQIFEMMDAKARQDCVKEI-- 53
Query: 96 KFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD--IL 152
+L + + +L + + ++ I ++ + G + I + K +P+ +
Sbjct: 54 ---DLLKQLNHPNVIKYLDSF-IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
+Y +QL + +HS ++ ++KP+N+ ++ + LGD G LGR S A
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-----LGRFFSSKTTAAH 164
Query: 213 --LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257
+GTP YM+PE+ +F++D W GC + EM P++G
Sbjct: 165 SLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 20/167 (11%)
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFG----IPYLLLGRSLS 205
I+ Y QL +G+S LH ++ ++K +NLL+ Q + + DFG + G
Sbjct: 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 206 DSDMALRLGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
+ LGT +MAPE +RG D W GC I+EM T PW +
Sbjct: 165 QGQL---LGTIAFMAPEV----LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-- 215
Query: 265 HSVVIKK-----EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
H +I K P IP L P + +V + C E +RP ++L
Sbjct: 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 28/273 (10%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPL----KEDCAKVFVNKFE---ELFP 102
IG G FG V+L + S + +AVK + LP +D + ++ L
Sbjct: 8 IGSGSFGSVYLGMNASSGE------LMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
+ + V +L G S+ + I +++ G SV + G + + Q+ KG
Sbjct: 62 ELQHENIVQYL-GSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKG 118
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAP 221
++ LH+ G++ ++K +N+L+ + + DFGI L SLS P+
Sbjct: 119 LNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---TKTNGARPSLQGS 175
Query: 222 EQW-EPEVRGPISF--ETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCIP 277
W PEV S+ + D W GC ++EMLTG P+ ++ I+ + + P IP
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENASPEIP 233
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
S + + + FE D RP A++L H F
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 54/239 (22%)
Query: 49 HRIGRGPFGDVW----LATHH-------QSADDFDEYHELA---VKMLLPLKEDCAKVFV 94
+G G +G V AT + ++D ++ + A VK+L L+ + V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH---ENIV 63
Query: 95 NKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRY 154
N L FR G++ + ++ E ++ + + GG LP + Y
Sbjct: 64 N----LKEAFRRK-------------GRLYLVFEYVERTLLELLEASPGG-LPPDAVRSY 105
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
QL + I+ HS ++ ++KP N+L+SE L L DFG L R S + +
Sbjct: 106 IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR--PASPLTDYVA 163
Query: 215 TPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS-VEEIYH 265
T Y APE + V D W GC + E+L G +P F G S ++++Y
Sbjct: 164 TRWYRAPELLVGDTNYGKPV--------DVWAIGCIMAELLDG-EPLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 71/283 (25%), Positives = 128/283 (45%), Gaps = 33/283 (11%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK 103
++ LK +G G FG V+L + + ++ +AVK L + A+ + EL
Sbjct: 6 TIVLKRELGEGAFGKVFLGECY-HLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGD------------RIAQQRG---GKLPL 148
F + +++ +G+ + ++ E GD + G+L L
Sbjct: 65 F-QHENIVKFYGVCTEGDPPIMVFEYMEH--GDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDS 207
+L+ +Q+A G+ L S + +L N L+ +D +V +GDFG + R + +
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG-YDLVVKIGDFG-----MSRDVYTT 175
Query: 208 DMALRLGTPNYMAPEQW-EPE--VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263
D R+G + M P +W PE + + E+D W FG + E+ T G QPW+G S EE+
Sbjct: 176 DY-YRVGG-HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
+ + P P V ++++GC++ D + R + DI
Sbjct: 234 IECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 23/235 (9%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML---LPLKEDCAKVFVNKFEELFPKFRES 107
+G+G FG V LA + + + AVK+L + L++D + + + + + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELY------AVKVLKKDVILQDDDVECTMTE-KRVLALAGKH 55
Query: 108 QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLH 166
+ LH ++ M++ G GD + QR G+ P Y ++ G+ LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNG--GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 167 SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWE 225
G++ +LK N+LL + + DFG + + GTP+Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFG----MCKEGILGGVTTSTFCGTPDYIAPEILS 169
Query: 226 PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280
+ P D W G + EML G P+ G +E++ S I +++ P L
Sbjct: 170 YQ---PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS--ILEDEVRYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 127 MKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185
M+F G GD + Q G+ L Y ++ G+ LHS G++ +LK N++L
Sbjct: 75 MEFLNG--GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132
Query: 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSI 245
+ + DFG + D+ + GTP+Y+APE + +F D W FG +
Sbjct: 133 GHIKIADFG---MCKENVFGDNRASTFCGTPDYIAPEILQGL---KYTFSVDWWSFGVLL 186
Query: 246 MEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR-PLMAD 304
EML G P+ G +E++ S I+ + P P + ++++ FE D R ++ +
Sbjct: 187 YEMLIGQSPFHGDDEDELFES--IRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGN 244
Query: 305 I-LHAFESSQNAVYNDGEWTGLGSRAL 330
I H F + N WT L R L
Sbjct: 245 IRGHPFFKTIN-------WTALEKREL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 34/285 (11%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFEELFPK 103
++ + +G G G V+ A H + LAVK++ L + + K +++ E L+
Sbjct: 3 IQYQEILGHGNGGTVYKAYHLLTR------RILAVKVIPLDITVELQKQIMSELEILYKC 56
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+S + +G + +I I +F +G D K+P + R + + KG++
Sbjct: 57 --DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLT 109
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
L S+ +L ++KPSN+L++ Q+ L DFG+ L +S +GT YMAPE+
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV-----STQLVNSIAKTYVGTNAYMAPER 164
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF------GKSVEEIYHSVVIKKEKPCIP 277
E G S D W G S ME+ G P+ G + ++ ++ P +P
Sbjct: 165 ISGEQYGIHS---DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221
Query: 278 SGL-PPAVENVIIGCFEYDLRNRPLMADIL-HAFESSQNAVYNDG 320
G + I C + RP +++ H F YNDG
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI----VQYNDG 262
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
QR G+ L Y +L + +LH ++ +LKP N+LL + L DFG+ L
Sbjct: 85 QREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL-- 142
Query: 201 GRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259
++ D D GTP Y+APE D W G + EMLTG+ P++ ++
Sbjct: 143 --NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA---VDWWTLGVLLYEMLTGLPPFYDEN 197
Query: 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
V E+Y ++ +E P G ++++IG D R
Sbjct: 198 VNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF 104
LK ++G G FG V L + D+ E ++AVK L + + FE
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGE--QVAVKSL---NHSGEEQHRSDFEREIEIL 60
Query: 105 R--ESQSVCWLHGISVINGK--ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLA 159
R + +++ G+ G + + M++ GS+ D + + R ++ L +L + Q+
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQIC 119
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
KG+ L S + +L N+L+ D + + DFG L + L + + P
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG-----LAKVLPEDKDYYYVKEPG-E 173
Query: 220 APEQW-EPEV--RGPISFETDTWGFGCSIMEMLTGIQP----------WFGKSVEEIYHS 266
+P W PE S +D W FG ++ E+ T P G + ++ +
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 267 VVIKKEK-----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+++ K P P P V +++ C+E + ++RP AD++ +
Sbjct: 234 RLLELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
D L IQ+A G+ L S + +L N+L+ E + + D G L R + +D
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG-----LSREIYSADY 179
Query: 210 ALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYH 265
R+ P + P +W P + G S ++D W FG + E+ + G+QP++G S +E+
Sbjct: 180 -YRV-QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
V ++ PC PP + +++ C++ RP DI
Sbjct: 238 MVRKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 13/175 (7%)
Query: 127 MKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185
M++ G GD + Q G+ Y ++ G+ LH G++ +LK N+LL +
Sbjct: 75 MEYLNG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132
Query: 186 DQLVLGDFGIPYL-LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCS 244
+ + DFG+ + G + + GTP+Y+APE + + + D W FG
Sbjct: 133 GHIKIADFGMCKENMNGEGKAST----FCGTPDYIAPEILKGQK---YNESVDWWSFGVL 185
Query: 245 IMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ EML G P+ G+ +E++ S I ++P P + ++ + FE D R
Sbjct: 186 LYEMLIGQSPFHGEDEDELFDS--ILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 51/194 (26%), Positives = 100/194 (51%), Gaps = 25/194 (12%)
Query: 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDIL-RYGIQLAKGISDLHSIGLLV-LNLKPS 178
IC+ M+F + DRI + +GG +P +IL + + + +G++ L+++ ++ ++KPS
Sbjct: 76 NNICMCMEFMDCGSLDRIYK-KGGPIP-VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPS 133
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDT 238
N+L++ Q+ L DFG+ L+ S++D+ +GT YM+PE+ + G + ++D
Sbjct: 134 NILVNSRGQIKLCDFGVSGELIN-SIADT----FVGTSTYMSPERIQG---GKYTVKSDV 185
Query: 239 WGFGCSIMEMLTGIQPWFGK-----------SVEEIYHSVVIKKEKPCIPSG-LPPAVEN 286
W G SI+E+ G P+ + ++ +V ++ P +PS P + +
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSSDFPEDLRD 244
Query: 287 VIIGCFEYDLRNRP 300
+ C D RP
Sbjct: 245 FVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 26/141 (18%)
Query: 138 IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
+ K I Y QL +G+ LHS G+L ++K SN+L++ L L DFG
Sbjct: 89 LLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFG--- 145
Query: 198 LLLGRSLSDS---DMALRLGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEM 248
L R + D R+ T Y PE ++ PEV D W GC + E+
Sbjct: 146 --LARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEV--------DMWSVGCILAEL 195
Query: 249 LTGIQPWFGKS----VEEIYH 265
G + G + +E+I+
Sbjct: 196 FLGKPIFQGSTELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 20/184 (10%)
Query: 139 AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198
+++ +P I +Y +QL + +HS ++ ++KP+N+ ++ + LGD G
Sbjct: 96 FKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG---- 151
Query: 199 LLGRSLSDSDMAL--RLGTPNYMAPEQWEPEVRGP-ISFETDTWGFGCSIMEMLTGIQPW 255
LGR S A +GTP YM+PE+ + +F++D W GC + EM P+
Sbjct: 152 -LGRFFSSKTTAAHSLVGTPYYMSPER----IHENGYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 256 FGKSVEEIYHSVVIKKEKPCIPSGLPP-----AVENVIIGCFEYDLRNRPLMADILHAFE 310
+G +++ + KK + C LP + +++ C D RP ++ +L +
Sbjct: 207 YG---DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263
Query: 311 SSQN 314
Sbjct: 264 EMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179
G + + +F + + I ++ G LP I Y QL +G++ HS G+L +LKP N
Sbjct: 70 KGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPEN 128
Query: 180 LLLSEHDQLVLGDFGIPYLLLGRSL-SDSDMAL-RLGTPNYMAPE------QWEPEVRGP 231
LL++ L L DFG L RS S + T Y APE + V
Sbjct: 129 LLINTEGVLKLADFG-----LARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV--- 180
Query: 232 ISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYH 265
D W GC E+L+ + GKS +++++
Sbjct: 181 -----DIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 66/287 (22%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-------MLLPLKEDCAKVFVNK 96
+ +++ +IGRG F +V+ AT + +A+K M + DC K ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATC------LLDGVPVALKKVQIFDLMDAKARADCIKE-IDL 55
Query: 97 FEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD--ILR 153
++L +V + + + ++ I ++ + G + I + K +P+ + +
Sbjct: 56 LKQL-----NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR- 212
Y +QL + +HS ++ ++KP+N+ ++ + LGD G LGR S A
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-----LGRFFSSKTTAAHS 165
Query: 213 -LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271
+GTP YM+PE+ +F++D W GC + EM P++G + +S+ K
Sbjct: 166 LVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI 220
Query: 272 EK---PCIPSG-LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314
E+ P +PS + ++ C D RP DI + ++ ++
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP---DITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 11/112 (9%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y ++ + + LH +G + +LKP N L+ + L DFG+ ++ + S +
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VV 159
Query: 214 GTPNYMAPEQWEPEVRGP-ISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
G+P+YMAPE +RG F D W GC + E L G P+ G + E +
Sbjct: 160 GSPDYMAPEV----LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (158), Expect = 2e-11
Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 62/237 (26%)
Query: 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK--FR 105
++G G +G V+ A ++ +A+K + E EE P R
Sbjct: 4 LEKLGEGTYGVVYKARDKKTG------EIVALKKIRLDNE----------EEGIPSTALR 47
Query: 106 ESQSVCWLHGIS---------VI--NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRY 154
E + L + VI K+ + ++ + + + +R G L I
Sbjct: 48 E---ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYL-DKRPGPLSPNLIKSI 103
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
QL +G++ HS +L +LKP N+L++ L L DFG L R+ + LR
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFG-----LARAFG---IPLRTY 155
Query: 215 TPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
T Y APE + V D W GC EM+TG +P F G S
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAV--------DIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 66/278 (23%), Positives = 126/278 (45%), Gaps = 25/278 (8%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHE-LAVKMLLPLKEDCAKVFVNKFE 98
++ T + +KH++G G +G+V+ + +Y +AVK L KED +V E
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGV-------WKKYSLTVAVKTL---KEDTMEVEEFLKE 52
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQ 157
K + ++ L G+ I +F G++ D + + ++ +L Q
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
++ + L + +L N L+ E+ + + DFG+ L+ G + + A
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA------- 165
Query: 218 YMAPEQWE-PE--VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273
P +W PE S ++D W FG + E+ T G+ P+ G + ++Y ++ K +
Sbjct: 166 -KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYR 223
Query: 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P G PP V ++ C++++ +RP A+I AFE+
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 114 HGISVINGKICIAMKFYEGSVGDRI--AQQRGGKLPLPDILRYGIQLAKGISDL---HSI 168
+G I G + + M++ + D++ +P + R + KG+ L H+I
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE--- 225
+ ++KP+N+L++ + Q+ L DFG+ L+ SL+ ++ +G +YMAPE+ +
Sbjct: 125 --IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-ASLAKTN----IGCQSYMAPERIKSGG 177
Query: 226 PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH--SVVIKKEKPCIPSGLPPA 283
P + ++D W G SI+EM G P+ ++ I+ S ++ + P +PSG
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 284 VENVIIGCFEYDLRNRPLMADIL-HAF-ESSQNAVYNDGEW 322
++ + C RP A +L H + +NA + EW
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEW 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 36/241 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL---------- 100
IGRG FG+V L H S + A+K+L +KFE +
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVY------AMKLL------------SKFEMIKRSDSAFFWE 92
Query: 101 ---FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
S+ + LH + + + M++ G GD + +P Y +
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG--GDLVNLMSNYDIPEKWARFYTAE 150
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
+ + +HS+G + ++KP N+LL + L L DFG + + D A +GTP+
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPD 208
Query: 218 YMAPEQWEPE-VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276
Y++PE + + G E D W G + EML G P++ S+ Y ++ K
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268
Query: 277 P 277
P
Sbjct: 269 P 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
L Y ++ G+ DLH + +LKP N+LL ++ + + D G L + + +
Sbjct: 104 ALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLG-----LAVKIPEGESI 158
Query: 211 L-RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
R+GT YMAPE + D WG GC I EM+ G P+ G+
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYT---LSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHEL-AVKML---LPLKEDCAKVFVNKFEELF 101
K+ ++G G FG V+LA + ++ EL A+K + E+C +
Sbjct: 2 KVIKQLGDGTFGSVYLARNKET-------GELVAIKKMKKKFYSWEECMNL--------- 45
Query: 102 PKFRESQS---------VCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDIL 152
RE +S + L + N ++ ++ EG++ + ++G I
Sbjct: 46 ---REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR 102
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL-SDSDMAL 211
Q+ +G++ +H G +LKP NLL+S + + + DFG L R + S
Sbjct: 103 SIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG-----LAREIRSRPPYTD 157
Query: 212 RLGTPNYMAPEQW--EPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS-VEEIY 264
+ T Y APE P+ D W GC + E+ T +P F G S ++++Y
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPV----DIWALGCIMAELYTL-RPLFPGSSEIDQLY 209
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKEDCAKVFVNKFEELFPKFRE 106
+G+G FG V LA + D+ A+K+L + +D V K +
Sbjct: 8 LGKGSFGKVMLA-ERKGTDEL-----YAIKILKKDVVIQDDDVECTMVEKRVLALSG--K 59
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDL 165
+ LH ++ M++ G GD + Q Q+ G+ P + Y ++A G+ L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNG--GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE 225
HS G++ +LK N++L + + DFG+ + ++ GTP+Y+APE
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAPEIIA 174
Query: 226 PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
+ P D W FG + EML G P+ G+ +E++ S++
Sbjct: 175 YQ---PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL-R 212
Y ++ G+ DLH ++ +LKP N+LL ++ + + D G L + + + R
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLG-----LAVEIPEGETIRGR 161
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+GT YMAPE + E +F D WG GC I EM+ G P+
Sbjct: 162 VGTVGYMAPEVVKNE---RYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
IQ+ + +HS ++ ++K +N+LL + + LGDFG + ++SD GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGT 208
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275
P Y+APE W R P S + D + G + E+LT +P+ G+++EE+ H + + P
Sbjct: 209 PYYVAPEIWR---RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP- 264
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRP 300
+P + P ++ ++ D + RP
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 37/244 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK----FRE 106
IGRG FG E+AV + + A +NK+E L FRE
Sbjct: 9 IGRGAFG------------------EVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE 50
Query: 107 SQSV-----C-W---LHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI- 156
++V C W LH + + M +Y G + + +LP D+ R+ I
Sbjct: 51 ERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP-EDMARFYIA 109
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
++ I +H + + ++KP N+LL + + L DFG + S +A+ GTP
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV--GTP 167
Query: 217 NYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
+Y++PE Q + G E D W G + EML G P++ +S+ E Y ++ +E+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227
Query: 275 CIPS 278
PS
Sbjct: 228 QFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 42/133 (31%), Positives = 61/133 (45%), Gaps = 23/133 (17%)
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQ 223
LH+ G++ +LKP NLLL + + L DFG + L GTP Y+APE
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYVKLVDFG-----FAKKLKSGQKTWTFCGTPEYVAPEI 163
Query: 224 WEPEVRGPI-----SFETDTWGFGCSIMEMLTGIQPWFGKSVE---EIYHSVVIKKEKPC 275
I F D W G + E+LTG P FG+ E EIY+ ++ K
Sbjct: 164 --------ILNKGYDFSVDYWSLGILLYELLTGRPP-FGEDDEDPMEIYNDILKGNGKLE 214
Query: 276 IPSGLPPAVENVI 288
P+ + A +++I
Sbjct: 215 FPNYIDKAAKDLI 227
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 70/259 (27%), Positives = 111/259 (42%), Gaps = 26/259 (10%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAV--KMLLPLKEDCAKVFVNKFEELFPKFRESQ 108
IGRG + V L ++ D+ + + V K L+ ED V K +F + +
Sbjct: 3 IGRGSYAKVLLVRLKKN----DQIYAMKVVKKELVHDDEDIDWVQTEK--HVFEQASSNP 56
Query: 109 SVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHS 167
+ LH ++ + +++ G GD + QR KLP Y ++ ++ LH
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNG--GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE 227
G++ +LK N+LL + L D+G+ LG + S GTPNY+APE E
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILRGE 171
Query: 228 VRGPISFETDTWGFGCSIMEMLTGIQPWF------GKSVEEIYHSVVIKKEKPC-IPSGL 280
G F D W G + EM+ G P+ + E+ V++ EKP IP L
Sbjct: 172 EYG---FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--EKPIRIPRFL 226
Query: 281 PPAVENVIIGCFEYDLRNR 299
+V+ G D + R
Sbjct: 227 SVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 39/139 (28%), Positives = 80/139 (57%), Gaps = 16/139 (11%)
Query: 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS---DLHSIGLLVLNLK 176
+G+I I M+ +G D++ + + G++P + + I + +G++ + H I + ++K
Sbjct: 71 DGEISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKI--MHRDVK 127
Query: 177 PSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGP-ISFE 235
PSN+L++ ++ L DFG+ L+ S+++S +GT +YM+PE+ ++G + +
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLID-SMANS----FVGTRSYMSPER----LQGTHYTVQ 178
Query: 236 TDTWGFGCSIMEMLTGIQP 254
+D W G S++EM G P
Sbjct: 179 SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 10/228 (4%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IGRG FG+V L H + + +L K + + D A + E F S V
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYA--MKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWV 105
Query: 111 CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGL 170
L + + + M++ G GD + +P Y ++ + +HS+G
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPG--GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-VR 229
+ ++KP N+LL + L L DFG + + D A +GTP+Y++PE + +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGD 221
Query: 230 GPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277
G E D W G + EML G P++ S+ Y ++ K P
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 40/147 (27%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD-SDMALR 212
YG ++ + LHS ++ ++K NL+L + + + DFG L +SD + M
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTF 155
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
GTP Y+APE E G D WG G + EM+ G P++ + E ++ +++++
Sbjct: 156 CGTPEYLAPEVLEDNDYGR---AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 212
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ P L P ++++ G + D + R
Sbjct: 213 R--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 22/172 (12%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
Q+ GK P + Y +++ G+ LH G++ +LK N++L + + DFG +
Sbjct: 93 QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFG----MC 148
Query: 201 GRSLSDSDMALRL--GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
+ D + R GTP+Y+APE + P D W +G + EML G P+ G+
Sbjct: 149 KEHMVDG-VTTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
Query: 259 SVEEIYHSVV---------IKKEKPCIPSGLPPAVENVIIGC---FEYDLRN 298
+E++ S++ + KE I GL + +GC E D+R
Sbjct: 205 DEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIRE 256
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 65/285 (22%), Positives = 105/285 (36%), Gaps = 67/285 (23%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
IGRG FG+VWL + + A+K+L K D + R+ +
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVY------AMKVLR--KSD---MIKRNQIAHVRAERDILA 56
Query: 110 VC---WLHGISVINGKIC---------IAMKFYEGSVGDRI-AQQRGGKLPLPDILR-YG 155
W I + M++ G GD + R P + R Y
Sbjct: 57 DADSPW------IVKLYYSFQDEEHLYLVMEYMPG--GDLMNLLIRKDVFP-EETARFYI 107
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI---------PYLLLGRSLSD 206
+L + +H +G + ++KP N+L+ + L DFG+ L S +
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 207 SDMALRL-----------------GTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEM 248
L GTP+Y+APE +RG P E D W G + EM
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV----LRGTPYGLECDWWSLGVILYEM 223
Query: 249 LTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGC 291
L G P++ +++E Y+ ++ KE P + P ++I
Sbjct: 224 LYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRL 268
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR-----LG 214
KG+ LHS G + ++K N+LL E + + DFG+ L D + +G
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL----ADGGDRTRKVRKTFVG 168
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
TP +MAPE E +V G F+ D W FG + +E+ TG P+
Sbjct: 169 TPCWMAPEVME-QVHG-YDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 48/188 (25%), Positives = 96/188 (51%), Gaps = 18/188 (9%)
Query: 128 KFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHD 186
KFY + +G +P + + + + K + LHS + ++ ++KPSN+L++ +
Sbjct: 88 KFY------KKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG 141
Query: 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGP-ISFETDTWGFGCSI 245
Q+ L DFGI L+ S++ + A G YMAPE+ PE+ ++D W G ++
Sbjct: 142 QVKLCDFGISGYLVD-SVAKTIDA---GCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 246 MEMLTGIQPW--FGKSVEEIYHSVVIKKEKPCIPSG-LPPAVENVIIGCFEYDLRNRPLM 302
+E+ TG P+ + +++ V+++ P +P+ P ++ + C + + + RP
Sbjct: 198 IELATGRFPYDSWKTPFQQLKQ--VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNY 255
Query: 303 ADIL-HAF 309
++L H F
Sbjct: 256 PELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 64/242 (26%), Positives = 92/242 (38%), Gaps = 58/242 (23%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-----------CAK-VFVNKFE 98
+GRG FG V LA + ++ + + A+K L K D C K +F
Sbjct: 7 LGRGHFGKVLLAEYKKTGELY------AIKAL--KKGDIIARDEVESLMCEKRIFETANS 58
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158
E P F + L +C M++ G GD + P + Y +
Sbjct: 59 ERHP-FLVN-----LFACFQTEDHVCFVMEYAAG--GDLMMHIHTDVFSEPRAVFYAACV 110
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR------ 212
G+ LH ++ +LK NLLL + + DFG L M
Sbjct: 111 VLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG---------LCKEGMGFGDRTSTF 161
Query: 213 LGTPNYMAPEQWEPEVRGPISFET------DTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266
GTP ++APE + ET D WG G I EML G P+ G EE++ S
Sbjct: 162 CGTPEFLAPE---------VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212
Query: 267 VV 268
+V
Sbjct: 213 IV 214
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 56/240 (23%), Positives = 107/240 (44%), Gaps = 30/240 (12%)
Query: 24 DHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL 83
L+ VV P + +IG G G V +AT + ++AVK +
Sbjct: 6 AALQLVV---DPGDPRSYLDNFV---KIGEGSTGIVCIATDKSTG------RQVAVKKMD 53
Query: 84 PLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQR 142
K+ ++ N E + + + ++ ++ ++ ++ + M+F EG ++ D + R
Sbjct: 54 LRKQQRRELLFN--EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR 111
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
+ I + + K +S LH+ G++ ++K ++LL+ ++ L DFG
Sbjct: 112 ---MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFG-----FCA 163
Query: 203 SLSDSDMALR---LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259
+S ++ R +GTP +MAPE R P E D W G ++EM+ G P+F +
Sbjct: 164 QVSK-EVPRRKSLVGTPYWMAPEVIS---RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
LK +G G FG V+LA + + D+ +AVK L K F + EL +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKML-VAVKALKDPTLAARKDF-QREAELLTNLQH 66
Query: 107 SQSVCWLHGISVINGKICIAMKFYE-GSVG--------------DRIAQQRGGKLPLPDI 151
V + +G+ + + ++ + G + D +Q G+L L +
Sbjct: 67 EHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
L Q+A G+ L S + +L N L+ + + +GDFG + R + +D
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG-----MSRDVYSTDY-Y 179
Query: 212 RLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS----VEEI 263
R+G + M P +W P + + E+D W FG + E+ T G QPWF S +E I
Sbjct: 180 RVGG-HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI---LHAF 309
V+++ + C P V ++++GC++ + + R + +I LHA
Sbjct: 239 TQGRVLERPRVC-----PKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 75 HELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC-WLHGISVI---------NGKIC 124
HE+A+K+L + D + E +FR ++C L+ +++ G +
Sbjct: 4 HEVAIKLL---RTDAPEE-----EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF 55
Query: 125 IAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183
++ G ++ + +A G LP + R +Q+ ++ H+ G++ +LKP N+++S
Sbjct: 56 AVFEYVPGRTLREVLAAD--GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 184 EHD----QLVLGDFGIPYLLLGRSLSDSDMALR----LGTPNYMAPEQWEPEVRGPISFE 235
+ VL DFGI LL G +D R LGTP Y APEQ E P++
Sbjct: 114 QTGVRPHAKVL-DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE---PVTPN 169
Query: 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285
+D + +G +E LTG + G SV EI + ++ P + LPP +
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQGASVAEILY----QQLSP-VDVSLPPWIA 214
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 45 LKLKHRIGRGPFGDVWLATHH-------QSADDFDEYHEL-AVKMLLPLKEDCAKVFVNK 96
L+LK ++G G FG+V L + A +FD L AVKML D K N
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA---DVTKTARND 63
Query: 97 F-EELFPKFR-ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQR--------GGKL 146
F +E+ R ++ ++ L G+ V + +C+ ++ E ++ QR +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 147 P---LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203
P + ++L +Q+A G+ L S+ + +L N L+ H + + DFG + R+
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG-----MSRN 178
Query: 204 LSDSD---MALRLGTP-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEM--LTGIQPWFG 257
L D + R P +MA WE + G + +D W FG ++ EM L QP+
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMA---WESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
Query: 258 KSVEEIYHSV----------VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
S E++ + + + P PS V +++ C+ D+++RP + +H
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPS----PVFKLMMRCWSRDIKDRPTF-NKIH 290
Query: 308 AF 309
F
Sbjct: 291 HF 292
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 30/271 (11%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF---EELFPKFRE 106
+IG+G FGDV+ + E+AVK + KF E+ ++
Sbjct: 2 KIGKGNFGDVYKGVLKGNT-------EVAVKT---CRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISD 164
V L G+ V I I M+ G G + R +L + +L+ + A G+
Sbjct: 52 PNIV-KLIGVCVQKQPIYIVMELVPG--GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW 224
L S + +L N L+ E++ L + DFG + R + G P +W
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFG-----MSREEEGGIYTVSDGLKQ--IPIKW 161
Query: 225 -EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280
PE G + E+D W +G + E + G P+ G S ++ + P P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLC 220
Query: 281 PPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P + +++ C+ YD NRP ++I + +
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 65/268 (24%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
RIG G G V+ H + + A+K++ ED + + + E+ + +
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLY------ALKVIYGNHEDTVRRQICREIEIL-RDVNHPN 133
Query: 110 VCWLHGISVINGKICIAMKFYEGSV--GDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS 167
V H + NG+I + ++F +G G IA ++ L D+ R Q+ GI+ LH
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----LADVAR---QILSGIAYLHR 186
Query: 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE 227
++ ++KPSNLL++ + + DFG+ +L +++ + + +GT YM+PE+ +
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSR-ILAQTMDPCNSS--VGTIAYMSPERINTD 243
Query: 228 VRGPI--SFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV---VIKKEKPCIPSGLPP 282
+ + D W G SI+E G P FG + + S+ + + P P+
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFP-FGVGRQGDWASLMCAICMSQPPEAPATASR 302
Query: 283 AVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ I C + + R +L H F
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 39/280 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML---LPLKEDCAKVFVNK 96
I P+ L L IG G FG VWL + E ++A+K + +ED F+ +
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGY-------WLEKRKVAIKTIREGAMSEED----FIEE 49
Query: 97 FEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
+ + K + V L+G+ IC+ +F E G + D + QR GK +L
Sbjct: 50 AQVMM-KLSHPKLV-QLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMC 106
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+ + +G++ L S ++ +L N L+ E+ + + DFG+ +L + S GT
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST-----GT 161
Query: 216 PNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKS----VEEIYHSV 267
P +W PEV S ++D W FG + E+ + G P+ +S VE I
Sbjct: 162 K---FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF 218
Query: 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+ K + +V ++ C++ +RP + +LH
Sbjct: 219 RLYKPRLA-----SQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 43/132 (32%), Positives = 71/132 (53%), Gaps = 13/132 (9%)
Query: 121 GKICIAMKFYEGSVGDRI---AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKP 177
I IAM++ EG D I ++RGG++ + + + KG+S LHS ++ ++KP
Sbjct: 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKP 133
Query: 178 SNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRG-PISFET 236
SN+LL+ Q+ L DFG+ G ++ GT YMAPE+ ++G P S +
Sbjct: 134 SNILLTRKGQVKLCDFGVS----GELVNSLAGTF-TGTSFYMAPER----IQGKPYSITS 184
Query: 237 DTWGFGCSIMEM 248
D W G +++E+
Sbjct: 185 DVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 48/207 (23%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH 166
S VC L GI + + + G + D + + + ++ D+L + +Q+AKG+S L
Sbjct: 68 SPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLE 126
Query: 167 SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW-- 224
+ L+ +L N+L+ + + + DFG+ LL + +++ G P +W
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL---DIDETEYHADGGK----VPIKWMA 179
Query: 225 -EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
E + + ++D W +G ++ E++T G +P+ G EI ++ K E+ P
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERLPQPPICTI 238
Query: 283 AVENVIIGCFEYDLRNRPLMADILHAF 309
V +++ C+ D RP +++ F
Sbjct: 239 DVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 67/269 (24%), Positives = 113/269 (42%), Gaps = 37/269 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEY--HELAVKMLLPLKEDC-AKVFVNK 96
++ L L IG G FG V EY ++AVK + K D A+ F+ +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQG----------EYTGQKVAVKNI---KCDVTAQAFLEE 49
Query: 97 FEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKL-PLPDILRYG 155
+ K V L G+ + NG + I M+ + RG L + +L++
Sbjct: 50 -TAVMTKLHHKNLVRLL-GVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+ +A+G+ L S L+ +L N+L+SE + DFG+ +G
Sbjct: 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA------------RVGSMGV 154
Query: 216 PNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKK 271
N P +W PE S ++D W +G + E+ + G P+ S++E+ V K
Sbjct: 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KG 213
Query: 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
+ P G P V ++ C+E + + RP
Sbjct: 214 YRMEPPEGCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 67/279 (24%), Positives = 107/279 (38%), Gaps = 39/279 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKF 97
IDP+ L +G G FG V L D +A+KM+ + ED +
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKID-------VAIKMIREGAMSED------DFI 47
Query: 98 EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYG 155
EE + K V L+G+ I I ++ ++R GKL +L
Sbjct: 48 EEAKVMMKLSHPNLV-QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+ + + L S G + +L N L+ E + + + DFG L R + D GT
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG-----LARYVLDDQYTSSQGT 161
Query: 216 PNYMAPEQWE-PEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKS----VEEIYHSV 267
P +W PEV S ++D W FG + E+ + G P+ S VE +
Sbjct: 162 K---FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
+ + K P V ++ C+ +RP +L
Sbjct: 219 RLYRPKLA-----PTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 36/271 (13%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
IG+G FG+V+ A ++ +A+K ++ L+E ++ + E F S
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQ------VVAIK-VIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 110 VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLP---LPDILRYGIQLAKGISDL 165
+ +G + K+ I M++ GS D + + GKL + ILR ++ G+ L
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILR---EVLLGLEYL 114
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE 225
H G + ++K +N+LLSE + L DFG+ L + GTP +MAPE
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---GTPFWMAPEVI- 170
Query: 226 PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS-----VVIKKEKPCIP-SG 279
+ + D W G + +E+ G P H ++ K P + +
Sbjct: 171 --KQSGYDEKADIWSLGITAIELAKGEPPLSD------LHPMRVLFLIPKNNPPSLEGNK 222
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
++ + C D + RP ++L H F
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 48/286 (16%)
Query: 41 DPTSLKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP L K RIG+G FG+V+ +++ E+ ++ L+E A+ + ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRT-------KEVVAIKIIDLEE--AEDEIEDIQQ 51
Query: 100 LFPKFRESQS--VCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLP---LPDILRY 154
+ S + +G + K+ I M++ G G + + G L + ILR
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG--GSALDLLKPGPLEETYIATILR- 108
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR-- 212
++ KG+ LHS + ++K +N+LLSE + L DFG+ L+D+ +
Sbjct: 109 --EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGV-----AGQLTDTQIKRNTF 161
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
+GTP +MAPE + + F+ D W G + +E+ G P +++ V+
Sbjct: 162 VGTPFWMAPEVIK---QSAYDFKADIWSLGITAIELAKGEPPN-----SDLHPMRVLF-- 211
Query: 273 KPCIPSGLPPAVE--------NVIIGCFEYDLRNRPLMADIL-HAF 309
IP PP +E + C D R RP ++L H F
Sbjct: 212 --LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP-YLLLGRSLSDSDMALR 212
Y ++ G+ DLH ++ +LKP N+LL +H + + D G+ ++ G+++ R
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----R 161
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+GT YMAPE + E +F D W GC + EM+ G P+
Sbjct: 162 VGTVGYMAPEVVKNE---RYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 43/223 (19%)
Query: 113 LHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLV 172
L+ K+ I ++F +G D I + L P I Q+ + ++ LHS ++
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 173 LNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTPNYMAPE--QWEPE 227
+LK N+LL+ + L DFG+ S + R +GTP +MAPE E
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNK------STLQKRDTFIGTPYWMAPEVVACETF 180
Query: 228 VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS------VVIKKEKPCIPSGLP 281
P ++ D W G +++E+ P H V++K I P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP----------HHELNPMRVLLK-----ILKSEP 225
Query: 282 PAVEN----------VIIGCFEYDLRNRPLMADIL-HAFESSQ 313
P ++ + C D +RP A++L H F S Q
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD-MALR 212
YG ++ + LHS ++ +LK NL+L + + + DFG L +SD M
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTF 155
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
GTP Y+APE E G D WG G + EM+ G P++ + E+++ +++++
Sbjct: 156 CGTPEYLAPEVLEDNDYGR---AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 212
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ P L P ++++ G + D + R
Sbjct: 213 R--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 20/190 (10%)
Query: 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL---HSIGLLVLNLK 176
+G+I I M+ +G D++ + + G++P + + I + KG++ L H I + ++K
Sbjct: 75 DGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVK 131
Query: 177 PSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFET 236
PSN+L++ ++ L DFG+ L+ DS +GT +YM+PE+ + S ++
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQGT---HYSVQS 183
Query: 237 DTWGFGCSIMEMLTG---IQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFE 293
D W G S++EM G I P K +E ++ V E S P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV---EGDPAESETSPRPRPPGRPLSS 240
Query: 294 YDLRNRPLMA 303
Y +RP MA
Sbjct: 241 YGPDSRPPMA 250
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 41 DPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP SL + +IG G G V +A S ++AVKM+ K+ ++ N E
Sbjct: 18 DPRSLLENYIKIGEGSTGIVCIAREKHSG------RQVAVKMMDLRKQQRRELLFN--EV 69
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQL 158
+ + + Q+V ++ ++ ++ + M+F +G ++ D ++Q R + + + +Q
Sbjct: 70 VIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQ- 128
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGT 215
+ LHS G++ ++K ++LL+ ++ L DFG + D+ R +GT
Sbjct: 129 --ALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------SKDVPKRKSLVGT 180
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259
P +MAPE R P E D W G ++EM+ G P+F S
Sbjct: 181 PYWMAPEVIS---RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 10/111 (9%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL-LGRSLSDSDMALR 212
Y +L G+ DL ++ +LKP N+LL + + + D G+ + G ++ R
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG-----R 161
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263
+GT YMAPE E +F D WG GC I EM+ G P F K E +
Sbjct: 162 VGTVGYMAPEVINNE---KYTFSPDWWGLGCLIYEMIQGQSP-FRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 15/145 (10%)
Query: 127 MKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185
M++ G GD + Q+ GK P + Y ++A G+ LHS G++ +LK N++L
Sbjct: 80 MEYVNG--GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE 137
Query: 186 DQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPE--QWEPEVRGPISFETDTWGFG 242
+ + DFG + ++ GTP+Y+APE ++P + D W FG
Sbjct: 138 GHIKIADFG----MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS-----VDWWAFG 188
Query: 243 CSIMEMLTGIQPWFGKSVEEIYHSV 267
+ EML G P+ G+ +E++ S+
Sbjct: 189 VLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 67/263 (25%), Positives = 112/263 (42%), Gaps = 29/263 (11%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF--EELFPKFRESQ 108
+G+G FG+V+ T + +AVK KED + KF E K +
Sbjct: 3 LGKGNFGEVFKGT-------LKDKTPVAVKTC---KEDLPQELKIKFLSEARILKQYDHP 52
Query: 109 SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGK--LPLPDILRYGIQLAKGISDLH 166
++ L G+ I I M+ G GD ++ R K L ++++ + A G++ L
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPG--GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 167 SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD---SDMALRLGTPNYMAPEQ 223
S + +L N L+ E++ L + DFG + R D S L+ + APE
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFG-----MSRQEDDGIYSSSGLKQIPIKWTAPEA 165
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
G S E+D W +G + E + G+ P+ G + ++ V C P P
Sbjct: 166 LN---YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-PQKCPD 221
Query: 283 AVENVIIGCFEYDLRNRPLMADI 305
V V+ C++Y NRP +++
Sbjct: 222 DVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 18/116 (15%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q + ++ H + ++KP N+L+++ Q+ L DFG +L G D + T
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG---PGDDYTDYVATR 164
Query: 217 NYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYH 265
Y APE Q+ P V D W GC E+LTG W GKS V+++Y
Sbjct: 165 WYRAPELLVGDTQYGPPV--------DVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL-----F 101
+ ++G G +G V+ A H ++ +A+K++ P++ED +E+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETG------QVVAIKVV-PVEED--------LQEIIKEISI 51
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
K +S + +G N + I M++ GSV D I + L +I Q K
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLK 110
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTPN 217
G+ LHS + ++K N+LL+E Q L DFG+ L MA R +GTP
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT------MAKRNTVIGTPF 164
Query: 218 YMAPEQWEPEVRGPISFE--TDTWGFGCSIMEMLTGIQPWFG 257
+MA PEV I + D W G + +EM G P+
Sbjct: 165 WMA-----PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
LK +G G FG V+LA + + D+ +AVK L ++ K F ++ EL +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKIL-VAVKTLKDASDNARKDF-HREAELLTNL-Q 65
Query: 107 SQSVCWLHGISVINGKICIAM---------KFYEGSVGDRIAQQRGG---KLPLPDILRY 154
+ + +G+ V + + KF D + G +L +L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
Q+A G+ L S + +L N L+ E+ + +GDFG + R + +D R+G
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFG-----MSRDVYSTDY-YRVG 179
Query: 215 TPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSV--- 267
+ M P +W P + + E+D W G + E+ T G QPW+ S E+ +
Sbjct: 180 G-HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238
Query: 268 -VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
V+++ + C P V ++++GC++ + R
Sbjct: 239 RVLQRPRTC-----PKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 43/152 (28%), Positives = 63/152 (41%), Gaps = 13/152 (8%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y ++ + LH +G++ ++K N+LL +VL DFG+ L + A
Sbjct: 110 YIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE---ERAYSF 166
Query: 214 -GTPNYMAPEQWEPEVRGPI---SFETDTWGFGCSIMEMLTGIQPWF--GKSVEEIYHSV 267
GT YMAPE +RG D W G E+LTG P+ G+ + S
Sbjct: 167 CGTIEYMAPEV----IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
Query: 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
I K KP P + + I E D + R
Sbjct: 223 RILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 41/288 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE---LFPKFRES 107
IG+G FG V+ A + + +AVKML KE+ + F+ L +F +
Sbjct: 13 IGQGAFGRVFQARAPGLLPY-EPFTMVAVKML---KEEASADMQADFQREAALMAEF-DH 67
Query: 108 QSVCWLHGISVINGKICIAMKFYE-------------------GSVGDRIAQQRGGKLPL 148
++ L G+ + +C+ ++ + LPL
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 149 --PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206
+ L Q+A G++ L + +L N L+ E+ + + DFG L R++
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG-----LSRNIYS 182
Query: 207 SDMALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEE 262
+D + N P +W P + E+D W +G + E+ + G+QP++G + EE
Sbjct: 183 ADYYK--ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
Query: 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ + V C P P + N++ C+ +RP A I +
Sbjct: 241 VIYYVRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IGRG + V L ++ + + + V + +D +V + +F + +
Sbjct: 3 IGRGSYAKVLLVRLKKT----ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 111 CWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIG 169
LH ++ +++ G GD + QR KLP Y +++ ++ LH G
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 170 LLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEV 228
++ +LK N+LL + L D+G + L D GTPNY+APE E
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPW 255
G F D W G + EM+ G P+
Sbjct: 173 YG---FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILR-YGIQLAKGISDLHSIGLLVLNLKPSNL 180
++C M++ G G+ ++ D R YG ++ + LHS ++ +LK NL
Sbjct: 69 RLCFVMEYVNG--GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL 126
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSD-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTW 239
+L + + + DFG L ++D + M GTP Y+APE E G D W
Sbjct: 127 MLDKDGHIKITDFG----LCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR---AVDWW 179
Query: 240 GFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
G G + EM+ G P++ + E+++ ++++ K P L ++++ G D R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179
+GK+ I ++F G D I + L P I Q+ + + LHS+ ++ +LK N
Sbjct: 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGN 140
Query: 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE--QWEPEVRGPISFETD 237
+LL+ + L DFG+ + ++L D +GTP +MAPE E P ++ D
Sbjct: 141 VLLTLDGDIKLADFGVSAKNV-KTLQRRDSF--IGTPYWMAPEVVMCETMKDTPYDYKAD 197
Query: 238 TWGFGCSIMEMLTGIQPWFGKSVEEIYHSV--------VIKKEKPCI--PSGLPPAVENV 287
W G +++EM +E +H + + K E P + PS +
Sbjct: 198 IWSLGITLIEM---------AQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248
Query: 288 IIGCFEYDLRNRPLMADIL-HAFESSQNAV 316
+ + RP A +L H F SS +
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSSVTSN 278
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 42/283 (14%)
Query: 41 DPTSLKLK-HRIGRGPFGDVWLATHHQSAD-------DFDEYHELA--VKMLLPLKEDCA 90
DP L K RIG+G FG+V+ +++ D +E + ++ + + C
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 91 KVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPD 150
+V K+ +G + K+ I M++ G G + R G
Sbjct: 61 SPYVTKY----------------YGSYLKGTKLWIIMEYLGG--GSALDLLRAGPFDEFQ 102
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
I ++ KG+ LHS + ++K +N+LLSE + L DFG+ L+D+ +
Sbjct: 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGV-----AGQLTDTQIK 157
Query: 211 LR--LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSV 267
+GTP +MAPE + + + D W G + +E+ G P + ++
Sbjct: 158 RNTFVGTPFWMAPEVIQ---QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-- 212
Query: 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ K P + + I C D RP ++L H F
Sbjct: 213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPK 103
LKL IG+G FGDV L + + ++AVK +K D A+ F+ + + +
Sbjct: 8 LKLLQTIGKGEFGDVMLGDYRGN--------KVAVKC---IKNDATAQAFLAE-ASVMTQ 55
Query: 104 FRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
R S V L I G + I ++ +GS+ D + + L +L++ + + + +
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
L + + +L N+L+SE + + DFG L + S + +L P
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFG-----LTKEASSTQDTGKL-------PV 163
Query: 223 QW-EPEVRGPISFET--DTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+W PE F T D W FG + E+ + G P+ ++++ V K K P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPD 222
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
G PP V +V+ C+ D RP + E
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 54/227 (23%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP + +L +G G +G V+ H ++ +LA ++ + D + +
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKTG-------QLAAIKVMDVTGDEEEEIKQEIN- 54
Query: 100 LFPKFRESQSVCWLHGISV------INGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDIL 152
+ K+ +++ +G + ++ ++ + M+F GSV D I +G L I
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
++ +G+S LH ++ ++K N+LL+E+ ++ L DFG+ L D + R
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRR 168
Query: 213 ---LGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+GTP +MAPE + F++D W G + +EM G P
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 114 HGISVINGKICIAMKFYEG-SVGDRIA--QQRGGKLPLPDILRYGIQLAKGISDLHSIGL 170
+ + N ++ I M EG +G+ +++ + I +Q+ + LH
Sbjct: 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR 134
Query: 171 LV-LNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVR 229
+V +L P+N++L E D++ + DFG L + +S + +GT Y PE + E
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFG----LAKQKQPESKLTSVVGTILYSCPEIVKNE-- 188
Query: 230 GPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL-PPAVENVI 288
P + D W FGC + +M T P++ ++ + +V +P +P G+ V +VI
Sbjct: 189 -PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGMYSEDVTDVI 246
Query: 289 IGCFEYDLRNRPLMADIL 306
C D RP DI+
Sbjct: 247 TSCLTPDAEARP---DII 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 14/173 (8%)
Query: 132 GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191
GS+ + G LP+ ++ Q+A+G++ L + +L N+L+ E +
Sbjct: 87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVA 146
Query: 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEM 248
DFG L R + + + + P +W PE G S ++D W FG + EM
Sbjct: 147 DFG-----LARLIKEDVYL----SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197
Query: 249 LT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
T G P+ G + E+Y + PC P+ P + +++ C+ + +RP
Sbjct: 198 FTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQEIYKIMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 50/210 (23%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
+IG G G V +AT + ++AVK + K+ ++ N E + + ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGK------QVAVKKMDLRKQQRRELLFN--EVVIMRDYHHEN 80
Query: 110 VCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI 168
V ++ ++ ++ + M+F EG ++ D + R + + + + + + +S LH+
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVC---LSVLRALSYLHNQ 137
Query: 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV 228
G++ ++K ++LL+ ++ L DFG + S +GTP +MAPE
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVIS--- 191
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
R P E D W G ++EM+ G P+F +
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 16/171 (9%)
Query: 142 RGGKLPL--PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199
K L D L IQ+A G+ L S + +L N L+ E + + DFG
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFG----- 169
Query: 200 LGRSLSDSD----MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQP 254
L R + +D + L +M PE + G + E+D W FG + E+ + G+QP
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAI---LYGKFTTESDIWSFGVVLWEIFSYGLQP 226
Query: 255 WFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
++G S +E+ + ++ PC P P V ++I C+ RP DI
Sbjct: 227 YYGFSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ +HS G++ +LKPSN+L++E+ L + DFG L R + D M + T
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG-----LAR-IQDPQMTGYVSTR 169
Query: 217 NYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256
Y APE W+ E D W GC EML G +P F
Sbjct: 170 YYRAPEIMLTWQ-----KYDVEVDIWSAGCIFAEMLEG-KPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 66/290 (22%), Positives = 125/290 (43%), Gaps = 28/290 (9%)
Query: 24 DHLRTVVATPTQTRPWIDPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKML 82
+ LRT+V+ DP ++ +IG+G G V+ A D E+A+K +
Sbjct: 6 EKLRTIVSIG-------DPKKKYTRYEKIGQGASGTVFTAI------DVATGQEVAIKQI 52
Query: 83 LPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQ 141
K+ ++ +N E L K ++ ++ ++ ++ + M++ G S+ D + +
Sbjct: 53 NLQKQPKKELIIN--EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET 110
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201
+ + + R +Q + LH+ ++ ++K N+LL + L DFG +
Sbjct: 111 CMDEAQIAAVCRECLQ---ALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167
Query: 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-V 260
S M +GTP +MAPE + GP + D W G +EM+ G P+ ++ +
Sbjct: 168 EQSKRSTM---VGTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+Y + P L P + + C E D+ R ++L H F
Sbjct: 222 RALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 61/260 (23%), Positives = 115/260 (44%), Gaps = 32/260 (12%)
Query: 29 VVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED 88
+V P R ++D +IG G G V +AT S +AVK + K+
Sbjct: 11 MVVDPGDPRTYLDNFI-----KIGEGSTGIVCIATVKSSGK------LVAVKKMDLRKQQ 59
Query: 89 CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLP 147
++ N E + + + ++V ++ ++ ++ + M+F EG ++ D + R +
Sbjct: 60 RRELLFN--EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ 117
Query: 148 LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207
+ + + + K +S LH+ G++ ++K ++LL+ ++ L DFG +
Sbjct: 118 IAAVC---LAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174
Query: 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
+ +GTP +MAPE R P E D W G ++EM+ G P+F +
Sbjct: 175 SL---VGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------- 221
Query: 268 VIKKEKPCIPSGLPPAVENV 287
K I LPP ++N+
Sbjct: 222 --LKAMKMIRDNLPPKLKNL 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 154 YGIQLAKGISDLHSIGLLVL-NLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD-SDMAL 211
YG ++ + LHS +V +LK NL+L + + + DFG L + D + M
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMKT 155
Query: 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271
GTP Y+APE E G D WG G + EM+ G P++ + E+++ +++++
Sbjct: 156 FCGTPEYLAPEVLEDNDYGR---AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212
Query: 272 EKPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ P L P ++++ G + D + R
Sbjct: 213 IR--FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML---LPLKEDCAKVFVNKFEELFPKFRES 107
+G+G FG V LA +S + AVK+L + L++D + + + + + R
Sbjct: 3 LGKGSFGKVMLARLKESGRLY------AVKVLKKDVILQDDDVECTMTE-KRILSLARNH 55
Query: 108 QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLH 166
+ L+ ++ M+F G GD + Q+ + Y ++ + LH
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNG--GDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 167 SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEP 226
G++ +LK N+LL L DFG+ + + S GTP+Y+APE +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---GTPDYIAPEILQE 170
Query: 227 EVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
+ GP D W G + EML G P+ ++ ++++ +++
Sbjct: 171 MLYGP---SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L + D++ Y Q+A+G+ L S + +L N+LLSE++ + + DFG L R +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG-----LARDIY 225
Query: 206 DSDMALRLGTP----NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260
+R G+ +MAPE +V + ++D W FG + E+ + G P+ G +
Sbjct: 226 KDPDYVRKGSARLPLKWMAPESIFDKV---YTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282
Query: 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
E + + + P P + +++ C++ D + RP + ++
Sbjct: 283 NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 54/232 (23%), Positives = 85/232 (36%), Gaps = 60/232 (25%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL----- 100
K K +G G + V+ A +A+K K+ + + +E
Sbjct: 4 KGKK-LGEGTYAVVYKA--RDKETG----RIVAIK----------KIKLGERKEAKDGIN 46
Query: 101 FPKFRESQ--------SVCWLHGISVINGKICIAMKFYEGS----VGDRIAQQRGGKLPL 148
F RE + ++ L + I + +F E + D+ L
Sbjct: 47 FTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-----VLTP 101
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD 208
DI Y + +G+ LHS +L +LKP+NLL++ L L DFG L RS +
Sbjct: 102 ADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFG-----LARSFGSPN 156
Query: 209 --MALRLGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGI 252
M ++ T Y APE + V D W GC E+L +
Sbjct: 157 RKMTHQVVTRWYRAPELLFGARHYGVGV--------DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 28/292 (9%)
Query: 39 WIDPTSLKLKHR-------------IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL 85
+IDPT L + +G G FG V AT + + D ++AVKML P
Sbjct: 18 YIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKS-DAVMKVAVKMLKPT 76
Query: 86 KEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKF-YEGSVGDRIAQQRGG 144
+ + ++ +++ L G I G I + ++ G + + + ++R
Sbjct: 77 AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES 136
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS- 203
L L D+L + Q+AKG++ L S + +L N+LL+ + + DFG L R
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG-----LARDI 191
Query: 204 LSDSDMALRLGT--P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259
++DS+ ++ P +MAPE +FE+D W +G + E+ + G P+ G
Sbjct: 192 MNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248
Query: 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
V+ ++ ++ + + P P + +++ C++ D RP I+
Sbjct: 249 VDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 50/287 (17%)
Query: 41 DPTSLKLK-HRIGRGPFGDVWLATHHQSAD-------DFDEYHELA--VKMLLPLKEDCA 90
DP L K +IG+G FG+V+ +++ D +E + ++ + + C
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 91 KVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLP 149
+V K+ +G + + K+ I M++ G S D + + +
Sbjct: 61 SPYVTKY----------------YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA 104
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
ILR ++ KG+ LHS + ++K +N+LLSEH ++ L DFG+ L+D+ +
Sbjct: 105 TILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV-----AGQLTDTQI 156
Query: 210 ALR--LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
+GTP +MAPE + + + D W G + +E+ G P E++
Sbjct: 157 KRNTFVGTPFWMAPEVIK---QSAYDSKADIWSLGITAIELAKGEPPH-----SELHPMK 208
Query: 268 VI----KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
V+ K P + ++ + C + RP ++L H F
Sbjct: 209 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 69/257 (26%), Positives = 107/257 (41%), Gaps = 23/257 (8%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF--EELFPKFRES 107
RIGRG FG+V+ + AD+ +AVK +E KF E K
Sbjct: 2 RIGRGNFGEVF--SGRLRADN----TPVAVK---SCRETLPPDLKAKFLQEARILKQYSH 52
Query: 108 QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS 167
++ L G+ I I M+ +G + G +L + ++++ A G+ L S
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW-EP 226
+ +L N L++E + L + DFG + R D A G P +W P
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFG-----MSREEEDGVYASTGGMKQ--IPVKWTAP 165
Query: 227 EV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPA 283
E G S E+D W FG + E + G P+ S ++ ++ PC P P A
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC-PELCPDA 224
Query: 284 VENVIIGCFEYDLRNRP 300
V ++ C+EYD RP
Sbjct: 225 VYRLMERCWEYDPGQRP 241
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 41/112 (36%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
QL +G+S H +L +LKP NLL++E +L L DFG L +S+ + + T
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFG---LARAKSVPTKTYSNEVVTL 167
Query: 217 NYMAPEQW--EPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYH 265
Y P+ E PI D WG GC + EM TG +P F G +V+E H
Sbjct: 168 WYRPPDVLLGSTEYSTPI----DMWGVGCILYEMATG-RPMFPGSTVKEELH 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 40/275 (14%)
Query: 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ 108
H IG G FG V+ AT+ + + +AVK + K K++++ +E +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNE------VVAVKKM----SYSGKQTNEKWQDII---KEVK 73
Query: 109 SVCWLHGISVINGKIC--------IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA- 159
+ L + I K C + M++ GS D + K PL ++ I
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGA 130
Query: 160 -KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR-LGTPN 217
+G++ LHS ++ ++K N+LL+E Q+ L DFG S S S A +GTP
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG--------SASKSSPANSFVGTPY 182
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCI 276
+MAPE G + D W G + +E+ P F ++ +YH + + + P +
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNDSPTL 240
Query: 277 PSG-LPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
S + + C + + RP A++L H F
Sbjct: 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 41/126 (32%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
G + + ++ + QL +G++ H +L +LKP NLL++E +L L DFG L +
Sbjct: 98 GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFG---LARAK 154
Query: 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWF-GKS 259
S+ + + T Y P+ + G + T D WG GC EM TG +P F G +
Sbjct: 155 SIPTKTYSNEVVTLWYRPPDI----LLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGST 209
Query: 260 VEEIYH 265
VEE H
Sbjct: 210 VEEQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 39/119 (32%), Positives = 55/119 (46%), Gaps = 30/119 (25%)
Query: 153 RYGI-QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS------ 205
RY + QL K + +HS ++ +LKPSN+LL+ ++ L DFG L RSLS
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG-----LARSLSELEENP 164
Query: 206 -DSDMALRLGTPNYMAPEQWEPEVRGPI-------SFETDTWGFGCSIMEMLTGIQPWF 256
+ + + T Y APE I + D W GC + EML G +P F
Sbjct: 165 ENPVLTDYVATRWYRAPE---------ILLGSTRYTKGVDMWSVGCILGEMLLG-KPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 32/284 (11%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKF--EELF 101
L +G+G FG V A Q + + ++AVKML K D + + +F E
Sbjct: 1 FTLGRMLGKGEFGSVREA---QLKSEDGSFQKVAVKML---KADIFSSSDIEEFLREAAC 54
Query: 102 PKFRESQSVCWLHGISV---INGKICIAMKFY----EGSVGDRIAQQRGGK----LPLPD 150
K + +V L G+S+ G++ I M G + + R G+ LPL
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
++R+ I +A G+ L S + +L N +L+E+ + + DFG L + + D
Sbjct: 115 LVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG-----LSKKIYSGDY- 168
Query: 211 LRLGTPNYMAPEQW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266
R G + + P +W E + +D W FG ++ E++T G P+ G EIY +
Sbjct: 169 YRQGCASKL-PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY-N 226
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+IK + P V ++ C+ + + RP + E
Sbjct: 227 YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 12/193 (6%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
Q+ G+ Y +L + LH ++ +LKP N+LL + L DFG L
Sbjct: 88 QKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFG----LS 143
Query: 201 GRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259
+L+D+ GT Y+APE E +G + D W G + EM G P++ +
Sbjct: 144 KANLTDNKTTNTFCGTTEYLAPEVLLDE-KG-YTKHVDFWSLGVLVFEMCCGWSPFYAED 201
Query: 260 VEEIYHSVVIKKEKPCIPSG-LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318
+++Y ++ K + P L + G + ++R + A E ++ +
Sbjct: 202 TQQMYRNIAFGKVR--FPKNVLSDEGRQFVKGLLNRNPQHR--LGAHRDAVELKEHPFFA 257
Query: 319 DGEWTGLGSRALT 331
D +W L + +T
Sbjct: 258 DIDWDLLSKKQIT 270
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 29/278 (10%)
Query: 41 DPTSLKLKHR-IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP L R IG G FG V+ A D +A+K + + + + + +E
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFAR------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 100 L--FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ K R ++ + G + + M++ GS D + K PL ++ +
Sbjct: 66 VRFLQKLRHPNTIQY-RGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVT 121
Query: 158 LA--KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+G++ LHS ++ ++K N+LLSE + LGDFG ++ + +GT
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGT 174
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKP 274
P +MAPE G + D W G + +E+ P F ++ +YH + + E P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNESP 232
Query: 275 CIPSG-LPPAVENVIIGCFEYDLRNRPLMADIL--HAF 309
+ SG N + C + ++RP +++L H F
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRP-TSEVLLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 17/190 (8%)
Query: 125 IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA--KGISDLHSIGLLVLNLKPSNLLL 182
+ M++ GS D + K PL ++ I +G++ LHS ++ ++K N+LL
Sbjct: 102 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 158
Query: 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFG 242
+E Q+ L DFG + S +GTP +MAPE G + D W G
Sbjct: 159 TEPGQVKLADFGSASIA-------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
Query: 243 CSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCIPSG-LPPAVENVIIGCFEYDLRNRP 300
+ +E+ P F ++ +YH + + E P + S N + C + ++RP
Sbjct: 212 ITCIELAERKPPLFNMNAMSALYH--IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRP 269
Query: 301 LMADIL-HAF 309
++L H F
Sbjct: 270 TSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 20/134 (14%)
Query: 127 MKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186
+K Y + G R G L + + QL KGI+ H +L +LKP NLL+++
Sbjct: 84 LKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG 137
Query: 187 QLVLGDFGIPYLLLGRS--LSDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFG 242
+L L DFG L R+ + + + + T Y AP+ + G ++ T D W G
Sbjct: 138 ELKLADFG-----LARAFGIPVNTFSNEVVTLWYRAPDV----LLGSRTYSTSIDIWSVG 188
Query: 243 CSIMEMLTGIQPWF 256
C + EM+TG +P F
Sbjct: 189 CIMAEMITG-RPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 50/246 (20%)
Query: 51 IGRGPFGDVWLATHHQSAD--------DFDEYHELA------VKMLLPLKEDCAKVFVNK 96
+G G +G V H ++ + D +E E+ +KML LK++
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE-------N 61
Query: 97 FEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI 156
EL FR GK+ + ++ E ++ + + + G P + Y
Sbjct: 62 IVELKEAFRR-------------RGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIY 107
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS---DSDMALRL 213
QL K I H ++ ++KP NLL+S +D L L DFG R+LS +++ +
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFG-----FARNLSEGSNANYTEYV 162
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVIKKE 272
T Y +PE + P D W GC + E+ G QP F G+S EI I+K
Sbjct: 163 ATRWYRSPELL---LGAPYGKAVDMWSVGCILGELSDG-QPLFPGES--EIDQLFTIQKV 216
Query: 273 KPCIPS 278
+P+
Sbjct: 217 LGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 13/182 (7%)
Query: 132 GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191
GS+ D + Q R P +L + +Q+AKG+ L ++ NL N+LL + +
Sbjct: 93 GSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIA 151
Query: 192 DFGIPYLLLGRSLSDSDMAL--RLGTP-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEM 248
DFG+ LL D TP +MA E + G + ++D W +G ++ EM
Sbjct: 152 DFGVADLL----YPDDKKYFYSEHKTPIKWMALESI---LFGRYTHQSDVWSYGVTVWEM 204
Query: 249 LT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
++ G +P+ G E+ ++ K E+ P V V++ C+ D RP ++ +
Sbjct: 205 MSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263
Query: 308 AF 309
F
Sbjct: 264 EF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
QR KLP Y +++ ++ LH G++ +LK N+LL + L D+G +
Sbjct: 88 QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG----MC 143
Query: 201 GRSLSDSDM-ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+ D + GTPNY+APE E G F D W G + EM+ G P+
Sbjct: 144 KEGIRPGDTTSTFCGTPNYIAPEILRGEDYG---FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 46/172 (26%), Positives = 87/172 (50%), Gaps = 17/172 (9%)
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL- 165
S + +G +G+I I M+ +G D++ ++ ++P + + I + +G++ L
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLR 120
Query: 166 --HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
H I + ++KPSN+L++ ++ L DFG+ L+ DS +GT +YM+PE+
Sbjct: 121 EKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPER 173
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTG---IQPWFGKSVEEIYHSVVIKKE 272
+ S ++D W G S++E+ G I P K +E I+ V+ E
Sbjct: 174 LQGT---HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+L R+G G +GDV+ A + + ELA ++ L+ + + E K
Sbjct: 12 ELIQRVGSGTYGDVYKARNLHTG-------ELAAVKIIKLEPGDDFSLIQQ-EIFMVKEC 63
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRG--GKLPLPDILRYGIQLAKGIS 163
+ ++ G + K+ I M++ G I G +L + + R +Q G++
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLA 120
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTPNYMA 220
LHS G + ++K +N+LL+++ + L DFG+ + + +A R +GTP +MA
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI------TATIAKRKSFIGTPYWMA 174
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
PE E G + D W G + +E L +QP
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 41/165 (24%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L L D++ Y Q+A+G+ L S + +L N+LLSE++ + + DFG L R +
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG-----LARDIY 224
Query: 206 DSDMALRLGTP----NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260
+R G +MAPE +V + ++D W FG + E+ + G P+ G +
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKV---YTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281
Query: 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
+E + + + + P P + ++++ C+ + +RP +++
Sbjct: 282 DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/228 (23%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
DP + +L +G G +G V+ H ++ +LA ++ + ED + K E
Sbjct: 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTG-------QLAAIKVMDVTEDEEEEI--KLEI 63
Query: 99 ELFPKFRESQSVCWLHGISVI------NGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDI 151
+ K+ +++ +G + + ++ + M+F GSV D + +G L I
Sbjct: 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI 123
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
++ +G++ LH+ ++ ++K N+LL+E+ ++ L DFG+ L D +
Sbjct: 124 AYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGR 177
Query: 212 R---LGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
R +GTP +MAPE + + +D W G + +EM G P
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG----RSLSDSDM 209
Y ++ + LH +G++ ++K N+LL +VL DFG+ L R+ S
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS---- 165
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISF--ETDTWGFGCSIMEMLTGIQPWF--GKSVEEIYH 265
GT YMAPE +RG D W G I E+LTG P+ G+ +
Sbjct: 166 --FCGTIEYMAPEI----IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
Query: 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGL 325
S I K P PS + P ++++ D + R L A A E ++ + +W L
Sbjct: 220 SRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR-LGAGPQGASEIKEHPFFKGLDWEAL 278
Query: 326 GSR 328
R
Sbjct: 279 ALR 281
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ KG+ +H+ G++ +LKP NL ++E +L + DFG L R +DS+M + T
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG-----LARQ-TDSEMTGYVVTR 179
Query: 217 NYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256
Y APE W + D W GC + EMLTG +P F
Sbjct: 180 WYRAPEVILNWMHYTQ-----TVDIWSVGCIMAEMLTG-KPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 12/149 (8%)
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW 224
LHS ++ ++K N+LL + L DFG + S M +GTP +MAPE
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVV 187
Query: 225 EPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCI--PSGLP 281
+ GP + D W G +EM+ G P+ ++ + +Y ++ P + P L
Sbjct: 188 TRKAYGP---KVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIATNGTPELQNPEKLS 242
Query: 282 PAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ + C E D+ R ++L H F
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPF 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 113 LHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLV 172
LH I + ++ + + Q GG P ++ + QL +G++ +H +L
Sbjct: 68 LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-NVRLFMFQLLRGLAYIHGQHILH 126
Query: 173 LNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPI 232
+LKP NLL+S +L L DFG L +S+ + + T Y P+ + G
Sbjct: 127 RDLKPQNLLISYLGELKLADFG---LARAKSIPSQTYSSEVVTLWYRPPDV----LLGAT 179
Query: 233 SFET--DTWGFGCSIMEMLTGIQPWF 256
+ + D WG GC +EML G QP F
Sbjct: 180 DYSSALDIWGAGCIFIEMLQG-QPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 76 ELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVG 135
+L ++ L+E+ F E K + ++ LH I + + ++ +
Sbjct: 31 KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLC 90
Query: 136 DRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195
+ + GG P ++ + QL +G+S +H +L +LKP NLL+S+ +L L DFG
Sbjct: 91 QYMDKHPGGLHP-ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFG- 148
Query: 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQ 253
L +S+ + + T Y P+ + G + T D WG GC +EM+ G+
Sbjct: 149 --LARAKSVPSHTYSNEVVTLWYRPPDV----LLGSTEYSTCLDMWGVGCIFVEMIQGVA 202
Query: 254 PWFG 257
+ G
Sbjct: 203 AFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 46/295 (15%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---------LKEDCAKVFVN 95
LK +G G FG V L + D+ E ++AVK L P LK++ ++ N
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGE--QVAVKSLKPESGGNHIADLKKEI-EILRN 62
Query: 96 KFEELFPKFRESQSVCWLHGISVINGKICIAMKFY-EGSVGDRIAQQRGGKLPLPDILRY 154
+ E K++ +C G + I + M+F GS+ + + + + K+ L L+Y
Sbjct: 63 LYHENIVKYK---GICTEDGGNGIK----LIMEFLPSGSLKEYLPRNKN-KINLKQQLKY 114
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
+Q+ KG+ L S + +L N+L+ Q+ +GDFG L +++ D
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG-----LTKAIET-DKEYYTV 168
Query: 215 TPNYMAPEQW-EPE--VRGPISFETDTWGFGCSIMEMLT--------------GIQPWFG 257
+ +P W PE ++ +D W FG ++ E+LT I P G
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228
Query: 258 K-SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ +V + + K P P P V ++ C+E+ R +++ FE+
Sbjct: 229 QMTVTRLVRVLEEGKRLPR-PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFP 102
+L RIG G +GDV+ A + + ELA ++ L+ ED A V + E +
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTG-------ELAAIKVIKLEPGEDFAVV---QQEIIMM 60
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRG--GKLPLPDILRYGIQLAK 160
K + ++ G + K+ I M+F G I G + + + R +Q
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ--- 117
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGTPN 217
G+ LHS G + ++K +N+LL+++ + L DFG+ + + +A R +GTP
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI------TATIAKRKSFIGTPY 171
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+MAPE E +G + D W G + +E L +QP
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 36/273 (13%)
Query: 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFEELFPKFRES 107
IG G FG V+ A ++ + +A+K M K+ K++++ + R
Sbjct: 21 REIGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQS-----NEKWQDIIKEVRFL 69
Query: 108 QSVCWLHGISVINGKIC--------IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
Q + + I K C + M++ GS D + + L +I
Sbjct: 70 QQLRHPNTIEY---KGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIAAICHGAL 125
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
+G++ LHS + ++K N+LL+E + L DFG SL + +GTP +M
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG------SASLVSPANSF-VGTPYWM 178
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCIPS 278
APE G + D W G + +E+ P F ++ +YH + + + P + S
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNDSPTLSS 236
Query: 279 -GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
N + C + ++RP ++L H F
Sbjct: 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 9/109 (8%)
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQW 224
LHS ++ +LKP NLLL + + DFG + + D L GTP Y+APE
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFG-----FAKKVPDRTFTL-CGTPEYLAPEVI 187
Query: 225 EPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
+ + G D W G + E + G P+F + IY ++ + K
Sbjct: 188 QSKGHGK---AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK 233
|
Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 40/117 (34%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ-LVLGDFGIPYLLLGRSL 204
LPL + Y QL + ++ +HS + +LKP NLL+ + L L DFG LL
Sbjct: 167 LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWFGKS 259
S S + R Y APE + G ++ T D W GC I EM+ G + G+S
Sbjct: 227 SVSYICSRF----YRAPEL----MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275
|
Length = 440 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 61/251 (24%), Positives = 108/251 (43%), Gaps = 38/251 (15%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA----KVF 93
W + L L +G G FG V A D+ +E +AVKML K+D
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEA-VGLDNPNETSTVAVKML---KDDATEKDLSDL 62
Query: 94 VNKFEELFPKFRESQSVCWLHGISVINGKICIAMKF-YEGSVGDRIAQQR---------- 142
V++ E + + +++ L G+ G + + +++ G++ D + +R
Sbjct: 63 VSEME-MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 143 ----GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198
L D++ + Q+A+G+ L S + +L N+L++E + + DFG
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG---- 177
Query: 199 LLGRSLSDSDMALRLGT---P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQ 253
L R + D + P +MAPE V + ++D W FG + E+ T G
Sbjct: 178 -LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLLWEIFTLGGS 233
Query: 254 PWFGKSVEEIY 264
P+ G VEE++
Sbjct: 234 PYPGIPVEELF 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 39/108 (36%), Positives = 52/108 (48%), Gaps = 17/108 (15%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD--MALRLG 214
QL +G+ +HS +L +LKPSNLLL+ + L + DFG L R+ S+ M +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-----LARTTSEKGDFMTEYVV 170
Query: 215 TPNYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GK 258
T Y APE E I D W GC E+L +P F GK
Sbjct: 171 TRWYRAPELLLNCS-EYTTAI----DVWSVGCIFAELLGR-KPLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 129 FYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188
+ + V I ++ L D+L + Q+AKG+S L S + +L N+LL+
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 189 VLGDFGIPYLLLGRSL-SDSDMAL----RLGTPNYMAPEQWEPEVRGPISFETDTWGFGC 243
+ DFG L R + +DS+ + RL +MAPE V +FE+D W +G
Sbjct: 254 KICDFG-----LARDIRNDSNYVVKGNARLPV-KWMAPESIFNCV---YTFESDVWSYGI 304
Query: 244 SIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM 302
+ E+ + G P+ G V+ ++ ++ + + P P + +++ C++ D RP
Sbjct: 305 LLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364
Query: 303 ADILHAFE 310
I+ E
Sbjct: 365 KQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 50/179 (27%), Positives = 74/179 (41%), Gaps = 44/179 (24%)
Query: 139 AQQRGGKLPLPDILRY-------------GI-----------QLAKGISDLHSIGLLVLN 174
A Q GGKL L IL Y GI +++ + LH G++ +
Sbjct: 68 AFQTGGKLYL--ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRD 125
Query: 175 LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPIS 233
LKP N+LL + L DFG L S+ + + GT YMAPE +R
Sbjct: 126 LKPENILLDAQGHVKLTDFG----LCKESIHEGTVTHTFCGTIEYMAPEIL---MRSGHG 178
Query: 234 FETDTWGFGCSIMEMLTGIQPWFG----KSVEEIYHSVVIKKEKPCIPSGLPPAVENVI 288
D W G + +MLTG P+ K++++I K K +P L P +++
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------KGKLNLPPYLTPEARDLL 231
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 174 NLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPIS 233
++KPSN+LL + + L DFGI L+ S++ + A G YMAPE+ +P R
Sbjct: 133 DVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDA---GCRPYMAPERIDPSARDGYD 188
Query: 234 FETDTWGFGCSIMEMLTGIQPW--FGKSVEEIYHSVVIKKEKPCIPSGLP----PAVENV 287
+D W G ++ E+ TG P+ + +++ + V+K + P + + P+ N
Sbjct: 189 VRSDVWSLGITLYEVATGKFPYPKWNSVFDQL--TQVVKGDPPILSNSEEREFSPSFVNF 246
Query: 288 IIGCFEYDLRNRPLMADIL 306
I C D RP ++L
Sbjct: 247 INLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ G+ +HS G++ +LKP NL ++E +L + DFG L R +D++M + T
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG-----LARH-ADAEMTGYVVTR 178
Query: 217 NYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
Y APE W + D W GC + EMLTG + GK
Sbjct: 179 WYRAPEVILNWMHYNQ-----TVDIWSVGCIMAEMLTGKTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
P + S+ L +G G FG+V+ + D EL V + L E C++ + F
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGD---AVELQVAVK-TLPESCSEQDESDF 56
Query: 98 --EEL-FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD--------RIAQQRGGKL 146
E L KF Q++ L G+S I ++ G GD R +R L
Sbjct: 57 LMEALIMSKFNH-QNIVRLIGVSFERLPRFILLELMAG--GDLKSFLRENRPRPERPSSL 113
Query: 147 PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH--DQLV-LGDFGIPYLLLGRS 203
+ D+L +AKG L + ++ N LL+ ++ + DFG + R
Sbjct: 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG-----MARD 168
Query: 204 LSDSDMALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259
+ + + G M P +W P + G + +TD W FG + E+ + G P+ G++
Sbjct: 169 IYRASYYRKGGRA--MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 260 VEEIYHSVVI--KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+E+ V + + P G P V ++ C+++ +RP A IL +
Sbjct: 227 NQEVMEFVTGGGRLDPP---KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 61/274 (22%), Positives = 122/274 (44%), Gaps = 26/274 (9%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+GRG FG+V+LA + ++ + VK L K++ + + ++F K +V
Sbjct: 13 LGRGEFGEVFLA-KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK-NV 70
Query: 111 CWLHGISVINGKICIAMKFYEGSVGD-----RIAQQRGGKL---PL--PDILRYGIQLAK 160
L G+ + +++ + +GD R + + KL PL + Q+A
Sbjct: 71 VRLLGLCREAEPHYMILEYTD--LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
G+ L + + +L N L+S ++ + L L + + +S+ N +
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREV-----KVSLLSLSKDVYNSEYYKLR---NALI 180
Query: 221 PEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276
P +W PE S ++D W FG + E+ T G P++G S EE+ + + K + +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
P G P + ++ C+ + ++RP ++++ A
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF-VNKFEELFPKF 104
K+ +IG G F +V A ++ +Y+ A+K + K+ + VN E+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTG----KYY--AIKCM---KKHFKSLEQVNNLREIQALR 52
Query: 105 RESQSVCWLHGISVI----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPD--ILRYGIQL 158
R S L I V+ G++ + + + ++ + I +G K PLP+ + Y QL
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELI---KGRKRPLPEKRVKSYMYQL 109
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG--------IPYLLLGRSLSDSDMA 210
K + +H G+ ++KP N+L+ + D L L DFG PY
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY------------T 156
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256
+ T Y APE + G + D W GC E+L+ + P F
Sbjct: 157 EYISTRWYRAPECLLTD--GYYGPKMDIWAVGCVFFEILS-LFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 22/158 (13%)
Query: 120 NGKICIAMKF-YEGS----VGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLN 174
NGK + + F Y S D + G LP I + QL KG++ H G++ +
Sbjct: 76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRD 135
Query: 175 LKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSD--SDMALRLGTPNYMAPEQWEPEVRGP 231
LKP NLL+ + L+ + D G LGR+ S + T Y APE + G
Sbjct: 136 LKPQNLLVDKQKGLLKIADLG-----LGRAFSIPVKSYTHEIVTLWYRAPEV----LLGS 186
Query: 232 ISFET--DTWGFGCSIMEMLTGIQPWF-GKS-VEEIYH 265
+ T D W GC EM QP F G S ++++ H
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRK-QPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 37/154 (24%)
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP-----------YLLLGRSLSDSDM 209
I +H +G + ++KP NLLL + L DFG+ Y L SL SD
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP-SDF 171
Query: 210 ALR----------------------LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIME 247
+ +GTP+Y+APE + ++ + D W G + E
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF---MQTGYNKLCDWWSLGVIMYE 228
Query: 248 MLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281
ML G P+ ++ +E Y V+ KE P +P
Sbjct: 229 MLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
+Y Q+ +GI HS ++ ++KP N+L+S+ + L DFG L +D
Sbjct: 104 KYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY--- 160
Query: 213 LGTPNYMAPEQWEPEVRGPISF--ETDTWGFGCSIMEMLTGIQPWF-GKS-VEEIYH 265
+ T Y APE + G + D W GC + EMLTG +P F G S ++++YH
Sbjct: 161 VATRWYRAPEL----LVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 13/166 (7%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L L D++ Y Q+AKG+ L S + +L N+LLSE++ + + DFG L R +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG-----LARDIY 230
Query: 206 DSDMALRLGTP----NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260
+R G +MAPE V + ++D W FG + E+ + G P+ G +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287
Query: 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
+E + + + + P P + ++ C+ + RP ++++
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 37/112 (33%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G++ H +L +LKP NLL++E +L L DFG L +S+ + + T
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFG---LARAKSVPTKTYSNEVVTL 168
Query: 217 NYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWF-GKSVEEIYH 265
Y P+ + G + T D WG GC EM +G +P F G +VE+ H
Sbjct: 169 WYRPPDV----LLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 33/115 (28%), Positives = 52/115 (45%), Gaps = 9/115 (7%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y Q+ L S+ ++ +LKP NLLL + + + DFG ++ R+ +
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LC 189
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
GTP Y+APE G + D W G I E+L G P++ IY ++
Sbjct: 190 GTPEYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241
|
Length = 340 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 33/268 (12%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKF 97
I+ LKL IG+G FGDV L + ++AVK LK+D A+ F+ +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--------RGQKVAVKC---LKDDSTAAQAFLAE- 50
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
+ R V L G+ + + I ++ GS+ D + + + L L + +
Sbjct: 51 ASVMTTLRHPNLVQLL-GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL 109
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
+ +G+ L + +L N+L+SE + DFG L + S + +L
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFG-----LAKEASQGQDSGKL--- 161
Query: 217 NYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P +W PE S ++D W FG + E+ + G P+ ++++ V
Sbjct: 162 ----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP 300
P G PP V V+ C+E D RP
Sbjct: 218 MEA-PEGCPPEVYKVMKDCWELDPAKRP 244
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ +HS ++ +LKPSNL ++E +L + DFG L R +D +M + T
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG-----LARH-TDDEMTGYVATR 181
Query: 217 NYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTG 251
Y APE W + D W GC + E+LTG
Sbjct: 182 WYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 106 ESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
+ V L GI ++ ++ + + G + D + + + +L + +Q+AKG+S
Sbjct: 67 DHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSY 124
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG--TP-NYMAP 221
L L+ +L N+L+ + + DFG+ LL D G P +MA
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----DVDEKEYHAEGGKVPIKWMAL 180
Query: 222 EQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280
E + ++D W +G ++ E++T G +P+ G EI ++ K E+ P
Sbjct: 181 ESIL---HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-PDLLEKGERLPQPPIC 236
Query: 281 PPAVENVIIGCFEYDLRNRP 300
V V++ C+ D +RP
Sbjct: 237 TIDVYMVLVKCWMIDAESRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 61/275 (22%), Positives = 109/275 (39%), Gaps = 55/275 (20%)
Query: 49 HRIGRGPFGDV----WLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF 104
+G G FG V +L + E+AVK L K +E
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEV-------EVAVKTLKQEHIAAGK------KEFL--- 44
Query: 105 RESQSVCWLH--------GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
RE+ + L G+ + + M+ G + + ++R ++P+ D+
Sbjct: 45 REASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRR--EIPVSDLKELA 101
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
Q+A G++ L S + +L N+LL Q + DFG + R AL G+
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG-----MSR-------ALGAGS 149
Query: 216 PNYMA------PEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYH 265
Y A P +W PE G S ++D W +G ++ E + G +P+ E+
Sbjct: 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209
Query: 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
+ + P P P + ++++ C++Y +RP
Sbjct: 210 MLESGERLPR-PEECPQEIYSIMLSCWKYRPEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD------MA 210
QL +G+ +HS ++ +LKPSNLL++E +L +GDFG + R LS S M
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFG-----MARGLSSSPTEHKYFMT 169
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV 260
+ T Y APE + D W GC EML Q + GK+
Sbjct: 170 EYVATRWYRAPELLLSLPE--YTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 36/119 (30%), Positives = 55/119 (46%), Gaps = 20/119 (16%)
Query: 148 LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS--LS 205
+ L ++ I +HS G+L +LKP N+LL ++V+ D+G L
Sbjct: 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 206 DSDMALR-------------LGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLT 250
D D+ R +GTP+YMAPE+ + G P S TD + G + +MLT
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPER----LLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 39/119 (32%), Positives = 53/119 (44%), Gaps = 22/119 (18%)
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+QL G++ LH +L +LK SNLLL+ L + DFG L R L+ T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG-----LAREYGSP---LKPYT 164
Query: 216 PN-----YMAPEQW--EPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS-VEEIYH 265
Y APE E I D W GC E+LT +P F GKS ++++
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAI----DMWSVGCIFAELLTK-KPLFPGKSEIDQLNK 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 24/139 (17%)
Query: 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182
+ I ++ E + + + Q L + QL +G+ +HS +L +LKP+N+ +
Sbjct: 91 VYIVQEYMETDLANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 183 SEHDQLVL--GDFGIPYLLLGRSLSDSD------MALRLGTPNYMAPEQWEPEVRGPISF 234
+ + LVL GDFG+ ++ D ++ L T Y +P + P ++
Sbjct: 148 NT-EDLVLKIGDFGLARIV------DPHYSHKGYLSEGLVTKWYRSPRL----LLSPNNY 196
Query: 235 E--TDTWGFGCSIMEMLTG 251
D W GC EMLTG
Sbjct: 197 TKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
QL +G+ +HS G++ +LKPSN+ ++E +L + DFG L R +D +M + T
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG-----LARQ-ADDEMTGYVATR 179
Query: 217 NYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTG 251
Y APE W + D W GC + E+L G
Sbjct: 180 WYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y ++ + LH +G++ ++K N+LL + +VL DFG+ + + A
Sbjct: 110 YSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE---DEVERAYSF 166
Query: 214 -GTPNYMAPEQWEPEVRGPISFE---TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV- 268
GT YMAP+ VRG D W G + E+LTG P F E+ + +
Sbjct: 167 CGTIEYMAPDI----VRGGDGGHDKAVDWWSMGVLMYELLTGASP-FTVDGEKNSQAEIS 221
Query: 269 --IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLG 326
I K +P P + +++I D + R L A E ++ + W L
Sbjct: 222 RRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR-LGCGPSDADEIKKHPFFQKINWDDLA 280
Query: 327 SR 328
++
Sbjct: 281 AK 282
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 5e-06
Identities = 58/263 (22%), Positives = 114/263 (43%), Gaps = 20/263 (7%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
+IG+G G V+ +A D E+A+K + ++ ++ +N E L + ++ +
Sbjct: 26 KIGQGASGTVY------TAIDIATGQEVAIKQMNLQQQPKKELIIN--EILVMRENKNPN 77
Query: 110 VCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI 168
+ ++ ++ + M++ G S+ D + + + + + R +Q + LHS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALDFLHSN 134
Query: 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV 228
++ ++K N+LL + L DFG + S M +GTP +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKA 191
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCIPSGLPPAVENV 287
GP + D W G +EM+ G P+ ++ + +Y + P L +
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248
Query: 288 IIGCFEYDLRNRPLMADIL-HAF 309
+ C E D+ R ++L H F
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPF 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 38/121 (31%), Positives = 53/121 (43%), Gaps = 34/121 (28%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG------IPYLLLGRSLSDSDMA 210
QL +G++ H +L +LKP NLL+SE +L L DFG +P ++ S+ +
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP----SKTYSNEVVT 166
Query: 211 L-------RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF--GKSVE 261
L LG+ Y S D WG GC EM TG +P F VE
Sbjct: 167 LWYRPPDVLLGSTEY--------------STSLDMWGVGCIFYEMATG-RPLFPGSTDVE 211
Query: 262 E 262
+
Sbjct: 212 D 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 42/186 (22%), Positives = 82/186 (44%), Gaps = 23/186 (12%)
Query: 122 KICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178
K+C + G GD ++Q G ++ Y ++ G+ +H+ ++ +LKP+
Sbjct: 71 KLCFILDLMNG--GDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPA 126
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDT 238
N+LL EH + + D G L S +GT YMAPE + +G +
Sbjct: 127 NILLDEHGHVRISDLG-----LACDFSKKKPHASVGTHGYMAPEVLQ---KGTAYDSSAD 178
Query: 239 W-GFGCSIMEMLTGIQPWFGKSVEEIYH----SVVIKKEKPCIPSGLPPAVENVIIGCFE 293
W GC + ++L G P+ ++ + ++ + E +P P +++++ G +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE---LPDSFSPELKSLLEGLLQ 235
Query: 294 YDLRNR 299
D+ R
Sbjct: 236 RDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ +HS G++ +LKPSN+ ++E +L + DFG L R D +M + T
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG-----LARHT-DDEMTGYVATR 179
Query: 217 NYMAPE---QWEPEVRGPISFE--TDTWGFGCSIMEMLTGIQPWF 256
Y APE W + + D W GC + E+LTG + F
Sbjct: 180 WYRAPEIMLNW-------MHYNQTVDIWSVGCIMAELLTG-KTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 35/153 (22%)
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL-------LGRSLSD---SDMA 210
I +H +G + ++KP NLLL + L DFG+ L R+L+ SD +
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 211 LR----------------------LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEM 248
+ +GTP+Y+APE + ++ + D W G + EM
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF---MQTGYNKLCDWWSLGVIMYEM 229
Query: 249 LTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281
L G P+ ++ +E Y V+ KE P +P
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 6e-06
Identities = 56/263 (21%), Positives = 114/263 (43%), Gaps = 20/263 (7%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
+IG+G G V+ +A D E+A++ + ++ ++ +N E L + ++ +
Sbjct: 27 KIGQGASGTVY------TAMDVATGQEVAIRQMNLQQQPKKELIIN--EILVMRENKNPN 78
Query: 110 VCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI 168
+ ++ ++ + M++ G S+ D + + + + + R +Q + LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN 135
Query: 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV 228
++ ++K N+LL + L DFG + S M +GTP +MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKA 192
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCIPSGLPPAVENV 287
GP + D W G +EM+ G P+ ++ + +Y + P L +
Sbjct: 193 YGP---KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 288 IIGCFEYDLRNRPLMADIL-HAF 309
+ C + D+ R ++L H F
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQF 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 29/106 (27%), Positives = 46/106 (43%), Gaps = 24/106 (22%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ LHS ++ +LKPSN+L++ + L + DFG L R + + T
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG-----LARGVDPDEDEKGFLTE 165
Query: 217 N-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTG 251
Y APE ++ + D W GC E+LT
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 127 MKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185
M++ G GD + Q QR K P Y ++ + LH G++ +LK N+LL
Sbjct: 75 MEYVNG--GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132
Query: 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSI 245
L DFG+ + ++ + GTP+Y+APE + GP D W G +
Sbjct: 133 GHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEILQELEYGP---SVDWWALGVLM 186
Query: 246 MEMLTGIQPWFGKSVEEIYHSVV 268
EM+ G P+ + ++++ S++
Sbjct: 187 YEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 62/314 (19%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSAD--------DFDEYHEL--AVKMLLPLKEDCAKVFV 94
L K ++G G FG+V L D + + L AVK+L P D K
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRP---DANKNAR 63
Query: 95 NKF-EELFPKFRESQ-SVCWLHGISVINGKICIAMKFYE---------------GSVGDR 137
N F +E+ R ++ L G+ V +C+ ++ E
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 138 IAQQRGGKLPLPD---ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194
A LP +L +Q+A G+ L S+ + +L N L+ E+ + + DFG
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 195 IP--------YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIM 246
+ Y + GR++ + +R +MA WE + G + +D W FG ++
Sbjct: 184 MSRNLYAGDYYRIQGRAV----LPIR-----WMA---WECILMGKFTTASDVWAFGVTLW 231
Query: 247 EMLT--GIQPWFGKSVEEIYHSV--VIKKEKPCIPSGLPPA----VENVIIGCFEYDLRN 298
E+L QP+ + E++ + + + + PP + +++ C+ D R
Sbjct: 232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291
Query: 299 RPLMADILHAFESS 312
RP +DI HAF +
Sbjct: 292 RPSFSDI-HAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 38/115 (33%), Positives = 53/115 (46%), Gaps = 19/115 (16%)
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
+PLP I Y QL +G++ HS +L +LKP NLL++ + L DFG L R
Sbjct: 94 LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG-----LAR 148
Query: 203 SLSDSDMALRLGTPN-----YMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLT 250
+ + +R T Y APE + G + T D W GC EM+T
Sbjct: 149 AFG---VPVRTYTHEVVTLWYRAPEI----LLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 25/200 (12%)
Query: 125 IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184
I ++F G D + + L P I Q + ++ LH ++ +LK N+L +
Sbjct: 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL 138
Query: 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE--QWEPEVRGPISFETDTWGFG 242
+ L DFG+ R++ D +GTP +MAPE E P ++ D W G
Sbjct: 139 DGDIKLADFGVSAKNT-RTIQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 195
Query: 243 CSIMEMLTGIQPWFGKSVEEIYHSV--------VIKKEKPCI--PSGLPPAVENVIIGCF 292
+++EM +E +H + + K E P + PS ++ + C
Sbjct: 196 ITLIEM---------AQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCL 246
Query: 293 EYDLRNRPLMADIL-HAFES 311
E ++ R +L H F +
Sbjct: 247 EKNVDARWTTTQLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 14/125 (11%)
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI--PYLLL 200
G + + + QL KG++ HS +L +LKP NLL++++ +L L DFG+ + +
Sbjct: 93 NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152
Query: 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWF-G 257
R S + L P+ + G + T D W GC E+ +P F G
Sbjct: 153 VRCYSAEVVTLWYRPPDVLF---------GAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203
Query: 258 KSVEE 262
V++
Sbjct: 204 NDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 52/219 (23%), Positives = 78/219 (35%), Gaps = 41/219 (18%)
Query: 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182
+C+ M Y+ + + R G LPL + +L + ++ LH G++ ++K N+ L
Sbjct: 161 VCMVMPKYKCDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218
Query: 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFG 242
E + VLGDFG L + GT +PE + P +TD W G
Sbjct: 219 DEPENAVLGDFGAACKLDAHPDTPQCYGW-SGTLETNSPELLALD---PYCAKTDIWSAG 274
Query: 243 CSIMEMLTGIQPWFGKSVEEIYHSV-----------------------------VIKKEK 273
+ EM FGK V+ + I
Sbjct: 275 LVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRP 334
Query: 274 P-CIP-----SGLPPAVENVIIGCFEYDLRNRPLMADIL 306
P IP G+ VE +I +D RP DIL
Sbjct: 335 PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373
|
Length = 392 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 61/244 (25%), Positives = 97/244 (39%), Gaps = 61/244 (25%)
Query: 38 PWIDPTS-LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
P+ D S + +IG+G FG+V+ A H ++ A+K +L E
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIV------ALKKVLMENE--------- 50
Query: 97 FEELFP--KFRESQSVCWLHGISVIN----------------GKICIAMKFYEGSVGDRI 138
+E FP RE + + L +V+N G + +F E + +
Sbjct: 51 -KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLA-GL 108
Query: 139 AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198
+ K L +I + L G+ +H +L ++K +N+L+++ L L DFG
Sbjct: 109 LSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG---- 164
Query: 199 LLGRSLSDSD------MALRLGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIM 246
L R+ S S R+ T Y PE + P PI D WG GC +
Sbjct: 165 -LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGP----PI----DMWGAGCIMA 215
Query: 247 EMLT 250
EM T
Sbjct: 216 EMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 8/118 (6%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
P P Y Q+ G+ LH ++ +LKP N+LL + + D G+ L
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW--FGKSVE 261
A GTP +MAPE + E F D + G ++ EM+ P+ G+ VE
Sbjct: 154 TKGYA---GTPGFMAPELLQGE---EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 38/170 (22%), Positives = 82/170 (48%), Gaps = 14/170 (8%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L + D++ + Q+++G+ L + L+ +L N+L++E ++ + DFG L R +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFG-----LSRDVY 178
Query: 206 DSDMALRLGTP----NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260
+ D ++ +MA E + + ++D W FG + E++T G P+ G +
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
E ++ +++ + P + N+++ C++ + RP ADI E
Sbjct: 236 ERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 30/171 (17%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ GI LHS G++ +LKPSN+++ L + DFG L R+ S M TP
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFMM----TP 184
Query: 217 NYMAPEQWEPEVRGPISFE--TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
+ PEV + ++ D W GC + EM+ G + G + ++ V+ + P
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 275 C--IPSGLPPAVENVIIGCFEYDLRNRP---------LMADILHAFESSQN 314
C L P V + NRP L D+L +S N
Sbjct: 245 CPEFMKKLQPTVRTYV--------ENRPKYAGYSFEKLFPDVLFPADSEHN 287
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 41/167 (24%), Positives = 66/167 (39%), Gaps = 44/167 (26%)
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP-----------YLLLGRSLSDSDMA 210
I +H +G + ++KP NLLL + L DFG+ Y +L +L + +
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 211 LR------------------------LGTPNYMAPEQWEPEVRGPISF--ETDTWGFGCS 244
+GTP+Y+APE V + E D W G
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-----VFLQTGYNKECDWWSLGVI 228
Query: 245 IMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP--PAVENVII 289
+ EML G P+ + +E Y ++ KE P +P P +++I
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIK 275
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
++ Y ++ G+ +H+ ++ +LKP+N+LL EH + + D G L S
Sbjct: 98 EMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG-----LACDFSKKKP 152
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+GT YMAPE + V S D + GC + ++L G P+
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 40/175 (22%), Positives = 83/175 (47%), Gaps = 16/175 (9%)
Query: 139 AQQRGGKLP--LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196
A+ G+ P L ++++ ++A G++ L++ + +L N +++ + +GDFG
Sbjct: 107 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG-- 164
Query: 197 YLLLGRSLSDSDMALRLGTP----NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-G 251
+ R + ++D + G +MAPE + V S D W FG + E+ +
Sbjct: 165 ---MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITSLA 218
Query: 252 IQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
QP+ G S E++ V+ P P V +++ C++++ + RP +I+
Sbjct: 219 EQPYQGLSNEQVL-KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ GI LHS G++ +LKPSN+++ L + DFG L R+ S M TP
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFMM----TP 177
Query: 217 NYMAPEQWEPEVRGPISFE--TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
+ PEV + ++ D W GC + EM+ + G+ + ++ V+ + P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 275 C--IPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
C L P V N + NRP A +
Sbjct: 238 CPEFMKKLQPTVRNYV--------ENRPKYAGL 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 37/180 (20%)
Query: 123 ICIAMKFYEGSVGD--RIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179
+C+ M + G G+ R+ Q Q G L Y ++ + LH +G++ +LKP N
Sbjct: 76 LCLVMDYCPG--GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 180 LLLSEHDQLVLGDFGIPYLL----------LGRSLSDSDMALRL---------------- 213
+LL E ++L DF + L + S +
Sbjct: 134 ILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFV 193
Query: 214 GTPNYMAPEQWEPEVRGP-ISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
GT Y+APE + G D W G + EML G P+ G + +E + S ++KKE
Sbjct: 194 GTEEYIAPEV----ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF-SNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR--SLSDSDMALRL 213
+QL +G+ LH ++ +LK SNLLL++ L + DFG L R L M ++
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFG-----LARTYGLPAKPMTPKV 169
Query: 214 GTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWF-GKS 259
T Y APE + G ++ T D W GC + E+L +P GKS
Sbjct: 170 VTLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 69/309 (22%), Positives = 123/309 (39%), Gaps = 70/309 (22%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF 104
LK +G G FG V L + + D E +AVK LK +C +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEM--VAVK---TLKRECG-----------QQN 49
Query: 105 RESQSVCWLHGISV---------INGKIC----------IAMKFYE-GSVGDRIAQQRGG 144
W I++ + K C + M++ GS+ D + +
Sbjct: 50 TSG----WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--- 102
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRS 203
KL L +L + Q+ +G++ LHS + +L N+LL ++D+LV +GDFG L ++
Sbjct: 103 KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL-DNDRLVKIGDFG-----LAKA 156
Query: 204 LSDSDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFG--K 258
+ + R+ + +P W E S+ +D W FG ++ E+LT K
Sbjct: 157 VPEGHEYYRV-REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215
Query: 259 SVEEIYH------------SVVIKKEK-PCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
EE+ ++ + + PC P P V ++ C+E + + RP +
Sbjct: 216 KFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFRPTFRSL 274
Query: 306 LHAFESSQN 314
+ + +
Sbjct: 275 IPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 33/121 (27%), Positives = 46/121 (38%), Gaps = 22/121 (18%)
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG--------IP 196
KL I Y +QL +GI+ LH +L ++K +N+L+ L + DFG P
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 197 YLLLGRSLSDSDMALRLGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLT 250
G + T Y PE ++ V D WG GC EM T
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV--------DIWGIGCVFAEMFT 222
Query: 251 G 251
Sbjct: 223 R 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 28/168 (16%)
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP-------Y 197
KLPL +L++ + +A G+ L + + +L N +L E + + DFG+ Y
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168
Query: 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256
GR + M ++ ++A E V S D W FG ++ E+ T G P+
Sbjct: 169 YRQGRI---AKMPVK-----WIAIESLADRVYTSKS---DVWAFGVTMWEIATRGQTPYP 217
Query: 257 GKSVEEIY----HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
G EIY H +K+ + C + +++ C+ D ++RP
Sbjct: 218 GVENHEIYDYLRHGNRLKQPEDC-----LDELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 53/226 (23%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP L K +IG G G+V+ AT + E+A+K + L++ ++ +N+
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGK------EVAIKKM-RLRKQNKELIINEILI 68
Query: 100 LFPKFRESQSV-------CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDI 151
+ ++ + +L + ++ + M++ + GS+ D I Q ++ P I
Sbjct: 69 M----KDCKHPNIVDYYDSYL-----VGDELWVVMEYMDGGSLTDIITQNFV-RMNEPQI 118
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
++ +G+ LHS ++ ++K N+LLS+ + L DFG L + +
Sbjct: 119 AYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-- 176
Query: 212 RLGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWF 256
+GTP +MAPE ++ + D W G +EM G P+
Sbjct: 177 -VGTPYWMAPEV----IKRKDYGPKVDIWSLGIMCIEMAEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 32/122 (26%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y +L I +H +G + ++KP N+L+ + L DFG L + +S + +
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--V 164
Query: 214 GTPNYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270
GTP+Y+APE + +G E D W G EM+ G P+ + + Y++++
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224
Query: 271 KE 272
+
Sbjct: 225 QR 226
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 17/128 (13%)
Query: 144 GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203
+L D++ Q+A+G+ L S + +L N+L++E + + + DFG L R
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFG-----LARG 183
Query: 204 LSDSDMALRLGTPN------YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256
+ D D + T N +MAPE V + ++D W FG + E+ T G P+
Sbjct: 184 VHDIDYYKK--TSNGRLPVKWMAPEALFDRV---YTHQSDVWSFGILMWEIFTLGGSPYP 238
Query: 257 GKSVEEIY 264
G VEE++
Sbjct: 239 GIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 21/278 (7%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
I P+ + + IG G FG+V+ + +A+K L P + +
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEAS 58
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGK---LPLPDILRYGI 156
+ +F ++ L G+ I ++ E D+ + G+ L +LR GI
Sbjct: 59 IMGQFSH-HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GI 116
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
A G+ L + + +L N+L++ + + + DFG L R L D D T
Sbjct: 117 --AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG-----LSRVLED-DPEGTYTTS 168
Query: 217 NYMAPEQWE-PEVRGPISFET--DTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P +W PE F + D W FG + E+++ G +P++ S E+ ++
Sbjct: 169 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR 228
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
P P P AV +++ C++ D RP DI++ +
Sbjct: 229 LPA-PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 24/113 (21%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS-LSDSD----MAL 211
Q+ +G+ +HS +L +LKPSNLLL+ + L + DFG L R + D +
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG-----LARIADPEHDHTGFLTE 168
Query: 212 RLGTPNYMAPEQWEPEVRGPISFET-----DTWGFGCSIMEMLTGIQPWF-GK 258
+ T Y APE ++ + D W GC + EML+ +P F GK
Sbjct: 169 YVATRWYRAPEIM-------LNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 61/276 (22%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
IDP+ + ++ IG G FG+V + ++A+K L D ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLP---GKKEIDVAIKTLKAGSSDKQRLDFLTEAS 57
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILR--YGIQ 157
+ +F ++ L G+ + + I ++ E D+ ++ GK + ++ GI
Sbjct: 58 IMGQFDHP-NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGI- 115
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
A G+ L + + +L N+L++ + + DFG L R L DS+ T
Sbjct: 116 -ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG-----LSRRLEDSE-----ATYT 164
Query: 218 YMA---PEQW-EPEVRGPISFET--DTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIK 270
P +W PE F + D W FG + E+++ G +P++ S +++ +V
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224
Query: 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
P P P A+ +++ C++ D RP + I+
Sbjct: 225 YRLPP-PMDCPSALYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 38/173 (21%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 147 PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206
L +++ ++A G++ L++ + +L N +++E + +GDFG + R + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG-----MTRDIYE 171
Query: 207 SDMALRLGTP----NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261
+D + G +M+PE + G + +D W FG + E+ T QP+ G S E
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
Query: 262 EIYHSV----VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
++ V ++ K P P + ++ C++Y+ + RP +I+ + +
Sbjct: 229 QVLRFVMEGGLLDK-----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 18/76 (23%), Positives = 36/76 (47%)
Query: 235 ETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEY 294
+ D + G + E+ TG P+ + +EIY ++ K +P P ++ ++ C +
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH 261
Query: 295 DLRNRPLMADILHAFE 310
D RP + +IL+
Sbjct: 262 DSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 34/124 (27%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204
++ D++ Q+A+G+ L S + +L N+L++E++ + + DFG L R +
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG-----LARDV 187
Query: 205 SDSDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260
++ D + T N P +W PE + ++D W FG + E+ T G P+ G V
Sbjct: 188 NNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245
Query: 261 EEIY 264
EE++
Sbjct: 246 EELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 58/299 (19%)
Query: 41 DPT-SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DPT + ++ IG+G +G V+ T+ + AVK+L P+ + EE
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGS------LAAVKILDPISD--------VDEE 64
Query: 100 LFPKFRESQS------VCWLHGI-----SVINGKICIAMKFYEG-SVGDRIAQ--QRGGK 145
+ ++ QS V +G+ ++ G++ + ++ G SV + + G +
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 146 LPLPDI--LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203
L I + YG L G+ LH+ ++ ++K +N+LL+ + L DFG+ L
Sbjct: 125 LDEAMISYILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWFGKSVE 261
L + +GTP +MAPE E + S++ D W G + +E+ G P F
Sbjct: 183 LRRNT---SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD---- 235
Query: 262 EIYHSVVIKKEKPCIPSGLPPAVEN----------VIIGCFEYDLRNRPLMADIL-HAF 309
H V K IP PP + + I C D RP + +L H F
Sbjct: 236 --MHPV---KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 65/302 (21%), Positives = 128/302 (42%), Gaps = 59/302 (19%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHEL----------AVKMLLPLKEDCAKVFV 94
L K ++G G FG+V L D+ L AVKML +ED K
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML---REDANKNAR 63
Query: 95 NKFEE---LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD-------RIAQQRGG 144
N F + + + ++ ++ L + + + +C+ ++ E GD Q+
Sbjct: 64 NDFLKEIKIMSRLKDP-NIIRLLAVCITSDPLCMITEYMEN--GDLNQFLSRHEPQEAAE 120
Query: 145 KLPLPDI----LRY-GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP--- 196
K + I L + Q+A G+ L S+ + +L N L+ ++ + + DFG+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 197 -----YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG 251
Y + GR++ + +R +M+ WE + G + +D W FG ++ E+LT
Sbjct: 181 YSGDYYRIQGRAV----LPIR-----WMS---WESILLGKFTTASDVWAFGVTLWEILTL 228
Query: 252 I--QPWFGKSVEEIYHSV--VIKKEKPCI----PSGLPPAVENVIIGCFEYDLRNRPLMA 303
QP+ S E++ + + + + P+ P ++ +++ C+ + + RP
Sbjct: 229 CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288
Query: 304 DI 305
+I
Sbjct: 289 EI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 27/117 (23%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR-SLSDSDMAL---- 211
QL + + +H+ + +LKP N+L + +L + DFG L R + +D+ A+
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG-----LARVAFNDTPTAIFWTD 165
Query: 212 RLGTPNYMAPE-------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSV 260
+ T Y APE ++ P + D W GC E+LTG +P F GK+V
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAI--------DIWSIGCIFAEVLTG-KPLFPGKNV 213
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 27/193 (13%)
Query: 132 GSVGDRIAQ--QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189
GSV D + +RG ++ P I + G+ LH + ++K +N+LL+ +
Sbjct: 105 GSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK 164
Query: 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIME 247
L DFG+ L L + +GTP +MAPE E + +++ D W G + +E
Sbjct: 165 LVDFGVSAQLTSTRLRRNT---SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
Query: 248 MLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE----------NVIIGCFEYDLR 297
+ G P + +++ + K IP PP + + I C D
Sbjct: 222 LGDGDPP-----LADLHPMRALFK----IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYE 272
Query: 298 NRPLMADIL-HAF 309
RP ++D+L H F
Sbjct: 273 KRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ GI LHS G++ +LKPSN+++ L + DFG L R+ + M TP
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTACTNFMM----TP 181
Query: 217 NYMAPEQWEPEVRGPISFE--TDTWGFGCSIMEMLTG 251
+ PEV + ++ D W GC + E++ G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 39/163 (23%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
+L + +Q+AKG++ L L+ +L N+L+ + + DFG+ LL + +
Sbjct: 111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKEYH 167
Query: 211 LRLGTPNYMAPEQW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266
G P +W E + + ++D W +G ++ E++T G +P+ G EI S
Sbjct: 168 AEGGK----VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS 222
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
++ K E+ P V +++ C+ D +RP +++ F
Sbjct: 223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 51/287 (17%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLA---THHQSA-----------DDFDEYHELAVKMLLPL 85
I+P+ L +G G FG V L + A +DF E ++ +K+ P
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHP- 59
Query: 86 KEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGK 145
+ L+G+ + I +F E +QR GK
Sbjct: 60 -----------------------KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK 96
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L +L + +G+ L + +L N L+S + + DFG+ +L +
Sbjct: 97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156
Query: 206 DSDMALRLGTPNYMAPEQWE-PEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261
S A P +W PEV S ++D W FG + E+ T G P+ KS
Sbjct: 157 SSSGA--------KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208
Query: 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHA 308
E+ ++ + + P V V+ C+ RP A++L A
Sbjct: 209 EVV-EMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRA 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS-L 204
L L D+LR+ Q+A+G+ L S + ++ N+LL++ + DFG L R +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFG-----LARDIM 263
Query: 205 SDSDMAL----RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259
+DS+ + RL +MAPE V + ++D W +G + E+ + G P+ G
Sbjct: 264 NDSNYVVKGNARLPV-KWMAPESIFDCV---YTVQSDVWSYGILLWEIFSLGKSPYPGIL 319
Query: 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
V ++ +V + + P PP + +++ C+ + RP + I
Sbjct: 320 VNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 42/129 (32%), Positives = 59/129 (45%), Gaps = 22/129 (17%)
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204
L P I Y QL +GI+ HS +L +LKP NLL+ L L DFG L R+
Sbjct: 95 GLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG-----LARAF 149
Query: 205 SDSDMALRLGTPN-----YMAPEQWEPEVRGPISFET--DTWGFGCSIMEMLTGIQPWF- 256
+ +R T Y APE + G + T D W GC EM+ +P F
Sbjct: 150 G---VPVRTYTHEVVTLWYRAPEI----LLGSRQYSTPVDIWSIGCIFAEMVNR-RPLFP 201
Query: 257 GKS-VEEIY 264
G S +++++
Sbjct: 202 GDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 17/127 (13%)
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204
+L D++ Q+A+G+ L S + +L N+L++E + + + DFG L R +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG-----LARDV 184
Query: 205 SDSDMALRLGTPN------YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFG 257
+ D + T N +MAPE V + ++D W FG + E+ T G P+ G
Sbjct: 185 HNIDYYKK--TTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 258 KSVEEIY 264
VEE++
Sbjct: 240 IPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
+L + +Q+AKG+ L L+ +L N+L+ + + + DFG+ LL G +
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 211 LRLGTPNYMAPEQW---EPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266
++ P +W E + ++D W +G +I E++T G +P+ G EI
Sbjct: 171 GKM-------PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PD 222
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
++ K E+ P V V++ C+ D +RP ++ F
Sbjct: 223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 39/175 (22%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 131 EGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190
+ V + ++ L D+L + Q+A+G+ L S + +L N+LL++ + +
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 191 GDFGIPYLLLGRS-LSDSDMALRLGT---PNYMAPEQWEPEVRGPISFETDTWGFGCSIM 246
DFG L R + DS+ + T +MAPE + +S D W +G +
Sbjct: 279 CDFG-----LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS---DVWSYGILLW 330
Query: 247 EMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
E+ + G P+ G V+ +++ + + P V ++++ C+ + RP
Sbjct: 331 EIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 40/235 (17%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109
+IG G FG+V+L H ++ +F + ++ + L ++ + VN EL +
Sbjct: 20 KIGNGRFGEVFLVKHKRT-QEFFCWKAISYRGLKEREKSQLVIEVNVMREL----KHKNI 74
Query: 110 VCWL-HGISVINGKICIAMKFYEGSVGDRIAQQ---RGGKLPLPDILRYGIQLAKGISDL 165
V ++ ++ N K+ I M+F + R Q+ GK+ I+ QL ++
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 166 HSI-----GLLVL--NLKPSNLLLSEHDQLV-----------------LGDFGIPYLLLG 201
H++ G VL +LKP N+ LS + + +GDFG L
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG-----LS 189
Query: 202 RSLSDSDMALR-LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+++ MA +GTP Y +PE E + ++D W GC I E+ +G P+
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKS-YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 11/123 (8%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L D++ Q+A+G+ L S + +L N+L++E + + + DFG L R +
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG-----LARDIH 191
Query: 206 DSDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261
D + T N P +W PE + ++D W FG + E+ T G P+ G VE
Sbjct: 192 HIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 262 EIY 264
E++
Sbjct: 250 ELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 34/101 (33%), Positives = 46/101 (45%), Gaps = 19/101 (18%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ GI LHS G++ +LKPSN+++ L + DFG L R+ S M TP
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFMM----TP 176
Query: 217 N-----YMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTG 251
Y APE + G D W GC + EM+ G
Sbjct: 177 YVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 35/106 (33%), Positives = 48/106 (45%), Gaps = 11/106 (10%)
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
LP I Q +G+ LH+ ++ +LKP N+L++ Q+ L DFG L R S
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG-----LARIYS 159
Query: 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFET--DTWGFGCSIMEML 249
MAL TP + PEV ++ T D W GC EM
Sbjct: 160 -CQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 16/101 (15%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD----MALR 212
Q+ +G+ LHS G+L ++KP NLL++ + L + DFG L R + + D M
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG-----LAR-VEEPDESKHMTQE 164
Query: 213 LGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTG 251
+ T Y APE + D W GC E+L
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
QL +G+ LHS ++ +LKP N+L++ Q+ L DFG+ + + S + T
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----T 172
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEML 249
Y APE ++ + D W GC EM
Sbjct: 173 LWYRAPEVL---LQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFE 98
ID + +K++ IG G FG+V E +A+K L E + F+++
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKR--EIF-VAIKTLKSGYTEKQRRDFLSE-A 56
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLP---LPDILRYG 155
+ +F + ++ L G+ + + I +F E D +Q G+ L +LR G
Sbjct: 57 SIMGQF-DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-G 114
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
I A G+ L + + +L N+L++ + + DFG L R L D
Sbjct: 115 I--AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG-----LSRFLEDDT-----SD 162
Query: 216 PNYMA------PEQWE-PEVRGPISFE-----TDTWGFGCSIMEMLT-GIQPWFGKSVEE 262
P Y + P +W PE I++ +D W +G + E+++ G +P++ S ++
Sbjct: 163 PTYTSSLGGKIPIRWTAPEA---IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
Query: 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ +++ P P P A+ +++ C++ D RP I+ +
Sbjct: 220 VINAIEQDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 56/269 (20%), Positives = 104/269 (38%), Gaps = 29/269 (10%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE--ELFPKFRESQ 108
+G+G F +++ +D V ++L + + + FE L +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 109 SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI 168
V L+G+ V + I + ++ + D + + L L QLA + L
Sbjct: 63 LV-KLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 169 GLLVLNLKPSNLLLSEHDQ-------LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAP 221
L+ N+ N+L++ + + L D GIP +L R + ++AP
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-------WIAP 173
Query: 222 EQWEPEVRGPISFET---DTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277
E +R + T D W FG +++E+ + G +P S E +++ +P
Sbjct: 174 EC----IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQDQHRLP 226
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADIL 306
+ N+I C+ YD RP IL
Sbjct: 227 MPDCAELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 57/208 (27%)
Query: 132 GSVGDRIAQQRGGKLPLPD-----ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186
GSV D + R L + ILR + +G++ LH ++ ++K N+LL+++
Sbjct: 94 GSVTDLVKGLRKKGKRLKEEWIAYILR---ETLRGLAYLHENKVIHRDIKGQNILLTKNA 150
Query: 187 QLVLGDFGIPYLLLGRSLSDSDMALR---LGTPNYMAPE------QWEPEVRGPISFETD 237
++ L DFG+ L DS + R +GTP +MAPE Q + +D
Sbjct: 151 EVKLVDFGVSAQL------DSTLGRRNTFIGTPYWMAPEVIACDEQPDAS----YDARSD 200
Query: 238 TWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC-----IPSGLPPAV-------- 284
W G + +E+ G P P IP PP +
Sbjct: 201 VWSLGITAIELADGKPPLC--------------DMHPMRALFKIPRNPPPTLKSPENWSK 246
Query: 285 --ENVIIGCFEYDLRNRPLMADIL-HAF 309
+ I C + RP M ++L H F
Sbjct: 247 KFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 27/109 (24%), Positives = 41/109 (37%), Gaps = 19/109 (17%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ G++ LH + +L P+N+ ++ + DFG L R + L
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG-----LARRYGYPPYSDTLSKD 181
Query: 217 NYMAP-EQWEPEV-----RGP--------ISFETDTWGFGCSIMEMLTG 251
M E+ +V R P F D W GC E+LTG
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 58/283 (20%), Positives = 108/283 (38%), Gaps = 82/283 (28%)
Query: 150 DILRYGI-QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY----------- 197
D+ R+ + + I +H +G + ++KP N+L+ + L DFG+
Sbjct: 101 DVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160
Query: 198 --LLLGRS-------------------LSDSD-----------MALR-LGTPNYMAPEQW 224
LL G+S +S D MA +GTP+Y+APE +
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220
Query: 225 EPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG--LPP 282
+ G E D W G + E L G P+ ++ E Y ++ +E P L
Sbjct: 221 LQQGYG---QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSV 277
Query: 283 AVENVIIGCFEYDLRNRPLMADILH------AFESSQNAVYNDGEWTGLGS--------- 327
E++I R L+ + + A E + + +W +
Sbjct: 278 EAEDLI----------RRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327
Query: 328 RALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKPLNARKPQTVD 370
+++TDTS ++P + QV + ++ A++ ++V+
Sbjct: 328 KSITDTS-------YFPTDELEQVPEAPALKQAAPAQQEESVE 363
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 26/122 (21%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS------DSDMA 210
Q+ G+ +HS +L +LKP NLL++ +L + DFG L R S M
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG-----LARGFSENPGENAGFMT 167
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFET-----DTWGFGCSIMEMLTGIQPWF-GK-SVEEI 263
+ T Y APE +SF++ D W GC + E+L G +P F GK V+++
Sbjct: 168 EYVATRWYRAPEIM-------LSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQL 219
Query: 264 YH 265
Sbjct: 220 NQ 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 11/148 (7%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q++ G+ L + +L N+LL + DFG L ++L + + T
Sbjct: 103 QVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFG-----LSKALGADENYYKAKTH 157
Query: 217 NYMAPEQWEPEVRGPISF--ETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKK-E 272
+ + PE F ++D W FG + E + G +P+ G E+ + +I+ E
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV--TQMIESGE 215
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP 300
+ P PP + +++ C+ Y + RP
Sbjct: 216 RMECPQRCPPEMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 40/182 (21%)
Query: 157 QLAKGISD----LH---SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
++A GI+ LH S ++V NL P +++ D+ P+L L
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--------PHLRLSLPGLLCTD 835
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269
+ Y+APE E I+ ++D +GFG ++E+LTG P E H ++
Sbjct: 836 TKCFISSAYVAPETRE---TKDITEKSDIYGFGLILIELLTGKSP---ADAEFGVHGSIV 889
Query: 270 KKEKPC-----IPSGLPPAVE--------------NVIIGCFEYDLRNRPLMADILHAFE 310
+ + C + + P++ N+ + C D RP D+L E
Sbjct: 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
Query: 311 SS 312
S+
Sbjct: 950 SA 951
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 37/164 (22%), Positives = 73/164 (44%), Gaps = 9/164 (5%)
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS--LSDS 207
D++ + Q+A G+ L S + +L N+L+ E + + DFG+ ++ S +S
Sbjct: 240 DLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299
Query: 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266
L L +MAPE + +S D W FG + E+ T G P+ + E +++
Sbjct: 300 STFLPL---KWMAPESIFNNLYTTLS---DVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ + + P+ + ++ C+E RP + ++H
Sbjct: 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 40/160 (25%), Positives = 60/160 (37%), Gaps = 44/160 (27%)
Query: 150 DILRYGI-QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI----------PYL 198
D+ R+ I +L I +H +G + ++KP N+L+ + L DFG+ Y
Sbjct: 101 DLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 199 LLGR-----SLSDSD-----MALRL--------------------GTPNYMAPEQWEPEV 228
G S+ S+ RL GTPNY+APE
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL--- 217
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
R + D W G + EML G P+ + E V+
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 632 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.86 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.82 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.75 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.13 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.12 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.95 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.78 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.27 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.07 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.77 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.68 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.38 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.76 | |
| PLN02236 | 344 | choline kinase | 95.52 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.55 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.05 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.86 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.04 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.4 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.1 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 91.7 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.25 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 89.51 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.08 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 89.03 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 84.68 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 84.64 | |
| smart00743 | 61 | Agenet Tudor-like domain present in plant sequence | 82.8 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 81.94 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 80.55 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=426.30 Aligned_cols=281 Identities=22% Similarity=0.355 Sum_probs=237.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+.+++|++.+.||+|+||+||+++.+.++ +.+|+|++++... .........+..++.. .+||+|+.++.
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~------kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~-v~hPFiv~l~y 92 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTG------KIYAMKVLKKKKIVEKKEVRHTKAERNILSK-IKHPFIVKLIY 92 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEEEEcccC------ceeehhhhhhhHhhhhhhHHHHHHHHHHHHh-CCCCcEeeeEE
Confidence 4567899999999999999999999988655 5899999987432 2223334445566666 58999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.|++.+.+|||+||+.| .|.-.+.+ .+.|++..++.|+.+|+.||.|||++|||||||||+|||||..|+++|+|||
T Consensus 93 sFQt~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 93 SFQTEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ecccCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccc
Confidence 99999999999999996 66655543 4689999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... .....++|||+.|||||++... +|+.++||||||+++|||++|.+||.+.+..+++..|.... .+
T Consensus 171 L~k~~~~~---~~~t~tfcGT~eYmAPEil~~~---gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~ 243 (357)
T KOG0598|consen 171 LCKEDLKD---GDATRTFCGTPEYMAPEILLGK---GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LP 243 (357)
T ss_pred cchhcccC---CCccccccCCccccChHHHhcC---CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CC
Confidence 99865332 2234558999999999999854 79999999999999999999999999999999998887432 35
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCC----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCCC
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPL----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYT 340 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 340 (632)
..|..++.+.+++++++|.+||++|.. +.+|.+ +++|.+++|+.+..+.+.+|+.|....
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~------HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR------HPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc------CcccccCCHHHHHhcCCCCCeecCCCC
Confidence 556779999999999999999999974 344332 789999999999999999999886544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=441.45 Aligned_cols=279 Identities=22% Similarity=0.332 Sum_probs=243.6
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.++.++|++++.||+|+||+|++|..+.+++ .+|||++++.. .+..+. ...+..++..+..||+++.++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e------~yAIK~LKK~~Il~~d~Ve~-~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNE------YYAIKVLKKGDILQRDEVES-LMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCc------EEEEEEeeccceeccccHHH-HHHHHHHHHHhccCCeEeeccc
Confidence 6788999999999999999999999998774 89999998843 233222 3334466666679999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 116 ISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.|++.+++|+||||+.|+. ++.....+.|++..++.|+++|+.||.|||++||||||||.+|||||.+|++||+|||+
T Consensus 437 ~fQT~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 437 CFQTKEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred ccccCCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999999854 44444457999999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+|.... ....++++||||.|||||++.+. .|+.++|||||||+|||||.|+.||.|++.++++..|+ ...+.
T Consensus 515 cKe~m~---~g~~TsTfCGTpey~aPEil~e~---~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~ 586 (694)
T KOG0694|consen 515 CKEGMG---QGDRTSTFCGTPEFLAPEVLTEQ---SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVR 586 (694)
T ss_pred ccccCC---CCCccccccCChhhcChhhhccC---cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCC
Confidence 986543 23356789999999999999854 79999999999999999999999999999999999988 67888
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcCCCCC
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYT 340 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 340 (632)
+|..++.+..++|+++|.+||++|..+ .+|.. ++||..++|+.+..+.+.||+.|...+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~------hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK------HPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh------CCccccCCHHHHhhccCCCCCCcccCC
Confidence 999999999999999999999999966 34443 889999999999999999999887544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=393.10 Aligned_cols=271 Identities=23% Similarity=0.379 Sum_probs=234.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
...++|++++.||.|+||.|.+++++.++ ..+|+|++.+...- ...+....+..+++.+ .||+++.+++.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g------~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~ 113 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSG------NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTF 113 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCC------ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEee
Confidence 67899999999999999999999998765 48999999764322 2222233344555555 599999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+.+.+|+||||.+| .|..++.+ .++|+++.+++|++||+.||+|||+++|++|||||+|||||++|++||+|||+|
T Consensus 114 ~d~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 114 KDNSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred ccCCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccce
Confidence 999999999999995 66666643 469999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
+.+.+ .+.+.||||.|+|||++... +|..++||||||+++|||+.|.+||...++.++++.|.. ....+
T Consensus 192 K~v~~------rT~TlCGTPeYLAPEii~sk---~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~--~~v~f 260 (355)
T KOG0616|consen 192 KRVSG------RTWTLCGTPEYLAPEIIQSK---GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE--GKVKF 260 (355)
T ss_pred EEecC------cEEEecCCccccChHHhhcC---CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--CcccC
Confidence 98743 35678999999999999854 788999999999999999999999999999999999884 56668
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
|+.+++++++|+.++|+.|-.+|. ...+|.+ +++|.+.+|+.+..+.+.+|+.|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~------H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKN------HPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhhhcCcCCCcccccc------CcccccccHHHHhhccccCCCCC
Confidence 999999999999999999999994 2334443 77999999999999999999877
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=414.85 Aligned_cols=271 Identities=22% Similarity=0.370 Sum_probs=237.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.-.+.||.+++.||+|+|++|++|+.+.++ ++||||++.+.- .+.....+..+...+.++.+||.|++|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~------keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATG------KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCC------ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 556789999999999999999999998766 599999996532 222334456666778888899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
|+++..+|+|+||++ |+|+++|.+. +.|++..++.|++||+.||+|||++|||||||||+|||||.++++||+|||.
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999998 8999999765 7999999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCC----------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH
Q 006772 196 PYLLLGRSLS----------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH 265 (632)
Q Consensus 196 ak~~~~~~~~----------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~ 265 (632)
|+.+...... .....+++||..|.+||++.. +..+..+|+|+|||+||+|+.|.+||.+.+...+++
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~---~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND---SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcC---CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 9987543221 122256899999999999974 467889999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccc
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSR 328 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~ 328 (632)
.|+ .....+|+..|+.+.+||.++|..||.+|++..+|.+ ++||.+++|+.+...
T Consensus 298 kI~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~------HpFF~~Vdw~nlw~~ 352 (604)
T KOG0592|consen 298 KIQ--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA------HPFFEGVDWENLWQQ 352 (604)
T ss_pred HHH--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh------CcccccCChhhhhhc
Confidence 987 5677789999999999999999999999999988877 889999999996643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=405.71 Aligned_cols=281 Identities=23% Similarity=0.351 Sum_probs=231.3
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
+.+..++|++++.||+|+||.||+|+.+.+++ .+|+|+|++... ..... ++.++.++.. ..++.|++|+
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~------iyAmK~LkKS~M~~~~Qv~h-V~aERdiL~~-~ds~~vVKLy 207 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGE------IYAMKILKKSEMLKKNQVEH-VRAERDILAE-VDSPWVVKLY 207 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCc------EEeeecccHHHHHhhhhHHH-HHHHHHHhhh-cCCCcEEEEE
Confidence 46788999999999999999999999887764 899999987543 22222 3344455555 6899999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
..|++.+++||||||++| ++..++.+ .+.|++..+++|+.+++.||+.||+.|+|||||||+|+|||..|++||+||
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 999999999999999995 55555544 368999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCC----------------------CCC-----CC-----------------ccccccCCCccCCccccCCCCC
Q 006772 194 GIPYLLLGR----------------------SLS-----DS-----------------DMALRLGTPNYMAPEQWEPEVR 229 (632)
Q Consensus 194 Glak~~~~~----------------------~~~-----~~-----------------~~~~~~GT~~YmAPE~~~~~~~ 229 (632)
||++.+... ... .. -....+|||.|||||++.+.
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-- 363 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-- 363 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--
Confidence 998644210 000 00 01124899999999999865
Q ss_pred CCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCC---HHH
Q 006772 230 GPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPL---MAD 304 (632)
Q Consensus 230 g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs---~~e 304 (632)
.|+..+|||||||||||||.|.+||.+.++.+++..|+.......+| ..+++++.+||.+||. ||++|.. +.|
T Consensus 364 -gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 364 -GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred -CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 58899999999999999999999999999999999999776666666 4678999999999999 9999986 555
Q ss_pred HHHHHHhhhhcccCCCCccccccccccCCCcCCCCC
Q 006772 305 ILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYT 340 (632)
Q Consensus 305 ll~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 340 (632)
|.. +++|.+++|+.+.... +|+.|...+
T Consensus 442 IK~------HPfF~~v~W~~l~~~~--apfvP~v~~ 469 (550)
T KOG0605|consen 442 IKK------HPFFKGVDWDHLREMP--APFVPQVNS 469 (550)
T ss_pred Hhc------CCccccCCcchhhcCC--CCCCCCCCC
Confidence 554 8899999999987654 777665443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=405.07 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=216.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.+|..++.||+|||+.||.+++..+++ .||+|++.+.. .....+.+..+.++.+. .+||||+.++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge------~~A~KvVpk~~l~k~~~reKv~~EIeIHr~-L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGE------VVAVKVVPKKLLKKPKQREKVLNEIEIHRS-LKHPNIVQFYHFFEDS 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCc------EEEEEEeehHHhcCcchHHHHHHHHHHHHh-cCCCcEEeeeeEeecC
Confidence 579999999999999999999977765 89999997632 22233334444455444 4799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+++|||+|+|+ |+|.+++. +.+.+++.+++.|+.||+.||.|||+++|||||||..|+||+++.++||+|||||..+
T Consensus 91 ~nVYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred CceEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee
Confidence 99999999998 78887776 3469999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
... .....+.||||+|+|||++.. ..+++.+||||+||+||-||.|++||...+..+++..|. .....+|..
T Consensus 169 e~~---~Erk~TlCGTPNYIAPEVl~k---~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ 240 (592)
T KOG0575|consen 169 EYD---GERKKTLCGTPNYIAPEVLNK---SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSH 240 (592)
T ss_pred cCc---ccccceecCCCcccChhHhcc---CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccc
Confidence 432 244567899999999999984 368899999999999999999999999999999999877 567778999
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++++||.++|+.||.+|||+++|+.
T Consensus 241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999999996
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=384.74 Aligned_cols=251 Identities=26% Similarity=0.462 Sum_probs=214.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|+.++++.++.||+|..|+||++.|+.++ +.+|+|++........+..+-++.+++..+ .||+|+.+|++|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~------~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTG------KIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCC------eEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEE
Confidence 355669999999999999999999999877 489999996544444444344444666666 8999999999999
Q ss_pred ECC-EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 119 ING-KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 119 ~~~-~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.++ .++|+||||+ |+|.+.+... +++++...-+++.++++||.|||. ++||||||||+|||++..|.+||||||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 999 5999999999 5666665443 689999999999999999999995 9999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhh
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-----SVEEIYHSVVIK 270 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-----~~~ei~~~i~~~ 270 (632)
++.+.. +...++.||..|||||.+.+. .|+.++||||||++++|+++|+.||... +.-+++..|. .
T Consensus 226 S~~lvn-----S~a~tfvGT~~YMsPERi~g~---~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~ 296 (364)
T KOG0581|consen 226 SGILVN-----SIANTFVGTSAYMSPERISGE---SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-D 296 (364)
T ss_pred cHHhhh-----hhcccccccccccChhhhcCC---cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-c
Confidence 887643 345678999999999999865 6889999999999999999999999874 5667777776 3
Q ss_pred ccCCCCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEKPCIPSG-LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~p~~p~~-lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+|..|.. +++++++||..||++||.+||++.++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 567778886 9999999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=391.84 Aligned_cols=272 Identities=26% Similarity=0.447 Sum_probs=231.0
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEee
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
....|+.+++.+.+.||+|+||+||+|.++... .||||++........ ...+.++..++.+ .+||||+.++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-------~vavK~~~~~~~~~~~~~~f~~E~~il~~-l~HpNIV~f~ 105 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD-------VVAVKIISDPDFDDESRKAFRREASLLSR-LRHPNIVQFY 105 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCce-------eEEEEEecchhcChHHHHHHHHHHHHHHh-CCCCCeeeEE
Confidence 445688899999999999999999999987642 499999976432221 2223334455555 5899999999
Q ss_pred EEEEECC-EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeeeeeCCeEEEecCC-cEEE
Q 006772 115 GISVING-KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG-LLVLNLKPSNLLLSEHD-QLVL 190 (632)
Q Consensus 115 ~~~~~~~-~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~-IvHRDLKP~NILld~~g-~vkL 190 (632)
|++.... .++|||||++ |+|.+++....++.+++..++.++.|||+||+|||+++ ||||||||+|||++.++ ++||
T Consensus 106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 106 GACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEE
Confidence 9998876 7999999998 67877776644679999999999999999999999999 99999999999999998 9999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||+++...... ...+...||+.|||||++.++ ...|+.++||||||++||||+||+.||.+....++...+...
T Consensus 186 ~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 186 ADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred CCCccceeecccc---ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999998754321 233446899999999999865 457999999999999999999999999999988888888888
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
..+|.+|..+++.+..+|.+||..||..||++.+++..|+.+.......
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 9999999999999999999999999999999999999999887665443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=382.59 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=209.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh------HHHHHHHHHHHhhhccCCCceeEee
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC------AKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~------~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
-.+.|.+.+.||+|+||.|-+|..++++ +.||||++++..... ......++.++++++ +||+|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tg------k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~ 242 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTG------KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIK 242 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccC------cEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEe
Confidence 3467899999999999999999998877 489999997643211 122234555666665 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC---CcEEE
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH---DQLVL 190 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~---g~vkL 190 (632)
+++...+..||||||++ |.|.+.+..+ +.+.+..-..|+.|++.||.|||++||+||||||+|||+..+ ..+||
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999998 6888888764 578888899999999999999999999999999999999876 68999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE-IYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e-i~~~i~~ 269 (632)
+|||+|+.... .+-+.+.||||.|.|||++.......+..++|+||+||+||-+|+|.+||.+..... +.++|..
T Consensus 321 tDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 321 TDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred cccchhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99999997642 234567899999999999987644444568999999999999999999999876554 6666654
Q ss_pred hccC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 KKEK--PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~~~~--p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.-. |..-..++.+..+||.+||..||++||++.|+|+
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3222 2223578999999999999999999999999876
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=389.16 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=222.4
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...|+++.+++.++||+|.||+||+|.+..+. .||+|.++... ...+.|. ++..++.++ +|++|++++++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-------~vavk~ik~~~-m~~~~f~-~Ea~iMk~L-~H~~lV~l~gV 269 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGST-------KVAVKTIKEGS-MSPEAFL-REAQIMKKL-RHEKLVKLYGV 269 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCC-------cccceEEeccc-cChhHHH-HHHHHHHhC-cccCeEEEEEE
Confidence 34478888999999999999999999998754 59999997643 2334455 444556665 78999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++.+|||||||. |+|++++....+..+...+.+.++.|||.|++||+++++|||||.++||||+++..+||+|||+
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccc
Confidence 999999999999998 9999999886678999999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
|+........... ...-.+.|.|||.+. .+.++.+||||||||+||||+| |+.||.+.+..+....+.. +.+.
T Consensus 350 Ar~~~d~~Y~~~~--~~kfPIkWtAPEa~~---~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-GyRl 423 (468)
T KOG0197|consen 350 ARLIGDDEYTASE--GGKFPIKWTAPEALN---YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-GYRL 423 (468)
T ss_pred ccccCCCceeecC--CCCCCceecCHHHHh---hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-cCcC
Confidence 9954322111111 112267899999997 6689999999999999999999 9999999999999888764 5566
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+-|..||+++.++|..||+.+|++|||++.+...|+++.
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 669999999999999999999999999999888887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=372.76 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=212.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.+|.+.++||+|+||.||+|+++.++ ..||||.+.+.+ .....+.+..+..+++.+ +|+||+.+++++.+++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~------~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSG------TEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDD 82 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCC------ceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCC
Confidence 68999999999999999999998766 489999997654 333444445555666666 4999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC------CcEEEEecC
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH------DQLVLGDFG 194 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~------g~vkL~DFG 194 (632)
.+|||||||. |+|.+++.+. +.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999 6888888654 589999999999999999999999999999999999999875 358999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK- 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~- 273 (632)
+|+.+... ....+.||++.|||||+++ ...|+.|+|+||+|++||+|++|+.||...+..+++..+......
T Consensus 161 fAR~L~~~----~~a~tlcGSplYMAPEV~~---~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~ 233 (429)
T KOG0595|consen 161 FARFLQPG----SMAETLCGSPLYMAPEVIM---SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV 233 (429)
T ss_pred hhhhCCch----hHHHHhhCCccccCHHHHH---hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence 99987533 2345679999999999997 457999999999999999999999999999999988877654433
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
+.++..+++.+.+|+...+.++|.+|-++.+..
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 445577888999999999999999999877654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=370.03 Aligned_cols=293 Identities=21% Similarity=0.299 Sum_probs=234.6
Q ss_pred cccccCCC-CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHH--HHHHHHHhhh
Q 006772 27 RTVVATPT-QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF--VNKFEELFPK 103 (632)
Q Consensus 27 ~~~~~~~~-~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~--~~~~~~il~~ 103 (632)
++.++... .....+..++|+++++||+|.-|+||||+.+.++ ..+|+|++.+......+.. ...+++|++
T Consensus 60 w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~------~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~- 132 (459)
T KOG0610|consen 60 WEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTN------CLFAMKVMDKESLASRKKLKRAQTEREILS- 132 (459)
T ss_pred hhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCC------ceEEEEEecHHHHhhhhHHHHHHHHHHHHH-
Confidence 33444333 3446678899999999999999999999998766 4899999977543322222 223344544
Q ss_pred ccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 104 FRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 104 l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
+.+||.++.|+..++.++..|++||||. |+|..++.++.++.|++..+++|+++++.||+|||-.|||+|||||+||||
T Consensus 133 ~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv 212 (459)
T KOG0610|consen 133 LLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV 212 (459)
T ss_pred hcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE
Confidence 4589999999999999999999999998 577777777788999999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccC-----------------------------C---CCC---------------------CCcc
Q 006772 183 SEHDQLVLGDFGIPYLLLG-----------------------------R---SLS---------------------DSDM 209 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~-----------------------------~---~~~---------------------~~~~ 209 (632)
-++|++-|+||-|+..... + ... ....
T Consensus 213 redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RS 292 (459)
T KOG0610|consen 213 REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARS 292 (459)
T ss_pred ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccc
Confidence 9999999999998753310 0 000 0011
Q ss_pred ccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 006772 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVII 289 (632)
Q Consensus 210 ~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~ 289 (632)
.+++||-.|+|||++.++ ..+.++|||+|||+|||||.|..||.|.+.++.+..|+.+....+-.+..+.++++||+
T Consensus 293 nSFVGThEYlAPEvI~G~---GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 293 NSFVGTHEYLAPEVIRGE---GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred cccccccccccceeeecC---CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 235899999999999976 57789999999999999999999999999999999988544333323467899999999
Q ss_pred HhhhcCcCCCCC----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 290 GCFEYDLRNRPL----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 290 ~cL~~DP~~RPs----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
++|.+||.+|.. ++||.+ ++||.+.+|.-+ +...||..|.
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~------HpFF~gVnWaLi--r~~~PP~iP~ 413 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKR------HPFFEGVNWALI--RCARPPEIPK 413 (459)
T ss_pred HHhccChhhhhccccchHHhhc------CccccCCChhhe--eccCCCcCCC
Confidence 999999999997 677665 889999999943 3455665553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.88 Aligned_cols=255 Identities=29% Similarity=0.493 Sum_probs=209.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
..++...+.||+|+||.||++.+++++ ...|||......... .+.+.++..++.++. ||||++++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g------~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTG------ELMAVKSVELEDSPT-SESLEREIRILSRLN-HPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCC------cceeeeeeecccchh-HHHHHHHHHHHHhCC-CCCEEeeCCcccccc
Confidence 457899999999999999999998764 479999986543222 233455556777776 999999999744443
Q ss_pred --EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEecCCce
Q 006772 122 --KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGDFGIPY 197 (632)
Q Consensus 122 --~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~DFGlak 197 (632)
.++|.|||+. |+|.+++....+ .|+++.+++|++||++||+|||++|||||||||+|||++. ++.+||+|||+++
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 7999999998 688888877654 8999999999999999999999999999999999999999 7999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~-~~~~ei~~~i~~~~~~p~~ 276 (632)
................||+.|||||++.. ......++|||||||++.||+||+.||.. ....+....+......|.+
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccccccCCccccCchhhcC--CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence 76542222233345789999999999973 11223599999999999999999999987 4444444455555567889
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|..+|+++++++.+|+++||++|||+.++|+
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 9999999999999999999999999999997
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=372.92 Aligned_cols=286 Identities=22% Similarity=0.347 Sum_probs=236.2
Q ss_pred CCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCce
Q 006772 34 TQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSV 110 (632)
Q Consensus 34 ~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I 110 (632)
...+..|...+|.++..||.|+||+|.+|..+.+.+ .+|||++++.- .+..+ -.-.+..++......|.+
T Consensus 340 ~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdE------LyAiKiLkKDViiQdDDve-ctm~EKrvLAL~~kppFL 412 (683)
T KOG0696|consen 340 SSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDE------LYAIKILKKDVIIQDDDVE-CTMVEKRVLALPGKPPFL 412 (683)
T ss_pred CCcccceeecccceEEEeccCccceeeeecccCcch------hhhhhhhccceeeecCccc-ceehhhhheecCCCCchH
Confidence 344456788999999999999999999999877664 79999998742 11111 111223455556678999
Q ss_pred eEeeEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEE
Q 006772 111 CWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 111 ~~l~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vk 189 (632)
+.++.+|++-+++|+||||+.| +|--.+.+ -++|.++.+..|+.+|+.||-|||++|||+||||..|||||.+|++|
T Consensus 413 ~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiK 490 (683)
T KOG0696|consen 413 VQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK 490 (683)
T ss_pred HHHHHHhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceE
Confidence 9999999999999999999996 44433332 36899999999999999999999999999999999999999999999
Q ss_pred EEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006772 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~ 269 (632)
|+|||+++.-.. ...++.++||||.|+|||++. +.+|+..+||||||++||||+.|++||.|.+.+++++.|..
T Consensus 491 i~DFGmcKEni~---~~~TTkTFCGTPdYiAPEIi~---YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 491 IADFGMCKENIF---DGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred eeeccccccccc---CCcceeeecCCCcccccceEE---ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999985322 334556789999999999997 66899999999999999999999999999999999999874
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH-HHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMAD-ILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~e-ll~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
..-.+|..+|.++.++....|.+.|.+|....- --+.++ .++||..++|+.++.+++++|+.|..
T Consensus 565 --hnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~--~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 565 --HNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIR--EHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred --ccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchh--hCcchhhccHHHHhhccCCCCCCCcc
Confidence 445679999999999999999999999985421 001111 27899999999999999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=365.94 Aligned_cols=258 Identities=21% Similarity=0.392 Sum_probs=209.6
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeE-E
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHG-I 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~-~ 116 (632)
.-+..+|++.++||+|+||+||++.+..++ ..||.|.++-... ....+..-.+..++++ .+||||+.+++ .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g------~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQ-L~HpNIVqYy~~~ 87 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDG------KLVALKKIQFGMMDAKARQDCVKEISLLKQ-LNHPNIVQYYAHS 87 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCc------chhhhhhcchhhccHHHHHHHHHHHHHHHh-cCCchHHHHHHHh
Confidence 345678999999999999999999998766 4899998863221 1222223333344554 47999999887 4
Q ss_pred EEECCE-EEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeeeeeCCeEEEecCCcE
Q 006772 117 SVINGK-ICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHS--IG--LLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 117 ~~~~~~-l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs--~~--IvHRDLKP~NILld~~g~v 188 (632)
+..+.. ++||||||. |+|...+.+.+ ++.+++..+|+|+.|++.||.++|+ .. |+||||||.||+|+.+|.+
T Consensus 88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence 555555 899999998 78888776543 4689999999999999999999999 55 9999999999999999999
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~ 268 (632)
||+|||+++.+... ..-..+.+|||.||+||.+.+. +|+++|||||+||++|||+.-++||.|.+..++...|.
T Consensus 168 KLGDfGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~~---~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~ 241 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSK---TTFAHSLVGTPYYMSPERIHES---GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE 241 (375)
T ss_pred eeccchhHhHhcch---hHHHHhhcCCCcccCHHHHhcC---CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH
Confidence 99999999987442 2233567899999999999854 79999999999999999999999999999888888887
Q ss_pred hhccCCCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 269 IKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 269 ~~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.+ +-|+.| ...|.++..||..|+..||+.||+...++..+.
T Consensus 242 qg-d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 242 QG-DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred cC-CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 54 455566 778999999999999999999998555554443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=362.93 Aligned_cols=272 Identities=23% Similarity=0.360 Sum_probs=221.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ +.||||++.+... .........+..++....+|++|+.+++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD------ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence 5899999999999999999987655 4899999875321 1111112223344556678999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+||||++ |+|.+.+... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998 5777776543 579999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
.. .......+||+.|||||++.. ..++.++|+|||||++|||++|+.||.+.+..++...+.. ....+|..+
T Consensus 153 ~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~ 224 (323)
T cd05616 153 WD---GVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSM 224 (323)
T ss_pred CC---CCccccCCCChhhcCHHHhcC---CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcC
Confidence 21 122234579999999999974 4688999999999999999999999999888888777663 445578889
Q ss_pred CHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 281 PPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
+.++.+++.+||++||.+|++. .+++ .+.++...+|..+..+...++..+.
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~------~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIK------EHAFFRYIDWEKLERKEVQPPYKPK 280 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHh------cCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 9999999999999999999975 4433 3678888999998888877776554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=371.98 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=218.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC----chhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL----KEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~----~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.....|++++.||+|+||+|++|.+..++ +.||+|++.+. ........+.++..++..+.+||||+.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~------~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e 87 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG------EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE 87 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCC------CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence 44578999999999999999999998776 48999987653 111234444555567788888999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC-CcEEEEec
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-DQLVLGDF 193 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~-g~vkL~DF 193 (632)
++.....+|+||||+. |+|++++.. .+++.+.++.+++.||+.|++|||++||+||||||+|||++.+ +++||+||
T Consensus 88 v~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 88 VFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred EEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 9999999999999999 599999976 4689999999999999999999999999999999999999999 99999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCC-CcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPI-SFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~-t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
|++.... .......+.|||+.|+|||++.+.. .| ..++|+||+|++||.|++|..||...+...++..|. ..
T Consensus 166 G~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~--~~ 238 (370)
T KOG0583|consen 166 GLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR--KG 238 (370)
T ss_pred ccccccC---CCCCcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh--cC
Confidence 9998653 1234456789999999999998652 14 488999999999999999999999988888877754 66
Q ss_pred CCCCCCCC-CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPSGL-PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~~l-p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+|..+ ++++.+|+.+||..||.+|+++.+|+.
T Consensus 239 ~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 77789999 999999999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=360.03 Aligned_cols=274 Identities=21% Similarity=0.323 Sum_probs=225.2
Q ss_pred cCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCce
Q 006772 31 ATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110 (632)
Q Consensus 31 ~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I 110 (632)
+..++....++.++|++...||.|.-+.||+|++...++ .||||++.-.+....-..++++...+ .+-+||||
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e------~VAIK~inLEkc~~~ld~l~kE~~~m-sl~~HPNI 86 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNE------VVAIKIINLEKCNNDLDALRKEVQTM-SLIDHPNI 86 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCC------EEEEEEeehhhhhhhHHHHHHHHHHh-hhcCCCCc
Confidence 344455566788999999999999999999999998775 89999997655544444455554444 44589999
Q ss_pred eEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEE
Q 006772 111 CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 111 ~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vk 189 (632)
+.++..|+.++.+|+||.||. ||+++.+.......|++..+..+++++++||.|||.+|.||||||+.||||+.+|.+|
T Consensus 87 v~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 87 VTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred ceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEE
Confidence 999999999999999999998 8999999887667799999999999999999999999999999999999999999999
Q ss_pred EEecCCceeccCCCCCCCcc-ccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 006772 190 LGDFGIPYLLLGRSLSDSDM-ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~-~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~ 268 (632)
|+|||.+..+.......... .++.||+.|||||+++.+. ..|+.|+||||||++.+||++|..||....+.+++..-+
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~-~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL 245 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL-HGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL 245 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcc-cCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999987765543222222 5568999999999976554 469999999999999999999999999999888765544
Q ss_pred hhccCCC-----CC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH--HHHhhh
Q 006772 269 IKKEKPC-----IP----SGLPPAVENVIIGCFEYDLRNRPLMADILH--AFESSQ 313 (632)
Q Consensus 269 ~~~~~p~-----~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~--~Le~~~ 313 (632)
. +..|. ++ ...+..++.+|..||++||.+|||++++++ .|...+
T Consensus 246 q-n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 246 Q-NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred c-CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 2 33331 11 235668999999999999999999999996 344443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=364.62 Aligned_cols=270 Identities=21% Similarity=0.351 Sum_probs=210.0
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|+.++|++.+.||+|+||.||+|.+..... ....+.||||++..............+..++..+.+|+||+.+++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDK-KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCC-cccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4667899999999999999999998643221 123357999999754332222223334456677778999999999876
Q ss_pred E-CCEEEEEEecCC-CCHHHHHHHhc------------------------------------------------------
Q 006772 119 I-NGKICIAMKFYE-GSVGDRIAQQR------------------------------------------------------ 142 (632)
Q Consensus 119 ~-~~~l~LVmEy~~-GsL~d~l~~~~------------------------------------------------------ 142 (632)
. ++.++++|||++ |+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 5 456899999998 68887776421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCC
Q 006772 143 ------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216 (632)
Q Consensus 143 ------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~ 216 (632)
...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ........+++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCc
Confidence 13478889999999999999999999999999999999999999999999999976432111 11112234678
Q ss_pred ccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 006772 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYD 295 (632)
Q Consensus 217 ~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~D 295 (632)
.|||||++.+ ..++.++|||||||+||||++ |..||.+....+...........+..|..+++++.+++.+||+.|
T Consensus 241 ~y~aPE~~~~---~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 241 KWMAPESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred cccCcHHhhc---CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 8999999864 368899999999999999997 999998866444333444444555667889999999999999999
Q ss_pred cCCCCCHHHHHHHHHhhh
Q 006772 296 LRNRPLMADILHAFESSQ 313 (632)
Q Consensus 296 P~~RPs~~ell~~Le~~~ 313 (632)
|.+||++.++++.|+.+.
T Consensus 318 p~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 318 PKERPTFSALVEILGDLL 335 (338)
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.27 Aligned_cols=270 Identities=24% Similarity=0.375 Sum_probs=218.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+|++.+.||+|+||.||+|.+..++ +.||||++.+.. ......+ ..+..++..+.+|++|+.+++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~-~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTD------ELYAIKILKKDVIIQDDDVECT-MVEKRVLALPGKPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHH-HHHHHHHHhcCCCCceeeeEEEEEcC
Confidence 5899999999999999999987655 489999987532 1122222 23334556666778899999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||++ |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999998 577766644 357899999999999999999999999999999999999999999999999998653
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
... .......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+..+. ...+.+|..
T Consensus 152 ~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~ 223 (324)
T cd05587 152 IFG---GKTTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKS 223 (324)
T ss_pred CCC---CCceeeecCCccccChhhhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCC
Confidence 211 122334579999999999974 367889999999999999999999999988888777765 345667888
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
+++++.+++.+||+.||.+|++. .++++ ++++...+|..+..+...+++.+
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~------hp~~~~~~~~~~~~~~~~~~~~~ 279 (324)
T cd05587 224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE------HAFFRRIDWEKLERREIQPPFKP 279 (324)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCccC
Confidence 99999999999999999999976 34333 67888889988776665555443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.10 Aligned_cols=264 Identities=21% Similarity=0.375 Sum_probs=215.0
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+..++ +.||||++.+... .....+. .+..++..+ +|+||+.+++.+..++.+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~-~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG------KYYAMKILKKEVIIAKDEVAHTL-TESRVLQNT-RHPFLTALKYSFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhHHHHHHH-HHHHHHHhC-CCCCCCCEEEEEEcCCEEEE
Confidence 46999999999999987655 4899999975321 1112222 233344444 78999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 73 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 148 (323)
T cd05571 73 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-- 148 (323)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--
Confidence 999998 567666654 357899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+...+...+. .....+|..+++++
T Consensus 149 -~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~ 222 (323)
T cd05571 149 -GATMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEA 222 (323)
T ss_pred -CCcccceecCccccChhhhcCC---CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHH
Confidence 1223346799999999998743 67899999999999999999999999988777776655 34556788999999
Q ss_pred HHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++|.+||+.||++|| ++.++++ ++++...+|..+..+...+++.+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~------h~~f~~~~~~~~~~~~~~~~~~~ 273 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIME------HRFFASINWQDVVQKKLEPPFKP 273 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 9999999999999999 7888775 77888899998877777666544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.34 Aligned_cols=282 Identities=20% Similarity=0.340 Sum_probs=233.8
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
..+..++|.+++.||+|.||+|-+++-+.++ +.+|||++++.- .+....-+.+ .+.++. ..||++..+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~------k~YAiKIlkKeviiakdEVAHTlTE-~RVL~~-~~HPFLt~LK 234 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATG------KLYAIKILKKEVIIAKDEVAHTLTE-NRVLQN-CRHPFLTSLK 234 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccC------ceeehhhhhhhheeehHHhhhhhhH-HHHHHh-ccCcHHHHhh
Confidence 4467799999999999999999999988776 589999998742 2222222222 233333 4789999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
..|+.++++|+||||..| .|.-.+.+ .+.|++..+++|..+|+.||.|||+++||+||||.+|+|||.+|++||+||
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeec
Confidence 999999999999999996 44433333 357999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++.-.. ....+.++||||.|+|||++... .|..++|||.+|+++|||++|+.||+..+.+.++..|. ...
T Consensus 313 GLCKE~I~---~g~t~kTFCGTPEYLAPEVleDn---DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed 384 (516)
T KOG0690|consen 313 GLCKEEIK---YGDTTKTFCGTPEYLAPEVLEDN---DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MED 384 (516)
T ss_pred ccchhccc---ccceeccccCChhhcCchhhccc---cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhh
Confidence 99985432 12345678999999999999855 67889999999999999999999999999998888877 456
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCC--HHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCCC
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPL--MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYT 340 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs--~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 340 (632)
..+|..++++++.|+..+|.+||.+|.. ..+.. +-+.+.||.+++|+....+.+.||+.|...+
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDak---Ei~~h~FF~~v~W~~~~~Kki~PPfKPqVtS 450 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAK---EIMRHRFFASVDWEATYRKKIEPPFKPQVTS 450 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHH---HHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence 6789999999999999999999999983 33322 2334789999999999999999999887544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.90 Aligned_cols=267 Identities=21% Similarity=0.356 Sum_probs=219.0
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++.+.||+|+||.||+|.++.++ +.||+|++.+.... .....+..+..++..+ +|+||+.+++.+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 88 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTG------EYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQ 88 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEE
Confidence 5689999999999999999999987665 48999998653211 1111222333445554 7999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++.+|+||||+. |+|.+.+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 9999999999998 577777754 3578999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.... .....+||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+..+.+..+.. ....+|
T Consensus 167 ~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~p 235 (329)
T PTZ00263 167 KVPD------RTFTLCGTPEYLAPEVIQSK---GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--GRLKFP 235 (329)
T ss_pred EcCC------CcceecCChhhcCHHHHcCC---CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCcCCC
Confidence 6532 12345799999999999744 578899999999999999999999999888877777653 455678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCC
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDT 333 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~ 333 (632)
..++..+.+||.+||+.||.+||+ +.+++. ++++.+.+|..+..+...++
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~------hp~f~~~~~~~~~~~~~~~~ 290 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN------HPYFHGANWDKLYARYYPAP 290 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc------CCccCCCCHHHHHhCCCCCC
Confidence 889999999999999999999996 566665 77888888988766555444
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.14 Aligned_cols=265 Identities=20% Similarity=0.308 Sum_probs=214.9
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|++..++ +.||||++.+.. ......+ ..+..++..+.+|++|+.+++++..++.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~-~~e~~il~~~~~hp~i~~~~~~~~~~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD------EVYAIKVLKKDVILQDDDVDCT-MTEKRILALAAKHPFLTALHCCFQTKDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCC------CEEEEEEEeHHHhhhhhHHHHH-HHHHHHHHhccCCCCccceeeEEEcCCeEEE
Confidence 46999999999999987655 489999987532 1111222 2333455556689999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+.+.. .+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-- 149 (321)
T cd05591 74 VMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-- 149 (321)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC--
Confidence 999998 567666654 357899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+..+.. ....+|..++.++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~ 223 (321)
T cd05591 150 -GVTTTTFCGTPDYIAPEILQE---LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEA 223 (321)
T ss_pred -CccccccccCccccCHHHHcC---CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHH
Confidence 122234579999999999874 3678899999999999999999999999988887777653 4455678899999
Q ss_pred HHHHHHhhhcCcCCCC-------CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRP-------LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RP-------s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.+++.+||+.||++|| ++.++++ ++++...+|..+..+...+++.+
T Consensus 224 ~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~------hp~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T cd05591 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQ------HPFFKEIDWVLLEQRKIKPPFKP 276 (321)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCCHHHHhc------CCccCCCCHHHHHhCCCCCCCCC
Confidence 9999999999999999 6666664 67888899998877666665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.37 Aligned_cols=276 Identities=22% Similarity=0.354 Sum_probs=216.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+|++.+.||+|+||.||+|++.... ..++.||+|++.+... .........+..++..+.+|++|+.+++++..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH---DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence 5899999999999999999875322 2346899999865321 111222344456677777899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999998 577777754 357999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhhccCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK----SVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~----~~~ei~~~i~~~~~~p~ 275 (632)
.... .......+||+.|||||++.+. ..++.++|||||||++|||++|..||... ....+...+. ...+.
T Consensus 156 ~~~~--~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~ 229 (332)
T cd05614 156 LSEE--KERTYSFCGTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPP 229 (332)
T ss_pred cccC--CCccccccCCccccCHHHhcCC--CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCC
Confidence 3221 1122345799999999998743 24678999999999999999999999753 2233333333 34566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
+|..+++.+.+++.+||+.||++|| ++.++++ ++++.+.+|..+......+++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~~ 289 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE------HPFFKGLDWEALALRKVNPPFRP 289 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 7888999999999999999999999 6667665 67888888887766555555433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=349.57 Aligned_cols=273 Identities=19% Similarity=0.329 Sum_probs=216.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.|++.+.||+|+||+||+|.+..++ +.||+|.+.+.... ........+..++..+ +|++++.+.+.+..++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCC------ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCC
Confidence 4889999999999999999987765 48999998653221 1112222333445544 7899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..++||||++ |+|.+.+.......+++..++.++.|++.||+|||+++|+||||||+|||+++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 9999999998 566666655444578999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhccCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--IKKEKPCIPS 278 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~--~~~~~p~~p~ 278 (632)
.. .......||..|||||++.+ ..++.++|||||||++|||++|+.||.+.+.......+. .......++.
T Consensus 154 ~~----~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 154 EG----ETVRGRVGTVGYMAPEVINN---EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226 (285)
T ss_pred CC----CeecCCCCCCCccCHhhhcC---CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc
Confidence 21 11234578999999999974 368899999999999999999999998765322211111 1233345677
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.+++++.+|+++||+.||.+||+ ++++++ ++++.+.+|..+..+.+.+++.|
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~------h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ------HPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc------CHhhcCCCHHHHHhCcCCcCCCC
Confidence 89999999999999999999997 677765 77888999999998888888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.57 Aligned_cols=276 Identities=20% Similarity=0.270 Sum_probs=225.1
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~ 112 (632)
....++.++|++.+.||+|+||.||+|.++..+. ..||+|++.+.. ......+ ..+..++..+ +||||+.
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~-~~E~~~l~~l-~hp~Iv~ 95 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDF-----PPVAIKRFEKSKIIKQKQVDHV-FSERKILNYI-NHPFCVN 95 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCC-----eEEEEEEEEHHHhhhhhhHHHH-HHHHHHHHhC-CCCCCcc
Confidence 3455677899999999999999999998765432 479999986422 1112222 2333444444 7999999
Q ss_pred eeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 113 LHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+++++..++.+|+||||+. |+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 96 ~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred eEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEe
Confidence 9999999999999999997 577777754 3579999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++.... .....+||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+...++..+..
T Consensus 174 DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-- 242 (340)
T PTZ00426 174 DFGFAKVVDT------RTYTLCGTPEYIAPEILLNV---GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-- 242 (340)
T ss_pred cCCCCeecCC------CcceecCChhhcCHHHHhCC---CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--
Confidence 9999976532 22345799999999998743 578899999999999999999999999888777777653
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
....+|..+++++.++|++||+.||++|+ +++++++ ++++.+.+|..+..+.+..+..|.
T Consensus 243 ~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~------hp~f~~~~~~~~~~~~~~~~~~p~ 307 (340)
T PTZ00426 243 GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE------HPWFGNIDWVSLLHKNVEVPYKPK 307 (340)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCC
Confidence 34456888999999999999999999996 7887765 788889999887777776665554
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=354.48 Aligned_cols=268 Identities=23% Similarity=0.358 Sum_probs=213.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhh--hccCCCceeEeeEEEEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFP--KFRESQSVCWLHGISVI 119 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~--~l~~h~~I~~l~~~~~~ 119 (632)
|++.+.||+|+||.||+|.+..++ +.||||++++.. ....+.+.+ +..++. ....|+||+.+++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~l~~-e~~~~~~~~~l~hp~i~~~~~~~~~ 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG------ELYAIKALKKGDIIARDEVESLMC-EKRIFETANSERHPFLVNLFACFQT 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHH-HHHHHHhccccCCCChhceeeEEEc
Confidence 688999999999999999987665 489999997532 111122222 222222 23469999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+|+||||+.| +|...+. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 9999999999995 5544442 35799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
.... .......+||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+..+....+.. ..+.+|.
T Consensus 151 ~~~~---~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~ 222 (324)
T cd05589 151 GMGF---GDRTSTFCGTPEFLAPEVLTET---SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR 222 (324)
T ss_pred CCCC---CCcccccccCccccCHhHhcCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC
Confidence 3221 1223346799999999998743 678899999999999999999999999888777766653 4455788
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.+++++.++|.+||+.||.+||+ +.++++ +.++.+.+|.....+...++..+
T Consensus 223 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~------~~~f~~~~~~~~~~~~~~~~~~~ 279 (324)
T cd05589 223 FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK------QPFFRDINWDDLLARKIKPPFVP 279 (324)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh------CCCcCCCCHHHHHhCCCCcCccC
Confidence 89999999999999999999994 555543 67788888887766666555443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.24 Aligned_cols=265 Identities=23% Similarity=0.390 Sum_probs=214.3
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+..++ +.||||++++... ....... .+..++....+|+||+.+++++..++.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-~e~~~l~~~~~hp~i~~~~~~~~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN------EFFAIKALKKDVVLEDDDVECTM-VERRVLALAWEHPFLTHLFCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhhHHHHH-HHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 47999999999999987655 4899999975321 1112222 223344555689999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 74 VMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 999998 566666644 3579999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
......+||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+..+++..+. ...+.+|..++.++
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~ 223 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQ---KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEA 223 (316)
T ss_pred --CccccccCCccccCHHHHcCC---CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHH
Confidence 222345799999999998743 57899999999999999999999999988887777654 45667788899999
Q ss_pred HHHHHHhhhcCcCCCCCHH-HHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRPLMA-DILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~-ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.+++.+||+.||.+||++. ++++ +.++...+|..+..+...+++.+
T Consensus 224 ~~ll~~~l~~~P~~R~~~~~~l~~------h~~~~~~~~~~~~~~~~~~~~~~ 270 (316)
T cd05592 224 KDCLSKLFERDPTKRLGVDGDIRQ------HPFFRGIDWERLEKREIPPPFKP 270 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHc------CcccCCCCHHHHHhCCCCCCcCC
Confidence 9999999999999999875 4443 66788888988777766665544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=353.85 Aligned_cols=276 Identities=22% Similarity=0.343 Sum_probs=221.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.++.++ +.||||++.+... .........+..++..+.+|++|+.+++++..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTD------ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 5889999999999999999987665 4899999875321 1111222233445566678899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+||||++ |+|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999998 577766644 3579999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
.. .......+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..++...+.. ....+|..+
T Consensus 153 ~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~ 224 (323)
T cd05615 153 VD---GVTTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSL 224 (323)
T ss_pred CC---CccccCccCCccccCHHHHcC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccC
Confidence 21 112234578999999999874 3688999999999999999999999999888877777653 445678889
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHH-HHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMAD-ILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~e-ll~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
+.++.+++.+||++||.+|++..+ ..+.+ ..+.++...+|..+..+...+++.+.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i--~~h~~f~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDI--REHAFFRRIDWDKLENREIQPPFKPK 280 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHH--hcCcccCCCCHHHHhcCCCCcCccCc
Confidence 999999999999999999997532 12222 23678889999988888777776554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=354.15 Aligned_cols=270 Identities=23% Similarity=0.390 Sum_probs=214.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||+||+|.+..++ +.||||++.+... .....+..+...+ .+..+|+||+.+++.+..++..|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~~-~~~l~hp~iv~~~~~~~~~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG------KFYAVKVLQKKAILKKKEQKHIMAERNVL-LKNVKHPFLVGLHYSFQTADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhHHHHHHHHHHHH-HhhCCCCCCCCeeEEEEeCCEEEE
Confidence 46999999999999987655 4899999865321 1122233333223 334579999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-- 149 (323)
T cd05575 74 VLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-- 149 (323)
T ss_pred EEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--
Confidence 999998 467666654 357999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+.. ....++..+++++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~ 223 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--KPLRLKPNISVSA 223 (323)
T ss_pred -CCccccccCChhhcChhhhcC---CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHH
Confidence 122334579999999999874 3688999999999999999999999999888887777653 3445667889999
Q ss_pred HHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 285 ENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.++|.+||+.||.+||++.+.+..+ +.++++...+|..+..+.+.+++.+.
T Consensus 224 ~~li~~~l~~~p~~R~~~~~~~~~i--l~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05575 224 RHLLEGLLQKDRTKRLGAKDDFLEI--KNHVFFSSINWDDLVNKKITPPFNPN 274 (323)
T ss_pred HHHHHHHhhcCHHhCCCCCCCHHHH--HcCCCcCCCCHHHHhhccCCCCcCCC
Confidence 9999999999999999875322211 23778888899888777776665554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.79 Aligned_cols=272 Identities=19% Similarity=0.300 Sum_probs=217.7
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.++.++ +.||||++.+.. ......+ ..+..++..+.+|+||+.+++++...+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~-~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESG------RLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFLTQLYCCFQTPDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCC------CEEEEEEEEHHHHhhccHHHHH-HHHHHHHHhccCCCchhceeeEEEcCCEEEE
Confidence 46999999999999987655 489999986532 1112222 2333445556689999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++| +|.+.+.. .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-- 149 (320)
T cd05590 74 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-- 149 (320)
T ss_pred EEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--
Confidence 9999984 66666643 357999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
........||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+..+++..+. .....+|..+++++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~ 223 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEM---LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDA 223 (320)
T ss_pred -CCcccccccCccccCHHHHcCC---CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHH
Confidence 1222345799999999998743 67889999999999999999999999988888777765 34556778899999
Q ss_pred HHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 285 ENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.++|.+||+.||.+||++.++...-+-+.++++...+|..+..+...+++.+.
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 276 (320)
T cd05590 224 VDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPR 276 (320)
T ss_pred HHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 99999999999999999844322223334788999999988777776665544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.14 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=217.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++...... ........+..++..+ +||||+.+++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISE------HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQ 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCC------CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccC
Confidence 47999999999999999999987655 48999998643211 1122223333444444 689999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||+. |+|.+++.. .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 99999999998 578777754 357899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.. .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+++..+.. ....+|..
T Consensus 152 ~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~ 220 (291)
T cd05612 152 RD------RTWTLCGTPEYLAPEVIQSK---GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKLEFPRH 220 (291)
T ss_pred cC------CcccccCChhhcCHHHHcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCcc
Confidence 32 12335789999999998743 578899999999999999999999999888887777653 45567888
Q ss_pred CCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 280 LPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
+++.+.+||.+||+.||.+||+ +.++++ +.++...+|..+..+...++.
T Consensus 221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~ 274 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN------HRWFKSVDWDDVPQRKLKPPI 274 (291)
T ss_pred CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc------CccccCCCHHHHhcCCCCCCE
Confidence 8999999999999999999995 777664 677888888877666555443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.69 Aligned_cols=266 Identities=22% Similarity=0.357 Sum_probs=213.5
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
+.||+|+||+||+|.++.++ ..||||++++... .........+..++..+.+|+||+.+++++...+.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv 74 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD------ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV 74 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence 47999999999999987655 4899999975321 111122223334555566899999999999999999999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||+. |+|.+.+.. .+.+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 75 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 149 (318)
T cd05570 75 MEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--- 149 (318)
T ss_pred EcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence 99998 566666643 357999999999999999999999999999999999999999999999999998653221
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+....+. ...+.+|..++.++.
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~ 224 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSY---QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAK 224 (318)
T ss_pred CCcccceecCccccCHHHhcC---CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHH
Confidence 122234578999999999974 368889999999999999999999999888877776655 344567788999999
Q ss_pred HHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 286 NVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
++|.+||+.||.+||++ .++++ ++++...+|.....+...++..+
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~------~~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKG------HPFFREIDWDKLERKEIKPPFKP 274 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 99999999999999998 66554 67888888887766665555433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.56 Aligned_cols=272 Identities=22% Similarity=0.351 Sum_probs=214.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||+||+|.++.++ +.||||++.+... ......+..+..++..+ +|++|+.+++.+..+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTG------HVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDK 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCC------CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecC
Confidence 57999999999999999999987655 4899999965321 11112233333444444 789999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++.+ .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 99999999998 577777754 357999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCC--------------------------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHH
Q 006772 200 LGRSLS--------------------------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIME 247 (632)
Q Consensus 200 ~~~~~~--------------------------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~E 247 (632)
...... .......+||+.|||||++.+. .++.++|+|||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~~DvwSlGvil~e 228 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT---GYNKLCDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC---CCCCchhhhhhHHHHHH
Confidence 221000 0011245799999999998743 68889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHhhhcCcC---CCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 248 MLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLR---NRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 248 mltG~~PF~~~~~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~cL~~DP~---~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
|++|..||.+.+..+.+..+........+|. .+++++.++|.+++. +|. .||++.||++ ++++.+.+|
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~------hp~f~~~~~ 301 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT------NPFFEGVDW 301 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC------CCCCCCCCH
Confidence 9999999999888888877765444444554 468999999998664 444 4689999876 789999999
Q ss_pred cccccccccCC
Q 006772 323 TGLGSRALTDT 333 (632)
Q Consensus 323 ~~~~~~~~~~~ 333 (632)
+.+..+....+
T Consensus 302 ~~~~~~~~~~~ 312 (363)
T cd05628 302 EHIRERPAAIP 312 (363)
T ss_pred HHHHhCCCCCC
Confidence 98765543333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.12 Aligned_cols=252 Identities=20% Similarity=0.321 Sum_probs=204.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+.|+.+.++|+|+||.||+++++.++ +.||||++.....+ ..+...-++..++ +..+|+|++.+..+|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tg------qIVAIKkF~Esedd~~VkKIAlREIrmL-KqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTG------QIVAIKKFVESEDDPVVKKIALREIRML-KQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcc------cEEEEEeeccCCccHHHHHHHHHHHHHH-HhcccchHHHHHHHHHhcc
Confidence 46888899999999999999998776 49999999754432 2233323333334 4458999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.++||+|||+-++++.+.+.. ..++...+..|+.|++.|+.|+|+++||||||||+||||+.+|.+||||||+|+.+..
T Consensus 75 klhLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 75 KLHLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeEEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999999999999999887765 4689999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK----------- 270 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~----------- 270 (632)
. ...++..+.|.+|.|||.+.+.. +|...+||||+||++.||++|.+.|.|.+.-+.+..|...
T Consensus 154 p---gd~YTDYVATRWYRaPELLvGDt--qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 P---GDNYTDYVATRWYRAPELLVGDT--QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred C---cchhhhhhhhhhccChhhhcccC--cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 3 23345567799999999998753 6889999999999999999999999998755443333310
Q ss_pred --------ccCCCCC----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 --------KEKPCIP----------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 --------~~~p~~p----------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+...+.| +.++..+.+|+.+||+.||.+|++.+++++
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0010111 245568899999999999999999999996
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.90 Aligned_cols=266 Identities=20% Similarity=0.319 Sum_probs=210.2
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+.... ..++.||||++.+... .........+..++..+ +||||+.+++.+..++.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA---DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccC---CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEE
Confidence 68999999999999875432 2346899999865321 11111222333444444 79999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||+.| +|.+.+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (323)
T cd05584 78 ILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-- 153 (323)
T ss_pred EEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--
Confidence 9999985 67666654 357889999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+. .....+|..+++++
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 227 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMRS---GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEA 227 (323)
T ss_pred -CCcccccCCCccccChhhccCC---CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHH
Confidence 1122345799999999998743 57889999999999999999999999988777666655 34456788899999
Q ss_pred HHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 285 ENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
.++|.+||++||++|| ++.++++ ++++....|..+......+++
T Consensus 228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~------h~~~~~~~~~~~~~~~~~~~~ 276 (323)
T cd05584 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQS------HPFFRHVNWDDLLARKVEPPF 276 (323)
T ss_pred HHHHHHHcccCHhHcCCCCCCCHHHHhc------CCCcCCCCHHHHhcCCCCCCc
Confidence 9999999999999999 6777665 677777788777665555443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=360.76 Aligned_cols=254 Identities=19% Similarity=0.292 Sum_probs=209.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
-.++|+++++||.|+||.||+|....+++ .||||.+++......+-.--++...+.++..||||+.+..++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~------~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGE------LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCc------eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 34789999999999999999999887664 799999986543332222223334567777899999999999887
Q ss_pred C-EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 G-KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~-~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+ .+|+|||||+.+|++++..+ ++.|++.+++.|+.||++||+|+|.+|+.||||||+|||+..+..+||+|||+|+.+
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 7 99999999999999999876 789999999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC------
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK------ 273 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~------ 273 (632)
.. ...++..+.|.+|.|||++.. .+-|+.+.|+|++||+++|+.+-++.|.|.+..+...+|..--..
T Consensus 161 ~S----kpPYTeYVSTRWYRAPEvLLr--s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RS----KPPYTEYVSTRWYRAPEVLLR--SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cc----CCCcchhhhcccccchHHhhh--ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 43 234556688999999999984 457999999999999999999999999998754433333310000
Q ss_pred -----------CCCC-----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 -----------PCIP-----------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 -----------p~~p-----------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+| +.+++++.++|.+|++.||.+||++.+.++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 0111 347789999999999999999999999886
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.88 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=213.4
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
+.||+|+||.||+|.++.++ ..||+|++++... .........+..++....+|++|+.+++++..++.+|+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 74 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG------EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence 47999999999999988665 4899999975321 111122223334455566899999999999999999999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||+. |+|.+.+.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .
T Consensus 75 ~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 149 (316)
T cd05620 75 MEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---G 149 (316)
T ss_pred ECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc---C
Confidence 99998 577776654 35789999999999999999999999999999999999999999999999999864321 1
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......+||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+..++...+. ...+.+|..++.++.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 224 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL---KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESK 224 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC---CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHH
Confidence 1223446799999999999743 68899999999999999999999999988877776654 345667888999999
Q ss_pred HHHHHhhhcCcCCCCCHH-HHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 286 NVIIGCFEYDLRNRPLMA-DILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~-ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
++|.+||+.||++||++. ++++ ++++...+|..+......++..+
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~------h~~f~~~~~~~~~~~~~~~~~~~ 270 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRG------HPFFKTINWTALEKRELDPPFKP 270 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 999999999999999974 5443 67788888887766665555444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.58 Aligned_cols=266 Identities=21% Similarity=0.357 Sum_probs=209.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
+.||+|+||+||+|.+..++ +.||+|++++... .........+..++..+.+|+||+.+++++..++.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 74 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE------RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 74 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence 47999999999999987665 4899999975321 111222333445556667899999999999999999999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--- 149 (329)
T cd05618 75 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--- 149 (329)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---
Confidence 99998 566666543 357999999999999999999999999999999999999999999999999998753221
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhhccCCCC
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---------SVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---------~~~ei~~~i~~~~~~p~~ 276 (632)
.......+||+.|+|||++.+. .++.++|+|||||++|||++|..||... ....+...+. .....+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~ 224 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRI 224 (329)
T ss_pred CCccccccCCccccCHHHHcCC---CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--cCCCCC
Confidence 1122346799999999999743 6788999999999999999999999521 1112223222 345567
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLM------ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~------~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
|..++.++.++|.+||+.||++||++ .++++ ++++...+|..+..+...+++.+
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~------hp~f~~~~~~~~~~~~~~~~~~~ 284 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG------HPFFRNVDWDLMEQKQVVPPFKP 284 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc------CCCCCCCCHHHHHcCCCCcCccC
Confidence 88999999999999999999999984 45543 78888899988777666665544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.56 Aligned_cols=264 Identities=20% Similarity=0.368 Sum_probs=212.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+..++ ..||+|++.+... .....+.+ +..++..+ +||||+.+++++..++.+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~-E~~~l~~l-~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNT-RHPFLTALKYAFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhHHHHHHHH-HHHHHHhC-CCCCCcceeeEEecCCEEEE
Confidence 46999999999999987655 4899999975321 11122222 23344444 78999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 73 v~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-- 148 (323)
T cd05595 73 VMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 148 (323)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--
Confidence 999998 566666543 357899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
........||+.|||||++.+ +.++.++|+|||||++|||++|..||...+..+....+. .....+|..+++++
T Consensus 149 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~ 222 (323)
T cd05595 149 -GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEA 222 (323)
T ss_pred -CCccccccCCcCcCCcccccC---CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHH
Confidence 112234579999999999864 367899999999999999999999999888777766655 34455788999999
Q ss_pred HHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++|.+||+.||.+|+ ++.++++ +.++....|.....+.+.+++.+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~~ 273 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVME------HRFFLSINWQDVVQKKLLPPFKP 273 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 9999999999999998 7777775 67888888888776666555544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.53 Aligned_cols=261 Identities=23% Similarity=0.405 Sum_probs=209.3
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
||+|+||.||+|.+..++ +.||+|++.+.. ......+. .+..++..+ +|+||+.+++.+..++..|+||
T Consensus 1 lg~G~~g~Vy~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~-~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ------RIYALKTIRKAHIVSRSEVTHTL-AERTVLAQV-NCPFIVPLKFSFQSPEKLYLVL 72 (312)
T ss_pred CCcCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHH-HHHHHHHhC-CCCcEeceeeEEecCCeEEEEE
Confidence 799999999999987655 489999986432 11122222 233444444 7999999999999999999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||++ |+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 73 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~ 147 (312)
T cd05585 73 AFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD---D 147 (312)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC---C
Confidence 9998 577777754 357999999999999999999999999999999999999999999999999998753221 1
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~ 286 (632)
......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+.+..+. .....+|..+++++.+
T Consensus 148 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 222 (312)
T cd05585 148 DKTNTFCGTPEYLAPELLLG---HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKD 222 (312)
T ss_pred CccccccCCcccCCHHHHcC---CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHH
Confidence 22234579999999999974 368899999999999999999999999988888777665 3456678899999999
Q ss_pred HHHHhhhcCcCCCCC---HHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 287 VIIGCFEYDLRNRPL---MADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 287 LI~~cL~~DP~~RPs---~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
+|.+||+.||.+||+ +.+++. ++++...+|..+..+...++..
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~------hp~~~~~~~~~~~~~~~~~~~~ 268 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKN------HPFFSQLSWKKLLMKGIQPPFK 268 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcC
Confidence 999999999999986 455554 6778777777666555555443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.08 Aligned_cols=271 Identities=20% Similarity=0.314 Sum_probs=213.5
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...+..++|++.+.||+|+||.||+|.+...+. .+....||||++...........+..+..++..+..|+||+.+++.
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 334566899999999999999999999765442 2334579999997544333233333444566677689999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc-----------------------------------------------------
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQR----------------------------------------------------- 142 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~----------------------------------------------------- 142 (632)
+...+.+|+||||+. |+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999998 68887775421
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCC
Q 006772 143 ---------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207 (632)
Q Consensus 143 ---------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~ 207 (632)
..++++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YV 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-ee
Confidence 13578889999999999999999999999999999999999999999999999876532211 01
Q ss_pred ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 006772 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286 (632)
Q Consensus 208 ~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~ 286 (632)
......++..|||||++.. ..++.++|||||||++|||++ |+.||..................+..|..+|+++.+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346 (374)
T ss_pred eccCCCCccceeCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHH
Confidence 1112235678999999863 468899999999999999997 999998876554444444444455567778999999
Q ss_pred HHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 287 VIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 287 LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
++.+||+.||.+||++.++++.|+.+
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.34 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=208.6
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
+.||+|+||.||+|.+..++ +.||||++++... .........+..++..+.+|+||+.+++++..++.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv 74 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR------RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV 74 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence 46999999999999987665 4899999975321 111222344455666777899999999999999999999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 149 (329)
T cd05588 75 IEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--- 149 (329)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence 99998 477666643 358999999999999999999999999999999999999999999999999998743221
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhhccCCCC
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---------VEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~---------~~ei~~~i~~~~~~p~~ 276 (632)
.......+||+.|+|||++.+. .++.++|+|||||++|||++|+.||.... .......+. .....+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 224 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--EKQIRI 224 (329)
T ss_pred CCccccccCCccccCHHHHcCC---CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH--cCCCCC
Confidence 1223346799999999999743 67889999999999999999999996321 112333332 345567
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCC------HHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPL------MADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs------~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
|..++.++.++|.+||+.||.+|++ +.++++ ++++...+|.....+...++..
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~------hp~~~~~~~~~~~~~~~~~~~~ 283 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS------HPFFRNIDWDLLEQKQVLPPYK 283 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc------CCCCCCCCHHHHHhCCCCCCcc
Confidence 8899999999999999999999998 455543 7788888898776555544433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.63 Aligned_cols=277 Identities=25% Similarity=0.387 Sum_probs=219.2
Q ss_pred cccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhh
Q 006772 25 HLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFP 102 (632)
Q Consensus 25 ~~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~ 102 (632)
..+..-+........|..+++.+..+||+|.||+||+|.|+. .||||+++... .+..+.|.++. ..+
T Consensus 374 ~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---------dVAVK~Lnv~~pt~~qlqaFKnEV-a~l- 442 (678)
T KOG0193|consen 374 SGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---------DVAVKLLNVDDPTPEQLQAFKNEV-AVL- 442 (678)
T ss_pred ccccccCCccccccccCHHHhhccceeccccccceeeccccc---------ceEEEEEecCCCCHHHHHHHHHHH-HHH-
Confidence 333333334444555888999999999999999999999975 69999997543 33444444443 333
Q ss_pred hccCCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 103 ~l~~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
+..+|.||+.+.|++...+. .||+.+|+|+.+..+.+....+|.+...+.|+.||++|+.|||.++|||||||..||||
T Consensus 443 kkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 443 KKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL 521 (678)
T ss_pred hhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE
Confidence 34579999999999987766 99999999854444444445789999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e 262 (632)
.+++++||+||||+..-.-- ..........|...|||||+++.+...+|++.+|||||||++|||++|..||.....++
T Consensus 522 ~~~~kVkIgDFGLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 522 HEDLKVKIGDFGLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred ccCCcEEEecccceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 99999999999998642111 11122333467899999999986667799999999999999999999999999777777
Q ss_pred HHHHHHhhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 263 IYHSVVIKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 263 i~~~i~~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+..++-.+...+. ....++.++++|+..||.+++++||.+.+|+..|+.+..
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 7666554433333 336788999999999999999999999999998877654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=352.64 Aligned_cols=279 Identities=22% Similarity=0.383 Sum_probs=220.3
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..++.++|++.+.||+|+||.||+|.+..++ ..||+|++.+.. .........++..++.. .+|+||+.+++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~-~~h~~iv~~~~ 110 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK------QVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIVQLHY 110 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh-CCCCCcceEEE
Confidence 3456789999999999999999999987665 489999986421 11112222333344444 47999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence 9999999999999998 577776643 368999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCC-CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
++........ ......+||+.|||||++.... ...++.++|+|||||++|||++|..||.+.+....+..+......
T Consensus 188 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 188 TCMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred ceeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 9876533211 1123457999999999986532 234789999999999999999999999998888777777654444
Q ss_pred CCCCC--CCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 274 PCIPS--GLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 274 p~~p~--~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
..+|. .++.++.++|.+||+.+|.+ |+++.++++ ++++.+.+|.....+...++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~------h~~~~~~~~~~~~~~~~~~~~ 324 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS------HPFFKNDQWTFDNIRETVAPV 324 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc------CcccCCCChhhHHhcCCCcCc
Confidence 55554 57999999999999999988 999999887 677877777754444444443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=349.16 Aligned_cols=264 Identities=21% Similarity=0.368 Sum_probs=212.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+..++ +.||+|++.+.. ......+.++ ..++.. .+|+||+.+++.+..++.+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E-~~~l~~-l~hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG------KYYAMKILKKEVIIAKDEVAHTLTE-SRVLKN-TRHPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHH-HHHHHh-CCCCCCcceEEEEEcCCEEEE
Confidence 46999999999999987655 489999997532 1222222232 233443 478999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+.+.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 73 v~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-- 148 (328)
T cd05593 73 VMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-- 148 (328)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--
Confidence 999998 567666644 357999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+....+. .....+|..+++++
T Consensus 149 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~ 222 (328)
T cd05593 149 -AATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADA 222 (328)
T ss_pred -ccccccccCCcCccChhhhcC---CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHH
Confidence 122234579999999999874 367899999999999999999999999888777666554 34556788999999
Q ss_pred HHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++|.+||+.||++|+ ++.++++ +.++.+.+|..+......+++.+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~------h~~~~~~~~~~~~~~~~~~~~~~ 273 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR------HSFFTGVNWQDVYDKKLVPPFKP 273 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 9999999999999997 7888775 67888888887776665555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.15 Aligned_cols=266 Identities=25% Similarity=0.422 Sum_probs=214.4
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||+||+|.+..++ +.||||++++.. ........ .+..++....+||||+.+++++..++.+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-~e~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN------QFFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhcchHHHHH-HHHHHHHhccCCCcCcceEEEEEeCCEEEE
Confidence 47999999999999987665 489999987532 11122222 233445555689999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++ |+|.+.+.. ...+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 149 (316)
T cd05619 74 VMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-- 149 (316)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--
Confidence 999998 577777654 347899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
........||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+..+....+. ...+.+|..++.++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~ 223 (316)
T cd05619 150 -DAKTCTFCGTPDYIAPEILLGQ---KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--MDNPCYPRWLTREA 223 (316)
T ss_pred -CCceeeecCCccccCHHHHcCC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHH
Confidence 1222345799999999998743 68899999999999999999999999988877776654 34456778899999
Q ss_pred HHHHHHhhhcCcCCCCCHH-HHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 285 ENVIIGCFEYDLRNRPLMA-DILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~-ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.+++.+||+.||.+||++. +++. ++++...+|..+..+...++..+.
T Consensus 224 ~~li~~~l~~~P~~R~~~~~~l~~------h~~~~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05619 224 KDILVKLFVREPERRLGVKGDIRQ------HPFFREIDWSALEEREIEPPFKPK 271 (316)
T ss_pred HHHHHHHhccCHhhcCCChHHHHc------CcccCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999999986 5443 677888888877766666665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=378.32 Aligned_cols=268 Identities=22% Similarity=0.391 Sum_probs=228.9
Q ss_pred CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 35 QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 35 ~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
...-.|.+.+.++.+.||+|.||+||+|+...... ......||||.++.......+..++++.+++..+ +|+||++|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p-~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLl 555 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLP-GQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLL 555 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCC-CccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEE
Confidence 33445888999999999999999999998765442 1344689999999877764555555555666665 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhc--------CC----CCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEE
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQR--------GG----KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLL 181 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------~~----~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NIL 181 (632)
|+|..++.+|+|+|||. |+|.+++.... +. +++..+.+.++.|||.|++||-++.+|||||..+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999998 99999887542 12 2888999999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCceeccCCCCCCCcccccc----CCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCC
Q 006772 182 LSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256 (632)
Q Consensus 182 ld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~----GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~ 256 (632)
|+++-.+||+|||+++-.-.. +++... -.++|||||.+. +++||.+||||||||+|||+++ |+.||.
T Consensus 636 Vge~l~VKIsDfGLsRdiYss-----DYYk~~~~t~lPIRWMppEsIl---y~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSS-----DYYKVRGNTLLPIRWMPPESIL---YGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred eccceEEEecccccchhhhhh-----hhhcccCCceeeeecCCHHHhh---cCcccchhhhhhhhhhhhhhhccccCccc
Confidence 999999999999999865332 222222 267999999997 7899999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 257 GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 257 ~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+.+.++..+.+..+.. ..-|..||.++.+||..||+.+|.+||+++||-..|+.+.
T Consensus 708 glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 708 GLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 9999999988876666 5569999999999999999999999999999999998765
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.45 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=206.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+.|++++.||+|+||+||+|.+..++ +.||||++.+... ......+..+..++..+ +|+||+.+++.+.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~ 73 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTH------ALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDK 73 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecC
Confidence 36999999999999999999987665 4899999965321 11122223333444444 789999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||++ |+|.+++.+. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998 5777777543 47899999999999999999999999999999999999999999999999997532
Q ss_pred cCCCC--------------------------------------------CCCccccccCCCccCCccccCCCCCCCCCcc
Q 006772 200 LGRSL--------------------------------------------SDSDMALRLGTPNYMAPEQWEPEVRGPISFE 235 (632)
Q Consensus 200 ~~~~~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~k 235 (632)
..... ........+||+.|||||++.+ ..++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~ 228 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR---KGYTQL 228 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC---CCCCCc
Confidence 10000 0000123579999999999874 368899
Q ss_pred cccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHh--hhcCcCCCCCHHHHHHHHHh
Q 006772 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGC--FEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 236 sDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~c--L~~DP~~RPs~~ell~~Le~ 311 (632)
+|||||||++|||++|..||...+..+....+........+|. .+++++.+||.+| +..+|..|+++.+++.
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~---- 304 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA---- 304 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc----
Confidence 9999999999999999999998887666555553333334443 6899999999994 4556666999999886
Q ss_pred hhhcccCCCCccccc
Q 006772 312 SQNAVYNDGEWTGLG 326 (632)
Q Consensus 312 ~~~~~~~~~~w~~~~ 326 (632)
++++...+|....
T Consensus 305 --hp~f~~~~~~~~~ 317 (381)
T cd05626 305 --HPFFSEVDFSSDI 317 (381)
T ss_pred --CcccCCCChhHHh
Confidence 7788888887543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=332.15 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=219.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
....++|++++.||+|-||.||+|+.+++. ..||+|++.+.. ....+..++++.++.+. .+||||.+++++
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~------~IvalKVlfKsqi~~~~v~~qlrREiEIqs~-L~hpnilrlY~~ 90 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSL------FIVALKVLFKSQILKTQVEHQLRREIEIQSH-LRHPNILRLYGY 90 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCC------cEEEEeeeeHHHHHHhcchhhhhheeEeecc-cCCccHHhhhhh
Confidence 446789999999999999999999998776 389999997643 22233334444444333 479999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
|.++..+||++||.. |+++..+.....+++++..+..|..|+|.||.|+|.++||||||||+|+|++..|..|++|||-
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 999999999999997 8999999877778999999999999999999999999999999999999999999999999998
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+-... .....+.|||..|++||...+. .++..+|+|++|+++||++.|.+||...+..+.+..|. ..+..
T Consensus 171 sV~~p-----~~kR~tlcgt~dyl~pEmv~~~---~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~ 240 (281)
T KOG0580|consen 171 SVHAP-----SNKRKTLCGTLDYLPPEMVEGR---GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLK 240 (281)
T ss_pred eeecC-----CCCceeeecccccCCHhhcCCC---CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--Hcccc
Confidence 75432 2334567999999999999855 68899999999999999999999999999889998876 56677
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|+.++.+++++|.+|+.++|.+|....|++.
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 88999999999999999999999999999886
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.89 Aligned_cols=278 Identities=23% Similarity=0.391 Sum_probs=216.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+..++|++.+.||+|+||.||+|.+..++ +.||+|++.+... ........++..++ +..+||||+.+++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~i~-~~~~hp~iv~~~~~~ 112 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQ------KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLFCAF 112 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhhHHHHHHHHHHH-HhCCCCCEeeEEEEE
Confidence 45689999999999999999999987665 4899999864211 11122233333443 445799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..++.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999998 577777643 36899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCC-CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... ......+||+.|||||++.... .+.++.++|+|||||+||||++|..||.+.+....+..+........
T Consensus 190 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05621 190 MKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267 (370)
T ss_pred eecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC
Confidence 86532211 1223467999999999986432 13478899999999999999999999999888777777765444455
Q ss_pred CCC--CCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 276 IPS--GLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 276 ~p~--~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
+|. .++..+++++.+||..++.+ |+++.++++ ++++....|.....+...++..
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~------hp~~~~~~~~~~~~~~~~~~~~ 325 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ------HPFFKNDQWNWDNIRETAAPVV 325 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc------CcccCCCCcChHhcCCCCCCcC
Confidence 554 56999999999999855543 889999876 6777666565433333334433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=354.80 Aligned_cols=287 Identities=21% Similarity=0.301 Sum_probs=218.1
Q ss_pred CCcccccccCCCccccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHH
Q 006772 12 ASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91 (632)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~ 91 (632)
....|+.++..-+.. .....++.++|++.+.||+|+||+||+|++..... .+....||||+++........
T Consensus 12 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~ 82 (375)
T cd05104 12 NGNNYVYIDPTQLPY--------DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFK-SDAAMTVAVKMLKPSAHLTER 82 (375)
T ss_pred cCceEEEecCCCCCC--------ccccccchHHeehhheecCCccceEEEEEEecccc-CccceeEEEEeccCCcCcHHH
Confidence 344666666543322 22334556789999999999999999998643211 123458999999754332222
Q ss_pred HHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhc----------------------------
Q 006772 92 VFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR---------------------------- 142 (632)
Q Consensus 92 ~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~---------------------------- 142 (632)
..+.++..++..+.+||||+.+++++..++..++||||++ |+|.+++....
T Consensus 83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (375)
T cd05104 83 EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC 162 (375)
T ss_pred HHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence 3333344566667689999999999999999999999998 68888775421
Q ss_pred ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeC
Q 006772 143 ---------------------------------------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKP 177 (632)
Q Consensus 143 ---------------------------------------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP 177 (632)
...+++..++.++.||+.||+|||+++|+||||||
T Consensus 163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 242 (375)
T cd05104 163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA 242 (375)
T ss_pred hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence 12478889999999999999999999999999999
Q ss_pred CeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCC
Q 006772 178 SNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256 (632)
Q Consensus 178 ~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~ 256 (632)
+|||++.++.+||+|||+++........ .......++..|||||++.+ ..++.++|+|||||++|||++ |..||.
T Consensus 243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 243 RNILLTHGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred hhEEEECCCcEEEecCccceeccCcccc-cccCCCCCCcceeChhHhcC---CCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999765332111 11112235678999999864 368899999999999999998 899998
Q ss_pred CCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 257 GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 257 ~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
.................+..|...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 319 GMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 8664443334444444555667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=347.21 Aligned_cols=273 Identities=21% Similarity=0.327 Sum_probs=212.6
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
+.||+|+||+||+|.+..++ +.||+|++.+.... ........+..++.++.+|++|+.+++++...+.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 74 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND------QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV 74 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence 47999999999999987665 48999999753221 12222344445667777899999999999999999999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--- 149 (327)
T cd05617 75 IEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--- 149 (327)
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence 99998 567666643 357999999999999999999999999999999999999999999999999998753221
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC------CH-HHHHHHHHhhccCCCCCC
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK------SV-EEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~------~~-~ei~~~i~~~~~~p~~p~ 278 (632)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||... .. ......+. .....+|.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~p~ 224 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRG---EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--EKPIRIPR 224 (327)
T ss_pred CCceecccCCcccCCHHHHCC---CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--hCCCCCCC
Confidence 122234679999999999874 36788999999999999999999999642 12 22333332 34455788
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.++..+.+++.+||+.||++|+++.+....-+-..++++...+|+.+..+...+++.+.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 283 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQ 283 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCC
Confidence 89999999999999999999998542221112223778999999988877777665543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.90 Aligned_cols=269 Identities=25% Similarity=0.407 Sum_probs=210.5
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||++.+.... ..++.||+|++.+..... .......+..++.++ +|+||+.+++++..++.+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP---DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEE
Confidence 57999999999999875322 234689999997532211 111122233444554 6899999999999999999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||++ |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 78 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~ 152 (318)
T cd05582 78 DFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---E 152 (318)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---C
Confidence 9998 677777754 357899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~ 286 (632)
......+||+.|||||++.+. .++.++|+|||||++|||++|+.||.+.+..+....+. .....+|..+++++.+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 227 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRR---GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQS 227 (318)
T ss_pred CceecccCChhhcCHHHHcCC---CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHH
Confidence 222346799999999998743 57889999999999999999999999988777776655 3445678889999999
Q ss_pred HHHHhhhcCcCCCCCHHH--HHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 287 VIIGCFEYDLRNRPLMAD--ILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 287 LI~~cL~~DP~~RPs~~e--ll~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
+|++||+.||++||++.+ +.+.+ .+.++...+|..+..+...++.
T Consensus 228 li~~~l~~~P~~R~~a~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T cd05582 228 LLRALFKRNPANRLGAGPDGVEEIK---RHPFFSTIDWNKLYRREIKPPF 274 (318)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHh---CCCCcCCCCHHHHHhcCCCCCc
Confidence 999999999999999655 22222 3667888888877665555444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.72 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=209.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+... .....+.+ +..++..+ .|+||+.+++++..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~-e~~~l~~~-~h~~iv~~~~~~~~ 72 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTG------EIVALKRMKKSLLFKLNEVRHVLT-ERDILTTT-KSEWLVKLLYAFQD 72 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhHHHHHHH-HHHHHHhC-CCCCCccEEEEEEc
Confidence 47999999999999999999987665 4899999865321 11222222 33444444 59999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..||||||++ |+|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 999999999998 577777754 35789999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC-
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP- 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p- 277 (632)
... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+.........|
T Consensus 151 ~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 221 (333)
T cd05600 151 IVT------YANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV 221 (333)
T ss_pred ccc------ccCCcccCccccChhHhcCC---CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC
Confidence 432 22345789999999998743 68899999999999999999999999988877766655322222222
Q ss_pred -----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccc
Q 006772 278 -----SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 278 -----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
..+++++.++|.+||..+|.+||++.++++ ++++.+.+|..+.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~------h~~~~~~~~~~~~ 269 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN------HPFFKEVDWNELR 269 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh------CcccCCCCHHHHh
Confidence 256899999999999999999999999887 6677777776644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.89 Aligned_cols=269 Identities=24% Similarity=0.385 Sum_probs=212.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||+||+|.+..++ +.||+|++.+... .....+..+. ..+.+..+|+||+.+++.+..++.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~-~~~l~~~~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG------KCYAVKVLQKKIVLNRKEQKHIMAER-NVLLKNVKHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHHhCCCCCCccEEEEEecCCEEEE
Confidence 46999999999999987655 4899999865321 1222223332 233344579999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||+.| +|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 149 (325)
T cd05604 74 VLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-- 149 (325)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--
Confidence 9999985 66666543 457999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+.. ....++...+.++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 223 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRK---QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTA 223 (325)
T ss_pred -CCCcccccCChhhCCHHHHcC---CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHH
Confidence 112234579999999999874 3678899999999999999999999999888887776653 3344566789999
Q ss_pred HHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++|.+||+.||.+||++.+.++.+ +.++++....|..+..+.+.++..+
T Consensus 224 ~~ll~~ll~~~p~~R~~~~~~~~~i--~~h~~f~~~~~~~~~~~~~~~~~~~ 273 (325)
T cd05604 224 WSILEELLEKDRQRRLGAKEDFLEI--QEHPFFESLSWTDLEQKKIPPPFNP 273 (325)
T ss_pred HHHHHHHhccCHHhcCCCCCCHHHH--hcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 9999999999999999876433322 2367888888888776666555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.52 Aligned_cols=269 Identities=23% Similarity=0.378 Sum_probs=211.7
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+..++ +.||+|++.+... .....+..+...+ .+...|+||+.+++.+..++.+|+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~-l~~~~h~~Iv~~~~~~~~~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE------KFYAVKVLQKKAILKKKEEKHIMSERNVL-LKNVKHPFLVGLHFSFQTADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC------CEEEEEEEEHHHHHhhhHHHHHHHHHHHH-HHhCCCCCCCceeEEEEcCCeEEE
Confidence 46999999999999987655 4899999865321 1112222332222 334579999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||+.| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-- 149 (325)
T cd05602 74 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-- 149 (325)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--
Confidence 9999985 67666643 357889999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.. ....++..+++.+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~ 223 (325)
T cd05602 150 -NGTTSTFCGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSA 223 (325)
T ss_pred -CCCcccccCCccccCHHHHcC---CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCcCCCCCCCHHH
Confidence 122344679999999999874 3688899999999999999999999999888877776653 3444567899999
Q ss_pred HHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++|.+||++||.+||++.+.+..+ ..+.++...+|+.+......++..+
T Consensus 224 ~~li~~~l~~~p~~R~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
T cd05602 224 RHLLEGLLQKDRTKRLGAKDDFMEI--KNHIFFSPINWDDLINKKITPPFNP 273 (325)
T ss_pred HHHHHHHcccCHHHCCCCCCCHHHH--hcCcccCCCCHHHHHhCCCCcCcCC
Confidence 9999999999999999887544322 2356778888988776655555433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=387.25 Aligned_cols=279 Identities=23% Similarity=0.389 Sum_probs=232.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecC---CchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---LKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~---~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
+.+++|.+++.||+|+||.|.+++++.++. .||+|++.+ .+... -.++.++..++.. .+.+=|+.++..
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~------VYAMK~lnK~eMlKr~~-tA~F~EERDimv~-~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEK------VYAMKILNKWEMLKRAE-TACFREERDIMVF-GNSEWIVQLHYA 143 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeecccc------chhHHHhhHHHHhhchh-HHHHHHHhHHHHc-CCcHHHHHHHHH
Confidence 677999999999999999999999998774 899999976 22222 2344555555443 346778999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
|+++.++|+|||||+ |+|+.++... .++|+..+++|+.+|+.||.-||+.|+|||||||+|||||.+|++||+|||.
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999998 5777777554 3899999999999999999999999999999999999999999999999998
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+-.+...+.. .....+|||.|++||++... ..|.|+..+||||+||++|||+.|..||+.++..+.|..|+.....
T Consensus 222 Clkm~~dG~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 222 CLKMDADGTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred HHhcCCCCcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 8666543222 22345899999999999743 2367999999999999999999999999999999999999988888
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCcCCCCC---HHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCC
Q 006772 274 PCIP--SGLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGY 339 (632)
Q Consensus 274 p~~p--~~lp~~l~~LI~~cL~~DP~~RPs---~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 339 (632)
..|| ..+|.++++||.+++. +|+.|.+ +.+|.. |+||.+++|+.+. ...+|+.|...
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~------HpFF~g~~W~~iR--~~~pP~vPevs 361 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN------HPFFEGIDWDNIR--ESVPPVVPEVS 361 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh------CccccCCChhhhh--hcCCCCCCcCC
Confidence 8888 5689999999999887 8899987 888776 8899999997654 45666655433
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.73 Aligned_cols=260 Identities=17% Similarity=0.300 Sum_probs=206.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|+.++|++.+.||+|+||.||+|.++... .....||+|+++....... ..+.++. ..+..+ +|+||+.+++++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~-~~l~~l-~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPS---KRELPVAIHTLRAGCSDKQRRGFLAEA-LTLGQF-DHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCC---CceeeEEEEecCCCCCHHHHHHHHHHH-HHHhcC-CCCCcCeEEEEEe
Confidence 56789999999999999999999876432 2346899999876433222 2333333 334443 7999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..++||||++| +|.+++.. ....+++.+++.++.||+.||+|||+++++||||||+|||++.++.++++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999996 55555543 34578999999999999999999999999999999999999999999999999875
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
....... .......++..|+|||.+.+ +.++.++|+|||||++||+++ |..||.+.+..+....+.. ...+..
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (266)
T cd05064 156 EDKSEAI--YTTMSGKSPVLWAAPEAIQY---HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPA 229 (266)
T ss_pred cccccch--hcccCCCCceeecCHHHHhh---CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCC
Confidence 4321111 11112235678999999864 468899999999999999875 9999998887776665543 344456
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
|..+|..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 78899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=361.61 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=214.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|.+.+.||+|+||.||+|+.+.+. +.||||.+.+..... .-.-++++.+++..+ +||||+.++..|+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~------~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTI------QVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccce------eEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccc
Confidence 57889999999999999999987665 489999997754322 222233444555554 7999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.+|+|+||+.|+|..++.. .+.++++.+..++.|++.||.|||+++|+|||+||.|||++..|++|++|||+|+.+..
T Consensus 75 ~~~vVte~a~g~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 75 HLWVVTEYAVGDLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred eEEEEehhhhhhHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9999999999998888865 46899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
.....+...|||.|||||++.+ .+|+..+|+|||||++|||++|++||...+..++...|. .++...|...+
T Consensus 153 ---~t~vltsikGtPlYmAPElv~e---~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S 224 (808)
T KOG0597|consen 153 ---NTSVLTSIKGTPLYMAPELVEE---QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTAS 224 (808)
T ss_pred ---CceeeeeccCcccccCHHHHcC---CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCccccc
Confidence 2233456789999999999984 489999999999999999999999999988888887776 45666688999
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+.+++..+|.+||.+|.+..+++.
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhc
Confidence 99999999999999999999999884
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.31 Aligned_cols=264 Identities=21% Similarity=0.344 Sum_probs=207.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+... ......+..+..++.. .+|+||+.+++++..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~~~~~~~~~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTG------KIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLYYSFQDA 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCC------CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHh-CCCCCcceEEEEEEcC
Confidence 47999999999999999999988765 4899999865321 1111222333344444 4799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++.. .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999997 677777754 357899999999999999999999999999999999999999999999999998632
Q ss_pred cCCCC------------CC--------------------------------CccccccCCCccCCccccCCCCCCCCCcc
Q 006772 200 LGRSL------------SD--------------------------------SDMALRLGTPNYMAPEQWEPEVRGPISFE 235 (632)
Q Consensus 200 ~~~~~------------~~--------------------------------~~~~~~~GT~~YmAPE~~~~~~~g~~t~k 235 (632)
..... .. ......+||+.|||||++.+. .++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~ 228 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ---GYGQE 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC---CCCCc
Confidence 11000 00 000124699999999998743 68899
Q ss_pred cccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHhhhcCcCCC---CCHHHHHHHHH
Q 006772 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNR---PLMADILHAFE 310 (632)
Q Consensus 236 sDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~cL~~DP~~R---Ps~~ell~~Le 310 (632)
+|+|||||++|||++|..||.+.+..+.+..+........+|. .++.++.+||.+||. +|.+| +++.+++.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~--- 304 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS--- 304 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc---
Confidence 9999999999999999999998888777776654333444454 578999999999997 77776 48888776
Q ss_pred hhhhcccCCCCcccc
Q 006772 311 SSQNAVYNDGEWTGL 325 (632)
Q Consensus 311 ~~~~~~~~~~~w~~~ 325 (632)
++++.+.+|+.+
T Consensus 305 ---hp~~~~~~~~~~ 316 (377)
T cd05629 305 ---HPFFRGVDWDTI 316 (377)
T ss_pred ---CCCcCCCCHHHH
Confidence 778888888765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=347.65 Aligned_cols=263 Identities=21% Similarity=0.375 Sum_probs=210.0
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|.+..++ +.||+|++.+... .....+.. +..++.. .+|+||+.+++.+..++.+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~-e~~~l~~-~~hp~i~~~~~~~~~~~~~~l 72 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG------RYYAMKILKKEVIVAKDEVAHTLT-ENRVLQN-SRHPFLTALKYSFQTHDRLCF 72 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHH-HHHHHHh-CCCCCCCceEEEEEcCCEEEE
Confidence 46999999999999987655 4899999975321 11222222 2233333 478999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
||||++| +|.+.+.. .+.+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 73 v~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~- 149 (325)
T cd05594 73 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 149 (325)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-
Confidence 9999984 66665543 3579999999999999999999998 79999999999999999999999999998754221
Q ss_pred CCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHH
Q 006772 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPA 283 (632)
Q Consensus 204 ~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~ 283 (632)
........||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+....+. .....+|..++++
T Consensus 150 --~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~ 222 (325)
T cd05594 150 --GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPE 222 (325)
T ss_pred --CcccccccCCcccCCHHHHcc---CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHH
Confidence 112234579999999999864 367899999999999999999999999988777766654 3455678889999
Q ss_pred HHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 284 VENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
+.++|.+||+.||++|+ ++.++++ +.++.+..|.....+...+++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~------h~~~~~~~~~~~~~~~~~~~~~ 273 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ------HKFFAGIVWQDVYEKKLVPPFK 273 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcC
Confidence 99999999999999997 7888775 6788888888766555555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=341.33 Aligned_cols=310 Identities=22% Similarity=0.355 Sum_probs=245.6
Q ss_pred cccccCCCccccccccC--CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC--chhhHH
Q 006772 16 YELFEGDPDHLRTVVAT--PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL--KEDCAK 91 (632)
Q Consensus 16 ~~~~~~~~~~~~~~~~~--~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~--~~~~~~ 91 (632)
-|...++++....++.. ...++..+..++|.+++.||+|+|++|-+++++++. +.+|+|++++. +.+..-
T Consensus 221 he~~~~~~~~~~~a~~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~------qiyamkvvkkel~nddedi 294 (593)
T KOG0695|consen 221 HESIKDDSEDLKPAIDGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTD------QIYAMKVVKKELVNDDEDI 294 (593)
T ss_pred chhhhcCccchhhhhhhccccccccccccccceeeeeecCcchhhhhheehcccc------eeeehhhHHHHhcCCcccc
Confidence 34555566665544443 334556678899999999999999999999998876 48999999863 333333
Q ss_pred HHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 006772 92 VFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGL 170 (632)
Q Consensus 92 ~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~-~~~~~l~~~~~~~ia~qIa~gL~yLHs~~I 170 (632)
...+.+...+.+..++|+++-++.+|+++..+|+|.||++|. |++.+ ++.++++++.+++|..+|+.||.|||++||
T Consensus 295 dwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg--dlmfhmqrqrklpeeharfys~ei~lal~flh~rgi 372 (593)
T KOG0695|consen 295 DWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGI 372 (593)
T ss_pred hhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc--ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCe
Confidence 455666677788889999999999999999999999999963 33322 234689999999999999999999999999
Q ss_pred eeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh
Q 006772 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT 250 (632)
Q Consensus 171 vHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt 250 (632)
|+||||..|+|+|..|++||+|+|..+..... ...++++||||+|.|||+++++ .|.+.+|||+||++++||+.
T Consensus 373 iyrdlkldnvlldaeghikltdygmcke~l~~---gd~tstfcgtpnyiapeilrge---eygfsvdwwalgvlmfemma 446 (593)
T KOG0695|consen 373 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP---GDTTSTFCGTPNYIAPEILRGE---EYGFSVDWWALGVLMFEMMA 446 (593)
T ss_pred eeeeccccceEEccCCceeecccchhhcCCCC---CcccccccCCCcccchhhhccc---ccCceehHHHHHHHHHHHHc
Confidence 99999999999999999999999998864332 2345678999999999999976 68889999999999999999
Q ss_pred CCCCCCC-------CCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh-hcccCCCCc
Q 006772 251 GIQPWFG-------KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ-NAVYNDGEW 322 (632)
Q Consensus 251 G~~PF~~-------~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~-~~~~~~~~w 322 (632)
|+.||.- .+.++.+.+++. .....+|..++-.+..++...|.+||.+|....--. -|..++ ++||..++|
T Consensus 447 grspfdivgm~n~d~ntedylfqvil-ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~-g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 447 GRSPFDIVGMDNPDMNTEDYLFQVIL-EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQT-GFSDIKSHAFFRSIDW 524 (593)
T ss_pred CCCCcceecCCCcccchhHHHHHHHh-hhcccccceeehhhHHHHHHhhcCCcHHhcCCCccc-chhhhhcchhhhhCCH
Confidence 9999972 223333333332 345567899999999999999999999997542111 223332 678999999
Q ss_pred cccccccccCCCcCCCCCC
Q 006772 323 TGLGSRALTDTSSVKGYTA 341 (632)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~ 341 (632)
+.++.+...+|+.|.....
T Consensus 525 d~leqk~v~ppf~p~i~~d 543 (593)
T KOG0695|consen 525 DLLEQKQVLPPFQPQITDD 543 (593)
T ss_pred HHHhhcccCCCCCCccccc
Confidence 9999999999998875544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.53 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=201.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+.++|++.++||+|+||.||+|.+..++ +.||+|.+.............++..++..+ +|+||+.+++++..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTE------NLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCC------CEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCC
Confidence 3578999999999999999999987655 489999986533222122222333445554 789999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+..++||||+.|+|.+.+... +..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 999999999999988887643 3468999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP------ 274 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p------ 274 (632)
.. ........||+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+....+......+
T Consensus 155 ~~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 155 VP---TKTYSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred CC---CccccCceecccccChHHhcCC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 21 1122335689999999998642 357889999999999999999999999887766554443211100
Q ss_pred -----------CC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 -----------CI-----------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 -----------~~-----------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ ...+++++.+||.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 01 1346789999999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=345.53 Aligned_cols=267 Identities=19% Similarity=0.341 Sum_probs=213.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||+||+|.+..++ +.||||++++... ........++..++. ..+|++|+.+++++..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~~~~i~~~~~~~~~~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATG------DIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQYAFQDK 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceeeEEecC
Confidence 47999999999999999999987665 4899999975322 112223334434443 45899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999997 5777777553 357999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCC---CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEV---RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
..... .......||+.|+|||++.... ...++.++|+|||||++|||++|..||...+..+.+..+........+
T Consensus 153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (330)
T cd05601 153 TANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230 (330)
T ss_pred CCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence 33211 1122347899999999986321 235788999999999999999999999988877777666544333334
Q ss_pred C--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccc
Q 006772 277 P--SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 277 p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
| ..+++++.+|+.+||. ||.+||++.+++. ++++...+|..+.
T Consensus 231 ~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~------h~~~~~~~~~~~~ 275 (330)
T cd05601 231 PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC------HPFFSKIDWNNIR 275 (330)
T ss_pred CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC------CCCcCCCCHHHHh
Confidence 4 3579999999999998 9999999998875 7788888887654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.09 Aligned_cols=265 Identities=22% Similarity=0.359 Sum_probs=210.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+... .........+..++..+ +|+||+.+++++..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTG------HIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDE 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC
Confidence 47999999999999999999987665 4899999964321 11122233344555554 699999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 99999999998 567776654 357999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCC-----------------------------------CccccccCCCccCCccccCCCCCCCCCcccccchhHHH
Q 006772 200 LGRSLSD-----------------------------------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCS 244 (632)
Q Consensus 200 ~~~~~~~-----------------------------------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvv 244 (632)
....... ......+||+.|||||++.. ..++.++|+|||||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~i 228 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ---TGYNKECDWWSLGVI 228 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC---CCCCCeeeeecchhH
Confidence 3211000 01113469999999999864 368899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHhhhcCcCCCCC---HHHHHHHHHhhhhcccCC
Q 006772 245 IMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQNAVYND 319 (632)
Q Consensus 245 L~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~cL~~DP~~RPs---~~ell~~Le~~~~~~~~~ 319 (632)
+|||++|..||.+.+..+....+........+|. .+++++.++|.+|+. +|.+|++ +.+++. ++++.+
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~------h~~~~~ 301 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS------HPFFKG 301 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc------CCCcCC
Confidence 9999999999999888777766654333334443 578999999999996 9999998 888766 778888
Q ss_pred CCccccc
Q 006772 320 GEWTGLG 326 (632)
Q Consensus 320 ~~w~~~~ 326 (632)
.+|..+.
T Consensus 302 ~~~~~~~ 308 (364)
T cd05599 302 VDWEHIR 308 (364)
T ss_pred CCHHHHh
Confidence 8887644
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.18 Aligned_cols=269 Identities=24% Similarity=0.384 Sum_probs=210.7
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
+.||+|+||.||+|++..++ +.||+|++.+... .....+..+...+ .+..+|+||+.+++.+...+..|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~~-l~~~~h~~iv~~~~~~~~~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG------SFYAVKVLQKKTILKKKEQNHIMAERNVL-LKNLKHPFLVGLHYSFQTAEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC------CEEEEEEEEHHHHHHhhHHHHHHHHHHHH-HHhCCCCCccceeeEEEcCCEEEE
Confidence 47999999999999987655 4899999865321 1122233333223 344579999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||++| +|.+.+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 149 (321)
T cd05603 74 VLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-- 149 (321)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--
Confidence 9999985 66666543 357899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l 284 (632)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+.+..+. .....+|...+.++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~ 223 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRK---EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAA 223 (321)
T ss_pred -CCccccccCCcccCCHHHhcC---CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHH
Confidence 122234579999999999874 368889999999999999999999999988877777665 34456778899999
Q ss_pred HHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 285 ENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 285 ~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++|.+||+.||.+||+...- .++...+.++...+|..+..+...++..+
T Consensus 224 ~~li~~~l~~~p~~R~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T cd05603 224 CDLLVGLLHKDQRRRLGAKAD--FLEIKNHVFFSPINWDDLYHKRITPPYNP 273 (321)
T ss_pred HHHHHHHccCCHhhcCCCCCC--HHHHhCCCCcCCCCHHHHhcCCCCCCcCC
Confidence 999999999999999976421 12223467788888887766655555433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.28 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=198.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhcc--CCCceeEeeEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFR--ESQSVCWLHGISV 118 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~--~h~~I~~l~~~~~ 118 (632)
++|++.+.||+|+||.||+|.+...+. +.||+|.+...... ....+.++ ..++..+. .||||+.+++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCC-----eEEEEEEEecccCCCCchHHHHHH-HHHHHhhcccCCCCcceEEEEEe
Confidence 479999999999999999999865432 57999998653221 11222232 23344432 6999999999875
Q ss_pred E-----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 119 I-----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 119 ~-----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. +..+++||||+.|+|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 75 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 3 45689999999999999887665567899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++..... .......||+.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+....+......
T Consensus 155 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ----MALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred cceEeccCC----cccccccccccccChHHHhC---CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999765322 12234568999999999864 36788999999999999999999999988766655555422110
Q ss_pred C-------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 P-------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p-------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ .+...+++.+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 011356788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=347.48 Aligned_cols=265 Identities=22% Similarity=0.425 Sum_probs=212.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+.... ........+..++..+ +|+||+.+++++..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTG------QVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDE 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCC------CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecC
Confidence 47999999999999999999987655 48999998753211 1122233333444444 699999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||+. |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 99999999997 5787777654 58999999999999999999999999999999999999999999999999998765
Q ss_pred cCCC--------------------------CCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCC
Q 006772 200 LGRS--------------------------LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQ 253 (632)
Q Consensus 200 ~~~~--------------------------~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~ 253 (632)
.... ..........||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---CCCCceeeEecchhhhhhccCCC
Confidence 3321 000112345789999999999754 68899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHhhhcCcCCCCC-HHHHHHHHHhhhhcccCCCCccccc
Q 006772 254 PWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNRPL-MADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 254 PF~~~~~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~cL~~DP~~RPs-~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
||...+..+.+..+........+|. .+++++.++|.+||. ||.+||+ +.++++ ++++.+.+|....
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~------hp~~~~~~~~~~~ 297 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS------HPFFKGIDWENLR 297 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc------CCCcCCCCHHHHh
Confidence 9999887777776664223333343 469999999999997 9999999 999886 6788888887644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.86 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=200.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.++.++ +.||||++.............++..++..+ +|+||+.+++++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNG------KLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCC------CEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCC
Confidence 478999999999999999999987655 489999987543222122222333444444 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..|+||||+.+++.+.+... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 77 TLTLVFEYVHTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred eEEEEEECCCcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99999999999999888654 35789999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhccCCC-----
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKEKPC----- 275 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~~p~----- 275 (632)
. ........||+.|+|||++.+. ..++.++|+|||||++|||++|..||.+... .+....+......+.
T Consensus 156 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 156 P---SHTYSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred C---CccCCCCcccCCCCChHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 1 1222345689999999998643 3578899999999999999999999987542 222222211100000
Q ss_pred ----------------CC---------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 276 ----------------IP---------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 276 ----------------~p---------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
.+ ...++++.+|+.+||+.||++|||+.++++ +++|.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~------h~~f~~~ 294 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS------HEYFSDL 294 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc------CcccccC
Confidence 00 124568899999999999999999999886 5666544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=359.80 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=214.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
-|++++.||.|+-|.|-+|++..++ +.+|||++.+...... ...-.+.+.++.++..|||++.+++++..+.+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TG------qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETG------QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ceeccccccCCCCceehhhhccccc------ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 3689999999999999999998777 4899999977532111 11112223445677899999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+|+|+||++ |.|++++.+ ++++++.++.+++.||+.|+.|+|..+|+||||||+|+|||..+++||+|||+|.+-..
T Consensus 87 lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999998 789999876 47999999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
. .-..+.||+|.|.|||++++..+ -..++||||.||+||.||||+.||.+++...++.++. .....+|..+|
T Consensus 165 g----klLeTSCGSPHYA~PEIV~G~pY--dG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~--~G~f~MPs~Is 236 (786)
T KOG0588|consen 165 G----KLLETSCGSPHYAAPEIVSGRPY--DGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ--RGVFEMPSNIS 236 (786)
T ss_pred C----ccccccCCCcccCCchhhcCCCC--CCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH--cCcccCCCcCC
Confidence 3 33456799999999999998743 2479999999999999999999999999998888876 56777899999
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++++||++||..||++|.+++||++
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhh
Confidence 99999999999999999999999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.37 Aligned_cols=265 Identities=22% Similarity=0.367 Sum_probs=203.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCC----------CcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCC
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSAD----------DFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQ 108 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~----------~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~ 108 (632)
+..++|++.++||+|+||.||+|.+....+ .......||+|.+........ ..+.++ ..++.++ +|+
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E-~~~l~~l-~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE-VKILSRL-KDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHH-HHHHhhc-CCC
Confidence 456799999999999999999998754321 012334799999976433322 334333 3455555 789
Q ss_pred ceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 006772 109 SVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR-----------------GGKLPLPDILRYGIQLAKGISDLHSIGL 170 (632)
Q Consensus 109 ~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~-----------------~~~l~~~~~~~ia~qIa~gL~yLHs~~I 170 (632)
||+.+++++...+..|++|||+. |+|.+++.... ...+++..++.++.||+.||.|||+++|
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999997 58888775431 1246788999999999999999999999
Q ss_pred eeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh
Q 006772 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT 250 (632)
Q Consensus 171 vHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt 250 (632)
+||||||+|||++.++.+||+|||+++....... ........++..|||||++.. +.++.++|+|||||++|||++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILM---GKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhc---CCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999876532211 011122345789999999863 468899999999999999987
Q ss_pred --CCCCCCCCCHHHHHHHHHhh------ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 251 --GIQPWFGKSVEEIYHSVVIK------KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 251 --G~~PF~~~~~~ei~~~i~~~------~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
+..||.+.+..+....+... ......|..+|..+.++|.+||+.||++||++.+|.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67888887766554433211 1122345678999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.95 Aligned_cols=273 Identities=20% Similarity=0.326 Sum_probs=214.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||+||++.+..++ +.||+|.+...... ........+..++..+ +|++|+.+++.+..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCC------ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCC
Confidence 4899999999999999999987654 48999998653211 1112122233455555 7899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+||||+. |+|.+.+.......+++..+..++.|++.||+|||+++|+||||||+|||+++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999998 567666655444579999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhccCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--IKKEKPCIPS 278 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~--~~~~~p~~p~ 278 (632)
.. .......|++.|||||++.+ ..++.++|+|||||++|||++|..||.+.+.......+. .......++.
T Consensus 154 ~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05605 154 EG----ETIRGRVGTVGYMAPEVVKN---ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE 226 (285)
T ss_pred CC----CccccccCCCCccCcHHhcC---CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc
Confidence 21 11233578999999999864 368889999999999999999999998865533222221 1233445667
Q ss_pred CCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.+++.+.+||.+||+.||++|| +++++++ +.++...+|..+..+...+++.|
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA------HPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc------CcCccCCCHHHHhhCCCCCCCCC
Confidence 8999999999999999999999 7777765 67888888988877766666544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.33 Aligned_cols=272 Identities=22% Similarity=0.353 Sum_probs=213.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+... ......+..+..++..+ +|++|+.+++.+..+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTG------HIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDK 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC
Confidence 47999999999999999999988665 4899999964321 11112223333444444 789999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++.+ .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 99999999998 577777654 357999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCC--------------------------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHH
Q 006772 200 LGRSLS--------------------------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIME 247 (632)
Q Consensus 200 ~~~~~~--------------------------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~E 247 (632)
...... .......+||+.|||||++.+. .++.++|+|||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~~~~DiwSlGvilye 228 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT---GYNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC---CCCCcceeccccceeee
Confidence 221000 0011235799999999998743 68889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHhhhcCcCCCCC---HHHHHHHHHhhhhcccCCCCc
Q 006772 248 MLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNRPL---MADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 248 mltG~~PF~~~~~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~cL~~DP~~RPs---~~ell~~Le~~~~~~~~~~~w 322 (632)
|++|..||.+.+..+.+..+........+|. .+++++.++|.+|+. ||.+|++ +.+++. ++++.+.+|
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~------hp~f~~~~~ 301 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS------HPFFEGVDW 301 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc------CCCCCCCCH
Confidence 9999999999888887777664333344454 478999999999875 9999995 555554 889999999
Q ss_pred cccccccccCC
Q 006772 323 TGLGSRALTDT 333 (632)
Q Consensus 323 ~~~~~~~~~~~ 333 (632)
..+..+....+
T Consensus 302 ~~~~~~~~~~~ 312 (360)
T cd05627 302 GHIRERPAAIP 312 (360)
T ss_pred HHHhcCCCCCC
Confidence 98776544443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=340.65 Aligned_cols=268 Identities=21% Similarity=0.369 Sum_probs=209.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||++.+..++ +.||+|++.+... ........++..++ ...+|++|+.+++++..+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~l~~~~~~~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTE------RIYAMKILNKWEMLKRAETACFREERNVL-VNGDCQWITTLHYAFQDE 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEeHHHHHhhHHHHHHHHHHHHH-HhCCCCCEeeEEEEEEcC
Confidence 57999999999999999999987655 4899999864221 11112223333333 345799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..||||||+. |+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999998 5777777543 357899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
..... ......+||+.|||||++.+.. .+.++.++|+|||||+||||++|+.||...+..+.+..+.....+..+|
T Consensus 153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 153 NQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred cCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 33211 1112357999999999986421 1357889999999999999999999999988877777766544444444
Q ss_pred C---CCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCccccc
Q 006772 278 S---GLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 278 ~---~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
. .++.++.+++.+||..++.+ |++++++++ +.++.+.+|+.+.
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~------h~~f~~~~~~~~~ 278 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK------HAFFEGIDWENIR 278 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc------CCCcCCCCHHHHh
Confidence 3 46899999999999866544 457777665 6788888888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=351.47 Aligned_cols=293 Identities=21% Similarity=0.304 Sum_probs=224.5
Q ss_pred cCCCCCcccccccCCCccccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch
Q 006772 8 HKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE 87 (632)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~ 87 (632)
..++..-+|.+.+. +.-|......++.++|++++.||+|+||.||+|.+..... ......||||++.+...
T Consensus 10 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~ 80 (400)
T cd05105 10 SISPDGHEYIYVDP--------MQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSR-SQPVMKVAVKMLKPTAR 80 (400)
T ss_pred eeCCCCceeeeecc--------ccCCCCCceeccccceehhheecCCCCceEEEEEEcccCC-CCCceEEEEEecCCCCC
Confidence 33445556665533 3344445666788999999999999999999998754332 11234799999976443
Q ss_pred hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhc------------------------
Q 006772 88 DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR------------------------ 142 (632)
Q Consensus 88 ~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~------------------------ 142 (632)
....+.+..+..++..+..||||+.+++++...+.+||||||++ |+|.+++....
T Consensus 81 ~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (400)
T cd05105 81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD 160 (400)
T ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccc
Confidence 33333333344566777679999999999999999999999998 68877765421
Q ss_pred ----------------------------------------------------------------------CCCCCHHHHH
Q 006772 143 ----------------------------------------------------------------------GGKLPLPDIL 152 (632)
Q Consensus 143 ----------------------------------------------------------------------~~~l~~~~~~ 152 (632)
...+++.+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~ 240 (400)
T cd05105 161 ESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLL 240 (400)
T ss_pred ccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHH
Confidence 1247888899
Q ss_pred HHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCC
Q 006772 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPI 232 (632)
Q Consensus 153 ~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~ 232 (632)
.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ .......++..|||||++.+ ..+
T Consensus 241 ~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~ 316 (400)
T cd05105 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD---NLY 316 (400)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC---CCC
Confidence 99999999999999999999999999999999999999999999765332111 11223356788999999864 367
Q ss_pred CcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 233 SFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 233 t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+.++|||||||++|||++ |..||..................+..+..++.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 317 ~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 899999999999999997 9999988654443333333444556678899999999999999999999999999998876
Q ss_pred hh
Q 006772 312 SQ 313 (632)
Q Consensus 312 ~~ 313 (632)
+.
T Consensus 397 l~ 398 (400)
T cd05105 397 LL 398 (400)
T ss_pred Hc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.44 Aligned_cols=268 Identities=22% Similarity=0.400 Sum_probs=209.2
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+..++|++.+.||+|+||.||+|.+..++ +.||+|++.+... ........++..++ +..+||||+.+++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~e~~i~-~~~~hp~iv~~~~ 110 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR------KVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLFY 110 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCC------cEEEEEEEEHHHhhhhHHHHHHHHHHHHH-HhCCCCCCCeEEE
Confidence 3456689999999999999999999988765 4899999864221 11122233333333 3458999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.+..++.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 111 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999998 567766643 368999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCC-CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++....... ......+||+.|||||++.... .+.++.++|+|||||++|||++|..||.+.+....+..+......
T Consensus 188 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 188 TCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred ceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 9986533211 1223457999999999987532 224788999999999999999999999998888777777654444
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 274 PCIP--SGLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 274 p~~p--~~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
..+| ..++.++.++|.+||..++.+ |+++.++++ +.++.+..|.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~------h~~~~~~~~~ 313 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR------HLFFKNDQWA 313 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc------CcccCCCChh
Confidence 4444 368999999999999844433 678888886 5566555443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.97 Aligned_cols=265 Identities=22% Similarity=0.382 Sum_probs=212.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.+.||+|+||.||+|.+...+. ......||+|.+...........+.++...+..+ +|+||+.+++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC
Confidence 456789999999999999999998765442 1233579999987544333232233333444444 78999999999998
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRG--------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~--------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~ 184 (632)
.+..|++|||++ |+|.+++..... ..+++..++.++.|++.||.|||+++++||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 899999999998 688888765321 46889999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHH
Q 006772 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263 (632)
Q Consensus 185 ~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei 263 (632)
++.++|+|||+++........ .......+++.|+|||.+.. +.++.++|+|||||++|||++ |..||.+.+..++
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY---GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc---CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999998764322111 11223456889999999863 468899999999999999998 9999999888877
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
...+.. ...+..|..+|+++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 236 ~~~i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 766553 34455678899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.54 Aligned_cols=248 Identities=21% Similarity=0.387 Sum_probs=208.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|....+||+|..|.||.|....++ ..||||.+........+-.+++. .++ +-.+|+||+.++..+...+.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~------~~VaiK~m~l~~Q~~keLilnEi-~Vm-~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTK------QEVAIKRMDLRKQPKKELLLNEI-LVM-RDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCC------ceEEEEEEEeccCCchhhhHHHH-HHH-HhccchHHHHHHHHhcccce
Confidence 56888999999999999999988766 48999999765544434444443 333 34589999999988888899
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+++|||||+ |+|.|.+.. ..+++.++..++++++.||+|||.++|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 345 LWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999 577776654 3699999999999999999999999999999999999999999999999999887654
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p~~p~~l 280 (632)
.. ....+.+|||+|||||++.. ..|.+++||||||+|++||+.|++||...++......|...+ .+...+..+
T Consensus 422 ~~---~KR~TmVGTPYWMAPEVvtr---k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 422 EQ---SKRSTMVGTPYWMAPEVVTR---KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL 495 (550)
T ss_pred cc---CccccccCCCCccchhhhhh---cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence 32 23456789999999999974 478899999999999999999999999888776665555332 333466889
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++++++|+.+||+.|+++|+++.|||+
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 999999999999999999999999997
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=345.59 Aligned_cols=264 Identities=20% Similarity=0.348 Sum_probs=206.7
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhc--cCCCceeEeeEEEEECCEEEE
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKF--RESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l--~~h~~I~~l~~~~~~~~~l~L 125 (632)
||+|+||+||+|.+..++ +.||||++.+.... .......+. .++... .+||+|+.++..+..++.+|+
T Consensus 1 lG~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR------RIYAMKVLSKKEIVAKKEVAHTIGER-NILVRTLLDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCC------CEEEEEEEeHHHHhhhhHHHHHHHHH-HHHHHhccCCCCcCcceEEEEecCCeEEE
Confidence 799999999999987665 48999998642211 111222222 233333 379999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||+. |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-- 149 (330)
T cd05586 74 VTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-- 149 (330)
T ss_pred EEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--
Confidence 999998 577766653 357999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC-CCCCHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP-SGLPPA 283 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p-~~lp~~ 283 (632)
.......+||+.|||||++.+. ..++.++|+|||||++|||++|..||.+.+..+++..+... ...+| ..++++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 224 (330)
T cd05586 150 -NKTTNTFCGTTEYLAPEVLLDE--KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNVLSDE 224 (330)
T ss_pred -CCCccCccCCccccCHHHHcCC--CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHH
Confidence 1122345799999999998643 24788999999999999999999999998888777666533 23334 357999
Q ss_pred HHHHHHHhhhcCcCCCCC----HHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 284 VENVIIGCFEYDLRNRPL----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
+.++|.+||+.||.+||+ +.++++ ++++.+.+|..+..+.+.++..+
T Consensus 225 ~~~li~~~L~~~P~~R~~~~~~~~~ll~------h~~~~~~~~~~~~~~~~~~~~~~ 275 (330)
T cd05586 225 GRQFVKGLLNRNPQHRLGAHRDAVELKE------HPFFADIDWDLLSKKQITPPFKP 275 (330)
T ss_pred HHHHHHHHcCCCHHHCCCCCCCHHHHhc------CccccCCCHHHHHhCCCCCCccC
Confidence 999999999999999995 555443 77888888888776666665544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=346.55 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=206.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+... .........+..++..+ .|++|+.+++.+..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTN------ALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDK 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC------CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcC
Confidence 47999999999999999999987665 4899999864321 11112223333455554 789999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999998 578777754 357899999999999999999999999999999999999999999999999997532
Q ss_pred cCCC----------------------------------------CCCCccccccCCCccCCccccCCCCCCCCCcccccc
Q 006772 200 LGRS----------------------------------------LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTW 239 (632)
Q Consensus 200 ~~~~----------------------------------------~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvw 239 (632)
.... .........+||+.|||||++.+. .++.++|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Diw 228 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT---GYTQLCDWW 228 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC---CCCcceeee
Confidence 1000 000011235799999999999743 678899999
Q ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCC---CHHHHHHHHHhhhh
Q 006772 240 GFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRP---LMADILHAFESSQN 314 (632)
Q Consensus 240 SlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RP---s~~ell~~Le~~~~ 314 (632)
||||++|||++|+.||.+.+..+....+........+| ..+++++.++|.+|+ .+|.+|+ ++.++++ +
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~------h 301 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA------H 301 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC------C
Confidence 99999999999999999988776655554333333333 368999999999977 5999999 8888876 6
Q ss_pred cccCCCCccccc
Q 006772 315 AVYNDGEWTGLG 326 (632)
Q Consensus 315 ~~~~~~~w~~~~ 326 (632)
+++...+|....
T Consensus 302 ~~~~~~~~~~~~ 313 (376)
T cd05598 302 PFFKGIDFASLI 313 (376)
T ss_pred CCcCCCCHHHHh
Confidence 777777776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=348.56 Aligned_cols=258 Identities=21% Similarity=0.360 Sum_probs=212.0
Q ss_pred CCcCC--CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDP--TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~--~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
.|... +.|+.+++||+|+||.||+|++..++ +.||+|++..... .....+..++..++.++ +||||+.|.
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tg------kivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~ 182 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETG------KIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLE 182 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccC------cEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCccccee
Confidence 45444 77999999999999999999998776 4899999976542 23334444444555554 799999999
Q ss_pred EEEEEC--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 115 GISVIN--GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 115 ~~~~~~--~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++-+.. +.+|||+|||+.+|..++.. .+-.|++.++.-|+.||+.||+|||++||+|||||.+|||||.+|.+||+|
T Consensus 183 eivt~~~~~siYlVFeYMdhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 183 EIVTSKLSGSIYLVFEYMDHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred eEEEecCCceEEEEEecccchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecc
Confidence 988775 79999999999988877753 356899999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||||+++.... ...++..+-|.+|.|||++.+.. .|+.++|+||.||+|.||++|++.|.|.+..+.++.|.....
T Consensus 262 FGLAr~y~~~~--~~~~T~rVvTLWYRpPELLLG~t--~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG 337 (560)
T KOG0600|consen 262 FGLARFYTPSG--SAPYTSRVVTLWYRPPELLLGAT--SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG 337 (560)
T ss_pred ccceeeccCCC--CcccccceEEeeccChHHhcCCc--ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence 99999875542 22356667799999999999874 689999999999999999999999999987776666653221
Q ss_pred CCC--------CC-------------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPC--------IP-------------------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~--------~p-------------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.|. +| ..+|+...+|+..+|..||.+|.|+.+.|+
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 11 246778899999999999999999998775
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.14 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=197.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|+++.++ +.||+|++..... .....+.+ +..++..+ +|+||+.+++++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~~~~ 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETK------EIVAIKKFKDSEENEEVKETTLR-ELKMLRTL-KQENIVELKEAFRRR 72 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCC------cEEEEEEEecccccccchhhHHH-HHHHHHhC-CCccccchhhhEecC
Confidence 47999999999999999999987665 4899999875322 11222233 33444444 789999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+.+|+||||+++++++.+... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred CEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999998888776543 3579999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc--------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-------- 272 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-------- 272 (632)
... ........||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+....+.....
T Consensus 152 ~~~--~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 152 EGS--NANYTEYVATRWYRSPELLLGA---PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred ccc--cccccccccccccCCcHHHcCC---CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 221 1122345789999999998743 578899999999999999999999998765443322211000
Q ss_pred ------------CC----------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 ------------KP----------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ------------~p----------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ .....+|.++.+||.+||+.||++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 011237888999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.90 Aligned_cols=256 Identities=15% Similarity=0.249 Sum_probs=209.2
Q ss_pred cCCCCeEEE--eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 40 IDPTSLKLK--HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 40 I~~~~y~l~--~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
|+.++++.. ..||+|++|.||+|.+.. +.||||++....... ......++..++.++ +||||+.+++
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g 85 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNN--------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYG 85 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECC--------EEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEee
Confidence 556666666 689999999999998732 489999997643322 112223333455555 6889999999
Q ss_pred EEEE----CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEE
Q 006772 116 ISVI----NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 116 ~~~~----~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vk 189 (632)
++.+ ...+++||||++ |+|.+++.. .+.+++...+.++.|++.||.|||+. +++||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEE
Confidence 9876 357899999999 577777754 35789999999999999999999984 999999999999999999999
Q ss_pred EEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006772 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~ 269 (632)
|+|||+++..... .....||..|+|||++.+. ...++.++|||||||++|||++|..||.+.+..+++..+..
T Consensus 164 l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 164 IICHGLEKILSSP------PFKNVNFMVYFSYKMLNDI-FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred EcccchHhhhccc------cccccCcccccCHHHhhhc-cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 9999998754321 1234689999999998642 24689999999999999999999999999888888877766
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
...++.+|..+|+++.+++.+||+.||++||++.|+++.|+.++
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 66677777789999999999999999999999999999998765
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.32 Aligned_cols=277 Identities=18% Similarity=0.335 Sum_probs=218.0
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+++.++|++.+.||+|+||.||+|.++..... .....||+|.+..............+...+..+ +|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKG-EAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCC-CcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEc
Confidence 46789999999999999999999987642211 123579999886543222222222233344444 6899999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEE
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQR--------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~--------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vk 189 (632)
.++..|+||||+. |+|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 8899999999998 68888886532 12356778899999999999999999999999999999999999999
Q ss_pred EEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 006772 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~ 268 (632)
|+|||+++........ .......++..|+|||.+.+ +.++.++|+|||||++|||++ |..||.+.+..+....+.
T Consensus 160 L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~---~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 160 IGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD---GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred ECcCCccccccccccc-cccCCCcccccccCHHHhcc---CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999998765332211 11122345778999999863 467889999999999999998 899999888777665554
Q ss_pred hhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 269 ~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
....+..+..+++.+.+++.+||+.||++||++.++++.|+...++.|.+.+|
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 236 -DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 33445567788999999999999999999999999999999999998988877
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.19 Aligned_cols=253 Identities=20% Similarity=0.294 Sum_probs=193.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
+|++.+.||+|+||.||+|.+..++ ..||||.+..... .....+.++ ..++..+ +|+||+.+++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E-~~~l~~l-~hpniv~~~~~~~~~~ 72 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG------EKVAIKKINDVFEHVSDATRILRE-IKLLRLL-RHPDIVEIKHIMLPPS 72 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC------CEEEEEEechhhccchhHHHHHHH-HHHHHhC-CCCCEeeecceEeccC
Confidence 5899999999999999999987665 4899999864221 122223333 3444444 799999999887543
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 121 ----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 121 ----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..+|+||||+.++|.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 73 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence 358999999999998887543 47999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh------
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK------ 270 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~------ 270 (632)
+................||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhcc-ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 7643222111122345789999999998642 246788999999999999999999999876643322111100
Q ss_pred --------------------ccCCCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 --------------------KEKPCI---PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 --------------------~~~p~~---p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+ -..+++++.++|.+||+.||++||++.|+++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 1346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.30 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=206.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++++.||+|+||.||+|.+..++ +.||||++.+... .........+..++..+ +|++|+.+++.+..+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~------~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~ 73 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTK------ALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK 73 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCC------CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeC
Confidence 36999999999999999999987665 4899999865321 11122233333445544 789999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+||||||++ |+|.+++.+. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998 5777777543 57899999999999999999999999999999999999999999999999997532
Q ss_pred cCCC--------------------------------------------CCCCccccccCCCccCCccccCCCCCCCCCcc
Q 006772 200 LGRS--------------------------------------------LSDSDMALRLGTPNYMAPEQWEPEVRGPISFE 235 (632)
Q Consensus 200 ~~~~--------------------------------------------~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~k 235 (632)
.... .........+||+.|||||++.+. .++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~ 228 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT---GYTQL 228 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC---CCCCe
Confidence 1000 000001234799999999999743 68899
Q ss_pred cccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCC---HHHHHHHHH
Q 006772 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPL---MADILHAFE 310 (632)
Q Consensus 236 sDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs---~~ell~~Le 310 (632)
+|||||||+||||++|+.||.+.+..+....+........+| ..+++++.++|.+|+ .||.+|++ +.++++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~--- 304 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA--- 304 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc---
Confidence 999999999999999999999988777666655433333344 467999999999987 59999997 777665
Q ss_pred hhhhcccCCCCcccc
Q 006772 311 SSQNAVYNDGEWTGL 325 (632)
Q Consensus 311 ~~~~~~~~~~~w~~~ 325 (632)
++++...+|...
T Consensus 305 ---hp~f~~~~~~~~ 316 (382)
T cd05625 305 ---HPFFKTIDFSSD 316 (382)
T ss_pred ---CCCcCCcChHHH
Confidence 677877777653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=349.71 Aligned_cols=295 Identities=21% Similarity=0.312 Sum_probs=230.5
Q ss_pred hcccCCCCCcccccccCCCccccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecC
Q 006772 5 IRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP 84 (632)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~ 84 (632)
+....+.+..+|+.. ||+ ..+......|+.++|.+.+.||+|+||.||+|.++.... ......||+|+++.
T Consensus 7 ~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~ 77 (401)
T cd05107 7 VIESVSSDGHEYIYV--DPM------QLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSH-SQSTMKVAVKMLKS 77 (401)
T ss_pred EeeeeccCCceEEEE--CCC------CCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCC-CCCceEEEEEecCC
Confidence 344667777888887 443 345555677888999999999999999999999764321 12335899999976
Q ss_pred CchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcC--------------------
Q 006772 85 LKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG-------------------- 143 (632)
Q Consensus 85 ~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~-------------------- 143 (632)
.........+..+..++..+..|+||+.+++.+..++.+|+||||+. |+|.+++.+...
T Consensus 78 ~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (401)
T cd05107 78 TARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGG 157 (401)
T ss_pred CCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccc
Confidence 43332222233444566777669999999999999999999999998 688888764311
Q ss_pred ----------------------------------------------------------------------------CCCC
Q 006772 144 ----------------------------------------------------------------------------GKLP 147 (632)
Q Consensus 144 ----------------------------------------------------------------------------~~l~ 147 (632)
..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (401)
T cd05107 158 STPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALS 237 (401)
T ss_pred cccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCC
Confidence 2467
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCC
Q 006772 148 LPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE 227 (632)
Q Consensus 148 ~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~ 227 (632)
+..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++........ .......++..|||||++..
T Consensus 238 ~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~- 315 (401)
T cd05107 238 YMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN- 315 (401)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC-
Confidence 7888999999999999999999999999999999999999999999999865322111 11122356889999999864
Q ss_pred CCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 228 VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 228 ~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
..++.++|+|||||++|||++ |..||......+..........++..|..++.++.+++.+||..||.+||++.+|+
T Consensus 316 --~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 316 --NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred --CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 357889999999999999998 89999876655554444444555667788999999999999999999999999999
Q ss_pred HHHHhh
Q 006772 307 HAFESS 312 (632)
Q Consensus 307 ~~Le~~ 312 (632)
+.|+.+
T Consensus 394 ~~L~~~ 399 (401)
T cd05107 394 HLVGDL 399 (401)
T ss_pred HHHHHH
Confidence 998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.21 Aligned_cols=268 Identities=21% Similarity=0.384 Sum_probs=211.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||++.++.++ +.||+|++.+... ......+.++..++. ..+|++|+.+++.+..+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNAD------KVFAMKILNKWEMLKRAETACFREERDVLV-NGDNQWITTLHYAFQDE 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC------CEEEEEEEeHHHHHHhhHHHHHHHHHHHHh-hCCCCCEeeEEEEEecC
Confidence 47999999999999999999987655 4899999864221 111222233333333 35789999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||+. |+|.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999997 6788777653 357899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.... .......+||+.|||||++... ..+.++.++|+|||||++|||++|+.||.+.+..+.+..+.....+..+|
T Consensus 153 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 153 MEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230 (332)
T ss_pred ccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence 3221 1112335799999999998632 12357889999999999999999999999988888877776544443344
Q ss_pred ---CCCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCccccc
Q 006772 278 ---SGLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 278 ---~~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
..+++++.+|+.+||..++.+ |+++.++++ ++++.+.+|+.+.
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~------h~~f~~~~~~~~~ 278 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ------HPFFTGIDWDNIR 278 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC------CCCcCCCCHHHHh
Confidence 467999999999999765544 678888776 7788888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=331.95 Aligned_cols=264 Identities=21% Similarity=0.344 Sum_probs=204.3
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHH--HHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK--VFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~--~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
||+|+||+||++.+..++ +.||+|.+.+....... .....+..++..+ +|++|+.+.+++..++.+|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATG------KLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCC------cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEe
Confidence 799999999999987665 48999998653222111 1112233444444 89999999999999999999999
Q ss_pred cCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 129 FYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 129 y~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|++ |+|.+.+... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++.......
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-- 151 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-- 151 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--
Confidence 998 4666555432 23578999999999999999999999999999999999999999999999999987653221
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhccCCCCCCCCC
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~~~~~p~~p~~lp 281 (632)
.......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||..... .+....+. .....++..++
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 225 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFS 225 (280)
T ss_pred -ccccccCCCcCccCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc--ccCCCCcccCC
Confidence 11233578999999999974 3678899999999999999999999986542 22222222 23345667899
Q ss_pred HHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 282 PAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
+++.+++.+||+.||++|| +++++++ ++++++..|..+......+|+.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~ 278 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT------HPLFRDLNWRQLEAGMLPPPFV 278 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc------ChhhhcCCHhHHhhccCCCCCC
Confidence 9999999999999999999 5566665 6788888888877666665544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.79 Aligned_cols=273 Identities=20% Similarity=0.307 Sum_probs=216.3
Q ss_pred CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 35 QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 35 ~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
.....++.++|++.+.||+|+||.||+|.+..... ......+|+|.+..............+..++..+.+|+||+.++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 33556788999999999999999999999865432 12335899999875433222222233335566666899999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCe
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQ--------------RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~--------------~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~N 179 (632)
+++..++.++++|||+. |+|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 99999999999999997 6888777542 23578999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCC
Q 006772 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258 (632)
Q Consensus 180 ILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~ 258 (632)
||+++++.+||+|||+++.+...... .......++..|+|||++.+ ..++.++|+|||||++|||++ |..||.+.
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYY-RKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEEcCCCeEEeCccccccccccccce-eccCCCCCCccccCHHHhcc---CCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999998865332111 11112234678999999864 357889999999999999998 99999988
Q ss_pred CHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+..+.+..+. ....+..+..++.++.+|+.+||..||++|||+.++++.|+.+.
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 8777766554 34455667888999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.27 Aligned_cols=277 Identities=19% Similarity=0.338 Sum_probs=225.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
++.+.|+.-+.||+||||+||-+..+.++ +.||+|.+.+.. ....+...-.+.++++++ +.++|+.+-..|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTG------KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAf 254 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATG------KMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAF 254 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecch------hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeee
Confidence 56688999999999999999999888766 489999885432 112222222333455554 567999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+.+.+|+||..|+| +|.-++.+..+..|++..+++|+++|+.||++||..+||+|||||+|||||+.|++.|+|+|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 999999999999996 4444444444468999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhcc
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVIKKE 272 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~~~~ 272 (632)
..+... ......+||.+|||||++..+ .|+...|||||||+||||+.|+.||..... +++-+++. ..
T Consensus 335 vei~~g----~~~~~rvGT~GYMAPEvl~ne---~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~~ 405 (591)
T KOG0986|consen 335 VEIPEG----KPIRGRVGTVGYMAPEVLQNE---VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--ED 405 (591)
T ss_pred EecCCC----CccccccCcccccCHHHHcCC---cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--cc
Confidence 866432 233456899999999999855 599999999999999999999999986432 34444443 34
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHH-----HHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMA-----DILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~-----ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
...+++..++++++|.+.+|++||++|.... ++.+ +++|.+.+|..++...++||+.|..
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~------HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE------HPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh------CcccccCCHhHHhccCCCCCCCCCc
Confidence 5557899999999999999999999998654 4444 8899999999999999999988753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.62 Aligned_cols=269 Identities=22% Similarity=0.401 Sum_probs=209.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++.+... ......+.++..++.. .+|++|+.+++++..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTG------QVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITNLHYAFQDE 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh-CCCCCCCceEEEEecC
Confidence 57999999999999999999987665 4899999864211 1111222333334433 4899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+|+||||+. |+|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 99999999997 5777777542 457999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
..... .......||+.|||||++.... .+.++.++|+|||||++|||++|+.||.+.+..+.+..+........++
T Consensus 153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 153 LADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 33211 1112346899999999986321 2357889999999999999999999999988877777766443333333
Q ss_pred ---CCCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCcccccc
Q 006772 278 ---SGLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLGS 327 (632)
Q Consensus 278 ---~~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~~ 327 (632)
..+++++.++|++||..++++ |+++.++++ ++++.+.+|..+..
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~------hp~~~~~~~~~~~~ 279 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD------HPFFEGIDWDNIRN 279 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc------CCCCCCCCHHHHhh
Confidence 357999999999988654433 778888887 77888888877653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.31 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=205.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---------hHH----HHHHHHHHHhhhccC
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---------CAK----VFVNKFEELFPKFRE 106 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---------~~~----~~~~~~~~il~~l~~ 106 (632)
...++|++++.||+|.||.|-||++..++ +.||||++.+.... ... +..+++..+++++ +
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~------~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~ 166 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDG------KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-H 166 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCC------cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-C
Confidence 45679999999999999999999987655 48999999763211 011 2344555666776 6
Q ss_pred CCceeEeeEEEEE--CCEEEEEEecCC-CCHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 107 SQSVCWLHGISVI--NGKICIAMKFYE-GSVGDRIAQQRGGK-LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 107 h~~I~~l~~~~~~--~~~l~LVmEy~~-GsL~d~l~~~~~~~-l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
|+||++|..+..+ .+.+|||+|||. |.+.. --..++ +++.++++|+++++.||+|||.+|||||||||+|+||
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL 243 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE
Confidence 7999999998765 478999999998 43221 122345 8999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCC--CccccccCCCccCCccccCCCC-CCCCCcccccchhHHHHHHHHhCCCCCCCCC
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSD--SDMALRLGTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~-~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~ 259 (632)
+++|++||+|||.+.......... .......|||.|||||.+.+.. ....+++.||||+||+||-|+.|+.||.+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999987653322111 1223458999999999998643 2223688999999999999999999999999
Q ss_pred HHHHHHHHHhhccCCCCCC--CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 260 VEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~--~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++.+|+. .+..+|. .+.+++++||.+||++||++|.+..+|..
T Consensus 324 ~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 ELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 9999999884 4444554 58999999999999999999999998875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.52 Aligned_cols=269 Identities=22% Similarity=0.365 Sum_probs=209.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.++.++|++.+.||+|+||.||+|.+...+. ....+.||+|++....... ...+. .+..++.++.+|+||+.+++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~-~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEK-SASCRTVAVKMLKEGATASEYKALM-TELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEecccccccc-ccccceeeeeeccCCCCHHHHHHHH-HHHHHHHhhccCcchhheeeeE
Confidence 3556899999999999999999998654332 2344689999987543222 22333 3345566777899999999887
Q ss_pred EE-CCEEEEEEecCC-CCHHHHHHHhc-----------------------------------------------------
Q 006772 118 VI-NGKICIAMKFYE-GSVGDRIAQQR----------------------------------------------------- 142 (632)
Q Consensus 118 ~~-~~~l~LVmEy~~-GsL~d~l~~~~----------------------------------------------------- 142 (632)
.. +..++++|||++ |+|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 467899999998 57777765422
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCC
Q 006772 143 ------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216 (632)
Q Consensus 143 ------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~ 216 (632)
...+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++.+..... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 12688999999999999999999999999999999999999999999999999976532211 11112234577
Q ss_pred ccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 006772 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYD 295 (632)
Q Consensus 217 ~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~D 295 (632)
.|||||++.+ ..++.++|||||||+||||++ |..||.+....+...........+..|...++++.+++.+||+.+
T Consensus 240 ~y~aPE~~~~---~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 240 KWMAPESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred cccCcHHhcC---CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence 8999999864 468899999999999999998 999998765444443444444555667788999999999999999
Q ss_pred cCCCCCHHHHHHHHHhhh
Q 006772 296 LRNRPLMADILHAFESSQ 313 (632)
Q Consensus 296 P~~RPs~~ell~~Le~~~ 313 (632)
|++||++.++++.|+.+.
T Consensus 317 p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 317 PEDRPTFSELVEILGDLL 334 (337)
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.67 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=217.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|..++.||+|+||.+++++++... +.|++|.+.-.... ..+.....+..++++ ..||||+-+.+.+..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~------~~~vlK~I~l~~~t~~~r~~A~~E~~lis~-~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDD------KLYVLKKINLEKLTEPERRSAIQEMDLLSK-LLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCC------ceEEEEEEeccccCchhhHHHHHHHHHHHh-ccCCCeeeeccchhcC
Confidence 368999999999999999999987655 48999998654322 222233334455566 5899999999999988
Q ss_pred CE-EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 121 GK-ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 121 ~~-l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+. +||||+||+ |++.+.+.+.++.-|+++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.++|+|||+|+.
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhh
Confidence 88 999999999 5888888888778899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
+.... ....+..||+.||+||.+.+. +|..++|+|||||++|||++-+.+|.+.+...+..+|.... -.+.|.
T Consensus 156 l~~~~---~~a~tvvGTp~YmcPEil~d~---pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~ 228 (426)
T KOG0589|consen 156 LNPED---SLASTVVGTPYYMCPEILSDI---PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPS 228 (426)
T ss_pred cCCch---hhhheecCCCcccCHHHhCCC---CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCc
Confidence 75532 234567899999999999865 79999999999999999999999999999888887777443 456789
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
..+.+++.+|..||..+|+.||++.++|..
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999999999963
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.30 Aligned_cols=257 Identities=23% Similarity=0.421 Sum_probs=208.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|+.++|++.++||+|+||.||+|.+... ..||+|.+..... ..+.+.+ +..++..+ +|+||+.+++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~-------~~v~iK~~~~~~~-~~~~~~~-e~~~l~~l-~h~~i~~~~~~~~ 71 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNS-------TKVAVKTLKPGTM-SVQAFLE-EANLMKTL-QHDKLVRLYAVVT 71 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCC-------ceEEEEEccCCch-hHHHHHH-HHHHHHhC-CCCCeeeEEEEEc
Confidence 57889999999999999999999986533 3699999865332 2233333 33444444 6999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..+++|||++ |+|.+++.......+++..++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 8999999999997 688888876656678999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
........ ......++..|+|||++.. +.++.++|+|||||++|+|++ |..||.+....+....+.. ......
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~ 225 (261)
T cd05072 152 VIEDNEYT--AREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPR 225 (261)
T ss_pred ecCCCcee--ccCCCccceecCCHHHhcc---CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 65332111 1122345678999999863 367889999999999999998 9999998877766655543 233344
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+..++.++.+++.+||+.||++||+++++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 56789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.42 Aligned_cols=262 Identities=20% Similarity=0.373 Sum_probs=209.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|++++|++.+.||+|+||.||+|.+...++ ....||||.+........ ..+..+ ..++..+ +|+||+++++.+.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~ 75 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTE-ASIMGQF-DHPNIIRLEGVVT 75 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHH-HHHHHhC-CCCCcceEeEEEe
Confidence 567899999999999999999999875432 235799999875443322 333333 3444444 6899999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..+++|||++ |+|.+++... .+.+++..++.++.|++.||+|||+++|+|+||||+|||+++++.++|+|||+++
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999998 4777777553 3578999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
....... ........++..|+|||.+.. ..++.++|+||||+++|||++ |..||......+....+.. ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (266)
T cd05033 155 RLEDSEA-TYTTKGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPP 229 (266)
T ss_pred ccccccc-ceeccCCCCCccccChhhhcc---CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 7631111 011112234678999999864 367889999999999999998 9999988877776665543 334445
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 230 ~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 678899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.95 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=204.7
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
||+|+||.||++.+..++ +.||+|.+..... .........+.+++..+ +|+||+.+++.+..+...|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG------KMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCC------cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEe
Confidence 799999999999987655 4899999864211 11122222334555555 79999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCC
Q 006772 129 FYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207 (632)
Q Consensus 129 y~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~ 207 (632)
|+. |+|.+.+.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||++...... .
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----K 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----c
Confidence 998 56766665544456899999999999999999999999999999999999999999999999998765321 1
Q ss_pred ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhccCCCCCCCCCHH
Q 006772 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVIKKEKPCIPSGLPPA 283 (632)
Q Consensus 208 ~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~~~~~p~~p~~lp~~ 283 (632)
......||..|+|||++.+. .++.++|+|||||++|||++|..||..... .++...... .........++++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEE---PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DEVKFEHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-cccccccccCCHH
Confidence 12234689999999998743 588999999999999999999999976432 222222221 1112222468999
Q ss_pred HHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 284 VENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
+.++|.+||+.||++||++.|+++.+ +.+.++...+|..+..+..++|+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~--~~h~~f~~~~~~~~~~~~~~~~~ 274 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDP--RKHEFFKTINFPRLEAGLIPPPF 274 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhh--hcChhhcCCCHHHHhcCcCCCCC
Confidence 99999999999999999998766433 24678888888877766655554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=329.46 Aligned_cols=272 Identities=22% Similarity=0.361 Sum_probs=214.3
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
....+..++|.+.+.||+|+||.||+|.+..... ......||+|+++........+....+..++.++.+|+||+.+++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSK-SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCC-CCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 3456777899999999999999999998643221 123357999998754333222333444456677778999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.+..++..+++|||+. |+|.+++.......+++.++..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999998 688888765444458999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++........ .......++..|+|||++.. +.++.++|+|||||++|||++ |..||.+....+...........
T Consensus 187 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 187 LARDIMNDSNY-VVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred ccccccCCCce-eecCCCCcccccCCHhhhcc---CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 98755322110 11122345788999999864 357889999999999999998 99999887755544444433444
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
+..+...++++.+++.+||+.+|++||++.+++..|+++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 455667899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.61 Aligned_cols=251 Identities=20% Similarity=0.343 Sum_probs=198.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.+.||+|+||.||+|.+..++ ..||+|++...........+..+..++..+ +|+||+.+++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCC------cEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE
Confidence 45689999999999999999999987665 489999987543322222233333455554 68999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++.+++||||++| +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999985 777776543 4789999999999999999999986 69999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH---------
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--------- 268 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~--------- 268 (632)
.... .......||+.|+|||++.+. .++.++|+|||||++|||++|+.||...+..++...+.
T Consensus 153 ~~~~-----~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 153 QLID-----SMANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccc-----cccccCCCCcCcCCHhHhcCC---CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 5422 122345789999999998743 68899999999999999999999998765544322110
Q ss_pred ------------------------------------hhccCCCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 ------------------------------------IKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ------------------------------------~~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+..+ ..+++++.+||.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011112222 246889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=349.28 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=206.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|.+.+.||+|+||.||+|....+. ...||+|.+........ .....+..++.. .+|+||+.+++.+..++.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~~vv~K~~~~~~~~~~-~~~~~E~~~l~~-l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDP-----KEKVVAKFVMLNDERQA-AYARSELHCLAA-CDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCC-----CeEEEEEEcccCCHHHH-HHHHHHHHHHHh-CCCCCEeEEEEEEEECCE
Confidence 45999999999999999999876542 14788887754433322 233334444444 479999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 123 ICIAMKFYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+||||||++ |+|.+.+... ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 6787776543 2357899999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.... ........+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.+..++...+... ....+|..
T Consensus 220 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~ 294 (478)
T PTZ00267 220 SDSV-SLDVASSFCGTPYYLAPELWER---KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCP 294 (478)
T ss_pred CCcc-ccccccccCCCccccCHhHhCC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCcc
Confidence 3321 1112334679999999999874 36889999999999999999999999998888777776543 33456778
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++++.++|.+||+.||++||++.++++
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 9999999999999999999999999885
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=322.92 Aligned_cols=264 Identities=18% Similarity=0.339 Sum_probs=207.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.+.||+|+||.||+|.++.+++ ....+|+|.++.............+..++..+ +||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 76 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK 76 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec
Confidence 567899999999999999999998865432 23479999986543222222223333444444 79999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..|++|||++| +|.+++... ...+++.+++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999985 677776543 35789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...............++..|+|||++.+ ..++.++|+|||||++||+++ |..||...+..+....+.. ...+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 231 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAP 231 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc---CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCC
Confidence 5332111111111233568999999864 367889999999999999887 9999998877766665543 2344456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..+|+.+.+++.+||+++|.+||++.++++.|+.+
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 77899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.95 Aligned_cols=273 Identities=20% Similarity=0.326 Sum_probs=215.0
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
+..+..++|.+.+.||+|+||.||+|.+...... ......+|+|.+..... .....+.. +..++..+..|+||+.++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS-EMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHH-HHHHHHHhcCCCCEeeEE
Confidence 4456678999999999999999999987543221 12235799999975432 22233333 335566666899999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCe
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~N 179 (632)
+++..++..|+||||+. |+|.+++.... ...+++.+++.++.|++.||+|||+++++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999998 68888886542 1358899999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCC
Q 006772 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258 (632)
Q Consensus 180 ILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~ 258 (632)
||++.++.+||+|||+++......... ......+++.|||||++.+ ..++.++|+|||||++|||++ |..||.+.
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhcc---CCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999987543211111 1111234578999999864 357889999999999999998 89999888
Q ss_pred CHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+..++...+. .......|..++.++.+++.+||..+|.+||++.++++.|+.+...
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 7776665543 3344556788999999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=323.61 Aligned_cols=263 Identities=21% Similarity=0.382 Sum_probs=207.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
++.++|++.+.||+|+||.||+|.+...+. .....||+|.+........ ..+.+ +..++..+ +|+||+.+.+++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~-E~~~l~~l-~h~niv~~~~~~~ 77 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGM--DHAQLVAIKTLKDINNPQQWGEFQQ-EASLMAEL-HHPNIVCLLGVVT 77 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCC--CCcceEEEEeccCCCCHHHHHHHHH-HHHHHhhC-CCCCeeeEEEEEe
Confidence 456789999999999999999998754332 2345899999975433222 33333 33455555 7899999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQR---------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~---------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
.++..|++|||++ |+|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 9999999999998 57877775321 1347889999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
++++.+||+|||+++........ .......++..|+|||++.+ +.++.++|+|||||++|||++ |..||.+.+..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMY---GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233 (283)
T ss_pred cCCCcEEeccccccccccCCcce-ecccCCCccceecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999998765332111 11223345778999999863 468899999999999999998 99999888776
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
++...+.. ...+..+..+++++.+++.+||+.||++||++.+|++.|..
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 66555543 33445678899999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.93 Aligned_cols=265 Identities=21% Similarity=0.342 Sum_probs=207.5
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+..++|++.+.||+|+||.||+|.+...++ .....||+|++...... ..+.+. .+..++.. .+|+||+.+++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~-~e~~~l~~-l~h~niv~~~g~~ 78 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEIL-DEAYVMAS-VDNPHVCRLLGIC 78 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCC--ccceeEEEEeccccCCHHHHHHHH-HHHHHHHh-CCCCCCCeEEEEE
Confidence 3566889999999999999999999865443 11235999998754332 223333 33344444 4799999999988
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..+ ..++++||+. |+|.+.+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 79 LTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred cCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence 764 5678999998 7888887653 346899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+........ .......++..|||||++.. ..++.++|+|||||++|||++ |..||.+.+..++.. +......+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~ 231 (316)
T cd05108 157 KLLGADEKE-YHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP 231 (316)
T ss_pred ccccCCCcc-eeccCCccceeecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCC
Confidence 865332111 11112234678999999863 468899999999999999998 999999877766543 334445555
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+..++.++.+++.+||+.||.+||++.+++..|..+..
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 677899999999999999999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.76 Aligned_cols=264 Identities=20% Similarity=0.310 Sum_probs=209.1
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
|+|..++|++.+.||+|+||.||+|.++.++. ...+|+|.+...........+.++..++.++.+|+||+.+++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCc----eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 57788999999999999999999999875442 12578888764332222222333445566777899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
..++.+|++|||++ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+||||||+|||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili 157 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence 99999999999998 67888776432 1358899999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
+.++.+||+|||+++..... .......++..|+|||++.. ..++.++|+|||||++|||+| |..||.+.+..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred cCCCcEEeCccccCcccchh----hhcccCCCcccccCHHHHhc---cCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999998632110 01111234668999998864 357889999999999999998 99999988777
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+....+. ....+..+..+++++.+++.+||+.||++||++.+++..|+.+.
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 231 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 6665543 22334456678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=328.00 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=203.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-H-HHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-A-KVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~-~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|+.+.+|++|+||.||+|+++++++ .||+|.++...+.. . -..+++. .++.++ +||||+.+..+.+-
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~e------IVALKr~kmekek~GFPItsLREI-niLl~~-~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDE------IVALKRLKMEKEKEGFPITSLREI-NILLKA-RHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcce------eEEeeecccccccCCCcchhHHHH-HHHHhc-CCCCeeeeEEEEec
Confidence 4789999999999999999999998875 89999998654321 1 1223443 344555 59999999887653
Q ss_pred --CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 --NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 --~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
-+.+|||||||+.+|..++...+ .+|...++..++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 36799999999998888887654 689999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--- 274 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--- 274 (632)
.+... ...++..+-|.+|.|||.+.+. ..|+.+.|+||+||++.||+++++.|.|.+..+....|......|
T Consensus 226 ~ygsp---~k~~T~lVVTLWYRaPELLLG~--~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 226 EYGSP---LKPYTPLVVTLWYRAPELLLGA--KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhcCC---cccCcceEEEeeecCHHHhcCC--cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 87543 2234445669999999999975 368999999999999999999999999988665555554211111
Q ss_pred --------------------------CCCC-CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------------------------CIPS-GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------------------------~~p~-~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.|+. .++..-.+|++.+|.+||.+|.|+.+.|+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111 25678899999999999999999999775
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.63 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=206.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|+..++||+|.||.||+|.+..++ +.||||++.-......-+.++++..++..+ +++||..+++.+..+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~------k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTK------KVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeecccc------ceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeeccc
Confidence 56888899999999999999998876 489999997544333223334444445554 56999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
++|+||||. |++++++.. +..+.+..+..++++++.||.|||+++.+|||||+.|||+..+|.+||+|||.+-.+..
T Consensus 86 LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999998 688887743 34558888999999999999999999999999999999999999999999999876644
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
... ...++.||+.|||||++.+. .|+.++||||||++.+||++|.+||....+......| -+..+|.+...++
T Consensus 164 ~~~---rr~tfvGTPfwMAPEVI~~~---~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S 236 (467)
T KOG0201|consen 164 TVK---RRKTFVGTPFWMAPEVIKQS---GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFS 236 (467)
T ss_pred hhh---ccccccccccccchhhhccc---cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccC
Confidence 322 22567999999999999843 6899999999999999999999999988775443322 3455666667899
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.+++||..||++||+.||++.++++
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 99999999999999999999999996
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.15 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=203.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
+.+.+.||.|.||.||+|.+.... ......|+||+++..... ....+.++. ..+.++ +|+||+.+++++...+..
T Consensus 1 ~~~~~~ig~G~fg~v~~~~~~~~~--~~~~~~V~vk~~~~~~~~~~~~~~~~e~-~~l~~l-~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 1 IKLIKQIGEGSFGKVYRAEWKQKD--NDKNQPVAVKILKPSSSEEEEEEFLNEI-QILRKL-RHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEEESSEEEEEEEEESTT--TSSEEEEEEEEESTTSSHHHHHHHHHHH-HHHHTH-SBTTBE-EEEEEESSSSE
T ss_pred CEEeeEEccCCCcEEEEEEEEccc--CCCCEEEEEEEeccccccccceeeeecc-cccccc-cccccccccccccccccc
Confidence 367899999999999999998311 134468999999664333 344555544 455666 899999999999988889
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
++||||++ |+|.+++.......+++..++.++.||+.||.|||+++++|+||+++|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999998 68999988765568999999999999999999999999999999999999999999999999999875222
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
... .......+...|+|||.+... .++.++||||||+++|||++ |+.||...+..++...+. ....+..+..++
T Consensus 157 ~~~-~~~~~~~~~~~~~aPE~~~~~---~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (259)
T PF07714_consen 157 SKY-KNDSSQQLPLRYLAPEVLKDG---EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-QGQRLPIPDNCP 231 (259)
T ss_dssp SSE-EESTTSESGGGGS-HHHHHHS---EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-TTEETTSBTTSB
T ss_pred ccc-ccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc-ccccceeccchh
Confidence 111 111223457899999998743 47899999999999999999 789999988888777774 455566788999
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
..+.++|.+||+.||++||++.++++.|
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=348.36 Aligned_cols=278 Identities=24% Similarity=0.436 Sum_probs=230.4
Q ss_pred ccccCCCCCCCC-cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecC---CchhhHHHHHHHHHHHhhh
Q 006772 28 TVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---LKEDCAKVFVNKFEELFPK 103 (632)
Q Consensus 28 ~~~~~~~~~~~~-I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~---~~~~~~~~~~~~~~~il~~ 103 (632)
..+.+|.....| +..++..+.++||+|+||+||+|..+..+.. ....||||..+- ...+...++.++. +++.+
T Consensus 141 ~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~EA-rvMr~ 217 (474)
T KOG0194|consen 141 FFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMKEA-RVMRQ 217 (474)
T ss_pred eeecccccccccEEeccCccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHHHH-HHHHh
Confidence 357777777766 6679999999999999999999998865421 112399999874 3345555665554 44444
Q ss_pred ccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 104 FRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 104 l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
.+|+||+.++|+...+..++||||+|. |+|.+++.... +.++..+...++.+.|.||+|||++++|||||-.+|+|+
T Consensus 218 -l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~ 295 (474)
T KOG0194|consen 218 -LNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY 295 (474)
T ss_pred -CCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee
Confidence 689999999999999999999999998 58888887643 379999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
+.++.+||+|||+++....... ......-...|+|||.+. .+.|++++|||||||++||+++ |..||.+....
T Consensus 296 ~~~~~vKISDFGLs~~~~~~~~---~~~~~klPirWLAPEtl~---~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 296 SKKGVVKISDFGLSRAGSQYVM---KKFLKKLPIRWLAPETLN---TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred cCCCeEEeCccccccCCcceee---ccccccCcceecChhhhc---cCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 9999999999999875321110 110112367999999997 4579999999999999999999 89999999999
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
++...|.....+...|...|.++..++.+||..||++||+|.++.+.|+.+....
T Consensus 370 ~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 370 EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 9999997777788888999999999999999999999999999999998876543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=319.56 Aligned_cols=258 Identities=23% Similarity=0.429 Sum_probs=210.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+..+|.+.+.||+|+||.||+|.+...+ ..||+|.+..... ....+.++. .++..+ .|++|+.+++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~-~~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTM-EVEEFLKEA-AVMKEI-KHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCC------ceEEEEEecCCch-HHHHHHHHH-HHHHhC-CCCChhheEEEEcC
Confidence 56788999999999999999999987654 4899999865332 233444433 344444 68999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.++++|||++ |+|.+.+.......+++..++.++.|++.||+|||+++++||||||+|||+++++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 999999999997 6788887665556789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+....+. ....+..+
T Consensus 154 ~~~~~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 227 (263)
T cd05052 154 MTGDTYT--AHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERP 227 (263)
T ss_pred cccceee--ccCCCCCccccCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCC
Confidence 5332111 1112234668999998864 367889999999999999998 999999888777666554 33456677
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..+|.++.+++.+||+.||++||++.++++.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 88999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.85 Aligned_cols=264 Identities=18% Similarity=0.313 Sum_probs=208.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.+.||+|+||.||+|.+..+.. ......||||++...........+.++..++.. .+|+||+.+++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR-LQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhc-CCCCCcCeEEEEEcC
Confidence 566789999999999999999998765421 123458999999754433333333333344444 478999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQ--------------RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~--------------~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~ 184 (632)
.+..++++||+. ++|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 999999999998 5677776422 1235888999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHH
Q 006772 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263 (632)
Q Consensus 185 ~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei 263 (632)
++.+||+|||+++........ .......+++.|+|||++.. +.++.++|+|||||++|||++ |..||.+....++
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY---GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCceEecccccccccccchhe-eeccCccCCccccCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999998765322111 11122345789999999863 468889999999999999998 8999998888777
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
...+.. ......+..++..+.+++.+||+.||.+||++++|+..|+
T Consensus 236 ~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 236 IEMIRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 766654 3344567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.31 Aligned_cols=250 Identities=19% Similarity=0.298 Sum_probs=195.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhcc--CCCceeEeeEEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFR--ESQSVCWLHGISVI 119 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~--~h~~I~~l~~~~~~ 119 (632)
+|++.+.||+|+||.||+|.++.++ +.||+|.+...... ......++ ..++..+. .|+||+.+++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG------HFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC------cEEEEEEeccCcCCCCCchHHHHH-HHHHHHhhhcCCCCeeeeeeeecc
Confidence 5899999999999999999988765 48999998653211 11122222 23333332 69999999988764
Q ss_pred -----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 120 -----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 120 -----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
...++++|||+.+++.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 74 SRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred ccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 356899999999999888876555569999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... .......||..|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+....+......+
T Consensus 154 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07863 154 LARIYSCQ----MALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226 (288)
T ss_pred ccccccCc----ccCCCccccccccCchHhhC---CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence 98765321 11233468999999999864 368899999999999999999999998877655444433211000
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 -------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 -------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....++.++.++|.+||+.||++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011356788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=326.04 Aligned_cols=273 Identities=20% Similarity=0.306 Sum_probs=214.9
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCC-CcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSAD-DFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~-~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...+..++|++.+.||+|+||.||+|.+..... .......||+|.+...........+..+..++..+.+|+||+.+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 345778999999999999999999998643221 1123357999998654322222223333445666668999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
.+...+..|++|||+. |+|.+++.... ...+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999998 58887776532 13578889999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~ 259 (632)
|++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|+||||+++|||++ |..||.+.+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999865332111 11122345778999999864 357889999999999999998 899999888
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..++...+.. ......+..++.++.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 245 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 VEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 8877766543 33445677899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=323.29 Aligned_cols=273 Identities=20% Similarity=0.321 Sum_probs=212.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.|+..+.||+|+||+||+|.+..++ +.||+|.+.+.... ........+..++..+ +|++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATG------KMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCC------cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCC
Confidence 4788899999999999999987655 48999998653211 1112222333455554 7899999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|++|||+.| +|.+.+.......+++..+..++.|++.||.|||+++|+||||||+|||+++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999985 66666655444579999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--hccCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI--KKEKPCIPS 278 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~--~~~~p~~p~ 278 (632)
.. .......|+..|+|||++.+ ..++.++|+|||||++|||++|..||.+.........+.. ......++.
T Consensus 154 ~~----~~~~~~~g~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05632 154 EG----ESIRGRVGTVGYMAPEVLNN---QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226 (285)
T ss_pred CC----CcccCCCCCcCccChHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc
Confidence 21 12234578999999999864 3688899999999999999999999988765433222221 122344567
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.+++++.+|+.+||+.||++||+ +.++++ +.++....|.....+...+++.+
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR------HPFFRNMNFKRLEAGMLDPPFVP 283 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc------ChhhhcCCHHHHhcCcCCCCCCC
Confidence 88999999999999999999999 455554 56777777777666666655543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=347.82 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=194.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
..+|++.+.||+|+||.||+|.+..++ +.||||.+...... ..++..++..+ +|+||+.+++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~------~~vAiK~i~~~~~~-----~~~Ei~il~~l-~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTS------EKVAIKKVLQDPQY-----KNRELLIMKNL-NHINIIFLKDYYYTEC 132 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCC------CEEEEEEEecCcch-----HHHHHHHHHhc-CCCCCcceeeeEeecc
Confidence 468999999999999999999987655 48999988543221 22333444444 789999988776432
Q ss_pred -------CEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEE
Q 006772 121 -------GKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVL 190 (632)
Q Consensus 121 -------~~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL 190 (632)
..+++||||+++++.+.+... .+..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||
T Consensus 133 ~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred cccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 257799999999988877643 346799999999999999999999999999999999999999665 7999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||+|+.+... .......||+.|||||++.+. ..++.++|+|||||++|||++|.+||.+.+..+....+...
T Consensus 213 ~DFGla~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 213 CDFGSAKNLLAG----QRSVSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred eccccchhccCC----CCcccCCCCcCccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999865322 122345789999999998643 35889999999999999999999999988765544443321
Q ss_pred ccC---------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEK---------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~---------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
... ..+|...|+++.+||.+||++||.+||++.|++.
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 110 1134567889999999999999999999999886
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.13 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=199.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|++..++ +.||+|.+.............++..++..+ +|+||+.+++++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTE------NLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCC------CeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCC
Confidence 478999999999999999999987654 489999987543222222222233444444 6899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..|+||||+++++.+.+... +..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 78 SLTLVFEYLDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred eEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99999999999988887653 34689999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-------- 273 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-------- 273 (632)
. ........+|+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+....+......
T Consensus 157 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 157 P---TKTYSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred C---ccccccccccccccCCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 1 1122234679999999998642 35788999999999999999999999987765544433211000
Q ss_pred ------------CC--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ------------PC--------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ------------p~--------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+. ....+++++.++|.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 11347889999999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=320.80 Aligned_cols=263 Identities=21% Similarity=0.377 Sum_probs=210.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|+.++|++.+.||+|+||.||+|.++.... ......||+|.+....... ...+.+ +..++..+ .|+||+.+++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~-e~~~l~~~-~~~~i~~~~~~~~ 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLN-EASVMKEF-NCHHVVRLLGVVS 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHH-HHHHHHhC-CCCceeEEEEEEc
Confidence 677899999999999999999999875431 1234689999986543222 223333 33444444 7899999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEE
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQR--------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~--------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vk 189 (632)
.++..+++|||+. |+|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999997 68888876532 13478889999999999999999999999999999999999999999
Q ss_pred EEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 006772 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~ 268 (632)
|+|||+++........ .......++..|+|||.+.. +.++.++|+|||||++|||++ |..||.+.+..+....+.
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 160 IGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD---GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred ECCcccchhhccCccc-ccCCCCCccccccCHHHHhc---CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 9999998765332211 11223456889999999863 457889999999999999998 999999888777766655
Q ss_pred hhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 269 ~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
....+.+|..++.++.+++.+||+.+|++||++.+++..|+
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 44556678889999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.24 Aligned_cols=263 Identities=19% Similarity=0.353 Sum_probs=206.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|..++|+..+.||+|+||.||+|.+..++. ....+|+|.+..... ...+.+..+ ..++..+ .|+|++.+.+++.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~ 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSE-ASIMGQF-SHHNIIRLEGVVT 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHH-HHHHhcC-CCCCeeEEEEEEc
Confidence 567899999999999999999999875432 234799999865432 222333333 3444444 6899999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..+..|+||||+++ +|.+++.. ..+.+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999985 66666543 34678999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
.................+..|+|||++.. ..++.++|+|||||++|||++ |..||...+..+....+.. ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~ 231 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPA 231 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhc---CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCC
Confidence 65322111111111123457999999863 357889999999999999998 9999988877776666653 234444
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
+..++.++.+++.+||+.||++||++.++++.|+++
T Consensus 232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=363.59 Aligned_cols=272 Identities=24% Similarity=0.394 Sum_probs=225.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
|.+++++.++.+.||+|.||.||.|+......+.. ...||||.+++.........+-++..+++++ .||||+.+.|++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVC 764 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCcc-ceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEee
Confidence 66778999999999999999999999886654322 3579999998765544444334444555554 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR-----GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~-----~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
.+.+..+|++|||+ |+|+.++.+.+ ...++..+.+.++.|||+|+.||+++++|||||..+|+||+....+||+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 99999999999998 67888776542 3568899999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+|+-+....+...... ..-...|||||.+. .+.+|.++|||||||+|||++| |..||.+.+..++...+..+
T Consensus 845 DFGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~---d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGE-AMLPVKWMPPESLK---DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred ccchhHhhhhchheeccCc-cccceecCCHHHHh---hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 9999984322211111111 11247899999997 4679999999999999999999 99999999999988877665
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
+ +...|..||..+.++|..||+.+|++||++..|++.+..+.+..
T Consensus 921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 5 77889999999999999999999999999999999887776544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=316.98 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=204.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|++++|++.+.||+|+||.||+|.++.. ..+|+|.+..... ....+.+ +..++..+ +|+||+.+++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~a~K~~~~~~~-~~~~~~~-e~~~l~~l-~h~~i~~~~~~~~~ 70 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQ-------IKVAIKAINEGAM-SEEDFIE-EAKVMMKL-SHPKLVQLYGVCTQ 70 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccC-------ceEEEEecccCCc-cHHHHHH-HHHHHHHC-CCCCceeEEEEEcc
Confidence 5678999999999999999999987542 3699998864332 2233444 33445554 68999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..+++|||++ |+|.+.+... .+.+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 71 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 71 QKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CCCEEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999998 6777776543 34689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||.+.+. .++.++|+||||+++|||++ |+.||...+..+....+.. ...+..|
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~ 223 (256)
T cd05114 150 VLDDEYT--SSSGAKFPVKWSPPEVFNFS---KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRP 223 (256)
T ss_pred cCCCcee--ccCCCCCchhhCChhhcccC---ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCC
Confidence 4322111 11122356789999998643 57889999999999999999 9999998887777666653 3344556
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
...+.++.+++.+||+.||.+||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 77889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=350.14 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=203.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++.+.||+|+||+||+|.+..++ +.||||++..... .....+.+ +...+.. .+|++++.++..+.
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~-Ei~~l~~-~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDG------EPFAVKVVDMEGMSEADKNRAQA-EVCCLLN-CDFFSIVKCHEDFA 101 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCC------CEEEEEEEecccCCHHHHHHHHH-HHHHHhc-CCCCcEEEeeccee
Confidence 4479999999999999999999987655 4899999865432 22222222 2233333 36889988877665
Q ss_pred ECC--------EEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc
Q 006772 119 ING--------KICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ 187 (632)
Q Consensus 119 ~~~--------~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~ 187 (632)
..+ .+++||||++ |+|.+.+.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence 332 4789999998 68888776432 357899999999999999999999999999999999999999999
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
+||+|||+++.+.... ........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+
T Consensus 182 vkL~DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 182 VKLGDFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRR---KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred EEEEecccCeeccccc-cccccccccCCcceeCHHHhCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999998653321 1122334679999999999974 36889999999999999999999999998887777766
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. .....+|..+++++.+++.+||+.||.+||++.++++
T Consensus 258 ~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 54 3344567889999999999999999999999999886
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.60 Aligned_cols=271 Identities=22% Similarity=0.327 Sum_probs=213.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+..++|.+.+.||+|+||.||+|.+...... ......+|+|.+...... ....+.. +..++..+.+|+||+.++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS-EMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHH-HHHHHHhccCCCCeeeEEEE
Confidence 45668999999999999999999987532211 123357999998754332 2233333 34556667689999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEE
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLL 181 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NIL 181 (632)
+..++.+|++|||+. |+|.+++.... ...+++.+++.++.||+.||+|||+++|+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 998999999999998 68888876532 245889999999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCH
Q 006772 182 LSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260 (632)
Q Consensus 182 ld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~ 260 (632)
++.++.+||+|||+++........ .......++..|||||++.+ +.++.++|+|||||++|||++ |..||.+.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFD---RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHcc---CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999765322111 11111234568999999864 368889999999999999999 8999998887
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 261 ~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
.+.+..+.. ......+..++.++.+++.+||..||++||++.++++.|+.+...
T Consensus 243 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 777666543 344556788899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.49 Aligned_cols=264 Identities=19% Similarity=0.345 Sum_probs=206.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+..++|++.+.||+|+||.||+|.+.....+ .....||||.+..... .....+.++. .++.. .+|+||+.+++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~-~~l~~-l~~~~iv~~~~~~ 78 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEA-SVMKE-FNCHHVVRLLGVV 78 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCC-CceeEEEEEeccccCCHHHHHHHHHHH-HHHHh-CCCCCeeeEEEEE
Confidence 35668899999999999999999987643221 2235799999865332 2222333333 34444 4789999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRG--------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~--------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
..++..++||||+. |+|.+++..... ..+++..++.++.|++.||+|||+++++||||||+|||+++++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 98899999999998 578777754321 235778899999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i 267 (632)
+|+|||+++........ .......+++.|||||++.+ +.++.++|+|||||++|||++ |..||.+.+..+....+
T Consensus 159 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EECCCCCccccCCccee-ecCCCCccCHhhcChhHhhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998754322111 11112345788999999863 468899999999999999999 78999988777666554
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
. ....+..+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 235 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 M-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 4 33445567889999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=321.67 Aligned_cols=264 Identities=23% Similarity=0.414 Sum_probs=209.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|.+.+.||+|+||.||+|.+..... ....+.||||.+.............++..++..+ .|+||+.+++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 79 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEP-ENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTE 79 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccC-cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEec
Confidence 356789999999999999999998765321 1223589999987654442233333334555555 68999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
++..+++|||++ |+|.+++.... ...+++..+..++.|++.||+|||+++++||||||+|||++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 999999999998 57877775432 24578899999999999999999999999999999999999999
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYH 265 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~ 265 (632)
.++|+|||+++........ .......+++.|+|||++.+ +.++.++|+|||||++|||++ |..||.+.+..+...
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred eEEECCcccceecccCcce-ecCCCCcccceecChhhhcc---CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999998754322111 11122345789999999874 468899999999999999998 999999888777666
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.+. ....+..+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 554 33344456789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.34 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=206.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++. ...+++|.++..... ..+.+ ..+..++.++.+|+||+.+++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~ik~~~~~~~~~~~~~~-~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL----KMNAAIKMLKEFASENDHRDF-AGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC----cceeEEEEccccCCHHHHHHH-HHHHHHHHhhcCCCchhheEEEEccCC
Confidence 689999999999999999998865442 125788888643322 22333 333455667768999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 122 KICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
.+|++|||++ |+|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|||+++++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999998 68888886532 13588999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYH 265 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~ 265 (632)
.+||+|||++...... ........+..|+|||++.. ..++.++|+|||||++|||++ |..||.+.+..+...
T Consensus 157 ~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 157 ASKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNY---SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred eEEECCcCCCccccce----eccCCCCcCccccCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999988532110 01111123557999999864 367889999999999999997 999999988877666
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+.. ...+..|..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 KLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 5543 33445677899999999999999999999999999998877664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.95 Aligned_cols=263 Identities=19% Similarity=0.356 Sum_probs=206.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|+..+|++.+.||+|+||.||+|.+...+. ....||||++...... ....+.. +..++..+ +|+||+.+.+++.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~-e~~~l~~l-~h~ni~~~~~~~~ 75 (269)
T cd05065 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGK---REIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF-DHPNIIHLEGVVT 75 (269)
T ss_pred CChHHeEEEeEecCCCCCeEEEEEEecCCC---CceeEEEEEcCCCCCHHHHHHHHH-HHHHHHhC-CCcCcceEEEEEC
Confidence 456789999999999999999999876542 2347999998754322 2333333 33444444 7999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..+++|||++| +|.+++.. ..+.+++.+++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 99999999999985 66665543 34578999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCcccccc--CCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 198 LLLGRSLSDSDMALRL--GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~--GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
................ .+..|+|||++.. +.++.++|+|||||++|||++ |..||...+..+....+. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~ 230 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRL 230 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhcc---CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcC
Confidence 6533211111111111 2457999999863 468889999999999999887 999999888777666654 23344
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
+.+..+|..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 45678899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=335.01 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=195.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
...++|++.+.||+|+||.||+|.+..++ +.||||++...........+.++..++..+ +|+||+.+++++..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 143 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTG------RLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH 143 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCC------CEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc
Confidence 34578999999999999999999987655 489999996544333333334444455554 68999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++.+++||||+.|..+.. ....++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 144 ~~~~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred CCeEEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 999999999999643321 124567888899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhccCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE---EIYHSVVIKKEKP 274 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~---ei~~~i~~~~~~p 274 (632)
.... .......||..|+|||++.... ....+.++|||||||++|||++|+.||...... .....+ .....+
T Consensus 219 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 294 (353)
T PLN00034 219 AQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPP 294 (353)
T ss_pred cccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCC
Confidence 3221 1123457899999999985321 112356899999999999999999999753322 222222 223445
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+..++.++.+||.+||+.||++||++.|+++
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 567789999999999999999999999999887
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.74 Aligned_cols=271 Identities=20% Similarity=0.342 Sum_probs=209.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ +.||+|.+.+.... ........+..++..+ .|++++.+.+.+..++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCC------ceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCC
Confidence 4788999999999999999998765 48999998653211 1111122233444444 7899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+||||+. |+|.+++.......+++.+++.++.|++.||.|||+++|+||||||+|||+++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999998 577777755444579999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhccCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE---EIYHSVVIKKEKPCIP 277 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~---ei~~~i~~~~~~p~~p 277 (632)
.. .......||..|||||++.. ..++.++|+|||||++|||++|..||...... +...... ......++
T Consensus 154 ~~----~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (285)
T cd05630 154 EG----QTIKGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYS 225 (285)
T ss_pred CC----ccccCCCCCccccChHHHcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcC
Confidence 21 11223478999999999874 46889999999999999999999999875321 2222221 12233456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
..+++++.+|+.+||+.||++||+ +.|+++ ++++...+|..+......+++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~------h~~~~~~~~~~~~~~~~~~~~~ 282 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE------HPLFKQINFKRLEAGMLEPPFK 282 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc------ChhhhccCHHHHhcCCCCCCCC
Confidence 788999999999999999999999 778775 5667677777665555554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.70 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=212.3
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.-+.|..+.+.-++-||.|+.|.||+|+.+. +.||||+++..++...+. +.+ .+|+||+.+.|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~n--------etVAVKKV~elkETdIKH--------LRk-LkH~NII~FkG 179 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHN--------ETVAVKKVRELKETDIKH--------LRK-LKHPNIITFKG 179 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccC--------ceehhHHHhhhhhhhHHH--------HHh-ccCcceeeEee
Confidence 3445667778888999999999999998764 479999986554433322 222 37999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
+|.+.-.+|||||||. |-|.+.+.. +..++......+..+||.|+.|||.+.|||||||.-||||+.+..+||+|||
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEecccc
Confidence 9999999999999998 888888864 4588999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
-++..... .+...++||..|||||+++.+ +.++|+|||||||+|||||||..||...+...|..-+-......
T Consensus 258 TS~e~~~~----STkMSFaGTVaWMAPEvIrne---PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L 330 (904)
T KOG4721|consen 258 TSKELSDK----STKMSFAGTVAWMAPEVIRNE---PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL 330 (904)
T ss_pred chHhhhhh----hhhhhhhhhHhhhCHHHhhcC---CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc
Confidence 88765321 344568999999999999855 78999999999999999999999998877655544443344556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+.|+.||.-++-||+.||+..|.+||++.+|+..|+-...
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 6789999999999999999999999999999987765433
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.34 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=204.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
+|++.+.||+|+||.||++.+..++ ..||+|.+..............+..++..+ +|+|++.+.+.+..++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD------QKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC------ceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEE
Confidence 5899999999999999999987655 489999986433222222222333344444 789999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
|++|||++ |++.+++.......+++..++.++.|++.||.|||+++|+|+||||+|||+++++.++|+|||++......
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999998 57888877655667899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCH
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~ 282 (632)
. .......|++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.. ......|..++.
T Consensus 154 ~---~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (255)
T cd08219 154 G---AYACTYVGTPYYVPPEIWENM---PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-GSYKPLPSHYSY 226 (255)
T ss_pred c---cccccccCCccccCHHHHccC---CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-CCCCCCCcccCH
Confidence 1 112234689999999998643 578899999999999999999999998877666555543 344456778999
Q ss_pred HHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 283 AVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 283 ~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+.++|.+||+.||++||++.+++.
T Consensus 227 ~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 227 ELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHHHHHHHhCCcccCCCHHHHhh
Confidence 9999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.38 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=194.5
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.-+...+|++.+.||+|+||.||+|.+..++ +.||||.... ..+. .+..++..+ +||||+.+++++
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~------~~vaiK~~~~------~~~~-~E~~il~~l-~HpnIv~~~~~~ 152 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTC------EHVVIKAGQR------GGTA-TEAHILRAI-NHPSIIQLKGTF 152 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCC------CEEEEechhh------hhhH-HHHHHHHhC-CCCCCCCEeEEE
Confidence 3456688999999999999999999998766 4899997532 1222 233455555 789999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++..|++||++.++|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 153 ~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 153 TYNKFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred EECCeeEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 999999999999999988887653 478999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhh
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-------VEEIYHSVVIK 270 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-------~~ei~~~i~~~ 270 (632)
..... .........||+.|+|||++.+ ..++.++|+|||||++|||++|..||.... .......+...
T Consensus 231 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 231 FPVDI--NANKYYGWAGTIATNAPELLAR---DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred ccccc--cccccccccCccCCCChhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 53221 1122334679999999999874 368899999999999999999998876432 11111111100
Q ss_pred ------------------------ccCCCCC---------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 ------------------------KEKPCIP---------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ------------------------~~~p~~p---------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......+ ..++.++.+||.+||+.||++|||+.|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000001 135678999999999999999999999886
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.43 Aligned_cols=248 Identities=21% Similarity=0.227 Sum_probs=192.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
-.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.++ ..++.. .+|+||+.+++++.
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E-~~~l~~-l~h~niv~~~~~~~ 90 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLG------INVAVKKLSRPFQNQTHAKRAYRE-LVLLKC-VNHKNIISLLNVFT 90 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCC------ceeEEEEecccccchhHHHHHHHH-HHHHHh-CCCCCEeeeeeeec
Confidence 3578999999999999999999987655 489999986532 1222233333 233443 47999999999886
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 119 IN------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 119 ~~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
.. ..+|+||||+++++.+.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 91 PQKSLEEFQDVYLVMELMDANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cCCCccccceeEEEEeCCCcCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEec
Confidence 54 3579999999998887763 2588999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK-- 270 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~-- 270 (632)
||+++..... .......||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+.+..+...
T Consensus 167 fg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 167 FGLARTACTN----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred CCCccccccC----ccCCCCcccCCCCCchhccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9998754221 122335789999999999743 6888999999999999999999999877654332222110
Q ss_pred ------------------ccCCC--------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 ------------------KEKPC--------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ------------------~~~p~--------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+. .+...++++.+||.+||..||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 01111 11124678999999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=332.99 Aligned_cols=270 Identities=22% Similarity=0.349 Sum_probs=206.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.+.||+|+||.||+|.+..... ....+.||||+++.............+..++..+.+|+||+.+++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCc-cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 456899999999999999999998754321 1334689999997543222222233344566777789999999987754
Q ss_pred -CCEEEEEEecCC-CCHHHHHHHhc-------------------------------------------------------
Q 006772 120 -NGKICIAMKFYE-GSVGDRIAQQR------------------------------------------------------- 142 (632)
Q Consensus 120 -~~~l~LVmEy~~-GsL~d~l~~~~------------------------------------------------------- 142 (632)
++.++++|||++ |+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 467899999998 68887775421
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccc
Q 006772 143 ----------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212 (632)
Q Consensus 143 ----------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~ 212 (632)
...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 241 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCC
Confidence 12468888999999999999999999999999999999999999999999999876422110 0111123
Q ss_pred cCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 006772 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGC 291 (632)
Q Consensus 213 ~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~c 291 (632)
.++..|+|||++.+ ..++.++|+|||||++|||++ |..||.+....+...........+..|..+++++.+++.+|
T Consensus 242 ~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 242 RLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCcceECcHHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 45678999999864 367889999999999999997 99999876543333333334445556777889999999999
Q ss_pred hhcCcCCCCCHHHHHHHHHhhhh
Q 006772 292 FEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 292 L~~DP~~RPs~~ell~~Le~~~~ 314 (632)
|+.||++||++.+|++.|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.17 Aligned_cols=265 Identities=22% Similarity=0.347 Sum_probs=206.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+..++.. ....||+|++..............+..++.. .+|+||+.+.+++.
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~ 79 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAG-VGSPYVCRLLGICL 79 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHHHHHHh-cCCCCCceEEEEEc
Confidence 35678999999999999999999998765532 1235899998654332222222233333333 47899999999886
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
. ...+++|||++ |+|.+.+... ...+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 5 45789999998 7888877543 3579999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
........ .......+++.|+|||++.+ ..++.++|+|||||++|||++ |..||.......+...+. ....+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~ 232 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILH---RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQ 232 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCC
Confidence 65322111 11112234678999999863 368899999999999999998 999998877666555443 3444555
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+..++.++.+++.+||+.||++||++.++++.|+.+.
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 6789999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.99 Aligned_cols=256 Identities=24% Similarity=0.424 Sum_probs=207.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++.++|++.+.||+|+||.||+|.+..+ +.||+|.++.... ....+.+ +..++..+ +|+|++.+++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~v~iK~~~~~~~-~~~~~~~-e~~~l~~l-~h~~i~~~~~~~~~ 72 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNT-------TPVAVKTLKPGTM-DPKDFLA-EAQIMKKL-RHPKLIQLYAVCTL 72 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCC-------eEEEEEeeCCCcc-cHHHHHH-HHHHHHHC-CCCCccceeEEEec
Confidence 6778999999999999999999986432 3799999875432 2233333 33455555 58999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..|++|||+. ++|.+++....+..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++.
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 999999999995 7888888665555789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... .......+..|+|||++.. ..++.++|+||||+++|||++ |+.||.+....+....+.. ......+
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 226 (261)
T cd05068 153 IKEDIYE--AREGAKFPIKWTAPEAALY---NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCP 226 (261)
T ss_pred ccCCccc--ccCCCcCceeccCcccccc---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 6422111 1111123457999999864 367889999999999999999 9999998887776665542 3334456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
..++.++.+++.+||+.||.+||++.+++..|++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 7889999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.10 Aligned_cols=264 Identities=23% Similarity=0.372 Sum_probs=207.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+..++|++.+.||+|+||.||+|.+.....+ .....||+|.+....... ...+.++ ..++..+ +|+||+.+++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~ 78 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLME-ALIMSKF-NHQNIVRLIGVS 78 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCC-CCceeEEEEEcCCCCCHHHHHHHHHH-HHHHHhC-CCCCEeeEEEEE
Confidence 45668899999999999999999998752211 123589999886543332 2334443 3444454 689999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRG-----GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QL 188 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~-----~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~v 188 (632)
...+..+++|||+. |+|.+++..... ..+++..++.++.||+.||+|||+++++||||||+|||++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 98899999999997 588888765431 2589999999999999999999999999999999999998765 69
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i 267 (632)
||+|||+++........ ........+..|||||++.+ +.++.++|+|||||++|||++ |..||.+.+..+....+
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 159 KIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD---GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred EeccCccccccCCccce-ecCCCCCccHhhCCHHHHhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998765322111 11112233568999999863 468999999999999999997 99999988877766554
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
. ....+..|..+|..+.+++.+||+.||++||++.++++.|+
T Consensus 235 ~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3 34556677889999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.54 Aligned_cols=253 Identities=23% Similarity=0.417 Sum_probs=200.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ +.||||.+..... .....+..+. .+..+..+|+|++.+++++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTG------TIMAVKRIRATVNSQEQKRLLMDL-DISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCC------cEEEEEEEecCCCcHHHHHHHHHH-HHHHHHcCCCCeeeeeEEEecCC
Confidence 47999999999999999999988665 4899999875432 2223333333 33345568999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..|++|||++|+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 74 DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred cEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999988887653 235789999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCC-CCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhccCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVR-GPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~-g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~~~~~p~~ 276 (632)
.... .......|+..|+|||.+.+... ..++.++|+|||||++|||++|+.||.... ..+....+. ....+.+
T Consensus 154 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 228 (283)
T cd06617 154 LVDS----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQL 228 (283)
T ss_pred cccc----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCC
Confidence 4321 11123467899999999865322 457889999999999999999999997532 222233332 2333444
Q ss_pred C-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 P-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
| ..+|.++.++|.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4 457999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.73 Aligned_cols=270 Identities=22% Similarity=0.337 Sum_probs=208.4
Q ss_pred CCCcCC-CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDP-TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~-~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
+.++++ +.|++.++||.|+||.||+|.+..++ ..|++|.+..........+.++. .++..+ .|+|++.+++
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~e~-~~l~~l-~h~~i~~~~~ 76 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETG------ALAAAKVIETKSEEELEDYMVEI-EILATC-NHPYIVKLLG 76 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCC------ceEEEEEeccCCHHHHHHHHHHH-HHHHhC-CCCcEeeeEE
Confidence 334444 56999999999999999999987655 48999998765544444444433 334444 6999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 116 ISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.+..++..|+||||++|+.++.+.......+++..++.++.|++.+|+|||+++++||||||+|||++.++.++|+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred EEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999996544444333345789999999999999999999999999999999999999999999999998
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE- 272 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~- 272 (632)
+...... ........++..|+|||++.+.. ...++.++|+|||||++|||++|..||...+..+....+.....
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06644 157 SAKNVKT---LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 233 (292)
T ss_pred ceecccc---ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc
Confidence 8653221 11223346889999999985321 33578899999999999999999999988776555444432111
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
....+..++.++.++|.+||+.||++||++.++++ ++++....|.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~~~~~ 278 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE------HPFVSSVTSN 278 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc------Cccccccccc
Confidence 12235678899999999999999999999999886 4555554444
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=312.62 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=204.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHH--HHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAK--VFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~--~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|.+...... ... .....+..++..+ +|+||+.+++++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 74 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTG------RELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLR 74 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCC------cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEc
Confidence 57999999999999999999987654 48999998643211 111 1122233344444 7999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++.++++|||++ ++|.+.+... +.+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||+++
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9999999999998 4777776543 468999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
................|+..|+|||++.+. .++.++|+||||+++|||++|+.||...+..+....+......+.+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGE---GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccC---CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 653322111111334678999999999754 47889999999999999999999998877666555555555566678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..++.++.++|.+||..||.+||++.+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 889999999999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.86 Aligned_cols=251 Identities=21% Similarity=0.367 Sum_probs=197.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.++||+|+||.||+|.+..++ ..+|+|.+...........+..+..++..+ +|+||+.+++++..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCC------cEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE
Confidence 55689999999999999999999987655 479999887543322222233333455555 69999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++.+|+||||+. |+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 999999999998 577777754 34789999999999999999999985 79999999999999999999999999986
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH----------
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV---------- 267 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i---------- 267 (632)
..... ......||..|+|||++.+. .++.++|+|||||++|||++|+.||...+..++...+
T Consensus 153 ~~~~~-----~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 153 QLIDS-----MANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred hhhhh-----ccccCCCCccccCHHHhcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 54221 12334689999999999743 5788999999999999999999999865543321110
Q ss_pred ---------------------------------HhhccCCCCCC-CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 268 ---------------------------------VIKKEKPCIPS-GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 268 ---------------------------------~~~~~~p~~p~-~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......+.++. ..+.++.+||.+||++||++||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 01111222222 36789999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.21 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=202.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhH-HHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCA-KVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|...++||+|.||.||+|++..+++ .||||.++..+. +.. ...+++. ..++.+ +|+||+.+.++|...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~------~VAIKKIkl~~~kdGi~~talREI-K~Lqel-~h~nIi~LiD~F~~~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGK------RVAIKKIKLGNAKDGINRTALREI-KLLQEL-KHPNIIELIDVFPHK 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCc------EEEEEEeeccccccCccHHHHHHH-HHHHHc-cCcchhhhhhhccCC
Confidence 478889999999999999999998774 899999975422 111 2223332 344444 699999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+.+.||+||++-+|...+.. +...++..++..|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.
T Consensus 74 ~~l~lVfEfm~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 74 SNLSLVFEFMPTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred CceEEEEEeccccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 99999999999998877764 35689999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-----
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC----- 275 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~----- 275 (632)
...... ...+-|.+|.|||.+.+. ..|+..+|+||.||++.||+.|.+-|.|.+.-+....|...-..|.
T Consensus 153 ~p~~~~---~~~V~TRWYRAPELLfGs--r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 153 SPNRIQ---THQVVTRWYRAPELLFGS--RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred CCCccc---ccceeeeeccChHHhccc--hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 543222 222569999999999876 3688999999999999999999999999886654444442111110
Q ss_pred -------------CC--------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 -------------IP--------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 -------------~p--------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+| +..+.++.+|+.++|.+||.+|.++.|.++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11 235668899999999999999999999876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.85 Aligned_cols=267 Identities=22% Similarity=0.378 Sum_probs=211.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|..++|.+.+.||+|+||+||++.+..... ......+|+|.+..........+.++ ..++.++ .|++|+.+++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHRE-AELLTNL-QHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCC-CCcceEEEEEecCCcCHHHHHHHHHH-HHHHHhC-CCCCcceEEEEEec
Confidence 567899999999999999999998644211 12234699999876544434444443 3455555 68999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR-----------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ 187 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~-----------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~ 187 (632)
++.++++|||++ |+|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|||+++++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999998 67777776432 135899999999999999999999999999999999999999999
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~ 266 (632)
++|+|||+++....... ........++..|+|||++.+. .++.++|+|||||++|||++ |..||...+..+....
T Consensus 159 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred EEeccCCccccccCCce-eecCCCCCccccccCHHHhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999875432211 0111223457789999998643 57889999999999999998 9999998887776666
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 267 i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+.. ...+..+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 235 i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 653 33344567789999999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=325.98 Aligned_cols=273 Identities=21% Similarity=0.323 Sum_probs=214.3
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCc-ccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDF-DEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~-~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...+...+|++.+.||+|+||.||+|.+...+++. .....||+|.+..............+..++.++.+|+||+.+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 44456678999999999999999999876433211 12347999988754333222223333456667768999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
.+..++.++++|||+. |+|.+++.+.. ...+++.+++.++.|++.||+|||+++|+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999998 58888876532 23578899999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~ 259 (632)
|++.++.+||+|||+++........ .......++..|||||++.. ..++.++|+|||||++|||++ |..||.+.+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc---CCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999998765322111 11112234568999999864 357889999999999999998 899999888
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+....+. ....+..+..++.++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 777766654 334455677889999999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.59 Aligned_cols=267 Identities=22% Similarity=0.385 Sum_probs=211.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|...+|.+.+.||+|+||.||+|.+..... ......+++|.+..........+.++ ...+..+ +|+||+.+++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSP-TKDKMLVAVKALKDPTLAARKDFQRE-AELLTNL-QHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCC-CCcceeeEEEecCCccHHHHHHHHHH-HHHHhcC-CCCCcceEEEEEcc
Confidence 456789999999999999999998654321 12335799999865444333444443 3445554 68999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~ 184 (632)
++..++||||++ |+|.+++.... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999997 67877776432 245899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHH
Q 006772 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263 (632)
Q Consensus 185 ~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei 263 (632)
++.++|+|||+++....... ........++..|+|||++.+. .++.++|+|||||++|||++ |..||...+..+.
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred CCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999875433211 1111233567899999998743 57889999999999999999 9999988887766
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
...+. ....+..+..+|.++.+++.+||+.||++||++.++++.|+.+..
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 65543 334444567789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.70 Aligned_cols=256 Identities=23% Similarity=0.419 Sum_probs=204.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|..++|++.++||+|+||.||+|.+..+. .||+|++...... ...+.+ +..++..+ +|+||+.+++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~valK~~~~~~~~-~~~~~~-E~~~l~~l-~~~~i~~~~~~~~- 71 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTMS-PEAFLQ-EAQVMKKL-RHEKLVQLYAVVS- 71 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-------eEEEEecccCccC-HHHHHH-HHHHHHhC-CCCCcceEEEEEC-
Confidence 56788999999999999999999875432 6999998753321 223333 33455554 6899999988764
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..+++|||+. |+|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||+++++.++|+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 456899999998 5888888765555789999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||++. .+.++.++|+|||||++|||++ |..||.+....++...+.. ......+
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 225 (262)
T cd05071 152 IEDNEYT--ARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCP 225 (262)
T ss_pred ccccccc--cccCCcccceecCHhHhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCc
Confidence 5332111 111234677899999886 3468899999999999999999 8999988877776665543 2334446
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..++..+.+++.+||+.||++||++.++++.|+..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 77899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.86 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=201.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
..|++.+.||+|+||.||+|.+..++ +.||+|.+...... ...+ ..+..++..+.+|+|++.+.+.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~~aik~~~~~~~~-~~~~-~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTGDE-EEEI-KQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCC------cEEEEEEEEcCCcc-HHHH-HHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 56889999999999999999987655 48999998654322 2233 33334556666899999999988753
Q ss_pred ----CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 121 ----GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 121 ----~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
...|++|||+. |+|.+++.......+++..+..++.|++.||+|||+++|+||||||+||++++++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 46899999998 5888877665556789999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+...... ........|+..|+|||++.... ...++.++|+|||||++|||++|..||...........+......
T Consensus 158 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 158 SAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred ceecccc---cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 8764321 11223457899999999986321 335788999999999999999999999876655444433322222
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+..++.++.+|+.+||..||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 3334568899999999999999999999999886
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.30 Aligned_cols=254 Identities=21% Similarity=0.396 Sum_probs=209.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||.|+||.||+|.+.. + ..+|+|.+..........+..+ ..++..+ +|+|++.+++++...+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~------~~~~~k~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-R------VRVAIKILKSDDLLKQQDFQKE-VQALKRL-RHKHLISLFAVCSVGE 75 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-C------CcEEEEeccccchhhHHHHHHH-HHHHhcC-CCcchhheeeeEecCC
Confidence 4679999999999999999999876 2 3799999876544333333333 3444444 6899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..+++|||++ |+|.+++....+..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999998 588888876556678999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
..... .....++..|+|||++.. ..++.++|+||||+++|+|++ |..||.+.+..+.+..+. ....+..+..
T Consensus 156 ~~~~~---~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (261)
T cd05148 156 EDVYL---SSDKKIPYKWTAPEAASH---GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAK 228 (261)
T ss_pred Ccccc---ccCCCCceEecCHHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCC
Confidence 22111 112345778999999863 367889999999999999998 899999888777776665 3345556788
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+++++.++|.+||+.||.+||++.++++.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 99999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.08 Aligned_cols=247 Identities=20% Similarity=0.221 Sum_probs=191.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||.+..... .....+.++ ..++. ..+|+||+.+++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E-~~~l~-~l~h~niv~~~~~~~~ 87 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYRE-LVLMK-CVNHKNIISLLNVFTP 87 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCC------ceEEEEEeCCcccChHHHHHHHHH-HHHHH-HhCCCchhceeeeeec
Confidence 478999999999999999999987654 4899999865322 222233332 23333 3479999999998764
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. ...|+||||+++++.+.+.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeC
Confidence 3 35799999999988877642 5889999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE- 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~- 272 (632)
|+++..... .......||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+.+..+.....
T Consensus 164 g~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 164 GLARTAGTS----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred cccccCCCc----cccCCccccCCccCHHHHcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 998754321 112335789999999998743 578899999999999999999999998765443332221100
Q ss_pred -------------------CC--------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 -------------------KP--------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 -------------------~p--------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ ..+...+.++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00 011223567899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=344.64 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=209.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHH--HHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF--EELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~--~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
-|.-++.||.|+||.||.|++..+.+ .||||.+.-......+...... ...+.+ ..|||++.+.+++..+.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~e------vVAIKKMsySGKQs~EKWqDIlKEVrFL~~-l~HPntieYkgCyLre~ 99 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDILKEVRFLRQ-LRHPNTIEYKGCYLREH 99 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccc------eeeeeeccccccccHHHHHHHHHHHHHHHh-ccCCCcccccceeeccc
Confidence 46667899999999999999998775 8999998654333333322222 122333 47999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..|||||||-||-.|++.-+ .+++.+.++..|+.+.+.||+|||+++.||||||..||||++.|.+||+|||.|....
T Consensus 100 TaWLVMEYClGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 100 TAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA- 177 (948)
T ss_pred hHHHHHHHHhccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence 99999999999988887655 3689999999999999999999999999999999999999999999999999886542
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC-CCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP-SGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p-~~l 280 (632)
...+++|||+|||||++.....|.|+-++||||||+++.|+...++|++.++....+..|. .+..|.++ ..+
T Consensus 178 ------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-QNesPtLqs~eW 250 (948)
T KOG0577|consen 178 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSNEW 250 (948)
T ss_pred ------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-hcCCCCCCCchh
Confidence 2356899999999999987778899999999999999999999999999988776665554 45666655 578
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+.+|+..||++-|.+|||.+++++
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 999999999999999999999998875
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.46 Aligned_cols=267 Identities=25% Similarity=0.420 Sum_probs=217.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++.+... .....+ ..+..++..+ +|+||+.+++++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~-~~e~~~l~~l-~h~~i~~~~~~~~~ 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSG------KYYALKILSKAKIVKLKQVEHV-LNEKRILQSI-RHPFLVNLYGSFQD 72 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCC------CEEEEEEEEHHHhhhhhHHHHH-HHHHHHHHhC-CCCCccceeeEEEc
Confidence 47999999999999999999987654 4899999865321 111222 2333445555 59999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+|+||||+. |+|.+++... +.+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 999999999995 6888877553 5799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
.... .....|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+. ...+.+|.
T Consensus 151 ~~~~------~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~ 219 (290)
T cd05580 151 VKGR------TYTLCGTPEYLAPEIILSK---GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPS 219 (290)
T ss_pred cCCC------CCCCCCCccccChhhhcCC---CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCc
Confidence 5322 2345689999999998643 57889999999999999999999998888766666554 44566788
Q ss_pred CCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
.++..+.+++.+||+.||.+|+ +++|++. ++++...+|..+....+..++.+
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~ 276 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN------HPWFAGIDWIALLQRKIEAPFIP 276 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc------CcccccCCHHHHhhccCCCCccC
Confidence 8999999999999999999999 6666654 67888888888776666555443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.20 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=195.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEE--C
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVI--N 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--~ 120 (632)
.|++.+.||+|+||.||++....... ...+.||+|++...... ....+.+ +..++..+ +|+||+.+.+++.. +
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPAND--GTGEMVAVKTLKRECGQQNTSGWKK-EINILKTL-YHENIVKYKGCCSEQGG 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccC--CCCceEEEEEeccccChHHHHHHHH-HHHHHHhC-CCCCEeeEEEEEecCCC
Confidence 35999999999999999987543221 23458999998754322 2233333 33455555 79999999988765 3
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
..++++|||+. |+|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||+++++.++|+|||+++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 46899999998 567666643 36999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH--H------------HHH
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE--E------------IYH 265 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~--e------------i~~ 265 (632)
..............++..|+|||.+.. ..++.++|+|||||++|||++|..||...... + ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE---NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc---cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 322111111112245678999999863 36788999999999999999999998653211 0 011
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
........+..+..++.++.+++.+||+.||++||+++++++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111122333456778999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=311.71 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=206.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+|..++|++.++||+|+||.||+|....+ +.||+|.+...... ...+.++ ..++..+ +|+|++.+++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~a~K~~~~~~~~-~~~~~~E-~~~l~~l-~h~~i~~~~~~~- 70 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGH-------TKVAIKSLKQGSMS-PEAFLAE-ANLMKQL-QHPRLVRLYAVV- 70 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCC-------ceEEEEEecCCCCc-HHHHHHH-HHHHHhc-CCcCeeeEEEEE-
Confidence 56778999999999999999999986532 47999998754332 2333333 3445554 689999998876
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..+++|||+. |+|.+++....+..+++.+++.++.|++.||+|||+++++||||||+||++++++.++|+|||++.
T Consensus 71 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 4567899999997 688888876656689999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
........ ......++..|+|||++.. +.++.++|+||||+++|||++ |+.||.+.+..+....+. .......
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 224 (260)
T cd05067 151 LIEDNEYT--AREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPR 224 (260)
T ss_pred ecCCCCcc--cccCCcccccccCHHHhcc---CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCC
Confidence 65322111 1122345778999999863 357889999999999999999 999999887766655543 2334456
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+..++.++.+++.+||+.||++||++++++..|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 77889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=308.29 Aligned_cols=249 Identities=25% Similarity=0.428 Sum_probs=204.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC--chhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL--KEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~--~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|.+.+.||+|+||.||+|.+..++ ..|++|.+... .......+.++. .++..+ +|+|++.+++.+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK------RVYAMKQIDLSKMNRREREEAIDEA-RVLAKL-DSSYIIRYYESFLDKG 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC------cEEEEEEeehhhCCHHHHHHHHHHH-HHHHhc-CCCCeehheeeeccCC
Confidence 5889999999999999999987655 48999998643 222233333333 344444 7999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|++|||++ ++|.+++.......+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++...
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 9999999997 588887776555689999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
... .......|++.|+|||++.+ +.++.++|+|||||++|||++|+.||...+..+....+.. ...+.++..+
T Consensus 153 ~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 225 (256)
T cd08529 153 DNT---NFANTIVGTPYYLSPELCED---KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMY 225 (256)
T ss_pred Ccc---chhhccccCccccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCcccc
Confidence 321 11223468899999999874 3578899999999999999999999998887666555543 3445566788
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.45 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=214.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.+.|++.+.||+|.||.||++.++.++ +.+|+|++.+..... .......+..+++.+..||||+.+++++++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg------~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTG------KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCC------ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 367999999999999999999998875 489999997754322 224556667888888889999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC----CcEEEEecC
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH----DQLVLGDFG 194 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~----g~vkL~DFG 194 (632)
...+++|||++. |.|.+.+... .+++.++..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999 6888988775 39999999999999999999999999999999999999743 479999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+|+.... .......+||+.|+|||++.. .+|+..+|+||+|+++|.|++|.+||.+.+..+.+..+.......
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~---~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG---RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC---CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 9987643 234566799999999999974 478999999999999999999999999999888888777544332
Q ss_pred CCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+ +.++..+.++|.+||..||..|+++.++|+
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 222 567999999999999999999999999886
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.19 Aligned_cols=257 Identities=19% Similarity=0.402 Sum_probs=201.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.+.||+|+||.||+|++..++ +.||||.+.... ......+.++ ..++..+ +|+|++.+++.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~ 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR------KPVALKKVQIFEMMDAKARQDCVKE-IDLLKQL-NHPNVIKYLDSFIE 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC------CEEEEEEeeccccCCHHHHHHHHHH-HHHHHhC-CCcceeeeeeeEEE
Confidence 58999999999999999999987655 489999876422 1222223333 3444444 78999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+..+++|||++ |+|.+++.... ...+++..++.++.|++.||+|||+++++|+||||+|||++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999 57777665432 346899999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhccCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--VEEIYHSVVIKKEKP 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--~~ei~~~i~~~~~~p 274 (632)
....... .......|++.|+|||.+.+. .++.++|+||||+++|||++|..||.... ..+....+......+
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 154 RFFSSKT---TAAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred eeccchh---HHHhcCCCCccccChhhhccC---CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 7653221 111234688999999998643 57889999999999999999999997653 234444333222222
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..+...+..+.++|.+||+.||++||++.++++.|+.++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 223467889999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=329.59 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=193.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++..... .....+.++ ..++.. .+|+||+.+++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E-~~~l~~-l~h~~ii~~~~~~~~ 94 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILE------RNVAIKKLSRPFQNQTHAKRAYRE-LVLMKC-VNHKNIIGLLNVFTP 94 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCC------cEEEEEEeCccccCchhHHHHHHH-HHHHHh-cCCCCccccceeecc
Confidence 578999999999999999999987655 4899999865321 222233332 233443 479999999887754
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. ..+|+||||+++++.+.+.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 95 QKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cccccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 3 45899999999998887743 5889999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++..... .......||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+.+..+......
T Consensus 171 G~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 171 GLARTAGTS----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred CCccccCCC----CcccCCcccCCcCCHHHHhCC---CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999764321 112335689999999999743 6888999999999999999999999987766554444321111
Q ss_pred --------------------CCC--------------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 --------------------PCI--------------------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 --------------------p~~--------------------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.+ ....+.++.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 100 0113467899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.95 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=210.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHH--HHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK--VFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~--~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.+|++.+.||.|+||+|-+|+.+.++ +.||||.+++.+....+ ..++++.++++.+ +||||+.++.+|...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sg------R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENk 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSG------REVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENK 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCC------cEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCC
Confidence 57999999999999999999987665 69999999875433323 3345555666655 799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+.|||||.. |.|+|++.+. +.+++.+++.+++||..|+.|+|.++++|||||.+|||||+++++||+|||++-++
T Consensus 126 dKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999997 7999999764 68999999999999999999999999999999999999999999999999999776
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCC-CcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPI-SFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~-t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
... .-..++||+|-|.+||++.+. +| ...+|.||||++||-+..|..||.|.+...+..+|..+.-+ .+
T Consensus 204 ~~~----kfLqTFCGSPLYASPEIvNG~---PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---EP 273 (668)
T KOG0611|consen 204 ADK----KFLQTFCGSPLYASPEIVNGT---PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---EP 273 (668)
T ss_pred ccc----cHHHHhcCCcccCCccccCCC---CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---CC
Confidence 432 234678999999999999865 34 47899999999999999999999999988887777643322 24
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
.-|.++.-||+.||..||++|.|+.+|...
T Consensus 274 ~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 566788999999999999999999998863
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=313.15 Aligned_cols=253 Identities=19% Similarity=0.340 Sum_probs=203.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.+.||+|+||.||+|.+... ..+|+|.+..... ....+.++. .++..+ +|+||+.+++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~aik~~~~~~~-~~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~ 70 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSM-SEDEFIEEA-KVMMKL-SHEKLVQLYGVCTK 70 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCC-------CcEEEEEcCCCcc-cHHHHHHHH-HHHhcC-CCCCeeeEEEEEcc
Confidence 5678999999999999999999986532 2699998865332 223344433 344444 69999999999998
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..+++|||+. |+|.+++... ...+++..++.++.|++.||+|||+++++|+||||+|||++.++.+||+|||+++.
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 889999999998 5677776543 34789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||++.+ +.++.++|+|||||++|||++ |..||...+..+....+.. ...+..+
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 223 (256)
T cd05113 150 VLDDEYT--SSVGSKFPVRWSPPEVLLY---SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRP 223 (256)
T ss_pred cCCCcee--ecCCCccChhhCCHHHHhc---CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCC
Confidence 5332111 1112235678999999863 357889999999999999998 9999988777666666543 3444456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
...+..+.+++.+||+.||.+||++.+|++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 77899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=315.16 Aligned_cols=260 Identities=25% Similarity=0.458 Sum_probs=212.1
Q ss_pred CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 35 QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 35 ~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
......++++++++..||.|+.|.||+++++.++ +..|||.+.+... +..++++... .++.+...+|.|++.
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~------~iiAVK~M~rt~Nkee~kRILmDl-dvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTG------HIIAVKQMRRTGNKEENKRILMDL-DVVLKSHDCPYIVQC 156 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccc------eEEEEEeecccCCHHHHHHHHHhh-hHHhhccCCCeeeee
Confidence 3344567888999999999999999999998876 4899999976543 3333333333 344556679999999
Q ss_pred eEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
+|+|..+..++|.||.|.--.. .+.....+++++.-+=++...++.||.||-. ++|+|||+||+|||+|+.|++||||
T Consensus 157 ~GyFi~n~dV~IcMelMs~C~e-kLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCD 235 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELMSTCAE-KLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCD 235 (391)
T ss_pred eeEEeeCchHHHHHHHHHHHHH-HHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeec
Confidence 9999999999999999974333 3433445689998888999999999999997 5899999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKK 271 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~ 271 (632)
||++-++... ...+...|.+.|||||.+..+....|+.++||||||++|+|+.||+.||.+.+.+ +.+..+. ..
T Consensus 236 FGIsGrlvdS----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ 310 (391)
T KOG0983|consen 236 FGISGRLVDS----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NE 310 (391)
T ss_pred ccccceeecc----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hc
Confidence 9998765432 2223346899999999999876778999999999999999999999999997654 4454554 46
Q ss_pred cCCCCCC--CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPS--GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~--~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++|.+|. ..++++.+++..||.+|+.+||.+.++++
T Consensus 311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 6677774 47999999999999999999999999886
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.39 Aligned_cols=282 Identities=23% Similarity=0.271 Sum_probs=240.5
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
...+..++++.+..||-|+||.|-++..+... ..+|+|++++.. ....++....+..++..+. .+.|++++
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~------~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLY 486 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQK------ATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLY 486 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccc------hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHH
Confidence 34556789999999999999999999876543 258999987632 2333444444556666664 89999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
-.|.++.++|+.||-|- |.+...+. .++.|+..++++|+..+++|++|||++|||+|||||+|+|||.+|.+||.||
T Consensus 487 rTfrd~kyvYmLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 487 RTFRDSKYVYMLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred HHhccchhhhhhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence 99999999999999997 56666654 3479999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+|+.+... ..+.++||||.|.|||++... ..+.++|.||||+++||+|+|.+||.+.++..+|..|..+-..
T Consensus 565 GFAKki~~g----~KTwTFcGTpEYVAPEIILnK---GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~ 637 (732)
T KOG0614|consen 565 GFAKKIGSG----RKTWTFCGTPEYVAPEIILNK---GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK 637 (732)
T ss_pred hhHHHhccC----CceeeecCCcccccchhhhcc---CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh
Confidence 999986432 344678999999999999854 6788999999999999999999999999999999999988888
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCCC
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYT 340 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 340 (632)
..+|..++....+||+++...+|.+|.. +.+|.+ |.+|.+.+|+.+.++.+.+|+.++..+
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk------H~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK------HRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh------hhhhhcCChhhhhhccCCCCccccCCC
Confidence 8999999999999999999999999986 455554 678999999999999999998776544
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.67 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=198.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|++..........+. .+..++.. ..|+||+.+++.+..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~------~~~aik~~~~~~~~~~~~~~-~e~~~l~~-~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTG------ELAAVKIIKLEPGDDFSLIQ-QEIFMVKE-CKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCC------eEEEEEEEecCccchHHHHH-HHHHHHHh-cCCCCeeeeeEEEEeCC
Confidence 468999999999999999999987654 48999998654333222222 23334444 47899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+||||++ |+|.+.+.. .+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999998 467776643 3578999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC---CC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC---IP 277 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~---~p 277 (632)
... .......|+..|+|||.+.......++.++|+|||||++|||++|..||...++.+....+......+. .+
T Consensus 158 ~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 158 ATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred ccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 211 112234688999999998644345678899999999999999999999976654433222211111111 12
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
..++..+.++|++||..||++||+++++++.
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 3578999999999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=312.00 Aligned_cols=251 Identities=17% Similarity=0.317 Sum_probs=196.0
Q ss_pred EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEec
Q 006772 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKF 129 (632)
Q Consensus 50 ~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy 129 (632)
.||+|+||.||+|.++... ....||+|++.............++..++.++ +|+||+.+.+++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEe
Confidence 4899999999999876432 12469999987654333333333334455555 7899999999875 4578999999
Q ss_pred CC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCc
Q 006772 130 YE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD 208 (632)
Q Consensus 130 ~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~ 208 (632)
++ |+|.+++.. ....+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++...........
T Consensus 76 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 98 566666643 3457999999999999999999999999999999999999999999999999998754322111111
Q ss_pred cccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 006772 209 MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENV 287 (632)
Q Consensus 209 ~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~L 287 (632)
.....++..|+|||++.. ..++.++|+|||||++|||++ |..||.+....+....+. ...++..|..+++++.++
T Consensus 155 ~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 230 (257)
T cd05115 155 RSAGKWPLKWYAPECINF---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYAL 230 (257)
T ss_pred cCCCCCCcccCCHHHHcc---CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHH
Confidence 111233578999999863 357889999999999999996 999999887776655443 445666788899999999
Q ss_pred HHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 288 IIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 288 I~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
|.+||..||++||++.+|.+.|+.
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHHHhh
Confidence 999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.94 Aligned_cols=263 Identities=24% Similarity=0.414 Sum_probs=208.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.++||+|+||.||+|....... ......+|+|.+..........+.++. .++..+ .|+||+.+++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQREA-ELLTVL-QHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCC-CCCceEEEEEecCcCCHHHHHHHHHHH-HHHhcC-CCCCCceEEEEEec
Confidence 567899999999999999999998643211 123357999998765544444444433 445555 78999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRG-------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~-------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~ 185 (632)
++..+++|||++ |+|.+++..... ..+++..++.++.||+.||+|||+++++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999998 678877765321 358899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHH
Q 006772 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIY 264 (632)
Q Consensus 186 g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~ 264 (632)
+.+||+|||+++........ .......+++.|+|||++.+ ..++.++|+|||||++|||++ |..||......+..
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY---RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 99999999998765322110 11122345788999999864 358899999999999999998 99999887766665
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 265 ~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
..+. ....+..+..+|+.+.+++.+||+.||.+||++.+|++.|+
T Consensus 235 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 5554 33445567789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.59 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=195.6
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||+|.+..++ +.||+|.+...... ....+.+ +..++..+ .|+||+.+++++..++..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 72 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN------TPVAVKSCRETLPPDLKAKFLQ-EARILKQY-SHPNIVRLIGVCTQKQPIYIVM 72 (252)
T ss_pred CccCcccCccEEEEEEecCC------ceEEEEecCccCCHHHHHHHHH-HHHHHHhC-CCCCcceEEEEEcCCCCeEEEE
Confidence 46999999999999987655 48999987654322 2233333 33455554 7999999999999999999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||+. ++|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus 73 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 150 (252)
T cd05084 73 ELVQGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-A 150 (252)
T ss_pred eeccCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-c
Confidence 9998 467766643 345689999999999999999999999999999999999999999999999999875422111 1
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......++..|+|||.+.+ +.++.++|+|||||++|||++ |..||...+.......+. .......+..++..+.
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 226 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNY---GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVY 226 (252)
T ss_pred ccCCCCCCceeecCchhhcC---CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHH
Confidence 11111123467999999863 457889999999999999998 999998777665554443 3345566788899999
Q ss_pred HHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 286 NVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
+++.+||+.||++||++.++++.|+
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 9999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.71 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=195.1
Q ss_pred EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 50 ~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
.||+|+||.||+|.++... ....+|+|++...... ..+.+.++ ..++.. ..|+||+.+++++. ++..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e-~~~l~~-l~h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK----SEKTVAVKILKNDNNDPALKDELLRE-ANVMQQ-LDNPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCC----CceEEEEEEccCCCCcHHHHHHHHHH-HHHHHh-CCCCCcceEEEEEc-CCCcEEEE
Confidence 6899999999999764322 2358999998654322 22233333 234444 47999999998875 45678999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||++ |+|.+++.. ...+++..++.++.|++.||+|||+++|+||||||.|||++.++.+||+|||+++.........
T Consensus 75 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 75 ELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9998 567777754 3478999999999999999999999999999999999999999999999999987653321111
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......++..|+|||.+.. +.++.++|+|||||++|||++ |..||...+..++...+. ....+..|..+++++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~ 228 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNY---YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMY 228 (257)
T ss_pred eecCCCCCCccccCHhHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 11122234679999999863 467889999999999999998 999999887776666554 3455667888999999
Q ss_pred HHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 286 NVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
++|.+||+.||++||++.+|.+.|+.
T Consensus 229 ~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 229 DLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHhccCchhCcCHHHHHHHHhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=315.45 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=204.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+..++|++.+.||+|+||.||+|.+..++.. ....+++|.+...... ...++..+. ..+. ...|+||+.+++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~-~~l~-~l~h~~iv~~~~~~ 78 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDHM-LAMG-SLDHAYIVRLLGIC 78 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHHH-HHHh-cCCCCCcceEEEEE
Confidence 34567899999999999999999998655431 1125788887533221 112222221 2223 34789999999986
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
. +...+++|||+. |+|.+++... .+.+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++
T Consensus 79 ~-~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 79 P-GASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred C-CCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 5 456788999998 7888887653 357899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... ........++..|+|||++.. +.++.++|+|||||++|||++ |..||.+....++... ......+.
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~ 231 (279)
T cd05111 157 DLLYPDDK-KYFYSEHKTPIKWMALESILF---GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGERLA 231 (279)
T ss_pred eeccCCCc-ccccCCCCCcccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCC
Confidence 86533211 111223456789999999863 468899999999999999998 9999998876655443 34445555
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+..++.++.+++.+||..||++||++.|+++.|..+.
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 66778999999999999999999999999999887755
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.49 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=196.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ +.||||.+..... .....+.++ ..++..+ +|+||+.+++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E-~~~l~~l-~h~niv~~~~~~~~~~ 72 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDG------KRVALKKMPNVFQNLVSCKRVFRE-LKMLCFF-KHDNVLSALDILQPPH 72 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCC------CEEEEEeccccccchHHHHHHHHH-HHHHHhC-CCCCcCCHhheecCCC
Confidence 5889999999999999999986554 4899999865321 222333333 3444444 7999999999988766
Q ss_pred -----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 122 -----KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 122 -----~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+|+||||+.++|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~~lv~e~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 73 IDPFEEIYVVTELMQSDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred ccccceEEEEeeccccCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccce
Confidence 7999999999988887754 357999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh------
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK------ 270 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~------ 270 (632)
+...... ........+|+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+....+...
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 151 RVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred eecccCc--cccCCCCCcCCCcCCHHHHcCC--CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 7643221 1122334679999999998753 24788999999999999999999999987765544433211
Q ss_pred -----------------ccCC-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 -----------------KEKP-------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 -----------------~~~p-------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+ ......++++.+||.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0011 122456889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=316.64 Aligned_cols=265 Identities=22% Similarity=0.356 Sum_probs=205.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCC----------cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCce
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADD----------FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~----------~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I 110 (632)
..++|++.+.||+|+||.||+|.+...+.. ......||+|.+..............+..++..+ +|+|+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCE
Confidence 457899999999999999999988654421 1123579999987654332233333334455555 68999
Q ss_pred eEeeEEEEECCEEEEEEecCC-CCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 111 CWLHGISVINGKICIAMKFYE-GSVGDRIAQQR---------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 111 ~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~---------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
+.+++++..++..+++|||+. ++|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999998 57777775542 12689999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh--CCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT--GIQPWFGK 258 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt--G~~PF~~~ 258 (632)
|++.++.++|+|||+++........ .......+++.|||||++.. +.++.++|+|||||++|||++ +..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL---GKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc---CCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999998765332211 11223456789999999864 368899999999999999998 78899887
Q ss_pred CHHHHHHHHHhh------ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 259 SVEEIYHSVVIK------KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 259 ~~~ei~~~i~~~------~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
+..++...+... ......+..+|.++.+++.+||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 766655544322 1112334567899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=320.03 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=199.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.++||+|+||.||+|.+..++ ..||+|.+.............++..++..+ +|+||+.+++++..++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTD------NLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCC------cEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCC
Confidence 478999999999999999999987655 489999986543222222222333444444 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..|+||||+.++|.+.+... ...+++..+..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||++.....
T Consensus 78 ~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 78 SLTLVFEYLDKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred eEEEEEeccccCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99999999999988887653 35789999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc---------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE--------- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~--------- 272 (632)
. ........+++.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+....+.....
T Consensus 157 ~---~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 157 P---TKTYSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred C---CCcccccceeecccCcHHHhCC--CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 1 1122234578999999998643 3477899999999999999999999998776554433321100
Q ss_pred --------CCCC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 --------KPCI-----------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 --------~p~~-----------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+ ...+++++.+||.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0011 1357889999999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=340.71 Aligned_cols=274 Identities=23% Similarity=0.390 Sum_probs=225.3
Q ss_pred cccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC-chhhHHHHHHHHHHHhhhccCC
Q 006772 29 VVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL-KEDCAKVFVNKFEELFPKFRES 107 (632)
Q Consensus 29 ~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~-~~~~~~~~~~~~~~il~~l~~h 107 (632)
-.+.|.-....|.++.+.+.++||+|.||+||.|.+..-.+ +..-.||||..+.. ..+..+.|+.+. .+++. -+|
T Consensus 375 ty~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~k--ge~iaVAvKtCK~d~t~d~tekflqEa-~iMrn-fdH 450 (974)
T KOG4257|consen 375 TYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEK--GERIAVAVKTCKTDCTPDDTEKFLQEA-SIMRN-FDH 450 (974)
T ss_pred cccCCCCCcceeehhhccHHHhhcCCcccceeeeEeccccc--CcceeeeeehhccCCChhhHHHHHHHH-HHHHh-CCC
Confidence 46777777888999999999999999999999999876432 33357999998763 334445555543 44444 489
Q ss_pred CceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 108 QSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 108 ~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
|||+++.|++.. ...+||||+++ |.|..++..++ ..++......|+.||+.||.|||++++|||||..+|||+....
T Consensus 451 phIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~ 528 (974)
T KOG4257|consen 451 PHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ 528 (974)
T ss_pred cchhheeeeeec-cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc
Confidence 999999999865 58999999999 89998887654 5899999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYH 265 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~ 265 (632)
.+||+|||+++.+....+.... ...-.+.|||||.+. ..++|.+||||-||+++||++. |..||.+....+...
T Consensus 529 CVKLaDFGLSR~~ed~~yYkaS--~~kLPIKWmaPESIN---fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 529 CVKLADFGLSRYLEDDAYYKAS--RGKLPIKWMAPESIN---FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred eeeecccchhhhccccchhhcc--ccccceeecCccccc---hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 9999999999987544322211 112267899999986 5579999999999999999988 999999987666544
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+ ..+.+++.|+.||+.+..|+.+||++||.+||.+.+|...|..+..
T Consensus 604 ~i-EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HI-ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred Ee-cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 44 4577888899999999999999999999999999999987766543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=339.28 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=187.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhh-----ccCCCceeEeeE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-----FRESQSVCWLHG 115 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~-----l~~h~~I~~l~~ 115 (632)
..++|++.+.||+|+||+||+|.+..++ +.||||+++..... ...... +..++.. ..++.+++.+..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~------~~vAvK~i~~~~~~-~~~~~~-e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRK------EYCAVKIVRNVPKY-TRDAKI-EIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCC------eEEEEEEEecchhh-HHHHHH-HHHHHHHHhhcCcccCcceeeeEE
Confidence 3478999999999999999999987655 48999999643221 111111 1122222 234566888888
Q ss_pred EEEEC-CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCC-------
Q 006772 116 ISVIN-GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHD------- 186 (632)
Q Consensus 116 ~~~~~-~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g------- 186 (632)
++..+ +.+|||||++.++|.+++... +.+++..++.++.||+.||+|||+ .+||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 199 YFQNETGHMCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEEcCCceEEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 77654 679999999999999988653 579999999999999999999998 5999999999999998766
Q ss_pred ---------cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC
Q 006772 187 ---------QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257 (632)
Q Consensus 187 ---------~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~ 257 (632)
.+||+|||++.... ......+||+.|||||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~---~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLGL---GWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccCCCCceEEECCCCccccCc------cccccccCCccccCcHHhhcC---CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999875321 122346799999999999743 688999999999999999999999998
Q ss_pred CCHHHHHHHHHhhccC-------------------------CCCC---------------CCCCHHHHHHHHHhhhcCcC
Q 006772 258 KSVEEIYHSVVIKKEK-------------------------PCIP---------------SGLPPAVENVIIGCFEYDLR 297 (632)
Q Consensus 258 ~~~~ei~~~i~~~~~~-------------------------p~~p---------------~~lp~~l~~LI~~cL~~DP~ 297 (632)
.+..+....+...... +... ...++.+.+||.+||.+||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 7765443332211000 0000 01135678999999999999
Q ss_pred CCCCHHHHHH
Q 006772 298 NRPLMADILH 307 (632)
Q Consensus 298 ~RPs~~ell~ 307 (632)
+||+++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=311.62 Aligned_cols=255 Identities=24% Similarity=0.443 Sum_probs=204.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.++||+|+||.||+|.+... ..||+|.+.+.... ...+.+ +..++.++ +|++++.+++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-------~~~~~k~~~~~~~~-~~~~~~-E~~~l~~l-~~~~i~~~~~~~~- 71 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGN-------TKVAVKTLKPGTMS-PESFLE-EAQIMKKL-RHDKLVQLYAVVS- 71 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCC-------ceeEEEEecCCCCC-HHHHHH-HHHHHHhc-CCCceEEEEeEEC-
Confidence 6778999999999999999999986533 36999998754332 233333 33455555 6899999988764
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.+..+++|||+. |+|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||+++++.++|+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeee
Confidence 566899999998 5888887655456789999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .......++..|+|||++.. ..++.++|+||||+++|||++ |..||.+.+..+....+. ....+..+
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 225 (260)
T cd05070 152 IEDNEY--TARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCP 225 (260)
T ss_pred ccCccc--ccccCCCCCccccChHHHhc---CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 533211 11112235678999999863 468889999999999999999 999999887777666554 33455567
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
...+.++.+++.+||..||.+||++.++.+.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 7889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=310.96 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=201.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
|++.+.||+|+||.||+|.+.... .....||||.++.... .....+.++. ..+.. .+|+|++.+++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~-l~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD---GSQLKVAVKTMKLDIHTYSEIEEFLSEA-ACMKD-FDHPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC---CCcceEEEEEeccCcCCHHHHHHHHHHH-HHHHh-CCCCCeeeEEeeeccCCc
Confidence 578899999999999999876533 1235799999875322 2223333333 34444 478999999988765443
Q ss_pred ------EEEEEecCC-CCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 123 ------ICIAMKFYE-GSVGDRIAQQR----GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 123 ------l~LVmEy~~-GsL~d~l~~~~----~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
.+++|||++ |+|.+.+.... ...+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEEC
Confidence 799999998 57777664432 2468999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+++........ .......++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+. .
T Consensus 156 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~ 230 (273)
T cd05035 156 DFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-H 230 (273)
T ss_pred Cccceeeccccccc-cccccccCCccccCHhhccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999865332211 11112234678999999863 367889999999999999999 999998888777766554 3
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
...+..|..++.++.+++.+||+.||.+||++.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 445567788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=313.88 Aligned_cols=267 Identities=18% Similarity=0.246 Sum_probs=209.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|+.++|++.+.||+|+||.||+|.+.... ......|++|.+..............+..++..+ .|+|++.+++++.
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~--~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~ 78 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCI 78 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCC--CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence 367789999999999999999999987633 1223589999987543332233233333445555 8999999999876
Q ss_pred E-CCEEEEEEecCC-CCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 119 I-NGKICIAMKFYE-GSVGDRIAQQRG------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 119 ~-~~~l~LVmEy~~-GsL~d~l~~~~~------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
. +...+++++|+. |+|.+++..... ..+++..++.++.|++.||+|||+++++||||||+|||+++++.+||
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 5 577899999998 688887765422 46899999999999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~ 269 (632)
+|||+++.+...... .......++..|+|||++.+. .++.++|+|||||++||+++ |+.||...+..++...+.
T Consensus 159 ~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~- 233 (280)
T cd05043 159 TDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVNK---EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK- 233 (280)
T ss_pred CCCCCcccccCCceE-EeCCCCCcchhccCHHHHhcC---CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-
Confidence 999999765332111 011123457789999998643 57899999999999999999 999999887776655444
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
....+..+..+|+++.+++.+||..||++||++.++++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 23344456678999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.49 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=195.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
++|.-...||+|+||.||+|..... ..||||.+.........+|.++. .++.++. |+|++.|.|+|.+.+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-------~~vAVK~~~~~~~~~~~eF~~Ei-~~ls~l~-H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-------TVVAVKRLSSNSGQGEREFLNEV-EILSRLR-HPNLVKLLGYCLEGGE 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-------CEEEEEEecCCCCcchhHHHHHH-HHHhcCC-CcCcccEEEEEecCCc
Confidence 5677778999999999999987543 47999988765433134455554 5556665 999999999999988
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG---LLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~---IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..+||+|||. |+|.+.+.......++|..+++|+.++|.||+|||... ||||||||+|||||++..+||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5999999998 89999887643338899999999999999999999854 9999999999999999999999999997
Q ss_pred eccCCCCCCCccccc-cCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhh
Q 006772 198 LLLGRSLSDSDMALR-LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---VEEIYH---SVVIK 270 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~-~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~---~~ei~~---~i~~~ 270 (632)
..... ....... .||.+|+|||++. .+..+.++||||||++|.|++||+.|..... ...+.. .....
T Consensus 226 ~~~~~---~~~~~~~~~gt~gY~~PEy~~---~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 226 LGPEG---DTSVSTTVMGTFGYLAPEYAS---TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCCcc---ccceeeecCCCCccCChhhhc---cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 54321 1111222 7999999999996 4679999999999999999999998877432 111111 11111
Q ss_pred -----ccCCCCC-CCCC-----HHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 271 -----KEKPCIP-SGLP-----PAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 271 -----~~~p~~p-~~lp-----~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
-..+.+. ...+ ..+..+..+|++.+|.+||+|.++++.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1112222 2222 23667889999999999999999998885443
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.13 Aligned_cols=255 Identities=24% Similarity=0.435 Sum_probs=203.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.+.||+|+||.||+|.+..+. .+|+|.+..... ....+.+ +..++..+ .|++++.+++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~lK~~~~~~~-~~~~~~~-E~~~l~~l-~h~~i~~~~~~~~- 71 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-------KVAIKTLKPGTM-MPEAFLQ-EAQIMKKL-RHDKLVPLYAVVS- 71 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-------eEEEEEcccCCc-cHHHHHH-HHHHHHhC-CCCCeeeEEEEEc-
Confidence 66788999999999999999999875432 699998865332 1223333 33444554 6899999988764
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.+..+++|||+. |+|.+++.......+++..+..++.|++.||+|||+++++||||||+|||+++++.++|+|||+++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 566899999998 5888888765555689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||.+.+ ..++.++|+||||+++|||++ |..||.+....+....+.. ...+..+
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 225 (260)
T cd05069 152 IEDNEYT--ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCP 225 (260)
T ss_pred ccCCccc--ccCCCccchhhCCHHHhcc---CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 5332111 1112245678999998863 467889999999999999999 9999998877766655542 3344556
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
...+..+.+++.+||+.||++||+++++++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 7889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=314.70 Aligned_cols=252 Identities=19% Similarity=0.220 Sum_probs=195.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+|++.+.||+|+||.||+|.+..++ ..||||.+...... ........+..++..+ .|+|++.+++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTG------QIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCC------cEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCe
Confidence 5899999999999999999987655 48999998643221 1112222233444444 59999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+|+||||+.|++.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 74 ~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 74 LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 999999999998888865433 6789999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-------- 273 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-------- 273 (632)
. ........+++.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+.......+......
T Consensus 154 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 154 P---VRVYTHEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred C---cccccCCcccccccChHHhcCC--CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 1 1112234578999999988643 24688999999999999999999999877644322221110000
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 -------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 -------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......+++++.++|.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0012357899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=316.08 Aligned_cols=262 Identities=23% Similarity=0.382 Sum_probs=206.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+|++.+.||+|+||.||+|.+..... ......+++|.+...... ....+.++. .++..+ .|+||+.+.+.+..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~-~~l~~l-~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG-RAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQV-NHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC-CCcceeEEEEecCCCCCHHHHHHHHHHH-HHHhhC-CCCCEeeEEEEEecCCC
Confidence 48899999999999999998754332 123357999988654332 223333433 344444 78999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCe
Q 006772 123 ICIAMKFYE-GSVGDRIAQQR----------------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~----------------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~N 179 (632)
.+++|||+. |+|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 999999998 67777765421 1357889999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCC
Q 006772 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258 (632)
Q Consensus 180 ILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~ 258 (632)
||+++++.+||+|||+++........ .......++..|+|||++.+. .++.++|+||||+++|||++ |..||.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~---~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccC---CcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999998754322111 111223457789999998643 57899999999999999998 99999988
Q ss_pred CHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+.++...+. .......+..++.++.+++.+||+.||++||++.++++.|+++.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 234 APERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 8777665543 33445567889999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=323.55 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=198.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--C
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN--G 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~--~ 121 (632)
.|+-.+.+|+|+||.||+|....+. ..||||........ .+.+-+++. ...||||+.+..+|... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~------~~vAIKKv~~d~r~-----knrEl~im~-~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE------EEVAIKKVLQDKRY-----KNRELQIMR-KLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC------ceeEEEEecCCCCc-----CcHHHHHHH-hcCCcCeeeEEEEEEecCCC
Confidence 4888899999999999999988764 38999998765443 333334554 45899999998887643 2
Q ss_pred ---EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC-CcEEEEecCC
Q 006772 122 ---KICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-DQLVLGDFGI 195 (632)
Q Consensus 122 ---~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~-g~vkL~DFGl 195 (632)
.+.+||||++-+|.+.+.+. .+.+++...++.|..||++||.|||+.+|+||||||+|+|+|.+ |.+||||||.
T Consensus 93 d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred chhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 45699999999999988753 34689999999999999999999999999999999999999965 8999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-- 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-- 273 (632)
|+.+... ....+...|..|.|||.+.+. ..|+.+.||||.||++.||+-|++.|.|++..+.+..|+.--..
T Consensus 173 AK~L~~~----epniSYicSRyYRaPELifga--~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 173 AKVLVKG----EPNISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred ceeeccC----CCceeEEEeccccCHHHHcCc--cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 9987543 222345669999999999975 36999999999999999999999999998866544443310000
Q ss_pred ----------------C---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ----------------P---------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ----------------p---------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
| -+...+++++.+|+.++|+++|.+|.++.|++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 023467899999999999999999999988875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.22 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=202.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE-
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV- 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~- 118 (632)
|+.++|++.+.||+|+||.||+|.... ..||+|.+..... .+.+.++ ..++..+ .|++++.+++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~k~~~~~~~--~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~ 70 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDAT--AQAFLAE-ASVMTQL-RHSNLVQLLGVIVE 70 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcC--------CcEEEEEeCCCch--HHHHHHH-HHHHHhC-CCCCeeeEEEEEEc
Confidence 667899999999999999999997642 3699999864322 2333333 3444444 6899999998754
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..+++|||++ |+|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence 4567999999998 588888766544568999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
..... .....++..|+|||++.. ..++.++|+|||||++|||++ |+.||...+..+....+. ....+..
T Consensus 151 ~~~~~------~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 220 (256)
T cd05082 151 EASST------QDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDA 220 (256)
T ss_pred ecccc------CCCCccceeecCHHHHcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCC
Confidence 54221 112234678999999864 357889999999999999998 999998887776665554 3345556
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+..+|+.+.+++.+||+.||++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 78899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=309.34 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=202.4
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||+|.+...+ .....||||.+..... ...+.+.++ ...+.++ +|+||+.+++.+.. ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG---GKVIPVAVKCLKSDKLSDIMDDFLKE-AAIMHSL-DHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCC---CCceEEEEeecCCcccHHHHHHHHHH-HHHHhhc-CCCCccceeEEEcC-CeEEEEE
Confidence 46899999999999986532 1224699999976554 233333333 3444444 68999999998887 8999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||++ |+|.+.+.......+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9997 688888876543578999999999999999999999999999999999999999999999999998764321111
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......++..|+|||++... .++.++|+|||||++|||++ |..||...+..++...+.........+..+|..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~---~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTR---TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ecccCCCCCceecCHHHhccc---CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 111234567899999998643 57889999999999999998 99999888877776666544455556678899999
Q ss_pred HHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 286 NVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
+++.+||+.+|++||++.++++.|.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.28 Aligned_cols=264 Identities=21% Similarity=0.329 Sum_probs=210.0
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+...+|++.+.||+|+||.||+|.+..+++ .....||+|.+....... ...+.+ +...+..+ .|+|++.+++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~i~~~~~~~ 78 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGE--KVKIPVAIKVLREETSPKANKEILD-EAYVMASV-DHPHVVRLLGIC 78 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCC--CcceEEEEEeccCCCCHHHHHHHHH-HHHHHHhC-CCCCcceEEEEE
Confidence 4566899999999999999999999876543 123479999887654322 233333 33444554 789999999988
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.. ...+++|||++ |+|.+.+... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence 76 78999999998 6888777653 346899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+........ .......++..|+|||.+. .+.++.++|+|||||++||+++ |..||.+.+..++...+. ......
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 231 (279)
T cd05057 157 KLLDVDEKE-YHAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLP 231 (279)
T ss_pred ccccCcccc-eecCCCcccccccCHHHhh---cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCC
Confidence 765322111 1111122467899999886 3467889999999999999998 999999988877766554 344455
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.|..++.++.+++.+||..||.+||++.++++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 67788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.99 Aligned_cols=269 Identities=20% Similarity=0.281 Sum_probs=208.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||.+.+..... .......+..++..+ .|++|+.+++.+..+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTG------KLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTE 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCC------cEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecC
Confidence 47999999999999999999987654 489999997643221 122223333444444 589999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..|++|||+.| +|.+++....+..+++..++.++.|++.||+|||+.+++|+||||+|||++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999985 8888776555568999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCC--------------------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCC
Q 006772 200 LGRSLS--------------------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQ 253 (632)
Q Consensus 200 ~~~~~~--------------------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~ 253 (632)
...... ........||..|+|||++.+ ..++.++|+||||+++|+|++|..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG---DGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC---CCCCchHHHHHHHHHHHHHhhCCC
Confidence 221100 001112468899999999874 357889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCC----HHHHHHHHHhhhhcccCCCCcccccc
Q 006772 254 PWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL----MADILHAFESSQNAVYNDGEWTGLGS 327 (632)
Q Consensus 254 PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs----~~ell~~Le~~~~~~~~~~~w~~~~~ 327 (632)
||.+.+..+.+..+............++.++.++|.+||+.||++||+ +.+++. ++++...+|..+..
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~------~~~~~~~~~~~~~~ 302 (316)
T cd05574 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ------HPFFRGVNWALIRH 302 (316)
T ss_pred CCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc------CchhhcCChhhccc
Confidence 999888777666655322222222337999999999999999999999 666665 55666677765443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.73 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=202.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+..+|++.+.||+|+||.||+|.++.. ..+|+|.+.+.... ...+.++. .++..+ +|+||+.+++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~-------~~~~iK~~~~~~~~-~~~~~~e~-~~l~~l-~~~~i~~~~~~~~~ 70 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGK-------IDVAIKMIREGAMS-EDDFIEEA-KVMMKL-SHPNLVQLYGVCTK 70 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCC-------ccEEEEEeccCCCC-HHHHHHHH-HHHHhC-CCCCEEEEEEEEcC
Confidence 5677899999999999999999987532 36999998643221 22333332 344444 68999999999998
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.+..|++|||++ ++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||++++++.+||+|||+++.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 71 QRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred CCceEEEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCccccee
Confidence 999999999997 5777777543 34789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||.+.+ ..++.++|+||||+++|||++ |..||...+..+....+.. ...+..|
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 223 (256)
T cd05059 150 VLDDQYT--SSQGTKFPVKWAPPEVFDY---SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRP 223 (256)
T ss_pred ccccccc--ccCCCCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCC
Confidence 5322111 1111123457999999874 357889999999999999999 8999988877776665542 3345567
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
..+|.++.+++.+||..+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 78999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.96 Aligned_cols=250 Identities=23% Similarity=0.442 Sum_probs=200.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-CC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVI-NG 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-~~ 121 (632)
.|++.+.||.|+||.||++.+..++ +.||+|.+..... .........+..++..+ +|++++.+.+.+.. ++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG------KQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC------cEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCC
Confidence 4899999999999999999987654 4799999864322 11122223333444444 68999998887653 45
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|++|||++ +++.+.+.......+++.+++.++.|++.||+|||+++|+||||||+||+++.++.++|+|||+++...
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 7899999998 578777776555679999999999999999999999999999999999999999999999999988653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
... .......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+.. ...+..+...
T Consensus 154 ~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (257)
T cd08223 154 NQC---DMASTLIGTPYYMSPELFSN---KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDY 226 (257)
T ss_pred ccC---CccccccCCcCccChhHhcC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCcccc
Confidence 321 12233568999999999864 3678899999999999999999999998776665555442 3344566789
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++++.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.53 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=199.5
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
+.||+|+||.||+|.+..++. ...+++|.++.............+..++.++.+|+||+.+++++...+..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC----eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 358999999999999876542 1257899887543222222233444566777789999999999999999999999
Q ss_pred cCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 129 FYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 129 y~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
|++ |+|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|||+++++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 998 68888876532 135789999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~ 272 (632)
|++...... ........+..|+|||++.. ..++.++|+|||||++|||++ |..||.+.+..+....+.. ..
T Consensus 157 gl~~~~~~~----~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~ 228 (270)
T cd05047 157 GLSRGQEVY----VKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 228 (270)
T ss_pred CCccccchh----hhccCCCCccccCChHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CC
Confidence 997532110 01111233567999999863 367889999999999999997 9999988877666655432 33
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
....+..++.++.+++.+||..||.+||++.+++..|+.+.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 44456778999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.30 Aligned_cols=249 Identities=19% Similarity=0.285 Sum_probs=195.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--CE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN--GK 122 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~--~~ 122 (632)
|++.+.||+|+||.||+|.+..++ +.||+|.++.............+...+..+.+|+|++.+++++.++ +.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~------~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 74 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTG------KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR 74 (282)
T ss_pred CceEeeccccccceEEEEEEcCCC------cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence 678999999999999999987655 4899999875422221111122334556666799999999999887 89
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
+++||||++|++.+.+... ...+++.+++.++.|++.||+|||+++++||||||+||+++. +.+||+|||+++.....
T Consensus 75 ~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 75 LALVFELMDMNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9999999999999887653 357899999999999999999999999999999999999999 99999999998765322
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc----------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE---------- 272 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~---------- 272 (632)
. ......++..|+|||++... +.++.++|+|||||++|||++|..||.+.+..+....+.....
T Consensus 153 ~----~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 P----PYTEYISTRWYRAPECLLTD--GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C----CcCCCCCCcccCChhHhhcC--CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 1 11234578999999987532 3467899999999999999999999988776554433321100
Q ss_pred ------CCCC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 ------KPCI-----------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ------~p~~-----------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+ ...++.++.++|.+||++||++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0011 1256789999999999999999999999886
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.83 Aligned_cols=263 Identities=21% Similarity=0.366 Sum_probs=208.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|..++|++.+.||+|+||.||+|+++...+ ....+.|++|.+...... ....+.+ +..++.++ +|+||+.+++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~~ 78 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRR-ELDMFRKL-SHKNVVRLLGLCR 78 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHH-HHHHHHhc-CCcceeeeEEEEC
Confidence 456889999999999999999999875543 233458999998654433 2233333 33455555 7899999999998
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRG-------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~-------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
..+..|+||||++ |+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 8899999999998 688777765431 16899999999999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~ 269 (632)
+|||+++....... .......++..|+|||.+.+ +.++.++|+||||+++|+|++ |..||......+....+..
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~ 233 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE---DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence 99999865432211 11223356788999999863 357789999999999999998 8899988776666665554
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.......+..+|..+.+++.+||+.||.+||++.+++..|.
T Consensus 234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 44344456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.80 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=201.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCC--------cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADD--------FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~--------~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~ 112 (632)
..++|++.++||+|+||.||+|.+...++. ......||+|.+.+.........+.++..++..+ +|+|++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCe
Confidence 457899999999999999999987543210 1122469999987643332222233344455554 6899999
Q ss_pred eeEEEEECCEEEEEEecCC-CCHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEE
Q 006772 113 LHGISVINGKICIAMKFYE-GSVGDRIAQQR----------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLL 181 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~----------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NIL 181 (632)
+++++..++..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999998 57777765421 024688899999999999999999999999999999999
Q ss_pred EecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh--CCCCCCCCC
Q 006772 182 LSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT--GIQPWFGKS 259 (632)
Q Consensus 182 ld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt--G~~PF~~~~ 259 (632)
+++++.+||+|||++........ ........++..|+|||++.. +.++.++|+|||||++|||++ +..||...+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILL---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhcc---CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999875432211 111122345778999999863 468899999999999999998 778998877
Q ss_pred HHHHHHHHHh------hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 260 VEEIYHSVVI------KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 260 ~~ei~~~i~~------~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
..+....+.. .......+..+|+.+.+++.+||+.||++||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6655443321 11122345668899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.39 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=204.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
+.||+|+||.||+|.+.... .....|++|.+..............+...+..+. |++++.+++++..++.++++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEE
Confidence 46999999999999987541 1235899999976544332222333334555554 9999999999999999999999
Q ss_pred cCC-CCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 129 FYE-GSVGDRIAQQR-------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 129 y~~-GsL~d~l~~~~-------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
|++ |+|.+++.... ...+++..++.++.|++.||+|||+++++||||||+||++++++.++|+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 996 68888776542 3679999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.... ........++..|+|||.+... .++.++|+|||||++|||++ |..||...+..+....+.. ......|..
T Consensus 157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd00192 157 DDDY-YRKKTGGKLPIRWMAPESLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEY 231 (262)
T ss_pred cccc-cccccCCCcCccccCHHHhccC---CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 3221 1112334578899999998743 67899999999999999999 6999999888777766653 455667788
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
+|+++.+++.+||+.||.+||++.++++.|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.05 Aligned_cols=268 Identities=23% Similarity=0.413 Sum_probs=229.1
Q ss_pred CCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee
Q 006772 32 TPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 32 ~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
.|+...+.+++.++.+.++||.|.||+||.|.|++-. -.||||.|+... ...++|+.+. .+++. .+|||++
T Consensus 256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkys------lTvAVKtLKEDt-MeveEFLkEA-AvMKe-ikHpNLV 326 (1157)
T KOG4278|consen 256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDT-MEVEEFLKEA-AVMKE-IKHPNLV 326 (1157)
T ss_pred cCCcchhhccchheeeeeccCCCcccceeeeeeeccc------eeeehhhhhhcc-hhHHHHHHHH-HHHHh-hcCccHH
Confidence 4666677789999999999999999999999998644 379999996543 4456666654 44444 4899999
Q ss_pred EeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 112 WLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
+|.++|+.+-..|||+|||. |+|+|++.+-.+..++.--.+.++.||..|++||..+++|||||..+|+|+.++..+|+
T Consensus 327 qLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 327 QLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred HHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEe
Confidence 99999999999999999998 99999998876667777788889999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~ 269 (632)
+||||++++.+..+.-. ....-.+.|.|||-+. +..++.++|||+|||+|||+.| |..||.|.+..+.|..+ .
T Consensus 407 ADFGLsRlMtgDTYTAH--AGAKFPIKWTAPEsLA---yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-E 480 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAH--AGAKFPIKWTAPESLA---YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-E 480 (1157)
T ss_pred eccchhhhhcCCceecc--cCccCcccccCccccc---ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-h
Confidence 99999998866533221 1112267899999986 5578999999999999999999 99999999988887654 4
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
++.+..-|.+||+.+.+||+.||+.+|.+||+++|+...|+.+.+
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 567777899999999999999999999999999999999988754
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.34 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=197.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
...|++.+.||+|+||.||+|.+..... .....||+|.++............++..++..+ .|+|++.+.+++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGD--NTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCC--CccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCC
Confidence 3568999999999999999998653221 234589999987654333222333343455554 789999999988765
Q ss_pred -CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 121 -GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 121 -~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
...++||||++ |+|.+++.+. ...+++..++.++.|++.||+|||+++++||||||+|||++.++.++|+|||+++.
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 57899999998 5666666443 34689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--------------HHHHH
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--------------VEEIY 264 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--------------~~ei~ 264 (632)
...............|+..|+|||.+.+ ..++.++|+|||||++|||+++..|+.... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQ---SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhcc---CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 5332211111223456788999999864 357889999999999999999876643211 00111
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 265 ~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
............+..++.++.+|+.+||+.||.+||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111222233445677899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=305.80 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=197.7
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
++||+|+||.||+|.+...+. ....+|+|.+...... ....+.++ ..++..+ .|+|++.+++++. ....+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLRE-ASVMAQL-DHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHH-HHHHHhc-CCCCeeeEEEEEc-CCceEEEE
Confidence 479999999999998765441 2258999998755432 22333333 3444444 6899999998765 45689999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||++ |+|.+++... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++.........
T Consensus 75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9998 6888887653 378999999999999999999999999999999999999999999999999987653221111
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......++..|+|||.+.. +.++.++|+|||||++|||++ |..||...+..+....+. .......|..++..+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 228 (257)
T cd05060 153 RATTAGRWPLKWYAPECINY---GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIY 228 (257)
T ss_pred ccccCccccccccCHHHhcC---CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHH
Confidence 11111224568999999863 468889999999999999998 999998887766655554 3444556788999999
Q ss_pred HHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 286 NVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
++|.+||..||++||++.++++.|+..
T Consensus 229 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 229 SIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.63 Aligned_cols=254 Identities=20% Similarity=0.359 Sum_probs=199.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE---
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI--- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--- 119 (632)
..|++.+.||.|+||.||+|.+..++ +.||+|.+...... ... ...+..++..+.+|+|++.+++++..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~a~K~~~~~~~~-~~~-~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTEDE-EEE-IKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCC------cEEEEEEEecChHH-HHH-HHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 68999999999999999999987655 48999998653322 222 23334556666789999999998753
Q ss_pred ---CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 120 ---NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 120 ---~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
++.+|++|||+. |+|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 467899999998 5888887765556789999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+...... ........|++.|+|||++.... ...++.++|+|||||++|||++|..||....+.+....+......
T Consensus 168 ~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 168 SAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred hhhhhcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 8654221 11223456899999999986321 235788999999999999999999999876654443333222222
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+..++.++.++|.+||..||.+||++.||++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 2233468999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.96 Aligned_cols=256 Identities=25% Similarity=0.450 Sum_probs=207.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.+.||+|+||.||+|.+..+ +.||||.+...... ...+.++. .+++.+ .|++++.+++++..
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~-------~~~~vK~~~~~~~~-~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~ 72 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGT-------TKVAVKTLKPGTMS-PEAFLQEA-QIMKKL-RHDKLVQLYAVCSE 72 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCC-------ceEEEEEecCCccC-HHHHHHHH-HHHhhC-CCCCEeeeeeeeec
Confidence 6778999999999999999999986532 36999998754322 23343333 344444 68999999999988
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..+++|||++ ++|.+.+.......+++..++.++.|++.||.|||+++++|+||||+||++++++.++|+|||++..
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence 899999999998 5788888665556799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |+.||.+.+.......+.. ......+
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 226 (261)
T cd05034 153 IEDDEYT--AREGAKFPIKWTAPEAANY---GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRP 226 (261)
T ss_pred ccchhhh--hhhccCCCccccCHHHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 5321111 1112234578999999874 357889999999999999998 9999998877766666543 3344456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
...|.++.+++.+||..||.+||+++++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 7789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.67 Aligned_cols=263 Identities=19% Similarity=0.349 Sum_probs=200.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCC----------CcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCce
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSAD----------DFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSV 110 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~----------~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I 110 (632)
.++|++.++||+|+||.||+|.+..... .......||+|++........ ..+.+ +..++..+ +|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~-E~~~l~~l-~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK-EIKIMSRL-KDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHH-HHHHHHhC-CCCCc
Confidence 4679999999999999999997653211 011234799999875433222 33333 33445555 78999
Q ss_pred eEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 111 CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG---------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 111 ~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~---------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
+.+++++..++..+++|||+. |+|.+++..... ..+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999998 688877765321 2477889999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh--CCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT--GIQPWFGK 258 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt--G~~PF~~~ 258 (632)
|++.++.++|+|||+++.+...... .......+++.|++||.... +.++.++|+|||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~---~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILL---GKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhc---CCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999998765322111 11122234678999998753 468899999999999999998 78999877
Q ss_pred CHHHHHHHHHh------hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 259 SVEEIYHSVVI------KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 259 ~~~ei~~~i~~------~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
+..+....... .......+..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 76655433211 11122345678899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.64 Aligned_cols=255 Identities=21% Similarity=0.360 Sum_probs=194.9
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEE-ECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISV-INGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~-~~~~l~LV 126 (632)
+.||+|+||.||+|.+..... ....||||.+..... .....+..+ ..++.. .+|+|++.+++++. .++..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~e-~~~l~~-l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG---QKIHCAVKSLNRITDLEEVEQFLKE-GIIMKD-FSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCC---ceEEEEEEecCccCCHHHHHHHHHH-HHHHcc-CCCCCcceEEEEeecCCCCcEEE
Confidence 468999999999998754331 235799999864332 222333333 334444 47999999999765 45678999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||+. |+|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||+++++.+||+|||+++........
T Consensus 76 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99998 6777776543 345678888999999999999999999999999999999999999999999998754332111
Q ss_pred C-CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHH
Q 006772 206 D-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPA 283 (632)
Q Consensus 206 ~-~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~ 283 (632)
. .......++..|+|||.+.. ..++.++|+|||||++|||++ |.+||...+..++...+. ....+..+..+|..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDP 230 (262)
T ss_pred eecccccCcCCccccChhHhcc---CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHH
Confidence 1 11122345778999999863 368889999999999999999 567787777666555443 33455566778999
Q ss_pred HHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 284 VENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.41 Aligned_cols=257 Identities=19% Similarity=0.338 Sum_probs=199.0
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
|.+.+.||+|+||.||+|.+...+. ...||+|.++... ....+.+..+ ..++..+ +|+||+.+++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~----~~~~a~k~~~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDS----ILKVAVKTMKIAICTRSEMEDFLSE-AVCMKEF-DHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCC----eeeEEEEecccCcCCHHHHHHHHHH-HHHHHhC-CCCCcceEEEEEccCCc
Confidence 3577899999999999999865442 1369999886532 2223333333 3445554 799999999876432
Q ss_pred ----CEEEEEEecCC-CCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 121 ----GKICIAMKFYE-GSVGDRIAQQ----RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 121 ----~~l~LVmEy~~-GsL~d~l~~~----~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
...+++|||+. |+|.+.+... ....+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence 24789999998 6777766432 12458999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+++........ .......+++.|+|||.+.. ..++.++|+|||||++|||++ |..||.+....++...+..
T Consensus 155 Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 229 (272)
T cd05075 155 DFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLAD---RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ- 229 (272)
T ss_pred CCCcccccCcccce-ecCCcccCCcccCCHHHccC---CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 99998865322111 11122345778999999864 357889999999999999999 8999998877777666543
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
...+..+..++..+.++|.+||+.||++||++.++++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 344456778999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.97 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=203.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.+.|+..++||+|+||+||+|+.+.++ +.||+|++..... +.......++..++..+.+.+||+.+++++.++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g------~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTG------KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCC------CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 456888889999999999999998876 4899999976543 222233334445566665444499999999887
Q ss_pred C------EEEEEEecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 121 G------KICIAMKFYEGSVGDRIAQQRG--GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 121 ~------~l~LVmEy~~GsL~d~l~~~~~--~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
+ .+++|+||++-+|.+++..... ..++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|
T Consensus 84 ~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence 6 8999999999999999877643 3577789999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+|+... .+...++...+|.+|.|||++.+.. .|+...|+||+||++.||++++..|.+.+..+....|...-.
T Consensus 164 FGlAra~~---ip~~~yt~evvTlWYRaPEvLlGs~--~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 164 FGLARAFS---IPMRTYTPEVVTLWYRAPEVLLGST--SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred cchHHHhc---CCcccccccEEEeeccCHHHhcCCC--cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 99998542 2233355668899999999998763 489999999999999999999999999987665555552221
Q ss_pred CC----------------CCC------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KP----------------CIP------------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p----------------~~p------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.| .++ +..+++..+++.+||+++|.+|.|++..+.
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 11 111 122348899999999999999999998776
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=306.99 Aligned_cols=262 Identities=23% Similarity=0.399 Sum_probs=206.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+++.++|.+.+.||+|+||.||+|.+..... ....||||...... ....+.+.+ +..++..+ .|+|++.+++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~-e~~~l~~~-~h~~i~~~~~~~ 76 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPEN---EKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQF-DHPHIVKLIGVI 76 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCC---CCcceEEEecCCcCCHHHHHHHHH-HHHHHHhC-CCCchhceeEEE
Confidence 3567889999999999999999998765421 22469999886544 233333333 33444554 689999999887
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.. +..|++|||++ |+|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 64 56789999998 6787777543 346899999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+......... .....++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+. ....+.
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~ 228 (270)
T cd05056 155 RYLEDESYYK--ASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLP 228 (270)
T ss_pred eeccccccee--cCCCCccccccChhhhcc---CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence 7654321111 112234568999999863 357899999999999999996 999999887766655543 344556
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+..+|.++.++|.+||..+|.+||++.+++..|+.+.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 67889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.67 Aligned_cols=249 Identities=23% Similarity=0.404 Sum_probs=197.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHH-HHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF-VNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~-~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
|++.+.||+|+||.||+|.+..++ ..||+|.+........... ...+...+..+ +|++|+.+.+++..+...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG------QKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT------EEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC------eEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccc
Confidence 789999999999999999998765 3899999987654433321 12233455555 799999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
+++|||+.+ +|.+++.. ...+++..++.++.||+.||++||+++|+|+||||+|||++.++.++|+|||++.....
T Consensus 74 ~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~- 150 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE- 150 (260)
T ss_dssp EEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-
T ss_pred cccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 999999997 88888863 35889999999999999999999999999999999999999999999999999875411
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhccCC--CCC
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE---EIYHSVVIKKEKP--CIP 277 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~---ei~~~i~~~~~~p--~~p 277 (632)
.........+|..|+|||++.. ...++.++|+||||+++|+|++|..||...... ............. ...
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQ--GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTT--TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred --cccccccccccccccccccccc--cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 1223344578999999999861 235788999999999999999999999987322 2222222111111 111
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+.++.++|.+||+.||++||++.++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223489999999999999999999999886
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.76 Aligned_cols=243 Identities=26% Similarity=0.423 Sum_probs=191.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++..... .....+.++ ..++.++ +|+|++.+++.+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTR------RILAVKVIPLDITVELQKQIMSE-LEILYKC-DSPYIIGFYGAFFVEN 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCC------cEEEEEEEecCCChHHHHHHHHH-HHHHHhC-CCCCeeeEEEEEEECC
Confidence 47899999999999999999987655 4899999865422 222333333 3344444 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..+++|||++|..++.. ..+++..+..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||++.....
T Consensus 73 ~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 73 RISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999999997555433 2578999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhhccCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-------EEIYHSVVIKKEKP 274 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-------~ei~~~i~~~~~~p 274 (632)
.......||..|+|||++.+. .++.++|+|||||++|+|++|..||..... .+....+. ....+
T Consensus 148 -----~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 218 (279)
T cd06619 148 -----SIAKTYVGTNAYMAPERISGE---QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPP 218 (279)
T ss_pred -----ccccCCCCChhhcCceeecCC---CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCC
Confidence 122345789999999998743 578899999999999999999999975321 12222222 12222
Q ss_pred CC-CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CI-PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~-p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. ....++++.++|.+||+.||++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22 2457889999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.93 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=199.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
-|++.+.||+|+||.||+|.+..++ ..+++|.+..........+.++. .++..+ +|+|++.+++.+..++..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~e~-~~l~~l-~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEI-DILASC-DHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCC------eEEEEEEeCCCCHHHHHHHHHHH-HHHHHC-CCCCeeeEEEEEeeCCEE
Confidence 3688899999999999999987655 47899998655444444444433 344444 799999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 124 CIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 124 ~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
|+||||+.|+.++.+.......+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+|||++.......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999999644444333334579999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCCCCCCCC
Q 006772 204 LSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKPCIPSGL 280 (632)
Q Consensus 204 ~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p~~p~~l 280 (632)
.......|+..|+|||++... ....++.++|+|||||++|||++|..||...+..+....+.... .....|..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 234 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcccc
Confidence 122334689999999998532 13457889999999999999999999998877665544443221 122345678
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++.++|.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.07 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=199.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
..+|++.+.||+|+||.||+|...... ....||+|.+..... ..++..++..+ +|+||+.+++.+..++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~----~~~~v~vK~~~~~~~------~~~E~~il~~l-~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDE----QRKKVIVKAVTGGKT------PGREIDILKTI-SHRAIINLIHAYRWKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCc----cceeEEEEecccccc------HHHHHHHHHhc-CCCCccceeeeEeeCC
Confidence 357999999999999999999765322 235899998864321 12233444454 6899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.+|++||++.+++.+++. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++....
T Consensus 160 ~~~lv~e~~~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEEehhcCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999999999999998883 346899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh--------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE---EIYHSVVIK-------- 270 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~---ei~~~i~~~-------- 270 (632)
... ........||+.|+|||++.. ..++.++|+|||||++|||++|..||.+.... ..+..+...
T Consensus 238 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 238 HPD-TPQCYGWSGTLETNSPELLAL---DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccc-cccccccccccCccCHhHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 211 112234579999999999974 36889999999999999999999999875421 111111110
Q ss_pred -----------------ccCCC--CC-----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 271 -----------------KEKPC--IP-----SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 271 -----------------~~~p~--~p-----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
..++. .| ..++.++.++|.+||..||++||++.|++. +++|....|+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~------~p~f~~~~~~~ 385 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS------LPLFTKEPINL 385 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh------Cchhhccchhh
Confidence 00111 11 235678999999999999999999999987 55565554443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.48 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=198.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
..++|++.+.||+|+||.||+|.+..++ +.||+|.++.........+.+ +..++..+ +|+||+.+++.+..+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~-e~~~~~~l-~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTG------ELAAIKVIKLEPGEDFAVVQQ-EIIMMKDC-KHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCC------cEEEEEEEecCchhHHHHHHH-HHHHHHhC-CCCCeeeEEEEEEeC
Confidence 3468999999999999999999987655 489999987543333233333 32344444 799999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..|++|||++| +|.+++.. .+.+++.+++.++.|++.||+|||+++++|+||||+|||++.++.++|+|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 999999999984 77776643 357999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-C--
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC-I-- 276 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~-~-- 276 (632)
... ........|+..|+|||++.....+.++.++|+|||||++|||++|..||....+.............+. .
T Consensus 157 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 157 TAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred cCc---ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 321 1122345789999999997533344678899999999999999999999977654433322222221111 1
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...++..+.++|.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1257789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.15 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=202.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.++||.|+||.||+|.+..++ ..||+|.+..........+..+. .++..+ +|+|++.+++.+..++.
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETG------LFAAAKIIQIESEEELEDFMVEI-DILSEC-KHPNIVGLYEAYFYENK 76 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCC------cEEEEEEEeeCCHHHHHHHHHHH-HHHHhC-CCCceeEEEEEEecCCe
Confidence 67999999999999999999987544 48999998765444444444443 455555 49999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++| +|.+++. .....+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 77 LWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred EEEEeeccCCCcHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 9999999996 5555544 3345799999999999999999999999999999999999999999999999998765422
Q ss_pred CCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--CCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--CIP 277 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--~~p 277 (632)
. ........||+.|+|||.+..+. ...++.++|+|||||++|||++|..||...+..+....+.. ...+ ..+
T Consensus 156 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (280)
T cd06611 156 T---LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-SEPPTLDQP 231 (280)
T ss_pred c---ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-CCCCCcCCc
Confidence 1 11223356899999999975321 23577899999999999999999999998877665555432 2222 235
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..++.++.++|.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 678999999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.03 Aligned_cols=264 Identities=20% Similarity=0.354 Sum_probs=205.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++.++|++.+.||+|+||.||+|.+.... +......||+|++..............+..++..+ .|+|++.+++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccC-CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC
Confidence 56789999999999999999999875311 01233589999987543322222233333444454 78999999999998
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCC
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR--------------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~--------------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~ 178 (632)
+...|++|||+. |+|.+++.... ...+++..++.++.|++.||+|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 899999999998 58888876432 124788899999999999999999999999999999
Q ss_pred eEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCC
Q 006772 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFG 257 (632)
Q Consensus 179 NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~ 257 (632)
|||++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred heEecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998754322111 11112234678999999864 368899999999999999998 8899998
Q ss_pred CCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 258 KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 258 ~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.+..+....+.. ......+..++.++.+++.+||+.||.+||++.|+++.|+
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 236 MAHEEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 887776665543 3334456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=303.88 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=206.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.+.||+|+||.||+|.... +.||+|.+..... ....+.++. .++..+ .|+|++.+++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~--------~~v~iK~~~~~~~-~~~~~~~e~-~~l~~l-~~~~i~~~~~~~~~ 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRG--------QKVAVKCLKDDST-AAQAFLAEA-SVMTTL-RHPNLVQLLGVVLQ 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecC--------cEEEEEEeccchh-HHHHHHHHH-HHHHhc-CCcceeeeEEEEcC
Confidence 677899999999999999999998642 4799999975433 233444433 444554 68999999999988
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.+..++||||++ ++|.+++.......+++..++.++.|++.||.|||+++++||||||+|||++.++.++|+|||+++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 899999999998 6888887665445799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.... .....++..|+|||++.. +.++.++|+||||+++|||++ |..||...+..++...+. ....+..+
T Consensus 152 ~~~~------~~~~~~~~~~~ape~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 221 (256)
T cd05039 152 ASQG------QDSGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAP 221 (256)
T ss_pred cccc------cccCCCcccccCchhhcC---CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCc
Confidence 5221 112234678999999863 467889999999999999997 999998887776655544 23345567
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
..+|+++.++|.+||..+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.28 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=200.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||.|+||.||+|.+..++ ..+++|.+..........+.++ ..++..+ +|+|++.+++.+..++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~e-~~~l~~~-~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATG------ELVAIKVIKLEPGDDFEIIQQE-ISMLKEC-RHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCC------CEEEEEEEEcCchhhHHHHHHH-HHHHHhC-CCCChhceEEEEEeCC
Confidence 368999999999999999999987654 3799999876544333333333 3344444 7999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|++|||++| ++.+++.. ....+++..+..++.|++.||+|||+++|+|+||||+||++++++.++|+|||++....
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999996 55555543 33579999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---CCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP---CIP 277 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p---~~p 277 (632)
... .......++..|+|||.+.......++.++|+|||||++|||++|..||...+..+....+......+ ..+
T Consensus 153 ~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 153 ATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred hhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccch
Confidence 211 11233468889999999864423467889999999999999999999998877555443333221111 123
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+.++.+++.+||..||.+||++.+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.08 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=198.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+.++|+..+.||+|+||.||++.+..++ +.||+|.+..............+..++.++..|+||+.+++++..+
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSG------TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCC------CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 4567888899999999999999987655 4899999875432222222333344566666799999999999989
Q ss_pred CEEEEEEecCCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 121 GKICIAMKFYEGSVGDRIAQ---QRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~---~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
+..+++|||+.+++.++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++
T Consensus 76 ~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 76 GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 99999999999877665432 2346799999999999999999999985 9999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~~p~ 275 (632)
...... .......|++.|+|||++.......++.++|+|||||++|||++|+.||..... .+....+. ....+.
T Consensus 156 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 230 (288)
T cd06616 156 GQLVDS----IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPI 230 (288)
T ss_pred HHhccC----CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCc
Confidence 754321 111233678999999998743223578899999999999999999999976542 12222221 122222
Q ss_pred CC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ ..++.++.+||.+||+.||++||++.+|++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22 347899999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=303.91 Aligned_cols=255 Identities=25% Similarity=0.467 Sum_probs=204.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|..++|++.++||+|+||.||+|.+... ..+|+|.+..... ....+.+ +..++..+ +|++++.+++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~-------~~~~iK~~~~~~~-~~~~~~~-e~~~l~~l-~~~~i~~~~~~~~~ 72 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKH-------TKVAVKTMKPGSM-SVEAFLA-EANVMKTL-QHDKLVKLHAVVTK 72 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCC-------ccEEEEecCCChh-HHHHHHH-HHHHHHhc-CCCCcceEEEEEcC
Confidence 5678999999999999999999986543 2699998865332 2233333 33455554 68999999888776
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
...+++|||++ |+|.+++.......+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++..
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceee
Confidence 77899999997 6888888765556789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .......++..|+|||++.. +.++.++|+|||||++|+|++ |..||.+.+.......+.. ......+
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 225 (260)
T cd05073 152 IEDNEY--TAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRP 225 (260)
T ss_pred ccCCCc--ccccCCcccccccCHhHhcc---CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCc
Confidence 532211 11112345678999999863 367889999999999999999 9999998876666555442 3334456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
...+.++.+++.+||+.||++||++.+++..|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 7789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.37 Aligned_cols=256 Identities=19% Similarity=0.400 Sum_probs=200.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.+.||+|+||.||+|.+..++ +.+|||.+..... .....+.++. .++..+ +|+||+.+++.+..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~~e~-~~l~~~-~h~~i~~~~~~~~~ 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDG------VPVALKKVQIFDLMDAKARADCIKEI-DLLKQL-NHPNVIKYYASFIE 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCC------ceEEEEeeeehhhhhHHHHHHHHHHH-HHHHHc-cCCchhhhhheeEe
Confidence 57899999999999999999987655 4899998764322 1222333332 344444 79999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
++..+++|||++| +|.+++... ....+++..++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 9999999999985 777776542 2356899999999999999999999999999999999999999999999999988
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhccCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV--EEIYHSVVIKKEKP 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~--~ei~~~i~~~~~~p 274 (632)
....... .......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||.+... .+....+......+
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~~ape~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08229 154 RFFSSKT---TAAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227 (267)
T ss_pred hccccCC---cccccccCCcCccCHHHhcCC---CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence 7543221 112234689999999998643 578899999999999999999999976543 23333333222222
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..+...++++.+++.+||+.||.+||++.+|++.++++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 22356889999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=310.58 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=214.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-------hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-------EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-------~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
+.|.-.+.||+|..+.|-++.++.+++ ++|+|++.-.. .....+....+..++.++..||+|+.+++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~------e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGK------EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhccccc------ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 456777889999999999998887764 78999885321 12233334455677889999999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
+++++..+|+|.|.|+ |.|.|++... -.+++...+++++|+..|++|||.++||||||||+|||+|++.++||+|||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 9999999999999998 9999999764 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCC---CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
+|+.+... ......||||+|+|||.+... ....|+..+|.|++|++||-+|.|.+||......-++..|+.++
T Consensus 169 Fa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 169 FACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred eeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 99876432 334567999999999998743 24468899999999999999999999999988777788887665
Q ss_pred cCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
-...-| ..++.+.++||++||+.||.+|.|++|.|.
T Consensus 245 yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 554444 468899999999999999999999999886
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.98 Aligned_cols=275 Identities=20% Similarity=0.353 Sum_probs=211.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+|++.+.||.|+||.||+|.+.... ..+..||+|++...... ...+....+..++..+.+|++|+.+++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH---DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC---CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence 4899999999999999999875422 23468999998653211 11222333445667777899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..|+||||++ |+|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999998 5787777643 47899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhccCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS----VEEIYHSVVIKKEKPC 275 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~----~~ei~~~i~~~~~~p~ 275 (632)
..... .......|+..|+|||.+... ...++.++|+||||+++|+|++|..||.... ..++...+. ...+.
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 230 (290)
T cd05613 156 HEDEV--ERAYSFCGTIEYMAPDIVRGG-DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPP 230 (290)
T ss_pred ccccc--cccccccCCcccCChhhccCC-CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh--ccCCC
Confidence 32211 122345689999999998643 2346789999999999999999999997432 233333322 23455
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
+|..+++.+.+++.+||+.||++|| ++.+++. ++++....|+.+..+....++
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~ 288 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK------HPFFQKINWDDLAAKKVPAPF 288 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc------CcccccCCHHHHhhccCCCCC
Confidence 6788999999999999999999997 5666655 667778888776555444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=307.69 Aligned_cols=264 Identities=21% Similarity=0.362 Sum_probs=197.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
...+|++.+.||+|+||.||+|....... ..++.||+|.+..........+.++. .++..+ .|+|++.+.+++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~-~~l~~l-~h~~iv~~~~~~~~~ 77 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQD--NTGEVVAVKKLQHSTAEHLRDFEREI-EILKSL-QHDNIVKYKGVCYSA 77 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcC--CCCcEEEEEEeccCCHHHHHHHHHHH-HHHHhC-CCCCeeEEEEEEccC
Confidence 34689999999999999999998642111 23358999998765544444444443 445554 79999999987654
Q ss_pred -CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 -NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 -~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
...+++||||++ |+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 356899999997 6888777543 3468999999999999999999999999999999999999999999999999988
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHH--------------
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI-------------- 263 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei-------------- 263 (632)
................++..|+|||++.+ +.++.++|+|||||++|||++|..|+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhcc---CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 65322110000111123456999999864 3578899999999999999998777643321100
Q ss_pred -HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 264 -YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 264 -~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
...+.........+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0111222233345677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.27 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=197.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||.+...... ....+.+ +..++..+.+|+||+.+++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~v~lK~~~~~~~~~~~~~~~~~-E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTG------KLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCC------cEEEEEeehhhccccCCchHHHH-HHHHHHHccCCCCccceeeeEeec
Confidence 47999999999999999999987655 48999987643221 1122333 345667777889999999988776
Q ss_pred CE-----EEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEE
Q 006772 121 GK-----ICIAMKFYEGSVGDRIAQQR---GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLG 191 (632)
Q Consensus 121 ~~-----l~LVmEy~~GsL~d~l~~~~---~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~ 191 (632)
+. .|++|||+++++.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+
T Consensus 74 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 74 EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 55 89999999999988886543 246899999999999999999999999999999999999998 8999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++..... ........+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.+.+..+....+....
T Consensus 154 dfg~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 228 (295)
T cd07837 154 DLGLGRAFSIP---VKSYTHEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228 (295)
T ss_pred ecccceecCCC---ccccCCcccccCCCChHHhhCC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 99998764321 1112223568899999988632 247889999999999999999999998876554433332111
Q ss_pred cCC------------------C--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKP------------------C--------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p------------------~--------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+ . ....+++++.++|.+||..||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 01357889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=304.11 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=198.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--h--hhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--E--DCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+++|++.+.||+|+||.||+|.+..++ +.||||.+.... . .........+..++..+ +|+||+.+++++
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 73 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTG------RELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCL 73 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCC------cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEe
Confidence 468999999999999999999987655 489999875321 1 11112223333445555 799999999987
Q ss_pred EE--CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 118 VI--NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 118 ~~--~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.. ...++++|||++ |+|.+++... ..+++..++.++.|++.||+|||+++|+|+||||+|||++.++.++|+|||
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 74 RDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred ccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCc
Confidence 65 357889999998 5777776543 468999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++.................|+..|+|||++.+. .++.++|+|||||++|||++|+.||...+.......+......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06652 152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE---GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228 (265)
T ss_pred cccccccccccccccccCCCCccccChhhhcCC---CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCC
Confidence 987643221122223345689999999998743 57889999999999999999999998876555544444344455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..|..++..+.+++++|+. +|++||++++++.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 5677888999999999995 9999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.81 Aligned_cols=256 Identities=20% Similarity=0.427 Sum_probs=202.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDC-AKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|.++... ... ...+.+ +..++..+ .|++++.+++.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~-ei~~l~~~-~~~~i~~~~~~~~~ 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG------RVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL-DHPNVIKYLASFIE 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC------CEEEEEEeecccccchhhHHHHHH-HHHHHHhC-CCCCeeeeeeeeec
Confidence 58999999999999999999987554 489999886422 111 223333 33444554 78999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
++..+++|||++ |+|.+++... ....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence 999999999998 5887777543 2356899999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhccCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--VEEIYHSVVIKKEKP 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--~~ei~~~i~~~~~~p 274 (632)
....... .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.... ..+....+.. ...+
T Consensus 154 ~~~~~~~---~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 226 (267)
T cd08224 154 RFFSSKT---TAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYP 226 (267)
T ss_pred eeccCCC---cccceecCCccccCHHHhcc---CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCC
Confidence 7643221 11233468899999999864 357889999999999999999999997653 2233333322 2333
Q ss_pred CCCC-CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPS-GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~-~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..|. ..+.++.++|.+||..+|++||++.+|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 3444 78889999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.33 Aligned_cols=253 Identities=14% Similarity=0.188 Sum_probs=191.9
Q ss_pred EEeEEccc--CceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 47 LKHRIGRG--PFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 47 l~~~IG~G--~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
+++.||+| +|++||++.++.++ ..||+|.+..... ......+.++..+++. .+||||+.+++++..++..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG------EYVTVRRINLEACTNEMVTFLQGELHVSKL-FNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeecccC------cEEEEEEechhhccHHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEECCEE
Confidence 56789999 78999999988766 4899999865432 2233344444444444 4789999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
|+||||++ |++.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999998 67888876554556999999999999999999999999999999999999999999999999865443211
Q ss_pred CCC----CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-----
Q 006772 203 SLS----DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK----- 273 (632)
Q Consensus 203 ~~~----~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~----- 273 (632)
... ........++..|+|||++.+. ...++.++|+|||||++|||++|..||...+..+...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 110 0011123567889999998643 235789999999999999999999999876544332222111000
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ---------------------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ---------------------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......+++++.+||.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011235678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=300.63 Aligned_cols=247 Identities=22% Similarity=0.380 Sum_probs=195.2
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
+.||+|+||.||+|.... + +.||+|.+..............+..++..+ +|+||+.+.+++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~------~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-K------TPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecC-C------cEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEE
Confidence 468999999999998542 2 479999987654332222223333445554 79999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCC
Q 006772 129 FYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207 (632)
Q Consensus 129 y~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~ 207 (632)
|++ |+|.+++... ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++.........
T Consensus 73 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 149 (250)
T cd05085 73 LVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-- 149 (250)
T ss_pred CCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc--
Confidence 998 5777666443 356899999999999999999999999999999999999999999999999998754322111
Q ss_pred ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 006772 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286 (632)
Q Consensus 208 ~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~ 286 (632)
......++..|+|||++.. +.++.++|+||||+++|||++ |..||.+.........+. .......+..++.++.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNY---GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYK 225 (250)
T ss_pred cCCCCCCcccccCHHHhcc---CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 1112234678999999863 467889999999999999998 999999887766655543 34445567789999999
Q ss_pred HHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 287 VIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 287 LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
++.+||+.+|++||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=310.91 Aligned_cols=248 Identities=19% Similarity=0.333 Sum_probs=198.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.+|++.+.||+|+||.||+|.+..++ +.||+|.+..........+.++. .++.. ..|+|++.+.+.+..+..
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~e~-~~l~~-~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATG------QEVAIRQMNLQQQPKKELIINEI-LVMRE-NKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCC------cEEEEEEEecCCcchHHHHHHHH-HHHHh-CCCCCEeeEEEEEEeCCE
Confidence 68999999999999999999976554 48999998754433333333333 34444 479999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++ |+|.+++.. ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999998 577776643 3689999999999999999999999999999999999999999999999998875432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p~~p~~l 280 (632)
.. .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+.... .....+..+
T Consensus 169 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06654 169 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (296)
T ss_pred cc---cccCcccCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcccc
Confidence 11 11223468999999999864 357889999999999999999999998877644333332211 122345678
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.+.+++.+||..||++||++.+++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=304.85 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=198.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--h--hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--D--CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+|+..+.||+|+||.||+|.+..++ +.||+|.+..... . ........+..++..+ +|+||+.+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 74 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTG------RELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLR 74 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCC------cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEE
Confidence 47999999999999999999987655 4899998864321 1 1112223333455555 6999999999876
Q ss_pred E--CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 119 I--NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 119 ~--~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
. ++.++++|||++ ++|.+.+... +.+++...+.++.|++.||+|||+++|+||||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 75 DRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred cCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 5 367899999998 5777777543 4689999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
++................++..|+|||++.+. .++.++|+|||||++|||++|+.||......+...........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGE---GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ 229 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCC---CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC
Confidence 87653221112222334688999999998643 578899999999999999999999987765554444444445566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|..+++.+.+++ +||..||++||+++|+++
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 7788899999999 688889999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.72 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=206.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|..++|+..+.||+|+||.||+|.+..+++. ....||+|.+..............+..++..+ +|+||+.+++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~ 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGET--VKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLS 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCc--ceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcC
Confidence 5568899999999999999999998765531 12368999887543322222223333444444 79999999998865
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
. ..+++|||++ |++.+.+... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 4 5678999998 6888877543 34689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... .......++..|+|||++.+ ..++.++|+|||||++|||++ |..||.+....+....+ .....+..+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 233 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY---RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQP 233 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc---CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCC
Confidence 5322111 11122345778999999863 367889999999999999997 99999887765554433 344455556
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
..++.++.+++.+||..||++||++.++++.|+.+.+.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 77899999999999999999999999999988876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.24 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=201.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC--chhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL--KEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~--~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
...|...+.||+|+||.|..|.++.+++ .||||++... +....++.+++. .++..+ +|+||+.+.+++..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~------~VAIKKi~~~F~~~~~akRtlREl-klLr~~-~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGE------KVAIKKILNPFENQIDAKRTLREL-KLLRHL-RHENIIGLLDIFRP 92 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCC------EeehhhhhhhhhchHHHHHHHHHH-HHHHHh-cCCCcceEEeeccc
Confidence 3567778999999999999999998774 8999998732 223333333333 445555 49999999998765
Q ss_pred -----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 120 -----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 120 -----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
-+.+|+|+|+|+-+|...+... ..++...+..++.||++||.|+||.+|+||||||+|+|++.+...||+|||
T Consensus 93 ~~~~~f~DvYiV~elMetDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELMETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ccccccceeEEehhHHhhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccc
Confidence 2679999999988888877543 359999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV------ 268 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~------ 268 (632)
+|+..... .....++..+-|.+|.|||++.. ...||.+.||||.||++.||++|++.|.|.+....+..|.
T Consensus 171 LAR~~~~~-~~~~~mTeYVaTRWYRAPElll~--~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 171 LARYLDKF-FEDGFMTEYVATRWYRAPELLLN--SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred ceeecccc-CcccchhcceeeeeecCHHHHhc--cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 99987543 22344456678999999999964 4579999999999999999999999999977543333222
Q ss_pred ------------------hhccCCCCC-----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 ------------------IKKEKPCIP-----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ------------------~~~~~p~~p-----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+..| +..++.+.+|+.+||..||.+|+|++|.|.
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111122222 467899999999999999999999999775
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.72 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=184.2
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--CCEEEE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI--NGKICI 125 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--~~~l~L 125 (632)
.++||+|+||.||+|.++... ..+.||+|.+...... ....+ +..++..+ +|+||+.+++++.. +..+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~----~~~~~aiK~~~~~~~~--~~~~~-E~~~l~~l-~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK----DDRDYALKQIEGTGIS--MSACR-EIALLREL-KHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCC----CCceEEEEEECCCCCc--HHHHH-HHHHHHhc-CCCCCcceeeeEecCCCcEEEE
Confidence 468999999999999876422 2358999998653321 22223 33445554 78999999988754 467899
Q ss_pred EEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE----ecCCcEEEEecC
Q 006772 126 AMKFYEGSVGDRIAQQR-------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL----SEHDQLVLGDFG 194 (632)
Q Consensus 126 VmEy~~GsL~d~l~~~~-------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl----d~~g~vkL~DFG 194 (632)
+|||+.+++.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99999999888875431 2358999999999999999999999999999999999999 456799999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---------HHHH
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE---------EIYH 265 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~---------ei~~ 265 (632)
+++................||+.|||||++.+. ..++.++|+|||||++|||++|+.||.+.... ....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCC--CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 998754332222233446789999999998643 24788999999999999999999999753311 1111
Q ss_pred HHHhhccC------------C------------C------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 266 SVVIKKEK------------P------------C------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 266 ~i~~~~~~------------p------------~------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+...... + . .....+.++.+||.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11100000 0 0 00123567889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=304.10 Aligned_cols=254 Identities=21% Similarity=0.371 Sum_probs=199.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
++|++.+.||+|+||.||+|.+..++ +.+++|++...... ... ...+..++.++..|+||+.+++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~-~~~-~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTG------QLVAIKIMDIIEDE-EEE-IKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCC------cEEEEEEEecCchh-HHH-HHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 78999999999999999999987654 48999998754432 233 3334455666778999999999987644
Q ss_pred -----EEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 122 -----KICIAMKFYEG-SVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 122 -----~l~LVmEy~~G-sL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
.+|++|||+++ +|.+++.... +..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 58999999995 7777765433 468999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|++....... .......|+..|+|||++.... ...++.++|+|||||+||+|++|..||...........+....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 158 GVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred ccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 9987643211 1123346899999999986431 2346789999999999999999999998766554444433221
Q ss_pred c-CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 E-KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~-~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ....+..++.++.++|.+||..||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11122347889999999999999999999999886
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.69 Aligned_cols=279 Identities=21% Similarity=0.339 Sum_probs=216.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+|++.+.||+|+||.||+|.+.... .....||||++++... .........+..++..+.+|++|+.+++.+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~---~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~ 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH---DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc---cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence 4889999999999999999865432 2235899999865321 111222334445667777899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
...|+||||+. |+|.+.+.. ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||+++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999998 577777654 347899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhccCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS----VEEIYHSVVIKKEKPC 275 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~----~~ei~~~i~~~~~~p~ 275 (632)
.... ........|+..|+|||.+.+. ....+.++|+||||+++|||++|..||.... ..++...+. ...+.
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~ 230 (288)
T cd05583 156 LAEE--EERAYSFCGTIEYMAPEVIRGG-SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPP 230 (288)
T ss_pred cccc--ccccccccCCccccCHHHhcCC-CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCC
Confidence 3321 1112234689999999998643 1236789999999999999999999996432 223333332 23455
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCc
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSS 335 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~ 335 (632)
.|..++.++.+++.+||+.||++||++.++...|+ +.++...+|..+.++...+++.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~ 287 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN---HPFFQGIDWDDLAAKRIPAPFK 287 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc---CcccccCCHHHHhhhccCCCCC
Confidence 67789999999999999999999999887665443 6788899998887777666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=307.41 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=197.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE---
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV--- 118 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~--- 118 (632)
.++|++.+.||+|+||.||+|.+..++ +.+|+|++...... ...+ ..+..++..+.+|+|++.+++++.
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~~-~~~~-~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNG------SKAAVKILDPIHDI-DEEI-EAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCC------ceeEEEeeccccch-HHHH-HHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 378999999999999999999987654 48999988653322 1222 333345666668999999999874
Q ss_pred --ECCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 119 --INGKICIAMKFYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 119 --~~~~l~LVmEy~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
.++..+++|||++ |+|.+.+... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 3467999999998 5677666432 2357899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|+++...... .......|++.|+|||++... ....++.++|+|||||++|||++|+.||...+.......+....
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 169 GVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred CceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9987653221 112234689999999998532 12357889999999999999999999998776544333322111
Q ss_pred -cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 -EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 -~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....|..++.++.++|.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112234567889999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.39 Aligned_cols=270 Identities=22% Similarity=0.303 Sum_probs=206.9
Q ss_pred CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 35 QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 35 ~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
....+|+.++|++.++||+|||..||++....+. +.||+|++...+.+..+...++ ....+++ +|||+.++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~------~~YAlKkI~c~~~~~~e~~~rE-id~~rkf-~s~~vl~l~ 84 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTG------HLYALKKILCHSQEDIEEALRE-IDNHRKF-NSPNVLRLV 84 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcc------cchhhheeeccchHHHHHHHHH-HHHHHhh-CCcchHHHH
Confidence 4456899999999999999999999999866554 5899999977664444443333 2334444 679988876
Q ss_pred EEEEE-----CCEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEec
Q 006772 115 GISVI-----NGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLSE 184 (632)
Q Consensus 115 ~~~~~-----~~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld~ 184 (632)
+.... .+..||+++|+. |+|.|.+...+ +..+++.+.+.|+.+|++||++||+.. +.||||||.|||+++
T Consensus 85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~ 164 (302)
T KOG2345|consen 85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD 164 (302)
T ss_pred HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence 55433 356999999997 99999998764 347899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCceeccCCCCCCC------ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC
Q 006772 185 HDQLVLGDFGIPYLLLGRSLSDS------DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258 (632)
Q Consensus 185 ~g~vkL~DFGlak~~~~~~~~~~------~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~ 258 (632)
++.++|.|||.+....-.-.... +-.....|..|.|||.+.-+.+..++.++|||||||+||+|+.|..||...
T Consensus 165 ~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 165 SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 99999999998765421111111 112234689999999998877788899999999999999999999999642
Q ss_pred CH--HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 259 SV--EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 259 ~~--~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
-. ..+...+...+...+.....|..+.++|..||+.||.+||++.+++..++.+
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11 0011111111111122245899999999999999999999999999887654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=307.78 Aligned_cols=255 Identities=18% Similarity=0.361 Sum_probs=194.2
Q ss_pred EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHh--hhccCCCceeEeeEEEEECCEEEE
Q 006772 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELF--PKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 50 ~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il--~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
.||+|+||.||+|.+..++ +.||+|.+.+... ........++..++ ....+|++++.+++.+..++..++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF 74 (279)
T ss_pred CcccCCCeEEEEEEECCCC------cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence 3899999999999987654 4899999865321 11111111222222 223478999999999998999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||+.| +|.+++.. .+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++......
T Consensus 75 v~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 75 ILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (279)
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence 9999984 66666543 357999999999999999999999999999999999999999999999999998654221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhccCCCCCCCCCH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE--EIYHSVVIKKEKPCIPSGLPP 282 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~--ei~~~i~~~~~~p~~p~~lp~ 282 (632)
......||+.|+|||.+.. ...++.++|+|||||++|||++|..||...... ...... .......+|..+++
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 224 (279)
T cd05633 151 ---KPHASVGTHGYMAPEVLQK--GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSP 224 (279)
T ss_pred ---CccCcCCCcCccCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCH
Confidence 1223468999999999853 224788999999999999999999999764321 111111 11234456778999
Q ss_pred HHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccc
Q 006772 283 AVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 283 ~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
++.++|.+||..||.+|| +++++++ ++++.+.+|....
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~------h~~~~~~~~~~~~ 267 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKE------HVFFKGIDWQQVY 267 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHh------CccccCCCHhHHh
Confidence 999999999999999999 5888766 6677777776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=305.71 Aligned_cols=253 Identities=20% Similarity=0.298 Sum_probs=189.9
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||+|...... ....+|+|.+....... ...+.++ ...+.. .+|+||+.+++.+...+..|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e-~~~~~~-l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGM----SKARVVVKELRASATPDEQLLFLQE-VQPYRE-LNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCC----CCeEEEEeecCccCChHHHHHHHHH-HHHHHh-CCCCCcceEEEEECCCCceEEEE
Confidence 36999999999999754321 23478999876433222 2233333 233444 47999999999999999999999
Q ss_pred ecCC-CCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 128 KFYE-GSVGDRIAQQRG---GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~---~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
||+. |+|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 688888765432 335678889999999999999999999999999999999999999999999986532221
Q ss_pred CCCCccccccCCCccCCccccCCC----CCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcc----CC
Q 006772 204 LSDSDMALRLGTPNYMAPEQWEPE----VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE----KP 274 (632)
Q Consensus 204 ~~~~~~~~~~GT~~YmAPE~~~~~----~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~----~p 274 (632)
... ......+++.|+|||++... ....++.++|+|||||++|||++ |..||......+....+..... .+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 111 11223457789999997531 12346789999999999999999 8889988776665554443221 23
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
..+..++..+.+++..|| .||++||++++|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 345578899999999999 5999999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=300.17 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=203.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKIC 124 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~ 124 (632)
+++.+.||+|+||.||+|.+...+. .....||+|++..............+...+..+ +|++++.+++++..++..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 4678999999999999999876441 123589999997654432222333344555565 8999999999999999999
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 125 IAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 125 LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
++|||++ ++|.+.+.......+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+|||+++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999998 577777765433338999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCH
Q 006772 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282 (632)
Q Consensus 204 ~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~ 282 (632)
..... ...+++.|+|||.+. ...++.++|+|||||++|+|++ |..||...+..+....+.. ...+..+..++.
T Consensus 158 ~~~~~--~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (258)
T smart00219 158 YYKKK--GGKLPIRWMAPESLK---DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPP 231 (258)
T ss_pred ccccc--cCCCcccccChHHhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCH
Confidence 11111 123678999999985 3467899999999999999998 8999988877777666553 344556777999
Q ss_pred HHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 283 AVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 283 ~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
++.+++.+||..||++||++.++++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 99999999999999999999998874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.24 Aligned_cols=266 Identities=20% Similarity=0.366 Sum_probs=223.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..||++...+.+.||.|.||+|++|+.+..+ +....||||.|+.-..+..+.-+-.+..|+-+. .||||++|.|+-
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg---kre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVV 699 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG---KREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVV 699 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCC---CcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEE
Confidence 4588899999999999999999999988765 345689999998755444443333344555554 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
+....++||+|||+ |+|..++ +.+.+.|+..+..-+++.|+.|+.||-+.++|||||..+|||++.+-.+|++|||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFL-R~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFL-RQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHH-hhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999998 5655544 555678999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccC--CCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 197 YLLLGRSLSDSDMALRLG--TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~G--T~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+.+.... ...+++.-| .++|.|||.+. +.++|.+|||||||++|||.++ |+.||..++..+....|..+. +
T Consensus 779 Rvledd~--~~~ytt~GGKIPiRWTAPEAIa---~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-R 852 (996)
T KOG0196|consen 779 RVLEDDP--EAAYTTLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-R 852 (996)
T ss_pred eecccCC--CccccccCCccceeecChhHhh---hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc-C
Confidence 9764432 222333333 57999999996 6689999999999999999877 999999999999888887554 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+-|..||..|.+||..||++|-.+||.+.+|+..|+++.+
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 44589999999999999999999999999999999988764
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.50 Aligned_cols=252 Identities=22% Similarity=0.409 Sum_probs=198.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|.+..... .....+.++ ..++..+ +|+||+.+++.+..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~e-~~~l~~~-~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTG------VTMAMKEIRLELDESKFNQIIME-LDILHKA-VSPYIVDFYGAFFIEG 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCC------cEEEEEEeecccCHHHHHHHHHH-HHHHHhc-CCCcHHhhhhheecCC
Confidence 47999999999999999999987655 4899998865322 222333333 3444554 7899999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEG-SVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..|+||||++| +|..++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999999996 5555443321 2478999999999999999999997 5999999999999999999999999999865
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCC---CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhccC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEV---RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--IKKEK 273 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~--~~~~~ 273 (632)
.... ......|++.|+|||++.+.. ...++.++|+|||||++|||++|..||...........+. .....
T Consensus 153 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 153 LVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred ccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 4221 122346788999999985431 2346889999999999999999999998765544333221 22344
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++..++.++.++|.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 5677789999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=310.26 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=204.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|.|+.||++.+..++ +.+|+|++.... ... .+.+.++..+ -+..+||||+.++.....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg------~~fa~kiin~~k~~~~~-~e~l~rEarI-C~~LqHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTG------LEFAAKIINTKKLSARD-FQKLEREARI-CRKLQHPNIVRLHDSIQE 81 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccch------HHHHHHHhhhhhhcccc-HHHHHHHHHH-HHhcCCCcEeehhhhhcc
Confidence 367999999999999999999988766 478888875321 222 2223444344 344589999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC---CcEEEEecCC
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH---DQLVLGDFGI 195 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~---g~vkL~DFGl 195 (632)
.+..|||+|+|.| +|..-+... --+++..+-.|++||+.+|.|+|+++|||||+||+|+||... .-+||+|||+
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred cceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccce
Confidence 9999999999996 555545443 357899999999999999999999999999999999999743 3589999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
|..+.+ ......+.|||.|||||++.. .+|+..+|+|+.|++||-+|.|.+||.+.+...++++|+...-..+
T Consensus 160 Ai~l~~----g~~~~G~~GtP~fmaPEvvrk---dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 160 AIEVND----GEAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP 232 (355)
T ss_pred EEEeCC----ccccccccCCCcccCHHHhhc---CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC
Confidence 987752 233456789999999999984 4899999999999999999999999999999999999986544332
Q ss_pred --CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 --IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 --~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.-+.++++.++|+++||..||.+|.|+.|.|+
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 23678999999999999999999999999775
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.93 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=193.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
-.++|++.+.||+|+||.||+|.+..++ +.||||.+...... ....+.+ +..++..+ +|+||+.+++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~~ 84 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLR------QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHM-KHENVIGLLDVFT 84 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCC------CEEEEEEeCchhhhhHHHHHHHH-HHHHHHhc-CCCchhhhhhhhc
Confidence 3578999999999999999999987655 48999998653221 1222333 33444444 6899999988775
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 119 IN------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 119 ~~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
.. ...|++|+++.++|.+.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 85 PATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccccccccCcEEEEeecCCCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcC
Confidence 43 4579999999888877663 34799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++.... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 162 fg~~~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07878 162 FGLARQADD------EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233 (343)
T ss_pred CccceecCC------CcCCccccccccCchHhcCC--ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 999876432 22345789999999998642 3578899999999999999999999988765443333321100
Q ss_pred ---------------------CCCCC--------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 ---------------------KPCIP--------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ---------------------~p~~p--------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+..+ ...++.+.+||.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111 245677899999999999999999999886
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.31 Aligned_cols=246 Identities=20% Similarity=0.291 Sum_probs=188.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+...+|++.+.||+|+||.||+|.+..++ ..||+|+..+... . .+..++..+ +|+||+.+++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~valK~~~~~~~------~-~E~~~l~~l-~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQP------DPVVLKIGQKGTT------L-IEAMLLQNV-NHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCC------ceEEEEeCCcccc------H-HHHHHHHhC-CCCCCcChhheEEe
Confidence 44467999999999999999999987654 4899998543221 1 122344444 78999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++..|+||||+.|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 129 ~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 129 GAITCMVLPHYSSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred CCeeEEEEEccCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999999999999999888653 457999999999999999999999999999999999999999999999999998743
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCC-CCCCH--H-------HHHHHHHh
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW-FGKSV--E-------EIYHSVVI 269 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF-~~~~~--~-------ei~~~i~~ 269 (632)
... .......||+.|+|||++.+ ..++.++|+|||||++|||+++..|+ ..... . .....+..
T Consensus 208 ~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 208 VVA----PAFLGLAGTVETNAPEVLAR---DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred ccC----cccccccccccccCCeecCC---CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 211 12234568999999999974 36889999999999999999865554 33211 0 00111110
Q ss_pred h-c-cCCCCC------------------------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 K-K-EKPCIP------------------------------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~-~-~~p~~p------------------------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. . ....++ ..++.++.+||.+||+.||.+|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 0 011111 245677888999999999999999999886
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.55 Aligned_cols=248 Identities=20% Similarity=0.346 Sum_probs=194.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ ..+|+|.+..............+..++..+ +|+||+.+++++..++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSG------LIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCC------eEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCE
Confidence 47999999999999999999987665 379999886543222222222333455555 78999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+|++|||++| +|.+++... +.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999984 777776543 578999999999999999999998 589999999999999999999999999886542
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI----------- 269 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~----------- 269 (632)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 152 ~~-----~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 152 DS-----MANSFVGTRSYMSPERLQG---THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cc-----ccccCCCCcCccChhHhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 21 1234578999999999864 3578899999999999999999999976553332211110
Q ss_pred ------------------------hccCCCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 ------------------------KKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ------------------------~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+..| ..++.++.+++.+||..||++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112222 236789999999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.42 Aligned_cols=250 Identities=19% Similarity=0.288 Sum_probs=193.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ ..||+|.+....... ...+.+ +..++..+ +|+|++.+++++...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g------~~~~~k~~~~~~~~~~~~~~~~~-ei~~l~~l-~h~~i~~~~~~~~~~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH------EIVALKRVRLDDDDEGVPSSALR-EICLLKEL-KHKNIVRLYDVLHSDK 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC------cEEEEEEeecccccccCccchhH-HHHHHHhc-CCCCeeeHHHHhccCC
Confidence 5899999999999999999987665 489999986432211 112222 33444444 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.++++|||+.+++.+.+... .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++....
T Consensus 73 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 73 KLTLVFEYCDQDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred ceEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 99999999999998887653 35799999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhcc--------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVIKKE-------- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~-~~~~~ei~~~i~~~~~-------- 272 (632)
. ........+++.|+|||++.+. ..++.++|+|||||++|||++|..||. +.+..+.+..+.....
T Consensus 152 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 152 P---VRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred C---CCCcCCCccccCCcChHHHhCC--cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 1 1112234578999999998643 246889999999999999999888854 4444433333221000
Q ss_pred ----------CCC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 ----------KPC---------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ----------~p~---------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+. ....+++++.++|.+||+.||.+|||+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 11347889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=305.64 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=201.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||.|+||.||+|.+..++ ..||+|.+..... .....+. .+..++..+ +|+|++.+.+.+..+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~-~e~~~l~~l-~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTN------QVVAIKVIDLEEAEDEIEDIQ-QEIQFLSQC-RSPYITKYYGSFLKGS 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCC------eEEEEEEeeccccchHHHHHH-HHHHHHHHc-CCCCeeeeeEEEEECC
Confidence 47899999999999999999987655 4899999865432 2222333 333444555 5999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+|+||+.| +|.+++.. .++++..++.++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++...
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999985 77777653 278999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC-
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG- 279 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~- 279 (632)
... .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...++.+....+. ....+..+..
T Consensus 150 ~~~---~~~~~~~~~~~y~~PE~~~~~---~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 222 (274)
T cd06609 150 STM---SKRNTFVGTPFWMAPEVIKQS---GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNK 222 (274)
T ss_pred ccc---cccccccCCccccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccc
Confidence 321 122335688999999998743 58899999999999999999999998877665554443 2344445555
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++.+++.+||..||++||++.++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 8999999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.11 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=205.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||.|+||.||.+.+..++ +.+++|.+.... ......+.+ +..++.++ +|+||+.+++++..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~-e~~~l~~~-~h~~i~~~~~~~~~~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDD------SLVVWKEVNLTRLSEKERRDALN-EIVILSLL-QHPNIIAYYNHFMDDN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCC------cEEEEEEEeecccchhHHHHHHH-HHHHHHhC-CCCCeeEEEeEEecCC
Confidence 5899999999999999999987655 479999876432 222233333 33455554 7899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.++++|||++ |+|.+.+.......+++.++..++.|++.||.|||+.+++|+||||+||++++++.+||+|||++....
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 9999999998 588888876545678999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
... .......|++.|+|||++.+. .++.++|+||||+++|||++|..||...+..+....+... .....+..+
T Consensus 153 ~~~---~~~~~~~~~~~y~ape~~~~~---~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08221 153 SEY---SMAETVVGTPYYMSPELCQGV---KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG-NYTPVVSVY 225 (256)
T ss_pred ccc---ccccccCCCccccCHhhcCCC---CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCCCcccc
Confidence 322 122345689999999998643 4678999999999999999999999988877776666533 333445778
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
+.++.+++.+||..||.+||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 9999999999999999999999998873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=308.11 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=187.1
Q ss_pred EEcccCceEEEEEEEcCCCC------------------CcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee
Q 006772 50 RIGRGPFGDVWLATHHQSAD------------------DFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 50 ~IG~G~FG~VylA~~~~~~~------------------~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
.||+|+||.||+|.....+. .......||+|++..........+.++ ..++.. .+|+||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~-~~~~~~-l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFET-ASLMSQ-VSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHH-HHHHhc-CCCCCee
Confidence 59999999999998643211 112234699999865443333333333 344444 4789999
Q ss_pred EeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-----
Q 006772 112 WLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----- 186 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----- 186 (632)
++++++..+...++||||++|..++.+.....+.+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999996544544444456899999999999999999999999999999999999998654
Q ss_pred --cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHH-hCCCCCCCCCHHHH
Q 006772 187 --QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEML-TGIQPWFGKSVEEI 263 (632)
Q Consensus 187 --~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Eml-tG~~PF~~~~~~ei 263 (632)
.+|++|||++...... ....++..|+|||.+.+. ..++.++|+|||||++|||+ +|..||......+.
T Consensus 160 ~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG--NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cceeeecCCccccccccc-------cccccCCcccCchhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 4899999987543211 123568889999988642 35788999999999999995 69999988765554
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
.... ......|...++++.++|.+||+.+|++||++.++++.|
T Consensus 231 ~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFY---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 3222 123345566778999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.37 Aligned_cols=248 Identities=20% Similarity=0.323 Sum_probs=200.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+.|++.+.||+|+||.||+|.+..++ +.||+|.+..... .....+.++ ..++..+ +|+|++.+.+++..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~E-i~~l~~l-~h~niv~~~~~~~~ 86 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTN------EVVAIKKMSYSGKQSNEKWQDIIKE-VRFLQQL-RHPNTIEYKGCYLR 86 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCC------cEEEEEEEeccccCcHHHHHHHHHH-HHHHHhC-CCCCEEEEEEEEEe
Confidence 56999999999999999999987654 4899999864322 222233333 3444554 79999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++..|+||||+.|++.+.+... ...+++..+..++.|++.||.|||+.+|+||||+|+||++++++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 87 EHTAWLVMEYCLGSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred CCeEEEEHHhhCCCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 9999999999999998887654 357899999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC-CC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI-PS 278 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~-p~ 278 (632)
.. .....|++.|+|||++.+...+.++.++|+||||+++|||++|..||.+.+.......+.. ...+.. +.
T Consensus 166 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (307)
T cd06607 166 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLSSN 237 (307)
T ss_pred CC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCCCCCch
Confidence 22 1234678899999998543345688899999999999999999999988776554443332 223332 34
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++.++.++|.+||+.||++||++.+++.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 57889999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.09 Aligned_cols=258 Identities=23% Similarity=0.406 Sum_probs=203.3
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...++.++|++.+.||+|+||.||+|.+..++ +.||||.++.... .....+..+. .++.+...|+||+.+++
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~e~-~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTG------HVMAVKQMRRTGNKEENKRILMDL-DVVLKSHDCPYIVKCYG 81 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCC------eEEEEEEEeccCChHHHHHHHHHH-HHHHhccCCCchHhhhe
Confidence 34567799999999999999999999987654 4899999975432 2233333433 34455667999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..+...|++|||+.+.+.+++... ...+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~v~e~~~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 82 YFITDSDVFICMELMSTCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eeecCCeEEEEeeccCcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 99999999999999998877776553 3589999999999999999999997 599999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCC-CCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhcc
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKE 272 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~ 272 (632)
++..+.... ......++..|+|||.+.+.. .+.++.++|+||||+++|||++|+.||..... .+.+..+.. ..
T Consensus 161 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~ 235 (296)
T cd06618 161 ISGRLVDSK----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EE 235 (296)
T ss_pred cchhccCCC----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-CC
Confidence 987543211 112235788999999987442 34578899999999999999999999976433 333333332 22
Q ss_pred CCCCCC--CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPS--GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~--~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+..+. .++.++.+++.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 333332 47899999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.09 Aligned_cols=255 Identities=19% Similarity=0.238 Sum_probs=189.5
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
+.||+|+||.||+|.+.... ....+|+|.+.............++..++..+ +|+||+.+++.+......++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY----TPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCC----CceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEE
Confidence 46899999999999865321 23479999987544322222223333444554 78999999999988889999999
Q ss_pred cCC-CCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 129 FYE-GSVGDRIAQQRG---GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 129 y~~-GsL~d~l~~~~~---~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
|++ |+|.+++..... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 998 677777764321 2456778889999999999999999999999999999999999999999999865322211
Q ss_pred CCCccccccCCCccCCccccCCCCC----CCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc----cCCC
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVR----GPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKK----EKPC 275 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~----g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~----~~p~ 275 (632)
........|+..|+|||++..... ..++.++|+|||||++|||++ |..||......+......... ..+.
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 -YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred -eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 111123457889999999863211 235789999999999999996 999998776655443322211 1122
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.....++.+.+++.+|| .+|++||++++|+..|+
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 33457889999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.15 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=205.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..+. +.||+|.+.+..... ....+.++..++.. .+|+||+.+++.+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETR------QRFAMKKINKQNLILRNQIQQVFVERDILTF-AENPFVVSMFCSFETK 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCC------cEEEEEEeehhhhhhHHHHHHHHHHHHHHHh-CCCCCeeeeEEEEecC
Confidence 47999999999999999999987655 489999986543211 11122223333443 4789999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+.+++||||++| +|.+++... +.+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 999999999985 666666442 57899999999999999999999999999999999999999999999999998642
Q ss_pred cCCCCC------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 200 LGRSLS------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 200 ~~~~~~------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
...... ........|+..|+|||.+.. ..++.++|+|||||++|||++|..||.+.+..+....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111000 001112457889999999864 36789999999999999999999999998887776665
Q ss_pred Hhhcc-CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcccc
Q 006772 268 VIKKE-KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGL 325 (632)
Q Consensus 268 ~~~~~-~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~ 325 (632)
..... .+..+..+|+++.++|.+||+.||++||++.++.+.++ ++++...+|...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~---~~~~~~~~~~~~ 284 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ---HRFFLGLDWNGL 284 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh---CccccCCCHHHH
Confidence 53321 22233468999999999999999999998655444333 566766777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.85 Aligned_cols=253 Identities=22% Similarity=0.422 Sum_probs=200.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|++.+|++.+.||+|+||.||+|.+... +.+|+|.+...... ...+..+. .++..+ .|++++.+++++..
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~-------~~~~~k~~~~~~~~-~~~~~~e~-~~l~~l-~~~~i~~~~~~~~~ 70 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEK-------RKVAIKTIREGAMS-EEDFIEEA-QVMMKL-SHPKLVQLYGVCTE 70 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCC-------CeEEEEECCCCCCC-HHHHHHHH-HHHHhC-CCCCeeeEEEEEcc
Confidence 4678999999999999999999987532 37999988643322 23344433 444444 68999999999998
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
....+++|||+.| +|.+++.. ..+.+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++..
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 71 RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred CCceEEEEEcCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceee
Confidence 8999999999985 66666543 335789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
....... ......++..|+|||++.+ +.++.++|+||||+++|||++ |..||......+....+.. ...+..|
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~aPe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 223 (256)
T cd05112 150 VLDDQYT--SSTGTKFPVKWSSPEVFSF---SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKP 223 (256)
T ss_pred cccCccc--ccCCCccchhhcCHhHhcc---CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCC
Confidence 5322111 1112234678999999864 367889999999999999998 9999988777766665542 2334446
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
...+.++.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 67899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=304.83 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=198.9
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||+|.+............+|||.+..... .....+.++ ..++..+ +|+||+.+++++..++..+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKE-AHLMSNF-NHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHH-HHHHHhc-CCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999998865432223335799998865332 223333333 3344444 7999999999999899999999
Q ss_pred ecCC-CCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-----cEEEEecCCc
Q 006772 128 KFYE-GSVGDRIAQQR-----GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-----QLVLGDFGIP 196 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~-----~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-----~vkL~DFGla 196 (632)
||++ |+|.+++.... ...+++.+++.++.|++.||+|||+++++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9998 68888876532 23478899999999999999999999999999999999999888 8999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+........ .......++..|+|||++.+ +.++.++|+|||||++|||++ |..||...+..+....+. ....+.
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~ 233 (269)
T cd05044 159 RDIYKSDYY-RKEGEGLLPVRWMAPESLLD---GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQ 233 (269)
T ss_pred ccccccccc-ccCcccCCCccccCHHHHcc---CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccC
Confidence 755322111 11122345789999999863 468899999999999999998 999998877666655443 234455
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.+..+|.++.++|.+||+.+|.+||++.++++.|+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 67788999999999999999999999999998775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.72 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=200.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||.|+||+||+|.+..++ ..+|+|++...... ....+.++ ...+..+ .|++++.+++.+..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~~~ 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNN------EKVAIKRIDLEKCQTSVDELRKE-VQAMSQC-NHPNVVKYYTSFVVGD 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCC------cEEEEEEeccCCcchHHHHHHHH-HHHHHhc-CCCCEEEEEEEEeeCC
Confidence 47999999999999999999976544 48999998653322 22333333 3344444 7899999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
..+++|||++| +|.+++..... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||++..+
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 99999999985 77777755432 57899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCC-CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC-
Q 006772 200 LGRSLSD-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP- 277 (632)
Q Consensus 200 ~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p- 277 (632)
....... .......|+..|+|||++... ..++.++|+|||||++|||++|+.||...+..+.+...... ..+.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 229 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQV--HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLET 229 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccc--cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCC
Confidence 4332211 112334689999999998643 25788999999999999999999999887766555554432 222222
Q ss_pred ----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 ----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 257899999999999999999999999886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.78 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=191.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
...|.+.+.||+|+||.||+|.+...+ +.||||..... .+. .+..++.++ +|+||+.+++++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~------~~vavK~~~~~------~~~-~E~~iL~~L-~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP------QRVVVKAGWYA------SSV-HEARLLRRL-SHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC------CEEEEeccccc------CHH-HHHHHHHHC-CCCCCCcEEEEEEECC
Confidence 457999999999999999999987655 48999964321 112 233444554 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..|||||++.|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEEEEEccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99999999999999888653 34799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhhcc-
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--------VEEIYHSVVIKKE- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--------~~ei~~~i~~~~~- 272 (632)
... ........||+.|||||++.+. .++.++|||||||+||||++|..|+.... ..++...+.....
T Consensus 313 ~~~-~~~~~~~~GT~~Y~APE~~~~~---~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 313 SWS-TPFHYGIAGTVDTNAPEVLAGD---PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ccc-cccccccCCCcCCcCHHHHcCC---CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 211 1112345799999999999743 68899999999999999999877654321 2222222221110
Q ss_pred CCCCC-------------------------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIP-------------------------------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p-------------------------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...++ ..++.++.+||.+||+.||.+|||+.|+|+
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00011 134568999999999999999999999997
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.69 Aligned_cols=249 Identities=23% Similarity=0.412 Sum_probs=203.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||++.+..++ +.||+|.+.... ......+.++ ...++.+ +|+||+.+.+.+..++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG------KQYVIKEINISKMSPKEREESRKE-VAVLSNM-KHPNIVQYQESFEENG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC------CEEEEEEEEhHhCChHHHHHHHHH-HHHHHhC-CCCCeeeeEeeecCCC
Confidence 5899999999999999999987654 489999986422 2222233333 3344444 6899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|+||||+. ++|.+.+.......+++..++.++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++....
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 9999999998 588887765544578999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
... .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+.. ...+..+..+
T Consensus 153 ~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 225 (256)
T cd08218 153 STV---ELARTCIGTPYYLSPEICEN---RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHY 225 (256)
T ss_pred cch---hhhhhccCCccccCHHHhCC---CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccC
Confidence 221 11123458899999999864 3578899999999999999999999998877777666543 4445567889
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++.++|.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.69 Aligned_cols=264 Identities=22% Similarity=0.343 Sum_probs=201.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
..++|++.+.||+|+||.||+|.+...+. ..+..||||++...... ....+.++ ...+..+ .|+||+.+.+++..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~e-i~~l~~l-~~~~i~~~~~~~~~ 77 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGD--NTGEQVAVKSLNHSGEEQHRSDFERE-IEILRTL-DHENIVKYKGVCEK 77 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCC--CCceEEEEEEeccccchHHHHHHHHH-HHHHHhC-CCCChheEEeeeec
Confidence 34678999999999999999998764421 23468999999765443 23333333 3444554 78999999988876
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 --NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 --~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
+...+++|||++ |+|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||++.++.++|+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 557999999998 5787777553 236899999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH--------------
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE-------------- 262 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e-------------- 262 (632)
.................++..|+|||.+.. ..++.++|+|||||++|||++|..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRT---SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHcc---CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence 765422111111112234567999999864 367889999999999999999999987643221
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 263 i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..............+..++.++.+++.+||+.||++||++.|+++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11122222333444567889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.40 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=203.5
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
||.|+||.||+|.+..++ ..||+|++.+.... .....+..+..++..+ +|+||+.+.+.+..+...|++||
T Consensus 1 lg~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN------RTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCC------cEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEe
Confidence 699999999999987654 48999998653321 2222233333445555 79999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCC
Q 006772 129 FYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207 (632)
Q Consensus 129 y~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~ 207 (632)
|++ |+|.+.+.+. ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 74 YCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 998 5777777543 468999999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--VEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 208 ~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
......|++.|++||.+.. ..++.++|+||||+++|+|++|..||.... ..+.+..+......+.+|..+++++.
T Consensus 148 ~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILN---KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAK 224 (262)
T ss_pred ccccccCCcCccChhHhcC---CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHH
Confidence 2233468999999999863 357889999999999999999999998876 55666665544566777888899999
Q ss_pred HHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCcc
Q 006772 286 NVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~ 323 (632)
++|.+||+.||++||+ ++|+++ +++|.+.+|+
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~~~~ 261 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK------HKWFNGFDWE 261 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc------ChhhhCCCCC
Confidence 9999999999999999 677665 6777777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.88 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=202.6
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
||+|+||+||+|.+..++ +.||+|.+.+... .........+..++..+ +|+|++.+++.+...+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATG------KMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCC------cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEe
Confidence 699999999999887654 4899999865321 11122222333455555 59999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCC
Q 006772 129 FYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDS 207 (632)
Q Consensus 129 y~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~ 207 (632)
|++ ++|.+++.......+++.+++.++.|++.||.|||+++++||||||+|||+++++.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----K 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC----C
Confidence 998 57777776554457999999999999999999999999999999999999999999999999988754321 1
Q ss_pred ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhccCCCCCCCCCHH
Q 006772 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVIKKEKPCIPSGLPPA 283 (632)
Q Consensus 208 ~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~~~~~p~~p~~lp~~ 283 (632)
......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..... .++...+. .....++..++++
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGE---VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--EMAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCC---CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--cccccCCccCCHH
Confidence 22234578899999998643 578899999999999999999999977543 22222221 2344566778999
Q ss_pred HHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCC
Q 006772 284 VENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTS 334 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~ 334 (632)
+.++|.+||+.||.+|| ++.+++. ++++...+|........++++
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~------h~~~~~~~~~~~~~~~~~~~~ 274 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE------HPLFKDLNWRRLEAGMLEPPF 274 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh------ChhhhcCChhhhhcCCCCCCC
Confidence 99999999999999999 5555554 677888888876655444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.44 Aligned_cols=262 Identities=15% Similarity=0.143 Sum_probs=188.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHH--HH-----HHHHHh--hhccCCCce
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF--VN-----KFEELF--PKFRESQSV 110 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~--~~-----~~~~il--~~l~~h~~I 110 (632)
|..++|++.+.||+|+||.||+|.+..+.. ....+|+|+..........+. .. .....+ .....|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC---INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcc---cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 445789999999999999999999876521 123677776433221111110 00 000011 122468889
Q ss_pred eEeeEEEEECC----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 111 CWLHGISVING----KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 111 ~~l~~~~~~~~----~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
+.+++++.... ..+++|+++..++.+.+... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 98888765442 45789999888877776543 3568888999999999999999999999999999999999999
Q ss_pred cEEEEecCCceeccCCCC----CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HH
Q 006772 187 QLVLGDFGIPYLLLGRSL----SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VE 261 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ 261 (632)
.++|+|||+|+....... .........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+ ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~---~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA---CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999986532211 11122334699999999998743 68899999999999999999999998763 22
Q ss_pred HHHHHH----Hhh-ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 262 EIYHSV----VIK-KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 262 ei~~~i----~~~-~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
+..... ... ......+..++.++.+++..|++.+|++||++.+|++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 211111 111 011112356789999999999999999999999999865
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.71 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=199.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++.++|++.+.||+|+||.||++... ++.||+|.+..... ...+.++ ..++..+ +|+|++.+.+++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~iK~~~~~~~--~~~~~~e-~~~l~~~-~~~~i~~~~~~~~~ 70 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYT--------GQKVAVKNIKCDVT--AQAFLEE-TAVMTKL-HHKNLVRLLGVILH 70 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccC--------CCceEEEeecCcch--HHHHHHH-HHHHHhC-CCCCcCeEEEEEcC
Confidence 35678999999999999999998642 24799999864322 2333333 3444444 78999999998865
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+ ..+++|||+. |+|.+++.......+++..++.++.|++.||.|||+++++||||||+|||++.++.++|+|||+++.
T Consensus 71 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 71 N-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred C-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 4 4799999998 5888888765555789999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.... ......+..|+|||.+.+ +.++.++|+|||||++|||++ |..||...+..+....+. ....+..+
T Consensus 150 ~~~~------~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 219 (254)
T cd05083 150 GSMG------VDNSKLPVKWTAPEALKH---KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPP 219 (254)
T ss_pred cccc------CCCCCCCceecCHHHhcc---CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCC
Confidence 3211 112234568999999863 468889999999999999998 999999888776665554 33444456
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
..+|..+.+++.+||+.+|++||++.++++.|+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 788999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.37 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=185.8
Q ss_pred eEEcccCceEEEEEEEcCCCCC------cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 49 HRIGRGPFGDVWLATHHQSADD------FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~------~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.||+|+||.||+|.......+ ......|++|.+..........+.++ ..++.. .+||||+.+++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~-~~~l~~-l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET-ASMMRQ-VSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHH-HHHHHh-CCCCCEeeEEEEEecCCC
Confidence 4689999999999986432210 11234689998865443333333333 233333 478999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc-------EEEEecCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ-------LVLGDFGI 195 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~-------vkL~DFGl 195 (632)
.+++|||++++.++.+.......+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999965555555444567999999999999999999999999999999999999987764 89999998
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHH-hCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEML-TGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Eml-tG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+..... .....|+..|||||.+.. ...++.++|||||||++|||+ +|..||......+... .. ....
T Consensus 159 ~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~--~~~~ 226 (262)
T cd05077 159 PITVLS-------RQECVERIPWIAPECVED--SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FY--EGQC 226 (262)
T ss_pred CccccC-------cccccccccccChhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HH--hcCc
Confidence 865421 122357889999998853 235788999999999999998 5899988766544322 11 1122
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
......+.++.+||.+||+.||.+||++.+|++.|
T Consensus 227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 23344568899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.33 Aligned_cols=257 Identities=19% Similarity=0.337 Sum_probs=198.1
Q ss_pred EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHh--hhccCCCceeEeeEEEEECCEEEE
Q 006772 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELF--PKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 50 ~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il--~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
.||+|+||.||+|.+..++ +.||+|.+.+.... ........+..++ .....|++++.+.+.+..++..|+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 74 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 74 (278)
T ss_pred CcccCCCeEEEEEEEecCC------CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence 3899999999999987554 48999998653211 1111111122222 222478999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||||+.| +|.+++.. .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||++......
T Consensus 75 v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 75 ILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (278)
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence 9999985 56555543 357999999999999999999999999999999999999999999999999998654221
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhccCCCCCCCCC
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---VEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~---~~ei~~~i~~~~~~p~~p~~lp 281 (632)
......|+..|+|||++... ..++.++|+||+||++|||++|..||.... .......+ ....+.+|..++
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s 223 (278)
T cd05606 151 ---KPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFS 223 (278)
T ss_pred ---CCcCcCCCcCCcCcHHhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCC
Confidence 12334789999999998632 247889999999999999999999998763 23322222 234456677889
Q ss_pred HHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCcccccccc
Q 006772 282 PAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRA 329 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~ 329 (632)
.++.+++.+||..||.+|| ++.++++ ++++.+.+|.......
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~------~~~~~~~~~~~~~~~~ 270 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------HPFFRSLDWQMVFLQK 270 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh------CccccCCCchHhhhcc
Confidence 9999999999999999999 8888875 6777778787665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.57 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=199.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--------HHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--------AKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--------~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
+|.+...||.|+||.||+|.+..++ +.||+|.+....... .......+..++..+ +|+||+.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 73 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG------ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLG 73 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC------cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEE
Confidence 4678899999999999999976544 489999886532211 111222333444554 7899999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++..+++|||++| +|.+++... +.+++..+..++.|++.||+|||+++++||||||+|||+++++.++|+|||
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 74 SSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred EEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccC
Confidence 99999999999999985 677776543 578999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCC---CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 195 IPYLLLGRSLS---DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 195 lak~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
+++........ ........|+..|+|||.+.+ +.++.++|+|||||++|+|++|..||...+.......+.. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~ 227 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ---TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-N 227 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhcc---CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-c
Confidence 98866432111 111123468899999999864 3578899999999999999999999988765544444332 3
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+.+|..++.++.++|.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 455677889999999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=312.67 Aligned_cols=250 Identities=20% Similarity=0.251 Sum_probs=183.6
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--CCEEEE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI--NGKICI 125 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--~~~l~L 125 (632)
..+||+|+||.||+|.+.... ....||+|.+...... ..+. ++..++..+ .|+||+.+++++.. +..+|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~----~~~~~a~k~~~~~~~~--~~~~-~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTGIS--MSAC-REIALLREL-KHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC----ccceEEEEEecCCCCc--HHHH-HHHHHHHhC-CCCCeeeEEEEEeccCCCeEEE
Confidence 468999999999999875432 2358999998654321 2222 233444444 68999999998754 568899
Q ss_pred EEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE----ecCCcEEEEecC
Q 006772 126 AMKFYEGSVGDRIAQQR-------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL----SEHDQLVLGDFG 194 (632)
Q Consensus 126 VmEy~~GsL~d~l~~~~-------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl----d~~g~vkL~DFG 194 (632)
+|||+.+++.+.+.... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99999999888875321 2358899999999999999999999999999999999999 566799999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH---------HHH
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE---------IYH 265 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e---------i~~ 265 (632)
+++................||+.|+|||++.+. ..++.++|+|||||++|||+||..||....... ...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCC--CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 998654332222223345789999999998642 347889999999999999999999997543210 000
Q ss_pred HHHhh-c-----------cCC------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 266 SVVIK-K-----------EKP------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 266 ~i~~~-~-----------~~p------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+... . ..+ ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0 000 001123567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.21 Aligned_cols=264 Identities=18% Similarity=0.300 Sum_probs=211.0
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|..-++++.+.|-+|||+.||+|.+...+ ..||+|++.... +.......++..+++.+..|+||+.+++.+.
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~------~~~AlKrm~~~d-e~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGG------KKYALKRMYVND-EEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCC------ceeeeeeeecCC-HHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 355678899999999999999999987653 489999987654 3445556666688899999999999988322
Q ss_pred E----C---CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEecCCcE
Q 006772 119 I----N---GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 119 ~----~---~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld~~g~v 188 (632)
. + -.++|.||||. |+|.|++..+....|++.++++|+.|+++|+.+||... |||||||-|||||+.+|+.
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 1 1 35789999999 79999998776667999999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeccCCCCCCCcc------ccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDM------ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~------~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e 262 (632)
||||||.|............. -..-.|+.|.|||++.--..-++++|+|||+|||+||-|+....||.+.....
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 999999885432111000000 01135899999999875445578999999999999999999999998754332
Q ss_pred HHHHHHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 263 IYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 263 i~~~i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
|+ .....+| +..+..+.+||+.||+.||.+||++.++++.+..+.+.
T Consensus 266 ----Il--ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 ----IL--NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----EE--eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 22 3333444 47889999999999999999999999999877776553
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.07 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=201.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ ..+|+|.+..... .....+. .+..+++.+ +|++++.+++.+..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~-~e~~~l~~~-~~~~i~~~~~~~~~~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ------KLVIIKQIPVEQMTKDERLAAQ-NECQVLKLL-SHPNIIEYYENFLEDK 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC------cEEEEEEEeccccccHHHHHHH-HHHHHHhhC-CCCchhheeeeEecCC
Confidence 5899999999999999999987654 4899999865421 2222222 333444444 6899999999998899
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCceec
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGlak~~ 199 (632)
..++||||++ ++|.+++.......+++..++.++.|++.+|+|||+++++|+||||+||++++++ .++|+|||++...
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999998 4788888765555689999999999999999999999999999999999998654 6799999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.. .....++..
T Consensus 153 ~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd08220 153 SSKS----KAYTVVGTPCYISPELCEG---KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDR 224 (256)
T ss_pred CCCc----cccccccCCcccCchhccC---CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCC
Confidence 3321 1223468899999999874 3578899999999999999999999998877666555543 334456778
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++++.+++.+||+.||.+||++.+++.
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 9999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.00 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=197.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||.|+||.||+|.+..++ ..||||.+...... ....+.+ +..++..+ +|+||+.+++++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~i~~~~~~~~~~~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTG------EVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKLLDVIHTEN 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCC------CEEEEEEccccccccccchHHHH-HHHHHHhc-CCCCCcchhhhcccCC
Confidence 5899999999999999999987655 48999988643221 1122233 33445555 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..++||||+.+++.+++.......+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 73 ~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 73 KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999988888766567899999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC-------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP------- 274 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p------- 274 (632)
. ........+++.|+|||++.+. ..++.++|+|||||++|||+||+.||.+.+..+....+......+
T Consensus 153 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 153 P---VRTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred C---ccccccccccccccCCeEEecC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1 1112233578899999988642 246789999999999999999999998876544333322111110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+++++.++|.+||+.||.+||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 011346789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.74 Aligned_cols=252 Identities=20% Similarity=0.321 Sum_probs=195.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.++.++ +.||+|.+..... .........+..++..+ .|+|++.+++++..+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETG------QIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCC------cEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCC
Confidence 47999999999999999999987654 4899999864322 11122223333444454 6899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..++||||+++++++.+... ...+++..++.++.||+.||+|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999999998777766543 34789999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc---------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE--------- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~--------- 272 (632)
... ......++..|+|||++.+. ..++.++|+|||||++|||++|..||.+.+..+....+.....
T Consensus 153 ~~~---~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 153 PGD---DYTDYVATRWYRAPELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred Ccc---cccCcccccccCCHHHHhCC--CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 211 12234578899999998642 3578899999999999999999999998765443332221000
Q ss_pred -----------CCC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 -----------KPC---------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 -----------~p~---------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+. .-..++..+.+|+.+||+.||++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 01246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=306.23 Aligned_cols=246 Identities=19% Similarity=0.318 Sum_probs=187.5
Q ss_pred eEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||+|.++..+.. ......||+|.+........+.+.+ +..++.. .+|+|++.+++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-e~~~l~~-~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQ-LSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHH-HHHHHHh-CCCCChhheeeEEEeCCCcEEEE
Confidence 4699999999999988654321 1123468888875433222233332 3333444 47999999999999989999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc--------EEEEecCCcee
Q 006772 128 KFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ--------LVLGDFGIPYL 198 (632)
Q Consensus 128 Ey~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~--------vkL~DFGlak~ 198 (632)
||++| +|.+++.. .+..+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++|||++..
T Consensus 79 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 79 EYVKFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred ecCCCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99985 56666543 3347899999999999999999999999999999999999988765 69999998764
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
... .....+++.|+|||++.+. ..++.++|+|||||++|||++| ..||...+...... + ......+|
T Consensus 158 ~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~--~~~~~~~~ 225 (258)
T cd05078 158 VLP-------KEILLERIPWVPPECIENP--QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-F--YEDRHQLP 225 (258)
T ss_pred cCC-------chhccccCCccCchhccCC--CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-H--HHccccCC
Confidence 321 1234678899999998642 2478899999999999999998 46666655443322 2 13345567
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
...+.++.++|.+||+.||++||+++++++.|
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 77889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.07 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=193.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|++.+.||+|+||.||+|.++.++ +.||||.+........ ..+. ++..++..+ +|+||+.+++++..+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~-~E~~~l~~l-~h~~i~~~~~~~~~~ 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTG------QLVALKEIRLEHEEGAPFTAI-REASLLKDL-KHANIVTLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCC------cEEEEEEEecccccCCchhHH-HHHHHHhhC-CCcceeeEEEEEecC
Confidence 478999999999999999999987554 4899999865332211 2222 233445554 789999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+..|+||||+.++|.+.+... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 999999999999998887654 3478999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhccC------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEK------ 273 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~~~~~------ 273 (632)
.. ........++..|+|||++.+. ..++.++|+|||||++|||++|..||.+.. ..+....+......
T Consensus 155 ~~---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 155 VP---SKTYSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred CC---CccccccccccccCCcHHhhcC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 11 1111223568899999998642 347889999999999999999999997655 22222211100000
Q ss_pred ------------------C----CCCCCCC--HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ------------------P----CIPSGLP--PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ------------------p----~~p~~lp--~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ .....++ .++.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0001234 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.80 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=198.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
+|++.++||.|+||.||+|++..++ ..||||.+..............+..++..+ +|+|++.+++.+...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTG------EIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCC------eEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcE
Confidence 5899999999999999999987655 489999987543322222222333455555 689999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYEGSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
+|||||+.|++.+++.... ...+++..+..++.|++.||+|||+++++||||||+||++++++.++|+|||++......
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 74 MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9999999999988876543 246899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP-------- 274 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p-------- 274 (632)
........++..|++||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+....+......+
T Consensus 154 ---~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 154 ---VNTFSNEVVTLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred ---ccccccccccccccChHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 1112234578899999998643 246789999999999999999999999877655444332111000
Q ss_pred --------C-----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------C-----------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------~-----------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. +.+.+++++.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 11346788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.79 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=198.3
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHH--HHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF--VNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~--~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
+.||+|+||.||+|.+..++ +.||+|++.+......... ...+..++....+|+|++.+++.+..++..|++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG------DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV 75 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC------CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence 56899999999999987655 4899999865332111111 122223344455899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC
Q 006772 127 MKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205 (632)
Q Consensus 127 mEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~ 205 (632)
|||++| +|.+++... +.+++..+..++.|++.||.|||+.+++||||+|+|||+++++.++|+|||+++....
T Consensus 76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999984 777666443 4789999999999999999999999999999999999999999999999998875322
Q ss_pred CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc--CCCCCCCCCHH
Q 006772 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE--KPCIPSGLPPA 283 (632)
Q Consensus 206 ~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~--~p~~p~~lp~~ 283 (632)
.....|+..|+|||.+.+. .++.++|+||||+++|||++|..||...+..+.+..+..... ....+..++++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGV---GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred ---cccCCCCcCccChhhhcCC---CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHH
Confidence 1234578999999998743 478899999999999999999999998887776666543222 12233468999
Q ss_pred HHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 284 VENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
+.+++.+||+.||++||++.++.+.+ .++++.+.+|+
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l---~~~~~~~~~~~ 260 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIK---SHPFFKSINWD 260 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHH---cChHhhcCCCC
Confidence 99999999999999999765443322 25677777774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=305.71 Aligned_cols=248 Identities=20% Similarity=0.345 Sum_probs=198.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.+|++.+.||.|+||.||+|.+..++ +.||+|.+..........+.++ ..++..+ +|+|++.+++.+..++.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~e-~~~l~~l-~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATG------QEVAIKQINLQKQPKKELIINE-ILVMKEL-KNPNIVNFLDSFLVGDE 90 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCC------cEEEEEEEecccCchHHHHHHH-HHHHHhc-CCCceeeeeeeEecCce
Confidence 57999999999999999999987655 4899999865433333333333 3344444 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||+.| +|.+.+.. ..+++.+++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999985 55555532 3689999999999999999999999999999999999999999999999998875432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p~~p~~l 280 (632)
.. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.... .....+..+
T Consensus 168 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06655 168 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (296)
T ss_pred cc---ccCCCcCCCccccCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccC
Confidence 21 11223468899999999864 357889999999999999999999999887655443333221 122345678
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.+.++|.+||..||.+||++.+++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.23 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=198.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+|++.+.||+|+||.||+|.+..++ ..||+|.+..... .........+..++..+ +|+|++.+++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETG------ETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCC------ceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCe
Confidence 5899999999999999999987655 4899999875432 11122223333445555 59999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
.++||||+.++|.+++... ...+++.+++.++.||+.||+|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 74 ~~~v~e~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 74 FVLVMEYMPSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred eEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9999999977888877654 357999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP-------- 274 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p-------- 274 (632)
.. .......|+..|+|||++.+. ..++.++|+|||||++|||++|.+||.+.+..+.+..+......+
T Consensus 153 ~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 153 EP--RLYSHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CC--CccccccCcccccCceeeecc--ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc
Confidence 11 122345689999999998642 346889999999999999999988888776555444433211111
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+..+.++.++|.+||..||++||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011345789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=326.85 Aligned_cols=247 Identities=19% Similarity=0.328 Sum_probs=200.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccC-----CCceeEeeEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE-----SQSVCWLHGISV 118 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~-----h~~I~~l~~~~~ 118 (632)
+|.+.+.||+|+||.|-+|.++++++ .||||+++.......+. ..+..++..+.. --|+++++++|.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e------~VAIKIiKN~k~f~~Q~--~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGE------IVAIKIIKNKKRFLRQA--QIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCc------EEEEEeeccChHHHHHH--HHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 68889999999999999999998885 89999998654432221 112234444442 347999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC--cEEEEecCCc
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD--QLVLGDFGIP 196 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g--~vkL~DFGla 196 (632)
..+++|||.|.+.-+|.+++..++...|++..++.++.||+.||.+||+.+|||.||||+||||.+-+ .+||+|||.|
T Consensus 259 fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 259 FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999999999999999988878899999999999999999999999999999999999998544 7999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-----
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK----- 271 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~----- 271 (632)
..... ..++.+-+..|.|||++.+ .+|+.+.|+|||||++.||++|.+.|.|.+..+.+..|+.-.
T Consensus 339 c~~~q------~vytYiQSRfYRAPEVILG---lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 339 CFESQ------RVYTYIQSRFYRAPEVILG---LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred cccCC------cceeeeeccccccchhhcc---CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 76422 2335677999999999985 489999999999999999999999999998776555554100
Q ss_pred ---------------------------------------------cCCCCCC-----------CCCHHHHHHHHHhhhcC
Q 006772 272 ---------------------------------------------EKPCIPS-----------GLPPAVENVIIGCFEYD 295 (632)
Q Consensus 272 ---------------------------------------------~~p~~p~-----------~lp~~l~~LI~~cL~~D 295 (632)
.....|. .-...+.++|.+||+.|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0001120 01136789999999999
Q ss_pred cCCCCCHHHHHH
Q 006772 296 LRNRPLMADILH 307 (632)
Q Consensus 296 P~~RPs~~ell~ 307 (632)
|.+|++..+.++
T Consensus 490 P~~R~tp~qal~ 501 (586)
T KOG0667|consen 490 PAERITPAQALN 501 (586)
T ss_pred chhcCCHHHHhc
Confidence 999999988775
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.47 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=211.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHH-HHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKV-FVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~-~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.=|.+.+.||+|.|+.|-+|+|.-+++ .||||++.+.+.+.... .+..+.. ..++-+||||++||.+..++.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGe------kVAVKviDKTKlD~~st~hlfqEVR-CMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGE------KVAVKVIDKTKLDTLSTGHLFQEVR-CMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccc------eeEEEEecccccchhhhhHHHHHHH-HHHHhcCcCeeeeeehhcccc
Confidence 358899999999999999999987775 89999998765443322 1222222 345668999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-cCCcEEEEecCCceec
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-EHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-~~g~vkL~DFGlak~~ 199 (632)
.+|||+|+=+ |+|.|++..+. ..+.+..+.+|+.||+.||.|+|+..+|||||||+|+.+- +-|.+||+|||++-.+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999998 69999998764 4789999999999999999999999999999999998765 6789999999998544
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
. +.....+.||+..|-|||++.+..+. .+++|||||||+||.+.+|++||...+..+.+.+|+ .-+...|..
T Consensus 170 ~----PG~kL~TsCGSLAYSAPEILLGDsYD--APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKYtvPsh 241 (864)
T KOG4717|consen 170 Q----PGKKLTTSCGSLAYSAPEILLGDSYD--APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKYTVPSH 241 (864)
T ss_pred C----CcchhhcccchhhccCchhhhcCccC--CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccccCchh
Confidence 3 23445678999999999999876322 368999999999999999999999998888888877 456778999
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++++||..||.+||.+|.+.+||..
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 9999999999999999999999999874
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=295.41 Aligned_cols=247 Identities=24% Similarity=0.419 Sum_probs=194.8
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
++||+|+||.||+|.+.. + +.||+|.+...... ....+.+ +..++.++ .|++|+.+++++...+..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~------~~v~~K~~~~~~~~~~~~~~~~-e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N------TEVAVKTCRSTLPPDLKRKFLQ-EAEILKQY-DHPNIVKLIGVCVQKQPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeC-C------CcEEEEeccccCCHHHHHHHHH-HHHHHHhC-CCCCeEEEEEEEecCCCeEEEE
Confidence 479999999999999765 3 47999988654333 2223333 33444444 6899999999999999999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||+. ++|.+++... ...+++..++.++.+++.||+|||+++++||||||+|||++.++.++|+|||++.........
T Consensus 72 e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 149 (251)
T cd05041 72 ELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT- 149 (251)
T ss_pred EcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-
Confidence 9997 5676666543 347899999999999999999999999999999999999999999999999998754321111
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVE 285 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~ 285 (632)
.......++..|+|||++.+ +.++.++|+|||||++|||++ |..||...........+.. ......|..+|.++.
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNY---GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIY 225 (251)
T ss_pred eccccCcceeccCChHhhcc---CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHH
Confidence 11111234567999999863 468899999999999999999 8999988776665555432 334456778899999
Q ss_pred HHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 286 NVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
+++.+||..+|.+||++.|+++.|+
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.19 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=192.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
++|++.+.||+|+||.||+|.+..++ ..||||.+.+..... ...+.. +..++..+ +|+||+.+++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~-E~~~l~~l-~h~niv~~~~~~~~~~ 76 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTG------VKVAIKKISPFEHQTFCQRTLR-EIKILRRF-KHENIIGILDIIRPPS 76 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCC------CeEEEEEecccccchhHHHHHH-HHHHHHhC-CCCCcCchhheeeccc
Confidence 68999999999999999999987665 489999986533222 222222 33445555 589999998876543
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 121 ----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 121 ----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
...|++|||+.+++.+.+.. +.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 35899999999988877643 47999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-----
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK----- 271 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~----- 271 (632)
+................||+.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+.......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 7653322222222335789999999987532 357889999999999999999999998765433222111000
Q ss_pred -------------------cCCC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 -------------------EKPC-----IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 -------------------~~p~-----~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+. ..+..++++.++|.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 01345788999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.27 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=210.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+-+.++..||.|+||+||+|..+.+. -..|-|++...+.+..+.++-+. +++..| .||+|+.|++.|..++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~------~lAAaKvIetkseEELEDylVEI-eILa~C-dHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETK------LLAAAKVIETKSEEELEDYLVEI-EILAEC-DHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccch------hhhhhhhhcccchhHHhhhhhhh-hhhhcC-CChHHHHHHHHHhccCc
Confidence 45688999999999999999887544 35678888777776666666655 456666 49999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
++|..|||.|+--|.+.-.-+..+++.++..++.|++.||.|||+++|||||||..|||+.-+|.++|+|||.+......
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999976555555445679999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCC
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPS 278 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~ 278 (632)
.....+++|||+|||||++..+. ..+|++++||||||++|.||..+.+|-...++...+..|. +..+|. .|+
T Consensus 184 ---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia-KSePPTLlqPS 259 (1187)
T KOG0579|consen 184 ---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLLQPS 259 (1187)
T ss_pred ---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh-hcCCCcccCcc
Confidence 12235689999999999987542 3579999999999999999999999998888877666654 233332 578
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++..+.+++.+||.+||..||++++|++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 99999999999999999999999999885
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=298.42 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=196.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+.+++.....||+|+||.||+|.+..++ ..||+|.+........+.+.++. .++..+ +|+||+.+++++..+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~~k~~~~~~~~~~~~~~~e~-~~l~~l-~h~~iv~~~~~~~~~ 77 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQ------VRIAIKEIPERDSRYVQPLHEEI-ALHSYL-KHRNIVQYLGSDSEN 77 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCC------cEEEEEEecCCCHHHHHHHHHHH-HHHHhc-CCCCeeeeeeeeccC
Confidence 3445555678999999999999987654 48999998765544444444443 344444 799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEecCCc
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKL--PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGDFGIP 196 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l--~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~DFGla 196 (632)
+..+++|||+. ++|.+.+... ...+ ++..+..++.||+.||+|||+++|+||||||+||+++. ++.++|+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999998 5777666543 2345 78889999999999999999999999999999999986 679999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~~p~ 275 (632)
....... .......|++.|+|||++... ...++.++|+||||+++|+|++|..||..... .............+.
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06624 157 KRLAGIN---PCTETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232 (268)
T ss_pred eecccCC---CccccCCCCccccChhhhccc-cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCC
Confidence 7653221 112234578999999998643 22477899999999999999999999976432 222222222234566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|..+++++.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 78889999999999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.54 Aligned_cols=250 Identities=22% Similarity=0.429 Sum_probs=196.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+..++|++.+.||+|+||+||+|.+..++ +.||+|++....... ...+.++ .+++..+ +|+||+.+++.+.
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E-~~~l~~l-~h~~i~~~~~~~~ 73 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTG------TVMAKKVVHIGAKSSVRKQILRE-LQIMHEC-RSPYIVSFYGAFL 73 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCC------cEEEEEEEEecCcchHHHHHHHH-HHHHHHc-CCCCcceEeeeEe
Confidence 34578999999999999999999987655 489999886543222 2333333 3444444 7999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..+.+++||||++| +|.+++.. .+.+++..+..++.+++.||.|||+ ++++||||||+||++++++.++|+|||++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 74 NENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred cCCEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 99999999999985 66555543 3578999999999999999999997 68999999999999999999999999987
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-----------HHHH
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-----------EIYH 265 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-----------ei~~ 265 (632)
...... ......|+..|+|||++.+ +.++.++|+|||||++|+|++|..||...... +...
T Consensus 152 ~~~~~~-----~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd06620 152 GELINS-----IADTFVGTSTYMSPERIQG---GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223 (284)
T ss_pred cchhhh-----ccCccccCcccCCHHHHcc---CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH
Confidence 654221 1123578999999999863 36788999999999999999999999865432 2222
Q ss_pred HHHhhccCCCCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 266 SVVIKKEKPCIPSG-LPPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 266 ~i~~~~~~p~~p~~-lp~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
.+. ....+.++.. ++.++.+|+.+||+.||++||++.|+++.
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 224 QIV-QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHh-hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 222 1223334433 88899999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=301.00 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=198.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
.++|++.+.||+|+||.||+|.+..++ +.+|+|.+...... ... ...+..++.++.+|+|++.+++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~------~~~aik~~~~~~~~-~~~-~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDG------SLAAVKILDPISDV-DEE-IEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCC------CEEEEEEecccccH-HHH-HHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 378999999999999999999987654 48999998653321 122 233345566666899999999988653
Q ss_pred ----CEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 121 ----GKICIAMKFYEG-SVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 121 ----~~l~LVmEy~~G-sL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+..|+||||++| +|.+++... ....+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 468999999985 777766532 3457899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|++........ ......|+..|+|||.+.... ...++.++|+|||||++|||++|+.||......+....+....
T Consensus 173 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 173 GVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred ccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 99876432211 112346889999999986431 1236789999999999999999999998876654443332211
Q ss_pred c-CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 E-KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~-~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ....+...+..+.++|.+||+.||++||++.+++.
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11234567789999999999999999999999886
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.37 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=199.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
..|+..++||.|+||.||+|.+..++ ..||||++..... .....+.++ ..++..+ .|++++.+.+.+..++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQ------QVVAIKIIDLEEAEDEIEDIQQE-ITVLSQC-DSPYVTKYYGSYLKGT 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCC------EEEEEEEEeccccHHHHHHHHHH-HHHHHhC-CCCCEeeEEEEEEECC
Confidence 46888899999999999999987655 4899999864332 222333333 3344444 7899999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|+||||++| +|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 99999999985 77776642 478999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
... .......++..|+|||++.+ ..++.++|+|||||++|||++|..||...+.......+ .....+.++..+
T Consensus 153 ~~~---~~~~~~~~~~~y~apE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (277)
T cd06640 153 DTQ---IKRNTFVGTPFWMAPEVIQQ---SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEF 225 (277)
T ss_pred CCc---cccccccCcccccCHhHhcc---CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhh
Confidence 321 11223467889999999863 35788999999999999999999999887766554433 233455566778
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++.+++.+||+.||++||++.+++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 999999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=342.23 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=197.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--h-hHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--D-CAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.++||+|+||.||+|.+..++ +.||||++..... . ....+.+ +..++..+ +||||+.+++++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg------~~VAIK~I~~~l~~~e~~~~rflr-Ei~ILs~L-~HPNIVkl~~v~~d 73 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS------RRVALKKIREDLSENPLLKKRFLR-EAKIAADL-IHPGIVPVYSICSD 73 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC------cEEEEEEECcccccCHHHHHHHHH-HHHHHHhC-CCcCcCeEEEEEee
Confidence 58999999999999999999987655 4899999865321 1 1223333 33444444 68999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEE
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR---------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~---------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vk 189 (632)
++..|++|||++ |+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence 999999999998 57777765321 13456778899999999999999999999999999999999999999
Q ss_pred EEecCCceeccCCCCC---------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC
Q 006772 190 LGDFGIPYLLLGRSLS---------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254 (632)
Q Consensus 190 L~DFGlak~~~~~~~~---------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P 254 (632)
|+|||+++........ .......+||+.|||||++.+. .++.++|+|||||++|||++|..|
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~---~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV---PASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC---CCCcHhHHHHHHHHHHHHHHCCCC
Confidence 9999999865211000 0011234699999999998743 678999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhhccC-CCCCCCCCHHHHHHHHHhhhcCcCCCC-CHHHHHHHHHhhh
Q 006772 255 WFGKSVEEIYHSVVIKKEK-PCIPSGLPPAVENVIIGCFEYDLRNRP-LMADILHAFESSQ 313 (632)
Q Consensus 255 F~~~~~~ei~~~i~~~~~~-p~~p~~lp~~l~~LI~~cL~~DP~~RP-s~~ell~~Le~~~ 313 (632)
|...+..++.......... ......+|+.+.+++.+||+.||++|| +++++++.|+...
T Consensus 231 F~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 231 YRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred CCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9886654433221111111 111246889999999999999999997 5677777776654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.49 Aligned_cols=248 Identities=19% Similarity=0.330 Sum_probs=197.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.+|++.+.||+|+||.||+|.+..++ +.||+|.+........+.+.++ ..++.. .+|+|++.+++.+..++.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~e-~~~l~~-~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATG------QEVAIKQMNLQQQPKKELIINE-ILVMRE-NKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCC------CEEEEEEEecCccchHHHHHHH-HHHHHh-CCCCCEeeEEEEEecCCE
Confidence 68999999999999999999987655 4899999865443333333333 233433 489999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++ ++|.+++.+ ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999998 466666543 3689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-ccCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK-KEKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~-~~~p~~p~~l 280 (632)
.. .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... ......|..+
T Consensus 168 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 168 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred Cc---cCcCcccCCccccCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 21 11223468899999999864 35788999999999999999999999876654332222211 1122345678
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=302.14 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=192.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-HHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-KVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.++.++ ..||+|.+........ ..+.+ +..++..+ .|+||+.+++++..++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~-e~~~l~~l-~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRING------QLVALKVISMKTEEGVPFTAIR-EASLLKGL-KHANIVLLHDIIHTKE 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCC------cEEEEEEecccCcCCCcHHHHH-HHHHHHhc-CCCCEeEEEEEEecCC
Confidence 68999999999999999999987655 4899999865332221 22223 33444554 6899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..|+||||+.+++++.+... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||+++....
T Consensus 77 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 77 TLTFVFEYMHTDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eEEEEEecccCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99999999999988877643 34678899999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhcc--------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKE-------- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~-------- 272 (632)
. ........+++.|+|||++.+. ..++.++|+|||||++|||++|..||.+.+. .+....+.....
T Consensus 156 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 156 P---SQTYSSEVVTLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C---CCCCCCccccccccCCceeecC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 1 1112334578999999998642 2467899999999999999999999987543 222222110000
Q ss_pred -------------CCCCC---------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 -------------KPCIP---------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 -------------~p~~p---------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+ ...++++.+++.+|++.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 012578999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.02 Aligned_cols=254 Identities=20% Similarity=0.358 Sum_probs=201.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc----------hhhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK----------EDCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~----------~~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
+|++.+.||+|+||.||+|.+.... .+.+|+|.+.... ......+..+ ..++.+...|+||+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~-----~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e-~~~l~~~~~h~~i~~~ 74 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNG-----QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE-VTIIKEQLRHPNIVRY 74 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCC-----CceeeeeEeeccccccccccccchHHHHHHHHH-HHHHhhcCCCCCeeeE
Confidence 4788999999999999999987622 2489999875321 1112222222 2334445689999999
Q ss_pred eEEEEECCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEE
Q 006772 114 HGISVINGKICIAMKFYEG-SVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~G-sL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vk 189 (632)
++.+..++..|++|||++| +|.+.+... ....+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred EeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEE
Confidence 9999999999999999985 777776543 34578999999999999999999996 7899999999999999999999
Q ss_pred EEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006772 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~ 269 (632)
|+|||++....... ......|+..|+|||.+.+ +.++.++|+||||+++|||++|..||...+.......+..
T Consensus 155 l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~---~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 227 (269)
T cd08528 155 ITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN---EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227 (269)
T ss_pred Eecccceeeccccc----ccccccCcccCcChhhhcC---CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh
Confidence 99999987653321 2234568999999999874 4578899999999999999999999988776665555543
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
....+......++++.++|.+||+.||++||++.|+...++
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 33333333467899999999999999999999999988664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=295.00 Aligned_cols=253 Identities=28% Similarity=0.503 Sum_probs=198.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ +.||+|.++..... ....+.++. .++..+ +|++|+.+++.+...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~-~~~~~l-~~~~i~~~~~~~~~~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG------ELMAVKEIRIQDNDPKTIKEIADEM-KVLELL-KHPNLVKYYGVEVHRE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC------cEEEEEEEECcccchHHHHHHHHHH-HHHHhC-CCCChhheeeeEecCC
Confidence 5899999999999999999886554 48999998754432 233333333 344444 7899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+++|+||++ ++|.+.+.. +..+++..+..++.|++.||+|||+++|+|+||||+||++++++.+||+|||++....
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred EEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 9999999998 567776654 3468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCc-cccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhccCCCCCC
Q 006772 201 GRSLSDSD-MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 201 ~~~~~~~~-~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~~~p~~p~ 278 (632)
........ .....+++.|+|||++.+.....++.++|+||||+++|||++|..||...+.. .....+. ....+.+|.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 229 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPD 229 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCc
Confidence 33221111 12346789999999987543234788999999999999999999999776432 2222222 244455565
Q ss_pred CC--CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GL--PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~l--p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. ++.+.++|.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 44 899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.99 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=198.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.|++|.+..... ...+.+ +..++..+ +|+|++.+.+.+..+.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~--~~~~~~-e~~~~~~l-~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETG------QVVAIKVVPVEED--LQEIIK-EISILKQC-DSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCC------cEEEEEEeecHHH--HHHHHH-HHHHHHhC-CCCcEeeeeeeeecCC
Confidence 468999999999999999999987644 4899999864322 333333 33445555 8999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|++|||+.| +|.+++.. ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred cEEEEEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 99999999995 66666543 34678999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-ccCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK-KEKPCIPSG 279 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~-~~~p~~p~~ 279 (632)
... .......|+..|+|||++.+. .++.++|+||||+++|+|++|+.||...+..+....+... ......+..
T Consensus 151 ~~~---~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 151 DTM---AKRNTVIGTPFWMAPEVIQEI---GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred cCc---cccccccCCccccCHHHHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 321 112234578999999998643 6788999999999999999999999887655443332211 111223456
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++.++|.+||+.||++||++.+++.
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 7889999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=297.37 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=196.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhH---HHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCA---KVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~---~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+|++.+.||.|+||.||+|.+.. + +.+|+|.+..... ... .....++..++..+ +|+||+.+.+++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~-~------~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQ-G------QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEEcC-C------CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEee
Confidence 47889999999999999997632 2 4799998864321 111 11223333445555 6899999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..+++|||++| +|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||||+||++++++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 99999999999985 676666442 478999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCC---CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-ccC
Q 006772 198 LLLGRSL---SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK-KEK 273 (632)
Q Consensus 198 ~~~~~~~---~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~-~~~ 273 (632)
....... .........|+..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES---GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM 227 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCC---CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence 5422111 11112234689999999998743 5788999999999999999999999876654433333322 234
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+..++.++.++|++||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 5567889999999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.21 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=195.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|.+...... ..+.+.+ +..++..+ +|+||+.+++++..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~i~~~~~~~~~~ 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG------QIVAIKKFLESEDDKMVKKIAMR-EIRMLKQL-RHENLVNLIEVFRRK 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC------CEEEEEeHhhccCcchhhHHHHH-HHHHHHhc-CCcchhhHHHhcccC
Confidence 47999999999999999999987654 48999998653222 1222333 33444444 789999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+..|+||||+++++++.+... ...+++..++.++.|++.||+|||+.+|+|+||+|+||++++++.++|+|||++....
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred CeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999998766665443 3468999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc--------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-------- 272 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-------- 272 (632)
... .......++..|+|||++.+. ..++.++|+|||||++|||++|.+||...+..+....+.....
T Consensus 152 ~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 152 APG---EVYTDYVATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred CCc---cccCcccceeeccCcHHhccc--cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 321 122334678999999998642 3467899999999999999999999987665443333221000
Q ss_pred ------------CCC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 ------------KPC---------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ------------~p~---------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+. ..+.++..+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 12367889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=306.43 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=197.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+.++|++.+.||+|+||.||+|.+..++ ..||+|.+....... .....+ +..++.++ +|+|++.+++++.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~i~~~~~~~~ 76 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSG------EIVALKKVRMDNERDGIPISSLR-EITLLLNL-RHPNIVELKEVVV 76 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCC------cEEEEEEEEeccCCCCCcchhhH-HHHHHHhC-CCCCCcceEEEEe
Confidence 4689999999999999999999987665 489999986432211 111222 23444444 6899999999887
Q ss_pred EC--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 119 IN--GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 119 ~~--~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.. +.+++||||+.++|.+++... ...+++.+++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 77 GKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred cCCCCeEEEEEecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcccee
Confidence 54 578999999999988888654 357999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP-- 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p-- 274 (632)
....... .......+++.|+|||.+.+. ..++.++|+|||||++|||++|..||.+.+..+.+..+......+
T Consensus 156 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 156 RTYGLPA---KPMTPKVVTLWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred eecCCcc---CCCCcccccccccChhhhcCC--CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 7653321 112223457889999998642 247889999999999999999999999888776655544311100
Q ss_pred ---------------CCC-----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 ---------------CIP-----------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ---------------~~p-----------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+ ...++++.++|.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 125788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=297.78 Aligned_cols=253 Identities=18% Similarity=0.259 Sum_probs=189.5
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|+||.||+|...... ....+++|.+...... ....+.++ ..++.. .+|+||+++++.+......|+||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e-~~~~~~-l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT----GVARVVVKELKANASSKEQNEFLQQ-GDPYRI-LQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC----CcceEEEEEecCCCChHHHHHHHHH-HHHHhc-cCCcchhheEEEecCCCccEEEE
Confidence 36999999999999764332 2245778877654322 22333333 233443 47999999999999999999999
Q ss_pred ecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 128 KFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
||++ |+|.+++.+.. ...+++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9998 58888776542 23567778889999999999999999999999999999999999999999998754321111
Q ss_pred CCCccccccCCCccCCccccCCCC----CCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhc----cCCC
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEV----RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKK----EKPC 275 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~----~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~----~~p~ 275 (632)
........|+..|+|||++.... ...++.++|+|||||++|||++ +..||...+..+.+..+.... ..+.
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 01122356789999999985321 2245789999999999999997 677898777666655544332 2244
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
++...++.+.+++.+|| .+|++||+++++++.|
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 45567899999999999 6899999999998866
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=306.15 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=202.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+.|+..+.||+|+||.||+|.+..++ ..||+|.+..... .....+.++ ...+..+ +|+|++.+++++..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~iv~~~~~~~~ 96 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTN------EVVAIKKMSYSGKQSNEKWQDIIKE-VKFLQRI-KHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCC------cEEEEEEEecCCCCchHHHHHHHHH-HHHHHhC-CCCCEEEEEEEEee
Confidence 45888999999999999999987655 4899999864322 122233333 3444554 68999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++..++||||+.|++.+.+... ...+++.++..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++...
T Consensus 97 ~~~~~lv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 97 EHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred CCeEEEEEeCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9999999999999988877654 457899999999999999999999999999999999999999999999999987643
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.. .....|++.|+|||++.....+.++.++|+|||||++|||++|..||...+.......+......+..+..
T Consensus 176 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T cd06635 176 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248 (317)
T ss_pred CC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcc
Confidence 21 12346889999999985332446788999999999999999999999887766655555443333334457
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
+++.+.++|.+||+.+|.+||++.++++..
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 889999999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.24 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=196.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhcc--CCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFR--ESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~--~h~~I~~l~~~~~~~ 120 (632)
.|++.+.||+|+||.||+|.+..++ +.||+|.+..... .....+.+ +..+++.+. .|++++.+++.+..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~-e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTG------RVVALKIINLDTPDDDVSDIQR-EVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCC------cEEEEEEecCCCCchhHHHHHH-HHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 5788899999999999999987654 4899999865322 22233333 334455554 589999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
...|++|||++| +|.+++.. +.+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999985 66666532 37899999999999999999999999999999999999999999999999998776
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC-
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS- 278 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~- 278 (632)
.... .......|+..|+|||.+... ..++.++|+|||||++|+|++|..||.+.+.......+. ....+.++.
T Consensus 152 ~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 225 (277)
T cd06917 152 NQNS---SKRSTFVGTPYWMAPEVITEG--KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDN 225 (277)
T ss_pred CCCc---cccccccCCcceeCHHHhccC--CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcc
Confidence 4322 122334689999999998632 246889999999999999999999998876554433222 222333444
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+.++.+++.+||+.||++||++.+++.
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 38899999999999999999999999886
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.49 Aligned_cols=252 Identities=23% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.+|+|.++...... ...+.+ +..++..+ .|+||+.+++++..
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~-e~~~l~~l-~h~ni~~~~~~~~~ 75 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTG------EIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCC------cEEEEEEEeeccccccchhhHHH-HHHHHHhc-CCCCEEEEEEEEEe
Confidence 368999999999999999999987654 489999986533221 112222 33444555 59999999998887
Q ss_pred C--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 N--GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 ~--~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
+ +..||+|||+.++|.+++.... ..+++..++.++.|++.||+|||+++++|+||||+|||++.++.++|+|||++.
T Consensus 76 ~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 76 SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred cCCCcEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 7 8999999999998888876543 468999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc------
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK------ 271 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~------ 271 (632)
...... .......+++.|+|||.+.+. ..++.++|+||||+++|||++|..||...+..+....+....
T Consensus 155 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 155 EYGSPL---KPYTQLVVTLWYRAPELLLGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred eccCCc---cccccccccccccCchhhcCC--ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 653321 122334578899999998643 236789999999999999999999998876655443332110
Q ss_pred -----------------------cCCCCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 -----------------------EKPCIPSG-LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 -----------------------~~p~~p~~-lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....++.. +++.+.++|++||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 01122333 6889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.16 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=201.7
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC-c-hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL-K-EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~-~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.|....|++.++||+||.++||++..... +.||+|.+... . .....-+.++ ..++.++..|..|+.|+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-------~iyalkkv~~~~~D~qtl~gy~nE-I~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDK-------QIYALKKVVLLEADNQTLDGYRNE-IALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCC-------cchhhhHHHHhhcCHHHHHHHHHH-HHHHHHhcCCceEEEEeee
Confidence 36668899999999999999999986543 35777765432 2 2333344444 4677889999999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
-..++.+||||||=+-+|...+.+. ...++.-.++.|..|++.++.++|.+||||.||||.|+|+-+ |.+||+|||+|
T Consensus 429 Ev~d~~lYmvmE~Gd~DL~kiL~k~-~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 429 EVTDGYLYMVMECGDIDLNKILKKK-KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred eccCceEEEEeecccccHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechh
Confidence 9999999999999998888777654 344554589999999999999999999999999999999976 89999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCC--------CCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRG--------PISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSV 267 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g--------~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i 267 (632)
..+...+ ........+||+.||+||.+.....+ ..+.+||||||||+||+|+.|++||.... ....+..|
T Consensus 507 ~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 507 NAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred cccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 8764432 12223456899999999998643222 25789999999999999999999997654 33344445
Q ss_pred HhhccCCCCCCCCCHH-HHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 268 VIKKEKPCIPSGLPPA-VENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~-l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+...+||..-+.. +.++|..||+.||.+||++.+||.
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 4433444566554444 999999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.38 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=199.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--h--hhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--E--DCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... . ......+..+..+++.+ +|++|+.+.+.+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~ 73 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTG------RELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCL 73 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCC------CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEE
Confidence 468999999999999999999987655 489999875321 1 11111222233445555 689999999987
Q ss_pred EEC--CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 118 VIN--GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 118 ~~~--~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
... +.++++|||++ ++|.+.+... +.+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 74 RDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EcCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccc
Confidence 653 56899999998 4777777543 468999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++................|+..|+|||++.+. .++.++|+|||||++|||++|+.||......+...++......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE---GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCC---CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCC
Confidence 987653221111222345689999999998743 57889999999999999999999998876665555555444556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+|..+++++.+++.+||. +|..||++.+++.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 6788999999999999999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=328.11 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=219.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
..|..+++++.++||+|.||.|++|.|+..+. ..-.||||.++..... ....|+++.. ++.++ +|+|+++|||+
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psg---k~V~VAVKclr~d~l~~~mddflrEas-~M~~L-~H~hliRLyGv 179 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSG---KHVNVAVKCLRDDSLNAIMDDFLREAS-HMLKL-QHPHLIRLYGV 179 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCC---cEEeEEEEeccCCccchhHHHHHHHHH-HHHhc-cCcceeEEeee
Confidence 34667889999999999999999999987553 3358999999876544 4455666554 34444 79999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
..+ ..+.+|||+++ |+|++.+.......|.......|+.|||.||.||.++++|||||..+|+||.....+||+||||
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 765 68889999998 8999999886667899999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
.+.+..............-...|.|||.+. +..++.+||+|+|||+||||+| |+.||.|.+..++++.|- .+++.
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLr---h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erL 334 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLR---HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERL 334 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhc---cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccC
Confidence 987744321111111112256899999997 5689999999999999999999 999999999999999887 67777
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.-|..||.++.+++..||..+|++||++..|.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 789999999999999999999999999999974
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=299.64 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=197.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ ..||+|.++.... .........+.+++..+ .|+||+.+.+++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG------EIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC------cEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECC
Confidence 47999999999999999999987655 4899999865322 11122223333444555 4999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..+++|||+++++++.+... ...+++.++..++.|++.||+|||+++++|+||||+||++++++.+||+|||++.....
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 74 RLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999999998888776544 35689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc----------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK---------- 271 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~---------- 271 (632)
... .......++..|+|||++.+. ..++.++|+||||+++|+|++|..||.+.+..+....+....
T Consensus 153 ~~~--~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 153 RPA--SPLTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred Ccc--ccccCcccccCCcCCchhcCC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 221 122345678999999998743 257889999999999999999999998765443222211100
Q ss_pred ----------c----------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 ----------E----------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ----------~----------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ...++..++.++.++|.+||..||++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00123446899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.69 Aligned_cols=247 Identities=27% Similarity=0.468 Sum_probs=198.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.++.++ +.||+|.+...... ....+.++ ..++..+ .|+||+.+++.+..++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e-~~~l~~~-~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTG------KIMAVKTIRLEINEAIQKQILRE-LDILHKC-NSPYIVGFYGAFYNNG 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCC------cEEEEEEEecccChHHHHHHHHH-HHHHHHC-CCCchhhhheeeecCC
Confidence 46888999999999999999987655 48999998764332 22333333 3444555 4999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
..+++|||+. ++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++...
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999 67777765543 688999999999999999999999 99999999999999999999999999988654
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhhccCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-----VEEIYHSVVIKKEKP 274 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-----~~ei~~~i~~~~~~p 274 (632)
... ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...+ ..+....+. ....+
T Consensus 152 ~~~-----~~~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 222 (265)
T cd06605 152 VNS-----LAKTFVGTSSYMAPERIQGN---DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPP 222 (265)
T ss_pred HHH-----HhhcccCChhccCHHHHcCC---CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCC
Confidence 221 11125688999999998743 67889999999999999999999997642 223333332 23344
Q ss_pred CCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSG-LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~-lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+.. ++.++.++|.+||..||++||++.+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 45554 8999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=342.00 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=194.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++++.||+|+||+||+|.+..++ ..||+|.+.... ......+.. +..++..+ .||||+.+++++.
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg------~~vAlKvIk~~~l~e~~~~~~~~-EI~IL~~L-~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQ------EFFCWKAISYRGLKEREKSQLVI-EVNVMREL-KHKNIVRYIDRFL 82 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCC------eEEEEEEEeccccCHHHHHHHHH-HHHHHHHc-CCCCcCeEEEEEE
Confidence 3478999999999999999999988655 489999986432 222233333 33444554 6899999999875
Q ss_pred E--CCEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeeeeeCCeEEEec--
Q 006772 119 I--NGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSI-------GLLVLNLKPSNLLLSE-- 184 (632)
Q Consensus 119 ~--~~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~-------~IvHRDLKP~NILld~-- 184 (632)
. ...+||||||++ |+|.+++.... .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 467999999998 68888876532 35799999999999999999999984 4999999999999964
Q ss_pred ---------------CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHH
Q 006772 185 ---------------HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEML 249 (632)
Q Consensus 185 ---------------~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Eml 249 (632)
.+.+||+|||+++.+.... ......||+.|+|||++.+. ...++.++|||||||+||||+
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge-~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHE-TKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhcc-CCCCCchhHHHHHHHHHHHHH
Confidence 2358999999997653221 12345789999999998643 235788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhhccCCCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 250 TGIQPWFGKSVEEIYHSVVIKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 250 tG~~PF~~~~~~ei~~~i~~~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|..||...+........+. ..+.+| ...+.++.+||.+||..+|.+||++.+++.
T Consensus 238 TGk~PF~~~~~~~qli~~lk--~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISELK--RGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHHh--cCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999987654333222222 223333 467899999999999999999999999984
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.88 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=199.7
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
+|++.+.||.|+||.||+|.+..++ ..||+|.+.... ....+.+.. +..++..+ +|+|++.+++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~-e~~~l~~l-~~~~i~~~~~~~~~~~ 72 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG------KILVWKEIDYGNMTEKEKQQLVS-EVNILREL-KHPNIVRYYDRIIDRS 72 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC------CEEEEEEEecccCCHHHHHHHHH-HHHHHHhc-CCCccceeeeeeecCC
Confidence 5899999999999999999987655 479999986432 222222322 33444444 68999999887754
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeeeeeCCeEEEecCCcEEEE
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLH-----SIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLH-----s~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+...|++|||++ ++|.+.+.... ...+++..++.++.||+.||+||| +.+++|+||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 73 NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 457899999998 57777776532 467899999999999999999999 8999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||++....... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+. ..
T Consensus 153 d~g~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~ 225 (265)
T cd08217 153 DFGLAKILGHDS---SFAKTYVGTPYYMSPEQLNH---MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EG 225 (265)
T ss_pred cccccccccCCc---ccccccccCCCccChhhhcC---CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cC
Confidence 999987653321 11223468999999999874 357889999999999999999999999887666555443 34
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+.++..++.++.+++.+||+.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 445677889999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=301.04 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=196.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-h-HHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-C-AKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|.+...... . ...+.+ +..++..+ +|+|++.+++++..+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~i~~~~~~~~~~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTN------ETIALKKIRLEQEDEGVPSTAIR-EISLLKEM-QHGNIVRLQDVVHSE 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCC------cEEEEEehhhccccccchHHHHH-HHHHHHhc-cCCCEeeEEEEEecC
Confidence 57999999999999999999987655 48999998643221 1 122333 33445555 789999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~DFGlak~~ 199 (632)
+..|+||||+++++.+.+.......+++..++.++.||+.||+|||+++++||||||+||+++. ++.+||+|||++...
T Consensus 74 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 74 KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999999999999888886654445788899999999999999999999999999999999985 567999999998754
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC------
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK------ 273 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~------ 273 (632)
... ........+++.|+|||.+.+. ..++.++|+|||||++|+|++|..||...+..+....+......
T Consensus 154 ~~~---~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 154 GIP---VRTFTHEVVTLWYRAPEILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred CCC---ccccccCceeecccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 221 1112234578899999988642 35788999999999999999999999887655444333211000
Q ss_pred -------------CC--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 -------------PC--------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 -------------p~--------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+. .....++++.+++.+||+.||++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 12356889999999999999999999999886
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.71 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=193.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.|++.+.||+|+||.||+|.+... ..++.||+|.+.... ........++ ..++..+ +|+||+.+++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACRE-IALLREL-KHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHH-HHHHHhc-CCCCccceEEEEeCC
Confidence 488999999999999999998762 123589999997632 1212222232 3344444 689999999999887
Q ss_pred --CEEEEEEecCCCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec----CCcEEEE
Q 006772 121 --GKICIAMKFYEGSVGDRIAQQRG---GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE----HDQLVLG 191 (632)
Q Consensus 121 --~~l~LVmEy~~GsL~d~l~~~~~---~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~----~g~vkL~ 191 (632)
+.+|+||||+++++.+.+..... ..+++..++.++.|++.||+|||+++|+||||||+|||++. ++.+||+
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 88999999999998888765432 37899999999999999999999999999999999999999 9999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH---------
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE--------- 262 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e--------- 262 (632)
|||+++................+|+.|+|||++.+. ..++.++|+|||||++|||++|..||.+.....
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence 999988653322211222335678999999987642 247889999999999999999999998654321
Q ss_pred HHHHHHh------------------------hccCCCCC-----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 263 IYHSVVI------------------------KKEKPCIP-----------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 263 i~~~i~~------------------------~~~~p~~p-----------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+.. ......++ ...+.++.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00111111 156678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.72 Aligned_cols=248 Identities=26% Similarity=0.478 Sum_probs=201.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ +.|++|.+..... .....+.++ ...+..+ .|++++.+++++..++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~------~~~~vk~~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTG------KIYALKKIHVDGDEEFRKQLLRE-LKTLRSC-ESPYVVKCYGAFYKEG 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCC------cEEEEEEeccCcchHHHHHHHHH-HHHHHhc-CCCCeeeEEEEEccCC
Confidence 47999999999999999999988755 4899999876543 222333333 3344444 4999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
.++++|||++ ++|.+++... ..+++..++.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999 6777777653 579999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhhccCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---SVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---~~~ei~~~i~~~~~~p~~ 276 (632)
..... ......++..|+|||.+... .++.++|+||||+++|+|++|..||... ...+....+. ....+..
T Consensus 151 ~~~~~---~~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 223 (264)
T cd06623 151 ENTLD---QCNTFVGTVTYMSPERIQGE---SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSL 223 (264)
T ss_pred ccCCC---cccceeecccccCHhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCC
Confidence 33211 11234678999999998643 6788999999999999999999999876 3344444443 3344555
Q ss_pred CCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSG-LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~-lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.. ++..+.++|.+||..+|++||++.++++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 666 8999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.12 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=199.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-----hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-----DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-----~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+|+..+.||+|+||.||+|.+..++ +.|++|.+..... +..+.+.++ ..++..+ +|++++.+.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~~~e-~~~l~~~-~h~~i~~~~~~~~ 72 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG------DFFAVKEVSLADDGQTGQEAVKQLEQE-IALLSKL-QHPNIVQYLGTER 72 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC------cEEEEEEEEEccccccchHHHHHHHHH-HHHHHhc-CCCCchheeeeEe
Confidence 4778899999999999999987544 4899999865331 122233333 2344444 7899999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.+..+|++|||++| +|.+++... ..+++..++.++.||+.||+|||+.+|+|+||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 73 EEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999999985 777776543 468999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... ......|+..|++||.+... ..++.++|+|||||++|+|++|..||......+....+......+.++
T Consensus 151 ~~~~~~----~~~~~~~~~~y~~pe~~~~~--~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd06632 151 QVVEFS----FAKSFKGSPYWMAPEVIAQQ--GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIP 224 (258)
T ss_pred eccccc----cccccCCCcceeCHHHhcCC--CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcC
Confidence 653321 12345689999999998643 137889999999999999999999998776555444444334556677
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.+++.+||+.||.+||++.+++.
T Consensus 225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 889999999999999999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=311.00 Aligned_cols=247 Identities=21% Similarity=0.225 Sum_probs=192.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||.+.+.. ......+.+ +..++.. ..|+||+.+++++..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~~~l~~-l~h~~iv~~~~~~~~ 86 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTG------QNVAIKKLSRPFQNVTHAKRAYR-ELVLMKL-VNHKNIIGLLNVFTP 86 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCC------CEEEEEecCccccChhHHHHHHH-HHHHHHh-cCCCCCcceeeeecc
Confidence 478999999999999999999987655 489999986432 222223333 3334444 478999999988764
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+ ...|+||||+.+++.+.+.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 87 QKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CCCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 3 35799999999998887753 3899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++...... ......||..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+..+......
T Consensus 163 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 163 GLARTAGTSF----MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred ccceeCCCCC----CCCCCcccccccCHHHHhC---CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9997653321 1223467899999999874 36889999999999999999999999877654433332211000
Q ss_pred --------------------CC--------------C-------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 --------------------PC--------------I-------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 --------------------p~--------------~-------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+. + +...+.++.++|.+||+.||++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 1134667899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.97 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=195.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------hHH---HHHHHHHHHhhhccCCCceeEee
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------CAK---VFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------~~~---~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
+|.+.+.||.|+||.||+|.+..++ +.||+|.+...... ... +.+..+..++..+ +|+|++.++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG------EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC------ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEE
Confidence 4788999999999999999876554 48999987532111 011 1122233344444 689999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++...+..++||||+. |+|.+++... +.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeec
Confidence 99999999999999998 5777776543 57899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++..... ..........|+..|+|||.+.... ..++.++|+||||+++|||++|..||...+..+....+......
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 153 GISKKSDDI-YDNDQNMSMQGSVFWMAPEVIHSYS-QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred ccccccccc-ccccccccccCCccccCHHHhcccc-CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 998754321 1111123346889999999987432 24788999999999999999999999876655444333323333
Q ss_pred CCCCC----CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIPS----GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p~----~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++. .++.++.++|.+||..||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 33333 46899999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=298.86 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=196.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKIC 124 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~ 124 (632)
|++.+.||+|+||.||+|.+..++ +.|+||.+.............++...+..+..|++++.+++++..++..+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG------ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC------cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence 678899999999999999987654 48999998654322111112223344556655999999999999999999
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 125 IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 125 LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
+||||+.|++.+.+.......+++..++.++.|++.+|.|||+++++|+||||+||++++++.++|+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 9999999999998876554578999999999999999999999999999999999999999999999999987653321
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC----------
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP---------- 274 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p---------- 274 (632)
......|+..|+|||++... ..++.++|+||||+++|||++|..||...+..+....+......+
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 ---PYTDYVSTRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ---CcCCCCCcccccCceeeecC--cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 12234678999999988532 347889999999999999999999998776544333222110000
Q ss_pred ------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 ------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......+.++.++|++||+.||++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001123688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=301.62 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=195.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh----hHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED----CAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~----~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+|++.+.||+|+||.||+|.+..++ +.||||.+...... ........+..++..+ +|+||+.+++++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~ 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG------RIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC------cEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec
Confidence 4889999999999999999987655 48999999754321 1112222233444444 59999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++..++||||+.|+|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 74 KSNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred CCEEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 99999999999888888875432 37999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC------
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK------ 273 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~------ 273 (632)
.... .......+++.|+|||.+.+. ..++.++|+|||||++|||++|.+||.+.+..+....+......
T Consensus 153 ~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 153 GSPN---RKMTHQVVTRWYRAPELLFGA--RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred cCCC---ccccccccceeeeCHHHHhCC--CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 3321 112233568899999988532 35788999999999999999998888876654443333211000
Q ss_pred ---------------CC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ---------------PC-----IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ---------------p~-----~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+. .....+.++.++|.+||+.||++||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00 11345788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.75 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=198.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+-|++.+.||+|+||.||+|.+..++ ..||||.+.............++...+..+ +|+||+.+++.+..++.
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 76 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQ------KVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK 76 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCC------cEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCe
Confidence 34788899999999999999887654 489999876433222222223333344444 78999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||+.| ++.+++. ...+++..+..++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 77 LWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999985 6665553 24789999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
.. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+. ....+.++..++
T Consensus 154 ~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06641 154 TQ---IKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYS 226 (277)
T ss_pred ch---hhhccccCCccccChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccC
Confidence 21 11223467899999999863 357789999999999999999999998877655554433 344555677889
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++.+++.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.46 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=197.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|+..+.||+|+||.||+|.+..++ ..||+|.+...........+..+..++..+ +|+||+.+++.+..++.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTK------EVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCC------eEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCc
Confidence 35667788999999999999886544 489999986443222222233333445554 69999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++| +|.+.+. .+.+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 77 LWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred eEEEEEccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999985 6666553 35789999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
.. .......|+..|+|||++.+. .++.++|+|||||++|||++|..||...........+. ....+..+..++
T Consensus 154 ~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06642 154 TQ---IKRNTFVGTPFWMAPEVIKQS---AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYS 226 (277)
T ss_pred cc---hhhhcccCcccccCHHHhCcC---CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccC
Confidence 21 112234678999999998743 57889999999999999999999998766555443332 234455566788
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999996
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.26 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=195.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhcc--CCCceeEeeEEEEECC
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFR--ESQSVCWLHGISVING 121 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~--~h~~I~~l~~~~~~~~ 121 (632)
|++.+.||+|+||.||+|.++.++ +.||+|.+....... .......+..++..+. .|++++.+.+++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG------RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC------CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678999999999999999987644 489999997432211 1111222223333332 6999999999998877
Q ss_pred E-----EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 122 K-----ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 122 ~-----l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
. ++++|||+.+++.+++.......+++..++.++.|++.||+|||+++++|+||||+|||++.++.++|+|||++
T Consensus 75 ~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 75 TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred CCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 6 99999999999988887654457999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP-- 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p-- 274 (632)
....... ......++..|+|||++.+. .++.++|+|||||++|||++|.+||.+.+..+....+......+
T Consensus 155 ~~~~~~~----~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 155 RIYSFEM----ALTSVVVTLWYRAPEVLLQS---SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred eeccCCc----ccccccccccccChHHhccC---CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 7653221 11223578899999998743 57889999999999999999999999887666555543211100
Q ss_pred ------------CC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 ------------CI-----------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ------------~~-----------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ ...+++.+.++|.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0234578899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=293.75 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=198.6
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
||.|+||.||+|.+..++ ..|++|.+...... ........+..++..+ .|+|++.+++.+..+...|++||
T Consensus 1 lg~g~~~~vy~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG------DIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCC------CEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEe
Confidence 689999999999987655 48999998654321 1112222223444554 59999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC--
Q 006772 129 FYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS-- 205 (632)
Q Consensus 129 y~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~-- 205 (632)
|+.| +|.+++... +.+++..++.++.||+.||+|||+++++|+||+|+|||+++++.++|+|||++.........
T Consensus 74 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 74 YLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9985 777777543 37899999999999999999999999999999999999999999999999998754322110
Q ss_pred ---CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC--
Q 006772 206 ---DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL-- 280 (632)
Q Consensus 206 ---~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l-- 280 (632)
........++..|++||.+... .++.++|+||||+++|+|++|..||......+....+.. .....|..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 226 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQ---GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEV 226 (265)
T ss_pred ccccccccCcccCccccCHHHhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccC
Confidence 1122334678899999998643 478899999999999999999999998888777766553 233344444
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
+..+.+++.+||+.+|.+||++.++.+.|+ ++++.+.+|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~---~~~~~~~~~ 265 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKN---HPFFKGIDW 265 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhc---CccccCCCC
Confidence 999999999999999999999944443332 667777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.74 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=200.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEe
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMK 128 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmE 128 (632)
-.||+|+||+||-|++..+. ..+|||-+........+- +.++.. +-+-..|.||+++.|.+..++.+-|.||
T Consensus 581 vVLGKGTYG~VYA~RD~~tq------vrIaIKEIpekdsr~~QP-LhEEIa-LH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQ------VRIAIKEIPEKDSREVQP-LHEEIA-LHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EEeecCceeEEEeeccccce------eEEEeeecccccchhhcc-HHHHHH-HHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 36899999999999998776 479999986544333222 222223 3333478999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-cCCcEEEEecCCceeccCCCC
Q 006772 129 FYEG-SVGDRIAQQRGGKL--PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-EHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 129 y~~G-sL~d~l~~~~~~~l--~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-~~g~vkL~DFGlak~~~~~~~ 204 (632)
-++| +|.+++.. +=+++ .+.+.-+|.+||++||.|||.+.|||||||-.|+|++ -.|.+||+|||-++.+.+-
T Consensus 653 qVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-- 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-- 729 (1226)
T ss_pred cCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--
Confidence 9995 66666654 44677 8899999999999999999999999999999999998 5799999999999887543
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhccCCCCCCCCCHH
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVVIKKEKPCIPSGLPPA 283 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~i~~~~~~p~~p~~lp~~ 283 (632)
...+.++.||..|||||++.... ..|..++|||||||++.||.||++||... ++.....++-.-+.-|++|..++.+
T Consensus 730 -nP~TETFTGTLQYMAPEvIDqG~-RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 730 -NPCTETFTGTLQYMAPEVIDQGP-RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred -CccccccccchhhhChHhhccCC-cCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 22334578999999999997543 35899999999999999999999999864 3443333444446678899999999
Q ss_pred HHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 284 VENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.+|.+|++.||.+||++.++|.
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhcc
Confidence 999999999999999999999886
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.34 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=195.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
|++.+.||.|++|.||+|.+..++ ..||+|++...... ....+.++. ..+..+ .|++++++++++..++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~E~-~~l~~l-~~~~iv~~~~~~~~~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTG------EIVALKKIRLETEDEGVPSTAIREI-SLLKEL-NHPNIVRLLDVVHSENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCC------CEEEEEEeecccccccchhHHHHHH-HHHHhc-CCCCccCHhheeccCCe
Confidence 677899999999999999987655 48999998653311 112333333 344444 69999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
.|++|||++++|.+++.......+++..++.++.|++.||+|||+++++||||+|+|||++.++.++|+|||+++.....
T Consensus 73 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 73 LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred EEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 99999999999988887654457899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc----------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE---------- 272 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~---------- 272 (632)
........++..|+|||++.+. ..++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 153 ---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 153 ---VRTYTHEVVTLWYRAPEILLGS--RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred ---ccccCccccccCCCCCceeecC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1112223568899999987642 2468899999999999999999999988765443322221100
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 -----------------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 -----------------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.......++.++.++|.+||+.||++||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00112457789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.97 Aligned_cols=245 Identities=21% Similarity=0.338 Sum_probs=185.6
Q ss_pred eEEcccCceEEEEEEEcCCCCC----cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADD----FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKIC 124 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~----~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~ 124 (632)
+.||+|+||.||+|.+..+... ......|++|.+...... ...+.++. .++..+ +|+||+.+++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETA-SLMSQL-SHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHH-HHHHcC-CCcchhheeeEEec-CCcE
Confidence 4699999999999998765411 011235888877644332 33333333 344444 79999999998877 7789
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-------cEEEEecCCc
Q 006772 125 IAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-------QLVLGDFGIP 196 (632)
Q Consensus 125 LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-------~vkL~DFGla 196 (632)
+||||+. |+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999998 5666666543 33789999999999999999999999999999999999999888 8999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
..... .....++..|+|||++... ...++.++|+|||||++|||++ |..||...+..+...... ....
T Consensus 156 ~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~ 224 (259)
T cd05037 156 ITVLS-------REERVERIPWIAPECIRNG-QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR 224 (259)
T ss_pred ccccc-------ccccccCCCccChhhhcCC-CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC
Confidence 76432 1223567889999998743 1357889999999999999999 688887765443332222 1222
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~L 309 (632)
.+.....++.++|.+||..||.+||++.++++.|
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2333348999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.16 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=197.5
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
|++.+.||+|+||.||+|.+.... ..+..||||++.... ....+.+.++. .++..+ +|+|++.+++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~-~~l~~l-~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED---GSFQKVAVKMLKADIFSSSDIEEFLREA-ACMKEF-DHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC---CCceEEEEEEeccccCChHHHHHHHHHH-HHHhcC-CCCCcceEEEEEccCCC
Confidence 577889999999999999876532 234689999986532 22233333333 445555 6899999999876532
Q ss_pred -----EEEEEEecCC-CCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 122 -----KICIAMKFYE-GSVGDRIAQQR----GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 122 -----~l~LVmEy~~-GsL~d~l~~~~----~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
..++++||+. |++.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 3478899998 67666654321 1357889999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+++........ .......+++.|++||.+... .++.++|+|||||++|||++ |..||.+.+..+.+..+..
T Consensus 156 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~---~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 230 (273)
T cd05074 156 DFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADN---VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK- 230 (273)
T ss_pred cccccccccCCcce-ecCCCccCchhhcCHhHHhcC---ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-
Confidence 99998765322111 111123456789999998633 57889999999999999999 8999988877666655543
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
......+...+..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 334445667889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.41 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=198.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.|...++||+|+||.||+|.+..++ ..|++|.+..... .....+.++ ..++..+ +|+|++.+++++..+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~~~~ 93 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTN------EVVAVKKMSYSGKQTNEKWQDIIKE-VKFLQQL-KHPNTIEYKGCYLKE 93 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCC------cEEEEEEEeccccCchHHHHHHHHH-HHHHHhC-CCCCCccEEEEEEeC
Confidence 4777888999999999999986654 4899999864322 222233333 3444554 689999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
...|++|||+.|++.+.+... ...+++.+++.++.||+.||.|||+++++|+||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~lv~e~~~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 94 HTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 999999999999988887653 4578999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
......|+..|+|||++.....+.++.++|+|||||++|||++|..||...+.......+............+
T Consensus 173 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
T cd06633 173 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW 245 (313)
T ss_pred -------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 1223568999999999854323467889999999999999999999998877555444443322222233467
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+.+++.+||+++|.+||++.+++.
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 889999999999999999999999886
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.29 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=192.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||.+...... ........+..+++.+ .|++|+.+++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTK------QIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTK 83 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCC------cEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecc
Confidence 468999999999999999999987655 48999988643211 1111112223444444 789999999987654
Q ss_pred C--------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 121 G--------KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 121 ~--------~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
+ ..++||||+.+++.+.+... ...+++.+++.++.||+.||+|||+++++|+||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred cccccCCCceEEEEEcCCCcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 3 46999999999888877543 34789999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCC-CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 193 FGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 193 FGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
||++......... ........++..|+|||.+.+. ..++.++|+||||+++|||++|..||.+.+.......+....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCC--cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999765332211 1112334678899999988643 236789999999999999999999998876544332222110
Q ss_pred cC--C---------------CCC-------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EK--P---------------CIP-------------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~--p---------------~~p-------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. + .++ ...+..+.++|.+||..||.+||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0 001 123567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=284.93 Aligned_cols=247 Identities=23% Similarity=0.448 Sum_probs=198.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
+|++.+.||+|+||.||++.+..++ ..+++|++..........+.++. ..+..+ .|+++..+.+.+..++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~e~-~~l~~l-~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTG------KEVAIKVIKLESKEKKEKIINEI-QILKKC-KHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCC------cEEEEEEecccchhHHHHHHHHH-HHHHhC-CCCCEeEEEEEEecCCeE
Confidence 5889999999999999999987654 48999999765443333444433 444554 499999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
+++|||++ ++|.+.+... ...+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEEEecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999 5776666543 257899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC--C
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG--L 280 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~--l 280 (632)
.. .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....... ...+..+.. +
T Consensus 152 ~~----~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (253)
T cd05122 152 KA----RNTMVGTPYWMAPEVINGK---PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKW 223 (253)
T ss_pred cc----ccceecCCcccCHHHHcCC---CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCccccc
Confidence 11 2345688999999998743 478899999999999999999999988755444333332 333333333 4
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+.++|.+||+.||++||++.+++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 899999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.47 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=199.4
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.++.++ ..||+|.+..... .....+ ..+..+++.+ .|+|++.+++.+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~-~~E~~~l~~~-~h~~i~~~~~~~~~~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS------EHCVIKEIDLTKMPVKEKEAS-KKEVILLAKM-KHPNIVTFFASFQENG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC------ceEEEEEeeHhhccchhhHHH-HHHHHHHHhC-CCCChhhhhheeccCC
Confidence 5899999999999999999987655 3799999864311 122222 3333444544 6899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCceec
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGlak~~ 199 (632)
..+++|||+. ++|.+++.......+++..++.++.|++.||.|||+++++|+||||+||++++++ .++|+|||++...
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 9999999997 5888887765555689999999999999999999999999999999999999886 4699999988765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.... .......|++.|+|||++.. ..++.++|+||||+++|||++|..||...+..+....+.. ...+..+..
T Consensus 153 ~~~~---~~~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (257)
T cd08225 153 NDSM---ELAYTCVGTPYYLSPEICQN---RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPN 225 (257)
T ss_pred cCCc---ccccccCCCccccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCC
Confidence 3211 11123458999999999863 3578899999999999999999999988776665554432 333445667
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+.++.++|.+||..+|++||++.++++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 8899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.31 Aligned_cols=262 Identities=19% Similarity=0.325 Sum_probs=211.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+.++.+.++++||+|.||+|.+++-.. ...||+|++++.........+.++..++.++ +||||+.+.++|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeee
Confidence 4667889999999999999999998543 3589999999887766644444455666777 8999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++.+|++||||+ |+|.+++..+.-..+.-.....++.||+.||+||.+.++|||||.+.|+|+|.++++||+|||.++
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 9999999999998 888888876532233445667799999999999999999999999999999999999999999988
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh--CCCCCCCCCHHHHHHHHHh---h--
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT--GIQPWFGKSVEEIYHSVVI---K-- 270 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt--G~~PF~~~~~~ei~~~i~~---~-- 270 (632)
-+-....... ....+-.++|||||.+. -+++|.+||+|+||+++||+++ .+.||...+.+++...... .
T Consensus 686 ~lysg~yy~v-qgr~vlpiRwmawEsil---lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 686 NLYSGDYYRV-QGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccCCceee-ecceeeeeeehhHHHHH---hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 5432211110 11123368999999986 5689999999999999999876 8999998887766554321 1
Q ss_pred -ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 271 -KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 271 -~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..-+..|..||..+.++|.+||.+|-.+||+++++...|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122346788999999999999999999999999999887653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.90 Aligned_cols=241 Identities=18% Similarity=0.304 Sum_probs=189.3
Q ss_pred CCeEEEeEE--cccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRI--GRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~I--G~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.+ |+|+||.||++.++.++ ..+|+|.+.+......+. .....+.+|+|++.+++.+..+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~e~------~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQ------KLFVQKIIKAKNFNAIEP------MVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCC------cEEEEEEEehhhcchhhH------HHHHHhhcCCCEEEEEEEEecC
Confidence 356666655 99999999999987765 479999986532211111 1111234799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCcee
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYL 198 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGlak~ 198 (632)
+..|+||||++ |+|.+++... ..+++.+++.++.|++.||+|||+.+++||||||+||+++.++ .++|+|||+++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999997 6888877543 3899999999999999999999999999999999999999998 999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHH-HHH-HhhccCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY-HSV-VIKKEKPCI 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~-~~i-~~~~~~p~~ 276 (632)
.... ....|+..|+|||++.+ ..++.++|+||||+++|||++|..||.......+. ... .........
T Consensus 160 ~~~~-------~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 160 IGTP-------SCYDGTLDYFSPEKIKG---HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred cCCC-------ccCCCCCcccChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 4321 22457899999999874 36788999999999999999999999865433221 111 111233345
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPL-MADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs-~~ell~ 307 (632)
+..+++.+.++|.+||+.||.+||+ ++++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 5679999999999999999999995 688875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=351.93 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=204.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
.+-...||.|.||.||-|.+..+++ ..|+|-++-.... ..-....++..++.. ..|||++.++|+-...+.+
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGe------llAvKEI~iq~~~~k~~~~i~eEm~vlE~-lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGE------LLAVKEIKIQDSDHKTFKLIAEEMKVLEG-LNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccc------hhhhhhhhcCccccccCcchHHHHHHHHh-ccCccccccCceeecHHHH
Confidence 4556789999999999999887765 6788877543222 111112333344443 4899999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
+|.||||+ |+|.+++.+ ++-.++.....|..|++.|+.|||++|||||||||+||||+.+|.+|++|||.|..+...
T Consensus 1310 ~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999998 677776643 345677788889999999999999999999999999999999999999999999876543
Q ss_pred C-CCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhccCCCCCCCC
Q 006772 203 S-LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 203 ~-~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~~~p~~p~~l 280 (632)
. ..+.......||+.|||||++.+........+.|||||||++.||+||+.||...+.+ ++...+ ..+..|++|..+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-~~gh~Pq~P~~l 1466 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-AAGHKPQIPERL 1466 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-hccCCCCCchhh
Confidence 2 1223344568999999999998765455667999999999999999999999886644 444443 457889999999
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++-+++|.+||+.||+.|.++.+|++
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 999999999999999999999988886
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.20 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=194.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|.....||+|+||.||++.+..++ ..||||.+..........+.++. ..+..+ +|+|++.+++.+..++.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~e~-~~l~~l-~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTG------KQVAVKKMDLRKQQRRELLFNEV-VIMRDY-HHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCC------CEEEEEEEecchHHHHHHHHHHH-HHHHhC-CCCcHHHHHHheecCCe
Confidence 45666788999999999999886554 48999998654433333343433 344444 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|++|||++| ++.+++. .+.+++.+++.++.||+.||+|||+++|+||||||+||++++++.++|+|||++.....
T Consensus 94 ~~lv~e~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 94 LWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEEeCCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999999986 5555442 24689999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~~ 279 (632)
. ........|+..|+|||.+.+ ..++.++|+||||+++|||++|..||...+..+....+.. ...+. ....
T Consensus 171 ~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (292)
T cd06658 171 E---VPKRKSLVGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHK 243 (292)
T ss_pred c---cccCceeecCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccc
Confidence 1 111233568999999999864 3578899999999999999999999998776655444332 11222 2235
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+..+.+++.+||..||.+||+++++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 7889999999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.15 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=204.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ ..||+|++.+.. ..........+..++..+..|+||+.+++++..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN------KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC------CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 47999999999999999999987654 489999986522 1222233334445566665699999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..+++|||++ ++|.+.+... +.+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999996 6787777543 47999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCC-----------------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH
Q 006772 200 LGRSLSD-----------------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262 (632)
Q Consensus 200 ~~~~~~~-----------------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e 262 (632)
....... .......|+..|+|||++.. ..++.++|+||||++++++++|..||...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE---KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCC---CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 4332110 11223467899999999864 357889999999999999999999999887666
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHH
Q 006772 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM----ADILH 307 (632)
Q Consensus 263 i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~----~ell~ 307 (632)
.+..+. .....+|..+++.+.++|.+||+.||.+||++ .+++.
T Consensus 230 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 555544 34455778899999999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.00 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=199.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ ..||||.+..... ...+.+.+ +...+..+ +|+||+.+.+++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~-e~~~l~~l-~~~~i~~~~~~~~~~~ 72 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTG------RKVAIKKISNVFDDLIDAKRILR-EIKLLRHL-RHENIIGLLDILRPPS 72 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCC------cEEEEEeeccccccchhhhhHHH-HHHHHHhc-CCcchhhhhhhhcccC
Confidence 5899999999999999999987654 4899999876432 22223333 33444444 6999999999887764
Q ss_pred -----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 122 -----KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 122 -----~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+|++|||+++++.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~~~~~lv~e~~~~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 73 PEDFNDVYIVTELMETDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred cccccceEEEecchhhhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 7899999999988877754 348999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC- 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~- 275 (632)
.................++..|+|||++.+.. .++.++|+||||+++|+|++|..||.+.+..+.+..+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS--RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred EeecccccccccccccccccCcCCceeeeccc--CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 87644321112233446789999999987531 578899999999999999999999998876665554443211111
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 ----------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ----------------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+++++.++|.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 12346889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.68 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=198.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+.|...+.||+|+||.||+|.+..++ ..+|+|.+.... ......+.++ ..++..+ +|+|++.+.+++..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~ 86 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNS------EVVAIKKMSYSGKQSNEKWQDIIKE-VRFLQKL-RHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCC------cEEEEEEEecccccChHHHHHHHHH-HHHHHhC-CCCCcccEEEEEEc
Confidence 55888899999999999999987654 479999986422 1222233333 2344444 78999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++..++||||+.|++.+.+... ...+++.+++.++.|++.||.|||+++++||||||+|||++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 87 EHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred CCeeEEEEEccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 9999999999999888877543 357899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.. .....|++.|+|||++.....+.++.++|+|||||++|+|++|..||...+..+....+.........+..
T Consensus 166 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 166 AP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (308)
T ss_pred cC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccc
Confidence 32 12346789999999975332345788999999999999999999999887655544443322222223457
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++..+.++|.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 8899999999999999999999999887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.96 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=196.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+|++.+.||.|+||.||+|.+..++ ..||+|.+.+... .....+.++ ...+..+ +|+||+.+++.+..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~~ 72 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK------KMFAMKYMNKQKCVEKGSVRNVLNE-RRILQEL-NHPFLVNLWYSFQDE 72 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC------cEEEEEEEehhhhcchhHHHHHHHH-HHHHHhC-CCCChHHHHHhhcCC
Confidence 5899999999999999999987655 4899999865322 222333333 3344444 789999999999989
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..|+||||+.| +|.+.+... ..+++..+..++.||+.||.|||+++++|+||||+||++++++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 999999999985 666666543 58999999999999999999999999999999999999999999999999988764
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhccCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV---EEIYHSVVIKKEKPCI 276 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~---~ei~~~i~~~~~~p~~ 276 (632)
.... ......|+..|+|||.+... .++.++|+||||+++|+|++|..||...+. .+.... .. ...+.+
T Consensus 151 ~~~~----~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~-~~~~~~ 221 (258)
T cd05578 151 TPDT----LTTSTSGTPGYMAPEVLCRQ---GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QE-TADVLY 221 (258)
T ss_pred CCCc----cccccCCChhhcCHHHHccc---CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hc-cccccC
Confidence 3221 22345688999999998744 478899999999999999999999998763 333222 21 255667
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCH--HHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLM--ADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~--~ell~ 307 (632)
|..++.++.++|++||+.||.+||++ .|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 88899999999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.29 Aligned_cols=248 Identities=22% Similarity=0.368 Sum_probs=195.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|.....||+|+||.||+|.+..++ +.||+|.+..........+.++ ..++..+ +|+|++.+++.+..++.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~e-~~~l~~l-~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSG------RQVAVKMMDLRKQQRRELLFNE-VVIMRDY-QHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCC------CEEEEEEEEecccchHHHHHHH-HHHHHhC-CCCchhhhhhheeeCCe
Confidence 45566678999999999999987554 4899999865433333333333 3344444 68999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|++|||++| ++.+.+. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 93 LWVLMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEEEecCCCCCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9999999995 5555443 24689999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p~~p~~l 280 (632)
.. .......|+..|+|||++.+ ..++.++|+|||||++|||++|+.||...+..+....+.... .....+..+
T Consensus 170 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06659 170 DV---PKRKSLVGTPYWMAPEVISR---TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243 (297)
T ss_pred cc---ccccceecCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence 11 11233568999999999864 357889999999999999999999998877666554433211 112233567
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.++.++|.+||+.||.+||++.+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 899999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=285.60 Aligned_cols=249 Identities=26% Similarity=0.491 Sum_probs=204.5
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+..++ ..|++|.+..... .....+. .+.+.+..+ +|+|++.+.+.+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~-~e~~~l~~l-~~~~~~~~~~~~~~~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG------KLYVLKEIDLSNMSEKEREDAL-NEVKILKKL-NHPNIIKYYESFEEKG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC------cEEEEEEeecccCChHHHHHHH-HHHHHHHhc-CCCChhheEEEEecCC
Confidence 5899999999999999999987654 4899999875432 2223333 333444554 5999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEG-SVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..+++|||++| +|.+.+.... +..+++..++.++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 99999999985 7777776543 46899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
..... .......|++.|+|||.+... .++.++|+||||+++|+|++|..||...+..++...... ...+.+|.
T Consensus 153 ~~~~~---~~~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 225 (258)
T cd08215 153 LSSTV---DLAKTVVGTPYYLSPELCQNK---PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPS 225 (258)
T ss_pred cccCc---ceecceeeeecccChhHhccC---CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCC
Confidence 53321 122334689999999998643 578899999999999999999999988877776666543 34555677
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++.++.+++.+||..||++||++.++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 89999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=290.66 Aligned_cols=252 Identities=24% Similarity=0.421 Sum_probs=196.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--h---HHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--C---AKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~---~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+|+..+.||+|+||.||+|.+..++ ..||+|.+...... . ....+..+...+..+ +|+|++.+++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~------~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTG------TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCC------cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceec
Confidence 4788899999999999999986655 48999998653311 1 112222233444444 7899999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCc
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIP 196 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGla 196 (632)
.++..++||||++| +|.+++.+ .+.+++..++.++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 99999999999995 66666654 34789999999999999999999999999999999999998776 5999999998
Q ss_pred eeccCCCCCCC-ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhcc
Q 006772 197 YLLLGRSLSDS-DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV---EEIYHSVVIKKE 272 (632)
Q Consensus 197 k~~~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~---~ei~~~i~~~~~ 272 (632)
........... ......||..|+|||.+.+. .++.++|+|||||++|+|++|..||..... ......+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE---QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC
Confidence 76543211111 11234688999999998643 578899999999999999999999975442 222222222344
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+.+|..+++++.+++.+||..||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 56677789999999999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=292.58 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=195.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
|++.+.||+|+||.||+|.+..++ ..+|+|.+.... ......+.++ ..++..+ +|+|++.+++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~~~~ 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTG------ELVALKKIRMENEKEGFPITAIRE-IKLLQKL-RHPNIVRLKEIVTSKGK 72 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCC------eEEEEEEEecccccccchHHHHHH-HHHHHhc-cCCCeeeheeeEecCCC
Confidence 678999999999999999987654 489999997643 1222233333 2344444 599999999999887
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+..++||||+++++.+.+.+. ...+++..++.++.||+.||+|||+++++|+||||+|||+++++.++|+|||++....
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 73 GSIYMVFEYMDHDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred CcEEEEeccccccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 899999999999888877653 2579999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP------ 274 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p------ 274 (632)
.... .......++..|+|||.+.+. ..++.++|+||||+++|||++|+.||...+.......+......+
T Consensus 152 ~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 152 KRNS--ADYTNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred CCCc--ccccccccccccCCceeeEcc--ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 3211 112334568899999987643 247889999999999999999999998877655444333211100
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 -----------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 -----------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+...+++++.+++.+||..||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001123889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.14 Aligned_cols=253 Identities=19% Similarity=0.260 Sum_probs=195.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ ..+|+|.+.... ......+. .+..++.++.+|+||+.+++++...
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~vK~~~~~~~~~~~~~~~~-~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTK------EVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCC------eEEEEEeeccccCcchhhhhhh-HHHHHHHHhcCCCCccceeeeeccC
Confidence 67999999999999999999987654 489999885421 12222233 3345566666899999999987653
Q ss_pred --CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 121 --GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 121 --~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
...|+||||+.++|.+.+.. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred CCceEEEEecccccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 46899999999988887754 2788999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCC--CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC---
Q 006772 199 LLGRSLS--DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK--- 273 (632)
Q Consensus 199 ~~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~--- 273 (632)
....... ........||..|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccCcchhcccccccccCceeeecc--ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 5332211 1122334689999999987642 35788999999999999999999999876654433332211100
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 --------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 --------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......++.++.++|.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0111337889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.34 Aligned_cols=257 Identities=17% Similarity=0.219 Sum_probs=182.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCccc---------cc----EEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDE---------YH----ELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~---------~~----~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~ 109 (632)
++|+++++||+|+||+||+|.++...+.... .. .++.|.+.. .......+..+..++..+ +|+|
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~Ei~il~~l-~Hpn 224 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA--GSRAAIQLENEILALGRL-NHEN 224 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc--chHHHHHHHHHHHHHHhC-CCCC
Confidence 6799999999999999999987543321000 00 011111111 111122223333444544 7999
Q ss_pred eeEeeEEEEECCEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 110 VCWLHGISVINGKICIAMKFYEGSVGDRIAQQR---GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 110 I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~---~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
|+.+++++...+..|++|+++.+++.+++.... .....+..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999999999988875432 12345677889999999999999999999999999999999999
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC-CCCC--CH-HH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGK--SV-EE 262 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P-F~~~--~~-~e 262 (632)
.+||+|||+++.+.... ........||..|+|||++.+ ..++.++|||||||++|||++|..+ |... .. .+
T Consensus 305 ~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 305 KIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAG---DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999998653321 111234579999999999974 3688999999999999999998754 4322 12 22
Q ss_pred HHHHHHhhc--------------------cCC----CC-----CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 263 IYHSVVIKK--------------------EKP----CI-----PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 263 i~~~i~~~~--------------------~~p----~~-----p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+...+.... ... .+ ...++.++.++|.+||+.||.+||++.|++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 221111000 000 00 0235678889999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.88 Aligned_cols=254 Identities=18% Similarity=0.227 Sum_probs=194.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|++.+.||+|+||.||+|.++.++ ..||+|.++.... .........+..++..+ +|+|++.+++++...
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~ 78 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTG------ELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCC------cEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCc
Confidence 478999999999999999999987654 4899999865321 11111122223344444 689999999887654
Q ss_pred C----------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 121 G----------KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 121 ~----------~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
. .+|++|||++|++.+.+... ...+++..++.++.|++.||+|||+.+|+||||||+||++++++.+||
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred chhhhccccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence 4 79999999999888877643 347899999999999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||++........ .......++..|+|||.+.+. ..++.++|+|||||++|||++|+.||...+..+....+...
T Consensus 158 ~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred CcccccccccCCcc--cccccceeccCccChHHhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999876533211 111223467889999988632 24678999999999999999999999876654433333221
Q ss_pred ccCC----------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEKP----------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~p----------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+ .....+|..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110 011246899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.99 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=192.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
++|+..++||.|+||.||+|.+..++ +.+|+|.+...... ....+.++ .+++..+ +|+||+.+++++..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG------MIFALKTITTDPNPDLQKQILRE-LEINKSC-KSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC------eEEEEEEEecCCchHHHHHHHHH-HHHHHhC-CCCCeeeeeeEEEccC
Confidence 47999999999999999999987654 48999998754332 23334443 3455554 69999999998765
Q ss_pred CCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+.+|+||||++ |+|.+++... ....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence 347899999998 5777766542 2456899999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhhc
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-----SVEEIYHSVVIKK 271 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-----~~~ei~~~i~~~~ 271 (632)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... ...+....+.. .
T Consensus 153 ~~~~~~-----~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~ 223 (287)
T cd06621 153 GELVNS-----LAGTFTGTSFYMAPERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-M 223 (287)
T ss_pred cccccc-----ccccccCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-C
Confidence 654321 1123457889999999864 36788999999999999999999999865 22333333322 1
Q ss_pred cCCCCC------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIP------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+..+ ..+++++.++|.+||+.||.+||++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 222222 234678999999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.58 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=193.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.++||+|+||.||+|.+..++ ..||||.+...... ......++ .+++..+ +|+||+.+++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~ 78 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG------RVVALKKILMHNEKDGFPITALRE-IKILKKL-KHPNVVPLIDMAVE 78 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC------cEEEEEEEEeccCCCCcchhHHHH-HHHHHhc-CCCCccchhhheec
Confidence 479999999999999999999987655 47999998643221 11222233 3444554 68999999887643
Q ss_pred C--------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 120 N--------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 120 ~--------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
. ..++++|||+.+++.+.+... ...+++..++.++.|++.||+|||+++|+||||||+|||+++++.++|+
T Consensus 79 ~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 79 RPDKSKRKRGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred ccccccccCceEEEEEecCCcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC
Confidence 2 357999999999888877543 3579999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCC--------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHH
Q 006772 192 DFGIPYLLLGRSLSD--------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263 (632)
Q Consensus 192 DFGlak~~~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei 263 (632)
|||++.......... .......|++.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999987653321111 112234678899999987642 3478899999999999999999999998776554
Q ss_pred HHHHHhhccCC---------------------CCC-------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 264 YHSVVIKKEKP---------------------CIP-------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 264 ~~~i~~~~~~p---------------------~~p-------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+......+ ..+ ..+++++.++|.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 44433211100 000 234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=292.60 Aligned_cols=248 Identities=24% Similarity=0.409 Sum_probs=199.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|+....||+|+||.||+|.+..++ ..|++|++..... ....+..+. +.+..+ +|+|++.+++.+..++.
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~-~~~~~~~e~-~~l~~l-~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATG------KEVAIKKMRLRKQ-NKELIINEI-LIMKDC-KHPNIVDYYDSYLVGDE 89 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCC------cEEEEEEEecCch-hHHHHHHHH-HHHHHC-CCCCeeEEEEEEEECCE
Confidence 56899999999999999999987544 4899999975443 223333333 344444 68999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|++|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999 68888776543 4799999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC--CCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI--PSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~--p~~ 279 (632)
.. .......++..|++||++.+ ..++.++|+||||+++|+|++|..||...+.......+.... .+.. +..
T Consensus 169 ~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 241 (286)
T cd06614 169 EK---SKRNSVVGTPYWMAPEVIKR---KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPPLKNPEK 241 (286)
T ss_pred ch---hhhccccCCcccCCHhHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCcchhh
Confidence 11 11223457889999999864 357889999999999999999999999877665554443322 2222 234
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++.++|.+||+.+|.+||++.+++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 8899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=293.77 Aligned_cols=247 Identities=22% Similarity=0.369 Sum_probs=196.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|...+.||+|+||.||+|.+..++ +.+++|.+..........+.++. .++.. .+|+|++.+++.+..++.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~e~-~~l~~-~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTG------RQVAVKKMDLRKQQRRELLFNEV-VIMRD-YQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCC------CEEEEEEEeccchhHHHHHHHHH-HHHHH-cCCCChheEEEEEEcCCe
Confidence 45666789999999999999987654 48999998654433333333333 33344 478999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|++|||+.| +|.+.+.. .++++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999999985 66666644 4789999999999999999999999999999999999999999999999998765422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC--CCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI--PSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~--p~~ 279 (632)
. ........|+..|+|||.+.+ ..++.++|+|||||++|||++|..||...+..+....+... ..+.. +..
T Consensus 168 ~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (285)
T cd06648 168 E---VPRRKSLVGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHK 240 (285)
T ss_pred C---CcccccccCCccccCHHHhcC---CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCccccc
Confidence 1 111223468999999999864 35788999999999999999999999887776665554422 22222 334
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++..+.++|.+||+.||++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 7899999999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=300.03 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=194.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
+|++.+.||+|+||.||+|.+.... ....||||.+..... ...+.+.+ +..++..+.+|+||+.+++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~-E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHH-HHHHHHHhcCCCChheeeeeeeecc
Confidence 5899999999999999999987651 124799999864321 11222333 334566667899999998865432
Q ss_pred ---CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 121 ---GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 121 ---~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..+|++|||+.++|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 46889999999998888754 3579999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCC-CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-----
Q 006772 198 LLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK----- 271 (632)
Q Consensus 198 ~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~----- 271 (632)
........ ........||..|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+.......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSF--QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 65432211 1122345789999999987532 357889999999999999999999998766443333222110
Q ss_pred ---------------------cCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 ---------------------EKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ---------------------~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.... ....++.++.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011 11346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.41 Aligned_cols=252 Identities=19% Similarity=0.304 Sum_probs=192.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
.+|++.+.||.|+||.||+|.+..++ ..||+|.+..........+.++ ..++..+ +|+||+.+++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~------~~v~iK~i~~~~~~~~~~~~~E-i~~l~~l-~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCD------KRVAVKKIVLTDPQSVKHALRE-IKIIRRL-DHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCC------cEEEEEEEecCCCchHHHHHHH-HHHHHhc-CCCcchhhHhhhccccc
Confidence 68999999999999999999987665 4899999866544333444443 3445555 789999888665433
Q ss_pred ------------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCc
Q 006772 121 ------------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQ 187 (632)
Q Consensus 121 ------------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~ 187 (632)
...|++|||+.++|.+.+.. +.+++..++.++.||+.||+|||+++|+||||||+|||++. ++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccccccccceEEEEeecccccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCce
Confidence 46899999999988777643 47899999999999999999999999999999999999984 557
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
++|+|||+++.+..............|+..|+|||.+... ..++.++|+|||||++|||++|+.||.+.+..+....+
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCc--cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8999999987653321111112233578899999987532 24778999999999999999999999877654433332
Q ss_pred Hhh-----------------------ccCCC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 268 VIK-----------------------KEKPC-----IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 268 ~~~-----------------------~~~p~-----~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
... ...+. ....++.++.++|.+||..||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 211 00111 11357789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=301.71 Aligned_cols=251 Identities=17% Similarity=0.221 Sum_probs=186.5
Q ss_pred eEEccc--CceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEE
Q 006772 49 HRIGRG--PFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICI 125 (632)
Q Consensus 49 ~~IG~G--~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~L 125 (632)
..||+| +||+||+|.+..++ +.||+|++..... ....+.+.++..+ .+..+|+||+.+++++..++..|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~-~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTG------TLVTVRITDLENCTEEHLKALQNEVVL-SHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCC------cEEEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCcceEeeeEecCCceEE
Confidence 456666 99999999987665 4899999865332 2222233333333 334579999999999999999999
Q ss_pred EEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCC
Q 006772 126 AMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 126 VmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~ 204 (632)
+|||+. |++.+++.+.....+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 999998 5788777665445689999999999999999999999999999999999999999999999986533211110
Q ss_pred CCC----ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc--------
Q 006772 205 SDS----DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-------- 272 (632)
Q Consensus 205 ~~~----~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-------- 272 (632)
... ......++..|||||++.+. ...++.++|+|||||++|||++|..||.+....+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccccCccCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 000 01112356779999998753 23578899999999999999999999987664443322211000
Q ss_pred -------------------------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 -------------------------------------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 -------------------------------------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+..+++++.+||++||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00112345678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=314.38 Aligned_cols=269 Identities=21% Similarity=0.282 Sum_probs=210.5
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+|.+-|..++.||-|+||+|-|+....+. ..||+|.|.+...- .....+..++.|+... +.+-|++|+..
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~------~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyyS 697 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTR------ALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYS 697 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchh------hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEE
Confidence 477888999999999999999999876654 58999999764321 1112233444555544 56779999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
|++++.+|+||+|++ |++-.++.+. +-|++..+++|++++..|+++.|..|+|||||||+|||||.+|++||+||||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence 999999999999999 5777777664 6899999999999999999999999999999999999999999999999999
Q ss_pred ceecc---------CC------CCCC------------------------CccccccCCCccCCccccCCCCCCCCCccc
Q 006772 196 PYLLL---------GR------SLSD------------------------SDMALRLGTPNYMAPEQWEPEVRGPISFET 236 (632)
Q Consensus 196 ak~~~---------~~------~~~~------------------------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ks 236 (632)
+.-+- .. +... ......+||++|+|||++. +..|+..+
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~---r~g~~q~c 852 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA---RTGYTQLC 852 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc---ccCccccc
Confidence 75331 00 0000 0011247999999999997 44789999
Q ss_pred ccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCC---HHHHHHHHHh
Q 006772 237 DTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPL---MADILHAFES 311 (632)
Q Consensus 237 DvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs---~~ell~~Le~ 311 (632)
||||.||+||||+.|+.||...++.+...+++.-.....++ ..++.++.++|.+++. +++.|.. .++|..
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKa---- 927 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKA---- 927 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcccchhhhhc----
Confidence 99999999999999999999988877666655443333444 6899999999988765 7888873 333433
Q ss_pred hhhcccCCCCccccc
Q 006772 312 SQNAVYNDGEWTGLG 326 (632)
Q Consensus 312 ~~~~~~~~~~w~~~~ 326 (632)
+.||.++||..+.
T Consensus 928 --HpfFkgIDfsslR 940 (1034)
T KOG0608|consen 928 --HPFFKGIDFSSLR 940 (1034)
T ss_pred --CccccccchHhhh
Confidence 7899999998754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=296.05 Aligned_cols=247 Identities=20% Similarity=0.341 Sum_probs=195.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||++.+..++ +.||+|.+........+.+.++. .++..+ +|+|++.+++.+..++.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~e~-~~l~~l-~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATG------QEVAIKQMNLQQQPKKELIINEI-LVMREN-KHPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCC------CEEEEEEeccccchHHHHHHHHH-HHHhhc-CCCCeeehhheeeeCCc
Confidence 68999999999999999999876544 47999998643333333333333 344444 68999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++ |+|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999998 566666643 3688999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~~ 279 (632)
.. .......|++.|+|||.+.. +.++.++|+|||||++|+|++|..||...+..+....+.. ...+. .+..
T Consensus 168 ~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (293)
T cd06647 168 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEK 240 (293)
T ss_pred cc---cccccccCChhhcCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCccc
Confidence 21 11223468899999999863 3578899999999999999999999987765443322221 12222 2346
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++..+.++|++||..+|++||++.+++.
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7889999999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=281.04 Aligned_cols=247 Identities=27% Similarity=0.498 Sum_probs=201.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||+|.+...+ +.|++|.+..... .....+.++ .+++.++ .|++++.+.+++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e-~~~l~~l-~~~~i~~~~~~~~~~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG------DFVAIKQISLEKIKEEALKSIMQE-IDLLKNL-KHPNIVKYIGSIETSD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC------cEEEEEEecccccCHHHHHHHHHH-HHHHHhC-CCCCccEEEEEEEeCC
Confidence 5889999999999999999987554 4899999976543 222333333 3444454 6899999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..+++|||++| +|.+.+... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 99999999985 777776543 579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
... .......++..|+|||.+... .++.++|+||||+++|+|++|..||...+......... ....+.++..+
T Consensus 151 ~~~---~~~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (254)
T cd06627 151 DVS---KDDASVVGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGI 223 (254)
T ss_pred CCc---ccccccccchhhcCHhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCC
Confidence 321 112334688999999998643 47889999999999999999999998776555444443 34555677889
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+.+++.+||..+|++||++.+++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 999999999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.12 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=194.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
++|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+ +..++..+ +|+||+.+++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~iv~~~~~~~~~ 76 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSG------KKVAIKKIPHAFDVPTLAKRTLR-ELKILRHF-KHDNIIAIRDILRPP 76 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCC------CEEEEEEeccccccccchHHHHH-HHHHHHhc-CCCCccCHHHhcccc
Confidence 68999999999999999999988665 4899999875322 12222333 33445555 59999998887653
Q ss_pred ---CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 ---NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 ---~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
...+|+||||+.|++.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 77 GADFKDVYVVMDLMESDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred CCCCceEEEEEehhhhhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 357899999999988877743 356999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCC-CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----
Q 006772 197 YLLLGRSLSD-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK----- 270 (632)
Q Consensus 197 k~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~----- 270 (632)
+......... .......|+..|+|||.+... ..++.++|+|||||++|||++|+.||.+.+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCC--cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 7653322211 111234789999999997632 35788999999999999999999999877644322221110
Q ss_pred -------------------ccCCCC-----CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 -------------------KEKPCI-----PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 -------------------~~~p~~-----p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...... ....++++.++|.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111 1346899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.94 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=193.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||.+.... ........+ +..++..+ +|+||+.+++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~ni~~~~~~~~~~ 76 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETN------EKVAIKKIANAFDNRIDAKRTLR-EIKLLRHL-DHENVIAIKDIMPPP 76 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCC------CeEEEEEecccccccchhHHHHH-HHHHHHhc-CCCCccchHHheecc
Confidence 57999999999999999999987655 489999986532 112222323 33444444 689999998877643
Q ss_pred -----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 121 -----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 121 -----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
..+|++|||+.++|.+.+.. .+.+++..++.++.|++.||.|||+++++||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35899999999998888754 35799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc----
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK---- 271 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~---- 271 (632)
++...... .......++..|+|||.+... ..++.++|+|||||++|+|++|..||.+.+.......+....
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 155 ARTTSEKG---DFMTEYVVTRWYRAPELLLNC--SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred ccccCCCc---ccccccccccCccChHHHhcC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 87653221 122334678999999988632 247889999999999999999999998765433222211100
Q ss_pred ----------------------cCC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 ----------------------EKP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ----------------------~~p---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+ .....+++++.++|.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000 012467899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=291.80 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=195.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
|++.+.||+|++|.||+|.+..++ ..+++|.+...... ....+.. +..++..+ +|++|+.+++++..++.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~-e~~~l~~l-~~~~i~~~~~~~~~~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG------EIVAIKKIKLRFESEGIPKTALR-EIKLLKEL-NHPNIIKLLDVFRHKGD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC------cEEEEEEeccccccchhHHHHHH-HHHHHHHh-cCCCcchHHHhhccCCC
Confidence 567889999999999999986554 48999998654322 1222223 33444555 58999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
.+++|||+++++.+.+... ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus 73 ~~~v~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 73 LYLVFEFMDTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEEEEeccCCCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 9999999999988877654 358999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP-------- 274 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p-------- 274 (632)
. .......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.+.+..+....+......+
T Consensus 152 ~---~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 152 V---RPYTHYVVTRWYRAPELLLGD--KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred c---ccccCccCcccccCcHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 2 112234578899999998642 257889999999999999999999998877544433332111110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+.++.++.++|.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011346789999999999999999999999886
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.91 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=200.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+|++.+.||+|+||.||++.+..++ ..+|+|.+..... .....+.. +..++..+ .|+||+.+.+++..+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~-e~~~l~~l-~~~~i~~~~~~~~~~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDN------QFYALKEVDLGSMSQKEREDAVN-EIRILASV-NHPNIISYKEAFLDGN 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCC------CEEEEEEEehhhccHHHHHHHHH-HHHHHHhC-CCCCchhhhhhhccCC
Confidence 5899999999999999999887655 4799999865322 22222223 23444555 5899999999999899
Q ss_pred EEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEG-SVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..|+||||++| +|.+.+.+.. +..+++..++.++.|++.||+|||+++++|+||+|.||+++.++.+||+|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 99999999985 6777665532 35789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
.... ......|++.|++||.+.+ ..++.++|+||||+++|||++|..||...+..+....+. ....+..+.
T Consensus 153 ~~~~-----~~~~~~~~~~~~~Pe~~~~---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 223 (256)
T cd08530 153 LKKN-----MAKTQIGTPHYMAPEVWKG---RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPP 223 (256)
T ss_pred hccC-----CcccccCCccccCHHHHCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCch
Confidence 5432 1123457899999999874 357889999999999999999999999888776655544 334445667
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++.++.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 88999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=324.10 Aligned_cols=274 Identities=22% Similarity=0.385 Sum_probs=224.5
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
|......|+.+++.+.+.||+|.||.|++|........ ......||||+++..........+..+..++..+.+|+|++
T Consensus 286 ~~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 286 PEDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred CcCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchh
Confidence 34446678889999999999999999999986543321 12246899999987655544555555667788889999999
Q ss_pred EeeEEEEECCEEEEEEecCC-CCHHHHHHHhc------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeee
Q 006772 112 WLHGISVINGKICIAMKFYE-GSVGDRIAQQR------------G--GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK 176 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~------------~--~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLK 176 (632)
.+.+++...+.+++|+||+. |+|++++.+.+ . ..++..+.+.++.|||.|++||+++.+|||||.
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 99999999999999999998 89999987764 0 138899999999999999999999999999999
Q ss_pred CCeEEEecCCcEEEEecCCceeccCCCCCCCccccccC--CCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCC
Q 006772 177 PSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG--TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQ 253 (632)
Q Consensus 177 P~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~G--T~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~ 253 (632)
.+|||+.++..+||+|||+|+.......... ..-.| ...|||||.+.. ..|+.+|||||||++||||+| |..
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~---~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD---RVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc---CcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999985433211110 00111 346999999974 368999999999999999999 999
Q ss_pred CCCCCC-HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 254 PWFGKS-VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 254 PF~~~~-~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
||.+.. ..+++. .+..+.+...|..|++++.++|+.||+.+|++||++.++.+.|+..
T Consensus 521 PYp~~~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 521 PYPGIPPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCCCcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 999966 556655 4456778888999999999999999999999999999999988874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.08 Aligned_cols=253 Identities=17% Similarity=0.238 Sum_probs=195.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH--------------HHHHHHHHHHhhhccCCC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA--------------KVFVNKFEELFPKFRESQ 108 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~--------------~~~~~~~~~il~~l~~h~ 108 (632)
+.+.+.+.||+|+||.||+|.+..++ +.||||.+........ ..+. ++..++..+ +|+
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~E~~~l~~l-~h~ 80 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTG------KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL-RELKIMNEI-KHE 80 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCC------CeEEEEEeeccccccccccchhhhcccccchhHH-HHHHHHHhC-CCc
Confidence 33346678999999999999987654 4899999865322110 0122 223344444 689
Q ss_pred ceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 109 SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 109 ~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
||+.+++++..++..|++|||+.|++.+.+.. ...+++..+..++.|++.||+|||+++|+|+||||+|||++.++.+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999999999999999999999999988854 3478999999999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCC-----------CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC
Q 006772 189 VLGDFGIPYLLLGRSL-----------SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257 (632)
Q Consensus 189 kL~DFGlak~~~~~~~-----------~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~ 257 (632)
+|+|||++........ .........+++.|+|||.+.+. ..++.++|+|||||++|||++|..||.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC--CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999876541111 01112233568899999998643 2468899999999999999999999998
Q ss_pred CCHHHHHHHHHhhccCCC--------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 258 KSVEEIYHSVVIKKEKPC--------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 258 ~~~~ei~~~i~~~~~~p~--------------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+..+.+..+......+. ....++.++.++|.+||+.||++||++++++.
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 876655544432111110 01345788999999999999999999999886
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=278.72 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=199.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
+|++.+.||+|+||.||+|.+..++ +.|++|++..... .....+ .++...+.++ +|++|+.+.+.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~-~~e~~~l~~l-~~~~i~~~~~~~~~~~ 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG------ELMAVKSVELSGDSEEELEAL-EREIRILSSL-QHPNIVRYYGSERDEE 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC------cEEEEEEeeccccchHHHHHH-HHHHHHHHHc-CCCCEeeEEEEEecCC
Confidence 4888999999999999999987654 4899999865442 222233 3333444554 599999999999888
Q ss_pred -CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 121 -GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 121 -~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+..+++|||++ ++|.+++... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 73 KNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred CCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 89999999996 5777776543 3899999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~~~~~p~~p 277 (632)
....... .......++..|+|||.+... .++.++|+||||+++|+|++|..||...+ .......+......+.+|
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 151 LGDIETG-EGTGSVRGTPYWMAPEVIRGE---EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred ccccccc-ccccCCCCCccccCHhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 6433210 012334678999999998643 47889999999999999999999998765 333333333334556678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..++.++.++|.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 889999999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.16 Aligned_cols=247 Identities=20% Similarity=0.312 Sum_probs=210.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH--HHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA--KVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~--~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
..|.+.+.||+|.|++|.+|++..++ ..||||.+.+...+.. +. +.++..++. ...||||++++.+....
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~------~~VaiK~idkt~ln~~~~~k-~~rev~imk-~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTG------TEVAIKIIDKTQLNPSKRQK-LGREVDIMK-SLNHPNIVKLFSVIETE 127 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCC------ceEEEEEehhcccChHHHHH-HHHHHHHHH-hcCCcceeeeeeeeeec
Confidence 57999999999999999999998765 5899999987543322 23 233333433 45899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
..+|+||||+. |.+.+++..+ +++.+.++..++.|+..|++|||+++|+|||||++||||+.+.++||+|||++..+
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 99999999997 6888888654 57888999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
... ....++||++.|.|||++.+.. ...+.+|+||+|++||-|+.|..||.+.+..+....++. .+..+|..
T Consensus 206 ~~~----~~lqt~cgsppyAaPEl~~g~~--y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--gk~rIp~~ 277 (596)
T KOG0586|consen 206 DYG----LMLQTFCGSPPYAAPELFNGKK--YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--GKYRIPFY 277 (596)
T ss_pred ccc----ccccccCCCCCccChHhhcCcc--cCCcceehhhhhhhheeeeecccccCCcccccccchhee--eeecccce
Confidence 532 2345689999999999998763 346899999999999999999999999888777666653 44556788
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.+++++|+++|..+|.+|++++++++
T Consensus 278 ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 278 MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eechhHHHHHHhhccCccccCCHHHhhh
Confidence 9999999999999999999999999886
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=321.80 Aligned_cols=147 Identities=22% Similarity=0.329 Sum_probs=121.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.++||.|+||.||+|.+..++ +.||||+++.... ......+..+..++. ...|++|+.++..+..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~------~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~ 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNS------KLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYSLQS 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC------cEEEEEEEehhhccCHHHHHHHHHHHHHHH-hcCCCCcCeEEEEEEE
Confidence 478999999999999999999987654 4899999865321 111222333333333 4479999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.+.+||||||+. |+|.+++... +.+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999997 5777777543 478999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.24 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=189.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDC-AKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|.+.+.||+|+||.||+|.+..++ ..||||.+.... ... ...+.+ +..++..+ .|+||+.+.+++..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-e~~~l~~l-~h~niv~~~~~~~~ 85 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTG------EKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHM-QHENVIGLLDVFTS 85 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCC------cEEEEEEecCccccccchhHHHH-HHHHHHhc-CCCCccchhheecc
Confidence 368999999999999999999987554 489999986532 111 122223 33444444 79999999988765
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. ...|+||||+.+++.+.. +..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred cccCCCCceEEEEecccccCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 4 356999999988765543 246899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE- 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~- 272 (632)
|+++.... ......++..|+|||.+.+. ..++.++|+|||||++|||++|+.||.+.+....+..+.....
T Consensus 162 g~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (342)
T cd07879 162 GLARHADA------EMTGYVVTRWYRAPEVILNW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233 (342)
T ss_pred CCCcCCCC------CCCCceeeecccChhhhcCc--cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99875321 12234678899999998642 2478899999999999999999999998775544433321100
Q ss_pred --------------------CCCC--------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 --------------------KPCI--------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 --------------------~p~~--------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+.. .+..++++.++|.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111 1246788999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.51 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=202.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+-|.++.+||+|+||.||+|.|+.++ +.+|||...-. ...++++.+ ..+++++ ..+++++++|.+..+..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG------~v~AIK~VPV~--sDLQEIIKE-ISIMQQC-~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESG------HVLAIKKVPVD--TDLQEIIKE-ISIMQQC-KSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccC------cEEEEEecCcc--chHHHHHHH-HHHHHHc-CCchhhhhhhhhccCCc
Confidence 55888999999999999999998876 48999998543 233444444 3556665 67999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
++||||||. |+..|.+. .+++++++.++..++++.+.||+|||...-||||||..||||+.+|++||+|||.|-.+..
T Consensus 103 LWIVMEYCGAGSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eEeehhhcCCCcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999998 88888765 4567999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~~ 279 (632)
.. ....+.+|||.|||||++..- .|+.++||||||++..||..|++||..-.+......|- .+.+|. -|..
T Consensus 182 TM---AKRNTVIGTPFWMAPEVI~EI---GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~KPE~ 254 (502)
T KOG0574|consen 182 TM---AKRNTVIGTPFWMAPEVIEEI---GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFKKPEE 254 (502)
T ss_pred hH---HhhCccccCcccccHHHHHHh---ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-CCCCCCCCChHh
Confidence 21 112457899999999999743 68899999999999999999999998866544322222 122232 3467
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++.+++++||-++|++|-++.++++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 8999999999999999999999988775
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.05 Aligned_cols=250 Identities=15% Similarity=0.183 Sum_probs=182.4
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC--chhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEE
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL--KEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKIC 124 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~--~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~ 124 (632)
+++.+|. +|.||.+++..++ +.||||++... .......+ ..+...+..+ .|+||+.+++++..++..|
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~-~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 75 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTN------TLVAVKKINLDSCSKEDLKLL-QQEIITSRQL-QHPNILPYVTSFIVDSELY 75 (314)
T ss_pred hhHhhcC--CceEEEEEecCCC------CEEEEEEEeccccchhHHHHH-HHHHHHHHhc-CCcchhhhhheeecCCeEE
Confidence 3344444 4555555555443 58999998754 22222333 3333444554 6899999999999999999
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 125 IAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 125 LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
++|||++ |++.+++.......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.+..+....
T Consensus 76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 9999998 677777766555678999999999999999999999999999999999999999999999999887653322
Q ss_pred CC----CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-------
Q 006772 204 LS----DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE------- 272 (632)
Q Consensus 204 ~~----~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~------- 272 (632)
.. ........++..|+|||++... ...++.++|+|||||++|||++|..||...+.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQN-LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 11 1111234578899999998643 23578899999999999999999999987654433221111000
Q ss_pred -------------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 -------------------------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 -------------------------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+..++.++.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00011123467899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=295.50 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=192.4
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-h-hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-D-CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
-.++|++.+.||+|+||.||+|.+..++ +.||||.+..... . ....+.+ +..++..+ +|+||+.+.+++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~~ 84 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTG------AKVAIKKLYRPFQSELFAKRAYR-ELRLLKHM-KHENVIGLLDVFT 84 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCC------cEEEEEEecccccchHHHHHHHH-HHHHHHhc-CCCCccceeeeec
Confidence 3578999999999999999999987655 4899999864321 1 1122333 33444444 7899999999887
Q ss_pred ECC------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 119 ING------KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 119 ~~~------~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
.+. ..++||||+.+++.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred CCccccccceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEee
Confidence 653 4689999998787776643 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||++..... ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+....+..+.....
T Consensus 162 fg~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 162 FGLARQTDS------EMTGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ccccccccc------CccccccCCcccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999875422 12234678999999998642 2478899999999999999999999987765443333221100
Q ss_pred C-----------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 K-----------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~-----------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ......+++++.++|.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0112467888999999999999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=289.39 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=192.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKIC 124 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~ 124 (632)
|....+||+|+||.||+|.+..++ ..||||.+..........+.++. .++..+ +|+|++.+++.+..++..|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~e~-~~l~~l-~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSG------KLVAVKKMDLRKQQRRELLFNEV-VIMRDY-QHENVVEMYNSYLVGDELW 93 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCC------eEEEEEEecccchhHHHHHHHHH-HHHHhc-CCcchhheeeEEEeCCEEE
Confidence 444578999999999999987655 48999988543333333333333 344444 6899999999999999999
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 125 IAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 125 LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
++|||++| +|.+.+. ...+++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 94 VVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred EEEecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 99999986 5555432 2468999999999999999999999999999999999999999999999999886543211
Q ss_pred CCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCCCCC
Q 006772 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPSGLP 281 (632)
Q Consensus 204 ~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~~lp 281 (632)
.......|+..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+..+....+.. ...+. ....++
T Consensus 171 ---~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (292)
T cd06657 171 ---PRRKSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVS 243 (292)
T ss_pred ---ccccccccCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-hCCcccCCcccCC
Confidence 11233568999999999863 3578899999999999999999999998776655444332 12222 234678
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.+.+++.+||+.||.+||++.+++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 99999999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.31 Aligned_cols=268 Identities=23% Similarity=0.357 Sum_probs=214.8
Q ss_pred cCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhh-ccCCCc
Q 006772 31 ATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-FRESQS 109 (632)
Q Consensus 31 ~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~-l~~h~~ 109 (632)
+.+.-+++-.+...+++.+.||+|.||.||+|.... +.||||++... ..+.+.++. .++.. ...|+|
T Consensus 198 ~~~~~sspl~~l~pl~l~eli~~Grfg~V~KaqL~~--------~~VAVKifp~~---~kqs~~~Ek-~Iy~lp~m~h~n 265 (534)
T KOG3653|consen 198 SGPAPSSPLLELDPLQLLELIGRGRFGCVWKAQLDN--------RLVAVKIFPEQ---EKQSFQNEK-NIYSLPGMKHEN 265 (534)
T ss_pred CCCCCCcccccCCchhhHHHhhcCccceeehhhccC--------ceeEEEecCHH---HHHHHHhHH-HHHhccCccchh
Confidence 445556677778899999999999999999998654 58999998642 334444443 44332 458999
Q ss_pred eeEeeEEEEECC----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeeee
Q 006772 110 VCWLHGISVING----KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS---------IGLLVLNL 175 (632)
Q Consensus 110 I~~l~~~~~~~~----~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs---------~~IvHRDL 175 (632)
|+.+.+.-.... .++||++|.+ |+|.+++..+ .++|.+..+++..+++||+|||+ ..|+||||
T Consensus 266 Il~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl 342 (534)
T KOG3653|consen 266 ILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL 342 (534)
T ss_pred HHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence 999988765544 7899999998 9999999764 79999999999999999999997 25999999
Q ss_pred eCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCC---CCcccccchhHHHHHHHHhCC
Q 006772 176 KPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGP---ISFETDTWGFGCSIMEMLTGI 252 (632)
Q Consensus 176 KP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~---~t~ksDvwSlGvvL~EmltG~ 252 (632)
|.+||||.+|+++.|+|||+|..+. ......+....+||.+|||||++.+...-+ .-.+.||||+|.+||||++.-
T Consensus 343 kSkNVLvK~DlTccIaDFGLAl~~~-p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 343 KSKNVLVKNDLTCCIADFGLALRLE-PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred cccceEEccCCcEEeeccceeEEec-CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 9999999999999999999998875 344455556689999999999998654322 124689999999999999852
Q ss_pred ------------CCCC-----CCCHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHHhhhcCcCCCCCHHHHHHHHH
Q 006772 253 ------------QPWF-----GKSVEEIYHSVVIKKEKPCIPSGL-----PPAVENVIIGCFEYDLRNRPLMADILHAFE 310 (632)
Q Consensus 253 ------------~PF~-----~~~~~ei~~~i~~~~~~p~~p~~l-----p~~l~~LI~~cL~~DP~~RPs~~ell~~Le 310 (632)
.||. ..+.+++...++.++.+|.+|+.+ ..-+.+.+..||..||+.|.|+.=+.+.+.
T Consensus 422 ~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 422 TDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred ccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 3443 245667888888889999999654 357899999999999999999988887776
Q ss_pred hhhh
Q 006772 311 SSQN 314 (632)
Q Consensus 311 ~~~~ 314 (632)
.+.+
T Consensus 502 ~l~~ 505 (534)
T KOG3653|consen 502 ELMM 505 (534)
T ss_pred HHhc
Confidence 6543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=298.18 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=194.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
-.++|++.+.||+|+||.||+|.+..++ ..||||++.... ........+ +..++.++ .|+|++.+.+++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~~ 84 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTG------RKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHM-DHENVIGLLDVFT 84 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCC------cEEEEEecccccchhhHHHHHHH-HHHHHHhc-cCCCHHHHHHHhh
Confidence 3578999999999999999999987655 489999986432 122223333 33444554 7899998887766
Q ss_pred ECCE------EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 119 INGK------ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 119 ~~~~------l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
.++. .++||||+.++|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 85 PASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccccccccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcc
Confidence 5544 899999999888887754 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||++...... .....++..|+|||.+.+. ..++.++|+|||||++|||++|+.||.+.+..+.+..+.....
T Consensus 162 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 162 FGLARHTDDE------MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred cccccccccc------ccCCcccccccCHHHHhCC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 9998754221 2334678899999998642 2578899999999999999999999988776555444332111
Q ss_pred CC-----------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KP-----------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p-----------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ .....+++++.++|.+||..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 10 011246889999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.12 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=192.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
|...++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+ +..++.++ +|+||+.+.++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-Ei~~l~~l-~h~~iv~~~~~ 84 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTG------LRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHM-KHENVIGLLDV 84 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCC------eEEEEEEecCcchhhHHHHHHHH-HHHHHHHc-CCCcccceeee
Confidence 445588999999999999999999987655 48999998653211 1222333 33444444 78999999988
Q ss_pred EEEC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 117 SVIN------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 117 ~~~~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
+... ...|++++++.+++.+.+.. ..+++..++.++.|++.||+|||+++|+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEE
Confidence 7643 35789999998888776643 36899999999999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||+++.... ......|+..|+|||.+.+. ..++.++|+|||||++|||++|+.||...+.......+...
T Consensus 162 ~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDD------EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred ecccccccccc------cccccccCCCccCHHHHhCc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999875321 12234678999999988642 35788999999999999999999999876654433322211
Q ss_pred cc---------------------CCCC--------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KE---------------------KPCI--------PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~---------------------~p~~--------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. .+.. ....++++.++|.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00 0011 1245788999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.18 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=190.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-h-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-E-DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||.+.+.. . ...+.+.. +..++..+ .|||++.+.+++..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~hpniv~~~~~~~~ 80 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTG------QNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL-RHENIISLSDIFIS 80 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCC------CEEEEEEecccccccchhHHHHH-HHHHHHhc-CCCCeeeEeeeEec
Confidence 467999999999999999999987655 489999875422 1 12223333 33444444 68999999998865
Q ss_pred -CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 -NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 -~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.+..|++|||+.+++.+.+.. ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.++|+|||++..
T Consensus 81 ~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 81 PLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred CCCcEEEEeehhccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 567899999998887776642 4688899999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--------
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK-------- 270 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~-------- 270 (632)
... ......++..|+|||.+.+ ...++.++|+|||||++|+|++|..||.+.........+...
T Consensus 158 ~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 158 QDP------QMTGYVSTRYYRAPEIMLT--WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred cCC------CcCCCcccccccCceeeec--cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 322 1123457889999998753 135788999999999999999999999876643222111100
Q ss_pred ----------------ccCCCCC-----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 ----------------KEKPCIP-----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ----------------~~~p~~p-----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......| ..+++++.++|.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0001111 357889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=284.09 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=194.3
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
|++.+.||+|+||.||+|.+..++ +.||+|++.... ......+..+ ...+..+ .|++++.+++++...+.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e-~~~l~~~-~~~~i~~~~~~~~~~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTG------EIVALKKIRLDNEEEGIPSTALRE-ISLLKEL-KHPNIVKLLDVIHTERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCC------cEEEEEEeccccccccccHHHHHH-HHHHHhc-CCCCHHHHHhhhhcCCc
Confidence 677889999999999999987655 489999987643 1112222222 2344444 59999999999998899
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
.++||||++++|.+.+.+.. ..+++..++.++.|++.||+|||+++|+||||+|+||++++++.++|+|||+++.....
T Consensus 73 ~~~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 73 LYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred eEEEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 99999999999988887643 47999999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc----------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE---------- 272 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~---------- 272 (632)
. .......++..|+|||.+... ..++.++|+|||||++|||++|..||.+.+..+.+..+.....
T Consensus 152 ~---~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 152 L---RTYTHEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred c---cccCccccCcCcCChHHhcCC--cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 1 122233567889999998642 2578899999999999999999999988765544333321100
Q ss_pred ---------CCC--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 ---------KPC--------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ---------~p~--------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+. .-+..+.++.++|.+||+.||++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 01234789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=282.01 Aligned_cols=248 Identities=25% Similarity=0.453 Sum_probs=193.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-----hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-----DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-----~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+|.+.+.||+|+||.||++.+..... .+++|+++.... .....+. .+..++.. .+|+|++.+++.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~-~e~~~l~~-l~h~~i~~~~~~~~ 72 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVA------EERLKVLKEIPVGELNPNETVQAN-QEAQLLSK-LDHPAIVKFHASFL 72 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCC------cceEEEeccccccccCcchHHHHH-HHHHHHHh-CCCCcHHHHHHHHh
Confidence 58999999999999999998875532 456666553221 1111222 22233444 37999999999888
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.+...+++|||+.| ++.+.+... ....+++..++.++.|++.||.|||+++++|+||||+||++++ +.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 73 ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCc
Confidence 88899999999984 776666542 3457899999999999999999999999999999999999975 6799999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
++...... .......|++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+....+. ....+.
T Consensus 152 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~ 224 (260)
T cd08222 152 SRLLMGSC---DLATTFTGTPYYMSPEALKH---QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPS 224 (260)
T ss_pred eeecCCCc---ccccCCCCCcCccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCC
Confidence 87653321 11223467899999999863 357789999999999999999999998776665555443 244555
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+..++.++.++|.+||..||++||++.++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 67788999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=285.84 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=196.7
Q ss_pred CCeEEE-eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l~-~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
++|++- +.||-|-.|+|-.+.++.+++ .+|+|+|.... . .+++.++--....|+||+.+++++..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~e------kfALKvL~Ds~-----K-ARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQE------KFALKVLLDSP-----K-ARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchh------hhHHHHHhcCH-----H-HHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 566665 578999999999999998885 79999985321 1 23333444556789999999998753
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEec
Q 006772 120 --NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGDF 193 (632)
Q Consensus 120 --~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~DF 193 (632)
...+.||||.|+ |.|+..+..+....|++.++..++.||+.|+.|||+.+|.||||||+|+|... |..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 256889999999 57888887776678999999999999999999999999999999999999974 457899999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVI 269 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~ 269 (632)
|+|+.... .....+.|-||+|.|||++..+ .|+...|+||+||++|-||.|.+||+.... ..+..+|..
T Consensus 209 GFAK~t~~----~~~L~TPc~TPyYvaPevlg~e---KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQE----PGDLMTPCFTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred ccccccCC----CccccCCcccccccCHHHhCch---hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 99987532 2344556789999999999755 588899999999999999999999986532 234445543
Q ss_pred hccCCCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 KKEKPCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~~~~p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ ...|| +.+|.+.+++|+.+|..+|.+|.++.++++
T Consensus 282 g--qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 G--QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c--CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 3 33344 357899999999999999999999999886
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=275.64 Aligned_cols=236 Identities=25% Similarity=0.418 Sum_probs=192.0
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
||+|+||.||++.+...+ ..+|+|.+...... ....+ ..+..++..+ .|++++.+++.+..++..|++|
T Consensus 1 lg~G~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~-~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 72 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG------KLYAMKVLKKKKIIKRKEVEHT-LTERNILSRI-NHPFIVKLHYAFQTEEKLYLVL 72 (250)
T ss_pred CCCCCceEEEEEEECCCC------cEEEEEEeehhhhcchHHHHHH-HHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEE
Confidence 699999999999987544 48999998653321 22233 3333444554 5999999999999999999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCC
Q 006772 128 KFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206 (632)
Q Consensus 128 Ey~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~ 206 (632)
||+. ++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 73 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--- 147 (250)
T cd05123 73 EYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--- 147 (250)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---
Confidence 9995 6888877653 368999999999999999999999999999999999999999999999999987653321
Q ss_pred CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 006772 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286 (632)
Q Consensus 207 ~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~ 286 (632)
.......++..|++||.+.+. ..+.++|+||||+++|+|++|..||...+..+....+.. ....+|..++.++.+
T Consensus 148 ~~~~~~~~~~~~~~Pe~~~~~---~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ 222 (250)
T cd05123 148 SRTNTFCGTPEYLAPEVLLGK---GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARD 222 (250)
T ss_pred CcccCCcCCccccChHHhCCC---CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHH
Confidence 122345678999999998643 477899999999999999999999988877666666543 556678889999999
Q ss_pred HHHHhhhcCcCCCCCHHH
Q 006772 287 VIIGCFEYDLRNRPLMAD 304 (632)
Q Consensus 287 LI~~cL~~DP~~RPs~~e 304 (632)
++.+||..||++||++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.19 Aligned_cols=239 Identities=21% Similarity=0.285 Sum_probs=197.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|.+...||.|+|+.|-.+.+..++ +..++|++.+...+. .++..++....+|+||+.+++.+.++.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~------~~~~vkii~~~~~~~-----~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTD------QEPAVKIISKRADDN-----QDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccc------cchhheecccccccc-----ccccchhhhhcCCCcceeecceecCCc
Confidence 478999999999999999999988766 478999997653322 222245566789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE-ecCCcEEEEecCCceec
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL-SEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl-d~~g~vkL~DFGlak~~ 199 (632)
+.|+|||++.| .+++.+... +.....+..|+.+|+.|+.|||++|+|||||||+|||+ ++.++++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999996 455555433 33337888899999999999999999999999999999 69999999999999875
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhccCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~~~p~~p~ 278 (632)
... ..+.+-|..|.|||+... ..|++++||||||++||+||+|+.||...+.. ++..++ ..+.+..
T Consensus 467 ~~~------~~tp~~t~~y~APEvl~~---~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~ 533 (612)
T KOG0603|consen 467 ERS------CDTPALTLQYVAPEVLAI---QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSE 533 (612)
T ss_pred chh------hcccchhhcccChhhhcc---CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcccc
Confidence 432 223355889999999973 47999999999999999999999999876654 454443 3455558
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+|.++++||++||+.||.+||++.+++.
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 89999999999999999999999999885
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.74 Aligned_cols=253 Identities=22% Similarity=0.392 Sum_probs=210.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE---
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI--- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--- 119 (632)
+.+++.+.||.|.+|.||++.+++++ +.+|+|++.+.... ++.++.+..+++...+|||++.+++++..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~------~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTG------QLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecC------ceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 56899999999999999999988766 47899998775543 23344555677788899999999998864
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 120 --NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 120 --~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
+++++||||||. ||.-|++....+.++.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.+||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 479999999998 79999998888889999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
..+... .....+.+|||.|||||++..+. ...|+.++|+||||++..||.-|.+|+.++-+...+..|.. +.+|
T Consensus 171 aQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR-NPPP 246 (953)
T KOG0587|consen 171 AQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NPPP 246 (953)
T ss_pred eeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-CCCc
Confidence 776442 22335568999999999997542 33577899999999999999999999998877655444331 1222
Q ss_pred C--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 C--IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~--~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. .|..++.++.++|..||.+|.++||++.++++
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 24678899999999999999999999998875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.07 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=205.3
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..++.++++-+..||.|.||+|++-.++.++ +..|||.+........+..+..+.....+..++|+|++++|+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg------~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSG------KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccC------cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 4467788888899999999999999998876 4899999987665444444444444455667899999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEec
Q 006772 118 VINGKICIAMKFYEGSVGDRIA---QQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~---~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
..++..+|-||+|.-|+..+.. ......+++.-.-.++...+.||.||-. .+|||||+||+||||+..|.+|||||
T Consensus 133 F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 133 FSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred hcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence 9999999999999976554433 2345688999888999999999999987 58999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~ 272 (632)
|++-.+... ...+.-.|...|||||.+..... .|+-+||+||||++|||+.||..||.+.+. -+...+++. +.
T Consensus 213 GIcGqLv~S----iAkT~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~-gd 286 (361)
T KOG1006|consen 213 GICGQLVDS----IAKTVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI-GD 286 (361)
T ss_pred cchHhHHHH----HHhhhccCCccccChhccCCccC-CcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc-CC
Confidence 997554321 11223368889999999987643 689999999999999999999999998653 333334443 33
Q ss_pred CCC--CCC---CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPC--IPS---GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~--~p~---~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.|. .+. ..+..+..+|.-||.+|-..||.+.++++
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 332 222 37889999999999999999999999886
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.19 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=196.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEE---EEEecCC-chhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELA---VKMLLPL-KEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VA---IK~l~~~-~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.-+++...||+|+|=+||+|.|..++ .+|| ||.-... +....+.+ ..+..+++. ..|+||++++..+.
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~g------iEVAWnqvk~~d~~q~~~~leR~-~~Ev~lLKs-L~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEG------IEVAWNQVKIRDVTQSPEELERL-YSEVHLLKS-LKHPNIIRFYDSWV 111 (632)
T ss_pred ceeehhhhcccccceeeeeccccccc------hhhHHHHHhHHHhhcChHHHHHH-HHHHHHHcc-CCCCceeeeeehee
Confidence 44677889999999999999986544 2444 2221111 22222333 333344444 58999999999887
Q ss_pred ECC--EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEe-cCCcEEEEe
Q 006772 119 ING--KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLS-EHDQLVLGD 192 (632)
Q Consensus 119 ~~~--~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld-~~g~vkL~D 192 (632)
+.. .+-+|+|++. |+|..++.+. ++++...+..|++||++||.|||++. |||||||.+||+|+ ..|.+||+|
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 654 4789999998 8988888765 57899999999999999999999985 99999999999998 458999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVVIKK 271 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~i~~~~ 271 (632)
+|||..... ......+|||.|||||++.. .|++.+||||||.+|+||+|+.-||.-+ ++.++|.++..+.
T Consensus 190 LGLAtl~r~-----s~aksvIGTPEFMAPEmYEE----~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi 260 (632)
T KOG0584|consen 190 LGLATLLRK-----SHAKSVIGTPEFMAPEMYEE----NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI 260 (632)
T ss_pred hhHHHHhhc-----cccceeccCccccChHHHhh----hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC
Confidence 999987632 34455789999999999863 5899999999999999999999999875 5889999988665
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+..+...-.++++++|.+||.. ..+||++.|||.
T Consensus 261 KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 55455566689999999999999 999999999997
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.21 Aligned_cols=241 Identities=22% Similarity=0.351 Sum_probs=201.8
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
+.||+|.||+||-|.+++++ +.||||++.+..- ...+..++.+..+++++ +||.|+.+...|++.+.+|+||
T Consensus 570 evLGSGQFG~VYgg~hRktG------rdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTG------RDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred hhccCCcceeeecceecccC------ceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEe
Confidence 78999999999999999877 5899999976532 23334456565666654 8999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cEEEEecCCceeccCCCC
Q 006772 128 KFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPYLLLGRSL 204 (632)
Q Consensus 128 Ey~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~vkL~DFGlak~~~~~~~ 204 (632)
|-+.|+.++.+.....+++++....++..||+.||.|||.++|+|.||||+||||.+.. .+||||||+|+.+...+.
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 99999999999988889999999999999999999999999999999999999997543 799999999998755433
Q ss_pred CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC----CCC
Q 006772 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP----SGL 280 (632)
Q Consensus 205 ~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p----~~l 280 (632)
..+.+|||.|+|||+++.+ .|+..-|+||.|+++|--|+|..||..+. ++..+|.. ...-+| ..+
T Consensus 723 ----RrsVVGTPAYLaPEVLrnk---GyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQN--AaFMyPp~PW~ei 791 (888)
T KOG4236|consen 723 ----RRSVVGTPAYLAPEVLRNK---GYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQN--AAFMYPPNPWSEI 791 (888)
T ss_pred ----hhhhcCCccccCHHHHhhc---cccccccceeeeEEEEEEecccccCCCcc--chhHHhhc--cccccCCCchhhc
Confidence 2457899999999999854 68889999999999999999999997543 33344432 222223 578
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++++.+||+.+|+..-++|.+.+.-+.
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 999999999999999999999876553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.01 Aligned_cols=257 Identities=20% Similarity=0.363 Sum_probs=204.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
.++++.+.||+|.||+||+|.++.. .||||++.... ...++++.+.-...+.+|+||..+.+.-..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe--------~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE--------DVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred heeEEEEEecCccccceeeccccCC--------ceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 7899999999999999999999753 69999996533 2444444433334457899999887765433
Q ss_pred --CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeeeeeCCeEEEecCCcEE
Q 006772 121 --GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS--------IGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 121 --~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs--------~~IvHRDLKP~NILld~~g~vk 189 (632)
.+++||++|.+ |||.|++.+. .++....++++..+|.||+|||. -.|.|||||..|||+.++|.+.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 37999999998 9999999763 79999999999999999999995 2499999999999999999999
Q ss_pred EEecCCceeccCC-CCCCCccccccCCCccCCccccCCCCCCCC---CcccccchhHHHHHHHHhC----------CCCC
Q 006772 190 LGDFGIPYLLLGR-SLSDSDMALRLGTPNYMAPEQWEPEVRGPI---SFETDTWGFGCSIMEMLTG----------IQPW 255 (632)
Q Consensus 190 L~DFGlak~~~~~-~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~---t~ksDvwSlGvvL~EmltG----------~~PF 255 (632)
|+|+|||-..... ...+......+||.+|||||++........ -..+||||||.++||++.. +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999766443 222333455789999999999975432111 1468999999999999863 6788
Q ss_pred CC-----CCHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 256 FG-----KSVEEIYHSVVIKKEKPCIPSGLP-----PAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 256 ~~-----~~~~ei~~~i~~~~~~p~~p~~lp-----~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+ .+.+++..-+..+..+|.+|..+. ..+..+|+.||..||.-|.++=-|.+.|.++.
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 75 345666666667788888887654 36778999999999999999988888887765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=274.79 Aligned_cols=219 Identities=18% Similarity=0.219 Sum_probs=174.9
Q ss_pred cCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCC-C
Q 006772 54 GPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-G 132 (632)
Q Consensus 54 G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~-G 132 (632)
|.||+||+|.+..++ +.||+|.+...... .++...+ ....|+|++.+++.+..++..|++|||++ |
T Consensus 4 g~~~~v~~~~~~~~~------~~~~~K~i~~~~~~-----~~~~~~~--~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQ------QTFILKGLRKSSEY-----SRERLTI--IPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCC------cEEEEEeecchhhh-----hhHHHHH--HhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 899999999998766 48999999754321 1111122 22358999999999999999999999998 5
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccc
Q 006772 133 SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212 (632)
Q Consensus 133 sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~ 212 (632)
+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++...... ....
T Consensus 71 ~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~ 142 (237)
T cd05576 71 KLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGE 142 (237)
T ss_pred CHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccC
Confidence 788887653 36899999999999999999999999999999999999999999999999987654221 1223
Q ss_pred cCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 006772 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCF 292 (632)
Q Consensus 213 ~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL 292 (632)
.++..|+|||++.. ..++.++|+||+||++|||++|..||...... . .......+|..+++.++++|.+||
T Consensus 143 ~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 143 AVENMYCAPEVGGI---SEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CcCccccCCcccCC---CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHc
Confidence 45778999999863 35788999999999999999999987643221 1 112233467788999999999999
Q ss_pred hcCcCCCCCH
Q 006772 293 EYDLRNRPLM 302 (632)
Q Consensus 293 ~~DP~~RPs~ 302 (632)
+.||++||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=283.26 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=202.9
Q ss_pred eEEE-eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 45 LKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 45 y~l~-~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
|++. +.||+|+|+.|--+...+++ .+||||++.+........++++ .+++..++.|+||+.|..+|+++...
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~------~EYAVKiidKq~gHsR~RvfRE-Ve~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTG------KEYAVKIIDKQPGHSRSRVFRE-VETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccc------hhhhhhhhhcCCchHHHHHHHH-HHHHHHhcCCccHHHHHHHhcccceE
Confidence 4544 57899999999999887766 4899999988755444444444 46677889999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc---EEEEecCCceec
Q 006772 124 CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLL 199 (632)
Q Consensus 124 ~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~---vkL~DFGlak~~ 199 (632)
|||||-|. |+|+..+.++ ..|++.++.++..+|+.||.|||.+||.||||||+|||-...++ +||+||.+..-.
T Consensus 152 YLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999998 6888888765 47999999999999999999999999999999999999876554 799999886533
Q ss_pred cC-C---CCCCCccccccCCCccCCccccC---CCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-------------
Q 006772 200 LG-R---SLSDSDMALRLGTPNYMAPEQWE---PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS------------- 259 (632)
Q Consensus 200 ~~-~---~~~~~~~~~~~GT~~YmAPE~~~---~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~------------- 259 (632)
.- . ........+.+|+..|||||+.. ++ ...|+.+.|.||||++||-||.|.+||.|.-
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~q-A~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQ-ATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccc-cccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 11 1 11223445678999999999874 22 3358899999999999999999999998632
Q ss_pred --HHHHHHHHHhhccCCCCCC----CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 260 --VEEIYHSVVIKKEKPCIPS----GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 260 --~~ei~~~i~~~~~~p~~p~----~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+++.|. .....||+ .++.+.+++|+.+|.+|+.+|.++..++.
T Consensus 309 ~CQ~~LFesIQ--EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQ--EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHh--ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 234566655 44556674 58999999999999999999999888775
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=306.59 Aligned_cols=269 Identities=16% Similarity=0.176 Sum_probs=174.0
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEe-eE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWL-HG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l-~~ 115 (632)
.+.+..++|++.+.||+|+||.||+|.+..+.. ..+..||||.+...... +....+ .+ ... .+.++..+ ..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~~--e~~~~e--~l-~~~-~~~~~~~~~~~ 197 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGAV--EIWMNE--RV-RRA-CPNSCADFVYG 197 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccchh--HHHHHH--HH-Hhh-chhhHHHHHHh
Confidence 455677899999999999999999999876521 12358999998643321 111111 11 110 11111111 11
Q ss_pred ----E-EEECCEEEEEEecCC-CCHHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 006772 116 ----I-SVINGKICIAMKFYE-GSVGDRIAQQRG------------------GKLPLPDILRYGIQLAKGISDLHSIGLL 171 (632)
Q Consensus 116 ----~-~~~~~~l~LVmEy~~-GsL~d~l~~~~~------------------~~l~~~~~~~ia~qIa~gL~yLHs~~Iv 171 (632)
. ...+..++|||||+. |+|.+++..... .......+..++.||+.||+|||+++|+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 1 245678999999998 577777654210 0112334667999999999999999999
Q ss_pred eeeeeCCeEEEec-CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCC-------------------C
Q 006772 172 VLNLKPSNLLLSE-HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRG-------------------P 231 (632)
Q Consensus 172 HRDLKP~NILld~-~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g-------------------~ 231 (632)
||||||+|||++. ++.+||+|||+|+.+.... .......+||+.|||||++...... .
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 9999999999996 6899999999997543211 1122346789999999976422111 2
Q ss_pred CCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc---------cCCCCC----------CCCCHHHHHHHHHhh
Q 006772 232 ISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK---------EKPCIP----------SGLPPAVENVIIGCF 292 (632)
Q Consensus 232 ~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~---------~~p~~p----------~~lp~~l~~LI~~cL 292 (632)
++.++|||||||+||||+++..|+... .......+.... ..+... ...+....+||.+||
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 345679999999999999977664322 111111111000 000000 111234568999999
Q ss_pred hcCcCCCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 293 EYDLRNRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 293 ~~DP~~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
++||++|||+.++++ ++++....+
T Consensus 435 ~~dP~kR~ta~e~L~------Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALA------HPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhC------CcCcCCCCc
Confidence 999999999999887 677765544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=308.79 Aligned_cols=281 Identities=22% Similarity=0.340 Sum_probs=224.6
Q ss_pred CccccccccCCCCCCCCcCC-CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHH
Q 006772 23 PDHLRTVVATPTQTRPWIDP-TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEEL 100 (632)
Q Consensus 23 ~~~~~~~~~~~~~~~~~I~~-~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~i 100 (632)
.|.+..+...++...-.|+. ..++..++||+|+||+||+|.+...++ ....+||||++..... ....+++++. .+
T Consensus 675 ~eplapS~~~~n~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege--~vKipVaiKvl~~~t~~~~s~e~LdeA-l~ 751 (1177)
T KOG1025|consen 675 VEPLAPSGFAANLALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGE--NVKIPVAIKVLIEFTSPKASIELLDEA-LR 751 (1177)
T ss_pred cCccccccccchhhheeechhhhhhhhceeccccceeEEeeeEecCCc--eecceeEEEEeeccCCchhhHHHHHHH-HH
Confidence 33444445555555555554 456777899999999999999876554 3345899999975433 3334444443 33
Q ss_pred hhhccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCe
Q 006772 101 FPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179 (632)
Q Consensus 101 l~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~N 179 (632)
+.+ .+|+|+++|.+++.... +.||++|++ |.|+|++..++ ..+...+.+.|..|||+||.|||.++++||||-.+|
T Consensus 752 mas-ldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRN 828 (1177)
T KOG1025|consen 752 MAS-LDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARN 828 (1177)
T ss_pred Hhc-CCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhh
Confidence 344 48999999999997765 889999999 89999998764 588999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCC
Q 006772 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258 (632)
Q Consensus 180 ILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~ 258 (632)
+|+..-.++|++|||+++.+......-. .....-.+.|||-|.++ ...|+.++|||||||++||++| |..|+.+.
T Consensus 829 VLVksP~hvkitdfgla~ll~~d~~ey~-~~~gK~pikwmale~i~---~~~~thqSDVWsfGVtiWElmTFGa~Py~gi 904 (1177)
T KOG1025|consen 829 VLVKSPNHVKITDFGLAKLLAPDEKEYS-APGGKVPIKWMALESIR---IRKYTHQSDVWSFGVTIWELMTFGAKPYDGI 904 (1177)
T ss_pred eeecCCCeEEEEecchhhccCccccccc-ccccccCcHHHHHHHhh---ccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence 9999999999999999998754322111 11112257899999987 5579999999999999999999 99999999
Q ss_pred CHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+.+++-..+ ..+++...|+.++.++..+|.+||..|+..||+++++...|.++.+
T Consensus 905 ~~~eI~dll-e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 905 PAEEIPDLL-EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CHHHhhHHH-hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 999886554 4567788899999999999999999999999999999988876643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=316.29 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=185.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
++|+.++.||+||||.||+++++-.+ +.||||++.-......-.-..++...++++ +||||+.++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDG------r~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDG------REYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccc------hhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCC
Confidence 57888999999999999999987544 689999997543222222233333445554 789998876321100
Q ss_pred --------------------------------------------------------------------------------
Q 006772 121 -------------------------------------------------------------------------------- 120 (632)
Q Consensus 121 -------------------------------------------------------------------------------- 120 (632)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------CEEEEEEecCCCCHHHHHHHhcCCCC-CHHHHHHHHHHHHHHH
Q 006772 121 -------------------------------------GKICIAMKFYEGSVGDRIAQQRGGKL-PLPDILRYGIQLAKGI 162 (632)
Q Consensus 121 -------------------------------------~~l~LVmEy~~GsL~d~l~~~~~~~l-~~~~~~~ia~qIa~gL 162 (632)
..+||=||||+-++++.+.+... .. ....+++++++|+.||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cchhhHHHHHHHHHHHHHH
Confidence 12789999999888877766532 22 4678999999999999
Q ss_pred HHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc------------C---CCCCCCccccccCCCccCCccccCCC
Q 006772 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL------------G---RSLSDSDMALRLGTPNYMAPEQWEPE 227 (632)
Q Consensus 163 ~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~------------~---~~~~~~~~~~~~GT~~YmAPE~~~~~ 227 (632)
.|+|+.|||||||||.||+||+++.+||+|||+|+... . ......+.+..+||.-|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999999999998721 0 01122245667899999999999876
Q ss_pred CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC------CCHHHHHHHHHhhhcCcCCCCC
Q 006772 228 VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG------LPPAVENVIIGCFEYDLRNRPL 301 (632)
Q Consensus 228 ~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~------lp~~l~~LI~~cL~~DP~~RPs 301 (632)
....|+.|+|+||||++++||+. ||.. .++.+ .++..-..+.+|.. --+.-..+|+.|++.||.+|||
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-sMERa--~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT-SMERA--SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCc-hHHHH--HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence 44579999999999999999984 5543 22221 12222223333322 2246678999999999999999
Q ss_pred HHHHHH
Q 006772 302 MADILH 307 (632)
Q Consensus 302 ~~ell~ 307 (632)
+.|+|+
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=282.55 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=196.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+...|++...||+|+||.||+|..++++. .....+|||+++..+.. -.....++ ..++..+ +|+|++.|..++.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~--kr~k~yAiKkfk~~kd~tGiS~SAcRE-iaL~REl-~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTND--KRTKEYAIKKFKGEKDGTGISMSACRE-IALLREL-KHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCc--ccchhhHHHHHhccCCCCCcCHHHHHH-HHHHHHh-cCCcchhHHHHHh
Confidence 34689999999999999999997766553 22458999999765321 11222222 2333333 7899999888877
Q ss_pred E-CCEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC----CcEEE
Q 006772 119 I-NGKICIAMKFYEGSVGDRIAQQR---GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH----DQLVL 190 (632)
Q Consensus 119 ~-~~~l~LVmEy~~GsL~d~l~~~~---~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~----g~vkL 190 (632)
. +..+++++||.+.+|+..+..++ .+.++...+..++.||+.|+.|||++=|+||||||.|||+..+ |.+||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 6 78999999999999999987663 3678999999999999999999999999999999999999887 89999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---------
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE--------- 261 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~--------- 261 (632)
+|||+++.+...-.+-.....++-|.+|.|||.+.+.. .||.+.|+|+.||++.||+|-++.|.+...+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~--hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR--HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccc--cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999998754432222223345699999999999863 5899999999999999999998888764321
Q ss_pred HHHHHHHhhccCC---------CCC--------------C------------CCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 262 EIYHSVVIKKEKP---------CIP--------------S------------GLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 262 ei~~~i~~~~~~p---------~~p--------------~------------~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
+...+|..--..| .+| . .-++...+|+.++|++||-+|.++++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 1112222100000 001 1 1234578999999999999999999877
Q ss_pred H
Q 006772 307 H 307 (632)
Q Consensus 307 ~ 307 (632)
+
T Consensus 336 e 336 (438)
T KOG0666|consen 336 E 336 (438)
T ss_pred c
Confidence 5
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=282.24 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=196.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHH---HHHHHhhhccCCCceeEeeEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVN---KFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~---~~~~il~~l~~h~~I~~l~~~ 116 (632)
++|.+++.||+|||++||+|.+... .+.||+|+-..-+. +..+.+.. ++..+- +-.+||.|++++++
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~E------qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIH-KeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTE------QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIH-KELDHPRIVKLYDY 535 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccch------hheeeEeeehhccchhhHhhhhHHHHHHHHHhhh-hccCcceeeeeeee
Confidence 6799999999999999999997643 36899997532111 11111111 122333 33479999999998
Q ss_pred EEE-CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeeeeeCCeEEEe---cCCcEEE
Q 006772 117 SVI-NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI--GLLVLNLKPSNLLLS---EHDQLVL 190 (632)
Q Consensus 117 ~~~-~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~--~IvHRDLKP~NILld---~~g~vkL 190 (632)
+.. .+..|-|+|||+|+.+|+.... .+.+++.+++.|+.||+.||.||... .|||-||||.||||- ..|.+||
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 864 5789999999999888877654 35899999999999999999999986 599999999999995 4578999
Q ss_pred EecCCceeccCCCCCCCc----cccccCCCccCCccccC-CCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHH
Q 006772 191 GDFGIPYLLLGRSLSDSD----MALRLGTPNYMAPEQWE-PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIY 264 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~----~~~~~GT~~YmAPE~~~-~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~ 264 (632)
+|||+++.+...+..... .+...||-+|++||.+. +.....++.++||||.||++|..+.|+.||.... ..+++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 999999998765544211 23457999999999885 2223457899999999999999999999998753 33443
Q ss_pred HH-HHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 265 HS-VVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 265 ~~-i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+. .+.+...-.|| +.+++++.++|++||++.-++|....++..
T Consensus 695 qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 32 22333444555 568999999999999999999998777654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=280.43 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=192.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccC-CC----ceeEeeEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE-SQ----SVCWLHGI 116 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~-h~----~I~~l~~~ 116 (632)
..+|.+...+|+|.||.|-.+.++.+. ..||||+++......... ..+...++++.+ -| -++.+.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~------~~vAlKIik~V~kYreAa--~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETK------EHVALKIIKNVDKYREAA--LIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCC------ceehHHHHHHHHHHhhHH--HHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 467999999999999999999998764 489999997654332222 112233444422 22 36677788
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC-----------
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH----------- 185 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~----------- 185 (632)
|.-.++.|||.|.+.-|+.|.+..+...++++..++.++.||+.+++|||+.+++|-||||+|||+-++
T Consensus 160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 888999999999999899999988777899999999999999999999999999999999999999432
Q ss_pred ---------CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCC
Q 006772 186 ---------DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256 (632)
Q Consensus 186 ---------g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~ 256 (632)
-.++|+|||.|.... ...+..+.|..|.|||++.+- +++.++||||+||+|+|+.||...|.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~------e~hs~iVsTRHYRAPEViLgL---GwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH------EHHSTIVSTRHYRAPEVILGL---GWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cceeccCCCcceEEEecCCcceec------cCcceeeeccccCCchheecc---CcCCccCceeeeeEEEEeeccceecc
Confidence 258999999887532 223556789999999999854 79999999999999999999999999
Q ss_pred CCCHHH---HHHHHHh--------hc--------cCC-----------------CCC--------CCCCHHHHHHHHHhh
Q 006772 257 GKSVEE---IYHSVVI--------KK--------EKP-----------------CIP--------SGLPPAVENVIIGCF 292 (632)
Q Consensus 257 ~~~~~e---i~~~i~~--------~~--------~~p-----------------~~p--------~~lp~~l~~LI~~cL 292 (632)
+.+..+ +.+.|.. +. .+. +.| +....++.+||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 876544 3333320 00 000 011 001126889999999
Q ss_pred hcCcCCCCCHHHHHH
Q 006772 293 EYDLRNRPLMADILH 307 (632)
Q Consensus 293 ~~DP~~RPs~~ell~ 307 (632)
..||.+|+|+.|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.32 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=191.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC----
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN---- 120 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~---- 120 (632)
+..-+.||+|+||.||+++++.++ +.||||.+++.......+..-++.++++++. |+||+.+.++-...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG------~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETG------RLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred eeehhhhcCCccceeeeecccccc------cchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 456688999999999999998877 4899999987654444455555567788886 99999998875443
Q ss_pred --CEEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec--CC--cEEEEe
Q 006772 121 --GKICIAMKFYE-GSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE--HD--QLVLGD 192 (632)
Q Consensus 121 --~~l~LVmEy~~-GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~--~g--~vkL~D 192 (632)
....+|||||. |+|...+.+-. ...+++.+.+.++.+++.||.|||.+||+||||||.||++-. +| ..||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 34679999998 57766665432 257999999999999999999999999999999999999853 34 469999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS----VEEIYHSVV 268 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~----~~ei~~~i~ 268 (632)
||.|+.+... +...+..||..|++||++.. ...|+.-+|.|||||++||.+||..||.... ..++...+.
T Consensus 168 fG~Arel~d~----s~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~ 241 (732)
T KOG4250|consen 168 FGAARELDDN----SLFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII 241 (732)
T ss_pred ccccccCCCC----CeeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence 9999976543 35567889999999999973 2468899999999999999999999986532 223333333
Q ss_pred hhcc-------------------CCCCCCCCCH----HHHHHHHHhhhcCcCCCC--CHHHHHHHHHhh
Q 006772 269 IKKE-------------------KPCIPSGLPP----AVENVIIGCFEYDLRNRP--LMADILHAFESS 312 (632)
Q Consensus 269 ~~~~-------------------~p~~p~~lp~----~l~~LI~~cL~~DP~~RP--s~~ell~~Le~~ 312 (632)
.++. ..++|..+++ .+..++..+|.-||++|- .+.+....+..+
T Consensus 242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1111 1123444444 455678888999999998 554444444333
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=316.48 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=182.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..+...+.||+|+||.||+|.+...+ ..||||.+......... +...+.++ +||||+.+++++..++.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~-----~~~~l~~l-~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNG------MQFVVKEINDVNSIPSS-----EIADMGKL-QHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCC------cEEEEEEccCCccccHH-----HHHHHhhC-CCCCcceEEEEEEcCCC
Confidence 34666789999999999999986554 48999998654322111 12334444 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH---SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLH---s~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.|+||||++ |+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++..++. ||.+..
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999998 67777763 4789999999999999999999 6699999999999999999888875 665433
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH--HHHHHHH--Hhh----
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV--EEIYHSV--VIK---- 270 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~--~ei~~~i--~~~---- 270 (632)
... .....||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ..+.... ...
T Consensus 832 ~~~-------~~~~~~t~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 832 LCT-------DTKCFISSAYVAPETRET---KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901 (968)
T ss_pred ccc-------CCCccccccccCcccccC---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch
Confidence 211 112367899999999874 4689999999999999999999999854211 0111100 000
Q ss_pred --ccCCCCC------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 271 --KEKPCIP------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 271 --~~~p~~p------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
...+... .....++.+++.+||+.||++||+|.|+++.|+.+.
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 0011111 112236778999999999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=253.91 Aligned_cols=235 Identities=25% Similarity=0.425 Sum_probs=186.9
Q ss_pred CceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCCC-
Q 006772 55 PFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEG- 132 (632)
Q Consensus 55 ~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~G- 132 (632)
+||.||+|.+..++ +.+|+|++....... ...+.++ ...+..+ +|++++.+.+.+......+++|||+++
T Consensus 1 ~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~e-~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 72 (244)
T smart00220 1 SFGKVYLARDKKTG------KLVAIKVIKKEKIKKKRERILRE-ISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGG 72 (244)
T ss_pred CceEEEEEEECCCC------cEEEEEEecccccccHHHHHHHH-HHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCC
Confidence 58999999987644 489999997654333 3333333 3444454 899999999999998999999999996
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccc
Q 006772 133 SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212 (632)
Q Consensus 133 sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~ 212 (632)
+|.+++.... .+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 73 ~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~ 146 (244)
T smart00220 73 DLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTF 146 (244)
T ss_pred CHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccc
Confidence 8887775532 38999999999999999999999999999999999999999999999999987653321 22345
Q ss_pred cCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhccCCCCCCC--CCHHHHHHHH
Q 006772 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKEKPCIPSG--LPPAVENVII 289 (632)
Q Consensus 213 ~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~-~~~~ei~~~i~~~~~~p~~p~~--lp~~l~~LI~ 289 (632)
.++..|++||.+.. ..++.++|+||||+++|+|++|..||.. .....+...+... .....+.. ++.++.+++.
T Consensus 147 ~~~~~~~~pE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 147 VGTPEYMAPEVLLG---KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP-KPPFPPPEWKISPEAKDLIR 222 (244)
T ss_pred cCCcCCCCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-CCCCccccccCCHHHHHHHH
Confidence 67889999999863 3578899999999999999999999987 4555554443322 22211122 8899999999
Q ss_pred HhhhcCcCCCCCHHHHHH
Q 006772 290 GCFEYDLRNRPLMADILH 307 (632)
Q Consensus 290 ~cL~~DP~~RPs~~ell~ 307 (632)
+||..||++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999886
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=250.18 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=196.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hH-HHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CA-KVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~-~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.|.-.++||+|.||+||+|+++.+.+ .||+|..+....+ .. ...+++. -+++. ..|.||++++++...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~e------ivalkrvrlddddegvpssalrei-cllke-lkhknivrl~dvlhsdk 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHE------IVALKRVRLDDDDEGVPSSALREI-CLLKE-LKHKNIVRLHDVLHSDK 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccc------eEEEEEEeccCCCCCCcHHHHHHH-HHHHH-hhhcceeehhhhhccCc
Confidence 45667899999999999999887765 8999998754322 11 1222322 22333 47999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.+-+|+|||..+|..++... ++.++.+.++.++.|+++||.|+|+++++||||||+|.||+.+|..||+|||+++.+.-
T Consensus 75 kltlvfe~cdqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 75 KLTLVFEFCDQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eeEEeHHHhhHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99999999999888888765 56899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP------ 274 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p------ 274 (632)
+-.-++..+-|.+|.+|.++.+. .-|+...|+||.||++.|+.. |++.|.|.+..+...+|...-..|
T Consensus 154 ---pvrcysaevvtlwyrppdvlfga--kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 154 ---PVRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred ---ceEeeeceeeeeeccCcceeeee--ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 11223344569999999999875 257889999999999999987 888899998777666655321111
Q ss_pred ------------CCC---------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 ------------CIP---------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ------------~~p---------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+| +.++..-+++++++|.-+|.+|.++++.++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111 122335689999999999999999988654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=283.34 Aligned_cols=265 Identities=18% Similarity=0.197 Sum_probs=178.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCC----------CcccccEEEEEEecCCchhhHHHHHHH------------
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSAD----------DFDEYHELAVKMLLPLKEDCAKVFVNK------------ 96 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~----------~~~~~~~VAIK~l~~~~~~~~~~~~~~------------ 96 (632)
.++.++|++.++||+|+||.||+|.+...+. .....+.||||.+........+.+.++
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 4578999999999999999999997643221 012335799999865433222222221
Q ss_pred -HHHHhhhccCCCc----eeEeeEEEEE--------CCEEEEEEecCC-CCHHHHHHHhc--------------------
Q 006772 97 -FEELFPKFRESQS----VCWLHGISVI--------NGKICIAMKFYE-GSVGDRIAQQR-------------------- 142 (632)
Q Consensus 97 -~~~il~~l~~h~~----I~~l~~~~~~--------~~~l~LVmEy~~-GsL~d~l~~~~-------------------- 142 (632)
+...+.++.++++ ++.+.+++.. ++..+|||||+. |+|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 1122333333332 3444454432 356899999998 67877775321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCC
Q 006772 143 --GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220 (632)
Q Consensus 143 --~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmA 220 (632)
...+++..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||+++...... ........+|+.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCcceeC
Confidence 1234567888999999999999999999999999999999999999999999986543211 111112234889999
Q ss_pred ccccCCCCCC-------------------CCCcccccchhHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHHh
Q 006772 221 PEQWEPEVRG-------------------PISFETDTWGFGCSIMEMLTGIQ-PWFGKSVE-----------EIYHSVVI 269 (632)
Q Consensus 221 PE~~~~~~~g-------------------~~t~ksDvwSlGvvL~EmltG~~-PF~~~~~~-----------ei~~~i~~ 269 (632)
||++...... ....+.|+||+||++|+|+++.. ||.+.... ..+..+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 9998532110 11234799999999999999875 77542110 011111
Q ss_pred hccCCCC--CCCCCHHHHHHHHHhhhcCc---CCCCCHHHHHH
Q 006772 270 KKEKPCI--PSGLPPAVENVIIGCFEYDL---RNRPLMADILH 307 (632)
Q Consensus 270 ~~~~p~~--p~~lp~~l~~LI~~cL~~DP---~~RPs~~ell~ 307 (632)
......+ ....++...+|+.+||..+| .+|+|++|+|+
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1122222 25678999999999999876 68999999886
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=248.11 Aligned_cols=220 Identities=24% Similarity=0.361 Sum_probs=176.4
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
-.+..+++.-+..||+|+||.|-+-++.+++ ...|+|.+...- ....++.+.+. .+......+|+++.++|.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg------~imAvKri~~tvn~q~q~r~L~dl-di~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSG------TIMAVKRIRATVNSQEQKRLLMDL-DIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCC------eEEEEeeehhhcChHHHHHHHHhh-hhhccCCCCCeEEEeehh
Confidence 3455677888899999999999999988876 489999997543 33333444443 334555689999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEec
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
....+.++|.||.|.-|+..+..+. +++.+++.-.=+++..++.||.|||++ .+||||+||+|||++.+|++|+|||
T Consensus 114 ~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 114 LFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 9899999999999998766554432 467899999999999999999999986 7999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCC-CCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHHHH
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVV 268 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g-~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~i~ 268 (632)
|++-.+... ...+.-.|...|||||.+..+.+. .|+-+|||||||+++.||.+++.||... ++-+.+.+++
T Consensus 194 GIsG~L~dS----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 194 GISGYLVDS----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred ccceeehhh----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 998765321 111224578899999999876543 7899999999999999999999999874 4556666665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=265.85 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=195.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.+.|+-..+||+|.||+||+|+.++++ +.||+|+....+ +......+++. .++ .+..|+|++.+..+|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~------kkvalkkvlmeneKeGfpitalrei-kiL-~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTG------KKVALKKVLMENEKEGFPITALREI-KIL-QLLKHENVVNLIEICRT 87 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCcc------chhHHHHHHHhccccCCcHHHHHHH-HHH-HHhcchhHHHHHHHHhh
Confidence 367888899999999999999988766 478888764322 11112223332 233 33478998887766543
Q ss_pred --------CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 120 --------NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 120 --------~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
...+|+|+.+|+.+|..++... ..+|++.++.+++.+++.||.|+|...|+|||+||+|+||+.+|.+||+
T Consensus 88 k~Tp~~r~r~t~ylVf~~cehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred ccCCcccccceeeeeHHHhhhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence 2459999999999888777543 4689999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCC-CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGR-SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~-~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+++.+... ......++..+-|.+|.+||.+.+. ..|+.+.|+|+.||++.||.|+.+.+.+.+..+..+.|...
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~--r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD--REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcc--cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 99999765332 2223345556679999999999975 36889999999999999999999999998876655544311
Q ss_pred c--------------------cCCCCC-------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 K--------------------EKPCIP-------------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~--------------------~~p~~p-------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ..++.| -.-+++..+|+.++|..||.+|+.+.++++
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0 001111 112357889999999999999999999886
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.36 Aligned_cols=243 Identities=24% Similarity=0.289 Sum_probs=187.5
Q ss_pred EeEEcccCceE-EEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEE
Q 006772 48 KHRIGRGPFGD-VWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIA 126 (632)
Q Consensus 48 ~~~IG~G~FG~-VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LV 126 (632)
.+.+|.|+-|+ ||+|.+. +|+||||.+.. ....+..++..++.....|+||+++++.-++.+.+||+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--------~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--------GREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--------CceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 36788998876 4899864 36899999853 22445566667788889999999999988889999999
Q ss_pred EecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CC--cEEEEecCCceec
Q 006772 127 MKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HD--QLVLGDFGIPYLL 199 (632)
Q Consensus 127 mEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g--~vkL~DFGlak~~ 199 (632)
.|.|..+|.|++... ......-.+.+..+.|++.||++||+.+||||||||+||||+. ++ .++|+|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999763 1111122456788999999999999999999999999999986 33 7899999999988
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC-CCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP-CIP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p-~~p 277 (632)
......-.......||-+|+|||++... .-+.++|+|||||++|+.++ |..||......+. .|+...... .+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~---~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRED---RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLE 736 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcc---ccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeec
Confidence 6654443445667899999999999865 34569999999999999999 5999976443332 233221111 111
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+....++.+||.+|++.||..||++.+++.
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111228999999999999999999999996
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-31 Score=286.55 Aligned_cols=427 Identities=22% Similarity=0.299 Sum_probs=294.9
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEec
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKF 129 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy 129 (632)
+|.|.||.|+++.-.... +.++.+|+|++++.... ........++.++..+..|+.++.++..++.++.++++++|
T Consensus 2 lg~g~~gkvfLvrk~~g~---da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGA---DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCcCCCcchHHHHHhccc---cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 699999999998643322 45578999998764321 11113334456667777899999999999999999999999
Q ss_pred CCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCc
Q 006772 130 YEGSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD 208 (632)
Q Consensus 130 ~~GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~ 208 (632)
..| ++.+.+.. ...+.+.....|...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++.......
T Consensus 79 ~rg--g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 79 LRG--GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred ccc--chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 997 34444433 35678889999999999999999999999999999999999999999999999987643211
Q ss_pred cccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 006772 209 MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVI 288 (632)
Q Consensus 209 ~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI 288 (632)
.|||..|||||++. ....++|+||||++++||+||..||.+ ++...|. ...+.+|..++..+++++
T Consensus 153 ---~cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~p~~l~~~a~~~~ 218 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEMPRELSAEARSLF 218 (612)
T ss_pred ---cccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCCchhhhHHHHHHH
Confidence 28999999999986 356799999999999999999999988 4555554 456778999999999999
Q ss_pred HHhhhcCcCCCCCHH-HHHHHHHhhhhcccCCCCccccccccccCCCcCCCCCCcccCcccCccCcccccCCCCCCCCCC
Q 006772 289 IGCFEYDLRNRPLMA-DILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDHLQVGDTVRSRKPLNARKPQ 367 (632)
Q Consensus 289 ~~cL~~DP~~RPs~~-ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~p~~~~~~~ 367 (632)
..++.++|.+|.... +.+ .+...+.++..++|.++..+...+++.+....+ ++..+.....++..|..+
T Consensus 219 ~~l~~r~p~nrLg~~~~~~--~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e----~~~~~fd~eft~~~P~ds---- 288 (612)
T KOG0603|consen 219 RQLFKRNPENRLGAGPDGV--DEIKQHEFFQSIDWNELEARSRPPPFKPGSITE----RDVAQFDPEFTSQVPADS---- 288 (612)
T ss_pred HHHHhhCHHHHhccCcchh--HHHhccchheeeeHhhHhhcCCCCCCCCcccch----hhhhhcCchhccCCcccC----
Confidence 999999999998652 222 233347889999999999999988887754442 333333333444444432
Q ss_pred cccCCCCceeeccCCCCCCCcEEEecCCCCCCccCChhhHHHHhhcccCCCeEEeecCCCCCCcceeeeeeecCCceeee
Q 006772 368 TVDVPAGTVVGLDADTDRNSSVLVKIPGLHNPLRVQESSLERVTFGLAAGDWVSLKDENSRHSSVGVLHSVQRDGSVSVG 447 (632)
Q Consensus 368 ~~~~p~g~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~e~v~~g~~~g~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (632)
|.+...+.+ ..-+.|+++|..- .++. -.+-....+
T Consensus 289 ----p~~~~~~s~-~~if~g~sfva~~-----------il~~-----------------------------~~~~~~~~~ 323 (612)
T KOG0603|consen 289 ----PLLSASGSD-HTIFSGPSFVAPG-----------VLED-----------------------------AVTAPFTES 323 (612)
T ss_pred ----CCCCCCccc-cchhcCCCccChH-----------Hhhc-----------------------------cccCCcchh
Confidence 111111111 0113344443221 1111 011123456
Q ss_pred eecccccccccccchhcceecccceEEEecccccCccccccccCCCccccceEEEEeeCCeEEEecCCCCcCCCCCCCCc
Q 006772 448 FIGLETLWRGNYSEIQMAKAYYVGQFVRVGANVFTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPGRFPLGHGSGSSL 527 (632)
Q Consensus 448 ~~~~~~~~~g~~~~~~~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 527 (632)
|...+.++.|+||.|+.|++..++|..++| +.+=| ....+.-..|+ .++.+-|+......+ .
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vk--ii~~~------~~~~~~e~~~~------~~~~~h~niv~~~~v----~ 385 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVK--IISKR------ADDNQDEIPIS------LLVRDHPNIVKSHDV----Y 385 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhhe--ecccc------ccccccccchh------hhhcCCCcceeecce----e
Confidence 777888999999999999999999999999 55544 33344444443 234444444433322 3
Q ss_pred CCCCceeEEEecCCch------hhhhhcc-ccccccchhhHHHHHHHHHHHhhheee
Q 006772 528 ADPSEVELVSFDTCPG------VVEKYKH-IEDYHWSVRPLAIALGLFAAMKLGWLV 577 (632)
Q Consensus 528 ~~~~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (632)
-|.-++=+|. .++.| +++||+- .|.-||+ +=|++|+=.|=+ -|++-
T Consensus 386 ~~~~~~~~v~-e~l~g~ell~ri~~~~~~~~e~~~w~-~~lv~Av~~LH~--~gvvh 438 (612)
T KOG0603|consen 386 EDGKEIYLVM-ELLDGGELLRRIRSKPEFCSEASQWA-AELVSAVDYLHE--QGVVH 438 (612)
T ss_pred cCCceeeeee-hhccccHHHHHHHhcchhHHHHHHHH-HHHHHHHHHHHh--cCeee
Confidence 3444444443 34443 3444433 4555776 557777777766 56655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=256.22 Aligned_cols=266 Identities=15% Similarity=0.256 Sum_probs=208.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+..+++++...+-+|.||.||.|.++... ++...+.|-+|.++..... ....++.+. ++..-.+|+|+..+.+++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEd-t~n~~q~v~vKTvk~~AS~iQv~~~L~es--~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREED-TYNDCQEVLVKTVKQHASQIQVNLLLQES--MLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccC-CcchHHHHHHHHHHhcccHHHHHHHHHHH--HHHhcCcCCCccceeEEEe
Confidence 56678999999999999999999887533 2344456777777543322 222222322 2223346999999988876
Q ss_pred EC-CEEEEEEecCC-CCHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 119 IN-GKICIAMKFYE-GSVGDRIAQQR------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 119 ~~-~~l~LVmEy~~-GsL~d~l~~~~------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
.+ ...++++.++. |+|..++..-+ .+.++-.+...++.|++.|++|||+++|||.||..+|++||+.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 54 66788888888 78777766322 145677788899999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~ 269 (632)
+|=.+++-+...++..-. ....-...||+||.+..+ .|+.++|+||||++||||+| |+.||..-++.++.+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n~---~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk- 512 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQNS---HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK- 512 (563)
T ss_pred ccchhccccCcccccccC-CCCCCcccccCHHHHhhh---hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-
Confidence 999999876554332110 112236789999999744 78999999999999999999 999999999999988776
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
++.+...|-+||+++..+|.-||+.+|++||+++++..-|.+..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 45667789999999999999999999999999999998876543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=244.32 Aligned_cols=248 Identities=17% Similarity=0.356 Sum_probs=193.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
|=+.++|++.+++|+|.|++|+.|.+..+++ .++||++++.+... +.++..++..+..++||+.+.++..
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~e------K~ViKiLKPVkkkK----IkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNE------KCVIKILKPVKKKK----IKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCc------eEEEeeechHHHHH----HHHHHHHHHhccCCCCeeehhhhhc
Confidence 4356899999999999999999999877665 89999998865432 3444567788889999999998876
Q ss_pred EC--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEecCC
Q 006772 119 IN--GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGDFGI 195 (632)
Q Consensus 119 ~~--~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~DFGl 195 (632)
+. ....|+.||++......+. ..++..+++.|+.+++.||.|+||+||+|||+||.|++||. .-..+|+|+|+
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred CccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 53 4577999999975555553 26888999999999999999999999999999999999995 45799999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC-CC-HHHHHHHHH-----
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KS-VEEIYHSVV----- 268 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~-~~-~~ei~~~i~----- 268 (632)
|.++-.. ......+.+..|.-||.+.. ...|+..-|+|||||+|..|+..+.||.. .+ .+++. .|.
T Consensus 180 AEFYHp~----~eYnVRVASRyfKGPELLVd--y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV-kIakVLGt 252 (338)
T KOG0668|consen 180 AEFYHPG----KEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-KIAKVLGT 252 (338)
T ss_pred HhhcCCC----ceeeeeeehhhcCCchheee--chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH-HHHHHhCh
Confidence 9876432 23344566889999999874 34578899999999999999999999764 33 33321 111
Q ss_pred ----------------------hhccCCCC----C----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 ----------------------IKKEKPCI----P----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ----------------------~~~~~p~~----p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+... + .-.++++.+|+.++|.+|-.+|+|+.|.+.
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111100 0 123589999999999999999999999775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=248.63 Aligned_cols=159 Identities=22% Similarity=0.348 Sum_probs=125.5
Q ss_pred cccccCCCccccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHH
Q 006772 16 YELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVN 95 (632)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~ 95 (632)
+.-.+++|+.++.===+|+.++..+...+|.+.++||=|.|++||||.+.+.. +.||+|+.+..... .+..+.
T Consensus 51 ~~~eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~------r~VAlKVvKSAqhY-tEaAlD 123 (590)
T KOG1290|consen 51 DDEEQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNK------RYVALKVVKSAQHY-TEAALD 123 (590)
T ss_pred CcccccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCC------eEEEEEEEehhhHH-HHHHHH
Confidence 33344555544444455888888888899999999999999999999998866 59999998643221 122222
Q ss_pred HHHHHhhhccC-------CCceeEeeEEEEE----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 006772 96 KFEELFPKFRE-------SQSVCWLHGISVI----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164 (632)
Q Consensus 96 ~~~~il~~l~~-------h~~I~~l~~~~~~----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~y 164 (632)
+. .++++++. ..+|+.|++.|.. +.++|+|+|++.-+|+.+|.....+.+++.-++.|+.||+.||.|
T Consensus 124 EI-klL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdY 202 (590)
T KOG1290|consen 124 EI-KLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDY 202 (590)
T ss_pred HH-HHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHH
Confidence 22 34444432 2468999988875 357999999999999999998877899999999999999999999
Q ss_pred HHhC-CceeeeeeCCeEEE
Q 006772 165 LHSI-GLLVLNLKPSNLLL 182 (632)
Q Consensus 165 LHs~-~IvHRDLKP~NILl 182 (632)
||.+ ||||-||||+|||+
T Consensus 203 LH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 203 LHRECGIIHTDLKPENVLL 221 (590)
T ss_pred HHHhcCccccCCCcceeee
Confidence 9985 89999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=272.21 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=202.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++..++|.|+||+||+|+++.+++ ..|+|+++....+......+++ .++..+ +|+||+-+++.+...+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~e------laavkvVkLep~dd~~~iqqei-~~~~dc-~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGE------LAAVKVVKLEPGDDFSGIQQEI-GMLRDC-RHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCc------hhhheeeeccCCccccccccce-eeeecC-CCcChHHHHhhhhhhc
Confidence 3789999999999999999999998775 7899999876655544433332 233333 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.++|.||||.|+.++-+.+. -+++++.++....++.+.||+|||+.+-+|||||-.|||+++.|.+||+|||.+..+..
T Consensus 86 klwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred CcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999996444444433 36899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhccCCC--CCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV-IKKEKPC--IPS 278 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~-~~~~~p~--~p~ 278 (632)
. . .....++||++|||||+..-+..+.|...+|+|++|+...|+..-++|-+..-+.+...... ....+|. -+.
T Consensus 165 t-i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 165 T-I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred h-h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 1 1 12245789999999999876678899999999999999999999899977766555433332 2222222 235
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
.+++.+.+|++.||.++|.+||+++.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 6889999999999999999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=263.08 Aligned_cols=202 Identities=19% Similarity=0.307 Sum_probs=166.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh---HH----HHHHHHHHHhhhc--cCCCcee
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC---AK----VFVNKFEELFPKF--RESQSVC 111 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~---~~----~~~~~~~~il~~l--~~h~~I~ 111 (632)
...+|..++.+|+|+||.|++|.++..+ .+|+||++.+...-. .+ --.-.+.+++..+ ..|+||+
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~------~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl 632 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENN------YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL 632 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccc------eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence 4478999999999999999999998765 489999997743210 00 0011233444444 3589999
Q ss_pred EeeEEEEECCEEEEEEecCC-C-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEE
Q 006772 112 WLHGISVINGKICIAMKFYE-G-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~-G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vk 189 (632)
++.++|++++++||+||-.. | +|.+++... ..+++.++..++.|++.|+++||+.||||||||-+|+.++.+|.+|
T Consensus 633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEE
Confidence 99999999999999999986 5 788888654 4899999999999999999999999999999999999999999999
Q ss_pred EEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC
Q 006772 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257 (632)
Q Consensus 190 L~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~ 257 (632)
|+|||.|... .......+.||..|.|||++.++.+ .....|||++|++||-+...+.||+.
T Consensus 711 lidfgsaa~~-----ksgpfd~f~gtv~~aapevl~g~~y--~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYT-----KSGPFDVFVGTVDYAAPEVLGGEKY--LGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred Eeeccchhhh-----cCCCcceeeeeccccchhhhCCCcc--CCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999987654 2334456789999999999987743 35789999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=257.33 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=190.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccC-----CCceeEeeEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE-----SQSVCWLHGIS 117 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~-----h~~I~~l~~~~ 117 (632)
.+|.+....|+|-|++|-.|.+...+ ..||||++..-.. +...-..+.+++.++.. .-|++.|+..|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~------~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARG------QEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCC------CeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 56888899999999999999887654 4899999975321 12222223345555532 23567777778
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCC
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGI 195 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGl 195 (632)
...+++|||+|.+.-+|.+.+.... +-.|.+..++.|+.|+..||..|-..||+|.||||.|||+++.. .+||||||.
T Consensus 504 ~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 8889999999999999998887652 35688899999999999999999999999999999999999754 679999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-- 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-- 273 (632)
|...... ..+.++-+..|.|||++.+. +|+...|+||.||+|||+.||+..|.|.+..+++...+....+
T Consensus 584 A~~~~en-----eitPYLVSRFYRaPEIiLG~---~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 584 ASFASEN-----EITPYLVSRFYRAPEIILGL---PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccc-----cccHHHHHHhccCcceeecC---cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 8765432 22233446789999999865 7899999999999999999999999999877765544311000
Q ss_pred -----------------------------------------C------------CCCCC---CCHHHHHHHHHhhhcCcC
Q 006772 274 -----------------------------------------P------------CIPSG---LPPAVENVIIGCFEYDLR 297 (632)
Q Consensus 274 -----------------------------------------p------------~~p~~---lp~~l~~LI~~cL~~DP~ 297 (632)
| .+|.. .-.++.+|+.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 0 01110 012688999999999999
Q ss_pred CCCCHHHHHH
Q 006772 298 NRPLMADILH 307 (632)
Q Consensus 298 ~RPs~~ell~ 307 (632)
+|.+..+.|.
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999998665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-26 Score=218.76 Aligned_cols=212 Identities=30% Similarity=0.518 Sum_probs=170.8
Q ss_pred EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecC
Q 006772 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFY 130 (632)
Q Consensus 51 IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~ 130 (632)
||+|++|.||++.+..++ +.+++|++.............++...+..+ .|++++.+++++......+++|||+
T Consensus 1 l~~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG------KKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCC------cEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecC
Confidence 689999999999986544 489999997654321122233333445555 4599999999999889999999999
Q ss_pred C-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEecCCceeccCCCCCCCc
Q 006772 131 E-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGDFGIPYLLLGRSLSDSD 208 (632)
Q Consensus 131 ~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~DFGlak~~~~~~~~~~~ 208 (632)
. ++|.+++.... ..+++..++.++.+++.+|.+||+++++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~ 149 (215)
T cd00180 74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---L 149 (215)
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---h
Confidence 9 67777765432 46899999999999999999999999999999999999999 89999999999876533211 1
Q ss_pred cccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 006772 209 MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVI 288 (632)
Q Consensus 209 ~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI 288 (632)
.....+...|++||.+... ..++.++|+|++|+++++| ..+.+++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~--~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l 194 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGK--GYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194 (215)
T ss_pred hhcccCCCCccChhHhccc--CCCCchhhhHHHHHHHHHH---------------------------------HHHHHHH
Confidence 2234578899999998642 2567899999999999999 6799999
Q ss_pred HHhhhcCcCCCCCHHHHHHH
Q 006772 289 IGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 289 ~~cL~~DP~~RPs~~ell~~ 308 (632)
.+|++.||.+||++.++++.
T Consensus 195 ~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHhhCCcccCcCHHHHhhC
Confidence 99999999999999998863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=221.25 Aligned_cols=211 Identities=26% Similarity=0.424 Sum_probs=166.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
|.+.+.||.|+||.||++.+..++ ..+|+|.+...... ....+.++ ...+..+ .|++++.+.+.+......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~e-~~~~~~~-~~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG------ELVAVKVLKKEKTEKQREEFLRE-IRILKKL-KHPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC------cEEEEEeeccccchHHHHHHHHH-HHHHHhC-CCCChhhheeeeecCCce
Confidence 578899999999999999987644 48999999764433 23333333 3344454 689999999998888999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 124 CIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 124 ~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
++++||+.+ +|.+.+.... ..+++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++......
T Consensus 73 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 73 YLVMEYCEGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEEEeccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 999999996 8888776542 12899999999999999999999999999999999999999999999999998875432
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC-CCH-HHHHHHHH
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSV-EEIYHSVV 268 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~-~~~-~ei~~~i~ 268 (632)
. ........++..|++||.+. ....++.++|+||||++++||++|+.||.. .+. .++...+.
T Consensus 152 ~--~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 152 L--AALLKTVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred c--cccccceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 1 01223346788999999984 234677899999999999999999999987 444 45555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=242.79 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=184.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
+.+--+.||-|.||.||-+++..++ +.||+|++...- -...+.++++... + ..-+|.|+....++.+..
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdg------rrvalkK~pnvfq~L~s~krvFre~km-L-cfFkHdNVLSaLDILQPph 125 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSG------KRVALKKMPNVFQNLASCKRVFREIKM-L-SSFRHDNVLSLLDILQPAN 125 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCc------cchhHhhcchHHHHHHHHHHHHHHHHH-H-HhhccccHHHHHHhcCCCC
Confidence 4445578999999999999876544 689999986432 1222333443322 2 234678877766665543
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 121 ----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 121 ----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..+|+++|+|..+|...+.. ...++...+.-+..||++||.|||+.+|+||||||.|.|++.|...||||||++
T Consensus 126 ~dfFqEiYV~TELmQSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 126 PSFFQELYVLTELMQSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred chHHHHHHHHHHHHHhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccc
Confidence 34778899998887777653 357888999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-----
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK----- 271 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~----- 271 (632)
+.-..+ ....++..+-|.+|.|||++++.. .|+.+.||||.||++.|++..+..|...++-+.++.|...-
T Consensus 204 Rvee~d--~~~hMTqEVVTQYYRAPEiLMGaR--hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 204 RTWDQR--DRLNMTHEVVTQYYRAPELLMGAR--RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred cccchh--hhhhhHHHHHHHHhccHHHhhcch--hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 864322 222334445688999999999863 58999999999999999999999998877665544443111
Q ss_pred -------------------cCCCCC--------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 -------------------EKPCIP--------SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 -------------------~~p~~p--------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..|.++ ..-..+...++.++|..||++|.+.++.+.
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 111111 112236677889999999999999888665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=234.35 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=186.9
Q ss_pred CCCcCC-CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEe-e
Q 006772 37 RPWIDP-TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWL-H 114 (632)
Q Consensus 37 ~~~I~~-~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l-~ 114 (632)
-+.|+. +.|.+.+.||+|.||.+-|++|++++. .+++|.++... ....+|.+++.--+ .+.+|.||+.- .
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t------~ivlKavp~p~-tt~~dF~rEfhY~~-~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKT------RIVLKAVPRPQ-TTQADFVREFHYSF-FLSPHQHIIDTYE 88 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCce------EEEeeccCcch-hhHHHHHHHhccce-eeccchhhhHHHH
Confidence 345555 789999999999999999999998874 89999886533 44577777775443 34566676654 4
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec--CCcEEEE
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE--HDQLVLG 191 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~--~g~vkL~ 191 (632)
..|++.+.++++|||++ |+|..-+.. ..+-+.-..+++.|++.||+|+|++++||||||.+||||-. ..++|||
T Consensus 89 vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 89 VAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred HHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEee
Confidence 55788889999999999 777665532 46778888999999999999999999999999999999953 3489999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCC--CCcccccchhHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGP--ISFETDTWGFGCSIMEMLTGIQPWFGKSVEE-IYHSVV 268 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~--~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e-i~~~i~ 268 (632)
|||+++.... ......-+..|-+||.+.....+. ..+.+|+|.||+++|.++||..||......+ -+....
T Consensus 166 DFG~t~k~g~------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 166 DFGLTRKVGT------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred ecccccccCc------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 9998765321 111122366899999876433333 4678999999999999999999998643221 111111
Q ss_pred --hhccCCCCC---CCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 269 --IKKEKPCIP---SGLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 269 --~~~~~p~~p---~~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
.+...+..| ..+++.+..+.++-|..+|++|--..+..
T Consensus 240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 123333444 45788999999999999999995444433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=230.37 Aligned_cols=279 Identities=17% Similarity=0.248 Sum_probs=220.6
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
+..|-.-.|+++++||+|+||.+++|.+.-+++ .||||.-...++... ++.+...++.+...+.|...+.+
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne------~VAIKfEPrkS~APQ---LrdEYr~YKlL~g~~GIP~vYYF 92 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNE------PVAIKFEPRKSEAPQ---LRDEYRTYKLLGGTEGIPQVYYF 92 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCc------eEEEEeccccCCcch---HHHHHHHHHHHcCCCCCCceeee
Confidence 334555679999999999999999999887764 899998765443322 22223445556678899999988
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-----cEEEE
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-----QLVLG 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-----~vkL~ 191 (632)
..++-+..||||++.-||.|++. ..+++|+..+++.+|.|++.-++|+|++.+|+|||||+|+||..-+ .+.++
T Consensus 93 GqeG~~NiLVidLLGPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 93 GQEGKYNILVIDLLGPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccccchhhhhhhhhCcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 88888889999999999888875 4678999999999999999999999999999999999999998544 68999
Q ss_pred ecCCceeccCCC----CCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---CHHHHH
Q 006772 192 DFGIPYLLLGRS----LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---SVEEIY 264 (632)
Q Consensus 192 DFGlak~~~~~~----~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---~~~ei~ 264 (632)
|||+|+.+.... ++.....+..||.+||+-....+. .-+.+.|+-|||-++.+.|.|..||.|. +..+.+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr---EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY 248 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR---EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY 248 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccc---hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence 999999874332 223334556899999999998865 5678999999999999999999999984 456677
Q ss_pred HHHHhhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc----cCCCCccccccc
Q 006772 265 HSVVIKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV----YNDGEWTGLGSR 328 (632)
Q Consensus 265 ~~i~~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~----~~~~~w~~~~~~ 328 (632)
+.|-..+...+ +..++|.++...+.-.-..+..+-|..+.+...|.++.... ....||..+...
T Consensus 249 eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~g 319 (449)
T KOG1165|consen 249 EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNNG 319 (449)
T ss_pred HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCCC
Confidence 77654433332 22678999999999999999999999998887777665542 234577766543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.68 Aligned_cols=247 Identities=21% Similarity=0.239 Sum_probs=188.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC--chhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL--KEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~--~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
-+.+|.-++.+|.|.- .|-.|.+.-.. +.||+|.+... .....+...++ ..+.....|+|++.++.+++
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~------~~v~ikk~~~pf~n~~~akra~re--l~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLG------RPVAIKKLSRPFQNQTHAKRAYRE--LKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhcc------CceehhhhcCccccCccchhhhhh--hhhhhhhcccceeeeeeccC
Confidence 3567888899999887 66667665443 58999987542 12222222232 22345568999999999987
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 119 IN------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 119 ~~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
-. ..+|+|||||.+++.+.+.. .++-.++..+..|++.|++|||+.+|+||||||+||++..++.+||.|
T Consensus 86 P~~~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred ccccHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeecc
Confidence 54 35899999999999988863 467788999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+|+..... -.++..+.|..|.|||++.+. .|.+.+||||+||++.||++|...|.|.+.-+.+.++...-.
T Consensus 162 fg~ar~e~~~----~~mtpyVvtRyyrapevil~~---~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 162 FGLARTEDTD----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred chhhcccCcc----cccCchhheeeccCchheecc---CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 9999764322 234456779999999999854 488999999999999999999999998775544443331100
Q ss_pred C--------------------C---------CCCC-----------CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 K--------------------P---------CIPS-----------GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~--------------------p---------~~p~-----------~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. + .+|. .-...+++++.+||..||++|.++.++|.
T Consensus 235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 0 1111 11236789999999999999999999886
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=234.39 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=197.0
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc---CCCceeEeeEEE-EE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR---ESQSVCWLHGIS-VI 119 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~---~h~~I~~l~~~~-~~ 119 (632)
+|++.++||+|+||.||++.+.... ...+|+|+.......... .+..+..++..+. ...+++.+...+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 8999999999999999999987653 247999988654322211 2222233333333 456888888888 57
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC-----CcEEEEecC
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-----DQLVLGDFG 194 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~-----g~vkL~DFG 194 (632)
+...||||+.+.-+|.++......+.|+..+++.++.|++.+|++||+.|++||||||+|++++.. ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 788999999999999998876666899999999999999999999999999999999999999865 368999999
Q ss_pred Cce--eccCCC----CCCCc-cccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 195 IPY--LLLGRS----LSDSD-MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 195 lak--~~~~~~----~~~~~-~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
+++ .+.... ..... ...+.||..|+++..+.+. ..+.+.|+||++.++.|++.|..||.+.........+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~---e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI---EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC---ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 998 432221 11111 2345699999999998754 5778999999999999999999999876532212222
Q ss_pred HhhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 268 VIKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 268 ~~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
........ .....+.++.++...+-..+...+|....+...|+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 11111111 33456788999999888899999999999988776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=222.29 Aligned_cols=278 Identities=19% Similarity=0.253 Sum_probs=215.3
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|-...|+++++||+|+||++|+|....+++ .||||+-........ +..+..+...+++...|+.+..++.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge------~VAiK~Es~~a~hpq---L~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGE------EVAIKLESSKAKHPQ---LLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCc------eEEEEeecccCCCcc---hhHHHHHHHHhccCCCCchhhhhcc
Confidence 3556789999999999999999999987775 899999765443332 2333455556667777777777888
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC---CcEEEEecCC
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH---DQLVLGDFGI 195 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~---g~vkL~DFGl 195 (632)
..++..+||+.+.-||.+++.. ..+.|+..+++.++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+
T Consensus 82 e~~ynvlVMdLLGPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 EKDYNVLVMDLLGPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccccceeeeeccCccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 8888999999999998888764 45689999999999999999999999999999999999999743 4688999999
Q ss_pred ceeccCC----CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Q 006772 196 PYLLLGR----SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV---EEIYHSVV 268 (632)
Q Consensus 196 ak~~~~~----~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~---~ei~~~i~ 268 (632)
|+.+-.. ..+........||.+|.+-....+. ..+.+.|+-|+|.+|.++..|..||.+... .+.++.|.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~---eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI---EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhh---hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 9876322 2222333456799999998877643 356789999999999999999999998643 34566665
Q ss_pred hhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc----cCCCCcccccccc
Q 006772 269 IKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV----YNDGEWTGLGSRA 329 (632)
Q Consensus 269 ~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~----~~~~~w~~~~~~~ 329 (632)
..+...+ ...+.|.++.-.+.-|-..-.++-|....|...|..+.+.. .--.||+.+..+.
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 4433322 23688999999999999999999999988877666655432 1235788766443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=240.91 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=191.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|..+++||+|.|+.||+|.+.... ...+.||+|.+...+.. .. ...+.+++..+..+.||..+.+++..++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~---~~~~~valk~i~~ts~p--~r-i~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQD---TKRRYVALKAIYRTSSP--SR-ILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhc---cccceEeeeecccccCc--hH-HHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 57999999999999999999886521 23368999999765432 22 33444667778899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-cCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-EHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-~~g~vkL~DFGlak~~~~ 201 (632)
+++||||++..-..-+.. .++..++..|+..++.||.++|++|||||||||+|+|.+ ..+.-.|.|||+|.....
T Consensus 110 v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999633333332 578999999999999999999999999999999999998 457889999999872110
Q ss_pred C-------C----------------------------------CCCCccccccCCCccCCccccCCCCCCCCCcccccch
Q 006772 202 R-------S----------------------------------LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWG 240 (632)
Q Consensus 202 ~-------~----------------------------------~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwS 240 (632)
. . ..........||++|.|||++.. .+..+.++|+||
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k--~~~QttaiDiws 263 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR--CPRQTTAIDIWS 263 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh--ccCcCCccceee
Confidence 0 0 00011123579999999999973 345688999999
Q ss_pred hHHHHHHHHhCCCCCCCCCHH--HHHHHHH------------hhcc------------------------CCC-------
Q 006772 241 FGCSIMEMLTGIQPWFGKSVE--EIYHSVV------------IKKE------------------------KPC------- 275 (632)
Q Consensus 241 lGvvL~EmltG~~PF~~~~~~--ei~~~i~------------~~~~------------------------~p~------- 275 (632)
.|+++.-++++..||.....+ .+.+.+. ..+. ...
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 999999999999999764321 1111000 0000 000
Q ss_pred -----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccC
Q 006772 276 -----IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318 (632)
Q Consensus 276 -----~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~ 318 (632)
..+..|..+.+|+.+||+.||.+|.++++.|+ ++||.
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk------HpFF~ 385 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK------HPFFD 385 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhc------CcCCc
Confidence 00223458899999999999999999999775 66664
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=214.86 Aligned_cols=161 Identities=18% Similarity=0.197 Sum_probs=126.0
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCcccc
Q 006772 132 GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211 (632)
Q Consensus 132 GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~ 211 (632)
|+|.+++... +..+++.+++.++.|++.||+|||+++ ||+|||++.++.+|+ ||+++..... .
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~ 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------Q 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------c
Confidence 6888888653 457999999999999999999999998 999999999999999 9998765321 1
Q ss_pred ccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhccCC-----CCCCCCCH--H
Q 006772 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIKKEKP-----CIPSGLPP--A 283 (632)
Q Consensus 212 ~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~~~~p-----~~p~~lp~--~ 283 (632)
..||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ......+....... ..+...+. +
T Consensus 64 ~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 64 SRVDPYFMAPEVIQG---QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred CCCcccccChHHhcC---CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 258999999999974 3688999999999999999999999976543 22333332211111 01122333 6
Q ss_pred HHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 284 VENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
+.++|.+||+.||.+||++.++++.+...
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 99999999999999999999999866543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=271.19 Aligned_cols=180 Identities=17% Similarity=0.163 Sum_probs=131.1
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC--------------
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-------------- 186 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-------------- 186 (632)
..++++|||++++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+||||+..|
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 457788999999999988643 35699999999999999999999999999999999999996544
Q ss_pred -----cEEEEecCCceeccCCCC------C-------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHH
Q 006772 187 -----QLVLGDFGIPYLLLGRSL------S-------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEM 248 (632)
Q Consensus 187 -----~vkL~DFGlak~~~~~~~------~-------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Em 248 (632)
.+|++|||+++....... . .......+||+.|||||++.+ ..++.++|||||||+||||
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~sDVwSlGviL~EL 208 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG---SSSNCASDVYRLGVLLFEL 208 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc---CCCCchhhhhhHHHHHHHH
Confidence 455666666543211000 0 000112468999999999874 3688999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 249 LTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 249 ltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++|..|+..... ....+... ..+.......+...+++.+||+.||.+||++.|+++
T Consensus 209 l~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 209 FCPVSSREEKSR--TMSSLRHR-VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhCCCchhhHHH--HHHHHHHh-hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999988754321 11122111 112111223456778999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-22 Score=203.12 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=189.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh---HHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC---AKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~---~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
|.+.+.||.|+||.||++.+. ..+++|.+.+..... ...+.+ +..++..+.+++++..+...+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~-e~~~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLR-EIQILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHH-HHHHHHHccCCcceeeEEEEEecCC
Confidence 788999999999999999876 378999987644332 233333 3345666766668999999987777
Q ss_pred EEEEEEecCCC-CHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCcee
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGlak~ 198 (632)
..+++++|+.| ++.+.+..... ..++......++.|++.++.|+|+.+++||||||+|||++..+ .++++|||+++.
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 88999999996 45533332211 2689999999999999999999999999999999999999988 799999999985
Q ss_pred ccCCCCCCC---ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhc
Q 006772 199 LLGRSLSDS---DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVIKK 271 (632)
Q Consensus 199 ~~~~~~~~~---~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~~~ 271 (632)
......... ......||..|++||.+.+.....++...|+||+|++++++++|..||..... .+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 543322111 23556899999999998742003577899999999999999999999887653 34444333222
Q ss_pred cC-C--CCCCCC----CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EK-P--CIPSGL----PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~-p--~~p~~l----p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. . ...... ...+.+++.+|+..+|..|.+..+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 11 1 111111 257999999999999999998877664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=221.11 Aligned_cols=169 Identities=18% Similarity=0.151 Sum_probs=122.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc----hhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK----EDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~----~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.++|++.+.||+|+||+||+|.++...+ +.||||++.... .......+..+..++..+.+++.+..++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPG-----TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCC-----eEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 4679999999999999999999875332 368999875321 12233445555567777754444434543
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeee-eCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNL-KPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDL-KP~NILld~~g~vkL~DFGla 196 (632)
.+..||||||++|..+..+. ... ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 90 --~~~~~LVmE~~~G~~L~~~~-----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLAR-----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred --cCCcEEEEEccCCCCHHHhC-----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 25689999999975444321 111 1467889999999999999999999 999999999999999999999
Q ss_pred eeccCCCCCC-----CccccccCCCccCCccccCCC
Q 006772 197 YLLLGRSLSD-----SDMALRLGTPNYMAPEQWEPE 227 (632)
Q Consensus 197 k~~~~~~~~~-----~~~~~~~GT~~YmAPE~~~~~ 227 (632)
+.+....... .+....++++.|+|||.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 8765433211 122456789999999999754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-24 Score=211.09 Aligned_cols=255 Identities=19% Similarity=0.327 Sum_probs=205.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhh--hccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFP--KFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~--~l~~h~~I~~l~~~ 116 (632)
-|+..++.+..+|.+...|+.|+|++..+ .++.|++.-.. ......+.+++.+. ++-.||||+.+.+.
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgn--------divakil~vr~--~t~risrdfneefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGN--------DIVAKILNVRE--VTARISRDFNEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCc--------chhhhhhhhhh--cchhhcchhhhhCcceeeecCCchhhhhhh
Confidence 37888999999999999999999998764 36778775321 12223333334433 33479999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ce-eeeeeCCeEEEecCCcEEEE--
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG-LL-VLNLKPSNLLLSEHDQLVLG-- 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~-Iv-HRDLKP~NILld~~g~vkL~-- 191 (632)
|.+.-.+.++..||+ |+|++.+++..+-..+-.++.+++.++++|++|||+.. ++ ---|....+++|++-+++|+
T Consensus 256 cnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarisma 335 (448)
T KOG0195|consen 256 CNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMA 335 (448)
T ss_pred ccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecc
Confidence 999999999999999 99999998877667788999999999999999999964 33 34788999999999887764
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|--++.. .....-.|.||+||.++.......-.++|+|||+++|||+-|.+.||...++.+.-.+|...+
T Consensus 336 d~kfsfq----------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg 405 (448)
T KOG0195|consen 336 DTKFSFQ----------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG 405 (448)
T ss_pred cceeeee----------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc
Confidence 3222111 111233789999999986544344568999999999999999999999999999888888889
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.++.+|+++++.+..||+-|+..||.+||.+..|+-.|+.+.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999999999999999999999999999999998888653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-22 Score=226.28 Aligned_cols=235 Identities=25% Similarity=0.439 Sum_probs=171.5
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
-..++|..++.|-.|+||.||+++|+.+.+ .+|+|+ .+.+ .+++ ||. ..
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trq------rfa~ki-Nkq~-----lilR-------------nil------t~ 128 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQ------RFAMKI-NKQN-----LILR-------------NIL------TF 128 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeecccccc------chhhcc-cccc-----hhhh-------------ccc------cc
Confidence 345899999999999999999999987663 688853 2211 0111 011 11
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
-+..+.| |+-..++... ++++.. ++.+++|||+.+|+|||+||+|.||..-|++|++|||+++..
T Consensus 129 a~npfvv-----gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 129 AGNPFVV-----GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred cCCccee-----chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 1222222 4434444221 344433 388999999999999999999999999999999999998764
Q ss_pred cCCCC--------C----CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 200 LGRSL--------S----DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 200 ~~~~~--------~----~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
..... . .-.....|||+.|.|||++..+ .|...+|||++|+++||.+-|..||+++++++++..+
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq---gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ---GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh---ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 22110 0 0011235899999999999743 6888999999999999999999999999999998887
Q ss_pred Hhhc-cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccc
Q 006772 268 VIKK-EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 268 ~~~~-~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
+... ..+.-...+++++++++.++|+.+|..|..... +++-.++.+|...+|..+.
T Consensus 271 isd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g---a~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 271 ISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG---ALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred hhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch---hhhhhhccceeecccchhh
Confidence 7432 223334678999999999999999999985442 4555668888888998544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=199.00 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=185.2
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCc-----------------------------ccccEEEEEEecCCch
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDF-----------------------------DEYHELAVKMLLPLKE 87 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~-----------------------------~~~~~VAIK~l~~~~~ 87 (632)
-..+..++|++++.||+|.-+.||-|+....+.+. ...=+.|||++.....
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 34466789999999999999999999764322111 0011567888754321
Q ss_pred -hhHHHHHHHH-HHH-------------------h----hhccCCCceeEeeEEEEEC----------------------
Q 006772 88 -DCAKVFVNKF-EEL-------------------F----PKFRESQSVCWLHGISVIN---------------------- 120 (632)
Q Consensus 88 -~~~~~~~~~~-~~i-------------------l----~~l~~h~~I~~l~~~~~~~---------------------- 120 (632)
.....+++.. +++ + ..+..||||+.+...|.+.
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1222222211 110 0 1234799999998776542
Q ss_pred -----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe--cCC--cEEEE
Q 006772 121 -----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS--EHD--QLVLG 191 (632)
Q Consensus 121 -----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld--~~g--~vkL~ 191 (632)
..+|+||.-++.+|.+++..+ ..+......++.|+++|+.|||.+||.|||||.+|||+. +++ ..+|+
T Consensus 311 g~g~~~tlylvMkrY~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ccCCCceEEEehhcchhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 258999999999999988654 467778888999999999999999999999999999984 444 56899
Q ss_pred ecCCceeccCCCCC---CCccccccCCCccCCccccCCCCCCCC----CcccccchhHHHHHHHHhCCCCCCCCCHHHHH
Q 006772 192 DFGIPYLLLGRSLS---DSDMALRLGTPNYMAPEQWEPEVRGPI----SFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264 (632)
Q Consensus 192 DFGlak~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~~g~~----t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~ 264 (632)
|||++-.-....+. .+.....-|...-||||+.... .|+. -.++|.|+.|.+.||+++...||++.-..-+-
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~-PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV-PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcC-CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 99987532221111 1122234577889999998643 2332 25799999999999999999999973221111
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 006772 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMAD 304 (632)
Q Consensus 265 ~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~e 304 (632)
..-......|..|+.+|+.+++++..+|+.||.+|++..-
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 1112334567789999999999999999999999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=193.03 Aligned_cols=238 Identities=22% Similarity=0.297 Sum_probs=146.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhccC---------CCce
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKFRE---------SQSV 110 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l~~---------h~~I 110 (632)
..+...+.||.|+|+.||.+++..+++ .+|+|+....... ..+.+ +++......+.. |-.+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~------~~avkvf~~~~~~~~~~~~~~-~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGE------EFAVKVFLLPADASANEYEQL-KEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEEEESSTTHTTHHHHH-HHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred eEEEEccccccCCceEEEEEEEccCCc------eEEEEEEecccccchHHHHHH-HHHHHHhhhhccCCCHHHHHHhceE
Confidence 367888999999999999999988775 8999997543221 12222 222212222111 1112
Q ss_pred eEeeEEEEE---------C---C-----EEEEEEecCCCCHHHHHHHh---cCC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 006772 111 CWLHGISVI---------N---G-----KICIAMKFYEGSVGDRIAQQ---RGG--KLPLPDILRYGIQLAKGISDLHSI 168 (632)
Q Consensus 111 ~~l~~~~~~---------~---~-----~l~LVmEy~~GsL~d~l~~~---~~~--~l~~~~~~~ia~qIa~gL~yLHs~ 168 (632)
+...+.... . . ..+++|+-+.++|.+.+.-. ... .+.....+.+..|+++.+++||+.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 222222211 1 1 24788999999888776432 111 122334456668999999999999
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCC-----CCCCCCcccccchhHH
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-----VRGPISFETDTWGFGC 243 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-----~~g~~t~ksDvwSlGv 243 (632)
|++|+||||+|+|++.+|.++|+||+........ ......+..|.+||..... ..-.++.+.|.|+||+
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 9999999999999999999999999976553221 1112345789999976432 1234788999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCC
Q 006772 244 SIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299 (632)
Q Consensus 244 vL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~R 299 (632)
++|.|.++..||........... ....+ ..+|+.++.||..+|+.||++|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~----~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW----DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG----GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccccc----cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 99999999999987644321110 11222 3789999999999999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-21 Score=216.26 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=175.1
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHH--HHhhhccCCCceeEeeEEEEECCEE
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE--ELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~--~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
.....+|.|.+|.|+.+......+.+. ...+.+| ..+ .+....+..... -......+|+|++.......+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~-~~~~r~~-~~~--~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFP-EKEFRVR-VKP--TESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccch-hhhhhcc-cCC--cccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 567889999999888887654443111 1122233 111 111121111111 1223334788876554444443333
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 124 CIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 124 ~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
+-.||||+++|..++... +.+...++--++.||+.|+.|||+.||.||||||+|+++..+|.+||+|||.+.......
T Consensus 397 ~~~mE~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 397 LQSMEYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhhhcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 344999999777777653 478999999999999999999999999999999999999999999999999987653322
Q ss_pred CCC-CccccccCCCccCCccccCCCCCCCCC-cccccchhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhh------ccCC
Q 006772 204 LSD-SDMALRLGTPNYMAPEQWEPEVRGPIS-FETDTWGFGCSIMEMLTGIQPWFGKSVEEIY-HSVVIK------KEKP 274 (632)
Q Consensus 204 ~~~-~~~~~~~GT~~YmAPE~~~~~~~g~~t-~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~-~~i~~~------~~~p 274 (632)
... ......+|+..|+|||.+.+. .|. ...||||.|++++.|.+|+.||.-....+.. ...... ....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~---~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGK---EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred chhhhhhcCcccCCcCcCccccccc---ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 211 234567899999999999865 343 5689999999999999999999865433211 111100 0111
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+-..+|.+.+.+|.++|+.||.+|.++++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 122467889999999999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-21 Score=220.07 Aligned_cols=252 Identities=18% Similarity=0.237 Sum_probs=184.9
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+|...+.||++.|=+|.+|.++.. .|+||++-+.. .-....+.++.+++-..+.++||.+.+.-+-..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--------~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--------LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--------eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHH
Confidence 689999999999999999987542 69999986543 445566666666665667789999988777677778
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
.|||-+|...+|+|++..+ .-+.+.+...|+.||+.||.-+|..||+|+|||.+||||+.-+.+.|+||..-|...-.
T Consensus 96 AylvRqyvkhnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHhhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 8999999999999998643 24677888999999999999999999999999999999999999999999965543111
Q ss_pred CCCCCcccccc----CCCccCCccccCCCC--------CCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006772 203 SLSDSDMALRL----GTPNYMAPEQWEPEV--------RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 203 ~~~~~~~~~~~----GT~~YmAPE~~~~~~--------~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~ 269 (632)
...+.+...+- --..|+|||.+.... ....+++-||||+||++.|+++ |++||.- .+++..-..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~ 250 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSG 250 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhcc
Confidence 11222222221 134799999986421 1126788999999999999998 7888842 111111000
Q ss_pred hccCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 270 KKEKPC--IPSGLPPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 270 ~~~~p~--~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
....+. ...--+..++.+|..|++.||.+|.++++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000000 001123479999999999999999999998864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=178.45 Aligned_cols=139 Identities=16% Similarity=0.114 Sum_probs=96.5
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-------------------------HHHHHHHHHHhh
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-------------------------KVFVNKFEELFP 102 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-------------------------~~~~~~~~~il~ 102 (632)
...||+|+||.||+|.+. ++ +.||||++++...... ..+...+..++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g------~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NG------EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK 74 (190)
T ss_pred CCccccccceEEEEEECC-CC------CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 467999999999999875 33 4899999975421100 011112334444
Q ss_pred hccCCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeeeeeCCeEE
Q 006772 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL-HSIGLLVLNLKPSNLL 181 (632)
Q Consensus 103 ~l~~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yL-Hs~~IvHRDLKP~NIL 181 (632)
.+. ++++.....+... ..+|||||++|+.+.... ...+.+++.+++.++.|++.+|.|| |+.||+||||||+|||
T Consensus 75 ~l~-~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIl 150 (190)
T cd05147 75 RLV-TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPR-LKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLL 150 (190)
T ss_pred HHH-HCCCCCCcEEEec--CCEEEEEEeCCCCCcchh-hhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 442 2332222222222 238999999975433221 1235789999999999999999999 7999999999999999
Q ss_pred EecCCcEEEEecCCcee
Q 006772 182 LSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 182 ld~~g~vkL~DFGlak~ 198 (632)
++ ++.++|+|||+|..
T Consensus 151 i~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 151 YH-DGKLYIIDVSQSVE 166 (190)
T ss_pred EE-CCcEEEEEcccccc
Confidence 98 58899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=173.05 Aligned_cols=193 Identities=14% Similarity=0.091 Sum_probs=135.3
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.....|++|+||+||++... +..++.+.+.....- .......++.+++.++.++++++.++++ +.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~--------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~ 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGG--------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG 72 (218)
T ss_pred ccceeecCCCcceEEEeecC--------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence 35678999999999987641 246776666543321 1122345566778888888888888775 44
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeee-eCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNL-KPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDL-KP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|++|||+.|..+.... +.. ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 73 ~~lvmeyI~G~~L~~~~-------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRP-------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEEEEeeecCccHHhhh-------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 69999999985443211 111 2457789999999999999999999 79999999999999999999985433
Q ss_pred CCC-----CCCc-----cccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC
Q 006772 202 RSL-----SDSD-----MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259 (632)
Q Consensus 202 ~~~-----~~~~-----~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~ 259 (632)
... ...+ ......++.|++|+...--. ..--.+.++++.|+.+|.++|+..++.++.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK-RTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-cchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 221 0000 11224688899998754211 111256789999999999999999876643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=169.60 Aligned_cols=139 Identities=18% Similarity=0.114 Sum_probs=99.0
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--h-------------------H----HHHHHHHHHHhh
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--C-------------------A----KVFVNKFEELFP 102 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~-------------------~----~~~~~~~~~il~ 102 (632)
.+.||+|+||.||+|.+. ++ +.||||++.+.... . . ......+...+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG------EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK 74 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC------CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence 468999999999999875 33 58999999764211 0 0 111122333344
Q ss_pred hccCCCceeEeeEEEEECCEEEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeE
Q 006772 103 KFRESQSVCWLHGISVINGKICIAMKFYEGS-VGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNL 180 (632)
Q Consensus 103 ~l~~h~~I~~l~~~~~~~~~l~LVmEy~~Gs-L~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NI 180 (632)
++. ++++.....+... ..||||||++|. +..... ....++..++..++.|++.+|.+||+ +||+||||||+||
T Consensus 75 ~l~-~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NI 149 (190)
T cd05145 75 RLY-EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNI 149 (190)
T ss_pred HHH-hCCCCCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhE
Confidence 443 3444333333222 248999999975 332222 23468889999999999999999999 9999999999999
Q ss_pred EEecCCcEEEEecCCceec
Q 006772 181 LLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~ 199 (632)
|++ ++.++|+|||++...
T Consensus 150 ll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EEE-CCCEEEEEcccceec
Confidence 999 899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=173.63 Aligned_cols=170 Identities=12% Similarity=0.135 Sum_probs=118.2
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHH---H-----HHHHHHHhhhccCCCceeE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKV---F-----VNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~---~-----~~~~~~il~~l~~h~~I~~ 112 (632)
-..+|+..+.||.|+||.||++... + ..+|||++.+........ + .+.+...+.++ .|++|..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~--~------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~ 99 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD--Y------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLAS 99 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC--C------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCc
Confidence 3578999999999999999997552 2 369999997643222111 1 22333345555 6788888
Q ss_pred eeEEEEEC--------CEEEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 113 LHGISVIN--------GKICIAMKFYEGS-VGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 113 l~~~~~~~--------~~l~LVmEy~~Gs-L~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
+..++... +..+|+|||++|. |.+.. .+++ ....+++.+|..||..|++|||+||+|||++
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS 169 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe
Confidence 77775533 4588999999984 44431 2333 2456999999999999999999999999999
Q ss_pred cCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHH
Q 006772 184 EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEM 248 (632)
Q Consensus 184 ~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Em 248 (632)
.+| ++|+|||..+..... ... ..+.. ...|..++|+||||+++.-+
T Consensus 170 ~~g-i~liDfg~~~~~~e~----~a~-----------d~~vl---er~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQR----KAK-----------DRIDL---ERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCC-EEEEECCCcccccch----hhH-----------HHHHH---HhHhcccccccceeEeehHH
Confidence 988 999999976543111 000 00222 12355789999999997654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=181.11 Aligned_cols=207 Identities=24% Similarity=0.293 Sum_probs=160.1
Q ss_pred cCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeeeeeCCeEEE
Q 006772 105 RESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGL-LVLNLKPSNLLL 182 (632)
Q Consensus 105 ~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~I-vHRDLKP~NILl 182 (632)
..|.|+..+.+.+..+...++|.+||. |+|.|.+... ...+++-....+.++|+.||+|||...| .|+.|++.|+++
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv 82 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV 82 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee
Confidence 368999999999999999999999997 9999998763 3567777888899999999999999876 999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCC----CCcccccchhHHHHHHHHhCCCCCCCC
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGP----ISFETDTWGFGCSIMEMLTGIQPWFGK 258 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~----~t~ksDvwSlGvvL~EmltG~~PF~~~ 258 (632)
|....+||+|||+....... ..........-..-|.|||.+....... .+.+.|+||||++++|+++.+.||...
T Consensus 83 d~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR 161 (484)
T ss_pred eeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence 99999999999997665321 0111111111234689999998642222 478899999999999999999999862
Q ss_pred ----CHHHHHHHHHhhccCCCCCC-----CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 259 ----SVEEIYHSVVIKKEKPCIPS-----GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 259 ----~~~ei~~~i~~~~~~p~~p~-----~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
++.++...+......+..|. .+++++..++.+||..+|.+||+++.+...++.+.
T Consensus 162 ~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 162 NLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 34455555543233333331 45668999999999999999999999887666544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-17 Score=190.25 Aligned_cols=251 Identities=19% Similarity=0.234 Sum_probs=171.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..+.|.+.+.||+|+||+||.|.+.+ ++.||+|+-++...-..-. -.+....+. ..-.+-|..++.+..-
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~WEfYI-~~q~~~RLk-~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPWEFYI-CLQVMERLK-PQMLPSIMHISSAHVF 765 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCceeeee-hHHHHHhhc-hhhhcchHHHHHHHcc
Confidence 344779999999999999999998765 2589999988755321110 011111111 1112334444444555
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-------CCcEEEE
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-------HDQLVLG 191 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-------~g~vkL~ 191 (632)
.+.-+||+||.+ |+|+|++. ..+-+++..+..++.|++.-+++||..+|||+||||+|+||.. +--++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 667789999999 99999997 4468999999999999999999999999999999999999953 3368999
Q ss_pred ecCCceeccCCCCCC-CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC-CCCCCHHHHHHHHHh
Q 006772 192 DFGIPYLLLGRSLSD-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEIYHSVVI 269 (632)
Q Consensus 192 DFGlak~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P-F~~~~~~ei~~~i~~ 269 (632)
|||.|--+. -..+ ......++|-.+-.+|+..+. ++++.+|.|.|+-+++-||.|+.- +.+...
T Consensus 844 DfG~siDm~--lfp~~~~F~~~~~td~f~C~EM~~gr---pWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~--------- 909 (974)
T KOG1166|consen 844 DFGRSIDMK--LFPDGTKFKAVWHTDLFDCIEMREGR---PWTYQIDYFGLAATVHVMLFGKYMEVKNGSS--------- 909 (974)
T ss_pred ecccceeee--EcCCCcEEeeeeccccchhHHHhcCC---CCchhhhhHHHHHHHHHHHHHHHHHhcCCcc---------
Confidence 999875331 1111 233456788999999998754 899999999999999999998542 000000
Q ss_pred hccCCCCCCCCCHH-HHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 270 KKEKPCIPSGLPPA-VENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 270 ~~~~p~~p~~lp~~-l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
......++..+..+ -.+++..+|..|-..=|...+|...|+.....
T Consensus 910 ~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 910 WMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred eeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 00111123333333 34567777775555556677777777665543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=157.21 Aligned_cols=132 Identities=16% Similarity=0.188 Sum_probs=96.5
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc----CCCceeEeeEEEEEC---
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR----ESQSVCWLHGISVIN--- 120 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~----~h~~I~~l~~~~~~~--- 120 (632)
.+.||+|+||.||. +.... ..+||++..........+ .++..++..+. .|+||+.+++++.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~-------~k~IKv~~~~~~~~~~~~-~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDA-------QRCIKIVYHRGDGGDKEI-RRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred cceecCCCceEEEE--CCCCc-------CeEEEEEeccccchHHHH-HHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 56899999999995 44332 347998876433333333 33344555553 589999999999886
Q ss_pred CEEE-EEEecCC---CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeeeeeCCeEEEecC----CcEEEE
Q 006772 121 GKIC-IAMKFYE---GSVGDRIAQQRGGKLPLPDILRYGIQLAKGI-SDLHSIGLLVLNLKPSNLLLSEH----DQLVLG 191 (632)
Q Consensus 121 ~~l~-LVmEy~~---GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL-~yLHs~~IvHRDLKP~NILld~~----g~vkL~ 191 (632)
+.++ +||||.. |+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 3544 7899944 588888854 246655 35678888888 99999999999999999999843 379999
Q ss_pred ecC
Q 006772 192 DFG 194 (632)
Q Consensus 192 DFG 194 (632)
||+
T Consensus 152 Dg~ 154 (210)
T PRK10345 152 DNI 154 (210)
T ss_pred ECC
Confidence 954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=160.42 Aligned_cols=143 Identities=16% Similarity=0.107 Sum_probs=100.5
Q ss_pred CeEEEeEEcccCceEEEEEE-EcCCCCCcccccEEEEEEecCCchh-----------------------hHHHHHHHHHH
Q 006772 44 SLKLKHRIGRGPFGDVWLAT-HHQSADDFDEYHELAVKMLLPLKED-----------------------CAKVFVNKFEE 99 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~-~~~~~~~~~~~~~VAIK~l~~~~~~-----------------------~~~~~~~~~~~ 99 (632)
-|++.+.||+|+||.||+|. +..++ +.||||+++..... ........+..
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSG------KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCC------cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 57889999999999999998 44333 58999998753210 01122233444
Q ss_pred HhhhccC-CCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeeeeeC
Q 006772 100 LFPKFRE-SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG-LLVLNLKP 177 (632)
Q Consensus 100 il~~l~~-h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~-IvHRDLKP 177 (632)
++.++.+ ...++.++.. +..+|||||++|..+.... .....+...++..++.|++.+|.+||++| |+||||||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR-LKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccc-cccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 4555532 1223333322 2358999999984332221 12235666778899999999999999999 99999999
Q ss_pred CeEEEecCCcEEEEecCCcee
Q 006772 178 SNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 178 ~NILld~~g~vkL~DFGlak~ 198 (632)
+|||++ ++.++|+|||.+..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-17 Score=176.14 Aligned_cols=173 Identities=24% Similarity=0.309 Sum_probs=127.7
Q ss_pred CEEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++||.|++|. .+|.+++.+.+ ....++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35889999998 78888886443 3567788899999999999999 9999999999999999999999999999876
Q ss_pred ccCCCC---CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 199 LLGRSL---SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 199 ~~~~~~---~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
...... .....+...||..||+||++.++ .|+.++||||||++|+|+++ -..+|..... +..+-.+..+|
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~---~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ---QYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhh---hhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCCCh
Confidence 533220 11233456899999999999865 68999999999999999997 4444432211 11111111111
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMA 303 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ 303 (632)
.+-... ++-..|+..++.+.|.+||++.
T Consensus 480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 480 EFLQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred HHhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 111122 3556899999999999999443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=147.97 Aligned_cols=134 Identities=21% Similarity=0.307 Sum_probs=97.6
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhH-----HHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCA-----KVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~-----~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+.||+|++|.||+|.+.. ..|++|+...... ... ......+..++..+ .++++.....++...+
T Consensus 2 ~~l~~G~~~~vy~~~~~~--------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG--------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEeeCC--------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCC
Confidence 579999999999998622 3689998754321 111 11122222344444 3556655555666677
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..+++|||++| +|.+.+... .. ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||++..
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 88999999986 666665432 12 7889999999999999999999999999999999 78999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=145.90 Aligned_cols=130 Identities=21% Similarity=0.264 Sum_probs=91.1
Q ss_pred EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhH-----HHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCA-----KVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 50 ~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~-----~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.||+|+||.||+|.+.. +.|++|....... ... ......+..++..+. ++++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~~~--------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG--------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeecCC--------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCC
Confidence 38999999999998432 4699998654221 110 111223334444443 3444433444456667
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.+++|||++| ++.+.+.... . .++.+++.+|.+||+.+++|+|+||+|||++ ++.++++|||++..
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CEEEEEEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 7899999986 5555543211 0 7889999999999999999999999999999 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.9e-15 Score=144.64 Aligned_cols=136 Identities=17% Similarity=0.166 Sum_probs=93.9
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh---------------------HHHHHHHHHHHhhh
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC---------------------AKVFVNKFEELFPK 103 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~---------------------~~~~~~~~~~il~~ 103 (632)
|.+.+.||+|+||.||+|... ++ +.||||++....... .......+..++..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DG------NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CC------CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 777899999999999999864 22 489999876422100 00011122233333
Q ss_pred ccCCC--ceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEE
Q 006772 104 FRESQ--SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLL 181 (632)
Q Consensus 104 l~~h~--~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NIL 181 (632)
+. +. .++.... .+..+++|||++|..+..+.. ......++.+++.++.++|+.+|+||||||+|||
T Consensus 90 l~-~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 90 LY-EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred HH-HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 32 23 2222222 345689999999744433211 1345678899999999999999999999999999
Q ss_pred EecCCcEEEEecCCceec
Q 006772 182 LSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 182 ld~~g~vkL~DFGlak~~ 199 (632)
+++++.++|+|||++...
T Consensus 158 l~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 158 VDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EcCCCcEEEEECCccccC
Confidence 999999999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-16 Score=180.72 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=189.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
....|.+.+.||+|.|+.|-++......+ ..+|+|.+.... ..........+..+-..+..|+|+..+.+....
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~-----~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPE-----SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCc-----ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 35678999999999999998887655443 367777665432 111122222233333444559999999998888
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeeeeeCCeEEEecCC-cEEEEecCCc
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH-SIGLLVLNLKPSNLLLSEHD-QLVLGDFGIP 196 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLH-s~~IvHRDLKP~NILld~~g-~vkL~DFGla 196 (632)
.+..++.++|..| ++.+.+.......++...+-.++.|+..++.|+| ..++.||||||+|.+++.++ ..++.|||+|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 8999999999875 5555542211225677889999999999999999 99999999999999999999 9999999999
Q ss_pred eeccCCCCCCCccccccC-CCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhccC-
Q 006772 197 YLLLGRSLSDSDMALRLG-TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY-HSVVIKKEK- 273 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~G-T~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~-~~i~~~~~~- 273 (632)
..+.............+| ++.|+|||...+.. -.....|+||.|+++.-|++|..||......... .........
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~--~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA--YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF 250 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchh--hcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence 766441222233344678 99999999987531 2356899999999999999999999875543321 111111111
Q ss_pred -CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 -PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 -p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......++....+++.+++..+|..|.+.+++..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 2233678899999999999999999999887664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=141.32 Aligned_cols=136 Identities=21% Similarity=0.239 Sum_probs=89.5
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHH---------------------HHHHHHhhhc
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFV---------------------NKFEELFPKF 104 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~---------------------~~~~~il~~l 104 (632)
.+.||+|+||.||+|.+. ++ +.||||++.+..... ..... ..+...+..+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 74 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DG------EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL 74 (187)
T ss_pred CcccccccceeEEEEECC-CC------CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence 467999999999999865 22 489999987532111 11110 1111222222
Q ss_pred cCC-CceeEeeEEEEECCEEEEEEecCCCC-HH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeE
Q 006772 105 RES-QSVCWLHGISVINGKICIAMKFYEGS-VG-DRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNL 180 (632)
Q Consensus 105 ~~h-~~I~~l~~~~~~~~~l~LVmEy~~Gs-L~-d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NI 180 (632)
..+ -.+..+.+. ...+++|||++|. +. ..+... .. ..++..++.+++.++.++|+ .+|+||||||+||
T Consensus 75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNI 146 (187)
T ss_pred HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence 221 122333222 2468999999972 11 111111 01 16788999999999999999 9999999999999
Q ss_pred EEecCCcEEEEecCCceec
Q 006772 181 LLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~ 199 (632)
|++ ++.++|+|||.+...
T Consensus 147 li~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEE-CCcEEEEECcccccc
Confidence 999 899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=163.88 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=96.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC--chh-----hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL--KED-----CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~--~~~-----~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
|...+.||+|+||+||++.+... .+++|+.... ... ...+....+..++..+ .|++++....++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~ 405 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYD 405 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEE
Confidence 45678999999999999987543 2344432211 111 1112223334445555 466777666666
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
......++||||++| +|.+.+. ....++.+++.+|.|||+.+++||||||+|||+ +++.++|+|||++
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 677778999999986 5555543 356789999999999999999999999999999 6789999999988
Q ss_pred ee
Q 006772 197 YL 198 (632)
Q Consensus 197 k~ 198 (632)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=126.72 Aligned_cols=133 Identities=17% Similarity=0.166 Sum_probs=101.3
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCC-CceeEeeEEEEECCEEEE
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRES-QSVCWLHGISVINGKICI 125 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h-~~I~~l~~~~~~~~~l~L 125 (632)
+.+.||+|.++.||++.... ..+++|...+... ...+ ..+...+..+.++ ..++.+......++..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~--~~~~-~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK--GADR-EREVAILQLLARKGLPVPKVLASGESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--------CeEEEEecCCCCc--hhHH-HHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence 35789999999999998743 3699999865432 1222 3333445555444 567777777777788999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 126 AMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI---GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 126 VmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~---~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+|||+.|.....+ +......++.+++.+|++||.. +++|+||+|+|||+++.+.++++|||++..
T Consensus 71 v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999997433211 5566778899999999999985 699999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-14 Score=165.44 Aligned_cols=276 Identities=19% Similarity=0.230 Sum_probs=196.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
..++++.+.+.+-+-+|.|+.+..+.-..++ +..++|+..... ....+....+ .......++|.++...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sg------h~~~~~v~~~ap~i~~~~~~s~r~~--s~~~i~p~~P~v~~~~ 870 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSG------HTRPSKVHGLAPKIRTNDYESIRSK--SNILITPRSPAVVRSF 870 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccc------cccchhhhccchhhccccccccCCc--cCccccCCCCceeccc
Confidence 3467789999999999999999998765554 234555443211 1101111111 0011112345555443
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
.-+......+|+|+|+.| ++...++.. +..+.+-++.+...+..+++|||+..+.|||++|.|+|...+++.+++||
T Consensus 871 ~s~~~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 871 PSFPCRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCCCCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcc
Confidence 335567789999999984 555555432 46777788889999999999999999999999999999999999999999
Q ss_pred CCceec-cC-----C----------CC--------CCC----ccccccCCCccCCccccCCCCCCCCCcccccchhHHHH
Q 006772 194 GIPYLL-LG-----R----------SL--------SDS----DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSI 245 (632)
Q Consensus 194 Glak~~-~~-----~----------~~--------~~~----~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL 245 (632)
|..... .. . .. ... ......||+.|.+||...+. .....+|+|++|+++
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~---~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR---RHGSAADWWSSGVCL 1025 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc---cCCCcchhhhhhhhh
Confidence 833221 00 0 00 000 12234789999999999865 455689999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhhccC-CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 246 MEMLTGIQPWFGKSVEEIYHSVVIKKEK-PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 246 ~EmltG~~PF~~~~~~ei~~~i~~~~~~-p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
+|.++|.+||....+.+++..+...... +.-|...+++.++++.+.+..+|.+|..+.. .-+.-.+.++.+.+|+.
T Consensus 1026 ~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~---~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG---AAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccc---ccccccCCccCCCCccc
Confidence 9999999999999999999887643322 3344678999999999999999999998763 22334578899999998
Q ss_pred ccccc
Q 006772 325 LGSRA 329 (632)
Q Consensus 325 ~~~~~ 329 (632)
+....
T Consensus 1103 l~~q~ 1107 (1205)
T KOG0606|consen 1103 LALQK 1107 (1205)
T ss_pred ccccc
Confidence 76543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-12 Score=132.66 Aligned_cols=144 Identities=17% Similarity=0.217 Sum_probs=94.0
Q ss_pred CcCCCCeEEE-eEEc-ccCceEEEEEEEcCCCCCcccccEEEEEEecCCc------hh------hHHHHHHHHHHHhhhc
Q 006772 39 WIDPTSLKLK-HRIG-RGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK------ED------CAKVFVNKFEELFPKF 104 (632)
Q Consensus 39 ~I~~~~y~l~-~~IG-~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~------~~------~~~~~~~~~~~il~~l 104 (632)
|.+++.+... ..|| .||.|+||.+.... ..++||.+.... .. .......++..++..+
T Consensus 26 ~~~~~~~~~~~~~lg~~~g~gtv~~v~~~~--------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L 97 (239)
T PRK01723 26 LFDPDFWQQQARVVGSAKGRGTTWFVQTPG--------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL 97 (239)
T ss_pred hcCHHHHhhcCceeecCCCCccEEEEEeCC--------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH
Confidence 5566555433 4577 88899999887531 368998875311 00 0111122233444444
Q ss_pred cCCCc--eeEeeEEEEE-CC---EEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeee
Q 006772 105 RESQS--VCWLHGISVI-NG---KICIAMKFYEG--SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK 176 (632)
Q Consensus 105 ~~h~~--I~~l~~~~~~-~~---~l~LVmEy~~G--sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLK 176 (632)
. +++ ++...++... .+ ..+|||||++| +|.+++.. ..++... +.+|+.+|.+||++||+|||||
T Consensus 98 ~-~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlk 169 (239)
T PRK01723 98 Y-EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLN 169 (239)
T ss_pred H-hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCC
Confidence 3 333 3444444332 22 23599999996 66666532 3455443 5689999999999999999999
Q ss_pred CCeEEEecCCcEEEEecCCcee
Q 006772 177 PSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 177 P~NILld~~g~vkL~DFGlak~ 198 (632)
|+|||++.++.++|+|||.+..
T Consensus 170 p~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 170 AHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred chhEEEcCCCCEEEEECCCccc
Confidence 9999999999999999997653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-12 Score=143.92 Aligned_cols=254 Identities=18% Similarity=0.132 Sum_probs=181.9
Q ss_pred CCeEEEeEEcc--cCceEEEEEEEcCCCCCcccccEEEEEEecCC-c-hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 43 TSLKLKHRIGR--GPFGDVWLATHHQSADDFDEYHELAVKMLLPL-K-EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 43 ~~y~l~~~IG~--G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~-~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..+.+.+.+|. |.+|.||.+.+... .....+|+|.-+.. . ......-.+++ ....++..|++.+..+..+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~----~s~~~~a~k~s~~p~s~p~~~~~k~~~~-~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNS----ESPHKFAVKKSKIPFSPPLDSKRKLREF-LSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcc----cCCcccccccccCCCCCccccccccchh-hcccccCccccccccCcccc
Confidence 45677899999 99999999987321 12347888873221 1 11111111221 22345567888888888888
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeeeeeCCeEEEecC-CcEEEEec
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAK----GISDLHSIGLLVLNLKPSNLLLSEH-DQLVLGDF 193 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~----gL~yLHs~~IvHRDLKP~NILld~~-g~vkL~DF 193 (632)
..+.+|+-+|++..++..+... ....++...++.+..+... ||.++|+.+++|-|+||.||++..+ ...+++||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cCCcceeeeccccchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 8999999999999887776654 3446888899999999999 9999999999999999999999999 78999999
Q ss_pred CCceeccCCCCCCCcc--ccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 194 GIPYLLLGRSLSDSDM--ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 194 Glak~~~~~~~~~~~~--~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|+...+.......... ....|...|++||...+ -++..+|+||+|.++.+..++..++...... .+..+-...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~----l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG----LATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc----ccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc
Confidence 9987764433221111 12257789999999864 5788999999999999998876664432100 011111112
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+-...+.++...+..+++.+|..|++...++.
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 233344566778888999999999999999887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-11 Score=136.21 Aligned_cols=140 Identities=21% Similarity=0.258 Sum_probs=90.9
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHH------------------------------------
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKV------------------------------------ 92 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~------------------------------------ 92 (632)
+.||.|++|.||+|+.+. ++.||||+.++........
T Consensus 123 ~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred cceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 579999999999998753 2489999987743211110
Q ss_pred ----HHHHHH---HHhhhccCCCceeEeeEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHH
Q 006772 93 ----FVNKFE---ELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAK-GIS 163 (632)
Q Consensus 93 ----~~~~~~---~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~-gL~ 163 (632)
+.++.. .+.....+++++.....+....+..+|||||++| ++.+...... ..+ +...++.+++. .+.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLN 271 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHH
Confidence 000000 1111223455554333333334557899999997 4444432211 122 23456666665 478
Q ss_pred HHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 164 yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
.+|..|++|+|+||.||+++.++.++|+|||++..+
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 899999999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-10 Score=110.65 Aligned_cols=128 Identities=19% Similarity=0.008 Sum_probs=84.6
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAM 127 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVm 127 (632)
.+.|+.|.++.||+++... ..|++|+........ .. ...+...+..+.+...++.++... ....++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~~--------~~~~lK~~~~~~~~~-~~-~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVAN--------KKYVVRIPGNGTELL-IN-RENEAENSKLAAEAGIGPKLYYFD--PETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEECC--------eEEEEEeCCCCcccc-cC-HHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEE
Confidence 4678999999999998641 479999876543111 11 122223333333333344444443 33357999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 128 KFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGL-----LVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 128 Ey~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~I-----vHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
||++|...... . .....++.+++.+|+.||+.++ +|+|++|.|||++ ++.++++||+.+.
T Consensus 71 e~i~G~~l~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99998433211 0 1123456799999999999885 9999999999999 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=6e-11 Score=133.58 Aligned_cols=143 Identities=19% Similarity=0.217 Sum_probs=85.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH--------------------------HHHHHH
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA--------------------------KVFVNK 96 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~--------------------------~~~~~~ 96 (632)
++|.. +.||+|++|.||+|+.+.++ +.||||++++.-.... .+...+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G------~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNG------REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCC------CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 45665 78999999999999987644 4899999976421110 000000
Q ss_pred -------------HHHHhhhc----cCCCceeEeeEEEEECCEEEEEEecCCC-CHHHHHHHhcC-C----CCCHHHHHH
Q 006772 97 -------------FEELFPKF----RESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRG-G----KLPLPDILR 153 (632)
Q Consensus 97 -------------~~~il~~l----~~h~~I~~l~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~-~----~l~~~~~~~ 153 (632)
+...+.++ .+.+.+....-+..-....+|||||+.| .+.+. ..... + .+....+..
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~-~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDV-AALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhH-HHHHhcCCCHHHHHHHHHHH
Confidence 00111111 1222222111111223456799999997 44432 11111 1 233333444
Q ss_pred HHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC----cEEEEecCCceecc
Q 006772 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLGDFGIPYLLL 200 (632)
Q Consensus 154 ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----~vkL~DFGlak~~~ 200 (632)
++.|+ +..|++|+|+||.||+++.+| .++++|||++..+.
T Consensus 272 ~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 44444 458999999999999999988 99999999987663
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-10 Score=128.55 Aligned_cols=246 Identities=21% Similarity=0.173 Sum_probs=166.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHH-HHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFV-NKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~-~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
..+|.++..||.|.|+.|+....+..+ +..|++|.+.+.......+.. -.+..+...+.-|.+++.....+.+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~-----~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEG-----DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCC-----CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 367999999999999999998743222 247888887653322222211 11222233445566777666666677
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC-CcEEEEecCCceec
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-DQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~-g~vkL~DFGlak~~ 199 (632)
.+.||-.|||+|...++.. .....+.+...+++..|++.++.++|++.++|+|+||+||++..+ +..++.|||++..+
T Consensus 339 r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 7788999999864333332 222467888999999999999999999999999999999999986 78899999988642
Q ss_pred cCCCCCCCccccccCCCccC-CccccCCCCCCCCCcccccchhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhccCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYM-APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~Ym-APE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P-F~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.-. . ....+.-+++ ..|.+.. ...+-.+.|++|||..+.|.+++..- ..+..-. .+ .....+..+
T Consensus 418 ~~~-----~-~~~~~~~r~~p~~~~~~e--~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----~i-~~~~~p~~~ 484 (524)
T KOG0601|consen 418 AFS-----S-GVFHHIDRLYPIAEILLE--DYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----TI-RSGDTPNLP 484 (524)
T ss_pred cee-----c-ccccccccccccchhhcc--ccccccccccccccccccccccCcccCcccccce----ee-ecccccCCC
Confidence 111 0 1112333444 2454442 23567899999999999999998653 2221111 11 112233333
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....++..+...+...|+..||.+.++..
T Consensus 485 -~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 485 -GLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -chHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 33488999999999999999999887664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=106.22 Aligned_cols=142 Identities=15% Similarity=0.104 Sum_probs=91.3
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-----------h----------hHHHHHH----HHHHHhhh
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-----------D----------CAKVFVN----KFEELFPK 103 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-----------~----------~~~~~~~----~~~~il~~ 103 (632)
..||.|-=+.||.|...........+..+|||+.+.... + ....... ++...+.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543110001235899999754110 0 0011111 33334444
Q ss_pred ccCC-CceeEeeEEEEECCEEEEEEecCCCCHH--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeeeeeCCe
Q 006772 104 FRES-QSVCWLHGISVINGKICIAMKFYEGSVG--DRIAQQRGGKLPLPDILRYGIQLAKGISDL-HSIGLLVLNLKPSN 179 (632)
Q Consensus 104 l~~h-~~I~~l~~~~~~~~~l~LVmEy~~GsL~--d~l~~~~~~~l~~~~~~~ia~qIa~gL~yL-Hs~~IvHRDLKP~N 179 (632)
+... -.++.++.+ ...+|||||+.|+.. ..+ +...++..+...+..+++.+|..| |..+|+|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 4332 234444433 456789999986311 122 122455666778889999999999 89999999999999
Q ss_pred EEEecCCcEEEEecCCcee
Q 006772 180 LLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 180 ILld~~g~vkL~DFGlak~ 198 (632)
||++ ++.+.|+|||.+-.
T Consensus 156 IL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEEE-CCcEEEEECCCcee
Confidence 9997 47899999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-08 Score=106.47 Aligned_cols=254 Identities=18% Similarity=0.223 Sum_probs=162.4
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeE----eeEE--EE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCW----LHGI--SV 118 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~----l~~~--~~ 118 (632)
+.+.+.||+|+-+.+|-.-. .+..+-|++++.......+. .+.+.+...||-+.. .... .-
T Consensus 13 i~~gr~LgqGgea~ly~l~e---------~~d~VAKIYh~Pppa~~aqk----~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE---------VRDQVAKIYHAPPPAAQAQK----VAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred cCCCccccCCccceeeecch---------hhchhheeecCCCchHHHHH----HHHhccCCCCcchhhhhcccHHHhhCC
Confidence 34567899999999996431 12345588765433222211 123344445554322 1110 11
Q ss_pred EC-CEEEEEEecCCC--CHHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 119 IN-GKICIAMKFYEG--SVGDRIAQ----QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 119 ~~-~~l~LVmEy~~G--sL~d~l~~----~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
.. ..+-+.|..+.| ...+++.- +..-.+.|.-+++.++.|+.+.+.||.+|.+-+|+.++|+|+++++.+.|.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 12 237788999886 22322221 112346788999999999999999999999999999999999999999998
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccC-CC-CCCCCCcccccchhHHHHHHHHhC-CCCCCCCC-------HH
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE-PE-VRGPISFETDTWGFGCSIMEMLTG-IQPWFGKS-------VE 261 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~-~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~-------~~ 261 (632)
|-..-.. . .........+|...|.+||.-. +. ..-.-+...|.|.||++++++|.| +.||.|.. +.
T Consensus 160 dsDsfqi-~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 160 DSDSFQI-N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred cccceee-c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 8432111 1 1223334457899999999865 21 122346789999999999999985 99998732 22
Q ss_pred H--HHHHHH---hhccCCCC------C-CCCCHHHHHHHHHhhhcC--cCCCCCHHHHHHHHHhhhhc
Q 006772 262 E--IYHSVV---IKKEKPCI------P-SGLPPAVENVIIGCFEYD--LRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 262 e--i~~~i~---~~~~~p~~------p-~~lp~~l~~LI~~cL~~D--P~~RPs~~ell~~Le~~~~~ 315 (632)
+ |..-.. .+..++.. | +.+++++..|..+|+..- +.-||+++..+.+|..+...
T Consensus 236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 236 ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 2 111000 11111111 1 457899999999999853 56899999888877766543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.6e-09 Score=112.22 Aligned_cols=191 Identities=18% Similarity=0.219 Sum_probs=131.0
Q ss_pred CCCceeEeeEEEEEC-----CEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC--Cceeeee
Q 006772 106 ESQSVCWLHGISVIN-----GKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSI--GLLVLNL 175 (632)
Q Consensus 106 ~h~~I~~l~~~~~~~-----~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~--~IvHRDL 175 (632)
.|.||+.++-+..+. ....+++|||. |++..++.+.+ ...+....-.+++-||+.||.|||+. -|+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 467788888776543 35778999998 88888887653 36788888999999999999999996 4999999
Q ss_pred eCCeEEEecCCcEEEEecCCceeccC-CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC
Q 006772 176 KPSNLLLSEHDQLVLGDFGIPYLLLG-RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254 (632)
Q Consensus 176 KP~NILld~~g~vkL~DFGlak~~~~-~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P 254 (632)
...-|++..+|.+|+.--.-...... ............|-++|.+||.=. ....+.++|||+||....||..+..-
T Consensus 205 Tc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~---~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 205 TCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT---TTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred chhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc---ccccccchhhhhhhHHHHHHHHheec
Confidence 99999999999988753221111000 000111112234678899999743 23456789999999999999887643
Q ss_pred -CCCCC---HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 255 -WFGKS---VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 255 -F~~~~---~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
-.+.+ .++.....+.... ..--+.++.+|++-.|..||+|.+++.
T Consensus 282 ~tnseS~~~~ee~ia~~i~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVIIGLE--------NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cCCCcceeehhhhhhhheeecc--------CccccCcCcccccCCCCCCcchhhhhc
Confidence 33322 1222222221111 122356899999999999999998774
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.3e-08 Score=95.66 Aligned_cols=142 Identities=19% Similarity=0.159 Sum_probs=96.8
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-------hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-------DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-------~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
....|-+|+=+.|+++.+.. +.+.||.-..... .-.......+..++.++... .|+-..-++.+
T Consensus 11 ~l~likQGAEArv~~~~~~G--------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG--------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeeccCC--------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEe
Confidence 45677889999999987643 3566665432211 11111122233445555433 44444455667
Q ss_pred CCEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cEEEEecC
Q 006772 120 NGKICIAMKFYEG--SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFG 194 (632)
Q Consensus 120 ~~~l~LVmEy~~G--sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~vkL~DFG 194 (632)
...-+|+|||++| ++.+++...............++.+|-..|.-||..+|||+||..+||+|..++ .+.++|||
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeec
Confidence 7777899999999 777777665433333344478889999999999999999999999999998766 35899999
Q ss_pred Cce
Q 006772 195 IPY 197 (632)
Q Consensus 195 lak 197 (632)
++.
T Consensus 162 ls~ 164 (229)
T KOG3087|consen 162 LSS 164 (229)
T ss_pred chh
Confidence 874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1e-07 Score=107.09 Aligned_cols=219 Identities=14% Similarity=0.142 Sum_probs=135.7
Q ss_pred cEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHH
Q 006772 75 HELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRY 154 (632)
Q Consensus 75 ~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~i 154 (632)
.+|.|..++...... ....++....++. .+||+|+.++...+.++.+|||+|-+.- |..++.+. ....+..-
T Consensus 38 ~~vsVF~~~~~~~~~-~~~~~~A~k~lKt-lRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~l-----~~~~v~~G 109 (690)
T KOG1243|consen 38 GPVSVFVYKRSNGEV-TELAKRAVKRLKT-LRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKEL-----GKEEVCLG 109 (690)
T ss_pred CceEEEEEeCCCchh-hHHHHHHHHHhhh-ccCchhhhhhhhhcccCceEEEeecccc-HHHHHHHh-----HHHHHHHH
Confidence 478888776554421 2222222222333 4799999999999999999999999973 23344332 35667777
Q ss_pred HHHHHHHHHHHH-hCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCC
Q 006772 155 GIQLAKGISDLH-SIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPIS 233 (632)
Q Consensus 155 a~qIa~gL~yLH-s~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t 233 (632)
+.||+.||.||| ..+++|++|.-..|+++..|..||++|-++....+..... ....--..|..|+.+... +
T Consensus 110 l~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~---~~~~~~~s~~~P~~~~~s-----~ 181 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA---KSLYLIESFDDPEEIDPS-----E 181 (690)
T ss_pred HHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc---ccchhhhcccChhhcCcc-----c
Confidence 889999999998 5689999999999999999999999999875543221100 001112246677765422 2
Q ss_pred cccccchhHHHHHHHHhCCCCCCC------CCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 234 FETDTWGFGCSIMEMLTGIQPWFG------KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 234 ~ksDvwSlGvvL~EmltG~~PF~~------~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...|.|-|||+++|++.|..+=.. ..+ ........ .+..-.+..-+...+++..|...-+--|=.+-+++.
T Consensus 182 ~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ip-k~~~~~~~--k~~~~~~~~r~n~~~~~~~~~~~~gff~n~fvd~~~ 258 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIP-KALIELYC--KKLGATELKRPNKLRFILECRLLGGFFRNDFVDTLL 258 (690)
T ss_pred cchhhhhHHHHHHHHhCcccCcchhhhccCccc-hhHHHHHH--HHhccccccccchhhHHHHHHhccccccchHHHHHH
Confidence 456999999999999999332111 111 00000000 000000111122566777777766666666666666
Q ss_pred HHHhh
Q 006772 308 AFESS 312 (632)
Q Consensus 308 ~Le~~ 312 (632)
.|+.+
T Consensus 259 fLeel 263 (690)
T KOG1243|consen 259 FLEEL 263 (690)
T ss_pred HHHhc
Confidence 66554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.2e-08 Score=93.20 Aligned_cols=132 Identities=20% Similarity=0.208 Sum_probs=87.1
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHH-----HHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVF-----VNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~-----~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
..|.+|+=+.+|++.+.. ..+++|.=.+.. .....+. ...+..++.++... .++...-+..+.+
T Consensus 2 ~~i~~GAEa~i~~~~~~g--------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-GV~~P~v~dvD~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-GVPVPIVYDVDPD 72 (204)
T ss_pred chhhCCcceeEEeeeccC--------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc-CCCCCeEEEEcCC
Confidence 357889999999986532 246666543321 1111111 22233444444332 4444445566777
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
...|+|||++|.++.-..... ...++..+-.-+.-||..||+|+||.++||+++.++ +.++|||+++.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 788999999997665332221 245667777778889999999999999999998765 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.6e-08 Score=96.70 Aligned_cols=140 Identities=16% Similarity=0.096 Sum_probs=89.8
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCC-CceeEeeEEEEEC---CEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRES-QSVCWLHGISVIN---GKIC 124 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h-~~I~~l~~~~~~~---~~l~ 124 (632)
+.|+.|.++.||++.... +..+++|+...............+..++..+..+ ..++.++.+.... +..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 578999999999998643 1368999876432210111223333444444332 2344455544432 3678
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 006772 125 IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS------------------------------------- 167 (632)
Q Consensus 125 LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs------------------------------------- 167 (632)
++|||++|........ ...++..+...++.+++..|.+||+
T Consensus 77 ~v~e~i~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 9999999742222110 0246666777777777777777773
Q ss_pred -------------------CCceeeeeeCCeEEEec--CCcEEEEecCCce
Q 006772 168 -------------------IGLLVLNLKPSNLLLSE--HDQLVLGDFGIPY 197 (632)
Q Consensus 168 -------------------~~IvHRDLKP~NILld~--~g~vkL~DFGlak 197 (632)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23599999999999998 6678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.2e-07 Score=97.72 Aligned_cols=209 Identities=17% Similarity=0.207 Sum_probs=147.1
Q ss_pred CceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE----CCEEEEEE
Q 006772 55 PFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI----NGKICIAM 127 (632)
Q Consensus 55 ~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~----~~~l~LVm 127 (632)
.-.+.|+++....+ ..|++|+++-... ...-...+. .+++ .|.|++.++.++.+ +..+++|+
T Consensus 288 ~~~Ttyk~~s~~DG------~~YvLkRlhg~r~~~~nk~t~lve~----wkkl-~h~NvV~frevf~t~tF~D~SlvlvY 356 (655)
T KOG3741|consen 288 FSITTYKATSNVDG------NAYVLKRLHGDRDQSTNKDTSLVEA----WKKL-CHTNVVPFREVFLTYTFGDLSLVLVY 356 (655)
T ss_pred ccceeEeeeeccCC------ceeeeeeeccccccCcccchHHHHH----HHHh-ccCceeehhhhhhhhccCcceEEEEE
Confidence 34677999876544 4799999943221 111222222 2232 68999999998874 45789999
Q ss_pred ecCC--CCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 128 KFYE--GSVGDRIAQQR-------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 128 Ey~~--GsL~d~l~~~~-------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
+|++ ++|+++..... +...++...|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|+-
T Consensus 357 DYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 357 DYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred ecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEec
Confidence 9998 58888775432 23567899999999999999999999999999999999999998999988
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhh
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEI-YHSVVIK 270 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P-F~~~~~~ei-~~~i~~~ 270 (632)
.|+...+.... . |.+.. -.+-|.=-||.++..+.||..- +......+. ...
T Consensus 437 C~i~Dvl~~d~---------------~--~~le~------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---- 489 (655)
T KOG3741|consen 437 CGIMDVLQEDP---------------T--EPLES------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---- 489 (655)
T ss_pred ccceeeecCCC---------------C--cchhH------HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH----
Confidence 88765543321 0 11111 1366888999999999998543 333333332 222
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+....+.+++++|.-+...++++ -++.+++.
T Consensus 490 -----I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 490 -----ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred -----hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 23567788999999999999987 45666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.1e-07 Score=94.55 Aligned_cols=77 Identities=16% Similarity=0.004 Sum_probs=63.7
Q ss_pred CEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-------CCcEEEE
Q 006772 121 GKICIAMKFYEG--SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-------HDQLVLG 191 (632)
Q Consensus 121 ~~l~LVmEy~~G--sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-------~g~vkL~ 191 (632)
...+||||+++| ++.+++........+......++.+++..+.-||..||+|+||+++|||++. +..+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 357899999998 5777764322345667778899999999999999999999999999999985 4689999
Q ss_pred ecCCce
Q 006772 192 DFGIPY 197 (632)
Q Consensus 192 DFGlak 197 (632)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.3e-08 Score=112.51 Aligned_cols=148 Identities=18% Similarity=0.200 Sum_probs=106.6
Q ss_pred HHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCceeccCC-CCCCCccc-----cccCCCccCCccccCCCCC
Q 006772 157 QLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR-SLSDSDMA-----LRLGTPNYMAPEQWEPEVR 229 (632)
Q Consensus 157 qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~-~~~~~~~~-----~~~GT~~YmAPE~~~~~~~ 229 (632)
+++.||.|+|.. ++||++|.|++|.++.++..||+.|+++-...+. .+....+. ...-...|.|||++...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-- 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-- 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc--
Confidence 445999999975 7999999999999999999999999987544331 11111111 11345789999999753
Q ss_pred CCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh--hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 230 GPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI--KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 230 g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~--~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
..+.++|+||+||++|-+.. |+.-+........+..... ......+...+|+++++-+.+++..|+..||++.+++
T Consensus 185 -~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 -TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred -cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 45789999999999999984 5555554433322222221 1223345578999999999999999999999877665
Q ss_pred H
Q 006772 307 H 307 (632)
Q Consensus 307 ~ 307 (632)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=3e-07 Score=90.61 Aligned_cols=96 Identities=19% Similarity=0.187 Sum_probs=60.0
Q ss_pred HHHHHHhhhccCCC-ceeEeeEEEEECCEEEEEEecCC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCc
Q 006772 95 NKFEELFPKFRESQ-SVCWLHGISVINGKICIAMKFYE--GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD-LHSIGL 170 (632)
Q Consensus 95 ~~~~~il~~l~~h~-~I~~l~~~~~~~~~l~LVmEy~~--GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~y-LHs~~I 170 (632)
+++...+.++.... +++.++.+ . ..+|||||++ |..+..+... .++......++.+++..+.. +|..||
T Consensus 56 ~~E~~~L~~l~~~Gv~vP~p~~~--~--~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~gi 128 (188)
T PF01163_consen 56 KKEFRNLKRLYEAGVPVPKPYDY--N--RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGI 128 (188)
T ss_dssp HHHHHHHHHCCCTT-SS--EEEE--E--TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTE
T ss_pred HHHHHHHHHHHHCCccCCcEEEE--e--CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCc
Confidence 33445556665442 45555433 2 3368999999 7555444432 22244566777788885555 579999
Q ss_pred eeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 171 vHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+|+||.+.|||++++ .+.++|||.+..
T Consensus 129 vHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 129 VHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred eecCCChhhEEeecc-eEEEEecCccee
Confidence 999999999999987 999999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.9e-06 Score=81.49 Aligned_cols=75 Identities=24% Similarity=0.302 Sum_probs=63.5
Q ss_pred EEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cEEEEecCCc
Q 006772 122 KICIAMKFYEG--SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIP 196 (632)
Q Consensus 122 ~l~LVmEy~~G--sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~vkL~DFGla 196 (632)
..+||||+++| +|.+++.... ..+......++.+++..+.-||..||+|+|+++.|||++.++ .+.|+||+-+
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 56899999997 5666665432 266777889999999999999999999999999999999887 8999999976
Q ss_pred ee
Q 006772 197 YL 198 (632)
Q Consensus 197 k~ 198 (632)
+.
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 54
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.5e-06 Score=86.48 Aligned_cols=132 Identities=17% Similarity=0.214 Sum_probs=86.5
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh----------------------HHHHHHHHHHHhhh
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC----------------------AKVFVNKFEELFPK 103 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~----------------------~~~~~~~~~~il~~ 103 (632)
.++..||-|-=+.||.|.+.+. .++|||.=+- .... .....+++.+.+..
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g-------~~~~vKfHR~-GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~ 165 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKG-------RKVAVKFHRL-GRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR 165 (304)
T ss_pred hhccccccCccceEEEEECCCC-------CEEEEEEeec-CchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence 4568999999999999986532 4899997321 1110 01111222233444
Q ss_pred ccCC-CceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 104 FRES-QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 104 l~~h-~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
+... -.++... ..+...+||||++|-.+..+ +++....-.++..|+.-+.-+-..||||+|+.+=|||+
T Consensus 166 L~~~G~~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV 235 (304)
T COG0478 166 LYPEGVKVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV 235 (304)
T ss_pred hhhcCCCCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE
Confidence 4322 1233322 33677899999999433221 22345555666777777777778999999999999999
Q ss_pred ecCCcEEEEecCC
Q 006772 183 SEHDQLVLGDFGI 195 (632)
Q Consensus 183 d~~g~vkL~DFGl 195 (632)
+++|.+.++||--
T Consensus 236 ~~dg~~~vIDwPQ 248 (304)
T COG0478 236 TEDGDIVVIDWPQ 248 (304)
T ss_pred ecCCCEEEEeCcc
Confidence 9999999999973
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.4e-05 Score=74.77 Aligned_cols=77 Identities=12% Similarity=-0.006 Sum_probs=64.0
Q ss_pred CEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc--EEEEecCCc
Q 006772 121 GKICIAMKFYEG--SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ--LVLGDFGIP 196 (632)
Q Consensus 121 ~~l~LVmEy~~G--sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~--vkL~DFGla 196 (632)
-..+||+|-+.| +|.+.+....-.+.+......++.+++..|.-||+.|+.|+|+-+.|||++..|. ++++||--+
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 357899999985 7777765432345677778899999999999999999999999999999997777 999999865
Q ss_pred e
Q 006772 197 Y 197 (632)
Q Consensus 197 k 197 (632)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.6e-05 Score=89.61 Aligned_cols=141 Identities=19% Similarity=0.263 Sum_probs=85.2
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH--------------------------HHHHHHH-----
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA--------------------------KVFVNKF----- 97 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~--------------------------~~~~~~~----- 97 (632)
..|+.++-|.||.|+.+. ++.||||+.++.-.... ..+..++
T Consensus 131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 679999999999999875 35899999876221100 0011110
Q ss_pred --------H----HHhhhccCCCceeEeeEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 006772 98 --------E----ELFPKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164 (632)
Q Consensus 98 --------~----~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~y 164 (632)
. +......+.+.+....-+..-.+.-.|+|||++| .+.+.. ..+...++...+.....++ -+..
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~-~l~~~g~d~k~ia~~~~~~--f~~q 280 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIA-ALKSAGIDRKELAELLVRA--FLRQ 280 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHH-HHHhcCCCHHHHHHHHHHH--HHHH
Confidence 0 1112222445544443333334566799999998 333332 1222344533332222222 1233
Q ss_pred HHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 165 LHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+-..|+.|.|..|.||+++.+|++.+.|||+...+
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 33489999999999999999999999999987655
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.8e-05 Score=75.21 Aligned_cols=135 Identities=11% Similarity=0.070 Sum_probs=74.8
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc-eeEeeEEEEECCEEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS-VCWLHGISVINGKICIAM 127 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~-I~~l~~~~~~~~~l~LVm 127 (632)
..||+|..+.||+.. + ..+++|...+.... ... .++.+.+..+..... ++..+.+....+...++|
T Consensus 7 ~~i~~G~t~~~y~~~----~------~~~VlR~~~~~~~~--~~i-~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----T------GKWMLKLYNPGFDK--ETI-KREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEec----C------CCEEEEeCCCCCCH--HHH-HHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence 578999999999831 1 24778887653311 222 333334444433322 455566666777888999
Q ss_pred ecCCCCH----------------HHHHHH----hcC---CCCCHHHHH-HHHH----------HHHH-HHHHHHh----C
Q 006772 128 KFYEGSV----------------GDRIAQ----QRG---GKLPLPDIL-RYGI----------QLAK-GISDLHS----I 168 (632)
Q Consensus 128 Ey~~GsL----------------~d~l~~----~~~---~~l~~~~~~-~ia~----------qIa~-gL~yLHs----~ 168 (632)
|+++|.. ...+.+ ... ...+..... .+.. ++.. ..++|.+ .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 9999841 111111 000 111111111 0100 0111 1222221 2
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++|+|+.|.||++++++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00041 Score=68.61 Aligned_cols=139 Identities=18% Similarity=0.189 Sum_probs=72.8
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCC-ceeEeeEEE---EECCEE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-SVCWLHGIS---VINGKI 123 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~-~I~~l~~~~---~~~~~l 123 (632)
++.|+.|..+.||+..... +.+++|..... . .......+..++..+..+. .++.++... ......
T Consensus 2 i~~l~~G~~n~~~~v~~~~--------~~~vlK~~~~~--~-~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~ 70 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--------GRYVLKFYRPP--D-AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP 70 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--------SEEEEEEESSH--H-HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred CccCCCCCeeeEEEEEECC--------cEEEEEEeCCC--C-CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence 4689999999999998654 27999997654 1 1222233333333333221 244444433 334568
Q ss_pred EEEEecCCCCHHHH-----------------HHHhc-----CCCCCHHH---------HHHH------------HHHHHH
Q 006772 124 CIAMKFYEGSVGDR-----------------IAQQR-----GGKLPLPD---------ILRY------------GIQLAK 160 (632)
Q Consensus 124 ~LVmEy~~GsL~d~-----------------l~~~~-----~~~l~~~~---------~~~i------------a~qIa~ 160 (632)
+++|++++|..... +.+.. ...+.... .... ...+..
T Consensus 71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (239)
T PF01636_consen 71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE 150 (239)
T ss_dssp EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence 99999999843322 11110 01111100 0000 111222
Q ss_pred -HHHHHHh-------CCceeeeeeCCeEEEe-cCCcEEEEecCCce
Q 006772 161 -GISDLHS-------IGLLVLNLKPSNLLLS-EHDQLVLGDFGIPY 197 (632)
Q Consensus 161 -gL~yLHs-------~~IvHRDLKP~NILld-~~g~vkL~DFGlak 197 (632)
.++.++. ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3334432 3599999999999999 66667899999654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=73.73 Aligned_cols=138 Identities=17% Similarity=0.131 Sum_probs=85.6
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHH-----------------------HHHHHHHHHhhh
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK-----------------------VFVNKFEELFPK 103 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~-----------------------~~~~~~~~il~~ 103 (632)
+...|..|-=+.||+|... .+..+|+|+++........ ...+++-..+.+
T Consensus 52 ~~g~istGKEA~Vy~a~~~-------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R 124 (268)
T COG1718 52 LVGCISTGKEANVYLAETG-------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKR 124 (268)
T ss_pred eEeeecCCcceEEEeeccC-------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3447888999999999742 2358999998653211100 111111112222
Q ss_pred cc-CCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEE
Q 006772 104 FR-ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLL 181 (632)
Q Consensus 104 l~-~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NIL 181 (632)
+. .+-.++..+.+ -...|||||+... +.-.-..+.-.+...++..+..++++.+.-|-. .++||+||..=|||
T Consensus 125 ~~eAGVrvP~Pi~~----~~nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 125 AYEAGVRVPEPIAF----RNNVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred HHHcCCCCCCceee----cCCeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 21 11122222222 2345899999743 111111122344455788889999999999988 89999999999999
Q ss_pred EecCCcEEEEecCCce
Q 006772 182 LSEHDQLVLGDFGIPY 197 (632)
Q Consensus 182 ld~~g~vkL~DFGlak 197 (632)
+. ++.+.++|||-|-
T Consensus 200 ~~-~~~p~iID~~QaV 214 (268)
T COG1718 200 VH-DGEPYIIDVSQAV 214 (268)
T ss_pred EE-CCeEEEEECcccc
Confidence 99 8999999999553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00029 Score=70.89 Aligned_cols=138 Identities=15% Similarity=0.110 Sum_probs=83.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHH-----HHHHh---hhcc--CCCce
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK-----FEELF---PKFR--ESQSV 110 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~-----~~~il---~~l~--~h~~I 110 (632)
-..+|...+.+-......|.+-.-.. ..+++|..........+.+..- ...++ ..+. .....
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~--------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG--------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC--------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 34678888888888888887765322 4789998765432222222111 01111 1111 12222
Q ss_pred eEeeEEEEE-----CCEEEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec
Q 006772 111 CWLHGISVI-----NGKICIAMKFYEGS-VGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184 (632)
Q Consensus 111 ~~l~~~~~~-----~~~l~LVmEy~~Gs-L~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~ 184 (632)
..++.+... ....+|+|||++|- +.+.. .+++ .++..+..+|.-||+.|+.|+|..|.|+++++
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence 222222211 23566899999983 22221 1222 24467788899999999999999999999996
Q ss_pred CCcEEEEecCCce
Q 006772 185 HDQLVLGDFGIPY 197 (632)
Q Consensus 185 ~g~vkL~DFGlak 197 (632)
+ .++++||+..+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 5 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00018 Score=85.84 Aligned_cols=188 Identities=15% Similarity=0.137 Sum_probs=122.8
Q ss_pred hhccCCCceeEeeEEEEECC----EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeee
Q 006772 102 PKFRESQSVCWLHGISVING----KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK 176 (632)
Q Consensus 102 ~~l~~h~~I~~l~~~~~~~~----~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLK 176 (632)
.....|+|+..++.+....- .+.+..+++.+ ++...+.. -+.++...++.+..++..||.|+|+....|.-|.
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~ 313 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLS 313 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEe
Confidence 33457888888777765432 22344556654 44444433 3578999999999999999999999977777666
Q ss_pred CC---eEEEecCCcEEEE--ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC
Q 006772 177 PS---NLLLSEHDQLVLG--DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG 251 (632)
Q Consensus 177 P~---NILld~~g~vkL~--DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG 251 (632)
.. +-..+..+....+ ||+.++.+...... ....-+..|-++|..... ........|+|.+|..+..+..+
T Consensus 314 ~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 314 ASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred cccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhhhc
Confidence 66 5555566666666 88887765332211 112235567788876533 22334457999999999999887
Q ss_pred CCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 252 IQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 252 ~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+-..... .....+........++..+|+..|+++|+++.+++.
T Consensus 389 ~~i~~~~~~-----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 389 EDISEKSAV-----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred Ccccccccc-----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 665211100 001112222237888999999999999999998876
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00035 Score=70.99 Aligned_cols=29 Identities=10% Similarity=-0.095 Sum_probs=25.7
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998888899999653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00088 Score=80.39 Aligned_cols=82 Identities=15% Similarity=0.144 Sum_probs=49.3
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCce--eEeeEEEEEC---CE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV--CWLHGISVIN---GK 122 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I--~~l~~~~~~~---~~ 122 (632)
.+.|+.|.+..+|+......+ ..+.+++|+..+...........++..++..+..+.++ +.++.++.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~----~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG----SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC----cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 577899999999998764321 11357788764422111122334444555555444443 5556665543 56
Q ss_pred EEEEEecCCCC
Q 006772 123 ICIAMKFYEGS 133 (632)
Q Consensus 123 l~LVmEy~~Gs 133 (632)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 89999999984
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0031 Score=62.83 Aligned_cols=131 Identities=18% Similarity=0.266 Sum_probs=88.0
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-------------------hhhHHHHHHHHHHHh-hhccCC
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-------------------EDCAKVFVNKFEELF-PKFRES 107 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-------------------~~~~~~~~~~~~~il-~~l~~h 107 (632)
...||+|+.=.||.- .. .....||++.+.. .......+.....+. .....+
T Consensus 6 ~~~i~~G~~R~cy~H--P~-------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~ 76 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW 76 (199)
T ss_pred CcccccCCCceEEEC--CC-------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence 357899999999862 11 1357899987765 222222233333333 334457
Q ss_pred CceeEeeEEEEECCEEEEEEecCC---C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 108 QSVCWLHGISVINGKICIAMKFYE---G----SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 108 ~~I~~l~~~~~~~~~l~LVmEy~~---G----sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
.+|..++|+.+++--+.+|+|.+. | +|.+++.+ +.++. . +...+-.-.+||-.++|+.+||+|.||
T Consensus 77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNI 149 (199)
T ss_pred cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccE
Confidence 789999999999988899999984 4 55555532 34555 3 333444556788899999999999999
Q ss_pred EEecCC----cEEEEe-cC
Q 006772 181 LLSEHD----QLVLGD-FG 194 (632)
Q Consensus 181 Lld~~g----~vkL~D-FG 194 (632)
++.... .+.|+| ||
T Consensus 150 v~~~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLG 168 (199)
T ss_pred EEEecCCCceEEEEEeCCC
Confidence 997443 577888 55
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0017 Score=73.35 Aligned_cols=74 Identities=22% Similarity=0.376 Sum_probs=52.1
Q ss_pred CEEEEEEecCCC---CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec----CCcEEEEec
Q 006772 121 GKICIAMKFYEG---SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE----HDQLVLGDF 193 (632)
Q Consensus 121 ~~l~LVmEy~~G---sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~----~g~vkL~DF 193 (632)
..-.|+||||+| +..+.+.+ ..++..++...+.+... +-+-..|++|.|=.|.||+++. ++.+.+.||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 456799999998 33455543 35666655554444333 2233468999999999999994 668999999
Q ss_pred CCceec
Q 006772 194 GIPYLL 199 (632)
Q Consensus 194 Glak~~ 199 (632)
|+...+
T Consensus 350 Gl~~~i 355 (538)
T KOG1235|consen 350 GLYAVI 355 (538)
T ss_pred cccccc
Confidence 987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=4.3e-05 Score=85.96 Aligned_cols=187 Identities=18% Similarity=0.134 Sum_probs=125.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc-eeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS-VCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~-I~~l~~~~~~~~ 121 (632)
.-+.+.+-.++|+++++|+++...+. ....+.+... .-.+-..+++.++ +||| .+...+-++.+.
T Consensus 242 kws~~fh~fvK~altknpKkRptaek-------lL~h~fvs~~------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEK-------LLQHPFVSQT------LSRRLAIELLDKV-NNPNPVVRYLEDYDGED 307 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhh-------heeceeeccc------hhhHHHHHHHHHc-cCCCCcccccccCCccc
Confidence 34667788999999999998766543 2335544221 1122333555665 4566 444445555677
Q ss_pred EEEEEEecCCCC--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 122 KICIAMKFYEGS--VGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~Gs--L~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
..+++|+++.+. ..+.+.. ..-.+...+...+.+.-++++++||+.-=+||| |||..+ +..++.||+....+
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred ccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 889999999852 2222111 011233344555667778899999998888999 777765 78999999987665
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~ 256 (632)
.... ...+..+|+.++|||+... +.+....|+||++.--.+|.-|.+|-.
T Consensus 382 ~~~~----~~~t~~~~~~~~~pev~~~---~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 382 TRTM----KPRTAIGTPEPLAPEVIQE---NTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred Cccc----ccccCCCCCCCCCchhhcc---cccccCCCccCCCcchhhcCCCCCCCC
Confidence 4332 2345678999999998763 467889999999998778887877743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.015 Score=58.05 Aligned_cols=126 Identities=21% Similarity=0.295 Sum_probs=80.2
Q ss_pred CCeEEEeEEcccCc-eEEEEEEEcCCCCCcccccEEEEEEecC---Cchh------------------hHHHHHHHHHHH
Q 006772 43 TSLKLKHRIGRGPF-GDVWLATHHQSADDFDEYHELAVKMLLP---LKED------------------CAKVFVNKFEEL 100 (632)
Q Consensus 43 ~~y~l~~~IG~G~F-G~VylA~~~~~~~~~~~~~~VAIK~l~~---~~~~------------------~~~~~~~~~~~i 100 (632)
.++++++.||.|.- |.||+++... +.+|+|++.. .... ...-|..+. +.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g--------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC-RA 107 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG--------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC-RA 107 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC--------eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH-Hh
Confidence 78999999999999 9999998643 4799999321 1110 000112222 22
Q ss_pred hhhcc--CCCce--eEeeEEEEEC------------------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHH
Q 006772 101 FPKFR--ESQSV--CWLHGISVIN------------------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158 (632)
Q Consensus 101 l~~l~--~h~~I--~~l~~~~~~~------------------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qI 158 (632)
+.++. +++++ ++++|+..-. -...||.||....- .+.. .-+.+|
T Consensus 108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~ 173 (207)
T PF13095_consen 108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQM 173 (207)
T ss_pred hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHH
Confidence 22222 33344 7777775322 11347777776421 1222 234567
Q ss_pred HHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 159 a~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+-|..+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 174 ~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 78888999999999999999986 3489999953
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0027 Score=61.80 Aligned_cols=130 Identities=15% Similarity=0.173 Sum_probs=79.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
..+..+.|++|++|.||++.++. ..+|+|+-+..+. ..-+..+.+++..+.....-..++.+. ..
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~--------~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg----~~ 87 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRG--------GEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYG----ED 87 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccC--------ceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence 34556889999999999998864 3799998765433 222344445454444433334444443 34
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeee-CCeEEEecCCcEEEEecCCce
Q 006772 124 CIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK-PSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 124 ~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLK-P~NILld~~g~vkL~DFGlak 197 (632)
++.|||++| .|.+..... +- +-...++..---|-..||-|..|. |..++|-.++.+.|+||-.|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 567999999 555443211 11 222334444334455789998886 444444455599999999775
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0093 Score=60.39 Aligned_cols=29 Identities=28% Similarity=0.287 Sum_probs=25.0
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++|+|+.|.|||+++++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999977666799999653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0053 Score=60.54 Aligned_cols=96 Identities=17% Similarity=0.208 Sum_probs=71.8
Q ss_pred HHhhhccCCCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCceee
Q 006772 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQ-RGGKLPLPDILRYGIQLAKGISDLHS---IGLLVL 173 (632)
Q Consensus 99 ~il~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~-~~~~l~~~~~~~ia~qIa~gL~yLHs---~~IvHR 173 (632)
.+++.+++.+++++++|.| +. ++++||.. +++.+..... .-...+|..+.+++.+++..+++|+. ..+.-.
T Consensus 11 lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc 86 (188)
T PF12260_consen 11 LLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC 86 (188)
T ss_pred HHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 4455666667899999988 33 46889998 4543211000 01246899999999999999999998 346668
Q ss_pred eeeCCeEEEecCCcEEEEecCCcee
Q 006772 174 NLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 174 DLKP~NILld~~g~vkL~DFGlak~ 198 (632)
|++|+|+-++++|++|++|...+..
T Consensus 87 Dv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 87 DVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred ecchHHeEEeCCCcEEEEechhcch
Confidence 9999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.043 Score=58.03 Aligned_cols=30 Identities=20% Similarity=0.204 Sum_probs=25.7
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999976666899999653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.035 Score=58.60 Aligned_cols=38 Identities=24% Similarity=0.311 Sum_probs=30.7
Q ss_pred HHHHHHHHh-------CCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 159 AKGISDLHS-------IGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 159 a~gL~yLHs-------~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
...++++.. .+++|+|+.+.||+++.++...|+||+.+
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 345555543 57999999999999999887789999964
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.023 Score=57.16 Aligned_cols=29 Identities=14% Similarity=0.188 Sum_probs=25.7
Q ss_pred CceeeeeeCCeEEEec-CCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSE-HDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~-~g~vkL~DFGlak 197 (632)
.++|+|+.+.|||++. ++.+.|+||-.|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999998 5789999998653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.065 Score=56.62 Aligned_cols=79 Identities=13% Similarity=0.119 Sum_probs=48.1
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCC--CceeEeeEEEEE--
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRES--QSVCWLHGISVI-- 119 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h--~~I~~l~~~~~~-- 119 (632)
...-.+.||.|..+.||...... ..+.+|..+.... ..++..+...+..+... -.++.+++++..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~--------~~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~ 83 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ--------GNPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ 83 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC--------CCEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence 34456789999999999986432 1467777533111 22334444444444443 245666666543
Q ss_pred -CCEEEEEEecCCCC
Q 006772 120 -NGKICIAMKFYEGS 133 (632)
Q Consensus 120 -~~~l~LVmEy~~Gs 133 (632)
.+..+||||+++|.
T Consensus 84 ~~g~~~LVmE~i~G~ 98 (297)
T PRK10593 84 SPGPDVLLLERLRGV 98 (297)
T ss_pred cCCCeEEEEeccCCE
Confidence 46789999999873
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.018 Score=59.09 Aligned_cols=28 Identities=21% Similarity=0.319 Sum_probs=24.7
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++|+|+.|.|||+++++ +.|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999999877 7899999664
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.097 Score=57.66 Aligned_cols=76 Identities=16% Similarity=0.083 Sum_probs=44.3
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc----h---hhHHHHHHHHHHHhhhccC--CCceeEeeEEEE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK----E---DCAKVFVNKFEELFPKFRE--SQSVCWLHGISV 118 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~----~---~~~~~~~~~~~~il~~l~~--h~~I~~l~~~~~ 118 (632)
.+.||.|.+..||++...... +.|.||.-.+.. . ..... ...+.+.+..+.. ..+++.++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~------~svIVKqa~p~~r~~g~~wpl~~eR-~~~Eae~L~~l~~~~p~~VPkV~~~-- 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGG------KSVIVKQALPYVRVVGESWPLTLDR-ARIEAEALKIQAKYVPDLVPKVYHY-- 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCC------eEEEEEecCcccccccccccccHHH-HHHHHHHHHHHHhhCCCCCCeEEEE--
Confidence 567999999999999875321 369999854321 1 11122 2222233333222 2345566554
Q ss_pred ECCEEEEEEecCCC
Q 006772 119 INGKICIAMKFYEG 132 (632)
Q Consensus 119 ~~~~l~LVmEy~~G 132 (632)
+.+..++||||+++
T Consensus 102 D~~~~~lVME~L~~ 115 (401)
T PRK09550 102 DEELAVTVMEDLSD 115 (401)
T ss_pred CCCCCEEEEecCCC
Confidence 44567899999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.0086 Score=63.42 Aligned_cols=131 Identities=18% Similarity=0.252 Sum_probs=82.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHH----------------------HHHHHHHhh
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF----------------------VNKFEELFP 102 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~----------------------~~~~~~il~ 102 (632)
+.++..||-|-=+.||.+-+... ++.++|.- .........+ ..++-..++
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G-------~~~~lK~H-RLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG-------NPLILKLH-RLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK 165 (465)
T ss_pred hhhccccccccccceEEEecCCC-------CchhHHHH-hhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence 55678999999999999976533 36777752 2111111110 111112234
Q ss_pred hccCCCcee-EeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEE
Q 006772 103 KFRESQSVC-WLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLL 181 (632)
Q Consensus 103 ~l~~h~~I~-~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NIL 181 (632)
.+..|.+-+ .. .+.+..|+|||++.|-.+-.+.+ ...+..+...++.-|--|-.+|+||+|..-=||+
T Consensus 166 aL~e~gfpVPkp----iD~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 166 ALYERGFPVPKP----IDHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred HHHHcCCCCCCc----ccccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 443333221 11 23467899999999833322221 1223344556666677788999999999999999
Q ss_pred EecCCcEEEEecC
Q 006772 182 LSEHDQLVLGDFG 194 (632)
Q Consensus 182 ld~~g~vkL~DFG 194 (632)
+++++.++++||-
T Consensus 235 v~dd~~i~vIDFP 247 (465)
T KOG2268|consen 235 VKDDDKIVVIDFP 247 (465)
T ss_pred EecCCCEEEeech
Confidence 9999999999997
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.091 Score=54.82 Aligned_cols=29 Identities=21% Similarity=0.252 Sum_probs=25.9
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+++|+|+.|.|||+++++.+.|+||+.+
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 46999999999999999877899999964
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.15 Score=55.07 Aligned_cols=29 Identities=17% Similarity=0.351 Sum_probs=25.3
Q ss_pred CceeeeeeCCeEEEec-CCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSE-HDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~-~g~vkL~DFGlak 197 (632)
.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4689999999653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.18 Score=52.89 Aligned_cols=28 Identities=32% Similarity=0.376 Sum_probs=25.3
Q ss_pred CceeeeeeCCeEEEecC----CcEEEEecCCc
Q 006772 169 GLLVLNLKPSNLLLSEH----DQLVLGDFGIP 196 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~----g~vkL~DFGla 196 (632)
.++|.|+.|.|||++++ +.+.|+||..|
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 58999999999999985 88999999965
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.23 Score=54.00 Aligned_cols=29 Identities=24% Similarity=0.326 Sum_probs=23.7
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++|+||.+.|||+++++ ++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 3589999999999997754 7799988653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.0034 Score=76.92 Aligned_cols=180 Identities=13% Similarity=-0.003 Sum_probs=111.6
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC-----CceeeeeeCCeEEEecCCcEEEE
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRG--GKLPLPDILRYGIQLAKGISDLHSI-----GLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~--~~l~~~~~~~ia~qIa~gL~yLHs~-----~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+...++.|+|+. |.+.+.+..... ..+...-+.....+...+..-+|+. -.+|++||+-|.+|..+..+|++
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence 345678899998 677777765422 2222333333334447777777764 27999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
++|+.+..... ..-.....+++.|+.|++... -.++.++|+|..++.+|+...|..+|-.-... +...++...
T Consensus 1383 k~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~---ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~ 1455 (2724)
T KOG1826|consen 1383 KGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNE---IKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNH 1455 (2724)
T ss_pred ccccccccCch---HhhhhhhhCCHHHHHHHHHHH---HhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCccccc
Confidence 99998832221 112234577899999999863 35777899999999999998888886322111 111122222
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
....++.-.|.+.-.....+|-..-..||.-...+
T Consensus 1456 tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isl 1490 (2724)
T KOG1826|consen 1456 TFFSIEKLKPGDANVEALHRLLWKYMERPGQYISL 1490 (2724)
T ss_pred ccccccccCCCcccHHHHHHHHHHhhhcchhhhhc
Confidence 22223333334433344444444455666544433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.41 Score=51.35 Aligned_cols=27 Identities=30% Similarity=0.381 Sum_probs=24.1
Q ss_pred ceeeeeeCCeEEEec-CCcEEEEecCCc
Q 006772 170 LLVLNLKPSNLLLSE-HDQLVLGDFGIP 196 (632)
Q Consensus 170 IvHRDLKP~NILld~-~g~vkL~DFGla 196 (632)
++|.||.+.|||+++ ++.++++||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 799999999999975 578999999965
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.4 Score=51.99 Aligned_cols=139 Identities=17% Similarity=0.176 Sum_probs=86.8
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-------------------------hhhHHHHHHHHHHH
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-------------------------EDCAKVFVNKFEEL 100 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-------------------------~~~~~~~~~~~~~i 100 (632)
.+-.+|..|-=+.||.|.-... ..+|||+++..- ..-.+....++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG-------~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RN 219 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDG-------SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRN 219 (520)
T ss_pred ecccccccCccceeEeeecCCC-------ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHH
Confidence 3456888899999999875432 469999976410 00111222333333
Q ss_pred hhhccCCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCe
Q 006772 101 FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSN 179 (632)
Q Consensus 101 l~~l~~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~N 179 (632)
+.++.... |+...-+.. ....|||+|+.++-.- .-.++...++...+..+-.|++.-+.-|.. .++||.||.-=|
T Consensus 220 LkRl~~aG-IP~PePIlL--k~hVLVM~FlGrdgw~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 220 LKRLNNAG-IPCPEPILL--KNHVLVMEFLGRDGWA-APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred HHHHHhcC-CCCCCceee--ecceEeeeeccCCCCc-CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 44432211 111111111 1235899999742111 111234578888899999999999988876 589999999999
Q ss_pred EEEecCCcEEEEecCCc
Q 006772 180 LLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 180 ILld~~g~vkL~DFGla 196 (632)
+|+-+ |.+.++|.+-+
T Consensus 296 ~Lyhd-G~lyiIDVSQS 311 (520)
T KOG2270|consen 296 LLYHD-GKLYIIDVSQS 311 (520)
T ss_pred heEEC-CEEEEEEcccc
Confidence 99865 89999998744
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.63 Score=51.44 Aligned_cols=75 Identities=13% Similarity=0.137 Sum_probs=42.8
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-------hhHHHHHHHHHHHhhhcc--CCCceeEeeEEE
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-------DCAKVFVNKFEELFPKFR--ESQSVCWLHGIS 117 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-------~~~~~~~~~~~~il~~l~--~h~~I~~l~~~~ 117 (632)
-.+.||.|....||+..+.. +.++||.-.+... ........+ ...+.... ....++.++.++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~--------~svVVKqa~p~~r~vga~wpl~~~R~~~E-a~aL~~~~~~~p~~VPkVy~~d 106 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSS--------GSFVIKQALPYIRCIGESWPMTKERAYFE-ATALREHGRLCPDHVPEVYHFD 106 (418)
T ss_pred eEEEcCCCceeeEEEEEcCC--------ccEEEEeCCccccCCCccccCCccHHHHH-HHHHHHhhhcCCCCCCeEEEEC
Confidence 47789999999999987521 2588998652111 011111111 22222222 123566666665
Q ss_pred EECCEEEEEEecCCC
Q 006772 118 VINGKICIAMKFYEG 132 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G 132 (632)
. +..+++|||+++
T Consensus 107 e--d~~vlvME~L~~ 119 (418)
T PLN02756 107 R--TMALIGMRYLEP 119 (418)
T ss_pred C--CCCEEEEeecCC
Confidence 4 556788999975
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.04 E-value=0.68 Score=48.42 Aligned_cols=29 Identities=24% Similarity=0.289 Sum_probs=24.4
Q ss_pred CceeeeeeCCeEEEecCCc-EEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQ-LVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~-vkL~DFGlak 197 (632)
.++|+|++|.|||+++++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997555 5699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.40 E-value=1.6 Score=47.97 Aligned_cols=28 Identities=18% Similarity=0.141 Sum_probs=23.2
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
...+|-||-+.|||.++ +.+.++||-.|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 45799999999999764 56999999854
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.10 E-value=0.43 Score=51.70 Aligned_cols=73 Identities=16% Similarity=0.078 Sum_probs=56.3
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+.+.|++|++..+++.- + ....+++++.++.+.+.-+.-+..+ ..=|||+.-.||||+ +|++.|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34677888887765442 2 1345778888888877777777664 589999999999999 89999999999985
Q ss_pred c
Q 006772 199 L 199 (632)
Q Consensus 199 ~ 199 (632)
-
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.70 E-value=0.79 Score=50.49 Aligned_cols=27 Identities=11% Similarity=0.150 Sum_probs=23.0
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..+|+||.|.|||++++ .+|++|.-++
T Consensus 228 aLlHGDlHtGSI~v~~~-~~kvIDpEFA 254 (409)
T PRK12396 228 ALIHGDLHTGSVFVKND-STKVIDPEFA 254 (409)
T ss_pred hhccCcCCCCCEEecCC-ceEEEccccc
Confidence 48999999999999975 5889987655
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.65 E-value=2.5 Score=44.62 Aligned_cols=76 Identities=9% Similarity=0.030 Sum_probs=39.7
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhc--cCCCceeEeeEEEEECCE
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF--RESQSVCWLHGISVINGK 122 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l--~~h~~I~~l~~~~~~~~~ 122 (632)
.+-.+.|+.|....+|+... . .+.+-||+-..... .++..+.+-++.+ ...-.++..+.+...++.
T Consensus 19 i~~~~~v~GG~i~~a~~~~~--~------~~~~FvK~~~~~~~----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT--D------GGSYFVKVNSESGR----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEET--T------S-EEEEEEEEGGGC----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeeeEecCCCChhheEEEEC--C------CccEEEEecChhhH----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 55677899899999998761 1 14788898652211 1122222223333 234456778888877777
Q ss_pred EEEEEecCCC
Q 006772 123 ICIAMKFYEG 132 (632)
Q Consensus 123 l~LVmEy~~G 132 (632)
.||+|||++.
T Consensus 87 ~fLlle~l~~ 96 (288)
T PF03881_consen 87 AFLLLEFLEM 96 (288)
T ss_dssp CEEEEE----
T ss_pred ceEEEEeecC
Confidence 8999999873
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.40 E-value=2.1 Score=45.88 Aligned_cols=31 Identities=19% Similarity=0.234 Sum_probs=27.7
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
.++|+|+.+.|++++.++-+=|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3799999999999999999999999987653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.25 E-value=5.7 Score=42.45 Aligned_cols=27 Identities=19% Similarity=0.124 Sum_probs=22.8
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.++||+|+.+.|||++ + .+.|+||+-+
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~ 222 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA 222 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence 3689999999999995 3 5789999954
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.17 E-value=0.61 Score=52.51 Aligned_cols=73 Identities=18% Similarity=0.198 Sum_probs=47.8
Q ss_pred cccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC----------CCCCCCCHHHHHHHHHhhhcCcCCCCCHH
Q 006772 234 FETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP----------CIPSGLPPAVENVIIGCFEYDLRNRPLMA 303 (632)
Q Consensus 234 ~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p----------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ 303 (632)
.++||||+|.++.|+.-|..-|......+....+..-...+ .+.-.++..+.++..+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 49999999999999999887766544333222221100000 11124566778899999999999998765
Q ss_pred HHH
Q 006772 304 DIL 306 (632)
Q Consensus 304 ell 306 (632)
++.
T Consensus 190 ~~~ 192 (725)
T KOG1093|consen 190 ELS 192 (725)
T ss_pred HHh
Confidence 544
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.51 E-value=0.65 Score=51.05 Aligned_cols=61 Identities=13% Similarity=0.160 Sum_probs=38.9
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeeeeeCCeEEEecCC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH-SIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLH-s~~IvHRDLKP~NILld~~g 186 (632)
..|+-+|.+| ++..++.. ...++....+++.--+.||--+- -.+++|.|+.|.||++.-+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 4566667777 44444433 24455556666655555554433 46899999999999997544
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.08 E-value=5.7 Score=49.21 Aligned_cols=30 Identities=23% Similarity=0.351 Sum_probs=25.3
Q ss_pred CCceeeeeeCCeEEEecCC--cEE-EEecCCce
Q 006772 168 IGLLVLNLKPSNLLLSEHD--QLV-LGDFGIPY 197 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g--~vk-L~DFGlak 197 (632)
+++||.|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4699999999999999875 555 99999653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=89.03 E-value=0.68 Score=48.47 Aligned_cols=28 Identities=21% Similarity=0.322 Sum_probs=24.7
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+++|+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999998 67899999954
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.68 E-value=0.66 Score=45.83 Aligned_cols=28 Identities=25% Similarity=0.272 Sum_probs=24.5
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
-.+|+|+.|.||++++++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 369999999999998877 8899999764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=84.64 E-value=1.1 Score=48.20 Aligned_cols=62 Identities=18% Similarity=0.189 Sum_probs=33.9
Q ss_pred EEEEecCCCCHHHHHHHhc---CCCCCH-HHHHHHHHHHHHHHHHHHh----CCceeeeeeCCeEEEecCC
Q 006772 124 CIAMKFYEGSVGDRIAQQR---GGKLPL-PDILRYGIQLAKGISDLHS----IGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 124 ~LVmEy~~GsL~d~l~~~~---~~~l~~-~~~~~ia~qIa~gL~yLHs----~~IvHRDLKP~NILld~~g 186 (632)
.||+++..++.. .+.... .|-.+. +-++.+..|+|.-.--.-. .+.+|-||||.|||+-++.
T Consensus 247 IIIfPLA~~Sad-kv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 316 (434)
T PF05445_consen 247 IIIFPLARCSAD-KVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSK 316 (434)
T ss_pred EEEEehhhcchh-hcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCC
Confidence 478888875422 221111 111122 2344556666543311222 4689999999999996544
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00743 Agenet Tudor-like domain present in plant sequences | Back alignment and domain information |
|---|
Probab=82.80 E-value=1.8 Score=34.19 Aligned_cols=38 Identities=21% Similarity=0.327 Sum_probs=32.6
Q ss_pred ecccceEEEecccccCccccccccCCCccccceEEEEeeCCeEEEecCC
Q 006772 467 AYYVGQFVRVGANVFTPRFEWPRKRGGEWATGKILQVLPNGCLVVGFPG 515 (632)
Q Consensus 467 ~~~~g~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (632)
.+++|+.|.++-.- .|+|-.|+|..++++++..|.|++
T Consensus 2 ~~~~G~~Ve~~~~~-----------~~~W~~a~V~~~~~~~~~~V~~~~ 39 (61)
T smart00743 2 DFKKGDRVEVFSKE-----------EDSWWEAVVTKVLGDGKYLVRYLT 39 (61)
T ss_pred CcCCCCEEEEEECC-----------CCEEEEEEEEEECCCCEEEEEECC
Confidence 46789988887431 789999999999998999999998
|
Domain in plant sequences with possible chromatin-associated functions. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=81.94 E-value=2 Score=42.62 Aligned_cols=30 Identities=23% Similarity=0.346 Sum_probs=21.4
Q ss_pred CceeeeeeCCeEEE-ecCCcEEEEecCCcee
Q 006772 169 GLLVLNLKPSNLLL-SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 169 ~IvHRDLKP~NILl-d~~g~vkL~DFGlak~ 198 (632)
.++|.||.|.|||+ +.++.++|+||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999997754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=80.55 E-value=2 Score=44.80 Aligned_cols=43 Identities=23% Similarity=0.264 Sum_probs=32.7
Q ss_pred HHHHHHHHHHHHhC--CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 155 GIQLAKGISDLHSI--GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 155 a~qIa~gL~yLHs~--~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
+..+-.++.-.|.. -++|.|+.|+|+|.++.+.++|+||--|.
T Consensus 138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33444444444444 48999999999999999999999998664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 632 | ||||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-04 |
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 632 | |||
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-39 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 6e-39 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-37 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-37 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-36 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 9e-36 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-35 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-34 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-33 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-31 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-31 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-31 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-30 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-29 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-28 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-27 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-27 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 9e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-26 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-25 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-24 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-24 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-24 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-23 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-23 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-23 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-22 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-22 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-22 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-21 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-21 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-21 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-21 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-21 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-21 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-21 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-20 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-20 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-20 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-20 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-20 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-20 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-20 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-20 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-19 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-19 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-19 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-19 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-19 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-19 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-19 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-19 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-19 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-19 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-19 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 6e-19 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-18 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-18 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-18 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-18 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-18 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-18 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-18 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-18 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-18 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-18 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-17 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-17 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-17 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-17 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-17 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-17 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-17 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-17 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-17 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-17 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-17 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-17 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-17 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-17 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 9e-17 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-16 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-16 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-16 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-16 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-16 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-16 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-16 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-16 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-16 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 7e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-16 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-16 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-16 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-15 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-15 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-15 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-15 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-15 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-15 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-15 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-15 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-15 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-15 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-14 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-14 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-14 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-14 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-14 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-14 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-14 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-14 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-14 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-14 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-14 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-13 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-13 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-13 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-13 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-13 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-13 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-13 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-13 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-13 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-12 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-12 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-12 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-11 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-11 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-11 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-11 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-11 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-11 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-11 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-11 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-11 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-11 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 9e-11 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-10 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-10 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-10 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-10 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-10 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-10 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-10 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-10 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-09 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-09 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 8e-09 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-08 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-08 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-08 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-08 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-07 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-06 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-05 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 8e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 9e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 9e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 9e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-04 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-04 |
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-39
Identities = 52/286 (18%), Positives = 105/286 (36%), Gaps = 26/286 (9%)
Query: 37 RPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVN 95
+ ID L ++ G++W + ++ VK+L D +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGN--------DIVVKVLKV--RDWSTRKSR 52
Query: 96 KFEELFPKFRESQ--SVCWLHGISV--INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD 150
F E P+ R +V + G + + GS+ + + + +
Sbjct: 53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112
Query: 151 ILRYGIQLAKGISDLHSIGLLVLN--LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD 208
+++ + +A+G++ LH++ L+ L ++++ E + + S
Sbjct: 113 AVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD-----VKFSFQSPG 167
Query: 209 MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
P ++APE + + D W F + E++T P+ S EI V
Sbjct: 168 RM---YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314
++ +P IP G+ P V ++ C D RP I+ E Q+
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-39
Identities = 62/274 (22%), Positives = 97/274 (35%), Gaps = 35/274 (12%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVN-----------KFE 98
IG G FG V+ A H +K + + A+ V +
Sbjct: 18 LIGSGGFGQVFKAKHRIDG------KTYVIKRV-KYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ F + + I M+F + G++ I ++RG KL L Q
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTP 216
+ KG+ +HS L+ +LKPSN+ L + Q+ +GDFG L SL + R GT
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFG-----LVTSLKNDGKRTRSKGTL 185
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276
YM+PEQ E D + G + E+L F S I
Sbjct: 186 RYMSPEQIS---SQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFTDLRDGII 236
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ ++ +RP ++IL
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 77/316 (24%), Positives = 130/316 (41%), Gaps = 35/316 (11%)
Query: 6 RAHKPAASFEYELFEGDPDHLRTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATH 64
H P + ++ P I L +K +IG G FG V A
Sbjct: 5 HHHHPMSDYD------IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW 58
Query: 65 HQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVING 121
H S ++AVK+L+ +D VN+F + + R ++ G
Sbjct: 59 HGS--------DVAVKILME--QDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPP 107
Query: 122 KICIAMKFYE-GSVGDRI-AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVL--NLKP 177
+ I ++ GS+ + +L L +AKG++ LH+ ++ NLK
Sbjct: 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167
Query: 178 SNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR--LGTPNYMAPEQWEPEVRGPISFE 235
NLL+ + + + DFG L R + + ++ + GTP +MAPE E P + +
Sbjct: 168 PNLLVDKKYTVKVCDFG-----LSRLKASTFLSSKSAAGTPEWMAPEVLRDE---PSNEK 219
Query: 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYD 295
+D + FG + E+ T QPW + ++ +V K ++ IP L P V +I GC+ +
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 296 LRNRPLMADILHAFES 311
RP A I+
Sbjct: 280 PWKRPSFATIMDLLRP 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 24/282 (8%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVN 95
W I + + RIG G FG V+ H ++AVKML + F N
Sbjct: 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKN 69
Query: 96 KFE-ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
E + K R ++ G ++ I ++ E S+ + K + ++
Sbjct: 70 --EVGVLRKTRH-VNILLFMGY-STAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLID 124
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Q A+G+ LH+ ++ +LK +N+ L E + + +GDFG+ S S L
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS- 183
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYHSVVIKKE 272
G+ +MAPE + P SF++D + FG + E++TG P+ + ++I V
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243
Query: 273 KPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P + S P ++ ++ C + RP IL E
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 57/297 (19%), Positives = 117/297 (39%), Gaps = 25/297 (8%)
Query: 27 RTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP- 84
R T + W I L++ IG+G FG V+ H E+A++++
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIE 66
Query: 85 -LKEDCAKVFVNKFE-ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQR 142
ED K F E + + R ++V G + + I +G + +
Sbjct: 67 RDNEDQLKAFKR--EVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI--PYLLL 200
L + + ++ KG+ LH+ G+L +LK N+ ++ ++V+ DFG+ +L
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVL 182
Query: 201 GRSLSDSDMALRLGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+ + ++ G ++APE E + P S +D + G E+ P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 255 WFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ + E I + + G+ + ++++ C+ ++ RP ++ E
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 58/273 (21%), Positives = 105/273 (38%), Gaps = 42/273 (15%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPL--KEDCAKVF--VNKFEELFP-- 102
R+G G +G+V+ + + AVK P +D A+ V E++
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLY------AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 103 ---KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ ++ W G + + + S+ + G LP + Y
Sbjct: 118 CCVRLEQA----WEE-----GGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDTL 167
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL-RLGTPNY 218
++ LHS GL+ L++KP+N+ L + LGDFG L L + + G P Y
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFG-----LLVELGTAGAGEVQEGDPRY 222
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVIKKEKPCIP 277
MAPE + G D + G +I+E+ ++ G+ +++ P
Sbjct: 223 MAPELLQ----GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ----GYLPPEFT 274
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+GL + +V++ E D + R +L
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 35/287 (12%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
ID L L+ IG G FG V+ A E+AVK ++ +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGD--------EVAVKAARHDPDEDISQTIENVRQ 55
Query: 99 --ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
+LF + ++ L G+ + +C+ M+F G + + G ++P ++ +
Sbjct: 56 EAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWA 111
Query: 156 IQLAKGISDLHSIGLLVL---NLKPSNLLLSEHDQLV--------LGDFGIPYLLLGRSL 204
+Q+A+G++ LH ++ + +LK SN+L+ + + + DFG L R
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG-----LAREW 166
Query: 205 SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
+ G +MAPE S +D W +G + E+LTG P+ G +
Sbjct: 167 HRTTKMSAAGAYAWMAPEVIRAS---MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223
Query: 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ V + K IPS P ++ C+ D +RP +IL +
Sbjct: 224 YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 61/274 (22%), Positives = 114/274 (41%), Gaps = 36/274 (13%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM--LLPLKEDCAKVFVNKFEEL--- 100
+IG G FG L + + +K + + + + L
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDG------RQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 101 -FP---KFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
P ++RES + NG + I M + E G + RI Q+G IL +
Sbjct: 81 KHPNIVQYRES----FEE-----NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR--L 213
+Q+ + +H +L ++K N+ L++ + LGDFGI R L+ + R +
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI-----ARVLNSTVELARACI 186
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
GTP Y++PE E + P + ++D W GC + E+ T + S++ + ++
Sbjct: 187 GTPYYLSPEICENK---PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
P + + +++ F+ + R+RP + IL
Sbjct: 244 P-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 63/295 (21%), Positives = 116/295 (39%), Gaps = 33/295 (11%)
Query: 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKV 92
P P + ++ + +IG+G FG V + +A+K L+ +
Sbjct: 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDK------SVVAIKSLILGDSEGETE 62
Query: 93 FVNKFEE------LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGK 145
+ KF+E + ++ L+G+ + M+F G + R+ +
Sbjct: 63 MIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL-LDKAHP 118
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVL--NLKPSNLLLSEHDQLV-----LGDFGIPYL 198
+ LR + +A GI + + ++ +L+ N+ L D+ + DFG
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG---- 174
Query: 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
L + S L G +MAPE E + + DT+ F + +LTG P+
Sbjct: 175 -LSQQSVHSVSGLL-GNFQWMAPETIGAE-EESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 259 SVEEI--YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
S +I + + + +P IP PP + NVI C+ D + RP + I+
Sbjct: 232 SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 41/281 (14%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM--LLPLKEDCAKVFVNKFEEL--- 100
++ + IG G +G L K + E ++ V++ L
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDG------KILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 101 -FP---KFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLP--DILR 153
P ++ + + N + I M++ E G + I + + L +LR
Sbjct: 63 KHPNIVRYYDR----IIDRT---NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 154 YGIQLAKGISDLHSIGLLVLN-----LKPSNLLLSEHDQLVLGDFGIPYLLLGRSL-SDS 207
QL + + H LKP+N+ L + LGDFG+ R L D+
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL-----ARILNHDT 170
Query: 208 DMAL-RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266
A +GTP YM+PEQ + ++D W GC + E+ + P+ S +E+
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227
Query: 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+ K + IP + +I +RP + +IL
Sbjct: 228 IREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 30/279 (10%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
ID ++++ +GRG FG V A ++A+K + E K F+ +
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAK--------DVAIKQIES--ESERKAFIVELR- 53
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG-GKLPLPDILRYGIQ 157
+ ++ L+G + +C+ M++ E GS+ + + + + +Q
Sbjct: 54 QLSRVN-HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 158 LAKGISDLHSIGLLVL---NLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALRL 213
++G++ LHS+ L +LKP NLLL ++ + DFG + +
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNK- 164
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI-YHSVVIKKE 272
G+ +MAPE +E S + D + +G + E++T +P+ V
Sbjct: 165 GSAAWMAPEVFEGS---NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+P + LP +E+++ C+ D RP M +I+
Sbjct: 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 50/282 (17%), Positives = 109/282 (38%), Gaps = 35/282 (12%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFP 102
+ +IG G V+ + + A+K + E+ ++ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVN--LEEADNQTLDSYRNEIAYLN 62
Query: 103 KFR-ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
K + S + L+ + + I + M+ + + ++ + + Y + +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEA 120
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPN 217
+ +H G++ +LKP+N L+ + L L DFGI + ++ GT N
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI-----ANQMQPDTTSVVKDSQVGTVN 174
Query: 218 YMAPE--------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVV 268
YM PE + + + IS ++D W GC + M G P+ + H+++
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ P +++V+ C + D + R + ++L H +
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/282 (17%), Positives = 109/282 (38%), Gaps = 35/282 (12%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFP 102
+ +IG G V+ + + A+K + E+ ++ +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVN--LEEADNQTLDSYRNEIAYLN 81
Query: 103 KFR-ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
K + S + L+ + + I + M+ + + ++ + + Y + +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEA 139
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPN 217
+ +H G++ +LKP+N L+ + L L DFGI + ++ GT N
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI-----ANQMQPDTTSVVKDSQVGTVN 193
Query: 218 YMAPE--------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVV 268
YM PE + + + IS ++D W GC + M G P+ + H+++
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ P +++V+ C + D + R + ++L H +
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 49/282 (17%), Positives = 109/282 (38%), Gaps = 35/282 (12%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFP 102
+ +IG G V+ + ++ A+K + E+ ++ +
Sbjct: 59 SILKQIGSGGSSKVFQVLN-------EKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLN 109
Query: 103 KFR-ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
K + S + L+ + + I + M+ + + ++ + + Y + +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEA 167
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPN 217
+ +H G++ +LKP+N L+ + L L DFGI + ++ G N
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI-----ANQMQPDTTSVVKDSQVGAVN 221
Query: 218 YMAPE--------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVV 268
YM PE + + + IS ++D W GC + M G P+ + H+++
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ P +++V+ C + D + R + ++L H +
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 44/303 (14%)
Query: 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVF---- 93
ID ++G G F V L H A+K +L ++D +
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDG------HFYALKRILCHEQQDREEAQREAD 78
Query: 94 ---------VNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRI--AQQ 141
+ + + R + + + + F++ G++ + I +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGA------------KHEAWLLLPFFKRGTLWNEIERLKD 126
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI------ 195
+G L IL + + +G+ +H+ G +LKP+N+LL + Q VL D G
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186
Query: 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
++L+ D A + T +Y APE + + I TD W GC + M+ G P
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP- 245
Query: 256 FGKSVEEIYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313
+ ++ + + + IP A+ ++ D RP + +L E+ Q
Sbjct: 246 YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
Query: 314 NAV 316
Sbjct: 306 PPA 308
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 58/282 (20%), Positives = 117/282 (41%), Gaps = 48/282 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+++ +IGRG F +V+ A +A+K V F+ + K R
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDG------VPVALK------------KVQIFDLMDAKAR 76
Query: 106 ES--QSVCWL-----------HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLP-- 149
+ + L + + + ++ I ++ + G + I + K +P
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
+ +Y +QL + +HS ++ ++KP+N+ ++ + LGD G+ GR S
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-----GRFFSSKTT 191
Query: 210 ALR--LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK--SVEEIYH 265
A +GTP YM+PE+ +F++D W GC + EM P++G ++ +
Sbjct: 192 AAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
Query: 266 SVVIKKEKPCIPSG-LPPAVENVIIGCFEYDLRNRPLMADIL 306
+ + + P +PS + ++ C D RP + +
Sbjct: 249 KIE-QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-30
Identities = 38/309 (12%), Positives = 83/309 (26%), Gaps = 51/309 (16%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELF--- 101
L +G+ AT ++ + F V + + + EE+
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESF------EVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 102 --------------PKFRESQSVCWLHGISVIN-----------GKICIAMKFYEGSVGD 136
+F + + + ++
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 137 RIAQ-----QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191
L L+ +Q+ + ++ LH GL+ L+P +++L + + L
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ--WEPEVRGPISFETDTWGFGCSIMEML 249
F ++S P A + ++F DTW G +I +
Sbjct: 254 GFEHLVRDGASAVSPIGRG--FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 250 TGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL--H 307
P + + +P V ++ G Y +R L +
Sbjct: 312 CADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 308 AFESSQNAV 316
+E + +
Sbjct: 366 EYEQLRTEL 374
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 52/295 (17%), Positives = 109/295 (36%), Gaps = 45/295 (15%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
P+ L +G+G FG TH ++ + + +K L+ E+ + F+
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEV------MVMKELIRFDEETQRTFL----- 55
Query: 100 LFPKFRESQ--------SVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD 150
+E + +V G+ + ++ ++ + G++ I + + P
Sbjct: 56 -----KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQ 109
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI-----------PYLL 199
+ + +A G++ LHS+ ++ +L N L+ E+ +V+ DFG+ L
Sbjct: 110 RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFG 257
+ +G P +MA PE+ + D + FG + E++ +
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMA-----PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
Query: 258 -KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ V P PP+ + + C + D RP + H E+
Sbjct: 225 YLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/280 (20%), Positives = 112/280 (40%), Gaps = 36/280 (12%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFEEL-------F 101
+GRG FG V+ A + ++ A+K + LP +E + + + + L
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNY------AIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 102 PKFRES---QSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLP-LPDILRYGI 156
++ + ++ S + I M+ ++ D + + + L +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL---------LGRSLSDS 207
Q+A+ + LHS GL+ +LKPSN+ + D + +GDFG+ + L + +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
++GT YM+PEQ S + D + G + E+L P F +E +
Sbjct: 186 RHTGQVGTKLYMSPEQIH---GNSYSHKVDIFSLGLILFELLY---P-FSTQMERVRTLT 238
Query: 268 VIKKEK-PCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
++ K P + + P ++ RP +I+
Sbjct: 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 59/295 (20%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHEL----AVKMLLP-LKEDCAKVFVNKFEEL 100
+L+ +GRG GDV+ A A+K++ L D VF + +
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTV----------RERIVALKLMSETLSSD--PVFRTRMQ-- 82
Query: 101 FPKFRESQSVCWL--------HGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDI 151
RE+++ L H I+G++ + M+ G + + +R G L P
Sbjct: 83 ----REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRA 136
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM-- 209
+ Q+ + H+ G ++KP N+L+S D L DFGI + +D +
Sbjct: 137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI-----ASATTDEKLTQ 191
Query: 210 -ALRLGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
+GT YMAPE+ ++ D + C + E LTG P+ G + + +
Sbjct: 192 LGNTVGTLYYMAPER----FSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247
Query: 268 VIKKEKPCIPS----GLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQ 313
+ PS G+P A + VI + +R L A A ++
Sbjct: 248 ---NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 35/285 (12%)
Query: 40 IDPTS--LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK--MLLPLKEDCAKVFVN 95
+ LK IGRG F V+ D + E+A L + + F
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGL------DTETTVEVAWCELQDRKLTKSERQRFKE 74
Query: 96 KFEELFPKFRESQSV-----CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLP 149
+ E L K + ++ W + I + + G++ + +R + +
Sbjct: 75 EAEML--KGLQHPNIVRFYDSWESTVKG-KKCIVLVTELMTSGTLKTYL--KRFKVMKIK 129
Query: 150 DILRYGIQLAKGISDLHSIGLLVL--NLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSD 206
+ + Q+ KG+ LH+ ++ +LK N+ ++ V +GD G L
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG-----LATLKRA 184
Query: 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-KSVEEIYH 265
S +GTP +MAPE +E + D + FG ++EM T P+ ++ +IY
Sbjct: 185 SFAKAVIGTPEFMAPEMYEEKY----DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
V + P V+ +I GC + R + D+L HAF
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 38/306 (12%), Positives = 79/306 (25%), Gaps = 60/306 (19%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE-- 99
P +L +G+ AT ++ V + + + EE
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETG------ESFEVHVPYFTERPPSNAIKQMKEEVL 125
Query: 100 ---LFPKFRESQSV-----------------------CWLHGISVINGKICIAMKFYEGS 133
L + + L + + +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 134 VGDRI-----AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188
+ L L+ +Q+ + ++ LH GL+ L+P +++L + +
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 245
Query: 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--------RGPISFETDTWG 240
L F + D + + + PE R ++F D W
Sbjct: 246 FLTGFEH-------LVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP 300
G I + P + + +P V ++ G Y +R
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRL 352
Query: 301 LMADIL 306
L +
Sbjct: 353 LPLQAM 358
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 56/291 (19%), Positives = 105/291 (36%), Gaps = 35/291 (12%)
Query: 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVF--VN 95
+ L+++ + G F V+ A S ++ A+K +L +E + V
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREY------ALKRLLSNEEEKNRAIIQEVC 77
Query: 96 KFEELFP-----KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQR-GGKLPLP 149
++L +F + S+ + + + +G + + + + G L
Sbjct: 78 FMKKLSGHPNIVQFCSAASIG-KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 150 DILRYGIQLAKGISDLHSIGLLVLN--LKPSNLLLSEHDQLVLGDFGI---PYLLLGRSL 204
+L+ Q + + +H +++ LK NLLLS + L DFG S
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 205 SDSDMAL------RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
S AL R TP Y PE + PI + D W GC + + P+
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 259 SVEEIYHSVVIKKEKPCIPSGLP--PAVENVIIGCFEYDLRNRPLMADILH 307
+ I + K IP ++I + + R +A+++H
Sbjct: 257 AKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 50/292 (17%), Positives = 100/292 (34%), Gaps = 42/292 (14%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE------- 98
+ +G+G FG V A + + A+K + E+ +++
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDS------RYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61
Query: 99 ----ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
+ + E ++ + I M++ E G++ D I + R
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWR 120
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI-----------PYLLLGR 202
Q+ + +S +HS G++ +LKP N+ + E + +GDFG+
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262
S ++ +GT Y+A E + G + + D + G EM+ G
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDG--TGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVN 236
Query: 263 IYHSVVIKKEKPCIPSGLPPAV----ENVIIGCFEYDLRNRPLMADIL-HAF 309
I ++ P + +I ++D RP +L +
Sbjct: 237 ILK--KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 76/320 (23%), Positives = 110/320 (34%), Gaps = 42/320 (13%)
Query: 20 EGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
E + L T P + + + R+GRG FG+V Q+ + AV
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG------FQCAV 88
Query: 80 KMLLPLKEDCAKVFVNKFEELFPKFRE--------SQSVCWLHGISVINGKICIAMKFYE 131
K KV + F E S + L+G + I M+ E
Sbjct: 89 K----------KVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 132 -GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV- 189
GS+G I ++ G LP L Y Q +G+ LH+ +L ++K N+LLS
Sbjct: 134 GGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAA 191
Query: 190 LGDFGIPYLLLGRSLSDSDMALR--LGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIM 246
L DFG L L S + GT +MAPE V G P + D W C ++
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV----VMGKPCDAKVDIWSSCCMML 247
Query: 247 EMLTGIQPWFG-KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
ML G PW IP P I + +R ++
Sbjct: 248 HMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
Query: 306 L-HAFESSQNAVYNDGEWTG 324
++ Q W G
Sbjct: 308 RRKVGKALQEVGGLKSPWKG 327
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 45/285 (15%), Positives = 88/285 (30%), Gaps = 45/285 (15%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFEELFPKFRESQ 108
+IG G FG V+ A+K PL + + +
Sbjct: 18 KIGSGEFGSVFKCVKRLDG------CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 109 SVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLP--DILRYGIQLAKGISDL 165
V + + I ++ GS+ D I++ ++ +Q+ +G+ +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLV-------------------LGDFGIPYLLLGRSLSD 206
HS+ L+ +++KPSN+ +S +GD G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH-------VTRI 184
Query: 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYH 265
S + G ++A E + + D + +++ G EI
Sbjct: 185 SSPQVEEGDSRFLANEVLQENY--THLPKADIFALALTVVCAAGAEPLPRNGDQWHEI-- 240
Query: 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ P IP L ++ D RP ++ H+
Sbjct: 241 ---RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 45/304 (14%), Positives = 80/304 (26%), Gaps = 52/304 (17%)
Query: 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELF 101
LKL + G V+L + +DF A+K+ E+ E F
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDF------ALKVFTMGAENSRSELERLHEATF 114
Query: 102 ----------------PKFRESQSVCWLHGISVIN-----------GKICIAMKFYEGSV 134
+ + + M +
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 135 GDRIAQ-----QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189
+ G + + QL + ++L S GL+ + P NL + +L+
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLM 234
Query: 190 LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEML 249
LGD P AP ++ + + W G SI +
Sbjct: 235 LGDVSA-------LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 250 TGIQPWFGKSVEEIYHSVVIKKEKPCIP-------SGLPPAVENVIIGCFEYDLRNRPLM 302
P+ + P + LP V+ +I +D R R L
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP 347
Query: 303 ADIL 306
+ +
Sbjct: 348 LEAM 351
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 53/293 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP-LKEDCAKVFVNKFEELFPKF 104
K+ ++G G V+LA D ++A+K + +E + + +FE
Sbjct: 14 KIVDKLGGGGMSTVYLAE------DTILNIKVAIKAIFIPPREK--EETLKRFE------ 59
Query: 105 RESQSVCWL--HGISVI------NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYG 155
RE + L I + + + M++ EG ++ + I G L + + +
Sbjct: 60 REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFT 117
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM---ALR 212
Q+ GI H + ++ ++KP N+L+ + L + DFGI ++LS++ +
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI-----AKALSETSLTQTNHV 172
Query: 213 LGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI--YHSVVI 269
LGT Y +PEQ +G TD + G + EML G P+ G++ I H I
Sbjct: 173 LGTVQYFSPEQ----AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---I 225
Query: 270 KKEKPCIPS----GLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQ 313
+ P + + +P ++ NVI+ E D NR + D+ ++
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 21/266 (7%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+G+G +G V+ + +A+K + ++ + K + +++
Sbjct: 30 LGKGTYGIVYAGRDLSNQV------RIAIKEIPERDSRYSQPLHEEIALH--KHLKHKNI 81
Query: 111 CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD--ILRYGIQLAKGISDLHS 167
G NG I I M+ GS+ + + + G L + I Y Q+ +G+ LH
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 168 IGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEP 226
++ ++K N+L++ + ++ + DFG L G + GT YMAPE +
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPEIIDK 197
Query: 227 EVRGPISFETDTWGFGCSIMEMLTGIQPW--FGKSVEEIYHSVVIKKEKPCIPSGLPPAV 284
RG D W GC+I+EM TG P+ G+ ++ V + K P IP +
Sbjct: 198 GPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEA 255
Query: 285 ENVIIGCFEYDLRNRPLMADIL-HAF 309
+ I+ CFE D R D+L F
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEF 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 40/278 (14%), Positives = 90/278 (32%), Gaps = 26/278 (9%)
Query: 13 SFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFD 72
S + + + A +T + + + H +G G F V+ AT D +
Sbjct: 35 SKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN 94
Query: 73 EYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE- 131
+ + +K+ P + E L P + + + + + Y
Sbjct: 95 K-QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM--FMKFYSAHLFQNGSVLVGELYSY 151
Query: 132 GSVGDRIAQQR---GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ- 187
G++ + I + +P ++ + +++ I +H ++ ++KP N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211
Query: 188 ----------LVLGDFGIPYLLLGRSLSDSDMAL--RLGTPNYMAPEQWEPEVRGPISFE 235
L L D G + L + T + E + P +++
Sbjct: 212 QDDEDDLSAGLALIDLG---QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK---PWNYQ 265
Query: 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
D +G ++ ML G E + ++
Sbjct: 266 IDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 30/302 (9%)
Query: 20 EGDPDHLRTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELA 78
+ V+ W ++ L L +IGRG FG+V+ + +A
Sbjct: 90 QPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR------ADNTLVA 143
Query: 79 VKMLLPLKEDCAKVFVNKF-EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSV 134
VK +E KF +E + ++ ++ L G+ I I M+ + G
Sbjct: 144 VKS---CRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 135 GDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194
+ + G +L + +L+ A G+ L S + +L N L++E + L + DFG
Sbjct: 200 LTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258
Query: 195 IPYLLLGRSLSDSDMALRLGTPNY----MAPEQWEPEVRGPISFETDTWGFGCSIMEMLT 250
+ R +D A G APE G S E+D W FG + E +
Sbjct: 259 -----MSREEADGVYAASGGLRQVPVKWTAPEAL---NYGRYSSESDVWSFGILLWETFS 310
Query: 251 -GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
G P+ S ++ V PC P P AV ++ C+ Y+ RP + I
Sbjct: 311 LGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
Query: 310 ES 311
+S
Sbjct: 370 QS 371
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 55/276 (19%), Positives = 103/276 (37%), Gaps = 50/276 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
++K I G G ++LA + +K L+ +
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGR-----PVVLKGLVHSGDA---EAQAMAM------A 128
Query: 106 ESQSVCWL-------------HGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDIL 152
E Q + + H + I M++ G + + +G KLP+ + +
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQKLPVAEAI 185
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
Y +++ +S LHSIGL+ +LKP N++L+E +QL L D G ++
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGA-----VSRINSFGYL-- 237
Query: 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
GTP + APE VR + TD + G ++ + + G+ V+ +
Sbjct: 238 YGTPGFQAPEI----VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------P 285
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHA 308
+ + ++ + D R R A+ + A
Sbjct: 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 55/311 (17%), Positives = 110/311 (35%), Gaps = 51/311 (16%)
Query: 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
++ L+ IG+G FG+VW E+AVK+ +E + +
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGE--------EVAVKIFSSREERS---WFREA 85
Query: 98 EELFPKFRESQSVCWLHGISVING----KICIAMKFYE-GSVGDRIAQQRGGKLPLPDIL 152
E +++ + ++ + ++E GS+ D + + + + ++
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMI 142
Query: 153 RYGIQLAKGISDLHSIGLLVL--------NLKPSNLLLSEHDQLVLGDFGIPYLLL-GRS 203
+ + A G++ LH + +LK N+L+ ++ + D G+
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPI--SFE-TDTWGFGCSIMEMLTGIQ------- 253
D R+GT YMAPE + + SF+ D + G E+
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 254 ---PWFGK-----SVEEIYHSVVIKKEKPCIPSGL-----PPAVENVIIGCFEYDLRNRP 300
P++ SVEE+ V +K +P IP+ + ++ C+ + R
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 301 LMADILHAFES 311
I
Sbjct: 323 TALRIKKTLSQ 333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 55/325 (16%), Positives = 109/325 (33%), Gaps = 70/325 (21%)
Query: 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
+++ +IG+G +G+VW+ ++AVK VF
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGE--------KVAVK-----------VFFTTE 72
Query: 98 EELFPKFRESQSVCWLH------------GISVINGKICIAMKFYE-GSVGDRIAQQRGG 144
E + + E + + ++ + ++E GS+ D +
Sbjct: 73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--- 129
Query: 145 KLPLPDILRYGIQLAKGISDLHSIGLLVLN--------LKPSNLLLSEHDQLVLGDFGIP 196
L +L+ G+ LH+ LK N+L+ ++ + D G+
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 197 YLLL-GRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFE-TDTWGFGCSIMEMLTGI 252
+ + D R+GT YM PE + + S+ D + FG + E+
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249
Query: 253 ----------QPWFGK-----SVEEIYHSVVIKKEKPCIPSGL-----PPAVENVIIGCF 292
P+ S E++ V IKK +P P+ + ++ C+
Sbjct: 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309
Query: 293 EYDLRNRPLMADI---LHAFESSQN 314
++ +R + L SQ+
Sbjct: 310 AHNPASRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 56/305 (18%), Positives = 113/305 (37%), Gaps = 53/305 (17%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE-ELFPK 103
+ L +G+G +G+VW + +AVK+ E + + E
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGE--------NVAVKIFSSRDEKS---WFRETELYNTVM 58
Query: 104 FRESQSVCWLHGISVING----KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQL 158
R +++ + + ++ + ++E GS+ D + L LR + +
Sbjct: 59 LR-HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSI 114
Query: 159 AKGISDLHSIGLLVLN--------LKPSNLLLSEHDQLVLGDFGIPYLL-LGRSLSDSDM 209
A G++ LH LK N+L+ ++ Q + D G+ + + D
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 210 ALRLGTPNYMAPEQWE--PEVRGPISFE-TDTWGFGCSIMEMLTGI----------QPWF 256
R+GT YMAPE + +V S++ D W FG + E+ + P++
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 257 GK-----SVEEIYHSVVIKKEKPCIPSGL-----PPAVENVIIGCFEYDLRNRPLMADIL 306
S E++ V + +++P IP+ ++ ++ C+ + R I
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 307 HAFES 311
Sbjct: 295 KTLTK 299
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 78/324 (24%), Positives = 138/324 (42%), Gaps = 65/324 (20%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP-LKEDCAKVFVNKFEELFPKF 104
+L +G G +V LA D ++ ++AVK+L L D F +F
Sbjct: 15 ELGEILGFGGMSEVHLAR------DLRDHRDVAVKVLRADLARD--PSFYLRFR------ 60
Query: 105 RESQSVCWLH----------GISVINGKIC--IAMKFYEG-SVGDRIAQQRGGKLPLPDI 151
RE+Q+ L+ G + I M++ +G ++ D + G +
Sbjct: 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRA 118
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
+ + ++ H G++ ++KP+N+++S + + + DFGI R+++DS ++
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-----ARAIADSGNSV 173
Query: 212 R-----LGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIY 264
+GT Y++PEQ RG + +D + GC + E+LTG P+ G S V
Sbjct: 174 TQTAAVIGTAQYLSPEQ----ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---- 225
Query: 265 HSVVIK--KEKPCIPS----GLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQ 313
SV + +E P PS GL ++ V++ + NR + AD++
Sbjct: 226 -SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
Query: 314 N---AVYNDGEWTGLGSRALTDTS 334
V D E T L S A + S
Sbjct: 285 PEAPKVLTDAERTSLLSSAAGNLS 308
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/259 (18%), Positives = 93/259 (35%), Gaps = 17/259 (6%)
Query: 60 WLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119
WL T + + + L + + + + +++ S
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD-ILRYGIQLAKGISDLHSIGLLVLNLKP 177
+ I M+ ++ D + ++ + L IQ+A+ + LHS GL+ +LKP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 178 SNLLLSEHDQLVLGDFGI---------PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV 228
SN+ + D + +GDFG+ +L + + ++GT YM+PEQ
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH--- 249
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVI 288
S + D + G + E+L + I V + P + + P ++
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVR-NLKFPLLFTQKYPQEHMMV 306
Query: 289 IGCFEYDLRNRPLMADILH 307
RP DI+
Sbjct: 307 QDMLSPSPTERPEATDIIE 325
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 20/272 (7%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
K +G G G + + ++AVK +LP A + +L +
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDN-------RDVAVKRILPECFSFAD----REVQLLRESD 75
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
E +V IA++ ++ + + +Q+ + + Q G++ L
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 166 HSIGLLVLNLKPSNLLLSEHDQ-----LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
HS+ ++ +LKP N+L+S + ++ DFG+ L S S + GT ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK--EKPCIPS 278
PE + + ++ D + GC +++ FGKS++ + ++ +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+I D + RP +L H F
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 53/255 (20%), Positives = 92/255 (36%), Gaps = 49/255 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
++K R+G G FG V H + ++A+K C + K E +
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTG------EQVAIKQ-------CRQELSPKNRERW--CL 61
Query: 106 ESQSVCWLHGIS-----------------VINGKICIAMKFYE-GSVGDRIAQ-QRGGKL 146
E Q + ++ N +AM++ E G + + Q + L
Sbjct: 62 EIQ---IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118
Query: 147 PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV---LGDFGIPYLLLGRS 203
I ++ + LH ++ +LKP N++L Q + + D G +
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG-----YAKE 173
Query: 204 LSDSDMAL-RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262
L ++ +GT Y+APE E + D W FG E +TG +P+
Sbjct: 174 LDQGELCTEFVGTLQYLAPELLEQKKYTV---TVDYWSFGTLAFECITGFRPFLPNWQPV 230
Query: 263 IYHSVVIKKEKPCIP 277
+H V +K I
Sbjct: 231 QWHGKVREKSNEHIV 245
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 56/310 (18%), Positives = 109/310 (35%), Gaps = 53/310 (17%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
L+L RG FG VW A +AVK+ + + N++E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNE--------YVAVKIFPIQDKQS---WQNEYEV 69
Query: 99 ELFPKFRESQSVCWL---HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRY 154
P + + ++ + ++ + + F+E GS+ D + + + ++
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHI 126
Query: 155 GIQLAKGISDLHSIGLLVLN----------LKPSNLLLSEHDQLVLGDFGIPYLLLGRSL 204
+A+G++ LH + + +K N+LL + + DFG+ L
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFEAGK 185
Query: 205 SDSDMALRLGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---- 258
S D ++GT YMAPE + + D + G + E+ + G
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 259 ------------SVEEIYHSVVIKKEKPCIPSGLPP-----AVENVIIGCFEYDLRNRPL 301
S+E++ VV KK++P + + I C+++D R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 302 MADILHAFES 311
+
Sbjct: 306 AGCVGERITQ 315
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 39/271 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS- 109
+G+G FG+V+LA QS LA+K+L A++ E + E QS
Sbjct: 17 LGKGKFGNVYLAREKQSK------FILALKVL-----FKAQLEKAGVEHQLRREVEIQSH 65
Query: 110 -----VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+ L+G ++ + +++ G+V + Q+ K Y +LA +S
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 123
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPNYM 219
HS ++ ++KP NLLL +L + DFG S + R GT +Y+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFG---------WSVHAPSSRRTDLCGTLDYL 174
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279
PE E + + D W G E L G P+ + +E Y I + + P
Sbjct: 175 PPEMIEGRMHDE---KVDLWSLGVLCYEFLVGKPPFEANTYQETYKR--ISRVEFTFPDF 229
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ ++I +++ RP++ ++L H +
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 54/328 (16%), Positives = 101/328 (30%), Gaps = 78/328 (23%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
+D +LKL IGRG +G V+ + + +AV KVF +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDER--------PVAV-----------KVFSFANRQ 50
Query: 100 LFPKFRESQSVCWLH-------------GISVINGKICIAMKFYE-GSVGDRIAQQRGGK 145
F + V + + + + M++Y GS+ ++
Sbjct: 51 NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---T 107
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLN---------LKPSNLLLSEHDQLVLGDFGI- 195
R + +G++ LH+ + L N+L+ V+ DFG+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 196 ----PYLLLGRSLSDSDMALRLGTPNYMAPE----QWEPEVRGPISFETDTWGFGCSIME 247
L+ D+ +GT YMAPE + D + G E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 248 MLTGIQ-------------PWFGK-----SVEEIYHSVVIKKEKPCIP------SGLPPA 283
+ + + + E++ V +K++P P S +
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 284 VENVIIGCFEYDLRNRPLMADILHAFES 311
++ I C++ D R
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 64/273 (23%), Positives = 107/273 (39%), Gaps = 41/273 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-- 108
+G+G F + + + A K++ + + E E
Sbjct: 23 LGKGGFAKCFEISDADTK------EVFAGKIV-----PKSLLLKPHQREKM--SMEISIH 69
Query: 109 ------SVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
V HG N + + ++ S+ + ++ L P+ Y Q+ G
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPN 217
LH ++ +LK NL L+E ++ +GDFG L + D + R GTPN
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGE---RKKVLCGTPN 180
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277
Y+APE + SFE D W GC + +L G P+ ++E Y IKK + IP
Sbjct: 181 YIAPEVLS---KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--IKKNEYSIP 235
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ P ++I + D RP + ++L F
Sbjct: 236 KHINPVAASLIQKMLQTDPTARPTINELLNDEF 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 40/286 (13%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W IDP+ L IG G FG V L + ++A+K ++E F
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGY-------WLNKDKVAIKT---IREGAMS--EEDF 50
Query: 98 -EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
EE + K + V L+G+ + IC+ +F E G + D + + + G +L
Sbjct: 51 IEEAEVMMKLSHPKLVQ-LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLG 108
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ + +G++ L ++ +L N L+ E+ + + DFG + R + D
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG-----MTRFVLDDQYTSST 163
Query: 214 GTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269
GT P +W PEV S ++D W FG + E+ + G P+ +S E+ +
Sbjct: 164 GT---KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-- 218
Query: 270 KKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P V ++ C+ +RP + +L
Sbjct: 219 --STGFRLYK-PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 62/305 (20%), Positives = 113/305 (37%), Gaps = 59/305 (19%)
Query: 33 PTQT-RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
P Q + T K +G G FG V+ + +A+K L+E +
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIP--EGEKVKIPVAIKE---LREATSP 58
Query: 92 VFVNKFEELFPKFRESQS--------VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR 142
+ E+ VC L GI + + + + G + D + ++
Sbjct: 59 KANKEI------LDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REH 110
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
+ +L + +Q+AKG++ L L+ +L N+L+ + + DFG L +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-----LAK 165
Query: 203 SLSDSDMALRLGTPNYMA-----PEQW-EPEVRGPISF-----ETDTWGFGCSIMEMLT- 250
L + Y A P +W E I ++D W +G ++ E++T
Sbjct: 166 LLGAEEKE-------YHAEGGKVPIKWMALES---ILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 251 GIQPWFGKSVEEIYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
G +P+ G EI + EK P P V ++ C+ D +RP +++
Sbjct: 216 GSKPYDGIPASEISSIL----EKGERLPQ-PPICTIDVYMIMRKCWMIDADSRPKFRELI 270
Query: 307 HAFES 311
F
Sbjct: 271 IEFSK 275
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 44/304 (14%)
Query: 23 PDHLRTVVATPTQTRPWIDPTSLK---LKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
P +DP S + +G+G F + + + A
Sbjct: 18 PGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK------EVFAG 71
Query: 80 KMLLPLKEDCAKVFVNKFEELFPKFRESQ--------SVCWLHGISVINGKICIAMKFYE 131
K++ + + E E V HG N + + ++
Sbjct: 72 KIV-----PKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 132 -GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190
S+ + ++ L P+ Y Q+ G LH ++ +LK NL L+E ++ +
Sbjct: 125 RRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 191 GDFGIPYLLLGRSLSDSDMALRL----GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIM 246
GDFG L + D + R GTPNY+APE + SFE D W GC +
Sbjct: 183 GDFG----LATKVEYDGE---RKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCIMY 232
Query: 247 EMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
+L G P+ ++E Y IKK + IP + P ++I + D RP + ++L
Sbjct: 233 TLLVGKPPFETSCLKETYLR--IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290
Query: 307 -HAF 309
F
Sbjct: 291 NDEF 294
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 58/283 (20%), Positives = 104/283 (36%), Gaps = 34/283 (12%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
+ + L +G G FG V L + +++AVKM +KE ++F
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGK-------WKGQYDVAVKM---IKEGSMS--EDEF 50
Query: 98 -EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIA--QQRGGKLPLPDIL 152
+E K + V +G+ I I ++ G + + G L +L
Sbjct: 51 FQEAQTMMKLSHPKLVK-FYGVCSKEYPIYIVTEYISN--GCLLNYLRSHGKGLEPSQLL 107
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
+ +G++ L S + +L N L+ + + DFG + R + D
Sbjct: 108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG-----MTRYVLDDQYVSS 162
Query: 213 LGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268
+GT P +W PEV S ++D W FG + E+ + G P+ + E+ V
Sbjct: 163 VGT---KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P + ++ C+ RP +L + E
Sbjct: 220 QGHRLYR-PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 56/270 (20%), Positives = 102/270 (37%), Gaps = 42/270 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS- 109
+G+G FG+V+LA Q+ +A+K+L +++ E + E QS
Sbjct: 22 LGKGKFGNVYLAREKQNK------FIMALKVL-----FKSQLEKEGVEHQLRREIEIQSH 70
Query: 110 -----VCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQLAKG 161
+ ++ +I + ++F G + Q+ G+ + +LA
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPR--GELYKEL--QKHGRFDEQRSATFMEELADA 126
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----GTPN 217
+ H ++ ++KP NLL+ +L + DFG S +LR GT +
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFG---------WSVHAPSLRRRTMCGTLD 177
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277
Y+ PE E + + D W G E L G+ P+ S E + I P
Sbjct: 178 YLPPEMIEGKTHDE---KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR--IVNVDLKFP 232
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307
L +++I Y R + ++
Sbjct: 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 8e-21
Identities = 55/262 (20%), Positives = 97/262 (37%), Gaps = 35/262 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE-------LFPK 103
IGRG FG+V+ + + A+K L D ++ + + E +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMY------AMKCL-----DKKRIKMKQGETLALNERIMLSL 245
Query: 104 FRESQS--VCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAK 160
+ + K+ + G GD + G D+ Y ++
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
G+ +H+ ++ +LKP+N+LL EH + + D G L S +GT YMA
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG-----LACDFSKKKPHASVGTHGYMA 358
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG---KSVEEIYHSVVIKKEKPCIP 277
PE + V D + GC + ++L G P+ K EI +P
Sbjct: 359 PEVLQKGV--AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELP 414
Query: 278 SGLPPAVENVIIGCFEYDLRNR 299
P + +++ G + D+ R
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRR 436
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 45/291 (15%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
+ I + L +G G FG+V+ + + E +AVK K+DC KF
Sbjct: 7 YGIAREDVVLNRILGEGFFGEVYEGVYT---NHKGEKINVAVKT---CKKDCTLDNKEKF 60
Query: 98 -EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
E + V L GI + I M+ Y G +G + ++ L + ++
Sbjct: 61 MSEAVIMKNLDHPHIVK-LIGI-IEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL 117
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Y +Q+ K ++ L SI + ++ N+L++ + + LGDFG L R + D D
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG-----LSRYIEDEDYYKAS 172
Query: 214 GT--P-NYMAPEQWEPEVRGPISF-----ETDTWGFGCSIMEMLT-GIQPWFGKSVEEIY 264
T P +M+PE I+F +D W F + E+L+ G QP+F +++
Sbjct: 173 VTRLPIKWMSPES--------INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224
Query: 265 HSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ EK P P PP + ++ C++YD +RP +++ +
Sbjct: 225 GVL----EKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 53/301 (17%), Positives = 102/301 (33%), Gaps = 42/301 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYH-ELAVKMLLPLKEDCAKVFVNKFE 98
I L +G+G F ++ + D + E+ +K+L + ++ F FE
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FE 61
Query: 99 E--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
+ K V +G+ V + + +F + GS+ + ++ + + L
Sbjct: 62 AASMMSKLSHKHLVL-NYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVA 119
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV--------LGDFGIPYLLLGRSLSDS 207
QLA + L L+ N+ N+LL + L D G + ++
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG-----ISITVLPK 174
Query: 208 DMALRLGTPNYMAPEQW-EPEV---RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEE 262
D+ W PE ++ TD W FG ++ E+ + G +P +
Sbjct: 175 DI--------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 263 IYHSVVIKK--EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320
+ P + N+I C +Y+ +RP I+ S
Sbjct: 227 KLQFYEDRHQLPAPK-----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281
Query: 321 E 321
Sbjct: 282 G 282
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 36/297 (12%)
Query: 33 PTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
P Q+ I L+L ++G G FG V + + +AVK L P +
Sbjct: 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS---GKTVSVAVKCLKPDVLSQPE 63
Query: 92 VFVNKFEE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPL 148
+ E + L+G+ V+ + + + GS+ DR+ ++ G L
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIR-LYGV-VLTPPMKMVTELAPLGSLLDRL-RKHQGHFLL 120
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD 208
+ RY +Q+A+G+ L S + +L NLLL+ D + +GDFG L R+L +D
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG-----LMRALPQND 175
Query: 209 MALRLGTPN-----YMAPEQWEPEVRGPISFET-----DTWGFGCSIMEMLT-GIQPWFG 257
+ + APE + T DTW FG ++ EM T G +PW G
Sbjct: 176 DHYVMQEHRKVPFAWCAPES--------LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
Query: 258 KSVEEIYHSVVIKKEK-PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313
+ +I H + + E+ P P P + NV++ C+ + +RP + +Q
Sbjct: 228 LNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 37/295 (12%)
Query: 31 ATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC 89
A + TR + I ++L IG G FGDV + + +A+K K
Sbjct: 2 AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYM---SPENPALAVAIKT---CKNCT 55
Query: 90 AKVFVNKF-EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGK 145
+ KF +E +F V L G+ + + I M+ G + + Q R
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVK-LIGV-ITENPVWIIMELCTLGELRSFL-QVRKYS 112
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L L ++ Y QL+ ++ L S + ++ N+L+S +D + LGDFG L R +
Sbjct: 113 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG-----LSRYME 167
Query: 206 DSDMALRLGT--P-NYMAPEQWEPEVRGPISF-----ETDTWGFGCSIMEMLT-GIQPWF 256
DS P +MAPE I+F +D W FG + E+L G++P+
Sbjct: 168 DSTYYKASKGKLPIKWMAPES--------INFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219
Query: 257 GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
G ++ + + P P PP + +++ C+ YD RP ++ +
Sbjct: 220 GVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 62/326 (19%), Positives = 112/326 (34%), Gaps = 51/326 (15%)
Query: 33 PTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
+ T L+ +G G FG V + + +K+ +++ +
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGE--SIKIPVCIKV---IEDKSGR 56
Query: 92 VFVNKFEELFPKFRESQS--------VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR 142
+ + L G+ + + ++ GS+ D + +Q
Sbjct: 57 QSFQAV------TDHMLAIGSLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHV-RQH 108
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
G L +L +G+Q+AKG+ L G++ NL N+LL Q+ + DFG +
Sbjct: 109 RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG-----VAD 163
Query: 203 SLSDSDMALRLGTPNYMAPEQW-EPEVRGPISFET-----DTWGFGCSIMEMLT-GIQPW 255
L D L P +W E I F D W +G ++ E++T G +P+
Sbjct: 164 LLPPDDKQLL--YSEAKTPIKWMALES---IHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218
Query: 256 FGKSVEEIYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
G + E+ + EK P V V++ C+ D RP ++ + F
Sbjct: 219 AGLRLAEVPDLL----EKGERLAQ-PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273
Query: 312 --SQNAVYNDGEWTGLGSRALTDTSS 335
Y + A
Sbjct: 274 MARDPPRYLVIKRESGPGIAPGPEPH 299
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 30/293 (10%)
Query: 28 TVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK 86
T+ W ++ T + +KH++G G +G+V+ +AVK LK
Sbjct: 204 TIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK------KYSLTVAVKT---LK 254
Query: 87 EDCAKVFVNKF-EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR 142
ED + V +F +E + + + V L G+ I +F G++ D + +
Sbjct: 255 EDTME--VEEFLKEAAVMKEIKHPNLVQ-LLGVCTREPPFYIITEFMTYGNLLDYLRECN 311
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
++ +L Q++ + L + NL N L+ E+ + + DFG L R
Sbjct: 312 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG-----LSR 366
Query: 203 SLSDSDMALRLGTPNYMAPEQWE-PEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258
++ G P +W PE S ++D W FG + E+ T G+ P+ G
Sbjct: 367 LMTGDTYTAHAGA---KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ ++Y + P G P V ++ C++++ +RP A+I AFE+
Sbjct: 424 DLSQVYELLEKDYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 68/283 (24%), Positives = 126/283 (44%), Gaps = 32/283 (11%)
Query: 38 PW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
W I SL+L+ ++G+G FG+VW+ T ++ +A+K LK +
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGT-------WNGTTRVAIKT---LKPGT--MSPEA 225
Query: 97 F---EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDIL 152
F ++ K R + V L+ + V I I ++ GS+ D + + G L LP ++
Sbjct: 226 FLQEAQVMKKLRHEKLVQ-LYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 283
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
Q+A G++ + + + +L+ +N+L+ E+ + DFG L R + D++ R
Sbjct: 284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG-----LARLIEDNEYTAR 338
Query: 213 LGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268
G P +W PE G + ++D W FG + E+ T G P+ G E+ V
Sbjct: 339 QGA---KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-V 394
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ + P P ++ +++ C+ + RP + E
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 62/333 (18%), Positives = 128/333 (38%), Gaps = 46/333 (13%)
Query: 8 HKPAASFEYELFEGDPDHLRTVVATPTQTR-PW-IDPTSLKLKHRIGRGPFGDVWLATHH 65
+ +Y++ + + + + + + R P + LK ++G+G FG V + +
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYD 63
Query: 66 QSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGK 122
D+ E +AVK L+ + + FE E+ + ++ G+ G+
Sbjct: 64 PLQDNTGE--VVAVKK---LQHSTEEH-LRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 116
Query: 123 --ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179
+ + M++ GS+ D + Q+ ++ +L+Y Q+ KG+ L + + +L N
Sbjct: 117 RNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175
Query: 180 LLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN-----YMAPEQWEPEVRGPISF 234
+L+ +++ +GDFG L + L ++ P + AP E S
Sbjct: 176 ILVENENRVKIGDFG-----LTKVLPQDKEYYKVKEPGESPIFWYAP---ESLTESKFSV 227
Query: 235 ETDTWGFGCSIMEMLT----------------GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+D W FG + E+ T G V + + P P
Sbjct: 228 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PD 286
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
G P + ++ C+ ++ RP D+ +
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 4e-20
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 27/286 (9%)
Query: 35 QTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF 93
TR + I ++L IG G FGDV + + +A+K K +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYM---SPENPAMAVAIKT---CKNCTSDSV 434
Query: 94 VNKF-EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLP 149
KF +E +F V L G+ + + I M+ G + + Q R L L
Sbjct: 435 REKFLQEALTMRQFDHPHIVK-LIGV-ITENPVWIIMELCTLGELRSFL-QVRKFSLDLA 491
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
++ Y QL+ ++ L S + ++ N+L+S +D + LGDFG L R + DS
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG-----LSRYMEDSTY 546
Query: 210 ALRLGT--P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYH 265
P +MAPE + +D W FG + E+L G++P+ G ++
Sbjct: 547 YKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
Query: 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ + P P PP + +++ C+ YD RP ++ +
Sbjct: 604 RIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 58/282 (20%), Positives = 106/282 (37%), Gaps = 32/282 (11%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W IDP L +G G FG V + +++A+KM +KE ++F
Sbjct: 19 WEIDPKDLTFLKELGTGQFGVVKYGK-------WRGQYDVAIKM---IKEGSMS--EDEF 66
Query: 98 -EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
EE + + V L+G+ I I ++ G + + + ++ + +L
Sbjct: 67 IEEAKVMMNLSHEKLVQ-LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLE 124
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ + + L S L +L N L+++ + + DFG L R + D + +
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG-----LSRYVLDDEYTSSV 179
Query: 214 GTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269
G+ P +W PEV S ++D W FG + E+ + G P+ + E +
Sbjct: 180 GS---KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P V ++ C+ RP +L
Sbjct: 237 GLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 34/285 (11%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFE 98
+ L+ +GRG +G V H S +AVK + + K +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSG------QIMAVKRIRATVNSQEQKRLLM--- 54
Query: 99 ELFPKFRESQS--VCWLHGISVINGKICIAMKFYEGSVGD--RIAQQRGGKLPLPDILRY 154
+L R +G G + I M+ + S+ + +G +P + +
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 155 GIQLAKGISDLHSIGLLVLN-----LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
+ + K + LHS L+ +KPSN+L++ Q+ + DFGI L D +
Sbjct: 115 AVSIVKALEHLHS----KLSVIHRDVKPSNVLINALGQVKMCDFGI-----SGYLVDD-V 164
Query: 210 ALR--LGTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266
A G YMAPE+ PE+ S ++D W G +++E+ P+
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
Query: 267 VVIKKEKPCIPSGL-PPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
V+++ P +P+ + C + + + RP +++ H F
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-20
Identities = 68/283 (24%), Positives = 126/283 (44%), Gaps = 32/283 (11%)
Query: 38 PW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
W I SL+L+ ++G+G FG+VW+ T + + +A+K LK +
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKT---LKPGT--MSPEA 308
Query: 97 F---EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDIL 152
F ++ K R + V L+ + V I I ++ GS+ D + + G L LP ++
Sbjct: 309 FLQEAQVMKKLRHEKLVQ-LYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 366
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212
Q+A G++ + + + +L+ +N+L+ E+ + DFG L R + D++ R
Sbjct: 367 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG-----LARLIEDNEYTAR 421
Query: 213 LGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268
G P +W PE G + ++D W FG + E+ T G P+ G E+ V
Sbjct: 422 QGA---KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ + P P ++ +++ C+ + RP + E
Sbjct: 479 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 60/253 (23%), Positives = 102/253 (40%), Gaps = 26/253 (10%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKEDCAKVFVNKFEELFPKFRE 106
IGRG F +V + Q+ + A+K++ + + + + E +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVY------AMKIMNKWDMLKRGEVSCFRE---ERDVLVNGD 119
Query: 107 SQSVCWLHGISVINGKICIAMKFYEGSVGD--RIAQQRGGKLPLPDILRYGIQLAKGISD 164
+ + LH + + M++Y G GD + + G ++P Y ++ I
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVG--GDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 165 LHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE-- 222
+H +G + ++KP N+LL + L DFG L S +A+ GTP+Y++PE
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV--GTPDYLSPEIL 235
Query: 223 --QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK---PCIP 277
G E D W G EM G P++ S E Y +V KE P +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295
Query: 278 SGLPPAVENVIIG 290
G+P + I
Sbjct: 296 EGVPEEARDFIQR 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 49/276 (17%), Positives = 94/276 (34%), Gaps = 51/276 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
L +G+G +V+ H ++ A+K+ + + ++ R
Sbjct: 12 LLSDILGQGATANVFRGRHKKTG------DLFAIKV-------FNNISFLRPVDVQ--MR 56
Query: 106 ESQ--------SVCWLHGI--SVINGKICIAMKFYE-GSVGDRIAQ-QRGGKLPLPDILR 153
E + ++ L I + M+F GS+ + + LP + L
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLS----EHDQLVLGDFGIPYLLLGRSLSDSD- 208
+ G++ L G++ N+KP N++ L DFG R L D +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG-----AARELEDDEQ 171
Query: 209 MALRLGTPNYMAPE-----QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF----GKS 259
GT Y+ P+ + + D W G + TG P+ +
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYD 295
+E+ + ++ K PSG V+ G ++
Sbjct: 232 NKEVMYKIITGK-----PSGAISGVQKAENGPIDWS 262
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 60/302 (19%), Positives = 116/302 (38%), Gaps = 45/302 (14%)
Query: 38 PW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
P + LK ++G+G FG V + + D+ E +AVK L+ + +
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE--VVAVKK---LQHSTEEH-LRD 57
Query: 97 FE---ELFPKFRESQSVCWLHGISVINGK--ICIAMKFYE-GSVGDRIAQQRGGKLPLPD 150
FE E+ + ++ G+ G+ + + M++ GS+ D + Q+ ++
Sbjct: 58 FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIK 115
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
+L+Y Q+ KG+ L + + +L N+L+ +++ +GDFG L + L
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG-----LTKVLPQDKEF 170
Query: 211 LRLGTPN-----YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT--------------- 250
++ P + AP E S +D W FG + E+ T
Sbjct: 171 FKVKEPGESPIFWYAP---ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
Query: 251 -GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
G V + + P P G P + ++ C+ ++ RP D+
Sbjct: 228 IGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 310 ES 311
+
Sbjct: 287 DQ 288
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 59/297 (19%), Positives = 112/297 (37%), Gaps = 43/297 (14%)
Query: 33 PTQT-RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
P Q + T K +G G FG V+ + +A+K L+E +
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIP--EGEKVKIPVAIKE---LREATSP 58
Query: 92 VFVNKFEELFPKFRESQS--------VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQR 142
+ E+ VC L GI + + + + G + D + ++
Sbjct: 59 KANKEI------LDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REH 110
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
+ +L + +Q+AKG++ L L+ +L N+L+ + + DFG L +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-----LAK 165
Query: 203 SLSDSDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258
L + P +W E + ++D W +G ++ E++T G +P+ G
Sbjct: 166 LLGAEEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
Query: 259 SVEEIYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
EI + EK P P V +++ C+ D +RP +++ F
Sbjct: 224 PASEISSIL----EKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 33/261 (12%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK------VFVNK--FEELFP 102
IG+G FG V + + + + A+K + K+ C + VF + L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMY------AMKYMN--KQKCVERNEVRNVFKELQIMQGLEH 74
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGD-RIAQQRGGKLPLPDILRYGIQLAKG 161
F + L + + + G GD R Q+ + + +L
Sbjct: 75 PF-----LVNLWYSFQDEEDMFMVVDLLLG--GDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAP 221
+ L + ++ ++KP N+LL EH + + DF I +L + + MA GT YMAP
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MA---GTKPYMAP 183
Query: 222 EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---VEEIYHSVVIKKEKPCIPS 278
E + SF D W G + E+L G +P+ +S +EI H+ + PS
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPS 241
Query: 279 GLPPAVENVIIGCFEYDLRNR 299
+ +++ E + R
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQR 262
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 39/287 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFE 98
+ L+ +G G G VW ++ H +AVK M ++ K +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTG------HVIAVKQMRRSGNKEENKRILM--- 72
Query: 99 ELFPKFRESQS--VCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI 156
+L + + G + N + IAM+ +++ ++ G +P + + +
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTV 131
Query: 157 QLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR--L 213
+ K + L G++ ++KPSN+LL E Q+ L DFGI L D A
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI-----SGRLVDD-KAKDRSA 185
Query: 214 GTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV---- 267
G YMAPE + D W G S++E+ TG P+ +
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN------CKTDFEVL 239
Query: 268 --VIKKEKPCIPSGL--PPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
V+++E P +P + ++ + C D R RP +L H+F
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 50/264 (18%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
IGRG FG+V + + F A+K+L NK+E L + +++
Sbjct: 82 IGRGAFGEVAVVKLKNADKVF------AMKIL------------NKWEML----KRAETA 119
Query: 111 C--------------W---LHGISVINGKICIAMKFYEGSVGD--RIAQQRGGKLPLPDI 151
C W LH + + + M +Y G GD + + +LP
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG--GDLLTLLSKFEDRLPEEMA 177
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
Y ++ I +H + + ++KP N+L+ + + L DFG L+ S +A+
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 212 RLGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269
GTP+Y++PE Q +G E D W G + EML G P++ +S+ E Y ++
Sbjct: 238 --GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
Query: 270 KKEK---PCIPSGLPPAVENVIIG 290
KE+ P + + +++I
Sbjct: 296 HKERFQFPTQVTDVSENAKDLIRR 319
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 60/265 (22%), Positives = 96/265 (36%), Gaps = 41/265 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--------EDCAKVFVNKFEELFP 102
+G+G FG+V + + A K L K E A E++
Sbjct: 192 LGKGGFGEVCACQVRATGKMY------ACKKLE--KKRIKKRKGEAMALNEKQILEKVNS 243
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLA 159
+F V L +C+ + G GD I P + Y ++
Sbjct: 244 RF-----VVSLAYAYETKDALCLVLTLMNG--GDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL-RLGTPNY 218
G+ DLH ++ +LKP N+LL +H + + D G L + + R+GT Y
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG-----LAVHVPEGQTIKGRVGTVGY 351
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK----SVEEIYHSVVIKKEKP 274
MAPE + E +F D W GC + EM+ G P+ + EE+ +K+
Sbjct: 352 MAPEVVKNE---RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKEVPE 406
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNR 299
P ++ D R
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAER 431
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 37/261 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML-----LPLKE-DCAK----VFVNKFEEL 100
+G+G FG V+LA ++ F A+K L L + +C V +E
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFF------AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 101 FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLA 159
F + + + M++ G GD + Q K L Y ++
Sbjct: 79 F--------LTHMFCTFQTKENLFFVMEYLNG--GDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNY 218
G+ LHS G++ +LK N+LL + + + DFG + ++ GTP+Y
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG----MCKENMLGDAKTNTFCGTPDY 184
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+APE + + D W FG + EML G P+ G+ EE++HS I+ + P P
Sbjct: 185 IAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--IRMDNPFYPR 239
Query: 279 GLPPAVENVIIGCFEYDLRNR 299
L +++++ F + R
Sbjct: 240 WLEKEAKDLLVKLFVREPEKR 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 71/297 (23%), Positives = 108/297 (36%), Gaps = 54/297 (18%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFE 98
LK IGRG +G V H S +AVK + + E K +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSG------QIMAVKRIRSTVDEKEQKQLLM--- 69
Query: 99 ELFPKFRESQS--VCWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILR 153
+L R S + +G G I M+ S + +P + +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 154 YGIQLAKGISDLHSIGLLVLNL-----KPSNLLLSEHDQLVLGDFGIPYLLLGRS--LSD 206
+ K ++ L L + KPSN+LL + L DFGI S L D
Sbjct: 130 ITLATVKALNHLKE----NLKIIHRDIKPSNILLDRSGNIKLCDFGI-------SGQLVD 178
Query: 207 SDMALR--LGTPNYMAPEQWEPEVRGPI-SFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263
S +A G YMAPE+ +P +D W G ++ E+ TG P+
Sbjct: 179 S-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK------ 231
Query: 264 YHSV------VIKKEKPCIPSGLP----PAVENVIIGCFEYDLRNRPLMADIL-HAF 309
++SV V+K + P + + P+ N + C D RP ++L H F
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 3e-19
Identities = 62/275 (22%), Positives = 107/275 (38%), Gaps = 25/275 (9%)
Query: 31 ATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLK 86
R + T +G+G FG V L+ + + + AVK+L +
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELY------AVKILKKDVVIQD 382
Query: 87 EDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGK 145
+D V K + + + LH ++ M++ G GD + Q+ G+
Sbjct: 383 DDVECTMVEK--RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG--GDLMYHIQQVGR 438
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
P + Y ++A G+ L S G++ +LK N++L + + DFG + ++
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIW 494
Query: 206 DSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
D GTP+Y+APE P D W FG + EML G P+ G+ +E++
Sbjct: 495 DGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
Query: 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
S I + P + + G R
Sbjct: 552 QS--IMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 49/276 (17%), Positives = 94/276 (34%), Gaps = 51/276 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
L +G+G +V+ H ++ A+K+ + + ++ R
Sbjct: 12 LLSDILGQGATANVFRGRHKKTG------DLFAIKV-------FNNISFLRPVDVQ--MR 56
Query: 106 E--------SQSVCWLHGI--SVINGKICIAMKFYE-GSVGDRIAQ-QRGGKLPLPDILR 153
E +++ L I + M+F GS+ + + LP + L
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLS----EHDQLVLGDFGIPYLLLGRSLSDSD- 208
+ G++ L G++ N+KP N++ L DFG R L D +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG-----AARELEDDEQ 171
Query: 209 MALRLGTPNYMAPE-----QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF----GKS 259
GT Y+ P+ + + D W G + TG P+ +
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYD 295
+E+ + ++ K PSG V+ G ++
Sbjct: 232 NKEVMYKIITGK-----PSGAISGVQKAENGPIDWS 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 67/289 (23%), Positives = 111/289 (38%), Gaps = 51/289 (17%)
Query: 30 VATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-----LP 84
+ + P P+ IG+G FG V LA H + AVK+L L
Sbjct: 25 INLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY------AVKVLQKKAILK 78
Query: 85 LKE-DCAK----VFVNKFE-----ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSV 134
KE V + + L F Q+ K+ + + G
Sbjct: 79 KKEEKHIMSERNVLLKNVKHPFLVGLHFSF---QT----------ADKLYFVLDYING-- 123
Query: 135 GD---RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191
G+ + QR P Y ++A + LHS+ ++ +LKP N+LL +VL
Sbjct: 124 GELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 181
Query: 192 DFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT 250
DFG L ++ + GTP Y+APE + P D W G + EML
Sbjct: 182 DFG----LCKENIEHNSTTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLY 234
Query: 251 GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
G+ P++ ++ E+Y + I + + + + +++ G + D R
Sbjct: 235 GLPPFYSRNTAEMYDN--ILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 67/314 (21%), Positives = 124/314 (39%), Gaps = 43/314 (13%)
Query: 25 HLRTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL 83
+ + T+ P + LK +G G FG V L + D+ E ++AVK
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGE--QVAVKS-- 57
Query: 84 PLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGK--ICIAMKFYE-GSVGDR 137
LK + + + E+ +++ GI +G I + M+F GS+ +
Sbjct: 58 -LKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 138 IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
+ + K+ L L+Y +Q+ KG+ L S + +L N+L+ Q+ +GDFG
Sbjct: 116 L-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG--- 171
Query: 198 LLLGRSLSDSDMALRLGTPN-----YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-- 250
L +++ + + APE + +D W FG ++ E+LT
Sbjct: 172 --LTKAIETDKEYYTVKDDRDSPVFWYAPECLM---QSKFYIASDVWSFGVTLHELLTYC 226
Query: 251 -------------GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLR 297
+V + +++ K PC P P V ++ C+E+
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPS 285
Query: 298 NRPLMADILHAFES 311
NR +++ FE+
Sbjct: 286 NRTSFQNLIEGFEA 299
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 55/285 (19%), Positives = 105/285 (36%), Gaps = 25/285 (8%)
Query: 21 GDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK 80
G + + + + + + +G+G FG V LA ++ D + AVK
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLY------AVK 54
Query: 81 ML----LPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD 136
+L + +D K + R + L ++ M+F G GD
Sbjct: 55 VLKKDVILQDDDVECTMTEK--RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG--GD 110
Query: 137 RIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195
+ Q+ + Y ++ + LH G++ +LK N+LL L DFG
Sbjct: 111 LMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG- 169
Query: 196 PYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+ + + GTP+Y+APE + D W G + EML G P
Sbjct: 170 ---MCKEGICNGVTTATFCGTPDYIAPEILQ---EMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 255 WFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ ++ ++++ + I ++ P+ L ++ + R
Sbjct: 224 FEAENEDDLFEA--ILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 6e-19
Identities = 59/288 (20%), Positives = 112/288 (38%), Gaps = 46/288 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-- 108
+G+G F V+ A + E+A+KM+ D ++ + E +
Sbjct: 19 LGKGSFAGVYRAESIHTG------LEVAIKMI-----DKKAMYKAGMVQRV--QNEVKIH 65
Query: 109 ------SVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
S+ L+ + + + ++ G + + + R + + Q+ G
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITG 124
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS---DSDMALRL---GT 215
+ LHS G+L +L SNLLL+ + + + DFG L+ GT
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG---------LATQLKMPHEKHYTLCGT 175
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275
PNY++PE R E+D W GC +L G P+ +V+ + +
Sbjct: 176 PNYISPEIAT---RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--VVLADYE 230
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF--ESSQNAVYNDG 320
+PS L +++I + +R ++ +L H F +S ++G
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 61/289 (21%), Positives = 119/289 (41%), Gaps = 25/289 (8%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFE 98
+ + +G G G V+ +H S +A K + L +K + + +
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSG------LVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 99 ELFPKFRESQS--VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
L E S + +G +G+I I M+ + GS+ + ++ G++P + +
Sbjct: 84 VL----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVS 137
Query: 156 IQLAKGISDLHSIGLLV-LNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
I + KG++ L ++ ++KPSN+L++ ++ L DFG+ L DS +G
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVG 192
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
T +YM+PE+ + S ++D W G S++EM G P +E+ + E
Sbjct: 193 TRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323
+ P + F D R + ++L + G ++
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 57/257 (22%), Positives = 99/257 (38%), Gaps = 30/257 (11%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML-----LPLKE-DCAKVFVNKFEELFPKF 104
+G+G FG V L + + A+K+L + E + F
Sbjct: 13 LGKGTFGKVILVREKATGRYY------AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGIS 163
+ L + ++C M++ G G+ R YG ++ +
Sbjct: 67 -----LTALKYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPE 222
LHS ++ ++K NL+L + + + DFG L +SD GTP Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFCGTPEYLAPE 175
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
E D WG G + EM+ G P++ + E ++ I E+ P L P
Sbjct: 176 VLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--ILMEEIRFPRTLSP 230
Query: 283 AVENVIIGCFEYDLRNR 299
++++ G + D + R
Sbjct: 231 EAKSLLAGLLKKDPKQR 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 30/282 (10%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W ++ T + +KH++G G +G+V+ +AVK LKED + V +F
Sbjct: 8 WEMERTDITMKHKLGGGQYGEVYEGVWK------KYSLTVAVKT---LKEDTME--VEEF 56
Query: 98 -EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
+E + + + V L G+ I +F G++ D + + ++ +L
Sbjct: 57 LKEAAVMKEIKHPNLVQ-LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
Q++ + L + +L N L+ E+ + + DFG L R ++
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG-----LSRLMTGDTYTAHA 170
Query: 214 GT--P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269
G P + APE S ++D W FG + E+ T G+ P+ G + ++Y +
Sbjct: 171 GAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P G P V ++ C++++ +RP A+I AFE+
Sbjct: 228 DYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 43/303 (14%)
Query: 26 LRTVVATPTQTRPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
L + +PW I SLKL+ ++G G FG+VW+AT ++++ ++AV
Sbjct: 165 LSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-------YNKHTKVAV 217
Query: 80 KMLLPLKEDCAKVFVNKF--EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGD 136
K +K V F E K + + LH + V I I +F GS+ D
Sbjct: 218 KT---MKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLD 271
Query: 137 RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196
+ G K PLP ++ + Q+A+G++ + + +L+ +N+L+S + DFG
Sbjct: 272 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG-- 329
Query: 197 YLLLGRSLSDSDMALRLGT--P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GI 252
L R + D++ R G P + APE G + ++D W FG +ME++T G
Sbjct: 330 ---LARVIEDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGR 383
Query: 253 QPWFGKSVEEIYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHA 308
P+ G S E+ ++ E+ P P P + N+++ C++ RP I
Sbjct: 384 IPYPGMSNPEVIRAL----ERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSV 438
Query: 309 FES 311
+
Sbjct: 439 LDD 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 32/293 (10%)
Query: 32 TPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA 90
++ I+ + + ++ IG G G+V +A+K LK
Sbjct: 37 RAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPG---QRDVPVAIKA---LKAGYT 90
Query: 91 KVFVNKFEE---LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKL 146
+ F + +F + L G+ I ++ E GS+ + + G+
Sbjct: 91 ERQRRDFLSEASIMGQFDHPNIIR-LEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQF 148
Query: 147 PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206
+ ++ + G+ L +G + +L N+L+ + + DFG L R L D
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG-----LSRVLED 203
Query: 207 SDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEE 262
A T P +W PE S +D W FG + E+L G +P++ + +
Sbjct: 204 DPDAAYTTT-GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
Query: 263 IYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ SV E+ P P G P A+ +++ C+ D RP + I+ ++
Sbjct: 263 VISSV----EEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 55/306 (17%), Positives = 115/306 (37%), Gaps = 49/306 (16%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
+ + + +G+G FG V+ D + +A+K + E + +F
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKD-EPETRVAIKT---VNEAASMRERIEFLN 77
Query: 99 --ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD-----------RIAQQRGGK 145
+ +F V L G+ + M+ GD
Sbjct: 78 EASVMKEFNCHHVVR-LLGVVSQGQPTLVIMELMTR--GDLKSYLRSLRPAMANNPVLAP 134
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L +++ ++A G++ L++ + +L N +++E + +GDFG + R +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG-----MTRDIY 189
Query: 206 DSDMALRLGT---P-NYMAPEQWEPEVRGPISF-------ETDTWGFGCSIMEMLT-GIQ 253
++D + G P +M+PE S +D W FG + E+ T Q
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPE----------SLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 254 PWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313
P+ G S E++ V+ P P + ++ C++Y+ + RP +I+ + +
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
Query: 314 NAVYND 319
+ +
Sbjct: 299 EPGFRE 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 37/309 (11%)
Query: 22 DPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM 81
+P++ + + ++ L +G G FG+V+ +D ++AVK
Sbjct: 9 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND-PSPLQVAVKT 67
Query: 82 LLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD-- 136
L E C++ F + KF V G+S+ + I M+ G GD
Sbjct: 68 ---LPEVCSEQDELDFLMEALIISKFNHQNIVR-CIGVSLQSLPRFILMELMAG--GDLK 121
Query: 137 ------RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-DQLV 189
R + L + D+L +A G L + ++ N LL+ V
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181
Query: 190 L--GDFGIPYLLLGRSLSDSDMALRLGTPNY-----MAPEQWEPEVRGPISFETDTWGFG 242
GDFG + R + + R G M PE + + G + +TDTW FG
Sbjct: 182 AKIGDFG-----MARDIYRASYY-RKGGCAMLPVKWMPPEAF---MEGIFTSKTDTWSFG 232
Query: 243 CSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL 301
+ E+ + G P+ KS +E+ V P P V ++ C+++ +RP
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPN 291
Query: 302 MADILHAFE 310
A IL E
Sbjct: 292 FAIILERIE 300
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 61/257 (23%), Positives = 104/257 (40%), Gaps = 40/257 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK----FRE 106
IGRG FG+V L H + + A+K+L +KFE + F E
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVY------AMKLL------------SKFEMIKRSDSAFFWE 118
Query: 107 SQSV---------CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ + L + + + M++ G GD + +P Y +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG--GDLVNLMSNYDVPEKWARFYTAE 176
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
+ + +HS+G + ++KP N+LL + L L DFG + + D A+ GTP+
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPD 234
Query: 218 YMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275
Y++PE + + G E D W G + EML G P++ S+ Y ++ K
Sbjct: 235 YISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293
Query: 276 IPSG--LPPAVENVIIG 290
P + +N+I
Sbjct: 294 FPDDNDISKEAKNLICA 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 63/296 (21%), Positives = 119/296 (40%), Gaps = 39/296 (13%)
Query: 32 TPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA 90
I P+ + + IG G FG+V+ S+ + +A+K LK
Sbjct: 32 QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEV--PVAIKT---LKAGYT 86
Query: 91 KVFVNKF-EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIA--QQRGGK 145
+ F E + +F + L G+ + I ++ E G +++ G+
Sbjct: 87 EKQRVDFLGEAGIMGQFSHHNIIR-LEGVISKYKPMMIITEYMEN--GALDKFLREKDGE 143
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
+ ++ +A G+ L ++ + +L N+L++ + + DFG L R L
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG-----LSRVLE 198
Query: 206 DSDMA--LRLGT--P-NYMAPEQWEPEVRGPISF-----ETDTWGFGCSIMEMLT-GIQP 254
D A G P + APE IS+ +D W FG + E++T G +P
Sbjct: 199 DDPEATYTTSGGKIPIRWTAPEA--------ISYRKFTSASDVWSFGIVMWEVMTYGERP 250
Query: 255 WFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
++ S E+ ++ P P P A+ +++ C++ + RP ADI+ +
Sbjct: 251 YWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 52/295 (17%), Positives = 108/295 (36%), Gaps = 45/295 (15%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G G V Q +AVK +L D A + + +L +
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQG-------RPVAVKRMLIDFCDIALMEI----KLLTESD 66
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-----QRGGKLPLPDILRYGIQLAK 160
+ +V + + + IA++ ++ D + + + + Q+A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHD-------------QLVLGDFGI-PYLLLGRSLSD 206
G++ LHS+ ++ +LKP N+L+S ++++ DFG+ L G+S
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 207 SDMALRLGTPNYMAPEQ----WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262
+++ GT + APE + + ++ D + GC +L+ + FG
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 263 IYHSVVIKKEKPCIPSGLPPAVENV-------IIGCFEYDLRNRPLMADIL-HAF 309
+ I + + ++ I ++D RP +L H
Sbjct: 247 ESN---IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 31/287 (10%)
Query: 22 DPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM 81
D + + + + + + +G+G FG V L + Y+ A+K+
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT----GRYY--AMKI 180
Query: 82 L----LPLKEDCAKVFVNK--FEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVG 135
L + K++ A + F + L + ++C M++ G G
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPF-----LTALKYSFQTHDRLCFVMEYANG--G 233
Query: 136 DRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDF 193
+ R YG ++ + LHS ++ +LK NL+L + + + DF
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293
Query: 194 GIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGI 252
G L + D GTP Y+APE E D WG G + EM+ G
Sbjct: 294 G----LCKEGIKDGATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGR 346
Query: 253 QPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
P++ + E+++ I E+ P L P ++++ G + D + R
Sbjct: 347 LPFYNQDHEKLFEL--ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 54/265 (20%), Positives = 92/265 (34%), Gaps = 38/265 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML-----LPLKE-DCAKVFVNKFEELFPKF 104
+GRG FG+V+ + + A K L K A V ++ +F
Sbjct: 193 LGRGGFGEVFACQMKATGKLY------ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEGSVGD-----RIAQQRGGKLPLPDILRYGIQLA 159
+ L +C+ M G GD + P + Y Q+
Sbjct: 247 -----IVSLAYAFETKTDLCLVMTIMNG--GDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL-RLGTPNY 218
G+ LH ++ +LKP N+LL + + + D G L + GTP +
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKTKGYAGTPGF 355
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK----SVEEIYHSVVIKKEKP 274
MAPE E F D + G ++ EM+ P+ + +E+ + ++
Sbjct: 356 MAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--VLEQAV 410
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNR 299
P PA ++ + D R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 37/281 (13%)
Query: 31 ATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-----LPL 85
R + T +G+G FG V L+ + + + AVK+L +
Sbjct: 8 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELY------AVKILKKDVVIQD 61
Query: 86 KE-DCAK----VFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ 140
+ +C V + F + LH ++ M++ G GD +
Sbjct: 62 DDVECTMVEKRVLALPGKPPF--------LTQLHSCFQTMDRLYFVMEYVNG--GDLMYH 111
Query: 141 -QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199
Q+ G+ P + Y ++A G+ L S G++ +LK N++L + + DFG +
Sbjct: 112 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG----M 167
Query: 200 LGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258
++ D GTP+Y+APE P D W FG + EML G P+ G+
Sbjct: 168 CKENIWDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
Query: 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
+E++ S I + P + + G R
Sbjct: 225 DEDELFQS--IMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 55/284 (19%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
+D T++ + +G G FG+V + +A+K LK + F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKK---EISVAIKT---LKVGYTEKQRRDFLG 95
Query: 100 ---LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI 156
+ +F + L G+ + + I ++ E D ++ + + ++
Sbjct: 96 EASIMGQFDHPNIIR-LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT- 215
+A G+ L +G + +L N+L++ + + DFG LGR L D A
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG-----LGRVLEDDPEAAYTTRG 209
Query: 216 ---P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIK 270
P + +PE + +D W +G + E+++ G +P++ S +++ +V
Sbjct: 210 GKIPIRWTSPEAIA---YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV--- 263
Query: 271 KEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
++ P P P A+ +++ C++ D NRP I+ +
Sbjct: 264 -DEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 53/292 (18%), Positives = 106/292 (36%), Gaps = 48/292 (16%)
Query: 40 IDPTSLKL-KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE 98
+ +L + +G G FG V + D +A+K+ LK+ K +
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID----VAIKV---LKQGTEKADTEEMM 58
Query: 99 E---LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRY 154
+ + V L G+ + + M+ G + + + ++P+ ++
Sbjct: 59 REAQIMHQLDNPYIVR-LIGV-CQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAEL 115
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
Q++ G+ L + +L N+LL + DFG L ++L D
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG-----LSKALGADDSYYTAR 170
Query: 215 TPN-----YMAPEQWEPEVRGPISF-----ETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263
+ + APE I+F +D W +G ++ E L+ G +P+ E+
Sbjct: 171 SAGKWPLKWYAPEC--------INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222
Query: 264 YHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ E+ C P PP + ++ C+ Y +RP + +
Sbjct: 223 MAFI----EQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 37 RPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA 90
+PW + +LKL R+G G FG+VW+ ++ + ++AVK LK+
Sbjct: 1 KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGY-------YNGHTKVAVKS---LKQGSM 50
Query: 91 KVFVNKF-EE--LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKL 146
+ F E L + + + V L+ + V I I ++ E GS+ D + G KL
Sbjct: 51 S--PDAFLAEANLMKQLQHQRLVR-LYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKL 106
Query: 147 PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD 206
+ +L Q+A+G++ + + +L+ +N+L+S+ + DFG L R + D
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG-----LARLIED 161
Query: 207 SDMALRLGTPNYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEE 262
++ R G P +W PE G + ++D W FG + E++T G P+ G + E
Sbjct: 162 NEYTAREGA---KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
Query: 263 IYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ ++ E+ P P + ++ C++ +RP + E
Sbjct: 219 VIQNL----ERGYRMVR-PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 40/293 (13%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFE 98
I L +G+G FG V A + + ++AVKM LK D A + +F
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLK---QEDGSFVKVAVKM---LKADIIASSDIEEFL 73
Query: 99 ---ELFPKFRES-----QSVCWLHGISVINGKICIAMKFYEGSVGD-------RIAQQRG 143
+F V + + F + GD +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH--GDLHAFLLASRIGENP 131
Query: 144 GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203
LPL ++R+ + +A G+ L S + +L N +L+E + + DFG L R
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG-----LSRK 186
Query: 204 LSDSDMALRLGTPN-----YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFG 257
+ D R G + ++A E + +D W FG ++ E++T G P+ G
Sbjct: 187 IYSGDYY-RQGCASKLPVKWLALESL---ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
Query: 258 KSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
EIY+ ++ P V +++ C+ D + RP + E
Sbjct: 243 IENAEIYNYLIGGNRLKQ-PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 25/281 (8%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF-- 97
+ IGRG FG V+ T + + AVK L V++F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDND---GKKIHCAVKS---LNRITDIGEVSQFLT 75
Query: 98 E-ELFPKFRESQSVCWLHGISVIN-GKICIAMKFYEGSVGDRIA--QQRGGKLPLPDILR 153
E + F +V L GI + + G + + + + GD + + D++
Sbjct: 76 EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKH--GDLRNFIRNETHNPTVKDLIG 132
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+G+Q+AKG+ L S + +L N +L E + + DFG L R + D +
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVH 187
Query: 214 GTPNYMAPEQW-EPE--VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269
P +W E + ++D W FG + E++T G P+ + +I ++
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ P P + V++ C+ RP ++++
Sbjct: 248 GRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 32/260 (12%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKED---CAKVFVNKFEELFPK 103
+G+G +G V+ A+ + A+K+L + K N EE+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIF---AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAK 160
F + L GK+ + +++ G G+ ++ +R G Y +++
Sbjct: 82 F-----IVDLIYAFQTGGKLYLILEYLSG--GELFMQL--EREGIFMEDTACFYLAEISM 132
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYM 219
+ LH G++ +LKP N++L+ + L DFG L S+ D + GT YM
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG----LCKESIHDGTVTHTFCGTIEYM 188
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279
APE R + D W G + +MLTG P+ G++ ++ I K K +P
Sbjct: 189 APEILM---RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK--ILKCKLNLPPY 243
Query: 280 LPPAVENVIIGCFEYDLRNR 299
L +++ + + +R
Sbjct: 244 LTQEARDLLKKLLKRNAASR 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 54/306 (17%)
Query: 38 PW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
P + LK ++G+G FG V L + D+ +AVK L D + F
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGA--LVAVKQLQHSGPDQQRDFQ-- 72
Query: 97 FEELFPKFRESQ--------SVCWLHGISVINGK--ICIAMKFYE-GSVGDRIAQQRGGK 145
RE Q + G+S G+ + + M++ G + D + Q+ +
Sbjct: 73 --------REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR 123
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
L +L Y Q+ KG+ L S + +L N+L+ + + DFG L + L
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG-----LAKLLP 178
Query: 206 DSDMALRLGTPN-----YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259
+ P + AP E S ++D W FG + E+ T + +
Sbjct: 179 LDKDYYVVREPGQSPIFWYAP---ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235
Query: 260 VEEIYHSV---------VIKKEK-----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
+++ + P P P V ++ C+ ++RP + +
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSAL 294
Query: 306 LHAFES 311
+
Sbjct: 295 GPQLDM 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 38/319 (11%)
Query: 22 DPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM 81
+P++ + + ++ L +G G FG+V+ +D ++AVK
Sbjct: 50 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND-PSPLQVAVKT 108
Query: 82 LLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD-- 136
L E C++ F + KF V G+S+ + I ++ G GD
Sbjct: 109 ---LPEVCSEQDELDFLMEALIISKFNHQNIVR-CIGVSLQSLPRFILLELMAG--GDLK 162
Query: 137 ------RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-DQLV 189
R + L + D+L +A G L + ++ N LL+ V
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222
Query: 190 L--GDFGIPYLLLGRSLSDSDMALRLGTPNY-----MAPEQWEPEVRGPISFETDTWGFG 242
GDFG + R + + R G M PE + + G + +TDTW FG
Sbjct: 223 AKIGDFG-----MARDIYRAGYY-RKGGCAMLPVKWMPPEAF---MEGIFTSKTDTWSFG 273
Query: 243 CSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL 301
+ E+ + G P+ KS +E+ V P P V ++ C+++ +RP
Sbjct: 274 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 302 MADILHAFES-SQNAVYND 319
A IL E +Q+ +
Sbjct: 333 FAIILERIEYCTQDPDVIN 351
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 53/284 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKEDCAKVFVNKFEELF 101
K + +G+G FG+V L + + AVK++ + K D +
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQEC------AVKVISKRQVKQKTDKESLL-------- 74
Query: 102 PKFRESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPD 150
RE Q ++ L+ G + + Y G G D I + + D
Sbjct: 75 ---REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG--GELFDEIISR--KRFSEVD 127
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSDS 207
R Q+ GI+ +H ++ +LKP NLLL + + + DFG+ +
Sbjct: 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE----ASK 183
Query: 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
M ++GT Y+APE + G + D W G + +L+G P+ G + +I
Sbjct: 184 KMKDKIGTAYYIAPEV----LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK- 238
Query: 268 VIKKEKPCIPS----GLPPAVENVIIGCFEYDLRNRPLMADILH 307
++K K + + +++I Y R D L
Sbjct: 239 -VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 63/311 (20%), Positives = 118/311 (37%), Gaps = 51/311 (16%)
Query: 33 PTQTRPW-IDPTSLKLKHR-IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC- 89
+ + +D L L+ + +G G FG V + +AVK+ LK +
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKT----VAVKI---LKNEAN 57
Query: 90 AKVFVNKFEE---LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGK 145
++ + + V + GI + M+ E G + + Q+
Sbjct: 58 DPALKDELLAEANVMQQLDNPYIVR-MIGI-CEAESWMLVMEMAELGPLNKYL--QQNRH 113
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
+ +I+ Q++ G+ L + +L N+LL + DFG L ++L
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG-----LSKALR 168
Query: 206 DSDMALRLGTPN-----YMAPEQWEPEVRGPISF-----ETDTWGFGCSIMEMLT-GIQP 254
+ + T + APE I++ ++D W FG + E + G +P
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPEC--------INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 255 WFGKSVEEIYHSVVIKKEK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ G E+ + EK C P+G P + +++ C+ YD+ NRP A +
Sbjct: 221 YRGMKGSEVTAML----EKGERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
Query: 311 SSQNAVYNDGE 321
+ V N+G
Sbjct: 276 NYYYDVVNEGH 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 61/312 (19%), Positives = 115/312 (36%), Gaps = 67/312 (21%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLAT-HHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
W L L +G G FG V +A D E +AVKM LK+D + ++
Sbjct: 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSD 132
Query: 97 FE---ELFPKFRESQSVCWLHGISVINGKICIAMKF---------------YEGSVGDRI 138
E+ + +++ L G +G + + +++ I
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 139 AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198
+ ++ D++ QLA+G+ L S + +L N+L++E++ + + DFG
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG---- 248
Query: 199 LLGRSLSDSDMALRLGTPNY------------MAPEQWEPEVRGPISF-------ETDTW 239
L R +++ D Y MAPE + ++D W
Sbjct: 249 -LARDINNID--------YYKKTTNGRLPVKWMAPE----------ALFDRVYTHQSDVW 289
Query: 240 GFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRN 298
FG + E+ T G P+ G VEE++ + P+ + ++ C+
Sbjct: 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQ 348
Query: 299 RPLMADILHAFE 310
RP ++ +
Sbjct: 349 RPTFKQLVEDLD 360
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 23/288 (7%)
Query: 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF--E 98
+ IG+G FG V+ + D + A+K L V F E
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYI---DQAQNRIQCAIKS---LSRITEMQQVEAFLRE 72
Query: 99 -ELFPKFRESQSVCWLHGI-SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
L + L GI G + + + G + I + + D++ +G
Sbjct: 73 GLLMRGLNHPNVLA-LIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFG 130
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+Q+A+G+ L + +L N +L E + + DFG L R + D +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFG-----LARDILDREYYSVQQH 185
Query: 216 PNYMAPEQW-EPE--VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKK 271
+ P +W E + ++D W FG + E+LT G P+ ++ H + +
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
Query: 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319
P P P ++ V+ C+E D RP ++ E +A+ D
Sbjct: 246 RLPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 59/184 (32%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 120 NGKICIAMKFYEGSVGD---RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK 176
GK+ + + F G GD R+ + D+ Y +LA + LHS+G++ +LK
Sbjct: 98 EGKLYLILDFLRG--GDLFTRL--SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153
Query: 177 PSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFE 235
P N+LL E + L DFG L S+ A GT YMAPE R +
Sbjct: 154 PENILLDEEGHIKLTDFG----LSKESIDHEKKAYSFCGTVEYMAPEVVN---RRGHTQS 206
Query: 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYD 295
D W FG + EMLTG P+ GK +E I K K +P L P ++++ F+ +
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTM--ILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 296 LRNR 299
NR
Sbjct: 265 PANR 268
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 48/281 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ ++G G +G+V L + + A+K++ K V + +L
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVER------AIKIIR--K---TSVSTSSNSKLL---E 85
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E ++ L+ + M+ Y+G G D I + K D
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG--GELFDEIIHR--MKFNEVDAAVI 141
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSD-MA 210
Q+ G++ LH ++ +LKP NLLL + + + DFG L + M
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG-----LSAVFENQKKMK 196
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270
RLGT Y+APE +R + D W G + +L G P+ G++ +EI ++
Sbjct: 197 ERLGTAYYIAPEV----LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK--VE 250
Query: 271 KEKPCIPS----GLPPAVENVIIGCFEYDLRNRPLMADILH 307
K K S + +++I ++D + R L
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 59/285 (20%), Positives = 105/285 (36%), Gaps = 47/285 (16%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM-----LLPLKEDCAKVFVNKFEEL 100
++G G +G+V L + A+K+ + + KF E
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEK------AIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 101 FPKFRESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLP 149
+ E ++ L + + +FYEG G ++I + K
Sbjct: 93 I--YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG--GELFEQIINR--HKFDEC 146
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSD 206
D Q+ GI LH ++ ++KP N+LL + + + DFG+ D
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF----SKD 202
Query: 207 SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIM-EMLTGIQPWFGKSVEEIYH 265
+ RLGT Y+APE ++ + + D W G IM +L G P+ G++ ++I
Sbjct: 203 YKLRDRLGTAYYIAPEV----LKKKYNEKCDVWSCGV-IMYILLCGYPPFGGQNDQDIIK 257
Query: 266 SVVIKKEKPCIPS----GLPPAVENVIIGCFEYDLRNRPLMADIL 306
++K K + + +I YD R + L
Sbjct: 258 K--VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 18/165 (10%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
++ G Y ++ + LH G++ +LKP N+LL+E + + DFG
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG-----T 176
Query: 201 GRSLSDSDMALR----LGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+ LS R +GT Y++PE + + +D W GC I +++ G+ P
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPP 231
Query: 255 WFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
+ + I+ I K + P P +++ D R
Sbjct: 232 FRAGNEYLIFQK--IIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 61/270 (22%), Positives = 100/270 (37%), Gaps = 44/270 (16%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL---------F 101
+G G +G V+L D Y A+K+L K V K +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLY---AMKVLK--KA----TIVQKAKTTEHTRTERQVL 112
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAK 160
R+S + LH K+ + + + G G+ + + ++ Y ++
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYING--GELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL------- 213
+ LH +G++ ++K N+LL + +VL DFG LS +A
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG---------LSKEFVADETERAYDFC 221
Query: 214 GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG----KSVEEIYHSVVI 269
GT YMAP+ G D W G + E+LTG P+ S EI I
Sbjct: 222 GTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--I 278
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
K +P P + +++I D + R
Sbjct: 279 LKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 64/325 (19%), Positives = 119/325 (36%), Gaps = 71/325 (21%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLAT-HHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
W L L +G G FG V +A D E +AVKM LK+D + ++
Sbjct: 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSD 86
Query: 97 FE---ELFPKFRESQSVCWLHGISVINGKICIAMKF---------------YEGSVGDRI 138
E+ + +++ L G +G + + +++ I
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 139 AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198
+ ++ D++ QLA+G+ L S + +L N+L++E++ + + DFG
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG---- 202
Query: 199 LLGRSLSDSDMALRLGTPNY------------MAPEQWEPEVRGPISF-------ETDTW 239
L R +++ D Y MAPE + ++D W
Sbjct: 203 -LARDINNID--------YYKKTTNGRLPVKWMAPE----------ALFDRVYTHQSDVW 243
Query: 240 GFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRN 298
FG + E+ T G P+ G VEE++ + P+ + ++ C+
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQ 302
Query: 299 RPLMADILHAFE----SSQNAVYND 319
RP ++ + + N Y D
Sbjct: 303 RPTFKQLVEDLDRILTLTTNEEYLD 327
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 51/294 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML---------------LPLKEDCA 90
LK IG+G +G V LA + A+K+L P A
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDN------TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 91 KVFVNKFEELFPK-FRESQ--------SVCWLHGISVI----NGKICIAMKFYE-GSVGD 136
+ + ++E +V L V+ + + + G V +
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVME 127
Query: 137 RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196
L Y L KGI LH ++ ++KPSNLL+ E + + DFG
Sbjct: 128 VPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG-- 182
Query: 197 YLLLGRSLSDSDMALRL--GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+ SD L GTP +MAPE + D W G ++ + G P
Sbjct: 183 ---VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 255 WFGKSVEEIYHSVVIKKEKPCIPS--GLPPAVENVIIGCFEYDLRNRPLMADIL 306
+ + + ++ IK + P + ++++I + + +R ++ +I
Sbjct: 240 FMDERIMCLHSK--IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 61/305 (20%), Positives = 109/305 (35%), Gaps = 53/305 (17%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHEL-AVKMLLPLKEDCAKVFVNK 96
W + L L +G G FG V LA D AVKM LK D + ++
Sbjct: 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSD 120
Query: 97 FE---ELFPKFRESQSVCWLHGISVINGKICIAMKF---------------YEGSVGDRI 138
E+ + +++ L G +G + + +++
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 139 AQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198
+ +L D++ Q+A+G+ L S + +L N+L++E + + + DFG
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG---- 236
Query: 199 LLGRSLSDSDMALRLGTPNY------------MAPEQWEPEVRGPISFETDTWGFGCSIM 246
L R + D Y MAPE + ++D W FG +
Sbjct: 237 -LARDIHHID--------YYKKTTNGRLPVKWMAPEAL---FDRIYTHQSDVWSFGVLLW 284
Query: 247 EMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
E+ T G P+ G VEE++ + PS + ++ C+ RP +
Sbjct: 285 EIFTLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQL 343
Query: 306 LHAFE 310
+ +
Sbjct: 344 VEDLD 348
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 46/238 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +GRG FG V S + K + D V +
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTY------MAKFVKVKGTDQVLVK-----------K 50
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E ++ LH ++ + +F G +RI +L +I+ Y
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISG--LDIFERINT-SAFELNEREIVSY 107
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLS--EHDQLVLGDFGIPYLLLGRSLSDSD-MAL 211
Q+ + + LHS + +++P N++ + + +FG R L D L
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG-----QARQLKPGDNFRL 162
Query: 212 RLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
P Y A PEV +S TD W G + +L+GI P+ ++ ++I ++
Sbjct: 163 LFTAPEYYA-----PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 9e-17
Identities = 59/308 (19%), Positives = 116/308 (37%), Gaps = 50/308 (16%)
Query: 37 RPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVN 95
+ I ++++ +G FG V+ A ++ +A+K LK+
Sbjct: 2 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPG-EQTQAVAIKT---LKDKAEGPLRE 57
Query: 96 KFE---ELFPKFRESQSVCWLHGISVINGKICIAMKF---------------YEGSVGDR 137
+F L + + VC L G+ + + + + +
Sbjct: 58 EFRHEAMLRARLQHPNVVC-LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 138 IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
+ L PD + Q+A G+ L S ++ +L N+L+ + + + D G
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG--- 173
Query: 198 LLLGRSLSDSDMALRLGTPN-----YMAPEQWEPEVRGPISF-----ETDTWGFGCSIME 247
L R + +D +L + +MAPE I + ++D W +G + E
Sbjct: 174 --LFREVYAAD-YYKLLGNSLLPIRWMAPEA--------IMYGKFSIDSDIWSYGVVLWE 222
Query: 248 MLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
+ + G+QP+ G S +++ + ++ PC P P V ++I C+ RP DI
Sbjct: 223 VFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIH 281
Query: 307 HAFESSQN 314
+ N
Sbjct: 282 SRLRAWGN 289
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 54/319 (16%), Positives = 105/319 (32%), Gaps = 76/319 (23%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
LK IG+G +G V +A +Q+ A+K++ + K+ +++
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTR------AIRAIKIM-----NKNKIRQINPKDVERIKT 77
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLP----- 149
E + ++ L+ + IC+ M+ G G D++
Sbjct: 78 EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG--GHLLDKL-NVFIDDSTGKCAMDV 134
Query: 150 ----------------------------------DILRYGIQLAKGISDLHSIGLLVLNL 175
I Q+ + LH+ G+ ++
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 176 KPSNLLLS--EHDQLVLGDFGI-PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPI 232
KP N L S + ++ L DFG+ + M + GTP ++APE
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE-SY 253
Query: 233 SFETDTWGFGCSIM-EMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS----GLPPAVENV 287
+ D W G ++ +L G P+ G + + + +K C + L P ++
Sbjct: 254 GPKCDAWSAGV-LLHLLLMGAVPFPGVNDADTISQ--VLNKKLCFENPNYNVLSPLARDL 310
Query: 288 IIGCFEYDLRNRPLMADIL 306
+ ++ R L
Sbjct: 311 LSNLLNRNVDERFDAMRAL 329
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 42/240 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G F V + E A K + ++ A EE+ R
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTG------LEYAAKFI-KKRQSRASRRGVSREEIE---R 64
Query: 106 ESQSVCWLHGISVIN--------GKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E + + +VI + + ++ G G D +AQ+ L + +
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSG--GELFDFLAQK--ESLSEEEATSF 120
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLGDFGIPYLLLGRSLSDSD-M 209
Q+ G++ LH+ + +LKP N++L + + + L DFG L + D
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-----LAHEIEDGVEF 175
Query: 210 ALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP ++A PE+ P+ E D W G +L+G P+ G + +E ++
Sbjct: 176 KNIFGTPEFVA-----PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 68/303 (22%), Positives = 117/303 (38%), Gaps = 54/303 (17%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
I + LK +G G FG V+LA + + + +AVK LK+ F+
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPT-KDKMLVAVKA---LKDPTLAA-RKDFQR 66
Query: 99 --ELFPKFRESQSVCWLHGISVINGKICIAMKF---------------YEGSVGDRIAQQ 141
EL + V +G+ + + ++ + D +Q
Sbjct: 67 EAELLTNLQHEHIVK-FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201
G+L L +L Q+A G+ L S + +L N L+ + + +GDFG +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG-----MS 180
Query: 202 RSLSDSDMALRLGTPN-----YMAPEQWEPEVRGPISF-------ETDTWGFGCSIMEML 249
R + +D R+G +M PE S E+D W FG + E+
Sbjct: 181 RDVYSTD-YYRVGGHTMLPIRWMPPE----------SIMYRKFTTESDVWSFGVILWEIF 229
Query: 250 T-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHA 308
T G QPWF S E+ + + P P V +V++GC++ + + R + +I
Sbjct: 230 TYGKQPWFQLSNTEVIECITQGRVLER-PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 309 FES 311
+
Sbjct: 289 LHA 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 58/306 (18%), Positives = 114/306 (37%), Gaps = 45/306 (14%)
Query: 33 PTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
P LK +G G FG V L + + D E +AVK LK D
Sbjct: 20 QGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKA---LKADAGP 74
Query: 92 VFVNKFE---ELFPKFRESQSVCWLHGISVINGK--ICIAMKFYE-GSVGDRIAQQRGGK 145
+ ++ ++ + + G G + + M++ GS+ D +
Sbjct: 75 QHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS 130
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS 205
+ L +L + Q+ +G++ LH+ + +L N+LL + +GDFG L +++
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG-----LAKAVP 185
Query: 206 DSDMALRLGTPN-----YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT---------- 250
+ R+ + APE + + +D W FG ++ E+LT
Sbjct: 186 EGHEYYRVREDGDSPVFWYAPECLK---EYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
Query: 251 -----GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305
+V + + + P P P V +++ C+E + RP ++
Sbjct: 243 KFLELIGIAQGQMTVLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPTFENL 301
Query: 306 LHAFES 311
+ ++
Sbjct: 302 IPILKT 307
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 62/301 (20%), Positives = 111/301 (36%), Gaps = 46/301 (15%)
Query: 20 EGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
+ + + + L IGRG + V L ++ + A+
Sbjct: 29 GIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIY------AM 82
Query: 80 KMLLPLKEDCAKVFVNKFEEL---------FPKFRESQSVCWLHGISVINGKICIAMKFY 130
+++ K VN E++ F + + LH ++ +++
Sbjct: 83 RVV-------KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135
Query: 131 EGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV 189
G GD + QR KLP Y +++ ++ LH G++ +LK N+LL +
Sbjct: 136 NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193
Query: 190 LGDFGIPYLLLGRSLSDSDMALRL-GTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIME 247
L D+G + L D GTPNY+APE +RG F D W G + E
Sbjct: 194 LTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEI----LRGEDYGFSVDWWALGVLMFE 245
Query: 248 MLTGIQPWF---------GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRN 298
M+ G P+ + + ++ I +++ IP L +V+ D +
Sbjct: 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQV--ILEKQIRIPRSLSVKAASVLKSFLNKDPKE 303
Query: 299 R 299
R
Sbjct: 304 R 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 44/276 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-FRESQS 109
+G G +G V ++ AVK+L K + + +E Q
Sbjct: 13 LGEGSYGKVKEVLDSETL------CRRAVKIL-------KKKKLRRIPNGEANVKKEIQL 59
Query: 110 --------VCWLHGISVING----KICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
V L V+ K+ + M++ + D + + + P+ Y
Sbjct: 60 LRRLRHKNVIQLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGY 114
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
QL G+ LHS G++ ++KP NLLL+ L + G+ L + +D G
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA-ADDTCRTSQG 173
Query: 215 TPNYMAPEQWEPEVRGPISF---ETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271
+P + PE G +F + D W G ++ + TG+ P+ G ++ +++ + I K
Sbjct: 174 SPAFQPPEI----ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--IGK 227
Query: 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
IP P + +++ G EY+ R + I
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP + +L +G G +G V+ H ++ A+K++ + D + +
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTG------QLAAIKVM-DVTGDEEEEIKQEINM 73
Query: 100 LFPKFRESQSV-----CWLHG-ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDI- 151
L K+ +++ ++ ++ ++ + M+F GSV D I +G L I
Sbjct: 74 L-KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 152 --LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
R ++ +G+S LH ++ ++K N+LL+E+ ++ L DFG+ L D +
Sbjct: 133 YICR---EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTV 183
Query: 210 ALR---LGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY 264
R +GTP +MAPE + F++D W G + +EM G P
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD------M 237
Query: 265 HSV----VIKKEKPCI--PSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
H + +I + ++ I C + RP ++ H F
Sbjct: 238 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 62/270 (22%), Positives = 106/270 (39%), Gaps = 46/270 (17%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL---------F 101
IGRG + V L ++ + A+K++ K VN E++ F
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIY------AMKVV-------KKELVNDDEDIDWVQTEKHVF 63
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAK 160
+ + LH ++ +++ G GD + QR KLP Y +++
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTPNYM 219
++ LH G++ +LK N+LL + L D+G + L D GTPNY+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPNYI 177
Query: 220 APEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWF---------GKSVEEIYHSVVI 269
APE +RG F D W G + EM+ G P+ + + ++ I
Sbjct: 178 APEI----LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--I 231
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
+++ IP L +V+ D + R
Sbjct: 232 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 57/268 (21%), Positives = 107/268 (39%), Gaps = 39/268 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS- 109
IG+G F V LA H + E+A+K++ D ++ ++LF RE +
Sbjct: 23 IGKGNFAKVKLARHILTG------REVAIKII-----DKTQLNPTSLQKLF---REVRIM 68
Query: 110 -------VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
+ L + + + M++ G V D + G++ + Q+
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSA 126
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL--GTPNYM 219
+ H ++ +LK NLLL + + DFG + L G P Y
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFG-----FSNEFTVGGK-LDAFCGAPPYA 180
Query: 220 APEQWE-PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
APE ++ + GP E D W G + +++G P+ G++++E+ + + K IP
Sbjct: 181 APELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDGQNLKELRER--VLRGKYRIPF 235
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADIL 306
+ EN++ + R + I+
Sbjct: 236 YMSTDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 41/236 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G FG V T + ++F A K + + E + +
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNF------AAKFV-------MTPHESDKETVR---K 203
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E Q ++ LH + ++ + +F G G +++A + K+ + + Y
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG--GELFEKVADEHN-KMSEDEAVEY 260
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLS--EHDQLVLGDFGIPYLLLGRSLSDSD-MAL 211
Q+ KG+ +H + L+LKP N++ + ++L L DFG L L + +
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG-----LTAHLDPKQSVKV 315
Query: 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GT + APE E + P+ + TD W G +L+G+ P+ G++ +E +V
Sbjct: 316 TTGTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 25/281 (8%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
+ IGRG FG V+ T + + AVK L V++F
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDND---GKKIHCAVKS---LNRITDIGEVSQFLT 139
Query: 99 --ELFPKFRESQSVCWLHGISVIN-GKICIAMKFYEGSVGDRIA--QQRGGKLPLPDILR 153
+ F +V L GI + + G + + + + GD + + D++
Sbjct: 140 EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKH--GDLRNFIRNETHNPTVKDLIG 196
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+G+Q+AKG+ L S + +L N +L E + + DFG L R + D +
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVH 251
Query: 214 GTPNYMAPEQW-EPE--VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVI 269
P +W E + ++D W FG + E++T G P+ + +I ++
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ P P + V++ C+ RP ++++
Sbjct: 312 GRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 40/283 (14%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNK 96
W ++ LKL IG+G FGDV L + +++AVK +K D A+ F+
Sbjct: 16 WALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKC---IKNDATAQAFLA- 63
Query: 97 FE-ELFPKFRESQSVCWLHGI-SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
E + + R S V L G+ G + I ++ GS+ D + + L +L+
Sbjct: 64 -EASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ + + + + L + +L N+L+SE + + DFG L + S + +L
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG-----LTKEASSTQDTGKL 176
Query: 214 GTP-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKK 271
P + APE S ++D W FG + E+ + G P+ ++++ V
Sbjct: 177 --PVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---- 227
Query: 272 EK----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
EK P G PPAV V+ C+ D RP + E
Sbjct: 228 EKGYKMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 61/248 (24%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVN-------- 95
++ +G G FG V + +LA K++ + N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATG------LKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 96 ------KFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKL 146
+ + F ES++ I + M++ +G G DRI L
Sbjct: 144 DHANLIQLYDAF----ESKN------------DIVLVMEYVDG--GELFDRIID-ESYNL 184
Query: 147 PLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD--QLVLGDFGIPYLLLGRSL 204
D + + Q+ +GI +H + +L L+LKP N+L D Q+ + DFG L R
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG-----LARRY 239
Query: 205 SDSD-MALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFG--CSIMEMLTGIQPWFGKS 259
+ + + GTP ++A PEV +SF TD W G + +L+G+ P+ G +
Sbjct: 240 KPREKLKVNFGTPEFLA-----PEVVNYDFVSFPTDMWSVGVIAYM--LLSGLSPFLGDN 292
Query: 260 VEEIYHSV 267
E +++
Sbjct: 293 DAETLNNI 300
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 47/238 (19%), Positives = 88/238 (36%), Gaps = 45/238 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G FG V + K + + +
Sbjct: 54 DILEELGSGAFGVVHRCVEKATG------RVFVAKFI-------NTPYPLDKYTVK---N 97
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E + LH ++ + ++F G G DRIA K+ +++ Y
Sbjct: 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG--GELFDRIAA-EDYKMSEAEVINY 154
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLS--EHDQLVLGDFGIPYLLLGRSLSDSD-MAL 211
Q +G+ +H ++ L++KP N++ + + + DFG L L+ + + +
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG-----LATKLNPDEIVKV 209
Query: 212 RLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
T + A PE+ R P+ F TD W G +L+G+ P+ G+ E +V
Sbjct: 210 TTATAEFAA-----PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFE 98
++ LKL IG+G FGDV L + +++AVK +K D A+ F+ +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKC---IKNDATAQAFLAEAS 238
Query: 99 ELFPKFRESQSVCWLHGI-SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
+ + R S V L G+ G + I ++ GS+ D + + L +L++ +
Sbjct: 239 VM-TQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 296
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
+ + + L + +L N+L+SE + + DFG L + S + +L
Sbjct: 297 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG-----LTKEASSTQDTGKL--- 348
Query: 217 NYMAPEQW-EPEV--RGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272
P +W PE S ++D W FG + E+ + G P+ ++++ V E
Sbjct: 349 ----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----E 400
Query: 273 K----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
K P G PPAV +V+ C+ D RP + E
Sbjct: 401 KGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 69/308 (22%), Positives = 112/308 (36%), Gaps = 48/308 (15%)
Query: 7 AHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQ 66
A K + + F + T ++ +G G FG V L H +
Sbjct: 6 AKKGSEQESVKEFLAKAK-EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 67 SADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL--------------FPKFRESQSVCW 112
S + + A+K+L K V K +++ FP F +
Sbjct: 65 SGNHY------AMKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFP-F-----LVK 105
Query: 113 LHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLPDILRYGIQLAKGISDLHSIGLL 171
L N + + M++ G G+ + +R G+ P Y Q+ LHS+ L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAG--GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 172 VLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGP 231
+LKP NLL+ + + + DFG + + L GTP +APE
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFG-----FAKRVKGRTWTLC-GTPEALAPEIIL---SKG 214
Query: 232 ISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGC 291
+ D W G I EM G P+F +IY I K PS +++++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK--IVSGKVRFPSHFSSDLKDLLRNL 272
Query: 292 FEYDLRNR 299
+ DL R
Sbjct: 273 LQVDLTKR 280
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 49/240 (20%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
++ +G G F V + ++ A K + + ++ V++ EE+ R
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEY------AAKFIKKRRLSSSRRGVSR-EEIE---R 57
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E ++ LH I + + ++ G G D +A++ L + ++
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSG--GELFDFLAEK--ESLTEDEATQF 113
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLGDFGIPYLLLGRSLSDSD-M 209
Q+ G+ LHS + +LKP N++L + + ++ L DFG + + +
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG-----IAHKIEAGNEF 168
Query: 210 ALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP ++A PE+ P+ E D W G +L+G P+ G++ +E ++
Sbjct: 169 KNIFGTPEFVA-----PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 59/282 (20%), Positives = 106/282 (37%), Gaps = 50/282 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G+G FG+V + ++ AVK++ K + R
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEY------AVKVI--NKASAKNKDTSTIL------R 70
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E + ++ L I + I + Y G G D I ++ + D R
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG--GELFDEIIKR--KRFSEHDAARI 126
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSD-MA 210
Q+ GI+ +H ++ +LKP N+LL + + + DFG L + M
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG-----LSTCFQQNTKMK 181
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIM-EMLTGIQPWFGKSVEEIYHSVVI 269
R+GT Y+APE +RG + D W G I+ +L+G P++GK+ +I +
Sbjct: 182 DRIGTAYYIAPEV----LRGTYDEKCDVWSAGV-ILYILLSGTPPFYGKNEYDILKR--V 234
Query: 270 KKEKPCIPS----GLPPAVENVIIGCFEYDLRNRPLMADILH 307
+ K + +++I + R L
Sbjct: 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 59/323 (18%), Positives = 117/323 (36%), Gaps = 45/323 (13%)
Query: 4 QIRAHKPAASFEYELFEGDPDHLRTVVATPTQTRPWIDPTSLKL-KHRIGRGPFGDVWLA 62
P + +E DP+ L+ + ++ +L + +G G FG V
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELK-------DKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 63 THHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE---LFPKFRESQSVCWLHGISVI 119
+ + ++A+K+ LK+ K + + + + L G+
Sbjct: 356 VYRMR----KKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGV-CQ 406
Query: 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178
+ + M+ G + + + ++P+ ++ Q++ G+ L + NL
Sbjct: 407 AEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR 465
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA------PEQW-EPEV--R 229
N+LL + DFG L ++L D Y A P +W PE
Sbjct: 466 NVLLVNRHYAKISDFG-----LSKALGADDSY-------YTARSAGKWPLKWYAPECINF 513
Query: 230 GPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVI 288
S +D W +G ++ E L+ G +P+ E+ + K C P PP + ++
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALM 572
Query: 289 IGCFEYDLRNRPLMADILHAFES 311
C+ Y +RP + +
Sbjct: 573 SDCWIYKWEDRPDFLTVEQRMRA 595
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 42/240 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G F V + E A K + ++ A EE+ R
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTG------LEYAAKFI-KKRQSRASRRGVCREEIE---R 64
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E ++ LH + + + ++ G G D +AQ+ L + +
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSG--GELFDFLAQK--ESLSEEEATSF 120
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLGDFGIPYLLLGRSLSDSD-M 209
Q+ G++ LH+ + +LKP N++L + + + L DFG L + D
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-----LAHEIEDGVEF 175
Query: 210 ALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP ++A PE+ P+ E D W G +L+G P+ G + +E ++
Sbjct: 176 KNIFGTPEFVA-----PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 60/268 (22%), Positives = 116/268 (43%), Gaps = 39/268 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-FRESQ- 108
+G G FG V LATH+++ ++A+K + ++ + K ++ + RE
Sbjct: 17 LGEGSFGKVKLATHYKTQ------QKVALKFI-------SRQLLKK-SDMHMRVEREISY 62
Query: 109 -------SVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
+ L+ + I + +++ G + D I ++ ++ + R+ Q+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICA 120
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL--GTPNYM 219
I H ++ +LKP NLLL ++ + + DFG L ++D + L+ G+PNY
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG-----LSNIMTDGNF-LKTSCGSPNYA 174
Query: 220 APEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
APE ++ GP E D W G + ML G P+ + + ++ + +P
Sbjct: 175 APEVINGKLYAGP---EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--VNSCVYVMPD 229
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADIL 306
L P +++I D R + +I
Sbjct: 230 FLSPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 50/242 (20%), Positives = 89/242 (36%), Gaps = 46/242 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKFEELFPK 103
+G G F V + + A K + K V E
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTG------LQYAAKFIKKRRTKSSRRGVSREDIE----- 62
Query: 104 FRESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDIL 152
RE +V LH + + + ++ G G D +A++ L +
Sbjct: 63 -REVSILKEIQHPNVITLHEVYENKTDVILILELVAG--GELFDFLAEK--ESLTEEEAT 117
Query: 153 RYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLGDFGIPYLLLGRSLSDSD 208
+ Q+ G+ LHS+ + +LKP N++L + + ++ + DFG L + +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG-----LAHKIDFGN 172
Query: 209 -MALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH 265
GTP ++A PE+ P+ E D W G +L+G P+ G + +E
Sbjct: 173 EFKNIFGTPEFVA-----PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 266 SV 267
+V
Sbjct: 228 NV 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 37/272 (13%)
Query: 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-----LPLKE-DCAK 91
P ++ +G G FG V L + + A+K+L + LK+ +
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYY------AMKVLKKEIVVRLKQVEHTN 54
Query: 92 VFVNKFEEL-FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQ-QRGGKLPLP 149
+ P F + + G +I + M + EG G+ + ++ + P P
Sbjct: 55 DERLMLSIVTHP-F-----IIRMWGTFQDAQQIFMIMDYIEG--GELFSLLRKSQRFPNP 106
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
Y ++ + LHS ++ +LKP N+LL ++ + + DFG + + D
Sbjct: 107 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG-----FAKYVPDVTY 161
Query: 210 ALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
L GTP+Y+APE V P + D W FG I EML G P++ + + Y
Sbjct: 162 TLC-GTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK- 214
Query: 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNR 299
I + P V++++ DL R
Sbjct: 215 -ILNAELRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 22/221 (9%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK-MLLPLKEDCAKVFVNKFE 98
DP L IG G FG V+ A ++++ +A+K M K+ K E
Sbjct: 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKE 104
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDI---LRYG 155
F + + G + + M++ GS D + + L +I
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTH-- 161
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
+G++ LHS ++ ++K N+LLSE + LGDFG ++ + +GT
Sbjct: 162 -GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-------VGT 213
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256
P +MAPE G + D W G + +E+ P F
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 40/282 (14%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP L +IG+G FG+V+ +++ +A+K++ L+E ++ + E
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQ------KVVAIKII-DLEEAEDEIEDIQQEI 71
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDI---LRYG 155
+S V +G + + K+ I M++ GS D + G L I LR
Sbjct: 72 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILR-- 126
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
++ KG+ LHS + ++K +N+LLSEH ++ L DFG+ L + + GT
Sbjct: 127 -EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GT 182
Query: 216 PNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV-----V 268
P +MA PEV + + D W G + +E+ G P H + +
Sbjct: 183 PFWMA-----PEVIKQSAYDSKADIWSLGITAIELARGEPPHSE------LHPMKVLFLI 231
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
K P + ++ + C + RP ++L H F
Sbjct: 232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKFEELFPKFRESQ 108
+GRG F V + E A K L +DC +++ L +
Sbjct: 37 LGRGKFAVVRQCISKSTG------QEYAAKFLKKRRRGQDCRAEILHEIAVL-ELAKSCP 89
Query: 109 SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
V LH + +I + +++ G G + + D++R Q+ +G+ L
Sbjct: 90 RVINLHEVYENTSEIILILEYAAG--GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 166 HSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSD-MALRLGTPNYMAP 221
H ++ L+LKP N+LL + + DFG + R + + + +GTP Y+A
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG-----MSRKIGHACELREIMGTPEYLA- 201
Query: 222 EQWEPEV--RGPISFETDTWGFG--CSIMEMLTGIQPWFGKSVEEIYHSV 267
PE+ PI+ TD W G + +LT P+ G+ +E Y ++
Sbjct: 202 ----PEILNYDPITTATDMWNIGIIAYM--LLTHTSPFVGEDNQETYLNI 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 70/312 (22%), Positives = 116/312 (37%), Gaps = 55/312 (17%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE- 98
I + LK +G G FG V+LA H + + +AVK LKE F+
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPE-QDKMLVAVKA---LKEASESA-RQDFQR 92
Query: 99 --ELFPKFRESQSVCWLHGISVINGKICIAMKF--------------YEGSVGDRIAQQR 142
EL + V G+ + + ++ + +
Sbjct: 93 EAELLTMLQHQHIVR-FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
G L L +L Q+A G+ L + + +L N L+ + + +GDFG + R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG-----MSR 206
Query: 203 SLSDSDMALRLGTPN-----YMAPEQWEPEVRGPISF-------ETDTWGFGCSIMEMLT 250
+ +D R+G +M PE S E+D W FG + E+ T
Sbjct: 207 DIYSTDYY-RVGGRTMLPIRWMPPE----------SILYRKFTTESDVWSFGVVLWEIFT 255
Query: 251 -GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAF 309
G QPW+ S E + +E P PP V ++ GC++ + + R + D+
Sbjct: 256 YGKQPWYQLSNTEAIDCITQGRELER-PRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
Query: 310 ES--SQNAVYND 319
++ VY D
Sbjct: 315 QALAQAPPVYLD 326
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 67/344 (19%), Positives = 117/344 (34%), Gaps = 59/344 (17%)
Query: 25 HLRTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL 83
H P T +D +K + IG G FG V A + A+K
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKR-- 59
Query: 84 PLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGKICIAMKF----------- 129
+KE +K F E+ K ++ L G G + +A+++
Sbjct: 60 -MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 130 ----YEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185
E IA L +L + +A+G+ L + +L N+L+ E+
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178
Query: 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGT---P-NYMAPEQWEPEVRGPISF------- 234
+ DFG L R ++ ++ P +MA E S
Sbjct: 179 YVAKIADFG-----LSR---GQEVYVKKTMGRLPVRWMAIE----------SLNYSVYTT 220
Query: 235 ETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFE 293
+D W +G + E+++ G P+ G + E+Y + P V +++ C+
Sbjct: 221 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWR 279
Query: 294 YDLRNRPLMADILHAFES--SQNAVYNDGEWTGLGSRALTDTSS 335
RP A IL + + Y + + A D S+
Sbjct: 280 EKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSA 323
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 30/281 (10%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP + ++ +G G FG V+ A + ++ A K++ E+ + ++ E
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGA------LAAAKVIETKSEEELEDYIV--EI 67
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQL 158
+ + L G +GK+ I ++F G+V I + L P I Q+
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQM 126
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGT 215
+ ++ LHS ++ +LK N+L++ + L DFG+ + R +GT
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN------LKTLQKRDSFIGT 180
Query: 216 PNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKE 272
P +MAPE E P ++ D W G +++EM P + + + I K
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKS 237
Query: 273 KP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P PS + + + + RP A +L H F
Sbjct: 238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 37/233 (15%), Positives = 85/233 (36%), Gaps = 25/233 (10%)
Query: 37 RPWIDPTSL-KLKHRIGRGP--FGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF 93
++ +L IG+G V LA + + + V+ + L E C+
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTG------EYVTVRRI-NL-EACSNEM 69
Query: 94 VNKF--EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPD 150
V E K ++ + + ++ + F GS D I +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 151 I---LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG----RS 203
I L+ + K + +H +G + ++K S++L+S ++ L ++ +
Sbjct: 130 IAYILQ---GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256
+ + +++PE + ++G ++D + G + E+ G P+
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVPFK 238
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 66/307 (21%), Positives = 103/307 (33%), Gaps = 56/307 (18%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W L +G G FG V AT + D +AVKM LK
Sbjct: 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS-DAAMTVAVKM---LKPSAHLTEREAL 73
Query: 98 E---ELFPKFRESQSVCWLHGISVINGKICIAM-----------------KFYEGSVGDR 137
++ ++ L G I G + F
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 138 IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
I + L L D+L + Q+AKG++ L S + +L N+LL+ + DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG--- 190
Query: 198 LLLGRSLSDSDMALRLGTPNY------------MAPEQWEPEVRGPISFETDTWGFGCSI 245
L R + + NY MAPE +FE+D W +G +
Sbjct: 191 --LARDIKNDS--------NYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFL 237
Query: 246 MEMLT-GIQPWFGKSV-EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMA 303
E+ + G P+ G V + Y + P P + +++ C++ D RP
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 304 DILHAFE 310
I+ E
Sbjct: 297 QIVQLIE 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 65/329 (19%), Positives = 120/329 (36%), Gaps = 62/329 (18%)
Query: 23 PDHLRTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM 81
P + R + + +++ IG G FG V+ A + + +AVKM
Sbjct: 26 PMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPY-EPFTMVAVKM 84
Query: 82 LLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGKICIAMKF--------- 129
LKE+ + F+ L +F V L G+ + +C+ ++
Sbjct: 85 ---LKEEASADMQADFQREAALMAEFDNPNIVK-LLGVCAVGKPMCLLFEYMAYGDLNEF 140
Query: 130 --------------YEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNL 175
+ S R++ L + L Q+A G++ L + +L
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200
Query: 176 KPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY-----MAPEQWEPEVRG 230
N L+ E+ + + DFG L R++ +D + + M PE
Sbjct: 201 ATRNCLVGENMVVKIADFG-----LSRNIYSAD-YYKADGNDAIPIRWMPPE-------- 246
Query: 231 PISF-------ETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
S E+D W +G + E+ + G+QP++G + EE+ + V C P P
Sbjct: 247 --SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC-PENCPL 303
Query: 283 AVENVIIGCFEYDLRNRPLMADILHAFES 311
+ N++ C+ +RP I +
Sbjct: 304 ELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 60/246 (24%), Positives = 92/246 (37%), Gaps = 57/246 (23%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVF---------- 93
K ++G G FGDV L S E +K + + ++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSG------LERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 94 ---VNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVG---DRI--AQQRGGK 145
+ K E+F E + I M+ EG G +RI AQ RG
Sbjct: 79 HPNIIKIFEVF----EDYH------------NMYIVMETCEG--GELLERIVSAQARGKA 120
Query: 146 LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGR 202
L + Q+ ++ HS ++ +LKP N+L S H + + DFG L
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG-----LAE 175
Query: 203 SLSDSD-MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE 261
+ GT YMAPE + ++F+ D W G + +LTG P+ G S+E
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEV----FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231
Query: 262 EIYHSV 267
E+
Sbjct: 232 EVQQKA 237
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 61/328 (18%), Positives = 111/328 (33%), Gaps = 56/328 (17%)
Query: 13 SFEYELFEGDPDHLRTVVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDF 71
S + R + ID L L +G G FG V Q
Sbjct: 3 SSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG-- 60
Query: 72 DEYHELAVKMLLPLKEDCAKVF-VNKFE---ELFPKFRESQSVCWLHGISVINGKIC--- 124
++AVK + K D + + +F F + L G+ +
Sbjct: 61 -TSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSHPNVIR-LLGVCIEMSSQGIPK 115
Query: 125 --IAMKFYEGSVGD-------RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNL 175
+ + F + GD + +PL +L++ + +A G+ L + L +L
Sbjct: 116 PMVILPFMKY--GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 176 KPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN-----YMAPEQWEPEVRG 230
N +L + + + DFG L + + D R G ++A E
Sbjct: 174 AARNCMLRDDMTVCVADFG-----LSKKIYSGDYY-RQGRIAKMPVKWIAIE-------- 219
Query: 231 PISF-------ETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
S ++D W FG ++ E+ T G+ P+ G E+Y ++ P
Sbjct: 220 --SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ-PEDCLD 276
Query: 283 AVENVIIGCFEYDLRNRPLMADILHAFE 310
+ ++ C+ D +RP + + E
Sbjct: 277 ELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 60/320 (18%), Positives = 115/320 (35%), Gaps = 76/320 (23%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W +L L +G G FG V AT Y +AVKM LKE+ + +
Sbjct: 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKM---LKENASPSELRDL 73
Query: 98 E---ELFPKFRESQSVCWLHGISVINGKICIAMKF-----------------------YE 131
+ + + L+G +G + + +++
Sbjct: 74 LSEFNVLKQVNHPHVIK-LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 132 GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191
+ L + D++ + Q+++G+ L + L+ +L N+L++E ++ +
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 192 DFGIPYLLLGRSLSDSDMALRLGTPNY------------MAPEQWEPEVRGPISF----- 234
DFG L R + + D +Y MA E S
Sbjct: 193 DFG-----LSRDVYEED--------SYVKRSQGRIPVKWMAIE----------SLFDHIY 229
Query: 235 --ETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGC 291
++D W FG + E++T G P+ G E +++ + P + +++ C
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQC 288
Query: 292 FEYDLRNRPLMADILHAFES 311
++ + RP+ ADI E
Sbjct: 289 WKQEPDKRPVFADISKDLEK 308
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 40/274 (14%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-F 104
L +G G FG V + H + H++AVK+L + + ++ K
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTG------HKVAVKIL-------NRQKIRS-LDVVGKIK 59
Query: 105 RESQ--------SVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYG 155
RE Q + L+ + + M++ G + D I + G++ + R
Sbjct: 60 REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLF 117
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-- 213
Q+ + H ++ +LKP N+LL H + DFG L +SD + LR
Sbjct: 118 QQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG-----LSNMMSDGEF-LRTSC 171
Query: 214 GTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
G+PNY APE + GP E D W G + +L G P+ + V ++ I+
Sbjct: 172 GSPNYAAPEVISGRLYAGP---EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK--IRGG 226
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
IP L +V +++ + D R + DI
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIR 260
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 64/339 (18%), Positives = 119/339 (35%), Gaps = 56/339 (16%)
Query: 6 RAHKPAASFEYELFEGDPDHLRTVVATPTQTRP---W-IDPTSLKLKHRIGRGPFGDVWL 61
KP +++ E + T + PTQ W +L+ +G G FG V
Sbjct: 6 YKQKPKYQVRWKIIESYEGNSYTFI-DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 62 ATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISV 118
AT + D ++AVKM LK ++ + +++ L G
Sbjct: 65 ATAFGLGKE-DAVLKVAVKM---LKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 119 INGKICIAMKFYEG-------------SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
G + + ++ D D+L + Q+A+G++ L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY------- 218
S + ++ N+LL+ +GDFG L R + + NY
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFG-----LARDIMNDS--------NYIVKGNAR 227
Query: 219 -----MAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFG-KSVEEIYHSVVIKK 271
MAPE + ++D W +G + E+ + G+ P+ G + Y V
Sbjct: 228 LPVKWMAPESI---FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284
Query: 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ P+ P + +++ C+ + +RP I +
Sbjct: 285 QMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 52/241 (21%), Positives = 89/241 (36%), Gaps = 29/241 (12%)
Query: 31 ATPTQTRPWIDPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC 89
+ + PW +L+ IG G V A ++A+K + L++
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKK------EKVAIKRI-NLEKCQ 54
Query: 90 AKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPL 148
+ E ++ + V+ ++ + MK GSV D I
Sbjct: 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114
Query: 149 PDILRYGI------QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
+L ++ +G+ LH G + ++K N+LL E + + DFG+
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-----SA 169
Query: 203 SLSDSDMALRL-------GTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
L+ R GTP +MAPE E F+ D W FG + +E+ TG P+
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGITAIELATGAAPY 227
Query: 256 F 256
Sbjct: 228 H 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 33/271 (12%), Positives = 63/271 (23%), Gaps = 64/271 (23%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
L G P W A +A+ + P + + +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQ------VALTFVDP-QGVLPDDVLQETL------SR 81
Query: 107 SQSVCWL--------HGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQ 157
+ + + + + ++ G S+ + +R
Sbjct: 82 TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQS 137
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
LA H G+ + PS + +S +VL
Sbjct: 138 LAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------- 174
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV-IKKEKPCI 276
M + + D G G S+ +L P V +P
Sbjct: 175 TMPDA----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224
Query: 277 PS----GLPPAVENVIIGCFEYDLRNRPLMA 303
P+ +P + V + D R
Sbjct: 225 PADIDRDIPFQISAVAARSVQGDGGIRSAST 255
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 68/270 (25%), Positives = 109/270 (40%), Gaps = 42/270 (15%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-- 108
+G G FG V + H + H++AVK+L + + + + RE Q
Sbjct: 24 LGVGTFGKVKVGKHELTG------HKVAVKIL-------NRQKIRSLDVVGKIRREIQNL 70
Query: 109 ------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQLA 159
+ L+ + I + M++ G G D I + G+L + R Q+
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSG--GELFDYICKN--GRLDEKESRRLFQQIL 126
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL--GTPN 217
G+ H ++ +LKP N+LL H + DFG L +SD + LR G+PN
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG-----LSNMMSDGEF-LRTSCGSPN 180
Query: 218 YMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276
Y APE + GP E D W G + +L G P+ V ++ I
Sbjct: 181 YAAPEVISGRLYAGP---EVDIWSSGVILYALLCGTLPFDDDHVPTLFKK--ICDGIFYT 235
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
P L P+V +++ + D R + DI
Sbjct: 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIR 265
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 69/272 (25%), Positives = 95/272 (34%), Gaps = 73/272 (26%)
Query: 20 EGDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAV 79
+ D + TVVATP Q S IG G FG V+ A S + A+
Sbjct: 31 DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV------AI 84
Query: 80 KMLLPLKEDCAKVFVNKFEELFPKFRESQS---------VCWLHGISVINGK-----ICI 125
K KV +K + RE Q V + K + +
Sbjct: 85 K----------KVLQDKRFKN----RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 126 AMKFYEGSVGDRIAQQRGGKLPLPDIL--RYGIQLAKGISDLHSIGLLVLNLKPSNLLL- 182
+ + +V K LP I Y QL + ++ +HS G+ ++KP NLLL
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD 190
Query: 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN--------YMAPE------QWEPEV 228
+ L L DFG + L G PN Y APE + +
Sbjct: 191 PDTAVLKLCDFG-----SAKQLVR-------GEPNVSYICSRYYRAPELIFGATDYTSSI 238
Query: 229 RGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
D W GC + E+L G QP F G S
Sbjct: 239 --------DVWSAGCVLAELLLG-QPIFPGDS 261
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 44/273 (16%), Positives = 85/273 (31%), Gaps = 66/273 (24%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSV 110
+ +G F + L A+K K + K + + S+
Sbjct: 39 LNQGKFNKIILCEKDN--------KFYALKKY-------EKSLLEKKRDFTKSNNDKISI 83
Query: 111 CW----------------------LHGISVINGKICIAMKFYEG-------SVGDRIAQQ 141
GI ++ I ++ E + +
Sbjct: 84 KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLN-----LKPSNLLLSEHDQLVLGDFGIP 196
+P+ I + S +H+ N +KPSN+L+ ++ ++ L DFG
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNE----KNICHRDVKPSNILMDKNGRVKLSDFG-- 197
Query: 197 YLLLGRSLSDSDMALRLGTPNYMAPE--QWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
+ D + GT +M PE E G + D W G + M + P
Sbjct: 198 ---ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNVVP 251
Query: 255 WFGK-SVEEIYHSVVIKKEKPCIPSGLPPAVEN 286
+ K S+ E++++ I+ + P +
Sbjct: 252 FSLKISLVELFNN--IRTKNIEYPLDRNHFLYP 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 43/284 (15%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
P + + ++G G +G V+ A H ++ +A+K + P++ D ++ E
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQ------IVAIKQV-PVESDLQEIIK---EI 75
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQL 158
+ +S V +G N + I M++ GSV D I + R L +I
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQST 134
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGT 215
KG+ LH + + ++K N+LL+ L DFG+ L+D+ MA R +GT
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGV-----AGQLTDT-MAKRNTVIGT 188
Query: 216 PNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV----VI 269
P +MA PEV + D W G + +EM G P+ H + +I
Sbjct: 189 PFWMA-----PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD------IHPMRAIFMI 237
Query: 270 KKEKP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P P + + C R +L H F
Sbjct: 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 57/280 (20%), Positives = 117/280 (41%), Gaps = 35/280 (12%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP +IG+G G V+ A + E+A++ + ++ ++ +N E
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATG------QEVAIRQMNLQQQPKKELIIN--EI 68
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQL 158
L + ++ ++ ++ ++ + M++ GS+ D + + + + + R +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---EC 125
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR---LGT 215
+ + LHS ++ ++K N+LL + L DFG + + + R +GT
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMVGT 179
Query: 216 PNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKE 272
P +MA PEV R + D W G +EM+ G P+ ++ + +Y +
Sbjct: 180 PYWMA-----PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNG 232
Query: 273 KPCI--PSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P + P L + + C E D+ R ++L H F
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 69/297 (23%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP L +IG G G V LA S ++AVKM+ L++ + E
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGR------QVAVKMM-DLRKQ------QRREL 88
Query: 100 LFPK---FRESQS--VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILR 153
LF + R+ Q V ++ ++ ++ + M+F + G++ D + +L I
Sbjct: 89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIAT 145
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR- 212
+ + ++ LH+ G++ ++K ++LL+ ++ L DFG + D+ R
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------SKDVPKRK 199
Query: 213 --LGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
+GTP +MA PEV R + E D W G ++EM+ G P+F
Sbjct: 200 SLVGTPYWMA-----PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF------------ 242
Query: 269 IKKEKP-----CIPSGLPPAVENV----------IIGCFEYDLRNRPLMADIL-HAF 309
+ P + PP ++N + D + R ++L H F
Sbjct: 243 --SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 54/242 (22%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVN---------- 95
+G G F +V+L + F A+K + N
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLF------ALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 96 ----KFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPL 148
E+++ ES + + M+ G G DRI ++ G
Sbjct: 66 ENIVTLEDIY----ESTT------------HYYLVMQLVSG--GELFDRILER--GVYTE 105
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLS 205
D Q+ + LH G++ +LKP NLL E+ ++++ DFG L +
Sbjct: 106 KDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG-----LSKMEQ 160
Query: 206 DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH 265
+ M+ GTP Y+APE + D W G +L G P++ ++ +++
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSK---AVDCWSIGVITYILLCGYPPFYEETESKLFE 217
Query: 266 SV 267
+
Sbjct: 218 KI 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/267 (17%), Positives = 92/267 (34%), Gaps = 36/267 (13%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-- 108
+G G FG VW A + E+ VK + KE + + +L E
Sbjct: 32 LGSGAFGFVWTAVDKEKN------KEVVVKFIK--KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 109 ------SVCWLHGISVINGKICIAMKFYE--GSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
++ + I G + M+ + + I + +L P QL
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVS 141
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
+ L ++ ++K N++++E + L DFG GT Y A
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG----SAAYLERGKLFYTFCGTIEYCA 197
Query: 221 PEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279
PE RGP E + W G ++ ++ P+ +EE + + P
Sbjct: 198 PEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCE--LEETVEAAIH------PPYL 246
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADIL 306
+ + +++ G + R + ++
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLV 273
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 45/238 (18%), Positives = 83/238 (34%), Gaps = 34/238 (14%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G G+V LA ++ A++++ K
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKV------AIRIISKRKFAIGSAREADPALNV--ET 189
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E + + + I ++ EG G D++ +L Y
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEG--GELFDKVVGN--KRLKEATCKLY 244
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSDSD-MA 210
Q+ + LH G++ +LKP N+LLS ++ + + DFG + L ++ M
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG-----HSKILGETSLMR 299
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEIYHSV 267
GTP Y+APE + D W G + L+G P ++ + +
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 68/333 (20%), Positives = 107/333 (32%), Gaps = 72/333 (21%)
Query: 22 DPDHLRT---VVATPTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHEL 77
DPD L P W LKL +GRG FG V A +
Sbjct: 2 DPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT-ATCRTV 60
Query: 78 AVKMLLPLKEDCAKVFVNKFE---ELFPKFRESQSVCWLHGISVINGK-ICIAMKF---- 129
AVKM LKE ++ +V L G G + + ++F
Sbjct: 61 AVKM---LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 130 -----------YEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPS 178
L L ++ Y Q+AKG+ L S + +L
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 179 NLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY------------MAPEQWEP 226
N+LLSE + + + DFG L R + +Y MAPE
Sbjct: 178 NILLSEKNVVKICDFG-----LARDIYKDP--------DYVRKGDARLPLKWMAPE---- 220
Query: 227 EVRGPISF-------ETDTWGFGCSIMEMLT-GIQPWFGKSV-EEIYHSVVIKKEKPCIP 277
+ ++D W FG + E+ + G P+ G + EE + P
Sbjct: 221 ------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-P 273
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
P + ++ C+ + RP ++++
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 45/238 (18%), Positives = 81/238 (34%), Gaps = 32/238 (13%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ K +GRG V H + E AVK++ + +
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTC------KEYAVKIIDVTGGGSFSAEEVQELREATL-K 72
Query: 106 ESQ---------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILR 153
E ++ L N + + G D + ++ L + +
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK--GELFDYLTEK--VTLSEKETRK 128
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD-MALR 212
L + I LH + ++ +LKP N+LL + + L DFG L + +
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG-----FSCQLDPGEKLREV 183
Query: 213 LGTPNYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP+Y+APE + E D W G + +L G P++ + + +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 42/237 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G+G FG+V + ++ AVK++ K + R
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEY------AVKVIN--KASAKNKDTSTIL------R 70
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E + ++ L I + I + Y G G D I ++ + D R
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG--GELFDEIIKR--KRFSEHDAARI 126
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSD-MA 210
Q+ GI+ +H ++ +LKP N+LL + + + DFG L + M
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG-----LSTCFQQNTKMK 181
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
R+GT Y+APE +RG + D W G + +L+G P++GK+ +I V
Sbjct: 182 DRIGTAYYIAPEV----LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 44/237 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
L++ IGRG +G+V +A + A K + K FV + +
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRR------AAKKI-------PKYFVEDVDRFK---Q 55
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E + ++ L+ N I + M+ G G +R+ + D R
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG--GELFERVVHK--RVFRESDAARI 111
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSD-MA 210
+ ++ H + + +LKP N L S L L DFG L M
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG-----LAARFKPGKMMR 166
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
++GTP Y++P+ + G E D W G + +L G P+ + E+ +
Sbjct: 167 TKVGTPYYVSPQV----LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 67/271 (24%), Positives = 101/271 (37%), Gaps = 75/271 (27%)
Query: 21 GDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK 80
DP+ + V+A+ +T + IG G FG V+ A +S E+A+K
Sbjct: 19 DDPNKVIKVLASDGKT-GEQREIAYTNCKVIGNGSFGVVFQAKLVES-------DEVAIK 70
Query: 81 MLLPLKEDCAKVFVNKFEELFPKFRESQS--------VCWLHGISVING------KICIA 126
KV +K + RE Q V L NG + +
Sbjct: 71 ----------KVLQDKRFKN----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 127 MKFYEGSVGDRIAQQRGGKLPLPDIL--RYGIQLAKGISDLHSIGLLVLNLKPSNLLL-S 183
+++ +V K +P +L Y QL + ++ +HSIG+ ++KP NLLL
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP 176
Query: 184 EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN--------YMAPE------QWEPEVR 229
L L DFG + L G PN Y APE + +
Sbjct: 177 PSGVLKLIDFG-----SAKILIA-------GEPNVSYICSRYYRAPELIFGATNYTTNI- 223
Query: 230 GPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
D W GC + E++ G QP F G+S
Sbjct: 224 -------DIWSTGCVMAELMQG-QPLFPGES 246
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 52/241 (21%), Positives = 88/241 (36%), Gaps = 39/241 (16%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
K IGRG V H + HE AVK++ E + + + E R
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATG------HEFAVKIMEVTAERLSPEQLEEVREAT--RR 148
Query: 106 ESQSVCWLHGIS----VI--------NGKICIAMKFYEGSVG---DRIAQQRGGKLPLPD 150
E L ++ +I + + + G D + ++ L +
Sbjct: 149 E---THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK--GELFDYLTEK--VALSEKE 201
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD-M 209
L + +S LH+ ++ +LKP N+LL ++ Q+ L DFG L + +
Sbjct: 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG-----FSCHLEPGEKL 256
Query: 210 ALRLGTPNYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266
GTP Y+APE E E D W G + +L G P++ + +
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 267 V 267
+
Sbjct: 317 I 317
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/330 (17%), Positives = 115/330 (34%), Gaps = 75/330 (22%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W +L+ +G G FG V AT + + ++AVKM LKE
Sbjct: 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKT-GVSIQVAVKM---LKEKADSSEREAL 95
Query: 98 E---ELFPKFRESQSVCWLHGISVINGKICIAMKF----------------------YEG 132
++ + +++ L G ++G I + ++
Sbjct: 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 133 SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192
+ ++ L D+L + Q+AKG+ L + +L N+L++ + + D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 193 FGIPYLLLGRSLSDSDMALRLGTPNY------------MAPEQWEPEVRGPI-----SFE 235
FG L R + NY MAPE + + +
Sbjct: 216 FG-----LARDIMSDS--------NYVVRGNARLPVKWMAPES--------LFEGIYTIK 254
Query: 236 TDTWGFGCSIMEMLT-GIQPWFGKSV-EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFE 293
+D W +G + E+ + G+ P+ G V Y + + P + ++ C+
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWA 313
Query: 294 YDLRNRPLMADILHAFE----SSQNAVYND 319
+D R RP ++ ++ A+Y +
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAEEAMYQN 343
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 65/285 (22%), Positives = 102/285 (35%), Gaps = 56/285 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-F 104
L +G G +G+V LA + + +AVK++ + +
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIV-------DM---KRAVDCPENIK 53
Query: 105 RESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILR 153
+E +V +G + +++ G G DRI +P PD R
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG--GELFDRIEPD--IGMPEPDAQR 109
Query: 154 YGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ QL G+ LH IG+ ++KP NLLL E D L + DFG L ++ L
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG-----LATVFRYNNRERLL 164
Query: 214 ----GTPNYMAPEQWEPEV------RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263
GT Y+A PE+ D W G + ML G PW S
Sbjct: 165 NKMCGTLPYVA-----PELLKRREFHAE---PVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 264 YHSVVIKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+S +K+ P + A ++ + R + DI
Sbjct: 217 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 58/277 (20%), Positives = 91/277 (32%), Gaps = 79/277 (28%)
Query: 21 GDPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVK 80
G + A R + +++ G+G FG V L + A+K
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSV------AIK 54
Query: 81 MLLPLKEDCAKVFVNKFEELFPKFRESQS------------VCWLHGISVINGK------ 122
KV + F + RE Q V + +
Sbjct: 55 ----------KVIQDP---RF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDIL--RYGIQLAKGISDLHSIGLLVLN--LKPS 178
+ + M++ ++ ++ P IL + QL + I LH + V + +KP
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160
Query: 179 NLLLSEHD-QLVLGDFGIPYLLLGRSLSDSDMALRLGTPN--------YMAPE------Q 223
N+L++E D L L DFG + LS PN Y APE
Sbjct: 161 NVLVNEADGTLKLCDFG-----SAKKLSP-------SEPNVAYICSRYYRAPELIFGNQH 208
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
+ V D W GC EM+ G +P F G +
Sbjct: 209 YTTAV--------DIWSVGCIFAEMMLG-EPIFRGDN 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 41/237 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+K +G+G F V H + E A K++ + + K E R
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTG------LEFAAKIIN--TKKLSARDFQKLE------R 54
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E++ ++ LH + G G + I + D
Sbjct: 55 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG--GELFEDIVAR--EFYSEADASHC 110
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSD-MA 210
Q+ + I+ HS G++ NLKP NLLL ++ + L DFG L ++DS+
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG-----LAIEVNDSEAWH 165
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP Y++PE + + D W G + +L G P++ + +Y +
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSK---PVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 64/280 (22%), Positives = 101/280 (36%), Gaps = 56/280 (20%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-FRESQ- 108
+G G +G+V LA + + +AVK++ + + +E
Sbjct: 15 LGEGAYGEVQLAVNRVTE------EAVAVKIV-------DM---KRAVDCPENIKKEICI 58
Query: 109 -------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQL 158
+V +G + +++ G G DRI +P PD R+ QL
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSG--GELFDRIEPD--IGMPEPDAQRFFHQL 114
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL----G 214
G+ LH IG+ ++KP NLLL E D L + DFG L ++ L G
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG-----LATVFRYNNRERLLNKMCG 169
Query: 215 TPNYMAPEQWEPEV------RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268
T Y+A PE+ D W G + ML G PW S +S
Sbjct: 170 TLPYVA-----PELLKRREFHAE---PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 269 IKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+K+ P + A ++ + R + DI
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/272 (17%), Positives = 88/272 (32%), Gaps = 44/272 (16%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-FRESQ- 108
+G G FG V+ +A+K + + ++ + E
Sbjct: 51 LGSGGFGSVYSGIRVSDN------LPVAIKHV-----EKDRISDWGELPNGTRVPMEVVL 99
Query: 109 ---------SVCWLHGISVINGKICIAMKFYEGS--VGDRIAQQRGGKLPLPDILRYGIQ 157
V L + ++ E + D I ++ G L + Q
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 157
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALRLGTP 216
+ + + H+ G+L ++K N+L+ + + L DFG LL +D D GT
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----GTR 212
Query: 217 NYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275
Y PE G W G + +M+ G P+ I + +
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVF 261
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+ +++I C +RP +I +
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 42/224 (18%), Positives = 75/224 (33%), Gaps = 42/224 (18%)
Query: 51 IGRGPFGDVWLATHHQ-----------SADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
+G G F VWLA + E E +K+L + + +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 100 LFPKFRES---QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI 156
K + + +H + + + ++ I + +PL + +
Sbjct: 87 HILKLLDHFNHKGPNGVH--------VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 157 QLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQ------LVLGDFGIPYLLLGRSLSDSDM 209
QL G+ +H G++ ++KP N+L+ D + + D G D
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN------ACWYDEHY 192
Query: 210 ALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTG 251
+ T Y +PE V P D W C I E++TG
Sbjct: 193 TNSIQTREYRSPE-----VLLGAPWGCGADIWSTACLIFELITG 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 49/229 (21%), Positives = 84/229 (36%), Gaps = 38/229 (16%)
Query: 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRES 107
K +G G G V H ++ A+K+L D K + + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKC------ALKLL----YDSPKAR--QEVDHHWQASGG 81
Query: 108 QSVCWLHGI----SVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPD---ILRYGIQ 157
+ + + + I M+ EG G RI ++ + I+R
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEG--GELFSRIQERGDQAFTEREAAEIMR---D 136
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSDSDMALRLG 214
+ I LHS + ++KP NLL + ++ L L DFG + + + +
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG-----FAKETTQNALQTPCY 191
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263
TP Y+APE PE D W G + +L G P++ + + I
Sbjct: 192 TPYYVAPEVLGPEKYDK---SCDMWSLGVIMYILLCGFPPFYSNTGQAI 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 48/244 (19%), Positives = 88/244 (36%), Gaps = 46/244 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKEDCAKVFVNKFEELF 101
+ +G G G+V LA ++ ++A+K++ + E
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTC------KKVAIKIISKRKFAIGSAREADPALNVE--- 63
Query: 102 PKFRESQSVCWLHGIS---VIN-------GKICIAMKFYEGSVG---DRIAQQRGGKLPL 148
E + L ++ +I I ++ EG G D++ +L
Sbjct: 64 ---TE---IEILKKLNHPCIIKIKNFFDAEDYYIVLELMEG--GELFDKVVGN--KRLKE 113
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPYLLLGRSLS 205
Y Q+ + LH G++ +LKP N+LLS + + + DFG + L
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG-----HSKILG 168
Query: 206 DSD-MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEI 263
++ M GTP Y+APE + D W G + L+G P ++ +
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 264 YHSV 267
+
Sbjct: 229 KDQI 232
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 53/245 (21%), Positives = 96/245 (39%), Gaps = 50/245 (20%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+L IG+GPF V + ++ F AVK++ E+L R
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQF------AVKIVD--VAKFTSSPGLSTEDLK---R 75
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLP----- 149
E+ + L +G + + +F +G I ++
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG--ADLCFEIVKRADAGFVYSEAVAS 133
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPYLLLGRSLSD 206
+R Q+ + + H ++ ++KP +LL+ + + LG FG + L +
Sbjct: 134 HYMR---QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG-----VAIQLGE 185
Query: 207 SDMAL--RLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262
S + R+GTP++MA PEV R P D WG G + +L+G P++G E
Sbjct: 186 SGLVAGGRVGTPHFMA-----PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ER 239
Query: 263 IYHSV 267
++ +
Sbjct: 240 LFEGI 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 55/239 (23%), Positives = 90/239 (37%), Gaps = 45/239 (18%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+K +G+G F V H + E A K++ + + K E R
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTG------LEFAAKIIN--TKKLSARDFQKLE------R 77
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E++ ++ LH + G G + I + D
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG--GELFEDIVAR--EFYSEADASHC 133
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPYLLLGRSLSDSD-MA 210
Q+ + I+ HS G++ NLKP NLLL+ + L DFG L ++DS+
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG-----LAIEVNDSEAWH 188
Query: 211 LRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP Y++ PEV + P S D W G + +L G P++ + +Y +
Sbjct: 189 GFAGTPGYLS-----PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 39/153 (25%)
Query: 125 IAMKFYEGSVGDRIAQQRGGKLPLPDIL--RYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182
+ M++ ++ + +P L Y QL + + +HS+G+ ++KP NLL+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 183 -SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN--------YMAPE------QWEPE 227
S+ + L L DFG + L P+ Y APE ++ P
Sbjct: 175 NSKDNTLKLCDFG-----SAKKLIP-------SEPSVAYICSRFYRAPELMLGATEYTPS 222
Query: 228 VRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
+ D W GC E++ G +P F G++
Sbjct: 223 I--------DLWSIGCVFGELILG-KPLFSGET 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 50/275 (18%), Positives = 87/275 (31%), Gaps = 48/275 (17%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF-VNKFEELFPKFRESQ- 108
+G+G FG V+ ++A+K++ +V + + E
Sbjct: 39 LGKGGFGTVFAGHRLTDR------LQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 109 -----------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
V L + ++ D I ++ G L +
Sbjct: 88 LWKVGAGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEK--GPLGEGPSRCF 144
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV-LGDFGIPYLLLGRSLSDSDMALRL 213
Q+ I HS G++ ++K N+L+ L DFG LL +D D
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----- 199
Query: 214 GTPNYMAPEQWEPEV-RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272
GT Y PE W G + +M+ G P+ I +
Sbjct: 200 GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQE--------ILEA 248
Query: 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307
+ P+ + P +I C +RP + +IL
Sbjct: 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 7e-11
Identities = 33/134 (24%), Positives = 53/134 (39%), Gaps = 28/134 (20%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
G L + + QL KG+ HS +L +LKP NLL++ + +L L +FG L
Sbjct: 93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG-----L 147
Query: 201 GRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEML 249
R+ +R + Y P+ + + D W GC E+
Sbjct: 148 ARAFGI---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSI--------DMWSAGCIFAELA 196
Query: 250 TGIQPWF-GKSVEE 262
+P F G V++
Sbjct: 197 NAGRPLFPGNDVDD 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 50/234 (21%), Positives = 97/234 (41%), Gaps = 42/234 (17%)
Query: 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE 98
W + +L ++GRG + +V+ A + + + ++ VK+L P+K+ K
Sbjct: 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPVKKKKIK------R 79
Query: 99 E--LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGD--RIAQQRGGKLPLPDILRY 154
E + R ++ L I A+ F + D ++ Q L DI Y
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFY 135
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL-SEHDQLVLGDFGIPYLLLGRSLS-DSDMALR 212
++ K + HS+G++ ++KP N+++ EH +L L D+G L + +R
Sbjct: 136 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LAEFYHPGQEYNVR 190
Query: 213 LGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
+ + + PE ++ + D W GC + M+ +P+F G
Sbjct: 191 VASRYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEPFFHGHD 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 38/134 (28%), Positives = 59/134 (44%), Gaps = 29/134 (21%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
G + + ++ + QL +G++ H +L +LKP NLL++E +L L DFG L
Sbjct: 92 DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG-----L 146
Query: 201 GRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEML 249
R+ S + Y P+ + ++ D WG GC EM
Sbjct: 147 ARAKSI---PTKTYDNEVVTLWYRPPDILLGSTDYSTQI--------DMWGVGCIFYEMA 195
Query: 250 TGIQPWF-GKSVEE 262
TG +P F G +VEE
Sbjct: 196 TG-RPLFPGSTVEE 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 53/240 (22%), Positives = 92/240 (38%), Gaps = 47/240 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
++K IG G + H + +F AVK++ K D EE+ R
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEF------AVKIIDKSKRDP-------TEEIEILLR 71
Query: 106 ESQ--SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPD---ILRYGIQ 157
Q ++ L + + + + +G G D+I +Q + +L
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKG--GELLDKILRQ--KFFSEREASAVLF---T 124
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQ----LVLGDFGIPYLLLGRSLSDSDMALR- 212
+ K + LH+ G++ +LKPSN+L + + + DFG + L + L
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG-----FAKQLRAENGLLMT 179
Query: 213 -LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIM-EMLTGIQPWFGKSVE---EIYHSV 267
T N++APE E + D W G ++ MLTG P+ + EI +
Sbjct: 180 PCYTANFVAPEVLERQGYDA---ACDIWSLGV-LLYTMLTGYTPFANGPDDTPEEILARI 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 48/238 (20%), Positives = 85/238 (35%), Gaps = 42/238 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+L +G+G F V + ++ A ++ + + K E R
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEY------AAMIIN--TKKLSARDHQKLE------R 59
Query: 106 ESQ--------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRY 154
E++ ++ LH G + G G + I + D
Sbjct: 60 EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG--GELFEDIVAR--EYYSEADASHC 115
Query: 155 GIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
Q+ + + H +G++ NLKP NLLL + + L DFG+ + G
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG---EQQAWFG 172
Query: 212 RLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
GTP Y++ PEV + P D W G + +L G P++ + +Y +
Sbjct: 173 FAGTPGYLS-----PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 36/134 (26%), Positives = 53/134 (39%), Gaps = 29/134 (21%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
G L + +QL GI+ H +L +LKP NLL++ +L + DFG L
Sbjct: 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG-----L 146
Query: 201 GRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEML 249
R+ +R T Y AP+ ++ + D W GC EM+
Sbjct: 147 ARAFGIP---VRKYTHEIVTLWYRAPDVLMGSKKYSTTI--------DIWSVGCIFAEMV 195
Query: 250 TGIQPWF-GKSVEE 262
G P F G S +
Sbjct: 196 NG-TPLFPGVSEAD 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 46/240 (19%), Positives = 92/240 (38%), Gaps = 59/240 (24%)
Query: 50 RIGRGPFGDVWLATHHQSADDFDEYHEL-AVKMLLPLKEDCAKVFVNKFEELFPK--FRE 106
+IG G +G V+ + + ++ A+K K ++ + + K RE
Sbjct: 10 KIGEGSYGVVFKCRNRDT-------GQIVAIK----------KFLESEDDPVIKKIALRE 52
Query: 107 --------SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158
++ L + ++ + ++ + +V + + +P + Q
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL-DRYQRGVPEHLVKSITWQT 111
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN- 217
+ ++ H + ++KP N+L+++H + L DFG R L+
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG-----FARLLTGP---SDYYDDEV 163
Query: 218 ----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS-VEEIYH 265
Y +PE Q+ P V D W GC E+L+G P + GKS V+++Y
Sbjct: 164 ATRWYRSPELLVGDTQYGPPV--------DVWAIGCVFAELLSG-VPLWPGKSDVDQLYL 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 62/280 (22%), Positives = 94/280 (33%), Gaps = 56/280 (20%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-- 108
IG G FG L + +AVK + + + RE
Sbjct: 28 IGSGNFGVARLMRDKLTK------ELVAVKYI-----ERGAAIDENVQ------REIINH 70
Query: 109 ------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQLA 159
++ + + + I M++ G G +RI G+ + + QL
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASG--GELYERICNA--GRFSEDEARFFFQQLL 126
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVL--GDFGIPYLLLGRSLSDSDMALRLGTPN 217
G+S HS+ + +LK N LL L DFG S+ S +GTP
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPA 182
Query: 218 YMAPEQWEPEV------RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--I 269
Y+A PEV G D W G ++ ML G P+ Y + I
Sbjct: 183 YIA-----PEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 270 KKEKPCIPSG--LPPAVENVIIGCFEYDLRNRPLMADILH 307
K IP + P ++I F D R + +I
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 42/164 (25%), Positives = 66/164 (40%), Gaps = 34/164 (20%)
Query: 113 LHGISVINGKICIAMKFYEGSVGD--RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGL 170
L + + + +F E D ++ + L I Y QL +G++ H +
Sbjct: 84 LIDVIHSERCLTLVFEFMEK---DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN-----YMAPE--- 222
L +LKP NLL++ L L DFG L R+ +R T Y AP+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFG-----LARAFGI---PVRSYTHEVVTLWYRAPDVLM 192
Query: 223 ---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEE 262
++ V D W GC EM+TG +P F G + ++
Sbjct: 193 GSKKYSTSV--------DIWSIGCIFAEMITG-KPLFPGVTDDD 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 39/139 (28%), Positives = 59/139 (42%), Gaps = 29/139 (20%)
Query: 136 DRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195
R L L + + QL +G++ H +L +LKP NLL+++ QL LGDFG
Sbjct: 95 SRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG- 153
Query: 196 PYLLLGRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETDTWGFGCS 244
L R+ + + Y AP+ + + D W GC
Sbjct: 154 ----LARAFGIP---VNTFSSEVVTLWYRAPDVLMGSRTYSTSI--------DIWSCGCI 198
Query: 245 IMEMLTGIQPWF-GKSVEE 262
+ EM+TG +P F G + EE
Sbjct: 199 LAEMITG-KPLFPGTNDEE 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 30/138 (21%)
Query: 141 QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
L + +Y Q+ GI HS ++ ++KP N+L+S+ + L DFG
Sbjct: 116 LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG-----F 170
Query: 201 GRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEML 249
R+L+ + Y APE ++ V D W GC + EM
Sbjct: 171 ARTLAA---PGEVYDDEVATRWYRAPELLVGDVKYGKAV--------DVWAIGCLVTEMF 219
Query: 250 TGIQPWF-GKS-VEEIYH 265
G +P F G S ++++YH
Sbjct: 220 MG-EPLFPGDSDIDQLYH 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 8e-10
Identities = 44/164 (26%), Positives = 59/164 (35%), Gaps = 34/164 (20%)
Query: 113 LHGISVINGKICIAMKFYEGSVGD--RIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGL 170
L I + F E D I + L I Y + +G+ LH +
Sbjct: 77 LLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 133
Query: 171 LVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN-----YMAPE--- 222
L +LKP+NLLL E+ L L DFG L +S R T Y APE
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFG-----LAKSFGS---PNRAYTHQVVTRWYRAPELLF 185
Query: 223 ---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEE 262
+ V D W GC + E+L P+ G S +
Sbjct: 186 GARMYGVGV--------DMWAVGCILAELLLR-VPFLPGDSDLD 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 51/237 (21%), Positives = 85/237 (35%), Gaps = 39/237 (16%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
+G G G V + ++ + F A+KML +DC K + EL + +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKF------ALKML----QDCPKAR--REVELHWRASQ 113
Query: 107 SQSVCWLHGI----SVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQLA 159
+ + + + I M+ +G G RI + + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSDSD-MALRLGT 215
+ I LHSI + ++KP NLL + L L DFG + + + + T
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-----FAKETTSHNSLTTPCYT 226
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIM-EMLTGIQPWFGKSV----EEIYHSV 267
P Y+APE PE D W G IM +L G P++ + +
Sbjct: 227 PYYVAPEVLGPEKYDK---SCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRI 279
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 34/108 (31%), Positives = 46/108 (42%), Gaps = 17/108 (15%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD-MALRLGT 215
Q+ GI LHS G++ +LKPSN+++ L + DFG L R+ S M + T
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFMMTPYVVT 189
Query: 216 PNYMAPE---QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y APE D W GC + EM+ G F G
Sbjct: 190 RYYRAPEVILGMG------YKENVDIWSVGCIMGEMIKG-GVLFPGTD 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 38/133 (28%), Positives = 53/133 (39%), Gaps = 29/133 (21%)
Query: 138 IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
+ + +P I QL +G+ LHS ++ +LKP N+L++ Q+ L DFG
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG--- 165
Query: 198 LLLGRSLSDSDMALRLGTPN-----YMAPE-----QWEPEVRGPISFETDTWGFGCSIME 247
L R S + L T Y APE + V D W GC E
Sbjct: 166 --LARIYSFQ---MAL-TSVVVTLWYRAPEVLLQSSYATPV--------DLWSVGCIFAE 211
Query: 248 MLTGIQPWF-GKS 259
M +P F G S
Sbjct: 212 MFRR-KPLFRGSS 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 34/131 (25%), Positives = 51/131 (38%), Gaps = 27/131 (20%)
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201
K L +I R L G+ +H +L ++K +N+L++ L L DFG L
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG-----LA 171
Query: 202 RSLSDSDMALRLG-TPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEML 249
R+ S + + T Y PE + P + D WG GC + EM
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI--------DLWGAGCIMAEMW 223
Query: 250 TGIQPWF-GKS 259
T P G +
Sbjct: 224 TR-SPIMQGNT 233
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 22/110 (20%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ KG+ +HS G++ +LKP NL ++E +L + DFG L R +D++M + T
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG-----LARH-ADAEMTGYVVTR 187
Query: 217 NYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y APE + V D W GC + EMLTG + F GK
Sbjct: 188 WYRAPEVILSWMHYNQTV--------DIWSVGCIMAEMLTG-KTLFKGKD 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 39/138 (28%), Positives = 51/138 (36%), Gaps = 34/138 (24%)
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-----QLVLGDFGIP 196
+ + + I + QL G++ HS L +LKP NLLLS D L +GDFG
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG-- 182
Query: 197 YLLLGRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETDTWGFGCSI 245
L R+ +R T Y PE + V D W C
Sbjct: 183 ---LARAFGIP---IRQFTHEIITLWYRPPEILLGSRHYSTSV--------DIWSIACIW 228
Query: 246 MEMLTGIQPWF-GKSVEE 262
EML P F G S +
Sbjct: 229 AEMLMK-TPLFPGDSEID 245
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 8e-09
Identities = 37/133 (27%), Positives = 52/133 (39%), Gaps = 29/133 (21%)
Query: 138 IAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
+ + LP I Q +G+ LH+ ++ +LKP N+L++ + L DFG
Sbjct: 109 LDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG--- 165
Query: 198 LLLGRSLSDSDMALRLGTPN-----YMAPE-----QWEPEVRGPISFETDTWGFGCSIME 247
L R S + L TP Y APE + V D W GC E
Sbjct: 166 --LARIYSYQ---MAL-TPVVVTLWYRAPEVLLQSTYATPV--------DMWSVGCIFAE 211
Query: 248 MLTGIQPWF-GKS 259
M +P F G S
Sbjct: 212 MFRR-KPLFCGNS 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 22/110 (20%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ +HS ++ +LKPSNL ++E +L + DFG L R + +M + T
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG-----LARH-TADEMTGYVATR 193
Query: 217 NYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y APE + V D W GC + E+LTG + F G
Sbjct: 194 WYRAPEIMLNWMHYNQTV--------DIWSVGCIMAELLTG-RTLFPGTD 234
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/247 (17%), Positives = 85/247 (34%), Gaps = 52/247 (21%)
Query: 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE 98
+ ++ I G +G V + +A+K + VN
Sbjct: 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEG-------IPVAIKRVF--NTVSDGRTVNILS 68
Query: 99 -ELFPK--FRESQSVCWLHG---ISVIN----------GKICIAMKFYEGSVGDRIAQQR 142
K RE + + H + + + K+ + + + I
Sbjct: 69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI---H 125
Query: 143 GGKLPLPDI-LRYGI-QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200
++ + ++Y + + G+ LH G++ +L P N+LL++++ + + DF L
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN-----L 180
Query: 201 GRSLS-DSDMALRLGTPNYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQ 253
R + D++ + Y APE + V D W GC + EM +
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLV--------DMWSAGCVMAEMFNR-K 231
Query: 254 PWF-GKS 259
F G +
Sbjct: 232 ALFRGST 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 51/269 (18%), Positives = 90/269 (33%), Gaps = 62/269 (23%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFE-ELFPK 103
++ +IG G FG++ L + + + +A+K+ E ++ E + +
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNE------YVAIKL-----EPMKSRAPQLHLEYRFYKQ 60
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+ ++ + ++ S+ D + L +L IQL +
Sbjct: 61 LGSGDGIPQVYYFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 164 DLHSIGLLVLNLKPSNLLL-----SEHDQLVLGDFG-------------IPYLLLGRSLS 205
+HS L+ ++KP N L+ + + DF IPY +SL+
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY-REHKSLT 178
Query: 206 DSDMALRLGTPNYMAP------EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-- 257
GT YM+ EQ S D G M L G PW G
Sbjct: 179 --------GTARYMSINTHLGKEQ---------SRRDDLEALGHMFMYFLRGSLPWQGLK 221
Query: 258 -KSVEEIYHSVVIKKEKPCIP---SGLPP 282
+++E Y + K I P
Sbjct: 222 ADTLKERYQKIGDTKRATPIEVLCENFPE 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 55/269 (20%), Positives = 91/269 (33%), Gaps = 64/269 (23%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFE-ELFPK 103
+L +IG G FGD++L T + + E+A+K+ E K E +++
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGE------EVAIKL-----ECVKTKHPQLHIESKIYKM 60
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+ + + + M+ S+ D K L +L Q+ I
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIE 119
Query: 164 DLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFG-------------IPYLLLGRSLSDS 207
+HS + ++KP N L+ + + + + DFG IPY ++L
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY-RENKNL--- 175
Query: 208 DMALRLGTPNYMAP------EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG---K 258
GT Y + EQ S D G +M G PW G
Sbjct: 176 -----TGTARYASINTHLGIEQ---------SRRDDLESLGYVLMYFNLGSLPWQGLKAA 221
Query: 259 SVEEIYHSVVIKKEKPCIP-----SGLPP 282
+ + Y + KK P G P
Sbjct: 222 TKRQKYERISEKKMS--TPIEVLCKGYPS 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 21/110 (19%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD-MALRLGT 215
Q+ GI LHS G++ +LKPSN+++ L + DFG L R+ S M + T
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFMMTPYVVT 226
Query: 216 PNYMAPE-----QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y APE ++ V D W GC + EM+ + F G+
Sbjct: 227 RYYRAPEVILGMGYKENV--------DIWSVGCIMGEMVRH-KILFPGRD 267
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 22/110 (20%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ KG+ +H+ G++ +LKP NL ++E +L + DFG L R +DS+M + T
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG-----LARQ-ADSEMTGYVVTR 189
Query: 217 NYMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y APE ++ V D W GC + EM+TG + F G
Sbjct: 190 WYRAPEVILNWMRYTQTV--------DIWSVGCIMAEMITG-KTLFKGSD 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 49/237 (20%), Positives = 82/237 (34%), Gaps = 39/237 (16%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE-ELFPKFR 105
+G G F H +S F AVK++ K A + E
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAF------AVKIIS--KRMEANT---QKEITALKLCE 63
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQLAKGI 162
++ LH + + M+ G G +RI ++ + +L +
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNG--GELFERIKKK--KHFSETEASYIMRKLVSAV 119
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSDSDMALR--LGTPN 217
S +H +G++ +LKP NLL ++ + + + DFG R + L+ T +
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG-----FARLKPPDNQPLKTPCFTLH 174
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-------SVEEIYHSV 267
Y APE D W G + ML+G P+ S EI +
Sbjct: 175 YAAPELLNQNGYDE---SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 57/266 (21%), Positives = 96/266 (36%), Gaps = 58/266 (21%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE-ELFPKF 104
+L +IG G FG+++L T+ Q+ + E+A+K+ + +E +++
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNE------EVAIKLENVKTKHP----QLLYESKIYRIL 59
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
+ + + V + M S+ D KL L +L Q+ +
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEF 118
Query: 165 LHSIGLLVLNLKPSNLLL---SEHDQLVLGDFG-------------IPYLLLGRSLSDSD 208
+HS L ++KP N L+ +Q+ + DFG IPY ++L
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY-RENKNL---- 173
Query: 209 MALRLGTPNYMAP------EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG---KS 259
GT Y + EQ S D G +M L G PW G +
Sbjct: 174 ----TGTARYASVNTHLGIEQ---------SRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
Query: 260 VEEIYHSVVIKKEKPCIP---SGLPP 282
++ Y + KK I G P
Sbjct: 221 KKQKYEKISEKKVATSIEALCRGYPT 246
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 32/116 (27%), Positives = 47/116 (40%), Gaps = 27/116 (23%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
QL +G+ +HS +L +LKP+NL ++ D L +GDFG L R + +
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG-----LARIMDPHYSHKGHLS 182
Query: 216 PN-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y +P + + D W GC EMLTG + F G
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAI--------DMWAAGCIFAEMLTG-KTLFAGAH 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 13/181 (7%)
Query: 136 DRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195
+ L L ++ Y Q+AKG+ L S + +L N+LLSE + + + DFG
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG- 238
Query: 196 PYLLLGRSLSDSDMALRLGT---P-NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT- 250
L R + +R G P +MAPE V + ++D W FG + E+ +
Sbjct: 239 ----LARDIYKDPDYVRKGDARLPLKWMAPETIFDRV---YTIQSDVWSFGVLLWEIFSL 291
Query: 251 GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
G P+ G ++E + + + + P P + ++ C+ + RP ++++
Sbjct: 292 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
Query: 311 S 311
+
Sbjct: 352 N 352
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 56/243 (23%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF------------ 93
+++ +GRG V+ + + A+K+L D V
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPY------ALKVL-KKTVDKKIVRTEIGVLLRLSHP 108
Query: 94 -VNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLP 149
+ K +E+F E+ + +I + ++ G G DRI ++ G
Sbjct: 109 NIIKLKEIF----ETPT------------EISLVLELVTG--GELFDRIVEK--GYYSER 148
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLLLGRSLSD 206
D Q+ + ++ LH G++ +LKP NLL + L + DFG L + +
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG-----LSKIVEH 203
Query: 207 SD-MALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIY 264
M GTP Y APE E D W G +L G +P++ + + ++
Sbjct: 204 QVLMKTVCGTPGYCAPEILR---GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260
Query: 265 HSV 267
+
Sbjct: 261 RRI 263
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 35/115 (30%), Positives = 48/115 (41%), Gaps = 26/115 (22%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+ +G+ +HS +L +LKPSNLLL+ L + DFG L R T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG-----LARVADPDHDHTGFLTE 190
Query: 217 N-----YMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKS 259
Y APE + + D W GC + EML+ +P F GK
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSI--------DIWSVGCILAEMLSN-RPIFPGKH 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 50/269 (18%), Positives = 90/269 (33%), Gaps = 62/269 (23%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFE-ELFPK 103
K+ RIG G FG ++ T+ + ++A+K E + + E +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKF-----EPRRSDAPQLRDEYRTYKL 61
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+ ++ + + S+ D + G K + + Q+ +
Sbjct: 62 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 164 DLHSIGLLVLNLKPSNLLL-----SEHDQLVLGDFG-------------IPYLLLGRSLS 205
+H L+ ++KP N L+ + + + DFG IPY ++L
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY-REKKNL- 178
Query: 206 DSDMALRLGTPNYMAP------EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG-- 257
GT YM+ EQ S D G M L G PW G
Sbjct: 179 -------SGTARYMSINTHLGREQ---------SRRDDLEALGHVFMYFLRGSLPWQGLK 222
Query: 258 -KSVEEIYHSVVIKKEKPCIP---SGLPP 282
+ ++ Y + KK+ + +G P
Sbjct: 223 AATNKQKYERIGEKKQSTPLRELCAGFPE 251
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 37/207 (17%)
Query: 130 YE----GSVGDRIAQQRGGKLPLPDILRYGIQL--AKGISDLHSIGLLVLNLKPSNLLLS 183
Y GS+ DR++ G PL +R I A GI+ LH + ++K +N+LL
Sbjct: 109 YVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167
Query: 184 EHDQLVLGDFGIPYLL--LGRSLSDSDMALRL-GTPNYMAPEQWEPEVRGPISFETDTWG 240
E + DFG L + + M R+ GT YMAPE +RG I+ ++D +
Sbjct: 168 EAFTAKISDFG----LARASEKFAQTVMTSRIVGTTAYMAPEA----LRGEITPKSDIYS 219
Query: 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVV-----IKKEKPCIPSGLPPAVEN--------- 286
FG ++E++TG P + E ++ I+ E+ I + + +
Sbjct: 220 FGVVLLEIITG-LPAVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276
Query: 287 --VIIGCFEYDLRNRPLMADILHAFES 311
V C RP + + +
Sbjct: 277 YSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 33/143 (23%), Positives = 53/143 (37%), Gaps = 30/143 (20%)
Query: 133 SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS----EHDQL 188
A ++ +LP + Q+ GI LH+ +L +LKP+N+L+ E ++
Sbjct: 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171
Query: 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPN-----YMAPE------QWEPEVRGPISFETD 237
+ D G R + L P Y APE + + D
Sbjct: 172 KIADMG-----FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI--------D 218
Query: 238 TWGFGCSIMEMLTGIQPWF-GKS 259
W GC E+LT +P F +
Sbjct: 219 IWAIGCIFAELLTS-EPIFHCRQ 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 34/201 (16%), Positives = 69/201 (34%), Gaps = 53/201 (26%)
Query: 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML----LPLKEDCAKVFVNKFEELFPK 103
+ +G G V + ++ ++ AVK++ ++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEY------AVKIIEKQPGHIRSRV-------------- 57
Query: 104 FRESQ---------SVCWLHGISVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPD- 150
FRE + +V L + + + G G I ++ +
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG--GSILSHIHKR--RHFNELEA 113
Query: 151 --ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFG----IPYLLLG 201
+++ +A + LH+ G+ +LKP N+L +Q + + DF I
Sbjct: 114 SVVVQ---DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 202 RSLSDSDMALRLGTPNYMAPE 222
+S ++ G+ YMAPE
Sbjct: 171 SPISTPELLTPCGSAEYMAPE 191
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 33/122 (27%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q + + LH ++ +LKPSNLL++ + L + DFG L R + +S T
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG-----LARIIDESAADNSEPTG 174
Query: 217 N------------YMAPE------QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-G 257
Y APE ++ + D W GC + E+ +P F G
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAM--------DVWSCGCILAELFLR-RPIFPG 225
Query: 258 KS 259
+
Sbjct: 226 RD 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 34/240 (14%), Positives = 70/240 (29%), Gaps = 46/240 (19%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYH--ELAVKMLLPLKEDCAKVFVNKFEELFPK 103
KLK R G ++ A + + ++K+ +D F + K
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLD---AKDGRLFNEQNFFQRAAK 101
Query: 104 FRESQSVCWLHGISVIN-------GKIC-----IAMKFYEGSVGDRIAQQRGGKLPLPDI 151
+ L+ ++ G + + S+ + L +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLL--SEHDQLVLGDFG-----------IPYL 198
L+ +L + LH + N+ N+ + + Q+ L +G + Y
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY- 220
Query: 199 LLGRSLSDSDMALRLGTPNYM---APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+ S G ++ + P R D G +++ L G PW
Sbjct: 221 -----VEGSRSPHE-GDLEFISMDLHKGCGPSRRS------DLQSLGYCMLKWLYGFLPW 268
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 51/240 (21%), Positives = 86/240 (35%), Gaps = 66/240 (27%)
Query: 51 IGRGPFGDVWLATHHQSADDF--------DEYHELA---VKMLLPLKE---DCAKVFVNK 96
IG+G FG V A H+ +H A +++L L++ D +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI-H 163
Query: 97 FEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI 156
E F FR H IC+ + ++ + I + + LP + ++
Sbjct: 164 MLENF-TFRN-------H--------ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAH 207
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLV--LGDFG---------IPYLLLGRSLS 205
+ + + LH ++ +LKP N+LL + + + DFG Y+ +S
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI---QSRF 264
Query: 206 DSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEE 262
Y A PEV D W GC + E+LTG P G+ +
Sbjct: 265 ------------YRA-----PEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGD 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 130 YE----GSVGDRIAQQRGGKLPLPDILRYGIQL--AKGISDLH-SIGLLVL--NLKPSNL 180
Y GSV + ++ + PL R I L A+G++ LH ++ ++K +N+
Sbjct: 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165
Query: 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL--RL-GTPNYMAPEQWEPEVRGPISFETD 237
LL E + V+GDFG L + + D + + GT ++APE G S +TD
Sbjct: 166 LLDEEFEAVVGDFG-----LAKLMDYKDTHVTTAVRGTIGHIAPEY---LSTGKSSEKTD 217
Query: 238 TWGFGCSIMEMLTGIQPW-FGKSVEEIYHSVV-----IKKEK-------PCIPSGLPP-A 283
+G+G ++E++TG + + + + ++ + KEK +
Sbjct: 218 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE 277
Query: 284 VENVI---IGCFEYDLRNRPLMADILHAFES 311
VE +I + C + RP M++++ E
Sbjct: 278 VEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 46/238 (19%), Positives = 82/238 (34%), Gaps = 60/238 (25%)
Query: 51 IGRGPFGDVWLATHHQSADDF--------DEYHELA---VKMLLPLKE-DCAKVFVNKFE 98
+G G FG V L H + + +Y A +L ++ D + K+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158
F + + H +C+ + S+ + I + + DI Y I++
Sbjct: 103 GKF-MYYD-------H--------MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 159 AKGISDLHSIGLLVLNLKPSNLLL--SEHDQLVLGDFGIPYLLLGRSLSDSDMALRL--- 213
K ++ L + L +LKP N+LL ++ ++ + + ++L
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 214 G--------------TPNYMAPE-----QWEPEVRGPISFETDTWGFGCSIMEMLTGI 252
G T Y APE W +D W FGC + E+ TG
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGW--------DVSSDMWSFGCVLAELYTGS 256
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 32/169 (18%), Positives = 61/169 (36%), Gaps = 28/169 (16%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEY-------------HELAVKMLLPLKEDCAKV 92
L +IG G FG ++LA + + EL + K+ K
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 93 FVNKFEEL--FPKFRESQSVCWLHGISVINGKI--CIAMKFYEGSVGDRIAQQRGGKLPL 148
K + P + G++ G+ + M+ + + G
Sbjct: 100 IERKQLDYLGIPL-------FYGSGLTEFKGRSYRFMVMERLGIDLQKIS--GQNGTFKK 150
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL--SEHDQLVLGDFGI 195
+L+ GI++ + +H + ++K +NLLL DQ+ L D+G+
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 33/125 (26%), Positives = 49/125 (39%), Gaps = 28/125 (22%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
QL K I LHS GLL ++KPSN+LL+ + + DFG L RS +
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFG-----LSRSFVNIRRVTNNIPL 171
Query: 217 NYMAPEQWEPEVRGPI---------------------SFETDTWGFGCSIMEMLTGIQPW 255
+ + + + + + D W GC + E+L G +P
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230
Query: 256 F-GKS 259
F G S
Sbjct: 231 FPGSS 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 36/167 (21%), Positives = 66/167 (39%), Gaps = 21/167 (12%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFV-NKFEELFPKF 104
K+ IG+G FG ++LA S++ VK+ D +F KF + K
Sbjct: 38 KVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93
Query: 105 RESQSVCWLHGISVI-------NGKICIAMKFYEGSVGDR-------IAQQRGGKLPLPD 150
+ Q + + +G K Y + DR I + +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS--EHDQLVLGDFGI 195
+L+ +++ + +H + ++K SNLLL+ DQ+ L D+G+
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 22/121 (18%), Positives = 40/121 (33%), Gaps = 27/121 (22%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
L G + +H G++ +LKP+N LL++ + + DFG L R+++ +
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG-----LARTINSEKDTNIVNDL 191
Query: 217 NYMAPEQWEPEVRGPI----------------------SFETDTWGFGCSIMEMLTGIQP 254
+ + D W GC E+L +Q
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 255 W 255
Sbjct: 252 H 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 29/174 (16%), Positives = 50/174 (28%), Gaps = 42/174 (24%)
Query: 120 NGK-ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLV-LNLKP 177
NG IC+ + + I + LPLP + + Q+ +G+ LH+ ++ ++KP
Sbjct: 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP 175
Query: 178 SNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE------------ 225
N+LLS ++Q + + P
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 226 --------------------------PEVR--GPISFETDTWGFGCSIMEMLTG 251
EV + D W C E+ TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 68/487 (13%), Positives = 121/487 (24%), Gaps = 182/487 (37%)
Query: 64 HHQSADDFD-EYHELAVKMLLPLKE-------DCA-------KVFVNK-FEELFPKFRES 107
HH DF+ H+ K +L + E DC + + + +
Sbjct: 2 HHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 108 QSVCWLHGISVINGKICIAMKFYEGS-------VGDRIAQQRGGKLPLPDILRYGIQLAK 160
L + + + KF E + I ++ + P Y Q +
Sbjct: 62 SGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKFLMSPIKTEQ--RQPSMMTRMYIEQRDR 118
Query: 161 GISD--------------LHSIGLLVLNLKPSNLL-----------------LSEHDQLV 189
+D + +L L+P+ + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC 178
Query: 190 LGDFGIPYLLLGRSLSDSDMALRLGT------PNYMAP-----------EQWEPEVRGPI 232
DF I +L L S + L PN+ + + E+R +
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 233 SFET---------DTW--------GFGCSIMEMLTGIQPWFGKSV------EEIYHSVVI 269
+ + C I+ + T K V H +
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSCKIL-LTTR-----FKQVTDFLSAATTTHISLD 292
Query: 270 KKEKP---------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314
C P LP V P I+
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-----------PRRLSIIAESIRDGL 341
Query: 315 AVYNDGEWTGLGSRALTDT--SSVKGYTAWYPLKDHLQVGDTVRSRKPLNARK------- 365
A ++ W + LT SS+ + L +P RK
Sbjct: 342 ATWD--NWKHVNCDKLTTIIESSL----------NVL---------EPAEYRKMFDRLSV 380
Query: 366 -PQTVDVPAGT-----------VVGLDADTDRNSSVLVK--------IPGLHNPLRVQ-- 403
P + +P V + + S++ K IP ++ L+V+
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440
Query: 404 -ESSLER 409
E +L R
Sbjct: 441 NEYALHR 447
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 31/151 (20%), Positives = 52/151 (34%), Gaps = 34/151 (22%)
Query: 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182
+CIA + + + + + PLP + QL + LH L +LKP N+L
Sbjct: 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRL---G--------------TPNYMAPE--- 222
+ L + +S+ ++ +R+ G T +Y PE
Sbjct: 157 VNSEFETLYNEHKSC--EEKSVKNTS--IRVADFGSATFDHEHHTTIVATRHYRPPEVIL 212
Query: 223 --QWEPEVRGPISFETDTWGFGCSIMEMLTG 251
W + D W GC + E G
Sbjct: 213 ELGW--------AQPCDVWSIGCILFEYYRG 235
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 26/125 (20%), Positives = 44/125 (35%), Gaps = 32/125 (25%)
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS---DSDMALRL 213
L G+ +HS G+L +LKP+N L+++ + + DFG L R++ + + L +
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFG-----LARTVDYPENGNSQLPI 218
Query: 214 GTPNYMAPEQWEPEVRGPISFET------------------------DTWGFGCSIMEML 249
P + T D W GC E+L
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 250 TGIQP 254
I+
Sbjct: 279 NMIKE 283
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 36/160 (22%), Positives = 60/160 (37%), Gaps = 26/160 (16%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE-ELFPKFR 105
+G G G V + ++ + F A+KML +DC K + E EL +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKF------ALKML----QDCPKA---RREVELHWRAS 68
Query: 106 ESQSVCWLHGI----SVINGKICIAMKFYEGSVG---DRIAQQRGGKLPLPDILRYGIQL 158
+ + + + + I M+ +G G RI + + +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGI 195
+ I LHSI + ++KP NLL + L L DFG
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 54/239 (22%), Positives = 81/239 (33%), Gaps = 66/239 (27%)
Query: 51 IGRGPFGDVWLATHHQSADDF---------DEYHELA---VKMLLPLKE---DCAKVFVN 95
+G G FG V H++ D Y E A +++L L + V
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV- 80
Query: 96 KFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYG 155
+ E F + H ICI + S D I + L I +
Sbjct: 81 QMLEWF-EHHG-------H--------ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 156 IQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-- 213
Q+ K ++ LHS L +LKP N+L + D + I R+L + D +++
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE--RTLINPD--IKVVD 180
Query: 214 -G--------------TPNYMAPE-----QWEPEVRGPISFETDTWGFGCSIMEMLTGI 252
G T +Y APE W S D W GC ++E G
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPEVILALGW--------SQPCDVWSIGCILIEYYLGF 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 46/231 (19%), Positives = 85/231 (36%), Gaps = 46/231 (19%)
Query: 51 IGRGPFGDVWLATHHQSADDF--------DEYHELA---VKMLLPLKEDCA--KVFVNKF 97
IG+G FG V A + + A V++L + + K ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ F FR H +C+ + ++ D + + L ++ Q
Sbjct: 122 KRHF-MFRN-------H--------LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 158 LAKGISDLHSIGLLVL--NLKPSNLLL--SEHDQLVLGDFGIPYLLLGRSLSDSDMALRL 213
+ + L + L ++ +LKP N+LL + + + DFG + +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG------SSCQLGQRIYQYI 219
Query: 214 GTPNYMAPEQWEPEVRG-PISFETDTWGFGCSIMEMLTGIQPWF-GKSVEE 262
+ Y +PE + G P D W GC ++EM TG +P F G + +
Sbjct: 220 QSRFYRSPEV----LLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVD 265
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 38/211 (18%), Positives = 82/211 (38%), Gaps = 43/211 (20%)
Query: 130 YE----GSVGDRIAQQRGGKLPLPDILRYGIQL--AKGISDLHSIGLLVLNLKPSNLLLS 183
Y+ G++ + + + R I + A+G+ LH+ ++ ++K N+LL
Sbjct: 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173
Query: 184 EHDQLVLGDFGIPYLLLGRSLSDSD--------MALRLGTPNYMAPEQWEPEVRGPISFE 235
E+ + DFG + + ++ D GT Y+ PE + ++G ++ +
Sbjct: 174 ENFVPKITDFG-----ISKKGTELDQTHLSTVVK----GTLGYIDPEYF---IKGRLTEK 221
Query: 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV------IKKEK------PCIPSGLPPA 283
+D + FG + E+L + +S+ ++ + P + + P
Sbjct: 222 SDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 284 ----VENVIIGCFEYDLRNRPLMADILHAFE 310
+ + C +RP M D+L E
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 632 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.39 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.88 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=466.22 Aligned_cols=274 Identities=19% Similarity=0.344 Sum_probs=233.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+++|++++.||+|+||+||+|+++.++ +.||||++.+.. .......+.++..++..+ +||||+.+++++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~ 101 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATS------REYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTF 101 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCC------CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence 34578999999999999999999998776 489999997532 111123344445666665 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
++++.+|||||||+ |+|.+++.+. +.+++.+++.|+.||+.||+|||+++|+||||||+||||+.+|++||+|||+|
T Consensus 102 ~~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 102 QDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 99999999999998 5888888654 58999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
+.+.... ......+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+..+++..+.. ..+.+
T Consensus 180 ~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~ 253 (311)
T 4aw0_A 180 KVLSPES-KQARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDF 253 (311)
T ss_dssp EECCTTT-TCCCBCCCCSCGGGCCHHHHHHS---CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCC
T ss_pred eecCCCC-CcccccCcccCcccCCHHHHcCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCC
Confidence 9764322 12234567999999999999754 688999999999999999999999999999998888774 45678
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccc
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSR 328 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~ 328 (632)
|..+++++++||.+||++||++|||++|++..-.-..|+||.+.+|+.+..+
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 305 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence 8999999999999999999999999999876544456899999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=463.97 Aligned_cols=279 Identities=25% Similarity=0.399 Sum_probs=230.4
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
...+++++|++++.||+|+||+||+|++..+. ..++.||||++++... ..... ...+..++..+ +||||+.++
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~-~~~E~~il~~l-~HpnIv~l~ 92 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGS---DARQLYAMKVLKKATLKVRDRVR-TKMERDILVEV-NHPFIVKLH 92 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSST---TTTCEEEEEEEESEEEEEEECC-------CCCCCC-CCTTEECEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCC---CCCEEEEEEEEehHHcChHHHHH-HHHHHHHHHHC-CCCCCCeEE
Confidence 44567889999999999999999999986433 2346899999976321 11122 22333445554 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++.+++.+|||||||+ |+|.+++.+. +.+++.+++.|+.||+.||+|||+++|+||||||+|||++.+|.+||+||
T Consensus 93 ~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DF 170 (304)
T 3ubd_A 93 YAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDF 170 (304)
T ss_dssp EEEEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESS
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccc
Confidence 99999999999999998 6888888654 58999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+|+..... .....+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+..+++..+.. ..
T Consensus 171 Gla~~~~~~---~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~ 242 (304)
T 3ubd_A 171 GLSKESIDH---EKKAYSFCGTVEYMAPEVVNRR---GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AK 242 (304)
T ss_dssp EEEEC--------CCCCSCCCCGGGCCHHHHHTS---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CC
T ss_pred ccceeccCC---CccccccccCcccCCHHHhccC---CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CC
Confidence 999865332 1233457899999999999754 688999999999999999999999999999888888763 45
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
+.+|..+|+++.+||.+||++||++|||+ +|+++ +++|.+.+|+.+..+.+.+|+.|
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~------Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR------HSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc------CccccCCCHHHHHhCCCCcCcCC
Confidence 67889999999999999999999999984 55554 88999999999999988888654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=444.02 Aligned_cols=269 Identities=22% Similarity=0.363 Sum_probs=223.3
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|++++|.+.++||+|+||+||+|++..... ...+..||||+++.......+.+.+ +..++.++ +||||+.+++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~-E~~il~~l-~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHR-EAELLTNL-QHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSCCHHHHHHHHH-HHHHHTTC-CCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCccc-CCCCEEEEEEEeCCCChHHHHHHHH-HHHHHHhC-CCCCCccEEEEE
Confidence 35788999999999999999999999864321 1234689999998766555555544 44566666 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR-----------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~-----------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~ 185 (632)
.+++.+|||||||+ |+|.+++.... ...+++.+++.++.||+.||+|||+++||||||||+||||+++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999998 78988886531 3579999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHH
Q 006772 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIY 264 (632)
Q Consensus 186 g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~ 264 (632)
+.+||+|||+|+........ .......||+.|||||++.+ +.|+.++|||||||+||||+| |+.||.+.+..++.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~---~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999865332111 11233468999999999974 479999999999999999999 99999999998888
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 265 ~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+.. ...+..|..+|+++.+||.+||+.||++|||+.+|+..|+.+..
T Consensus 241 ~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 77764 45667889999999999999999999999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=452.58 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=211.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+.++|+++++||+|+||+||+|+++.++ +.||||++.+... ....+.+.++..++..+ +||||+.+++++.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDG------RQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE 94 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTC------CEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCC------CEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE
Confidence 3579999999999999999999998766 4899999976432 22223334444566665 69999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+|||||||+ |+|.+++...++..+++.+++.|+.||+.||+|||+++||||||||+||||+.+|.+||+|||+|+.
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 999999999998 6899999876667789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
+... .......+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+..+++..+... ..+.++.
T Consensus 175 ~~~~---~~~~~~~~GT~~YmAPE~l~~~---~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~ 247 (350)
T 4b9d_A 175 LNST---VELARACIGTPYYLSPEICENK---PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSL 247 (350)
T ss_dssp CCHH---HHHHHHHHSCCTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCT
T ss_pred ecCC---cccccccCCCccccCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCc
Confidence 5321 1122456899999999999754 6899999999999999999999999999998888887653 4456778
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+|+++.+||.+||++||++|||+.|+++
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=441.42 Aligned_cols=266 Identities=23% Similarity=0.394 Sum_probs=212.3
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
.+.|+.++|++.++||+|+||+||+|+++. .||||+++... ....+.+ .++..++.++ +||||+.++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~f-~~E~~il~~l-~HpNIV~l~ 98 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---------DVAVKILKVVDPTPEQFQAF-RNEVAVLRKT-RHVNILLFM 98 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---------EEEEEECCCSSCCHHHHHHH-HHHHHHHTTC-CCTTBCCEE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---------cEEEEEEEecCCCHHHHHHH-HHHHHHHHhC-CCCCEeeEE
Confidence 345899999999999999999999998542 59999987543 2223333 3444555665 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++. ++.+|||||||+ |+|.+++... ..++++.+++.++.||+.||+|||+++||||||||+||||++++.+||+||
T Consensus 99 g~~~-~~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 99 GYMT-KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EEEC-SSSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCC
T ss_pred EEEE-CCeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeec
Confidence 9875 467899999998 6888877643 468999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-c
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-E 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~ 272 (632)
|+|+...... ........+||+.|||||++.+...++|+.++|||||||+||||+||+.||.+.+.......++... .
T Consensus 177 Gla~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~ 255 (307)
T 3omv_A 177 GLATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255 (307)
T ss_dssp SSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred cCceecccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 9998653221 1223345689999999999976556679999999999999999999999999876554433333332 3
Q ss_pred CC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 273 KP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 273 ~p---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
.| ..+..+|+++.+||.+||+.||++|||+.||++.|+.+++.+
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 33 345789999999999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=443.24 Aligned_cols=269 Identities=23% Similarity=0.391 Sum_probs=218.9
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|.+.++||+|+||+||+|+++.... ...++.||||+++.......+.+.++ ..++.++ +||||+.+++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E-~~il~~l-~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQRE-AELLTML-QHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC----CEEEEEEEESCCSHHHHHHHHHH-HHHHTTC-CCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCccc-CCCCeEEEEEEECcCCHHHHHHHHHH-HHHHHhC-CCCCCCcEEEEE
Confidence 45788999999999999999999999864321 12346899999987665555555444 4556665 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR-------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~-------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
.+++.+|||||||+ |+|.+++.... .+++++.+++.++.||+.||+|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 99999999999998 78888886532 24699999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHH
Q 006772 184 EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEE 262 (632)
Q Consensus 184 ~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~e 262 (632)
+++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~---~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY---RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred CCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcC---CCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999986533221 112234579999999999974 478999999999999999999 999999999888
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 263 i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+...+.. ..++..|..+|+++.+||.+||+.||++|||+.||++.|+.+..
T Consensus 269 ~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 AIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 8877654 45677899999999999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=444.22 Aligned_cols=268 Identities=20% Similarity=0.324 Sum_probs=220.2
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.+++++.++||+|+||+||+|.+..... ...++.||||+++........+.+.++..++.++ +||||+.+++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~-~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAP-GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCcc-CCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEE
Confidence 34778899999999999999999999754221 1334689999997644333333334444566665 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
..++.+|||||||+ |+|.+++.... ...+++.+++.++.|||.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 99999999999998 78999886432 2468999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
++++.+||+|||+|+....... .......+||+.|||||++.+ +.|+.++|||||||+||||+| |..||.+.+..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~---~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMY---GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred CCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999987543221 122344679999999999974 479999999999999999998 89999999998
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
++...+.. ...++.|..+|+++.+||.+||+.||++||++.||++.|+.+
T Consensus 255 ~~~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88877764 455667899999999999999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=449.13 Aligned_cols=270 Identities=21% Similarity=0.339 Sum_probs=224.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|++++|++.+.||+|+||+||+|.+...+. ....+.||||+++..........+..+..++.++.|||||+.++++|.
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCc-ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4888999999999999999999999876543 234468999999765544333334445567788889999999999987
Q ss_pred E-CCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 119 I-NGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 119 ~-~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
. ++.+|||||||+ |+|.+++.... ...+++.+++.|+.|||.||+|||+++||||||||+|||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 6 467999999998 68888886532 2458999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
++++.+||+|||+|+.+.... ........+||+.|||||++.+ ..|+.++|||||||+||||+| |..||.+.+..
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~---~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCCEEECcchhhhhcccCC-CceeeccccccccccCHHHHhc---CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999998653321 1122334679999999999974 479999999999999999998 99999997755
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+.+..++....++..|..+|+++.++|.+||+.||++|||+.+|++.|+.+.
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 5444555566778889999999999999999999999999999999988765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=431.16 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=200.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||+||+|+++.++ +.||||++.+... ......+.++..+++.+ +||||+.+++++.++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTG------QKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSK 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTC------CEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC
Confidence 58999999999999999999988766 4899999976432 12222334444556665 699999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+.+||||||++|+|.+++.+ .+++++.+++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+...
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999999999999999865 3589999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
.. ....+.+||+.|||||++.+.. .++.++|||||||++|||++|+.||.+.+..+++..+. ...+.+|..+
T Consensus 164 ~~----~~~~~~~GT~~Y~APE~~~~~~--y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~ 235 (275)
T 3hyh_A 164 DG----NFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFL 235 (275)
T ss_dssp ---------------CTTSCHHHHSSSS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTS
T ss_pred CC----CccCCeeECcccCChhhhcCCC--CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCC
Confidence 22 2234578999999999997542 24679999999999999999999999999888887776 3456678999
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|+++.+||.+||++||++|||+.|+++
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999999999999999999999886
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=443.93 Aligned_cols=257 Identities=25% Similarity=0.302 Sum_probs=212.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.+.+.|++.++||+|+||+||+|+++.++ +.||||+++..... .++..++..+ +||||+.+++++.+
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g------~~vAiK~i~~~~~~------~~E~~il~~l-~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTG------FQCAVKKVRLEVFR------VEELVACAGL-SSPRIVPLYGAVRE 121 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCC------THHHHTTTTC-CCTTBCCEEEEEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCC------CEEEEEEECHHHhH------HHHHHHHHhC-CCCCCCcEEEEEEE
Confidence 34578999999999999999999998776 48999999754321 2233455554 79999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCce
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPY 197 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGlak 197 (632)
++.+|||||||+ |+|.+++.+. +.+++.+++.|+.||+.||+|||+++||||||||+||||+.+| ++||+|||+|+
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999998 6888888654 5899999999999999999999999999999999999999988 69999999998
Q ss_pred eccCCCCCCC--ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-C
Q 006772 198 LLLGRSLSDS--DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-P 274 (632)
Q Consensus 198 ~~~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-p 274 (632)
.+........ .....+||+.|||||++.+. +|+.++|||||||+||||++|+.||.+.+..+++..+...... .
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~ 276 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK---PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch
Confidence 7644322211 22346899999999999854 6899999999999999999999999988776666666543322 2
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+|+.+|+++.+||.+||++||.+|||+.||++.|.....
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 4678999999999999999999999999999988776543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=442.19 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=209.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|++.++||+|+||+||+|+++.++ +.||||++........+.+ .++..++..+ +||||+.+++++.+++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg------~~vAiK~i~~~~~~~~~~~-~~Ei~il~~l-~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSG------KLVAVKKMDLRKQQRRELL-FNEVVIMRDY-QHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEGGGCSSGGGG-HHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCC------CEEEEEEEecCchhHHHHH-HHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 57999999999999999999998776 4899999975433333333 3344556665 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+|||||||+| +|.+++.+ +.+++.+++.|+.||+.||+|||+++||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999995 77776643 4799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~~ 279 (632)
. .....+.+||+.|||||++.+. +|+.++|||||||++|||++|+.||.+.+..+++..+... ..+. .+..
T Consensus 223 ~---~~~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~ 295 (346)
T 4fih_A 223 E---VPRRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHK 295 (346)
T ss_dssp S---SCCBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCSCGGG
T ss_pred C---CCcccccccCcCcCCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCcccc
Confidence 2 1233567899999999999744 6899999999999999999999999999988887776532 2222 3457
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|+++.+||.+||++||++|||+.|+++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8999999999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=423.12 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=202.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
+-|++.++||+|+||+||+|.++.++ ..||||++..... ....+.+.++..++.++ +||||+.+++++..
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTV 98 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCC------eEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeecc
Confidence 33588999999999999999998766 4899999965322 22223334444556665 79999999999865
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEec-CCcEEEEec
Q 006772 120 --NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLSE-HDQLVLGDF 193 (632)
Q Consensus 120 --~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld~-~g~vkL~DF 193 (632)
++.+|||||||+ |+|.+++.+. +.+++..++.|+.||+.||+|||+++ ||||||||+||||+. +|.+||+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence 356899999998 6888888654 58999999999999999999999998 999999999999984 799999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~~~~ 272 (632)
|+|+.... ....+.+||+.|||||++. ++|+.++|||||||+||||+||+.||.+.+ ..+++..+.....
T Consensus 177 Gla~~~~~-----~~~~~~~GTp~YmAPE~~~----~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 177 GLATLKRA-----SFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp TGGGGCCT-----TSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred cCCEeCCC-----CccCCcccCccccCHHHcC----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC
Confidence 99975322 2334578999999999985 358999999999999999999999998755 4555555544334
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++..+++++.+||.+||++||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 44566788999999999999999999999999886
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=443.64 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=210.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|++.++||+|+||.||+|+++.++ +.||||++........+.+. ++..++..+ +||||+.+++++.+++.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg------~~vAiK~i~~~~~~~~~~~~-~Ei~il~~l-~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSG------KLVAVKKMDLRKQQRRELLF-NEVVIMRDY-QHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEESTTCSSGGGHH-HHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCC------CEEEEEEEeccchhHHHHHH-HHHHHHHhC-CCCCCCceEEEEEECCE
Confidence 56999999999999999999998776 48999999765443333333 444556665 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+|||||||+| +|.+++.. +.+++.+++.|+.||+.||+|||+++||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 223 ~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999995 77776643 4799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-CCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-KPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-~p~~p~~l 280 (632)
. .....+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+++..+..... ....+..+
T Consensus 300 ~---~~~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 300 E---VPRRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 373 (423)
T ss_dssp S---CCCBCCCEECTTTCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSS
T ss_pred C---CccccccccCcCcCCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccC
Confidence 2 1233567899999999999744 689999999999999999999999999998888877654321 22344679
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|+++.+||.+||++||++|||+.|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=459.15 Aligned_cols=279 Identities=18% Similarity=0.316 Sum_probs=230.8
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhh--hccCCCceeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFP--KFRESQSVCW 112 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~--~l~~h~~I~~ 112 (632)
...++.++|++++.||+|+||+||+|+++.++ +.||||++.+... ........++..++. ...+||||+.
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg------~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~ 256 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCC------CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeE
Confidence 34567789999999999999999999998776 4899999965321 111222222222222 2347999999
Q ss_pred eeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 113 LHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+++++++++.+|||||||+ |+|.+++.+. +.|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+
T Consensus 257 l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999998 6888888654 589999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---SVEEIYHSVV 268 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---~~~ei~~~i~ 268 (632)
|||+|+.+.. ....+.+||+.|||||++... ..|+.++|||||||+||||++|..||.+. +..++...+.
T Consensus 335 DFGlA~~~~~-----~~~~t~~GTp~YmAPEvl~~~--~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~ 407 (689)
T 3v5w_A 335 DLGLACDFSK-----KKPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407 (689)
T ss_dssp CCTTCEECSS-----CCCCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred ccceeeecCC-----CCCCCccCCcCccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence 9999987533 233557999999999998632 25889999999999999999999999864 3344554444
Q ss_pred hhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 269 ~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
...+.+|..+|+++++||.+||++||.+|++ +.||++ |+||.+++|+.+..+.+.+|+.|..
T Consensus 408 --~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~------HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 408 --TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------SPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp --HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT------SGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred --CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc------CccccCCCHHHHHcCCCCcCccCCC
Confidence 4566788999999999999999999999997 577665 8999999999999999999987753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=418.23 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=189.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
++|++++.||+|+||+||+|+++.++ +.||||+++........+.+.++..++.++ +||||+.+++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDD------CNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTC------CEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCC------CEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCc
Confidence 47999999999999999999998766 489999997654443333344455666666 7999999999987543
Q ss_pred -----------EEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 122 -----------KICIAMKFYE-GSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 122 -----------~l~LVmEy~~-GsL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
.+|||||||+ |+|.+++..... ...++..++.|+.||+.||+|||+++|+||||||+|||++.+|.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 4799999998 688888764321 234566789999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCCCC---------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC
Q 006772 189 VLGDFGIPYLLLGRSLSD---------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS 259 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~---------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~ 259 (632)
||+|||+|+......... ......+||+.|||||++.+. .|+.++|||||||++|||++ ||.+..
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN---SYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTC---CCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC---CCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999998764322111 122346899999999999754 68999999999999999996 886533
Q ss_pred HH-HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 260 VE-EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 260 ~~-ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
.. .....+. ....|+.+...++++.+||.+||+.||++|||+.|+++ ++++.+.+|.
T Consensus 232 ~~~~~~~~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~------h~~~~~~~~p 289 (299)
T 4g31_A 232 ERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE------NAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGCCC---
T ss_pred HHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhCCCCCC
Confidence 21 2222222 12222222345678899999999999999999999876 6777777664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=411.59 Aligned_cols=258 Identities=20% Similarity=0.309 Sum_probs=198.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
++|.+.++||+|+||+||+|+++. +.||||++.... ...+..+.+.......+||||+.+++++..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g--------~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG--------EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT--------EEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC--------EEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 469999999999999999998742 489999996432 23333332222223347999999999998653
Q ss_pred ---EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeeeeeCCeEEEecCCcEE
Q 006772 122 ---KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI--------GLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 122 ---~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~--------~IvHRDLKP~NILld~~g~vk 189 (632)
.+|||||||+ |+|.+++.. ..+++..++.++.|++.||+|||++ +||||||||+||||+.++.+|
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 6899999998 688888754 3799999999999999999999987 999999999999999999999
Q ss_pred EEecCCceeccCCCCC-CCccccccCCCccCCccccCCCC---CCCCCcccccchhHHHHHHHHhCCCCCC---------
Q 006772 190 LGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEV---RGPISFETDTWGFGCSIMEMLTGIQPWF--------- 256 (632)
Q Consensus 190 L~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~---~g~~t~ksDvwSlGvvL~EmltG~~PF~--------- 256 (632)
|+|||+|+........ .......+||+.|||||++.+.. .+.++.++|||||||+||||+||..||.
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 9999999876443221 12223468999999999997542 1246789999999999999999976553
Q ss_pred -CC-----CHHHHHHHHHhhccCCCCCCC-----CCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 257 -GK-----SVEEIYHSVVIKKEKPCIPSG-----LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 257 -~~-----~~~ei~~~i~~~~~~p~~p~~-----lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+. ...++...+.....+|.+|.. ++..+.+||.+||+.||++|||+.||++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 21 234444445545556666643 33578999999999999999999999999987753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=421.05 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=209.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
++|++++.||+|+||.||+|+++.++ +.||||++++... ...+.+.+ +..++..+ +||||+.+++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~------~~vAiK~i~~~~~~~~~~~~~~~-Ei~il~~l-~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTG------QQVAIKKIPNAFDVVTNAKRTLR-ELKILKHF-KHDNIIAIKDILRPT 125 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEETTTTSSHHHHHHHHH-HHHHHHHC-CCTTBCCEEEECCCS
T ss_pred CCeEEEEEEecccCeEEEEEEECCCC------CEEEEEEECccccchHHHHHHHH-HHHHHHhc-CCCCcceEeeeeecc
Confidence 67999999999999999999998776 4899999975432 22233333 44556665 69999999998764
Q ss_pred -----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 120 -----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 120 -----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.+.+|||||||+|+|.+++.. .+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence 367999999999999988854 4689999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCC-CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSL-SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~-~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+|+.+..... ......+.+||+.|||||++.+. ..++.++||||+||++|||++|+.||.+.+..+.+..|......
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~--~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL--HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCC--CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9987643221 22334567999999999998753 24789999999999999999999999999988777766533222
Q ss_pred CC----------------------C-------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 274 PC----------------------I-------PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 274 p~----------------------~-------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
+. . .+.+++++.+||.+||+.||++|||+.|+|+ |+|+..
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~------Hp~f~~ 350 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR------HPFLAK 350 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT------SGGGTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc------CHhhCc
Confidence 21 0 1357899999999999999999999999876 667654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=410.87 Aligned_cols=281 Identities=20% Similarity=0.297 Sum_probs=228.7
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
.+..+..++|++.+.||+|+||+||+|+++.++ +.||||++++... .........+..++..+.+||||+.+
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l 89 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETG------DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCC------CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeE
Confidence 344577899999999999999999999998765 4899999975321 11122233444566666789999999
Q ss_pred eEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++..++.+||||||++ |+|.+++... +.+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|
T Consensus 90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcc
Confidence 999999999999999998 5787777654 5799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++..... .......+||+.|||||++.+. .++.++|||||||++|||++|..||.+.+..+++..+.. .
T Consensus 168 FG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~ 239 (353)
T 3txo_A 168 FGMCKEGICN---GVTTATFCGTPDYIAPEILQEM---LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--D 239 (353)
T ss_dssp CTTCBCSCC------------CCGGGCCHHHHHHH---HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C
T ss_pred ccceeecccC---CccccccCCCcCeEChhhcCCC---CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--C
Confidence 9999753221 2233456899999999998743 578899999999999999999999999999888888763 4
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLM------ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~------~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
...+|..+++++.+||.+||++||.+||++ .++++ +++|.+.+|..+..+.+.+|+.|..
T Consensus 240 ~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~------hp~f~~~~w~~l~~~~~~~p~~p~~ 305 (353)
T 3txo_A 240 EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR------HPFFKEIDWAQLNHRQIEPPFRPRI 305 (353)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh------CCcccCCCHHHHhcCcCCCCccCCC
Confidence 566788999999999999999999999998 66655 8899999999999999988887653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=406.36 Aligned_cols=259 Identities=21% Similarity=0.331 Sum_probs=200.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.++||+|+||+||+|+++... ...+.||||.+.+.... ..+ .++..++..+.+||||+.+++++.+++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~~~--~~~-~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQV---GPEEKIALKHLIPTSHP--IRI-AAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTT---SCEEEEEEEEECTTSCH--HHH-HHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccC---CCCCEEEEEEEccccCH--HHH-HHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 57999999999999999999876321 23368999998764432 233 3344566777789999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC-CcEEEEecCCceecc
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH-DQLVLGDFGIPYLLL 200 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~-g~vkL~DFGlak~~~ 200 (632)
+||||||++ |+|.+++ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999998 5788776 268999999999999999999999999999999999999977 899999999998653
Q ss_pred CCCCC-------------------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCC
Q 006772 201 GRSLS-------------------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255 (632)
Q Consensus 201 ~~~~~-------------------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF 255 (632)
..... .......+||+.|||||++.+. ..|+.++||||+||++|||++|+.||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--PNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCCccchhhhHHHHHHHHHCCCCC
Confidence 22110 1123446899999999998743 24789999999999999999999999
Q ss_pred CCCC-HHHHHHHHHhhc------------------------------------c----------------CCCCCCCCCH
Q 006772 256 FGKS-VEEIYHSVVIKK------------------------------------E----------------KPCIPSGLPP 282 (632)
Q Consensus 256 ~~~~-~~ei~~~i~~~~------------------------------------~----------------~p~~p~~lp~ 282 (632)
...+ ..+.+..|.... . .......+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 7543 333333222100 0 0011245789
Q ss_pred HHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 283 AVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 283 ~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
++.+||.+||+.||++|+|++|+++ |+||.+.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~------Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL------HPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT------SGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc------CcccCCC
Confidence 9999999999999999999999876 7777544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=398.18 Aligned_cols=276 Identities=20% Similarity=0.362 Sum_probs=231.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
++.++|++.+.||+|+||+||+|+++.++ +.||||++++.. ......+. .+..++..+ +||||+.++++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-~E~~~l~~l-~hp~iv~l~~~ 73 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTV-TESRVLQNT-RHPFLTALKYA 73 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHH-HHHHHHHSC-CCTTBCCEEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEeHHHhhhhhHHHHHH-HHHHHHHhC-CCCcCcceEEE
Confidence 46689999999999999999999987665 489999996531 11222233 333444444 79999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++.+|+||||++| +|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.+|++||+|||+
T Consensus 74 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 74 FQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999985 777777653 4799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
++..... .......+||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+..+++..+.. ....
T Consensus 152 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~ 223 (337)
T 1o6l_A 152 CKEGISD---GATMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIR 223 (337)
T ss_dssp CBCSCCT---TCCBCCCEECGGGCCGGGGSSS---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCC
T ss_pred hhhcccC---CCcccccccChhhCChhhhcCC---CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCC
Confidence 9754321 1233456899999999999743 688999999999999999999999999988888777663 4566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCC
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGY 339 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 339 (632)
+|..+++++.+||.+||+.||++|| ++.++++ +++|.+.+|..+..+.+.+|+.|...
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~------h~~f~~~~~~~~~~~~~~pp~~p~~~ 286 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME------HRFFLSINWQDVVQKKLLPPFKPQVT 286 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCCCCCCC
Confidence 7889999999999999999999999 7888776 88999999999998888888777543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=409.47 Aligned_cols=282 Identities=21% Similarity=0.338 Sum_probs=229.6
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
....+..++|++.+.||+|+||+||+|+++.++ +.||||++++... .........+..++.++.+||||+.+
T Consensus 45 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~------~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l 118 (396)
T 4dc2_A 45 ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTD------RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118 (396)
T ss_dssp ----CCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred cccCCChhHcEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCee
Confidence 345577889999999999999999999998765 4899999975322 11112234444566666789999999
Q ss_pred eEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++.+++.+||||||++| +|.+++.+. +.+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|
T Consensus 119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEee
Confidence 9999999999999999985 777777654 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---------CHHHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---------SVEEI 263 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---------~~~ei 263 (632)
||+++..... .......+||+.|||||++.+. .++.++|||||||++|||++|..||... ....+
T Consensus 197 FGla~~~~~~---~~~~~~~~gt~~Y~aPE~l~~~---~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 197 YGMCKEGLRP---GDTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp CTTCBCCCCT---TCCBCCCCBCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred cceeeecccC---CCccccccCCcccCCchhhcCC---CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 9999753221 2234557899999999999754 6889999999999999999999999643 22334
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM------ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~------~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
+..+. .....+|..+++++.+||.+||+.||.+||++ .|+++ +++|.+.+|+.+..+.+.+|+.|.
T Consensus 271 ~~~i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~------Hpff~~i~w~~l~~~~~~pp~~p~ 342 (396)
T 4dc2_A 271 FQVIL--EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG------HPFFRNVDWDMMEQKQVVPPFKPN 342 (396)
T ss_dssp HHHHH--HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH------STTTTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHh--ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc------CccccCCCHHHHHcCCCCCCCcCC
Confidence 44443 45667889999999999999999999999985 45544 889999999999999999988776
Q ss_pred CC
Q 006772 338 GY 339 (632)
Q Consensus 338 ~~ 339 (632)
..
T Consensus 343 ~~ 344 (396)
T 4dc2_A 343 IS 344 (396)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=400.58 Aligned_cols=277 Identities=23% Similarity=0.394 Sum_probs=227.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.+..++|++.+.||+|+||.||+|+++.++ +.||||++++.. ...... ...+..++..+.+||||+.+++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~-~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTN------QFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHH-HHHHHHHHHHHTTCTTBCCEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEhHHhhhhhhHHH-HHHHHHHHHhcCCCCCCCcEEE
Confidence 467789999999999999999999998765 489999997532 111222 3334455556668999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++.+++.+|+||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.+|++||+|||
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeECh
Confidence 9999999999999997 5888877653 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+++..+.. ..+
T Consensus 164 ~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~ 235 (345)
T 1xjd_A 164 MCKENMLG---DAKTNTFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNP 235 (345)
T ss_dssp TCBCCCCT---TCCBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC
T ss_pred hhhhcccC---CCcccCCCCCcccCChhhhcCC---CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCC
Confidence 99754221 1223456899999999999753 688999999999999999999999999998888877763 456
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHH-HHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMA-DILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~-ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
.+|..+++++.+||.+||+.||++||++. ++++ +++|.+.+|+.+..+.+.+|+.|..
T Consensus 236 ~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~------hp~f~~~~w~~l~~~~~~~p~~p~~ 294 (345)
T 1xjd_A 236 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ------HPLFREINWEELERKEIDPPFRPKV 294 (345)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG------SGGGTTCCHHHHHTTCSCC------
T ss_pred CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc------CccccCCCHHHHhhCCCCCCcCCCC
Confidence 67889999999999999999999999987 5544 8899999999999888888877653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=397.41 Aligned_cols=279 Identities=22% Similarity=0.346 Sum_probs=231.9
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+..++|++.+.||+|+||+||+|+++.++ +.||||++++... .........+..++..+.+||+|+.+++
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEE------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 4567789999999999999999999987654 5899999975321 1112223334455666668999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++...+.+||||||++ |+|.+++... +.+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|||
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence 9999999999999998 5888877654 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... .......+||+.|||||++.+. .++.++|||||||++|||++|..||.+.+..+++..+.. ...
T Consensus 167 ~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~ 238 (353)
T 2i0e_A 167 MCKENIWD---GVTTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNV 238 (353)
T ss_dssp TCBCCCCT---TCCBCCCCSCGGGCCHHHHTTC---CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC
T ss_pred cccccccC---CcccccccCCccccChhhhcCC---CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCC
Confidence 99754221 1233456899999999999743 688999999999999999999999999998888888764 456
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
.+|..+++++.+||.+||+.||.+||++ .++++ +++|.+.+|+.+..+.+.+|+.|..
T Consensus 239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~------h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE------HAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc------CccccCCCHHHHHhCCCCCCcCCCC
Confidence 6788999999999999999999999964 55554 7899999999999999999887753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=421.33 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=219.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++++.||+|+||.||+|.++.++ +.||||++........+.+ .++..++..+ +||||+.+++++.+++.
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg------~~~AiK~i~~~~~~~~~~~-~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATG------NNFAAKFVMTPHESDKETV-RKEIQTMSVL-RHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSHHHHHHH-HHHHHHHHHT-CCTTBCCEEEEEECSSE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCC------CEEEEEEEeccchhhHHHH-HHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence 68999999999999999999998776 4899999977654443433 4444555555 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC--CcEEEEecCCceec
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH--DQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~--g~vkL~DFGlak~~ 199 (632)
+|||||||+ |+|.+++... .+.+++.+++.|+.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999998 5888887543 3579999999999999999999999999999999999999854 89999999999876
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--CCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--CIP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--~~p 277 (632)
... ......+||+.|||||++.+. +|+.++|||||||+||||++|..||.+.+..+++..+....... ..+
T Consensus 308 ~~~----~~~~~~~GT~~y~APEv~~~~---~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 308 DPK----QSVKVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp CTT----SEEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred cCC----CceeeeEECccccCHHHhCCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence 432 233456899999999999854 68899999999999999999999999999988888876543322 223
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
..+|+++.+||.+||+.||.+||++.|+++ |+++....|..
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~------Hpw~~~~~~~~ 421 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTPGNAPG 421 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTSCCCCTT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcCcCCCCCCC
Confidence 678999999999999999999999999876 77877776654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=393.56 Aligned_cols=278 Identities=21% Similarity=0.348 Sum_probs=228.6
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+..++|++.+.||+|+||.||+|+++.++ +.||||++.+.. ..........+..++..+.+||||+.++++
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTD------RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCC------CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 356689999999999999999999998765 489999997542 222233344455666667789999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++.+|+||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.+|++||+|||+
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999998 5787777654 4799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---------CHHHHHHH
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---------SVEEIYHS 266 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---------~~~ei~~~ 266 (632)
++..... .......+||+.|+|||++.+. .++.++|+|||||++|||++|..||... ....++..
T Consensus 157 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 157 CKEGLRP---GDTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CBCSCCT---TCCBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred cccccCC---CCcccccCCCccccCccccCCC---CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 9753221 1233456899999999999753 6789999999999999999999999752 23334444
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM------ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 267 i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~------~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
+. .....+|..+++++.+||.+||+.||.+||++ .++++ +++|.+.+|+.+..+...+|+.+..
T Consensus 231 i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~------hp~f~~~~w~~~~~~~~~~p~~p~~ 300 (345)
T 3a8x_A 231 IL--EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG------HPFFRNVDWDMMEQKQVVPPFKPNI 300 (345)
T ss_dssp HH--HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HH--cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc------CCccCCCCHHHHHhCCCCCCcCCCC
Confidence 44 34566788999999999999999999999985 45443 8899999999998888888876653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=398.02 Aligned_cols=284 Identities=23% Similarity=0.375 Sum_probs=232.2
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhccCCCceeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l~~h~~I~~ 112 (632)
..+.+..++|++.+.||+|+||+||+|+++.++ +.||||++.+.... ....+. .+..++.+..+||||+.
T Consensus 31 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~-~e~~~ll~~~~hp~Iv~ 103 (373)
T 2r5t_A 31 SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEE------VFYAVKVLQKKAILKKKEEKHIM-SERNVLLKNVKHPFLVG 103 (373)
T ss_dssp BCTTCCGGGEEEEEEEECCTTCEEEEEEETTTC------CEEEEEEEEGGGBC--------------CCBCCCCCTTBCC
T ss_pred CCCCCChhheEEEEEEeeCCCeEEEEEEEcCCC------CEEEEEEEEHHHhhhhHHHHHHH-HHHHHHHHhCCCCCCCC
Confidence 345567789999999999999999999988765 48999999764321 112222 22233344568999999
Q ss_pred eeEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 113 LHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+++++..++.+||||||++| +|.+++.+. +.+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+
T Consensus 104 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 104 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999984 787777653 479999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++..... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+++..+..
T Consensus 182 DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-- 253 (373)
T 2r5t_A 182 DFGLCKENIEH---NSTTSTFCGTPEYLAPEVLHKQ---PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-- 253 (373)
T ss_dssp CCCBCGGGBCC---CCCCCSBSCCCCCCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--
T ss_pred eCccccccccC---CCccccccCCccccCHHHhCCC---CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--
Confidence 99999754322 1233456899999999999743 688999999999999999999999999998888888764
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
....++..+++++.+||.+||+.||.+||++.+.+..+ ..+.+|.+.+|+.+..+.+.+|+.|..
T Consensus 254 ~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i--~~h~~f~~~~w~~l~~~~~~pp~~p~~ 318 (373)
T 2r5t_A 254 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI--KSHVFFSLINWDDLINKKITPPFNPNV 318 (373)
T ss_dssp SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH--HTSGGGTTCCHHHHHTTCSCCSCCCSC
T ss_pred cccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH--hCCccccCCCHHHHHhCCCCCCCCCCC
Confidence 35567889999999999999999999999986433322 247899999999999999998887753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=427.08 Aligned_cols=279 Identities=22% Similarity=0.352 Sum_probs=234.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+..++|++++.||+|+||+||+|.++.++ +.||||++++.. .....+....+..++..+.+|++|+.+++
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~------~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSC------CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCC------cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3466789999999999999999999998765 489999997531 11112223334456666778999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++.+.+.+||||||++ |+|.+++... +.+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecc
Confidence 9999999999999998 5787777654 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... .......+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.+..+++..+. ....
T Consensus 488 la~~~~~~---~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~ 559 (674)
T 3pfq_A 488 MCKENIWD---GVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNV 559 (674)
T ss_dssp TCEECCCT---TCCBCCCCSCSSSCCHHHHTC---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCC
T ss_pred eeeccccC---CcccccccCCCcccCHhhhcC---CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCC
Confidence 99864322 223455789999999999974 368999999999999999999999999999999888877 4556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
.+|..+++++.+||.+||++||++||++ .||++ ++||.+.+|+.+..+.+.+|+.|..
T Consensus 560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~------h~ff~~i~w~~l~~~~~~pp~~p~~ 622 (674)
T 3pfq_A 560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE------HAFFRYIDWEKLERKEIQPPYKPKA 622 (674)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS------SGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc------CccccCCCHHHHHhCCCCCCCCCcC
Confidence 7889999999999999999999999987 55544 8899999999999999999887753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=384.89 Aligned_cols=273 Identities=22% Similarity=0.347 Sum_probs=230.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.++.++|++.+.||+|+||.||+|+++.++ +.||||++.+.... ...+...++..++.. .+||||+.++++
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~Iv~~~~~ 74 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNG------RYYAMKVLKKEIVVRLKQVEHTNDERLMLSI-VTHPFIIRMWGT 74 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS-CCBTTBCCEEEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhh-CCCCCCceEeEE
Confidence 456789999999999999999999987665 48999999653211 111223333344444 479999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+.+.+.+|+||||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.+|++||+|||+
T Consensus 75 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 75 FQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCc
Confidence 999999999999998 588887765 35799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
++.... .....+||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+..+.+..+.. ....
T Consensus 153 a~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~ 221 (318)
T 1fot_A 153 AKYVPD------VTYTLCGTPDYIAPEVVSTK---PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELR 221 (318)
T ss_dssp CEECSS------CBCCCCSCTTTCCHHHHTTC---CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCC
T ss_pred ceecCC------ccccccCCccccCHhHhcCC---CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCC
Confidence 986532 22346899999999999743 688999999999999999999999999988888877764 4566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
+|..+++++.++|.+||+.||++|| ++.++++ ++++.+.+|+.+..+.+.+|+.|.
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~------hp~f~~~~~~~~~~~~~~~p~~p~ 282 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN------HPWFKEVVWEKLLSRNIETPYEPP 282 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT------SGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc------CccccCCCHHHHHhCCCCCCCCCC
Confidence 7889999999999999999999999 7788776 889999999999988888887664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=398.98 Aligned_cols=282 Identities=21% Similarity=0.349 Sum_probs=231.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+..++|++.+.||+|+||+||+|+++.++ +.||||++.+.... .......++..++.. .+||||+.+++++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~------~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTR------KVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSPWVVQLFYAF 138 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHH-CCCTTBCCEEEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCC------cEEEEEEEehhhhhhhHHHHHHHHHHHHHHh-CCCCCCCeEEEEE
Confidence 55689999999999999999999998765 48999998642110 001112333344444 4799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+++.+||||||++ |+|.+++.. ..+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|||++
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999997 577777653 36999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCC-CCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVR-GPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~-g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... ......+||+.|||||++..... +.++.++|||||||++|||++|..||.+.+..+++..+........
T Consensus 216 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 216 MKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp EECCTTSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred EeeccCCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 87543211 12335689999999999975421 1278899999999999999999999999999888888876544444
Q ss_pred CC--CCCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCC
Q 006772 276 IP--SGLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGY 339 (632)
Q Consensus 276 ~p--~~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 339 (632)
+| ..+++++.+||.+||..+|.+ ||++.||++ +++|.+.+|..+..+...+|+.|...
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~------Hp~f~~~~w~~~~~~~~~~p~~p~~~ 355 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR------HLFFKNDQWAWETLRDTVAPVVPDLS 355 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT------SGGGCCSSCCSTTGGGSCCSCCCCCS
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc------CccccCCCHHHHhhcccCCCCCCcCC
Confidence 44 479999999999999999988 999999887 88999999999888888888877533
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=391.15 Aligned_cols=303 Identities=19% Similarity=0.306 Sum_probs=237.9
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
...++.++|++.+.||+|+||.||+|.+..++ +.||||++.+.. ......+. ++..++..+ +||||+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~-~E~~il~~l-~hp~Iv~l 80 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTK------KMYAMKYMNKQKCVERNEVRNVF-KELQIMQGL-EHPFLVNL 80 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHH-HHHHHHHTC-CCTTBCCE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEehhhcccHHHHHHHH-HHHHHHHhC-CCCCCCcE
Confidence 45567789999999999999999999988765 489999986532 11122333 333455555 79999999
Q ss_pred eEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++.+.+.+|+||||+.| +|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEec
Confidence 9999999999999999985 67666653 45799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---CHHHHHHHHHh
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---SVEEIYHSVVI 269 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---~~~ei~~~i~~ 269 (632)
||+++..... ......+||+.|+|||++.......++.++|||||||++|||++|..||... ...++...+.
T Consensus 159 FG~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~- 233 (384)
T 4fr4_A 159 FNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE- 233 (384)
T ss_dssp CTTCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-
T ss_pred cceeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-
Confidence 9999875322 2334568999999999997543456889999999999999999999999854 3444444433
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHHHHHhhhhcccCCCCccccccccccCCCcCCCCCCcccCccc
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPL-MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKGYTAWYPLKDH 348 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs-~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (632)
.....+|..+++++.+||.+||+.||.+||+ +.++++ ++++.+.+|+.+..+.+.+++.|.... ...+..
T Consensus 234 -~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~------hp~f~~~~w~~~~~~~~~p~~~p~~~~--~~~~~~ 304 (384)
T 4fr4_A 234 -TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN------FPYMNDINWDAVFQKRLIPGFIPNKGR--LNCDPT 304 (384)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT------SGGGTTCCHHHHHTTCSCCCCCCSCCS--SCCCCC
T ss_pred -hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc------ChhhhcCCHHHHHhCCCCCCCCCCCCC--CCCCCc
Confidence 4556678899999999999999999999998 666654 789999999999999998888776332 223333
Q ss_pred CccCcccccCCCCCC
Q 006772 349 LQVGDTVRSRKPLNA 363 (632)
Q Consensus 349 ~~~~~~~~s~~p~~~ 363 (632)
+.........+|...
T Consensus 305 ~~~~~~~~~~~~l~~ 319 (384)
T 4fr4_A 305 FELEEMILESKPLHK 319 (384)
T ss_dssp CCSTTSCTTCCC---
T ss_pred cChhhhhhccccccH
Confidence 433344444444433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=385.01 Aligned_cols=272 Identities=23% Similarity=0.354 Sum_probs=231.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.+..++|++.+.||+|+||.||+|.++.++ +.||||++.+... .....+ ..+..++..+ +||||+.+++
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~-~~E~~~l~~l-~hp~iv~~~~ 108 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESG------NHYAMKILDKQKVVKLKQIEHT-LNEKRILQAV-NFPFLVKLEF 108 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHH-HHHHHHHTTC-CCTTBCCEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCC------CEEEEEEEEhHHhccHHHHHHH-HHHHHHHHhC-CCCCCCeEEE
Confidence 345689999999999999999999988665 4899999865321 112222 3333455554 7999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++.+++.+||||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||
T Consensus 109 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccc
Confidence 9999999999999997 6888887654 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+++..+.. ...
T Consensus 187 ~a~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~ 255 (350)
T 1rdq_E 187 FAKRVKG------RTWTLCGTPEALAPEIILSK---GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKV 255 (350)
T ss_dssp TCEECSS------CBCCCEECGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC
T ss_pred cceeccC------CcccccCCccccCHHHhcCC---CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCC
Confidence 9987532 22346899999999999743 688999999999999999999999999998888887764 356
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.+|..+++++.++|.+||+.||.+||+ +.++++ +++|.+.+|..+..+.+.+|+.|.
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~------h~~f~~~~w~~~~~~~~~~p~~p~ 317 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN------HKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT------SGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh------CcCcCCCCHHHHhhccCCCCCCCC
Confidence 678899999999999999999999998 777765 789999999999988888887664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=399.71 Aligned_cols=280 Identities=20% Similarity=0.360 Sum_probs=227.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+..++|++.+.||+|+||+||+|+++.++ +.||||++.+..... ......++..++.. .+|+||+.+++++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~-~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNAD------KVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLHYAF 143 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHH-SCTTTBCCEEEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCC------cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHh-CCCCCEEEEEEEE
Confidence 45689999999999999999999998765 489999996421111 01112333344444 4899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+++.+||||||++ |+|.+++... .+.+++..++.|+.||+.||+|||+++|+||||||+|||++.++++||+|||++
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999997 6787777542 468999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+...... .......+||+.|||||++... ..+.++.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 223 ~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 223 LKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp EECCTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhcccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 8654321 1122346899999999998621 12358899999999999999999999999999988888887554444
Q ss_pred CCC---CCCCHHHHHHHHHhhhcCcCC--CCCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 275 CIP---SGLPPAVENVIIGCFEYDLRN--RPLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 275 ~~p---~~lp~~l~~LI~~cL~~DP~~--RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.+| ..+++++.+||.+||..+|++ ||+++|+++ +++|.+.+|+.+. ...+|+.|.
T Consensus 301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~------Hpff~~i~w~~l~--~~~~p~~P~ 360 (437)
T 4aw2_A 301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK------HPFFSGIDWDNIR--NCEAPYIPE 360 (437)
T ss_dssp CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT------SGGGTTCCTTTGG--GSCCSCCCC
T ss_pred cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC------CCccCCCCHHHHh--hCCCCCCCc
Confidence 444 458999999999999998888 999999876 8899999999983 566666554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=392.34 Aligned_cols=280 Identities=21% Similarity=0.364 Sum_probs=223.3
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+..++|++.+.||+|+||+||+|+++.++ +.||||++.+..... ....+.++..++.. .+|+||+.++++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~------~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~-~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTG------QVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRRWITQLHFA 129 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHH-SCTTTBCCEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh-cCCCCeeeEEEE
Confidence 356689999999999999999999998665 489999996522111 11112333344444 479999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+.+++.+||||||++ |+|.+++.+. +..+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999997 6888887654 35799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCC----CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE----VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~----~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
++....... ......+||+.|||||++... ..+.++.++|||||||++|||++|+.||.+.+..+++..+....
T Consensus 209 a~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 209 CLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp CEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred heeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 987543211 122346899999999998631 12357899999999999999999999999999888888877543
Q ss_pred cC---CCCCCCCCHHHHHHHHHhhhcCcCCC---CCHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 272 EK---PCIPSGLPPAVENVIIGCFEYDLRNR---PLMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 272 ~~---p~~p~~lp~~l~~LI~~cL~~DP~~R---Ps~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.. +..+..+|+++.+||.+||. +|.+| |+++|+++ +++|.+.+|+.+. ...+|+.|.
T Consensus 287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~------Hpff~~i~w~~l~--~~~~p~~p~ 349 (412)
T 2vd5_A 287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT------HPFFFGLDWDGLR--DSVPPFTPD 349 (412)
T ss_dssp HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT------SGGGTTCCSTTST--TSCCSCCCC
T ss_pred cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc------CCCcCCCCHHHHh--hcCCCCCCc
Confidence 33 33346899999999999999 99998 58888765 8899999999985 345666554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=376.17 Aligned_cols=281 Identities=19% Similarity=0.297 Sum_probs=223.1
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
...+..++|++.+.||+|+||.||+|++.... ..++.||||++++... ........++..++..+ +|+||+.+
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~ 86 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGA---NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDL 86 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSST---TTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccC---CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccce
Confidence 34567789999999999999999999985321 2346899999976421 11122223344455555 69999999
Q ss_pred eEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++..++.+||||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 87 IYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp EEEEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECC
T ss_pred eEEEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEe
Confidence 999999999999999998 5787777653 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++..... .......+||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+..+....+.. .
T Consensus 165 fg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~ 236 (327)
T 3a62_A 165 FGLCKESIHD---GTVTHTFCGTIEYMAPEILMRS---GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--C 236 (327)
T ss_dssp CSCC-------------CTTSSCCTTSCHHHHTTS---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--T
T ss_pred CCcccccccC---CccccccCCCcCccCHhhCcCC---CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--C
Confidence 9998754321 1122346799999999999743 678999999999999999999999999888887777663 4
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
...+|..+++++.++|.+||+.||++|| ++.++++ ++++.+.+|+.+..+...+++.+.
T Consensus 237 ~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~------hp~f~~~~~~~~~~~~~~~p~~p~ 300 (327)
T 3a62_A 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA------HPFFRHINWEELLARKVEPPFKPL 300 (327)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH------SGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc------CCcccCCCHHHHhhccCCCCCCCC
Confidence 5567889999999999999999999999 6777766 889999999998888777776554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=379.97 Aligned_cols=274 Identities=20% Similarity=0.307 Sum_probs=223.9
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCC-CcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSAD-DFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~-~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...+..++|++.+.||+|+||.||+|++..... .......||||+++..........+.++..++..+.+||||+.+++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345667899999999999999999999864322 1134468999999765443333334445566777778999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
++..++.+|+||||++ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999998 58888887543 23589999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~ 259 (632)
|++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999865432211 12233467889999999874 368999999999999999999 999999988
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
..++...+. ....+..|..+++++.++|.+||+.||.+||++.|+++.|+.+...
T Consensus 311 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 311 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GGGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 777766554 3455667889999999999999999999999999999999887643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=391.72 Aligned_cols=276 Identities=20% Similarity=0.360 Sum_probs=225.8
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
..+..++|++.+.||+|+||.||+|.+..++ +.||||++.+.. ......+ ..+..++.. .+||||+.++
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~-~~e~~~l~~-l~h~~iv~l~ 214 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATG------RYYAMKILKKEVIVAKDEVAHT-LTENRVLQN-SRHPFLTALK 214 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHC--------------CCCC-CSCTTSCCEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCC------CEEEEEEEEhhhhhhhHHHHHH-HHHHHHHHh-CCCCeEeeEE
Confidence 3456689999999999999999999988765 489999996431 1111222 222233444 4699999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEe
Q 006772 115 GISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
+++..++.+||||||++| +|.+++... +.+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 215 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 215 YSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECC
T ss_pred EEEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEcc
Confidence 999999999999999985 777777553 479999999999999999999998 9999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++..... .......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.+..++...+.. .
T Consensus 293 FG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~ 364 (446)
T 4ejn_A 293 FGLCKEGIKD---GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--E 364 (446)
T ss_dssp CCCCCTTCC--------CCSSSCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C
T ss_pred CCCceeccCC---CcccccccCCccccCHhhcCC---CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--C
Confidence 9998753221 122345689999999999974 3689999999999999999999999999988888777663 4
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
...+|..+++++.+||.+||+.||.+|| ++.|+++ +++|.+.+|..+..+.+.+|+.|.
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~------hp~f~~~~~~~~~~~~~~pp~~p~ 428 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ------HRFFAGIVWQHVYEKKLSPPFKPQ 428 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh------CccccCCCHHHHhhCcCCCCccCC
Confidence 5667889999999999999999999999 8998876 889999999999888888887664
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=374.28 Aligned_cols=271 Identities=18% Similarity=0.303 Sum_probs=219.7
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
....+..++|++.+.||+|+||.||+|.+..+++ ....||||+++..........+.++..++..+ +|+||+.+++
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 117 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEG 117 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEE
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEE
Confidence 3456778999999999999999999999876542 33579999997654333333334444555665 6999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++..||||||++| +|.+++.. ..+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 99988999999999985 77777644 34689999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++................+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+.. ...
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~ 272 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF---RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYR 272 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCC
Confidence 99876433222222233456889999999964 368889999999999999999 9999999988887776653 345
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
...+..+++++.++|.+||+.||++||++.++++.|+.+...
T Consensus 273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 567789999999999999999999999999999999887643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=368.45 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=209.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++.+.||+|+||.||+|.+..++ +.||||++.+.. ....+.+.+ +..++..+ +||||+.+++++.
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTG------REVAIKIIDKTQLNPTSLQKLFR-EVRIMKIL-NHPNIVKLFEVIE 84 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHH-HHHHHHHC-CCTTBCCEEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEhhcCCHHHHHHHHH-HHHHHHhC-CCCCEeeEEEEEE
Confidence 3468999999999999999999997766 489999996532 222233333 33445555 6999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++.+|+||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 9999999999997 6888888654 479999999999999999999999999999999999999999999999999987
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCC-CcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPI-SFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~-t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
..... ......+||+.|+|||++.+. .+ +.++|||||||++|||++|..||.+.+..++...+.. ....+
T Consensus 163 ~~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~ 233 (328)
T 3fe3_A 163 EFTVG----GKLDAFCGAPPYAAPELFQGK---KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRI 233 (328)
T ss_dssp GGSSS----CGGGTTSSSGGGCCHHHHHTC---CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCC
T ss_pred ecCCC----CccccccCCcceeCcccccCC---CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCC
Confidence 54322 233456899999999999754 33 5799999999999999999999999998888777663 45567
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|..+++++.+||.+||+.||.+|||+.++++
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8889999999999999999999999999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=373.00 Aligned_cols=278 Identities=21% Similarity=0.322 Sum_probs=227.8
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
|......+..++|++.+.||+|+||.||+|.+...+.. ......||||++.............++..++..+.+|+||+
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 44445567789999999999999999999998654321 13345899999976544333333444556667777899999
Q ss_pred EeeEEEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeee
Q 006772 112 WLHGISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK 176 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLK 176 (632)
.+++++..++..||||||++ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999998 58888887653 2469999999999999999999999999999999
Q ss_pred CCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCC
Q 006772 177 PSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPW 255 (632)
Q Consensus 177 P~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF 255 (632)
|+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceEEEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcC---CCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999986533211 112233467899999999874 368899999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 256 FGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 256 ~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
.+.+..++...+. ....+..+..+++++.++|.+||+.||++||++.++++.|+.+...
T Consensus 295 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 295 PGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp TTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 9998888776654 4456667889999999999999999999999999999999887643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.37 Aligned_cols=271 Identities=21% Similarity=0.339 Sum_probs=218.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+..... ...++.||||+++............++..++..+.+||||+.+++++.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccc-cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 3667899999999999999999999754321 234568999999765443333334445566777889999999999987
Q ss_pred ECC-EEEEEEecCC-CCHHHHHHHhcC-----------------------------------------------------
Q 006772 119 ING-KICIAMKFYE-GSVGDRIAQQRG----------------------------------------------------- 143 (632)
Q Consensus 119 ~~~-~l~LVmEy~~-GsL~d~l~~~~~----------------------------------------------------- 143 (632)
..+ .+++||||+. |+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 754 5999999998 588888765421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccc
Q 006772 144 -----------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALR 212 (632)
Q Consensus 144 -----------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~ 212 (632)
..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ........
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~ 255 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDA 255 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-TCEEC--C
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc-cchhcccc
Confidence 128999999999999999999999999999999999999999999999999997653321 11122345
Q ss_pred cCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 006772 213 LGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGC 291 (632)
Q Consensus 213 ~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~c 291 (632)
.||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+...........+..|..+++++.++|.+|
T Consensus 256 ~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 256 RLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp EECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCceeEChhhhcC---CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 68999999999874 468899999999999999998 99999987755544455555667778889999999999999
Q ss_pred hhcCcCCCCCHHHHHHHHHhhhh
Q 006772 292 FEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 292 L~~DP~~RPs~~ell~~Le~~~~ 314 (632)
|+.||.+||++.++++.|+.+..
T Consensus 333 l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999987754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.31 Aligned_cols=264 Identities=17% Similarity=0.227 Sum_probs=212.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+..++ +.||||++...... .. ..++..++..+.+|++++.+++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~--~~-~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNN------QQVAIKFEPRRSDA--PQ-LRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTT------EEEEEEEEECCTTS--CC-HHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCC------cEEEEEEeccCCcc--HH-HHHHHHHHHHHhcCCCCCeEEeecC
Confidence 345678999999999999999999987655 58999998654322 12 2333355666778999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc-----EEEEec
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ-----LVLGDF 193 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~-----vkL~DF 193 (632)
.+...++||||+.|+|.+++... +..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 77 ~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 77 EGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCceeEEEEEecCCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 99999999999988898888654 457999999999999999999999999999999999999988776 999999
Q ss_pred CCceeccCCCCCC----CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---CHHHHHHH
Q 006772 194 GIPYLLLGRSLSD----SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---SVEEIYHS 266 (632)
Q Consensus 194 Glak~~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---~~~ei~~~ 266 (632)
|+++......... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+. ...+.+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCC---CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 9998764332111 123456799999999998743 6889999999999999999999999884 34444444
Q ss_pred HHhhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 267 VVIKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 267 i~~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+......+. ....+|+++.++|.+||+.||++||++.+|++.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 433222222 3357899999999999999999999999999999887654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=391.75 Aligned_cols=278 Identities=21% Similarity=0.324 Sum_probs=228.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.+..++|++.+.||+|+||.||+|+++.++ +.||||++.+... .....+ ..+..++..+ +||||+.+++
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg------~~vAiK~l~k~~~~~~~~~~~~-~~E~~iL~~l-~hp~Iv~l~~ 252 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATG------KLYACKKLNKKRLKKRKGYQGA-MVEKKILAKV-HSRFIVSLAY 252 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHH-HHHHHHHHHC-CCTTBCCEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEEEhHHhhhhHHHHHH-HHHHHHHHhc-CCCCEeeEEE
Confidence 356789999999999999999999987665 4899999965321 111222 2333455554 7999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++...+.+||||||++ |+|.+++.... ...+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|
T Consensus 253 ~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEee
Confidence 9999999999999998 57777776543 35799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC----CHHHHHHHHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK----SVEEIYHSVV 268 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~----~~~ei~~~i~ 268 (632)
||+++...... ......+||+.|||||++.+. .++.++|||||||++|||++|..||.+. ...++...+.
T Consensus 333 FGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~---~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~ 406 (543)
T 3c4z_A 333 LGLAVELKAGQ---TKTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406 (543)
T ss_dssp CTTCEECCTTC---CCBCCCCSCTTTSCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH
T ss_pred cceeeeccCCC---cccccccCCccccChhhhcCC---CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh
Confidence 99998753321 122345899999999999753 6889999999999999999999999875 3455665554
Q ss_pred hhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHHHHHhhhhcccCCCCccccccccccCCCcCCC
Q 006772 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM-----ADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVKG 338 (632)
Q Consensus 269 ~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~-----~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 338 (632)
.....+|..+++++.+||.+||+.||++||++ .+|++ +++|.+.+|..+..+...+|+.|..
T Consensus 407 --~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~------Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 407 --EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT------HPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp --HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred --hcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc------CccccCCCHHHHHcCCCCCCCCCCc
Confidence 34566788999999999999999999999975 55554 8899999999999888888877653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=373.35 Aligned_cols=284 Identities=20% Similarity=0.325 Sum_probs=224.9
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
...+..++|++.+.||+|+||.||+|++.... ..++.||||++++... .........+..++..+.+|+||+.+
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 124 (355)
T 1vzo_A 48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124 (355)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred cccccccceEEEEEeccCCCEEEEEEEEcccC---CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEE
Confidence 34456689999999999999999999985422 2346899999864321 11111122333556667789999999
Q ss_pred eEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++..++.+||||||++ |+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 125 HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred EEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEee
Confidence 999999999999999998 5888887654 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC----CHHHHHHHHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK----SVEEIYHSVV 268 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~----~~~ei~~~i~ 268 (632)
||+++...... .......+||+.|+|||++.+. ...++.++|||||||++|||++|..||... ...++...+.
T Consensus 203 fG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 203 FGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp SSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred CCCCeecccCC--CCcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 99998653221 1223345799999999999743 235788999999999999999999999753 2344444433
Q ss_pred hhccCCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcC
Q 006772 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSV 336 (632)
Q Consensus 269 ~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~ 336 (632)
...+.+|..+++.+.+||.+||+.||.+|| ++.++++ +.++...+|..+..+...+++.+
T Consensus 280 --~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~------h~~f~~~~~~~l~~~~~~~p~~p 344 (355)
T 1vzo_A 280 --KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE------HLFFQKINWDDLAAKKVPAPFKP 344 (355)
T ss_dssp --HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCC
T ss_pred --ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc------CcchhcCChhHhhhccCCCCCCC
Confidence 345667889999999999999999999999 8888876 77888999998888777776654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.76 Aligned_cols=276 Identities=22% Similarity=0.304 Sum_probs=222.9
Q ss_pred CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 35 QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 35 ~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
.....+..++|++.+.||+|+||.||+|.+..... ...++.||||++.........+.+.++..++..+.+||||+.++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccc-cchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 33445677899999999999999999998743211 13346899999986554333344445556677777899999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeC
Q 006772 115 GISVINGKICIAMKFYEG-SVGDRIAQQRG----------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKP 177 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~----------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP 177 (632)
+++..++..++||||++| +|.+++..... ..+++..++.++.||+.||+|||+++|+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999985 88888876432 2589999999999999999999999999999999
Q ss_pred CeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCC
Q 006772 178 SNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256 (632)
Q Consensus 178 ~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~ 256 (632)
+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|+|||||++|||++ |..||.
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ceEEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876533211 111223457889999999864 368899999999999999999 999999
Q ss_pred CCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 257 GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 257 ~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+................+..+..+++++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 87755544455555556666788999999999999999999999999999999876643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.65 Aligned_cols=249 Identities=19% Similarity=0.323 Sum_probs=206.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++........+.+.+ +..++.. .+||||+.+++++..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~-E~~~l~~-l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATG------QEVAIRQMNLQQQPKKELIIN-EILVMRE-NKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTC------CEEEEEEEEGGGCSCHHHHHH-HHHHHHH-CCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCC------cEEEEEEeecccccHHHHHHH-HHHHHhc-CCCCCCCeEeEEEEECC
Confidence 368999999999999999999987655 489999986544333333333 3344444 47999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
.+|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999997 577777654 369999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKPCIPSG 279 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p~~p~~ 279 (632)
... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+.... .....+..
T Consensus 168 ~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T 3fxz_A 168 PEQ---SKRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (297)
T ss_dssp STT---CCBCCCCSCGGGCCHHHHHCS---CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGG
T ss_pred Ccc---cccCCccCCcCccChhhhcCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 321 223446799999999999743 68899999999999999999999999988766555544332 23345678
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++.+.++|.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999999999999999999999999886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=363.86 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=209.5
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
...|..++|++.+.||+|+||.||+|.+.. +.||||++..... .....+.+ +..++.++ +|+||+.++
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~-E~~~l~~l-~hp~iv~~~ 100 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG--------SDVAVKILMEQDFHAERVNEFLR-EVAIMKRL-RHPNIVLFM 100 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETT--------EEEEEEEECCCCCSHHHHHHHHH-HHHHHHHC-CCTTBCCEE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECC--------CcEEEEEecCCCCCHHHHHHHHH-HHHHHHhC-CCCCEeeEE
Confidence 344677899999999999999999998642 4799999976432 22233333 34555555 699999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEecCCcEEE
Q 006772 115 GISVINGKICIAMKFYEG-SVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~G-sL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld~~g~vkL 190 (632)
+++..++.+++||||++| +|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp EEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred EEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEE
Confidence 999999999999999984 8888775432 124899999999999999999999999 999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 181 ~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 181 CDFGLSRLKASTF---LSSKSAAGTPEWMAPEVLRDE---PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp CCCC--------------------CCTTSCHHHHTTC---CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred CCCCCCccccccc---cccccCCCCccccChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999997543221 122345789999999999744 5788999999999999999999999999888877777666
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.....+|..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 67778889999999999999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.91 Aligned_cols=260 Identities=18% Similarity=0.294 Sum_probs=217.1
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...|+.++|++.+.||+|+||.||+|.+.. +.||||++...... .......++..++..+ +||||+.+++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 74 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQG--------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLG 74 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETT--------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECC--------eeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEE
Confidence 345778999999999999999999999752 47999999764321 2222233333444554 7999999999
Q ss_pred EEEEC--CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEecCCcEEE
Q 006772 116 ISVIN--GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 116 ~~~~~--~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld~~g~vkL 190 (632)
++... +..++||||++ |+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp EECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred EEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeE
Confidence 98876 78899999998 58888887654446999999999999999999999999 999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||++... ......||+.|+|||++.+.....++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 155 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 226 (271)
T 3kmu_A 155 SMADVKFSF--------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226 (271)
T ss_dssp EGGGSCCTT--------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS
T ss_pred Eeccceeee--------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc
Confidence 999976432 112346899999999997654445566899999999999999999999999888877777777
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
...+.+|..+++++.++|.+||+.||++||++.++++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 7778889999999999999999999999999999999998765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=394.59 Aligned_cols=276 Identities=21% Similarity=0.361 Sum_probs=227.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
+..++|++.+.||+|+||.||+|.++.++ +.||||++.+... .........+..++..+ +|+||+.+++++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg------~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~ 253 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAY 253 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEE
Confidence 66789999999999999999999988665 4899999965321 11122223344555555 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.+++.+||||||++ |+|.+++.......+++..++.|+.||+.||+|||+++|+||||||+|||++.+|++||+|||++
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence 99999999999997 57777776554456999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhcc
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS----VEEIYHSVVIKKE 272 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~----~~ei~~~i~~~~~ 272 (632)
+..... ......+||+.|||||++.+. .++.++|||||||++|||++|..||.+.+ ..++...+. ..
T Consensus 334 ~~~~~~----~~~~~~~GT~~Y~APEvl~~~---~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~ 404 (576)
T 2acx_A 334 VHVPEG----QTIKGRVGTVGYMAPEVVKNE---RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EV 404 (576)
T ss_dssp EECCTT----CCEECCCSCGGGCCHHHHTTC---EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HC
T ss_pred eecccC----ccccccCCCccccCHHHHcCC---CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cc
Confidence 875322 123446899999999999743 58899999999999999999999998753 344554443 34
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
...+|..+++++.+||.+||+.||.+|| ++.|+++ +++|.+.+|..+..+.+.+|+.|.
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~------HpfF~~i~w~~l~~~~~~pp~~p~ 468 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE------HPLFKKLNFKRLGAGMLEPPFKPD 468 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh------ChhhccCCHHHHhcCCCCCCCCCC
Confidence 5667889999999999999999999999 6777776 889999999999888888887664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=371.85 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=195.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+.. ....... .++..++..+..|+||+.+++++..+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~-~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTG------EVVAVKKIFDAFQNSTDAQRT-FREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTC------CEEEEEEECC--CCHHHHHHH-HHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCC------CEEEEEEecccccChHHHHHH-HHHHHHHHhccCCCCCCeeeeEEecC
Confidence 68999999999999999999998766 489999986532 2222333 33445567777799999999998765
Q ss_pred C--EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 121 G--KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 121 ~--~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
+ .+||||||++|+|.+.+.. +.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 82 NDRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp TSSCEEEEEECCSEEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCEEEEEecccCcCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 4 7999999999998888764 3799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC------------------CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH
Q 006772 199 LLGRSL------------------SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV 260 (632)
Q Consensus 199 ~~~~~~------------------~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~ 260 (632)
...... ........+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 532110 01123345899999999998742 3688999999999999999999999999887
Q ss_pred HHHHHHHHhhccCCC---------------------------------------------CCCCCCHHHHHHHHHhhhcC
Q 006772 261 EEIYHSVVIKKEKPC---------------------------------------------IPSGLPPAVENVIIGCFEYD 295 (632)
Q Consensus 261 ~ei~~~i~~~~~~p~---------------------------------------------~p~~lp~~l~~LI~~cL~~D 295 (632)
.+.+..+......|. .+..+++++.+||.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 776665542221111 12367899999999999999
Q ss_pred cCCCCCHHHHHH
Q 006772 296 LRNRPLMADILH 307 (632)
Q Consensus 296 P~~RPs~~ell~ 307 (632)
|++|||+.|+++
T Consensus 317 P~~R~t~~e~l~ 328 (388)
T 3oz6_A 317 PNKRISANDALK 328 (388)
T ss_dssp GGGSCCHHHHTT
T ss_pred cccCCCHHHHhC
Confidence 999999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=353.00 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=205.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||+||+|.++.++ +.||||++..... ........++..++..+ +|+||+.+++++..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETH------EIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCC------ceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCC
Confidence 68999999999999999999998765 4899999975432 22222233334455555 6999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.++|||||++|++.+.+... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 75 KLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 99999999999998887654 46899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhccCC------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEIYHSVVIKKEKP------ 274 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P-F~~~~~~ei~~~i~~~~~~p------ 274 (632)
. ........||+.|+|||++.+. ..++.++|||||||++|||++|..| |.+.+..+....+......+
T Consensus 154 ~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 154 P---VRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp C---CSCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred c---cccccCCccccCCcChHHHcCC--CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 2 1223445789999999998743 2478999999999999999998777 55556665555544321111
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccC
Q 006772 275 ---------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318 (632)
Q Consensus 275 ---------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~ 318 (632)
.....+++++.+||.+||+.||++|||++|+++ +++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~ 287 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ------HPYFS 287 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGT
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc------Ccccc
Confidence 112357899999999999999999999999886 56664
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=361.81 Aligned_cols=271 Identities=17% Similarity=0.241 Sum_probs=214.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+-.++|++.+.||+|+||+||+|.+..++ +.||||++...... .. +..+..++..+.+|+||+.+++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~--~~-~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTN------EYVAIKLEPMKSRA--PQ-LHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTT------EEEEEEEEETTCSS--CC-HHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCC------cEEEEEEeccccch--HH-HHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 344578999999999999999999987655 48999998754322 12 2334456677778999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc-----EEEEec
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ-----LVLGDF 193 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~-----vkL~DF 193 (632)
.++..|+||||+.|+|.+++... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 76 ~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 76 CGKYNAMVLELLGPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred cCCccEEEEEeCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 99999999999988899888754 468999999999999999999999999999999999999999887 999999
Q ss_pred CCceeccCCCCCC----CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC---CHHHHHHH
Q 006772 194 GIPYLLLGRSLSD----SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK---SVEEIYHS 266 (632)
Q Consensus 194 Glak~~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~---~~~ei~~~ 266 (632)
|+++......... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+. ...+.+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG---KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcC---CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 9998754322111 11245689999999999974 36889999999999999999999999984 34444444
Q ss_pred HHhhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc----cCCCCcc
Q 006772 267 VVIKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV----YNDGEWT 323 (632)
Q Consensus 267 i~~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~----~~~~~w~ 323 (632)
+........ ....+| ++.+++.+||+.||.+||++.+|++.|+.+.... ....+|+
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 432221111 123455 9999999999999999999999999888776542 2346776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=362.36 Aligned_cols=266 Identities=20% Similarity=0.367 Sum_probs=210.7
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||+||+|.+..++ +.||+|.+..........+.++ ..++..+ +||||+.+++++.
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~------~~va~K~~~~~~~~~~~~~~~E-~~~l~~l-~hp~iv~~~~~~~ 77 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETG------EVMVMKELIRFDEETQRTFLKE-VKVMRCL-EHPNVLKFIGVLY 77 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTC------CEEEEEEESCCCHHHHHHHHHH-HHHHTTC-CCTTBCCEEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCC------cEEEEEEeccCCHHHHHHHHHH-HHHHHhC-CCcCcccEEEEEe
Confidence 467789999999999999999999998765 4899999876555544444444 3455555 6999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..++||||++| +|.+++... ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred cCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 99999999999985 777777553 4689999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCC-----------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHH-H
Q 006772 198 LLLGRSLSD-----------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIY-H 265 (632)
Q Consensus 198 ~~~~~~~~~-----------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~-~ 265 (632)
......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~ 233 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh
Confidence 763322111 01124579999999999974 36889999999999999999999998763221100 0
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
...........|..+|+++.++|.+||+.||++||++.++++.|+.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000001112346788999999999999999999999999999998887543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.30 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=196.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.++.++ +.||||++.............++..++..+ .||||+.+++++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTG------VYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSC------CEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCC------cEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECC
Confidence 468999999999999999999987655 489999997543322222233344555555 6999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 122 KICIAMKFYEGSVGDRIAQQR----GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~----~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.+||||||++|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999999999999999887653 2468999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--- 274 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--- 274 (632)
..... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 157 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 157 AFGIP---VNTFSSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp ETTSC---CCCCCCCCSCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred ecCCC---cccCCCCcccccccCchHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 75322 1222345789999999998642 357899999999999999999999999988777666554321110
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 275 -----------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 275 -----------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
..+..+++++.+||.+||+.||++|||+.|+++ ++++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~------hp~f~~~ 300 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH------HPWFAEY 300 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGGGG
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC------Chhhhcc
Confidence 112357899999999999999999999999886 5565443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=375.54 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=216.7
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...|+.++|++.+.||+|+||.||+|.+..++ +.||||+++..........+.++..++..+ +||||+.++++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 180 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADN------TLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGV 180 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEE
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCC------eEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEE
Confidence 34477899999999999999999999987654 489999987543322222233344555555 79999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++.+||||||++ |+|.+++... +..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 998899999999998 6888887653 34799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++........ .......+++.|+|||++.. +.++.++|||||||++|||++ |..||.+.+..+....+. .....
T Consensus 260 s~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 334 (377)
T 3cbl_A 260 SREEADGVYA-ASGGLRQVPVKWTAPEALNY---GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRL 334 (377)
T ss_dssp CEECTTSEEE-CCSSCCEEEGGGSCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCC
T ss_pred ceecCCCcee-ecCCCCCCCcCcCCHhHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 9864322111 11112235778999999863 468899999999999999998 999999988877765554 44556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..|..+|+++.+||.+||+.||++||++.++++.|+.+..
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 6788999999999999999999999999999999988753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=354.45 Aligned_cols=265 Identities=21% Similarity=0.352 Sum_probs=204.8
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|.+..++ .....||+|.+.........+.+.++..++..+ +||||+.+++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE---NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCC---CCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEE
Confidence 4567789999999999999999999987543 233579999987644333333333444455555 799999999987
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.++..|+||||++| +|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 86 -TENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp -CSSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred -ccCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 45678999999995 787777543 457999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......+|+.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..+....+.. ...+.
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~~~~ 237 (281)
T 1mp8_A 164 RYMEDSTY--YKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLP 237 (281)
T ss_dssp -----------------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCC
T ss_pred cccCcccc--cccccCCCcccccChhhccc---CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CCCCC
Confidence 86533211 11223356889999999863 368899999999999999997 9999998887776666543 34556
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
++..+|+++.++|.+||+.||++||++.++++.|+.+..
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 788999999999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.88 Aligned_cols=273 Identities=19% Similarity=0.306 Sum_probs=222.8
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...+..++|++.+.||+|+||.||+|.+..++.. .....||+|++...........+.++..++..+.+||||+.++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKE-DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSS-CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcc-cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3457789999999999999999999998765531 233589999997654433334344455666777789999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 117 SVINGKICIAMKFYEG-SVGDRIAQQR------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~G-sL~d~l~~~~------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
+..++.+|+||||++| +|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999985 8888886542 34689999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHH
Q 006772 184 EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEE 262 (632)
Q Consensus 184 ~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~e 262 (632)
.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhcc---CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 999999999999976533211 111233457889999999874 368899999999999999999 999999876555
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 263 i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
....+......+..|..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 5555555556666788899999999999999999999999999999887653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=357.13 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=200.9
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-------------------------HH
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-------------------------KV 92 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-------------------------~~ 92 (632)
..+..++|++.+.||+|+||.||+|.+..++ +.||||++.+...... .+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDN------TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTT------EEEEEEEEECC-------------------------------C
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCC------cEEEEEEeehhhhhhhcccccccccccccccccccccccchHH
Confidence 3455689999999999999999999987665 4899999975432110 11
Q ss_pred HHHHHHHHhhhccCCCceeEeeEEEEE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 006772 93 FVNKFEELFPKFRESQSVCWLHGISVI--NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG 169 (632)
Q Consensus 93 ~~~~~~~il~~l~~h~~I~~l~~~~~~--~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~ 169 (632)
.+.++..++..+ +||||+.+++++.. ++.+|+||||++| +|.+++ ..+.+++.+++.++.||+.||+|||+++
T Consensus 82 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 82 QVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HHHHHHHHHHTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 123333455555 79999999999886 5789999999985 554432 3357999999999999999999999999
Q ss_pred ceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHH
Q 006772 170 LLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEML 249 (632)
Q Consensus 170 IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Eml 249 (632)
|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.....++.++|+|||||++|||+
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999999999999999998754321 1223457999999999987542222477899999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 250 TGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 250 tG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|..||.+.+.......+.........+..+++++.++|.+||+.||++||++.|+++
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9999999988777666665433333334679999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.74 Aligned_cols=270 Identities=20% Similarity=0.331 Sum_probs=220.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|.+..... ...++.||||+++..........+.++..++..+ +||||+.+++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSST-TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCC-CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 35667899999999999999999999875321 1234689999998654433333344444556665 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeee
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR----------------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLN 174 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~----------------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRD 174 (632)
..++..|+||||++ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999998 58888887642 15799999999999999999999999999999
Q ss_pred eeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCC
Q 006772 175 LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQ 253 (632)
Q Consensus 175 LKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~ 253 (632)
|||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|+|||||++|||++ |..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc---CCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999765332111 12233467999999999874 368899999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 254 PWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 254 PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
||.+.+..++...+.. ...+..|..+|+++.++|.+||+.||++||++.++++.|+.+..
T Consensus 276 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9999888877766653 44556788999999999999999999999999999999988764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=351.33 Aligned_cols=260 Identities=20% Similarity=0.366 Sum_probs=214.8
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.+.||+|+||.||+|.+... +.||+|++....... +.+. ++..++.++ +||||+.+++++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~~~-~~~~-~E~~~l~~l-~h~~i~~~~~~~ 74 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMSE-EDFI-EEAEVMMKL-SHPKLVQLYGVC 74 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEEECTTSBCH-HHHH-HHHHHHHTC-CCTTBCCEEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCC-------CeEEEEEecccccCH-HHHH-HHHHHHHhC-CCCCEeeEEEEE
Confidence 457889999999999999999999998642 379999997654322 3333 344555555 589999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..++..|+||||++| +|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred ecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccc
Confidence 999999999999985 67777654 3457999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......||+.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..+....+.. ...+.
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~ 227 (269)
T 4hcu_A 154 RFVLDDQY--TSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLY 227 (269)
T ss_dssp GGBCCHHH--HSTTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCC
T ss_pred cccccccc--ccccCcccccccCCHHHhcC---CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccCC
Confidence 76432211 11223456889999999864 368899999999999999999 9999999988887776653 34555
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.|..+++++.+++.+||+.||++||++.++++.|+.+..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 678899999999999999999999999999999987753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.63 Aligned_cols=258 Identities=21% Similarity=0.342 Sum_probs=197.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+..++|++.+.||+|+||.||+|.+..++ +.||||++....... ......++ ....+..+||||+.+++++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~-~~~~~~~~h~~iv~~~~~~ 75 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSG------QIMAVKRIRATVNSQEQKRLLMDL-DISMRTVDCPFTVTFYGAL 75 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEC---CHHHHHHHHHHH-HHHHTTCCCTTBCCEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCC------eEEEEEEeecccCcHHHHHHHHHH-HHHHHhCCCCeEEEEeeee
Confidence 456789999999999999999999987665 489999997643322 22233333 3334556899999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecC
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
..++..|+||||++|+|.+.+... .+..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 76 FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp ECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred eccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 999999999999999988877653 346899999999999999999999998 99999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCC-CCCCCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhcc
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-VRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVVIKKE 272 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~i~~~~~ 272 (632)
+++..... .......||+.|+|||++... ....++.++|+|||||++|||++|..||... ..............
T Consensus 156 ~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 156 ISGYLVDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred Cccccccc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 98765332 122334689999999997432 2346889999999999999999999999864 34444444443333
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+..+++++.++|.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 33334578999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.04 Aligned_cols=273 Identities=20% Similarity=0.320 Sum_probs=218.4
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...++.++|++.+.||+|+||.||+|.+..... ......||||++...........+.++..++..+..||||+.++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSS-SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeecccc-CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345777999999999999999999999854221 1234689999997543332233344455667777789999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeee
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRG---------------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLN 174 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~---------------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRD 174 (632)
+..++..|+||||++ |+|.+++..... ..+++..++.++.||+.||+|||+++|+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999997 588888865432 2489999999999999999999999999999
Q ss_pred eeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCC
Q 006772 175 LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQ 253 (632)
Q Consensus 175 LKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~ 253 (632)
|||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ +.++.++|||||||++|||++ |..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhcc---CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999976533211 111233457889999999864 468899999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 254 PWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 254 PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
||.+.+.......+......+..|..+++++.+||.+||+.||.+||++.++++.|+.+..
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 9998775555555555566677788899999999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=358.89 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=204.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|++.+.||+|+||.||+|.+.. + +.||+|++...... .......++..++..+ +||||+.+++++..+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-G------RIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSE 91 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-S------CEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCS
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-C------CEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccC
Confidence 4789999999999999999999853 2 48999999654321 1122233344555555 699999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+.+||||||++|++.+.+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999999999998888654 3579999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-----
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC----- 275 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~----- 275 (632)
.. ........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+.
T Consensus 171 ~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 171 IP---VRSYTHEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp SC---CC---CCCCCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred CC---cccccCCcccCCcCCHHHhcCC--CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 22 1223345789999999998642 3578999999999999999999999998765554444432111110
Q ss_pred -----------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCC
Q 006772 276 -----------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGE 321 (632)
Q Consensus 276 -----------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~ 321 (632)
..+.+++++.+||.+||+.||++|||+.|+++ +++|.+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~~ 308 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN------HPYFKDLD 308 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTTSC
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc------CcccccCC
Confidence 12356789999999999999999999999886 67776554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=360.15 Aligned_cols=278 Identities=20% Similarity=0.317 Sum_probs=223.0
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCC-CcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSAD-DFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~-~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
|......+..++|++.+.||+|+||.||+|.+..... ....+..||||++...........+.++..++..+.+||||+
T Consensus 25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 3333455777999999999999999999999864322 112446899999976543333333444456667777899999
Q ss_pred EeeEEEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeee
Q 006772 112 WLHGISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLK 176 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLK 176 (632)
.+++++..++.+|+||||++ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999998 58888886543 1348999999999999999999999999999999
Q ss_pred CCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCC
Q 006772 177 PSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPW 255 (632)
Q Consensus 177 P~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF 255 (632)
|+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceEEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC---CCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999875432111 11223457889999999864 357899999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 256 FGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 256 ~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
.+.+..++...+. ....+..+..+++++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 261 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 261 PGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp TTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9988887766554 3445667889999999999999999999999999999999887653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=356.82 Aligned_cols=270 Identities=21% Similarity=0.324 Sum_probs=218.9
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...+..++|++.+.||+|+||.||+|.+..... ...+..||||++...........+.++..++..+ +||||+.++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKG-RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGG-CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCc-ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEE
Confidence 455677999999999999999999999854321 1234689999997644333333333444555555 79999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRG----------------------GKLPLPDILRYGIQLAKGISDLHSIGLLVL 173 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~----------------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHR 173 (632)
+..++..++||||++ |+|.+++..... ..+++.+++.++.||+.||+|||+++|+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999998 688888876432 348999999999999999999999999999
Q ss_pred eeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CC
Q 006772 174 NLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GI 252 (632)
Q Consensus 174 DLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~ 252 (632)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|+|||||++|||++ |.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC---CCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999986533211 111233457889999999874 357899999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 253 QPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 253 ~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.||.+.+..++...+. ....+..+..+++++.++|.+||+.||++||++.++++.|+.+.
T Consensus 251 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 251 NPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999988777665554 34456678899999999999999999999999999999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.91 Aligned_cols=259 Identities=19% Similarity=0.321 Sum_probs=214.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
++|++.+.||+|+||.||+|.++.++ +.||+|++.+.... ..+. +..+..++..+ .||||+.++++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~------~~~avK~i~~~~~~~~~~~~~~~~-~~~E~~il~~l-~hpnIv~l~~~ 83 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTG------LEYAAKFIKKRQSRASRRGVCREE-IEREVSILRQV-LHPNIITLHDV 83 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEBCSSTTCSSSBCHHH-HHHHHHHHTTC-CCTTBCCEEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCC------CEEEEEEEEccccccccchhHHHH-HHHHHHHHHhC-CCcCCCcEEEE
Confidence 67999999999999999999988765 48999999764321 1233 33344555555 59999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC----cEEEE
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLG 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----~vkL~ 191 (632)
+..++.+||||||++ |+|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 84 YENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 999999999999997 688887754 45799999999999999999999999999999999999999877 79999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++..... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+....
T Consensus 162 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 162 DFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp CCSSCEECCTT----CCCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred ecCCceEcCCC----CccccCCCCccEECchHHcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 99999875432 22345679999999999974 368899999999999999999999999999888887776432
Q ss_pred cCC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 272 EKP--CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 272 ~~p--~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
... .++..+++++.+||.+||..||.+||++.|+++ ++++...+|..
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~~~~~~~ 283 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR------HPWITPVDTQQ 283 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------STTTSCSSHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc------CcCcCCCchhh
Confidence 221 122578999999999999999999999999886 67777766654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.86 Aligned_cols=271 Identities=17% Similarity=0.309 Sum_probs=207.0
Q ss_pred CCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 35 QTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 35 ~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
+....++.++|++.+.||+|+||.||+|++.... ..+..||||+++..........+.++..++..+ +|+||+.++
T Consensus 37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 112 (373)
T 2qol_A 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPS---KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLE 112 (373)
T ss_dssp TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTT---SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEE
T ss_pred HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCC---CCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence 3445677789999999999999999999876332 233579999997643333333333444555555 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++..++..||||||++ |+|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 113 GVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeeCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcC
Confidence 99999999999999997 588777754 3457999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~ 272 (632)
|+++................+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+.. ..
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~ 267 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY---RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GY 267 (373)
T ss_dssp ----------------------CTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TE
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhcc---CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC
Confidence 999865432211111122345788999999874 468899999999999999998 9999999888877766553 33
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
....+..++.++.++|.+||+.||++||++.++++.|+.+..
T Consensus 268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 445577899999999999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=356.34 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=202.1
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-----hhHHHHHHHHHHHhhhcc--CCCceeEe
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-----DCAKVFVNKFEELFPKFR--ESQSVCWL 113 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-----~~~~~~~~~~~~il~~l~--~h~~I~~l 113 (632)
..++|++.+.||+|+||.||+|.+..++ +.||||++..... .......+ +..++..+. .||||+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~-e~~~l~~l~~~~h~niv~~ 79 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSG------HFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRL 79 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTC------CEEEEEEEEEECCCTTSSCCCHHHHH-HHHHHHHHHHHCCTTBCCE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCC------cEEEEEEEecccccccccccchhHHH-HHHHHHHHhhcCCCCeEEe
Confidence 4578999999999999999999987665 4899999864221 00112222 223333332 69999999
Q ss_pred eEEEEECC-----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 114 HGISVING-----KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 114 ~~~~~~~~-----~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
++++.... .+++||||+.|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred eeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence 99998765 6899999999999999877655569999999999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~ 268 (632)
||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+.
T Consensus 160 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 160 KLADFGLARIYSYQ----MALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp EECSCSCTTTSTTC----CCSGGGGCCCSSCCHHHHHT---SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred EEeeCccccccCCC----cccCCccccccccCchHHcC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999998754321 22345678999999999874 368899999999999999999999999988877666655
Q ss_pred hhccCCC-------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 IKKEKPC-------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ~~~~~p~-------------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+. ..+.+++++.+||.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 3221111 11357899999999999999999999999886
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=367.66 Aligned_cols=282 Identities=16% Similarity=0.196 Sum_probs=206.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHH--HHHH-------HHHhhhccCCCce
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVF--VNKF-------EELFPKFRESQSV 110 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~--~~~~-------~~il~~l~~h~~I 110 (632)
+..++|++.+.||+|+||.||+|.+..+.. ....+.||||++.........+. ..+. +........|+||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSC-CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccc-cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 345799999999999999999999876532 22346899999876543221111 1110 0011223469999
Q ss_pred eEeeEEEEEC----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe--c
Q 006772 111 CWLHGISVIN----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS--E 184 (632)
Q Consensus 111 ~~l~~~~~~~----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld--~ 184 (632)
+.+++++... ...||||||+.|+|.+++.. ..+.+++..++.++.||+.||+|||+++|+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998764 56899999997788877765 346899999999999999999999999999999999999999 8
Q ss_pred CCcEEEEecCCceeccCCCCC----CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH
Q 006772 185 HDQLVLGDFGIPYLLLGRSLS----DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV 260 (632)
Q Consensus 185 ~g~vkL~DFGlak~~~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~ 260 (632)
++.+||+|||+++.+...... ........||+.|||||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV---APSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC---CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 899999999999876432211 1112345699999999999743 589999999999999999999999986432
Q ss_pred HHHHHHHHhhcc--------CCC-CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc----ccCCCCccccc
Q 006772 261 EEIYHSVVIKKE--------KPC-IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA----VYNDGEWTGLG 326 (632)
Q Consensus 261 ~ei~~~i~~~~~--------~p~-~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~----~~~~~~w~~~~ 326 (632)
............ .+. .+..+|+++.++|..||+.||.+||++.+|++.|+.+... .....+|....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 211111110000 011 1267899999999999999999999999999988877653 23345565444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=356.58 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=199.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.++||+|+||+||+|.+..++ +.||||++..... ........+. ..+..+..|+||+.+++++..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~e~-~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDG------RLYAVKRSMSPFRGPKDRARKLAEV-GSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTS------CEEEEEEESSSCCSHHHHHHHHHHH-HHHHHHCCCTTBCCEEEEEEET
T ss_pred hheeeeheeccCCCeEEEEEEECCCC------eEEEEEEecccccChHHHHHHHHHH-HHHHHhcCCCcEEEEEEEEEeC
Confidence 67999999999999999999988655 4899999865332 2222222222 3344556899999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+.+||||||+.|+|.+.+... +..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELCGPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECCCCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEeccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999999999999999888765 4579999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+......+.++..+
T Consensus 209 ~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 209 TA----GAGEVQEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGL 277 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT----CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTS
T ss_pred cC----CCCcccCCCccccCHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCC
Confidence 32 12234569999999999863 588999999999999999999877765332 22333333333455789
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++++.++|.+||+.||++||++.|+++
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999999999886
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.96 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=203.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc----CCCceeEeeE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR----ESQSVCWLHG 115 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~----~h~~I~~l~~ 115 (632)
+-.++|++.++||+|+||.||+|.+..++ +.||||++...... ... ...+..++..+. .|+||+.+++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~-~~~-~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNK------KYYAVKVVRNIKKY-TRS-AKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECSCHHH-HHH-HHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCC------eEEEEEEeccchhh-hhh-hHHHHHHHHHhcccCCCCCCeecccc
Confidence 33578999999999999999999987655 48999999753322 122 233334445554 5999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-----------
Q 006772 116 ISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE----------- 184 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~----------- 184 (632)
++...+..||||||+.|+|.+++.......+++.+++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 104 KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 999999999999999889999998766567999999999999999999999999999999999999975
Q ss_pred --------------CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh
Q 006772 185 --------------HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT 250 (632)
Q Consensus 185 --------------~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt 250 (632)
++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILN---LGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTT---CCCCTTHHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcC---CCCCCccchHHHHHHHHHHHH
Confidence 78999999999986422 2234578999999999974 368999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhhccCCC------------------------CC--------------------CCCCHHHHH
Q 006772 251 GIQPWFGKSVEEIYHSVVIKKEKPC------------------------IP--------------------SGLPPAVEN 286 (632)
Q Consensus 251 G~~PF~~~~~~ei~~~i~~~~~~p~------------------------~p--------------------~~lp~~l~~ 286 (632)
|+.||.+.+..+....+.......+ +| ...++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999998887665554432111100 11 122477889
Q ss_pred HHHHhhhcCcCCCCCHHHHHH
Q 006772 287 VIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 287 LI~~cL~~DP~~RPs~~ell~ 307 (632)
||.+||+.||++|||+.|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999885
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=352.53 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=199.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+. ++ +.||+|++....... ......++..++..+ +||||+.+++++..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN-YG------ETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSS
T ss_pred ccchhhhhcccCCCEEEEEEEcC-CC------CEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCC
Confidence 68999999999999999999873 23 489999996543221 112223344555555 6999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.+|+||||++|+|.+.+... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 74 RLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CEEEEEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eEEEEEEecCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 99999999999988887643 35799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC-------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP------- 274 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p------- 274 (632)
. ........||+.|+|||++.+. ..++.++|+|||||++|||++|..||.+.+..+....+......+
T Consensus 153 ~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 153 P---VRKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp ------------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c---ccccccccccccccCchheeCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 1 1122345789999999998642 357899999999999999999999999988766555544221110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+...+++++.+||.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112457899999999999999999999999886
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.00 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=205.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
...++|++.+.||+|+||.||+|.+..++ +.||||++....... ......++..++..+ +|+||+.+++++.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTN------ETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIH 103 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTT------EEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCC------ceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEe
Confidence 34578999999999999999999988765 489999997543221 122223344555555 7999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-----cCCcEEEEec
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-----EHDQLVLGDF 193 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-----~~g~vkL~DF 193 (632)
.++.+||||||++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 104 ~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 104 HNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred cCCEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 99999999999999999988653 4799999999999999999999999999999999999994 4556999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++..... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......
T Consensus 182 g~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 182 GLARAFGIP---IRQFTHEIITLWYRPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp THHHHHC--------------CCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CCccccCCc---ccccCCCcCCccccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999765321 1223345789999999998743 24789999999999999999999999998877766655433222
Q ss_pred CCC----------------------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 274 PCI----------------------------PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 274 p~~----------------------------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
+.. +..+++++.+||.+||+.||++|||+.|+++ +++|.+.+|+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~~~~ 328 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE------HPYFSHNDFD 328 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSSSCSC
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC------CcccCCCCCC
Confidence 110 0116799999999999999999999999886 8888888875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.85 Aligned_cols=270 Identities=19% Similarity=0.320 Sum_probs=212.1
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...|+.++|++.+.||+|+||.||+|.+..++. .....||||+++..........+.++..++..+ .|+||+.++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 114 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGV 114 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCC--CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEE
Confidence 456788999999999999999999999875442 223479999997654333333333344455555 79999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+...+..+|||||++| +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 9988999999999986 77777754 346899999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++................+|+.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..++...+.. ...+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~ 269 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRL 269 (333)
T ss_dssp -----------------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCC
T ss_pred chhhccccccccccCCCCccccccCchhccc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-CCcC
Confidence 9865432211112223356889999999864 368899999999999999999 9999999888877766653 3455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+..+++++.++|.+||+.||++||++.++++.|+.+..
T Consensus 270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5678899999999999999999999999999999987764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.26 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=204.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|++..... ......+.++..++..+ .||||+.+++++..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILN------IKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE 82 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC------SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCC------CeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee
Confidence 478999999999999999999987665 4899999865322 11222233333444454 69999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++..|+||||++| +|.+++... +.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 9999999999985 888877654 4799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---C
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP---C 275 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p---~ 275 (632)
...... .......||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+............ .
T Consensus 161 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 161 LSETSL--TQTNHVLGTVQYFSPEQAKGE---ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235 (294)
T ss_dssp C---------------CCSSCCHHHHHTC---CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHH
T ss_pred cccccc--cccCccccCccccCHhHhcCC---CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchh
Confidence 532211 122345799999999999754 57889999999999999999999999988776554444322211 2
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCC-CHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRP-LMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RP-s~~ell~~Le~~~ 313 (632)
.+..+|+.+.++|.+||+.||.+|| ++.++++.|+.+.
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 3467899999999999999999999 8999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=349.96 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=210.0
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHH------HHHHHHHHHhhhccC
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK------VFVNKFEELFPKFRE 106 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~------~~~~~~~~il~~l~~ 106 (632)
|....+.+..++|++.+.||+|+||.||+|.+..++ +.||||++......... ..+.++..++..+ +
T Consensus 9 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 81 (287)
T 4f0f_A 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDK------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81 (287)
T ss_dssp ---CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTC------CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-C
T ss_pred cchhhhhhhhccceehhccccCCceeEEEEEEcCCc------eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-C
Confidence 445566788899999999999999999999987665 48999998653321111 2233344455555 6
Q ss_pred CCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEe
Q 006772 107 SQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLS 183 (632)
Q Consensus 107 h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld 183 (632)
|+||+.+++++.... ++||||++ |+|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 82 h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 82 HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp CTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES
T ss_pred CCCchhhheeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe
Confidence 999999999886554 79999998 6887777643 458999999999999999999999999 99999999999999
Q ss_pred cCCc-----EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC
Q 006772 184 EHDQ-----LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258 (632)
Q Consensus 184 ~~g~-----vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~ 258 (632)
.++. +||+|||+++.... ......||+.|+|||++... ...++.++|+|||||++|||++|..||...
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAE-EESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCS-SCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCceeEEeCCCCccccccc------cccccCCCccccCchhhccC-CCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 8876 99999999874321 23345789999999998533 345788999999999999999999999876
Q ss_pred CHHH--HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 259 SVEE--IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 259 ~~~e--i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+..+ ....+......+.++..+|+++.++|.+||+.||++||++.++++.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 232 SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 5333 3444445566677889999999999999999999999999999998875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=350.38 Aligned_cols=270 Identities=19% Similarity=0.266 Sum_probs=209.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++....... . ...+..++..+.+++++..+..++..++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~--~-~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKHP--Q-LHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEEC---CC--C-HHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCC------ceEEEEeecccccch--H-HHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 78999999999999999999987665 489999875433211 1 23344556677788888888888888999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecCCceec
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFGlak~~ 199 (632)
.++||||+.|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECCCCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999988988888643 4579999999999999999999999999999999999999 78999999999999876
Q ss_pred cCCCCCC----CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhcc
Q 006772 200 LGRSLSD----SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE---EIYHSVVIKKE 272 (632)
Q Consensus 200 ~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~---ei~~~i~~~~~ 272 (632)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.. +....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCC---CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 4332211 122345799999999999743 6889999999999999999999999874321 22222221111
Q ss_pred CC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc----cCCCCcccc
Q 006772 273 KP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV----YNDGEWTGL 325 (632)
Q Consensus 273 ~p---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~----~~~~~w~~~ 325 (632)
.. .....+|+++.++|.+||+.||++||++.++++.|+.+.... ....+|+.+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 11 123678999999999999999999999999999988876543 234566643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=355.13 Aligned_cols=269 Identities=20% Similarity=0.348 Sum_probs=206.9
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|++..... ..++.||||++........+.+.++ ..++..+ +|+||+.+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD--NTGEVVAVKKLQHSTEEHLRDFERE-IEILKSL-QHDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCS--SCCEEEEEEEESCCCHHHHHHHHHH-HHHHHTC-CCTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccC--CCCcEEEEEEcccCCHHHHHHHHHH-HHHHHhC-CCCCEeeEEEEE
Confidence 45677899999999999999999998643221 2346899999986655444444443 3455555 699999999988
Q ss_pred EE--CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 118 VI--NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 118 ~~--~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.. ...+++||||++ |+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 54 356899999997 5888887654 3469999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH------------
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE------------ 262 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e------------ 262 (632)
+++................||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcC---CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 99865432211122233457888999999874 368899999999999999999999986532210
Q ss_pred ---HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 263 ---IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 263 ---i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..............|..+|+++.++|.+||+.||++||++.++++.|+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111223344566788999999999999999999999999999999988764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.80 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=208.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
+.|++.+.||+|+||.||+|.+..++ +.||||++...... .....+.++..++..+ +||||+.+++++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNS------EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET
T ss_pred hheeeeeEEccCCCEEEEEEEEccCC------eEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC
Confidence 45999999999999999999987655 48999999754322 1112223334455555 699999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+..||||||+.|++.+.+... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CeEEEEEecCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 999999999999999888654 4589999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~l 280 (632)
. .....||+.|+|||++.+...+.++.++|||||||++|||++|..||.+.+..+....+.........+..+
T Consensus 206 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (348)
T 1u5q_A 206 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 278 (348)
T ss_dssp S-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred C-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence 2 234579999999999864334578899999999999999999999999988776666665444444455789
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.+.+||.+||+.||++||++.++++
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 999999999999999999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.11 Aligned_cols=261 Identities=18% Similarity=0.268 Sum_probs=208.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|++..++ +.||||++....... . ...+..++..+.+++++..+..+...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~--~-~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKHP--Q-LHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEEESCSSCC--H-HHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC------cEEEEEEecCCcchh--H-HHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 378999999999999999999987655 489999987543321 2 3344456677777788888877778889
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFGlak~ 198 (632)
..++||||+.|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEecCCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99999999988999888643 4579999999999999999999999999999999999999 4889999999999987
Q ss_pred ccCCCCCC----CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhc
Q 006772 199 LLGRSLSD----SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV---EEIYHSVVIKK 271 (632)
Q Consensus 199 ~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~---~ei~~~i~~~~ 271 (632)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+. .+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 64432111 112445799999999999743 688999999999999999999999987432 22222322211
Q ss_pred cCC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 272 EKP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 272 ~~p---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
... ..+..+|+++.++|.+||+.||++||++.++++.|+.+...
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 111 23367899999999999999999999999999999887654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=369.32 Aligned_cols=270 Identities=21% Similarity=0.322 Sum_probs=216.7
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|.+..... ....+.||||+++.............+..++..+ +|+||+.+++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCC-CCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence 34667899999999999999999999764321 1234689999997643333332233344555555 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRG-----GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QL 188 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~-----~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~v 188 (632)
..++..||||||++ |+|.+++..... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999997 588888876532 4689999999999999999999999999999999999999555 59
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i 267 (632)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus 224 kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp EECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EECCCccccccccccc-cccCCCcCCcccEECHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999975432211 112234568999999999864 368999999999999999998 99999999888877766
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.. ...+..+..+++++.+||.+||+.||++||++.++++.|+.+..
T Consensus 300 ~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 53 44556678899999999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.86 Aligned_cols=267 Identities=17% Similarity=0.309 Sum_probs=215.3
Q ss_pred CcCCCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.++.++|.+.+ .||+|+||.||+|.+.... .+..||||+++..........+.++..++..+ +||||+.+++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 79 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC 79 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCC----CcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe
Confidence 46678899987 9999999999999875432 23589999998654333333334444555665 799999999998
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..+..++||||++| +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 80 -QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -cCCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 56679999999985 77776643 3457999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+................||+.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..++...+. ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~ 233 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRME 233 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCC
T ss_pred eeeccCcceeeccccccccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCC
Confidence 876433221122233457899999999864 357889999999999999998 999999988777666554 345566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
+|..+|+++.++|.+||+.||++||++.++++.|+.+....
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 78899999999999999999999999999999998876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=366.52 Aligned_cols=269 Identities=13% Similarity=0.189 Sum_probs=207.6
Q ss_pred cCCCCeEEEeEEccc--CceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 40 IDPTSLKLKHRIGRG--PFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 40 I~~~~y~l~~~IG~G--~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+.++|++.+.||+| +||.||+|.++.++ +.||||++..... ......+.++..++..+ +||||+.++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 94 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTG------EYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRAT 94 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCC------CEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEE
Confidence 456899999999999 99999999998765 4899999975432 22233344444555555 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++.+||||||++ |+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999998 6888888776557899999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCC----CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 196 PYLLLGRSL----SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 196 ak~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
+........ ........+||+.|+|||++.+. ...++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 875432211 11122334789999999999753 2368899999999999999999999998865443332221110
Q ss_pred c--------------------------------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 E--------------------------------------------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~--------------------------------------------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ...++..+++++.+||.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 11234568899999999999999999999999886
Q ss_pred HHHhhhhcccCCCCc
Q 006772 308 AFESSQNAVYNDGEW 322 (632)
Q Consensus 308 ~Le~~~~~~~~~~~w 322 (632)
++++....|
T Consensus 334 ------hp~f~~~~~ 342 (389)
T 3gni_B 334 ------HSFFKQIKR 342 (389)
T ss_dssp ------SGGGGGC--
T ss_pred ------CHHHHHHhh
Confidence 666655443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=355.92 Aligned_cols=272 Identities=21% Similarity=0.326 Sum_probs=217.6
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+..... ...++.||||++...........+.++..++..+.+||||+.+++++.
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCc-cccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 3567899999999999999999998754221 134468999999765443333334445566777778999999999987
Q ss_pred EC-CEEEEEEecCCC-CHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 119 IN-GKICIAMKFYEG-SVGDRIAQQRG--------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 119 ~~-~~l~LVmEy~~G-sL~d~l~~~~~--------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
.. +.+++||||++| +|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 65 459999999984 88888765432 128999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
+.++.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhcc---ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999999999999997653321 1112233467899999999864 368899999999999999998 99999887644
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+...........+..+..+++++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 444444444556667888999999999999999999999999999999887643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.31 Aligned_cols=267 Identities=22% Similarity=0.357 Sum_probs=210.9
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...+..++|++.+.||+|+||.||+|.+..++.. ....||+|.+...... ....+.+ +..++..+ +|+||+.+++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~~K~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~iv~~~~ 82 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGES--IKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGSL-DHAHIVRLLG 82 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCS--CCEEEEEEEECCTTSCSCBCSCCH-HHHHHHTC-CCTTBCCEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCce--EEEEEEEEeccccccHHHHHHHHH-HHHHHhcC-CCCCcCeEEE
Confidence 4556788999999999999999999998776531 2235888887543221 1112222 22334444 7999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++. ++..++||||+. |+|.+++... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 876 566899999998 6888877643 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++...... .........||+.|+|||++.+ +.++.++|||||||++|||++ |..||.+.+..++...+. ....
T Consensus 161 ~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 235 (325)
T 3kex_A 161 VADLLPPDD-KQLLYSEAKTPIKWMALESIHF---GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGER 235 (325)
T ss_dssp GGGGSCCCT-TCCC-----CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCB
T ss_pred cccccCccc-ccccccCCCCcccccChHHhcc---CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCC
Confidence 998753322 1122234567889999999974 468999999999999999999 999999987776665554 3445
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+..|..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 66778899999999999999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.89 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=212.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+... ..||+|++...... ...+.++ ..++..+ +||||+.+++++.
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~~-~~~~~~E-~~~l~~l-~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ-------YDVAVKMIKEGSMS-EDEFFQE-AQTMMKL-SHPKLVKFYGVCS 73 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECBTTBC-HHHHHHH-HHHHHHC-CCTTBCCEEEEEC
T ss_pred EechhheeeeeeeccCCCceEEEEEecCc-------eeEEEEEeccCCCc-HHHHHHH-HHHHHhC-CCCCEeeEEEEEc
Confidence 46678999999999999999999987642 37999999764432 2333333 3445555 5899999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..++||||++ |+|.+++... +..+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred cCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccce
Confidence 9999999999997 5688777654 3469999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
....... .......+|+.|+|||++.+. .++.++|+||||+++|||++ |..||...+..+....+.. ......
T Consensus 153 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 226 (268)
T 3sxs_A 153 YVLDDQY--VSSVGTKFPVKWSAPEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYR 226 (268)
T ss_dssp ECCTTCE--EECCSCCCCGGGCCHHHHHHS---EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCC
T ss_pred ecchhhh--hcccCCCcCcccCCHHHHhcc---CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-CCCCCC
Confidence 6543211 112234567889999998743 57889999999999999999 9999999888777666543 445556
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
|..+++++.+++.+||+.||++||++.++++.|+.+.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 7788999999999999999999999999999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=355.99 Aligned_cols=280 Identities=18% Similarity=0.303 Sum_probs=221.8
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...+..++|++.+.||+|+||.||+|.+..... ....+.||||.+...........+.++..++..+ .|+||+.++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccC-CCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEE
Confidence 344667899999999999999999998763211 0223589999997654333333333344555555 68999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQR--------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ 187 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~--------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~ 187 (632)
+..++..++||||++ |+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 998899999999998 58888886542 146799999999999999999999999999999999999999999
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHS 266 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~ 266 (632)
+||+|||+++........ .......||+.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..+....
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred EEECcCcccccccccccc-ccccCCCCCCCccChhhhcc---CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 999999998765332111 11223457899999999874 368899999999999999999 8999999888777766
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 267 i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
+.. ...+..+..+++++.++|.+||+.||.+||++.++++.|+......+....|.
T Consensus 253 ~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 253 VME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 553 34455678999999999999999999999999999999988766555443333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.38 Aligned_cols=268 Identities=22% Similarity=0.326 Sum_probs=206.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+..... ..++.||||++.............++..++..+ +|+||+.+++++.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGD--NTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICT 93 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSS--SCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccC--ccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEe
Confidence 3456779999999999999999998643221 344689999997544322222333444555555 6999999999988
Q ss_pred EC--CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 119 IN--GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 119 ~~--~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.+ ..+++||||++| +|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 76 678999999985 888877554 45799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC--------------CHH
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK--------------SVE 261 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~--------------~~~ 261 (632)
++................||..|+|||++.+. .++.++|+|||||++|||++|..|+... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQS---KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCC---CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 98764432211223345688999999998643 5788999999999999999999875422 122
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
...............+..+++++.++|.+||+.||.+||++.++++.|+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222233344556678899999999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=358.27 Aligned_cols=266 Identities=21% Similarity=0.341 Sum_probs=207.7
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
..+..++|++.+.||+|+||.||+|.+..++.. ....||+|.+..... .....+. ++..++..+ +|+||+.++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~-~E~~~l~~l-~h~~iv~~~~~ 85 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEIL-DEAYVMASV-DNPHVCRLLGI 85 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHH-HHHHHHHHC-CBTTBCCEEEE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHH-HHHHHHHhC-CCCCEeEEEEE
Confidence 346678999999999999999999998765531 123579998865332 2223333 334455555 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++ .+++|||+. |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 88755 778888887 6888887654 45799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+. .....
T Consensus 164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~ 238 (327)
T 3poz_A 164 AKLLGAEEK-EYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERL 238 (327)
T ss_dssp HHHHTTTCC--------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCC
T ss_pred eeEccCCcc-cccccCCCccccccChHHhcc---CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCC
Confidence 987643221 112223457889999999974 468999999999999999999 999999988776655443 44556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+..++.++.+++.+||+.||++||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 6788899999999999999999999999999999887754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=363.63 Aligned_cols=264 Identities=21% Similarity=0.304 Sum_probs=210.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.++.++ +.||||++.+...... ++.+++.++.+||||+.+++++.+++.
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~-----~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATN------MEFAVKIIDKSKRDPT-----EEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTTCCCH-----HHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEcccCChH-----HHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 67999999999999999999998765 4899999976543321 223445566689999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC----CcEEEEecCCce
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH----DQLVLGDFGIPY 197 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~----g~vkL~DFGlak 197 (632)
+|+||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||+.++ +.+||+|||+++
T Consensus 91 ~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999998 588888764 3579999999999999999999999999999999999998543 359999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC---CCHHHHHHHHHhhccCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG---KSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~---~~~~ei~~~i~~~~~~p 274 (632)
..... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+ .+..++...+.......
T Consensus 169 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 169 QLRAE---NGLLMTPCYTANFVAPEVLERQ---GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242 (342)
T ss_dssp ECBCT---TCCBCCSSCCSSCCCHHHHHHH---HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred cCcCC---CCceeccCCCccccCHHHhcCC---CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence 75432 1223456899999999998743 578899999999999999999999986 35566666665433222
Q ss_pred --CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccccccCC
Q 006772 275 --CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTDT 333 (632)
Q Consensus 275 --~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~ 333 (632)
..+..+++++.+||.+||+.||++||++.++++ ++++ .+|..+....+.++
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~------hp~~--~~~~~~~~~~~~~~ 295 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR------HPWI--VHWDQLPQYQLNRQ 295 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT------SHHH--HTGGGSCCSCCCCC
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc------CCee--cCccccccccCCCc
Confidence 133578999999999999999999999999886 4444 23555544444333
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.43 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=200.7
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..|..++|++.+.||+|+||.||+|.+..+++ ....||||+++... ....+.+. ++..++..+ +|+||+.+++
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~-~E~~~l~~l-~h~~iv~~~~ 92 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFL-REAACMKEF-DHPHVAKLVG 92 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHH-HHHHHHTTC-CCTTBCCCCE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCC---cceeEEEEEecccccCHHHHHHHH-HHHHHHHHC-CCCceehhhc
Confidence 34667899999999999999999999876542 22379999997542 22333333 333455555 7999999999
Q ss_pred EEEECCEE------EEEEecCCC-CHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec
Q 006772 116 ISVINGKI------CIAMKFYEG-SVGDRIAQQRG----GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184 (632)
Q Consensus 116 ~~~~~~~l------~LVmEy~~G-sL~d~l~~~~~----~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~ 184 (632)
++...+.. ++||||+.| +|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 98876554 999999985 88888765432 25899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHH
Q 006772 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEI 263 (632)
Q Consensus 185 ~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei 263 (632)
++.+||+|||+++........ .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..++
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADN---LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp TSCEEECCCCC------------------CCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CCCEEEeeccccccccccccc-cccccccCcccccCchhhcCC---CCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999765332211 112234568899999998743 68899999999999999999 9999999887777
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
...+.. ...+..+..+++++.++|.+||+.||++||++.++++.|+++...
T Consensus 249 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 YNYLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 766553 445667789999999999999999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=358.96 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=199.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.........+.+.++..++..+ +|+||+.+++++..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCC------cEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 378999999999999999999988665 489999986544332223333444455554 7999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|+||||++| +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999985 77776643 3579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhccCCCCCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~~~p~~p~~ 279 (632)
... ........+||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+.. ..+...............
T Consensus 157 ~~~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (323)
T 3tki_A 157 YNN-RERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233 (323)
T ss_dssp ETT-EECCBCSCCSCGGGSCHHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGG
T ss_pred cCC-cccccCCCccCcCccCcHHhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcccc
Confidence 221 11222346799999999998643 12477899999999999999999999876543 223233222222222357
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++++.+||.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 8999999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.95 Aligned_cols=261 Identities=18% Similarity=0.275 Sum_probs=212.1
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
....|+.++|++.+.||+|+||.||+|.+... ..||||++....... ..+.+ +..++..+ .|+||+.+++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~~~-~~~~~-E~~~l~~l-~h~~i~~~~~ 86 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSMSE-DEFIE-EAKVMMNL-SHEKLVQLYG 86 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTT-------EEEEEEEECTTSBCH-HHHHH-HHHHHHTC-CCTTBCCEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCC-------CeEEEEEecCCCCCH-HHHHH-HHHHHhcC-CCCCEeeEEE
Confidence 44568889999999999999999999987632 379999997654332 33333 33455555 5999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++..|+||||++ |+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 87 VCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred EEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence 9999999999999997 5787777543 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++....... .......+|+.|+|||++.+ ..++.++|+||||+++|||++ |..||...+..+....+.. ...
T Consensus 166 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~ 239 (283)
T 3gen_A 166 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLR 239 (283)
T ss_dssp GGGGBCCHHH--HSTTSTTSCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCC
T ss_pred cccccccccc--ccccCCccCcccCCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccC
Confidence 9876532211 11223356889999999874 368899999999999999998 9999999888877766653 445
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
...|..+++.+.++|.+||+.||.+||++.++++.|+.+.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 5567889999999999999999999999999999988765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.84 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=199.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH---HHHHHHHHHHhhhccCCCceeEeeE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA---KVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~---~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.++.++|++.+.||+|+||.||+|.+.. ..||||++........ .+...++..++..+ +|+||+.+++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 73 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG--------DEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRG 73 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETT--------EEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcC--------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEE
Confidence 3567899999999999999999999752 4799999865432211 12233333444554 6999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeeeeeCCeEEEec-------
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG---LLVLNLKPSNLLLSE------- 184 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~---IvHRDLKP~NILld~------- 184 (632)
++..++..|+||||++| +|.+++. .+.+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~ 150 (271)
T 3dtc_A 74 VCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150 (271)
T ss_dssp EECCC--CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred EEecCCceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccc
Confidence 99999999999999985 5555542 458999999999999999999999999 999999999999986
Q ss_pred -CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHH
Q 006772 185 -HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI 263 (632)
Q Consensus 185 -~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei 263 (632)
++.+||+|||+++..... ......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+....
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 151 SNKILKITDFGLAREWHRT-----TKMSAAGAYAWMAPEVIRA---SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222 (271)
T ss_dssp SSCCEEECCCCC------------------CCGGGSCHHHHHH---CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred cCcceEEccCCcccccccc-----cccCCCCccceeCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 778999999998764321 2224578999999999874 3688999999999999999999999999888777
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 264 YHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 264 ~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
...+.........+..+++++.++|.+||+.||.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 777666666677888999999999999999999999999999998875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.49 Aligned_cols=249 Identities=19% Similarity=0.306 Sum_probs=206.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|.+..... . .....++..++..+ +||||+.+++++...+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~-~-~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSK------KTYMAKFVKVKGT-D-QVLVKKEISILNIA-RHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCCTH-H-HHHHHHHHHHHHHS-CCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCC------cEEEEEEEecCcc-c-HHHHHHHHHHHHhC-CCCCCCeEeEEEecCC
Confidence 368999999999999999999988765 4899999875432 2 22334444555554 7999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec--CCcEEEEecCCcee
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE--HDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~--~g~vkL~DFGlak~ 198 (632)
.+|+||||++| +|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999985 78877753 3357999999999999999999999999999999999999997 78999999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--C
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--I 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~ 276 (632)
.... .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..++...+........ .
T Consensus 154 ~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 154 LKPG----DNFRLLFTAPEYYAPEVHQHD---VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CCTT----CEEEEEESCGGGSCHHHHTTC---EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCC----CccccccCChhhcCcHHhcCC---CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence 5322 223445789999999999743 578899999999999999999999999988888777764332221 1
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+|+++.+||.+||+.||.+|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1478999999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.20 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=213.4
Q ss_pred CCeEEE-eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~-~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|.+. +.||+|+||.||+|.+..++ +.||||++..... .....+ .++..++..+.+|+||+.+++++..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~-~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTG------QEYAAKFLKKRRRGQDCRAEI-LHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEESEETTEECHHHH-HHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCC------CEEEEEEEehhhcchHHHHHH-HHHHHHHHhccCCCCEEEEEEEEEe
Confidence 457777 89999999999999987665 4899999875322 222333 3344566777789999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEecCC
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGDFGI 195 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~DFGl 195 (632)
++.+|+||||+.| +|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 9999999999985 7777765544578999999999999999999999999999999999999998 78999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC-
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP- 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p- 274 (632)
++..... .......||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+....+.......
T Consensus 181 a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 181 SRKIGHA----CELREIMGTPEYLAPEILNY---DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253 (327)
T ss_dssp CEEC-------------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred ccccCCc----cccccccCCcCccCCeeecC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence 9875332 12234579999999999974 468899999999999999999999999988877766655433222
Q ss_pred -CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcccccc
Q 006772 275 -CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGS 327 (632)
Q Consensus 275 -~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~ 327 (632)
..+..+++.+.++|.+||+.||++||++.++++ ++++...+|+.+..
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~------h~~~~~~~~~~~~~ 301 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS------HSWLQQWDFENLFH 301 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------CGGGCCCCTTCC--
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC------CHhhcccccccccC
Confidence 233578999999999999999999999999876 78888888876554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=376.03 Aligned_cols=259 Identities=25% Similarity=0.452 Sum_probs=214.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|..++|++.+.||+|+||+||+|.+... ..||||+++.... ..+.+.++ ..++..+ +||||+.+++++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~E-~~~l~~l-~h~~iv~l~~~~ 252 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKH-------TKVAVKTMKPGSM-SVEAFLAE-ANVMKTL-QHDKLVKLHAVV 252 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTT-------EEEEEEEECTTSB-CHHHHHHH-HHHHTTC-CCTTBCCEEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCc-------cEEEEEEecCCCc-cHHHHHHH-HHHHhhC-CCCCEeeEEEEE
Confidence 457789999999999999999999998542 4799999976443 23444443 3555555 799999999987
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
. ++.+||||||+. |+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 6 677999999997 68998887554457899999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......+|+.|+|||++.. +.++.++|||||||+||||++ |..||.+.+..++...+.. .....
T Consensus 332 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~ 405 (454)
T 1qcf_A 332 RVIEDNEY--TAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMP 405 (454)
T ss_dssp GGBCCHHH--HTTCSSSSCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCC
T ss_pred eEcCCCce--eccCCCcccccccCHHHhcc---CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 76532111 11122346789999999863 468999999999999999999 9999999988887776653 44556
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.|..+|+++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 68899999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.30 Aligned_cols=270 Identities=20% Similarity=0.302 Sum_probs=217.2
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeE
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~ 112 (632)
+...-|.++.++|++.+.||+|+||.||+|.+..++. ...||+|.+...........+.++..++.++.+||||+.
T Consensus 15 ~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp -CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTE----EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CCcccccccHHHccceeeeecCCCceEEEEEEccCCc----ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhh
Confidence 3445577888999999999999999999999876542 114599998754333223334444566777778999999
Q ss_pred eeEEEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeC
Q 006772 113 LHGISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKP 177 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP 177 (632)
+++++..++.+|+||||++ |+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 170 (327)
T 1fvr_A 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 170 (327)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred hceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence 9999999999999999997 58888886532 24799999999999999999999999999999999
Q ss_pred CeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCC
Q 006772 178 SNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256 (632)
Q Consensus 178 ~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~ 256 (632)
+|||++.++.+||+|||+++..... .......+|+.|+|||++.+. .++.++|+|||||++|||++ |..||.
T Consensus 171 ~NIl~~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 171 RNILVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHC---EECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceEEEcCCCeEEEcccCcCcccccc----ccccCCCCCccccChhhhccc---cCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999998743211 112233568899999998643 57889999999999999998 999999
Q ss_pred CCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 257 GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 257 ~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+.+..++...+. ....+..+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 244 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 244 GMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp TCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcHHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 988877766554 334556678899999999999999999999999999999887764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.55 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=201.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.............++..++..+ +|+||+.+++++..++.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTD------NLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCC------cEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCE
Confidence 68999999999999999999987665 489999986543221111111233444554 69999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
.||||||++|+|.+++... +..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 75 LTLVFEYLDKDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred EEEEecccccCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9999999999999888754 457999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC------- 275 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~------- 275 (632)
........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+.
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 154 ---TKTYDNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ------------CGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ---ccccccccCcccccChhhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence 1222345789999999998642 3578999999999999999999999999887776665543222111
Q ss_pred ---------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 276 ---------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 276 ---------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
.+..+++++.+||.+||+.||++|||+.|+++ ++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~ 287 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK------HPFFLS 287 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGGG
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc------Chhhhh
Confidence 11357889999999999999999999999886 666643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=347.50 Aligned_cols=268 Identities=24% Similarity=0.378 Sum_probs=195.5
Q ss_pred CCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCc
Q 006772 32 TPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQS 109 (632)
Q Consensus 32 ~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~ 109 (632)
.+......|..++|++.++||+|+||.||+|.+.. .||+|+++.... ...+.+ .++..++..+ +|+|
T Consensus 13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~vavK~~~~~~~~~~~~~~~-~~E~~~l~~l-~h~~ 81 (289)
T 3og7_A 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAF-KNEVGVLRKT-RHVN 81 (289)
T ss_dssp -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---------EEEEEEESCSSCCHHHHHHH-HHHHHHHTTC-CCTT
T ss_pred CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---------ceEEEEEeccCCCHHHHHHH-HHHHHHHHhC-CCCc
Confidence 34455667888999999999999999999997542 599999975432 222333 3333445554 6999
Q ss_pred eeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 110 VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 110 I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
|+.+++++ ..+..++||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 82 iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp BCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEeec-cCCccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCE
Confidence 99998854 5567899999998 577776643 34679999999999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH-HHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE-IYHSV 267 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e-i~~~i 267 (632)
||+|||+++...... .........||+.|+|||++.......++.++|||||||++|||++|..||.+....+ +...+
T Consensus 160 kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 160 KIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp EECCCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred EEccceecccccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 999999987543211 1122334578999999999874434578899999999999999999999998865444 33333
Q ss_pred HhhccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 268 VIKKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 268 ~~~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
......+. .+..+|+++.++|.+||+.||.+||++.++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 32222222 34578999999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=371.33 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=213.3
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...|+.++|++.+.||+|+||+||+|.+.. +.||||+++... ..+.+.++ ..++.++ +|+||+.++++
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~vavK~~~~~~--~~~~~~~E-~~~l~~l-~h~niv~~~~~ 254 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA--TAQAFLAE-ASVMTQL-RHSNLVQLLGV 254 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETT--------EEEEEEEESSCT--TSHHHHHH-HHHHHTC-CCTTBCCEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecC--------CeEEEEEeCCch--HHHHHHHH-HHHHHhc-cCCCEEEEEEE
Confidence 345788999999999999999999998752 479999997643 22344443 3455555 79999999999
Q ss_pred EEECC-EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 117 SVING-KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 117 ~~~~~-~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
+...+ .+||||||++ |+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 87664 7999999998 589998877654558999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..++...+. ...+
T Consensus 335 ~a~~~~~~------~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 404 (450)
T 1k9a_A 335 LTKEASST------QDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYK 404 (450)
T ss_dssp TCEECC------------CCCTTTSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCC
T ss_pred Cccccccc------ccCCCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99854221 122356889999999974 468999999999999999998 999999887777666654 3456
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+..|..+|+++.++|.+||+.||++||++.++++.|+.+..
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 67789999999999999999999999999999999988764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.27 Aligned_cols=264 Identities=22% Similarity=0.395 Sum_probs=219.5
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
....+..++|++.+.||+|+||.||+|.+..++ ..||+|++..... ..+.+.+ +..++..+ +|+||+.+++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~-~~~~~~~-E~~~l~~l-~h~~i~~~~~ 76 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTM-EVEEFLK-EAAVMKEI-KHPNLVQLLG 76 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGT------EEEEEEEECSCST-HHHHHHH-HHHHHHHC-CCTTBCCEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCC------EEEEEEecCcCHH-HHHHHHH-HHHHHHhC-CCCCEeeEEE
Confidence 345577899999999999999999999987655 4899999975433 2333333 33455555 6999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++..|+||||++ |+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999998 688888877656679999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
++....... ........+|+.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+. ....
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~ 230 (288)
T 3kfa_A 157 LSRLMTGDT--YTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYR 230 (288)
T ss_dssp GGGTSCSSS--SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCC
T ss_pred cceeccCCc--cccccCCccccCcCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCC
Confidence 987653321 112233457889999999864 368899999999999999999 999999888776665544 3455
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+..+..+|+++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 66778999999999999999999999999999998887654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=366.00 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=203.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.+.... .....+.++..++..+ +||||+.+++++..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQ------QKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe
Confidence 468999999999999999999997765 48999998642111 1111233333444444 69999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
++.+|+||||+.|+|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CCEEEEEEECCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999999999999998764 47999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
... ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+....+....+ ......+|..
T Consensus 159 ~~~----~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~ 230 (336)
T 3h4j_B 159 TDG----NFLKTSCGSPNYAAPEVINGKL--YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDF 230 (336)
T ss_dssp TTS----BTTCCCTTSTTTSCGGGSCCSG--GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTT
T ss_pred cCC----cccccccCCcCcCCHHHHcCCC--CCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCccc
Confidence 322 2234467999999999997542 1367999999999999999999999886554433222 1234556788
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++++.+||.+||+.||.+|||+.|+++
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9999999999999999999999999886
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.67 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=206.1
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.+..... ......++..++..+ .|+||+.++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 77 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSK------FILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGY 77 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCC------cEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhhe
Confidence 346689999999999999999999988765 489999986432111 122233344455554 58999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+...+..++||||++ |+|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 78 FHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccc
Confidence 999999999999998 5777777654 4799999999999999999999999999999999999999999999999998
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+..... .......||+.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+. .....
T Consensus 156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~ 225 (279)
T 3fdn_A 156 SVHAPS-----SRRTDLCGTLDYLPPEMIEGR---MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFT 225 (279)
T ss_dssp ESCC-------------CCCCTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCC
T ss_pred cccCCc-----ccccccCCCCCccCHhHhccC---CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCC
Confidence 854322 122345789999999998743 67889999999999999999999999988887776655 34556
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|..+++++.+||.+||+.||.+||++.|+++
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 78889999999999999999999999999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=353.92 Aligned_cols=258 Identities=19% Similarity=0.309 Sum_probs=210.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++...... ....+ .++..++..+ +||||+.++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~-~~E~~~l~~l-~hp~iv~~~~~ 82 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTG------LQYAAKFIKKRRTKSSRRGVSREDI-EREVSILKEI-QHPNVITLHEV 82 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTC------CEEEEEEEEBCCSTTCSSSBCHHHH-HHHHHHHHHC-CCTTBCCEEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCC------cEEEEEEEEccccccccchhhHHHH-HHHHHHHHhC-CCCCCCcEEEE
Confidence 57999999999999999999987665 48999999754321 12333 3344555555 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC----cEEEE
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLG 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----~vkL~ 191 (632)
+..++.+|+||||++ |+|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 999999999999997 588887753 35799999999999999999999999999999999999999888 89999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 161 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 161 DFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233 (326)
T ss_dssp CCTTCEECCTT----SCCCCCCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC
T ss_pred ECCCCeECCCC----CccccccCCcCcCCceeecC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC
Confidence 99999875322 12234579999999999864 368899999999999999999999999988877776665332
Q ss_pred cCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 272 EKPC--IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 272 ~~p~--~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
.... .+..+++.+.+||.+||+.||++||++.++++ ++++...+|.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~~~~~ 281 (326)
T 2y0a_A 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIKPKDTQ 281 (326)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH------STTTSCCSHH
T ss_pred CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc------CCCccCCcch
Confidence 2211 12578999999999999999999999999887 6666655543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=369.32 Aligned_cols=272 Identities=18% Similarity=0.259 Sum_probs=195.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
+.-.++|++.+.||+|+||.||+|.++.++ +.||||++.+... ...+.+. ++..++..+ +|+||+.++++
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~-~E~~~l~~l-~h~niv~l~~~ 120 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEK------RVVAIKKILRVFEDLIDCKRIL-REIAILNRL-NHDHVVKVLDI 120 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--------CEEEEEEECSTTSSHHHHHHHH-HHHHHHHHC-CCTTBCCEEEE
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCC------cEEEEEEechhhcCHHHHHHHH-HHHHHHHhC-CCCCCCceEEE
Confidence 334588999999999999999999988765 4899999965322 2223333 344555555 79999999999
Q ss_pred EEEC-----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 117 SVIN-----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 117 ~~~~-----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+... +.+||||||+.|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+
T Consensus 121 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 121 VIPKDVEKFDELYVVLEIADSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp CCCSCTTTCCCEEEEECCCSEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred EecCCcccCceEEEEEeccccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeec
Confidence 8543 57999999999999888854 3579999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCC------------------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHH
Q 006772 192 DFGIPYLLLGRSLS------------------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIME 247 (632)
Q Consensus 192 DFGlak~~~~~~~~------------------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~E 247 (632)
|||+++........ .......+||+.|+|||++.. ...++.++|||||||+|||
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL--QENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT--CCCCCTHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC--CCCCCcHhHHHHHHHHHHH
Confidence 99999875322110 012344678999999998743 2368999999999999999
Q ss_pred HHh-----------CCCCCCCCCH--------------------HHHHHHHHhhccCC----------------------
Q 006772 248 MLT-----------GIQPWFGKSV--------------------EEIYHSVVIKKEKP---------------------- 274 (632)
Q Consensus 248 mlt-----------G~~PF~~~~~--------------------~ei~~~i~~~~~~p---------------------- 274 (632)
|++ |.++|.+.+. .+.+..+......+
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 998 7777776541 11111111000000
Q ss_pred -------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccc
Q 006772 275 -------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSR 328 (632)
Q Consensus 275 -------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~ 328 (632)
...+.+++++.+||.+||+.||++|||++|+++ ++++....|......
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~------Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA------HPFFKEVRIAEVETN 411 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGTTTCCGGGCCC
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc------CHhhhhcCCCccCCC
Confidence 012456899999999999999999999999887 888888888765543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=369.37 Aligned_cols=250 Identities=20% Similarity=0.329 Sum_probs=206.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++...... .....+.++..++..+ +||||+.+++++..++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~------~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAG------QEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTT------EEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCC------cEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 67999999999999999999988765 48999999764422 2222334444555555 7999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe---cCCcEEEEecCCce
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS---EHDQLVLGDFGIPY 197 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld---~~g~vkL~DFGlak 197 (632)
..|+||||+. |+|.+.+... +.+++.++..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999998 5888888653 5799999999999999999999999999999999999998 46789999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+++..+.........+
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~---~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 162 EVEGE---QQAWFGFAGTPGYLSPEVLRKD---PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 235 (444)
T ss_dssp CCCTT---CCBCCCSCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EecCC---CceeecccCCcccCCHHHhcCC---CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc
Confidence 65332 1223446799999999999743 68899999999999999999999999999888888776544333222
Q ss_pred --CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 --SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 --~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.+||.+||+.||.+||++.|+++
T Consensus 236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 478999999999999999999999999887
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.25 Aligned_cols=265 Identities=19% Similarity=0.263 Sum_probs=193.4
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+...+|++.+.||+|+||.||+|.+..++ +.||||++..........+.+ +..++.++..|+||+.+++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~-e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSG------REYALKRLLSNEEEKNRAIIQ-EVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTC------CEEEEEEEEESSHHHHHHHHH-HHHHHHHHTTSTTBCCEEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCC------cEEEEEEecCCchHHHHHHHH-HHHHHHHhccCCChhhcccccc
Confidence 345568999999999999999999987665 489999986655444444433 3455667777999999999985
Q ss_pred E--------CCEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEecCCc
Q 006772 119 I--------NGKICIAMKFYEGSVGDRIAQQ-RGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLSEHDQ 187 (632)
Q Consensus 119 ~--------~~~l~LVmEy~~GsL~d~l~~~-~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld~~g~ 187 (632)
. ...++++|||+.|+|.+++... ..+.+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred ccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3 3458999999999999988764 3467999999999999999999999999 999999999999999999
Q ss_pred EEEEecCCceeccCCCCCC---------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC
Q 006772 188 LVLGDFGIPYLLLGRSLSD---------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~---------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~ 258 (632)
+||+|||+++......... .......||+.|+|||++.......++.++|||||||++|||++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998653321110 0112446899999999985333456889999999999999999999999876
Q ss_pred CHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
....+. ........+..++..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus 257 ~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 257 AKLRIV----NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHhh----cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 544332 2223334456788899999999999999999999999999987764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.28 Aligned_cols=265 Identities=21% Similarity=0.349 Sum_probs=210.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|.+.... .....||+|.+...........+.++..++..+ +||||+.+++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 82 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHK---GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGII 82 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTT---CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCC---CCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 4567789999999999999999999876543 223579999997653333233333444555555 699999999987
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.. +..|+||||++ |+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 54 56789999998 5777777653 457999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......+|+.|+|||++.+ ..++.++|+|||||++|||++ |..||...+..+....+. ....+.
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~ 234 (281)
T 3cc6_A 161 RYIEDEDY--YKASVTRLPIKWMSPESINF---RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLP 234 (281)
T ss_dssp GCC-----------CCCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCC
T ss_pred cccccccc--cccccCCCCcceeCchhhcc---CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCC
Confidence 76533211 11223457889999999863 368899999999999999998 999998877666555444 344556
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+..+++.+.++|.+||+.||++||++.++++.|+.+..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 678899999999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.41 Aligned_cols=257 Identities=19% Similarity=0.295 Sum_probs=201.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccC-CCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRE-SQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~-h~~I~~l~~~~ 117 (632)
+..++|++.+.||+|+||.||+|.+.. + +.||||++...... .....+.++..++..+.+ |+||+.+++++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~-~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEK-K------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTT-S------CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCC-C------CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 456789999999999999999998743 2 48999998754322 222223344455666654 49999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++.+|||||+..|+|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||+++
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 79 ITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred eeCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 999999999998889999988753 5799999999999999999999999999999999999997 6889999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCC--------CCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPE--------VRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVV 268 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~ 268 (632)
...... ........+||+.|+|||++.+. ....++.++|||||||++|||++|..||.... .......+.
T Consensus 156 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 156 QMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccCccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 653321 11122345799999999998531 12468899999999999999999999998754 334444555
Q ss_pred hhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.......+|...+.++.+||.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 445566778888999999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.05 Aligned_cols=263 Identities=19% Similarity=0.321 Sum_probs=201.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++...... .......++..++..+ +|+||+.+++++..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTG------QIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCC------cEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCC
Confidence 68999999999999999999987665 48999998654332 2223333344555555 6999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..++||||++|+++..+... .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999997666555443 35799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc---------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE--------- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~--------- 272 (632)
.. .......||+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 155 ~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 155 PS---DYYDDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp --------------GGGCCHHHHHTC--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc---cccCCCcCCccccChHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 21 122345789999999998642 3578999999999999999999999999887665444332110
Q ss_pred ----------CCCCC----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 273 ----------KPCIP----------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 273 ----------~p~~p----------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
....+ ..+++++.+||.+||+.||.+|||+.++++ ++++.+..+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~~~~~ 295 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH------HPYFENIREIE 295 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT------SGGGTTCC---
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc------ChHHHhccCHH
Confidence 00001 367889999999999999999999999886 67776655443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=377.79 Aligned_cols=262 Identities=23% Similarity=0.417 Sum_probs=218.8
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...|..++|++.+.||+|+||.||+|.++.++ ..||||+++..... .+.+.++ ..++..+ +|+||+.++++
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~vavK~~~~~~~~-~~~~~~E-~~~l~~l-~hpniv~l~~~ 284 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTME-VEEFLKE-AAVMKEI-KHPNLVQLLGV 284 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGT------EEEEEEECCSSSSC-HHHHHHH-HHHHHHC-CCTTBCCEEEE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCC------eEEEEEEecCcccc-hHHHHHH-HHHHHhc-CCCCEeeEEEE
Confidence 34567789999999999999999999987654 48999999764332 3444443 3455555 79999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++.+||||||+. |+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 999999999999998 7899988765556799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++....... .......+|+.|+|||++.. +.++.++|||||||+||||++ |..||.+.+..++...+. ...+.
T Consensus 365 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 438 (495)
T 1opk_A 365 SRLMTGDTY--TAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRM 438 (495)
T ss_dssp EECCTTCCE--ECCTTCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCC
T ss_pred ceeccCCce--eecCCCcCCcceeCHhHHhc---CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 987543211 11223356789999999864 468899999999999999999 999999988777665544 44556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..|..+|+++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 678899999999999999999999999999999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.34 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=203.1
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...++.++|++.+.||+|+||.||+|++.. +.||||++....... .. ...+..++..+ +||||+.++++
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~-~~-~~~E~~~l~~l-~hpniv~~~~~ 86 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPIQDKQS-WQ-NEYEVYSLPGM-KHENILQFIGA 86 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETT--------EEEEEEEECGGGHHH-HH-HHHHHHTSTTC-CCTTBCCEEEE
T ss_pred ccccchhhchhhheecccCceEEEEEEECC--------CEEEEEEeecCchHH-HH-HHHHHHHHhcC-CCCCchhhcce
Confidence 445788999999999999999999998752 489999996533221 11 12222334444 69999999999
Q ss_pred EEEC----CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeeeeeCCeEE
Q 006772 117 SVIN----GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI----------GLLVLNLKPSNLL 181 (632)
Q Consensus 117 ~~~~----~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~----------~IvHRDLKP~NIL 181 (632)
+... ..+|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 87 EKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred eccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence 8874 34799999998 588888754 3699999999999999999999999 9999999999999
Q ss_pred EecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCC--CCCCcccccchhHHHHHHHHhCCCCCCCC-
Q 006772 182 LSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVR--GPISFETDTWGFGCSIMEMLTGIQPWFGK- 258 (632)
Q Consensus 182 ld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~--g~~t~ksDvwSlGvvL~EmltG~~PF~~~- 258 (632)
++.++.+||+|||+++....... ........||+.|+|||++.+... ..++.++|||||||++|||++|+.||.+.
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ECCCCeEEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999987643321 122334679999999999875311 24567899999999999999999999763
Q ss_pred ---------------CHHHHHHHHHhhccCCCCCCC-----CCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 259 ---------------SVEEIYHSVVIKKEKPCIPSG-----LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 259 ---------------~~~ei~~~i~~~~~~p~~p~~-----lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
...++...+......+..+.. .++++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 223333333333333433332 34569999999999999999999999999988764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=365.01 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=203.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhc-----cCCCceeEeeEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF-----RESQSVCWLHGI 116 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l-----~~h~~I~~l~~~ 116 (632)
..+|++.+.||+|+||.||+|.+..++ +.||||++...... ...+.+ +..++..+ ..|+||+.+++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~------~~vAvK~~~~~~~~-~~~~~~-E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVH------QHVALKMVRNEKRF-HRQAAE-EIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTT------EEEEEEEECSCHHH-HHHHHH-HHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCC------cEEEEEEECCccch-HHHHHH-HHHHHHHHhhccccCCcCEEEEEee
Confidence 467999999999999999999988765 48999999754321 122222 22333333 267899999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc--EEEEecC
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ--LVLGDFG 194 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~--vkL~DFG 194 (632)
+...+.+|+||||+.|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 168 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 168 FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred cccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999999999999998776667999999999999999999999999999999999999999987 9999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 248 ~a~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 248 SSCYEHQ------RVYTYIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TCEETTC------CCCSSCSCGGGCCHHHHHTB---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cceecCC------cccccCCCCCccChHHHhCC---CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9976422 23346789999999999744 68899999999999999999999999988776655544221111
Q ss_pred C---------------------------------------------------------CCCCCCHHHHHHHHHhhhcCcC
Q 006772 275 C---------------------------------------------------------IPSGLPPAVENVIIGCFEYDLR 297 (632)
Q Consensus 275 ~---------------------------------------------------------~p~~lp~~l~~LI~~cL~~DP~ 297 (632)
. ++...++++.+||.+||+.||+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 0 1123478899999999999999
Q ss_pred CCCCHHHHHH
Q 006772 298 NRPLMADILH 307 (632)
Q Consensus 298 ~RPs~~ell~ 307 (632)
+|||+.|+++
T Consensus 399 ~Rpta~e~L~ 408 (429)
T 3kvw_A 399 VRMTPGQALR 408 (429)
T ss_dssp TSCCHHHHHT
T ss_pred hCCCHHHHhC
Confidence 9999999886
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=352.94 Aligned_cols=271 Identities=21% Similarity=0.294 Sum_probs=213.4
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
....++.++|++.+.||+|+||.||+|++...+. ..++.||||++........+.+.+ +..++..+ +|+||+.+++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~-E~~~l~~l-~h~~i~~~~~ 91 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGD--NTGALVAVKQLQHSGPDQQRDFQR-EIQILKAL-HSDFIVKYRG 91 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSS--SCSEEEEEEEESSCCHHHHHHHHH-HHHHHHTC-CCTTBCCEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCC--CcceEEEEEEeccCCHHHHHHHHH-HHHHHHhc-CCCceeEEEE
Confidence 3455778999999999999999999999643221 334689999998765544444444 34555555 7999999999
Q ss_pred EEE--ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 116 ISV--INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 116 ~~~--~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++. ..+.+|+||||++ |+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 887 4567999999996 67888776543 4699999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-----------
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE----------- 261 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~----------- 261 (632)
||+++................||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN---IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccC---CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 99998764332211222334688899999998743 5788999999999999999999998654322
Q ss_pred ---HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 262 ---EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 262 ---ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
............+..+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11222233445566788999999999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=341.00 Aligned_cols=260 Identities=21% Similarity=0.378 Sum_probs=214.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.+.||+|+||.||+|.+... +.||+|++...... .+.+.+ +..++..+ +|+||+.+++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vaiK~~~~~~~~-~~~~~~-e~~~l~~l-~h~~i~~~~~~~ 72 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMS-EEDFIE-EAEVMMKL-SHPKLVQLYGVC 72 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTTBC-HHHHHH-HHHHHHTC-CCTTBCCEEEEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCC-------CeEEEEEccccCCC-HHHHHH-HHHHHHhC-CCCCEeeEEEEE
Confidence 357889999999999999999999998632 37999999765432 233333 33455555 699999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..++..++||||++ |+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999998 5777777543 457999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......||+.|+|||++.+ ..++.++|+||||+++|||++ |..||.+.+..+....+.. ...+.
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~ 225 (267)
T 3t9t_A 152 RFVLDDQY--TSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLY 225 (267)
T ss_dssp GGBCCHHH--HSTTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCC
T ss_pred cccccccc--cccccccccccccChhhhcC---CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCC
Confidence 76432110 11123457889999999864 368899999999999999999 9999999888877766653 34455
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.|..+++++.+++.+||+.||++||++.++++.|+.+..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 677899999999999999999999999999999987653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=358.70 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=205.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.++.++ +.||+|++..... ......+.++..++..+ +||||+.+++++..++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTG------LEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 57999999999999999999987665 4899999975432 11222233444555555 6999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cEEEEecCCce
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPY 197 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~vkL~DFGlak 197 (632)
..|+||||+.| +|.+.+.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999984 78787754 35799999999999999999999999999999999999998654 59999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+++..+.........+
T Consensus 180 ~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 180 EVNDS----EAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CCTTC----CSCCCSCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EecCC----cccccCCCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 65322 22334679999999999974 368899999999999999999999999998888877776543332222
Q ss_pred --CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 --SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 --~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.+||.+||+.||++||++.++++
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 468999999999999999999999999885
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=353.05 Aligned_cols=266 Identities=21% Similarity=0.333 Sum_probs=208.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
..+..++|++.+.||+|+||.||+|.+..+++. ....||+|.+...... ....+. ++..++..+ +||||+.++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~iK~~~~~~~~~~~~~~~-~E~~~l~~l-~hp~iv~~~~~ 85 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEIL-DEAYVMASV-DNPHVCRLLGI 85 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCS--CCEEEEEEEECCCSSCCCHHHHH-HHHHHHTTC-CBTTBCCCCEE
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCce--EEEEEEEEeeccccCHHHHHHHH-HHHHHHHhC-CCCCeeEEEEE
Confidence 346678999999999999999999998876541 1235788888654322 233333 344455555 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++ .+++|+|+. |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 88765 778888887 6888887654 45799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+. .....
T Consensus 164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~ 238 (327)
T 3lzb_A 164 AKLLGAEEK-EYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERL 238 (327)
T ss_dssp -----------------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCC
T ss_pred eeEccCccc-cccccCCCccccccCHHHHcC---CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 986533211 112223456889999999974 368899999999999999999 999999988777665544 44556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 6788899999999999999999999999999999988764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=356.13 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=206.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+...........++..++..+ .|+||+.+++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNK------VRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCC------eEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCc
Confidence 68999999999999999999987665 489999997644333323333444555555 699999999998654
Q ss_pred ---CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 121 ---GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 121 ---~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
...|+||||++|+|.+++.. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEEEcccCcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 47899999999999888854 369999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--- 274 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--- 274 (632)
...............+||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTB--CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCC--CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 764332222223456899999999987532 357899999999999999999999999887655544443211111
Q ss_pred ---------------------C-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 275 ---------------------C-----IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 275 ---------------------~-----~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
. +...+++++.+||.+||+.||++||++.++++ ++++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~~ 319 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA------HPYLEQ 319 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc------Ccchhh
Confidence 0 12467899999999999999999999999886 566543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.35 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=200.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-----hhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-----DCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-----~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
++|++.+.||+|+||.||+|.++.++ +.||||++..... ...+. +.++..++..+ +||||+.+++++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~-~~~E~~~l~~l-~hpnIv~~~~~~ 95 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETG------QQFAVKIVDVAKFTSSPGLSTED-LKREASICHML-KHPHIVELLETY 95 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHTSSSCCHHH-HHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCC------CEEEEEEEEhhhccccccchHHH-HHHHHHHHHhC-CCCCCCcEEEEE
Confidence 67999999999999999999988765 4899999854211 11233 33344555555 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc---EEEE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLG 191 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~---vkL~ 191 (632)
..++.+||||||++ |+|.+.+.... +..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 99999999999998 67877776542 346899999999999999999999999999999999999987654 9999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.. .+++..+....
T Consensus 176 Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~ 248 (351)
T 3c0i_A 176 GFGVAIQLGESG---LVAGGRVGTPHFMAPEVVKRE---PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK 248 (351)
T ss_dssp CCTTCEECCTTS---CBCCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC
T ss_pred cCcceeEecCCC---eeecCCcCCcCccCHHHHcCC---CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC
Confidence 999998764321 122345799999999999743 67899999999999999999999998853 44555554322
Q ss_pred cCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPC--IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~--~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.... ....+++++.+||.+||+.||++||++.++++
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2211 11578999999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=350.65 Aligned_cols=259 Identities=19% Similarity=0.299 Sum_probs=195.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH--HHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA--KVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~--~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++........ ...+.++..++..+ +||||+.+++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDH------RDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEA 83 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCC------ceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeec
Confidence 478999999999999999999987655 4899999976432221 12223333344444 79999999998876
Q ss_pred CC----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 120 NG----KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 120 ~~----~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
.+ ..||||||++ |+|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 43 4599999998 5888877654 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++................||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...........+
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp CC------------------CCTTCCHHHHHTC---CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCC---CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 997654332222223445799999999999743 68899999999999999999999999988877665555332222
Q ss_pred C--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH-HHHHhh
Q 006772 275 C--IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAFESS 312 (632)
Q Consensus 275 ~--~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell-~~Le~~ 312 (632)
. .+..+++++.++|.+||+.||++||+..+++ +.|...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1 2356899999999999999999999655544 555443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=361.37 Aligned_cols=258 Identities=18% Similarity=0.284 Sum_probs=203.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccC-CCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRE-SQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~-h~~I~~l~~~ 116 (632)
.+..++|++.+.||+|+||.||+|.+.. + +.||||++..... ......+.++..++..+.+ |+||+.++++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~------~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-K------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-C------CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-C------CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 3455679999999999999999998754 2 4899999975432 2222233444456666654 8999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
+..++.+|||||+..|+|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||++
T Consensus 125 ~~~~~~~~lv~E~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 125 EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp EECSSEEEEEEECCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred EecCCEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9999999999998778999888653 4789999999999999999999999999999999999995 589999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCC--------CCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--------VRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSV 267 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i 267 (632)
+...... ........+||+.|||||++.+. ....++.++|||||||++|||++|..||.+.. .......+
T Consensus 202 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 202 NQMQPDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp CCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred ccccCCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 8653221 11122345799999999998642 12358899999999999999999999998754 33445555
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
........+|...+.++.+||.+||+.||.+||++.++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 5445556677888999999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=364.12 Aligned_cols=246 Identities=20% Similarity=0.273 Sum_probs=190.8
Q ss_pred CCeEEE-eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l~-~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
++|.+. +.||+|+||+||+|.++.++ +.||||++.... .. .++..++.++.+|+||+.+++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~------~~vAiK~~~~~~-----~~-~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQ------EKFALKMLQDCP-----KA-RREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECSH-----HH-HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCC------CEEEEEEeCcch-----hH-HHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 578887 78999999999999988765 489999996421 22 2223344455689999999998875
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEec
Q 006772 120 --NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGDF 193 (632)
Q Consensus 120 --~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~DF 193 (632)
++.+||||||++ |+|.+++.......+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 567999999998 58888887644457999999999999999999999999999999999999997 789999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH----HHHHHHh
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE----IYHSVVI 269 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e----i~~~i~~ 269 (632)
|+++..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+..... +...+..
T Consensus 209 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~ 281 (400)
T 1nxk_A 209 GFAKETTSH----NSLTTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281 (400)
T ss_dssp TTCEECC---------------CTTCCGGGSCC---CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred ccccccCCC----CccccCCCCCCccCHhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence 999865322 22345689999999999864 468899999999999999999999998754321 2333332
Q ss_pred hccCCCC--CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 KKEKPCI--PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~~~~p~~--p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....... ...+++++.+||.+||+.||++||++.++++
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222221 2568999999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.60 Aligned_cols=261 Identities=20% Similarity=0.328 Sum_probs=208.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.|..++|++.+.||+|+||.||+|.+..+++. ......||+|++........+.+.++ ..++..+ +|+||+.+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKL-SHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHH-HHHHHTS-CCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHH-HHHHHhC-CCCCEeEEEEEE
Confidence 45678999999999999999999998765421 01124799999976554444444443 3445555 699999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc--------E
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ--------L 188 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~--------v 188 (632)
..++..++||||++ |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999998 5888887654 345999999999999999999999999999999999999999887 9
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEEIYHSV 267 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~ei~~~i 267 (632)
||+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|||++| .+||...+........
T Consensus 161 kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 161 KLSDPGISITVLP-------KDILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG--GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeccCcccccccC-------ccccCCcCcccCHHHhCCC--CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 9999998864321 1234579999999998742 3588999999999999999995 5555555554433322
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.....+|...++++.++|.+||+.||++||++.++++.|+.+..
T Consensus 232 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 ---EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ---HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ---hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 34556677889999999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.92 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=200.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.++.++ ..||+|++...........+.++..++..+ +||||+.+++++...+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSG------LERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred hheeecceeccCCCeEEEEEEEccCC------ceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCe
Confidence 68999999999999999999987655 489999987543222222333344555555 68999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecCCc
Q 006772 123 ICIAMKFYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIP 196 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFGla 196 (632)
.|+||||++ |+|.+.+... .+..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999998 5888887654 34689999999999999999999999999999999999999 45678999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC- 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~- 275 (632)
+..... .......||+.|+|||++. +.++.++|+|||||++|||++|..||.+.+..+....+........
T Consensus 175 ~~~~~~----~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 175 ELFKSD----EHSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp CC--------------CTTGGGCCHHHHT----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred eecCCc----ccCcCcccccCcCChHHhc----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence 764322 1223457899999999985 3578999999999999999999999999888777665543322222
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+++++.+||.+||+.||++||++.|+++
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12457999999999999999999999999886
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=350.09 Aligned_cols=270 Identities=19% Similarity=0.276 Sum_probs=211.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..++.+.|++.+.||+|+||.||++.+..... ..++.||||++...........+.++..++..+ .|+||+.+++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTND--GTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCC 102 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCC--CCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEE
Confidence 34555666999999999999999997754332 345789999998654333333344444556665 589999999999
Q ss_pred EEC--CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 118 VIN--GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 118 ~~~--~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
... ..+++||||++ |+|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence 884 68999999998 477777643 359999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH------------
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE------------ 262 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e------------ 262 (632)
+++................||+.|+|||++.+. .++.++|||||||++|||++|..||.......
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY---KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCC---CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 998764332111122334678899999999743 57889999999999999999999997643210
Q ss_pred --HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 263 --IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 263 --i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
..............+..+++++.+||.+||+.||++||++.++++.|+.+...+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 112223344556678899999999999999999999999999999998876544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=344.88 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=207.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh---hHHHHHHHHHHHhhhccCCCceeEeeEEEE-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED---CAKVFVNKFEELFPKFRESQSVCWLHGISV- 118 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~---~~~~~~~~~~~il~~l~~h~~I~~l~~~~~- 118 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++...... .....+.++..++..+ +|+||+.+++++.
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETL------CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYN 77 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTC------CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cceeEeeEEecCCCeEEEEEEECCCC------cEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEc
Confidence 68999999999999999999987655 48999998653211 1122233444555555 6999999999884
Q ss_pred -ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 -INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 -~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..+..|+||||+++++.+.+.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 4567999999999888888877666789999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .........||+.|+|||++.+. ...++.++|+|||||++|||++|..||.+.+..+....+. .....++
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~ 233 (305)
T 2wtk_C 158 ALHPFA-ADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIP 233 (305)
T ss_dssp ECCTTC-SSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCC
T ss_pred ccCccc-cccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCC
Confidence 753321 11222345689999999998643 2234779999999999999999999999988877776655 3455678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.++|.+||+.||.+||++.++++
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 899999999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.05 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=206.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|++..........+ .++..++..+ +|+||+.+++++..++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~-~~E~~il~~l-~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATG------RVFVAKFINTPYPLDKYTV-KNEISIMNQL-HHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSHHHHHHH-HHHHHHHTTC-CSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCC------CEEEEEEecccchhhHHHH-HHHHHHHHhC-CCcCCCeEEEEEEeCC
Confidence 368999999999999999999988665 4899999976554333333 3344555555 7999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec--CCcEEEEecCCcee
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE--HDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~--~g~vkL~DFGlak~ 198 (632)
.+|+||||+. |+|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 9999999998 577777653 2357999999999999999999999999999999999999984 47899999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--CCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK--PCI 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~--p~~ 276 (632)
.... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+...... +..
T Consensus 201 ~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 273 (387)
T 1kob_A 201 LNPD----EIVKVTTATAEFAAPEIVDRE---PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 273 (387)
T ss_dssp CCTT----SCEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred cCCC----cceeeeccCCCccCchhccCC---CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 5432 122345799999999999743 6889999999999999999999999998887777666543322 223
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+++++.+||.+||+.||++||++.++++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 3578999999999999999999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=343.45 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=211.1
Q ss_pred CCcCCCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..++.++|++.+ .||+|+||.||+|.+.... ..+.||||++...... .....+.++..++..+ +|+||+.+++
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 85 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIG 85 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSS----SEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCC----ceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEE
Confidence 456778999999 9999999999999764321 2358999999754322 1122233344455555 7999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++ ..+..++||||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 98 6678899999998 578877764 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++................||+.|+|||++.+. .++.++|+||||+++|||++ |..||.+.+..++...+. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~ 238 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGER 238 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccC---CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 998764322111112233567899999998643 57889999999999999999 999999988877766554 3455
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+..|..+++++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 667889999999999999999999999999999999887643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=370.37 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=210.4
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|..++|++.+.||+|+||.||+|.+..+ ..||||+++..... .+.+.+ +..++..+ +||||+.+++++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~~-~~~~~~-E~~~l~~l-~hp~iv~~~~~~ 248 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTMS-PEAFLQ-EAQVMKKL-RHEKLVQLYAVV 248 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEECCTTSSC-HHHHHH-HHHHHHHC-CCTTBCCEEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCC-------ceEEEEEeccCCCC-HHHHHH-HHHHHHhC-CCCCEeeEEEEE
Confidence 447779999999999999999999998643 36999999764422 234433 34555555 689999999987
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.. +.+||||||++ |+|.+++....+..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 65 67899999998 68999887655567999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......+|+.|+|||++.. +.++.++|||||||++|||++ |..||.+.+..++...+. ...+..
T Consensus 328 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~ 401 (452)
T 1fmk_A 328 RLIEDNEY--TARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMP 401 (452)
T ss_dssp C----------------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred eecCCCce--ecccCCcccccccCHhHHhc---CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 86533211 11123356889999999863 468999999999999999999 999999998888777665 344566
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.|..+|+++.++|.+||+.||++||++.+|++.|+.+.
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 78899999999999999999999999999999998654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.20 Aligned_cols=266 Identities=26% Similarity=0.425 Sum_probs=207.2
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
..+..++|++.+.||+|+||.||+|.+..... ....||||+++... ....+.+. ++..++..+ +|+||+.++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~-~e~~~l~~l-~h~~i~~~~ 87 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL-DHRNLIRLY 87 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHH-HHHHHHHHC-CCTTBCCEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHH-HHHHHHHhC-CCCCcccEE
Confidence 45677899999999999999999998754331 22469999987542 12223333 333445555 699999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++..++ .++||||+. |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence 9987654 889999998 6888888654 357999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~ 272 (632)
|++.................+|+.|+|||++.+. .++.++|+||||+++|||++ |..||.+.+..+....+.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC
Confidence 9998764332211122334678899999998643 57889999999999999999 9999999998888777766556
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+..+..+|+++.++|.+||+.||++||++.++++.|+.+.
T Consensus 243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 66677889999999999999999999999999999998765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=348.38 Aligned_cols=261 Identities=19% Similarity=0.263 Sum_probs=200.9
Q ss_pred CCeEEE-eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~-~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+.|++. +.||+|+||.||+|.+..++ +.||||++..........+.++ ..++.++..|+||+.+++++..++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~E-~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITS------QEYAVKIIEKQPGHIRSRVFRE-VEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSC------CEEEEEEEECCSSCCHHHHHHH-HHHHHHTCCCTTBCCEEEEEEETT
T ss_pred eeEEecCceecCCceEEEEEEEEcCCC------cEEEEEEEeeCcchhHHHHHHH-HHHHHHhcCCCCeeeEEEEEeeCC
Confidence 679985 78999999999999987655 4899999976544433444444 345566678999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc---EEEEecCCce
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPY 197 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~---vkL~DFGlak 197 (632)
.+|+||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999998 6888888654 47999999999999999999999999999999999999998776 9999999987
Q ss_pred eccCCCC----CCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCH-----------
Q 006772 198 LLLGRSL----SDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSV----------- 260 (632)
Q Consensus 198 ~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~----------- 260 (632)
....... ........+||+.|+|||++.... ...++.++|||||||++|||++|..||.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6432111 111223456999999999986310 12477899999999999999999999987542
Q ss_pred ----HHHHHHHHhhccCCCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 261 ----EEIYHSVVIKKEKPCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 261 ----~ei~~~i~~~~~~p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
..+...+.. ....+| ..+++++.+||.+||+.||.+||++.|+++ ++++...
T Consensus 243 ~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~ 302 (316)
T 2ac3_A 243 PACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ------HPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------STTCC--
T ss_pred hhHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc------ChhhcCC
Confidence 233444432 233344 468999999999999999999999999887 5666543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.39 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=202.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
..++|++.+.||+|+||.||+|.+..++ +.||||++...... ...+ .++..++..+.+|+||+.+++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~-~~~~-~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTGDE-EEEI-KQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSST-THHH-HHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC------CeEEEEEEecCccc-HHHH-HHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3578999999999999999999987655 48999998754332 2333 3344556667789999999999887
Q ss_pred -----CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 -----NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 -----~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
++.+|+||||++| +|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 5689999999985 8888887655568999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCC--CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|++...... ........||+.|+|||++.... ...++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 174 g~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp TTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred cCceecCcC---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 998765321 11223457899999999986321 3457899999999999999999999999888776655554433
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+..+++.+.++|.+||..||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 333345678999999999999999999999999886
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.83 Aligned_cols=263 Identities=19% Similarity=0.285 Sum_probs=207.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhcc--CCCceeEeeEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFR--ESQSVCWLHGIS 117 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~--~h~~I~~l~~~~ 117 (632)
.++|++.+.||+|+||.||+|.+.... ++.||||++...... ....+.++ ..++..+. .||||+.+++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEEEEEBCTTSCBCTHHHH-HHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCC-----CEEEEEEEeccCcccccCCchhhHH-HHHHHhhhccCCCCeEeeeeee
Confidence 378999999999999999999985322 258999998643211 01112222 23333332 799999999988
Q ss_pred E-----ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 118 V-----INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 118 ~-----~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
. .....++||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred eecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence 7 45679999999999999998876556799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+....+.....
T Consensus 164 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ----MALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG----GGGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CcccccccCC----CCccccccccceeCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9998764321 12334578999999999974 3688999999999999999999999999887766655543211
Q ss_pred CC-------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 273 KP-------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 273 ~p-------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
.+ .++..+++++.+||.+||+.||++||++.++++ ++++.+..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~~~~~ 306 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQDLERC 306 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGTTCCCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc------Cccccccchh
Confidence 11 123568999999999999999999999999886 6666655443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=340.32 Aligned_cols=265 Identities=19% Similarity=0.259 Sum_probs=213.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-----h---hHHHHHHHHHHHhhhccCCCceeEe
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-----D---CAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-----~---~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
.++|++.+.||+|+||.||+|.++.++ +.||||++..... . ...+...++..++.++.+||||+.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTC------KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcC------ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 479999999999999999999987665 4899999975421 1 1122233444566777789999999
Q ss_pred eEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++..++..++||||++ |+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999998 5888887654 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCC---CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~ 269 (632)
||++...... .......||+.|+|||++.+. ....++.++|+||||+++|||++|..||.+.+..+....+..
T Consensus 168 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 168 FGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp CTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccchhhcCCC----cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 9999865332 122345789999999998521 133578899999999999999999999999888777766654
Q ss_pred hccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 270 KKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 270 ~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
.......+ ..+++++.++|.+||+.||++||++.++++ ++++....++.
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~~~ 294 (298)
T 1phk_A 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA------HPFFQQYVVEE 294 (298)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT------SGGGCTTC---
T ss_pred CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh------ChHhhhccchh
Confidence 43333222 468999999999999999999999999886 66776655544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=336.51 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=205.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ...... +.++..++..+ +|+||+.+++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~-~~~e~~~l~~l-~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTG------LEFAAKIINTKKLSARDFQK-LEREARICRKL-QHPNIVRLHDSIQE 76 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCHHHHHH-HHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCC------ceEEEEEeecccCCHHHHHH-HHHHHHHHHHc-CCCCcCeEEEEEEc
Confidence 478999999999999999999988765 489999986533 222222 33344555555 69999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc---EEEEecCC
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGI 195 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~---vkL~DFGl 195 (632)
++..++||||+.| +|.+.+... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 9999999999984 777777654 47999999999999999999999999999999999999987665 99999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+...... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+....+........
T Consensus 155 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (284)
T 3kk8_A 155 AIEVNDS----EAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227 (284)
T ss_dssp CEECCSS----CBCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eEEcccC----ccccCCCCCcCCcCchhhcC---CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC
Confidence 9765332 22234578999999999974 3678999999999999999999999999988887777664433332
Q ss_pred CC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+ ..+++++.++|.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22 478999999999999999999999999886
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.42 Aligned_cols=265 Identities=18% Similarity=0.264 Sum_probs=206.5
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc-----CCCcee
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR-----ESQSVC 111 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~-----~h~~I~ 111 (632)
..++ .++|++.+.||+|+||.||+|.+..++. +.||||+++.... .... ...+..++..+. .+.+++
T Consensus 14 g~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~-~~~~-~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 14 GDWL-QERYEIVGNLGEGTFGKVVECLDHARGK-----SQVALKIIRNVGK-YREA-ARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TCEE-TTTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEECSCHH-HHHH-HHHHHHHHHHHHHHCTTSCSCBC
T ss_pred Ccee-cccEEEEEEeeccCCeEEEEEEecCCCc-----eEEEEEEEccccc-chhH-HHHHHHHHHHHhhcCCCCceeEE
Confidence 4444 4789999999999999999999876542 4899999975432 2222 233333444443 233488
Q ss_pred EeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---------
Q 006772 112 WLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL--------- 182 (632)
Q Consensus 112 ~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl--------- 182 (632)
.+.+++...+..||||||+.|++++.+.......+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred EeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 88899999999999999999999999887655689999999999999999999999999999999999999
Q ss_pred ----------ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCC
Q 006772 183 ----------SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGI 252 (632)
Q Consensus 183 ----------d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~ 252 (632)
+.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|+|||||++|||++|.
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeec---CCCCCccchHHHHHHHHHHHhCC
Confidence 6788999999999976422 2234578999999999974 36889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhccCC------------------------------------------CCCCCCCHHHHHHHHH
Q 006772 253 QPWFGKSVEEIYHSVVIKKEKP------------------------------------------CIPSGLPPAVENVIIG 290 (632)
Q Consensus 253 ~PF~~~~~~ei~~~i~~~~~~p------------------------------------------~~p~~lp~~l~~LI~~ 290 (632)
.||.+.+..+....+....... ......++++.+||.+
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 9999887665444332211110 0011224589999999
Q ss_pred hhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 291 CFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 291 cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
||+.||++||++.++++ ++++.+.+++.
T Consensus 317 ~L~~dP~~Rpt~~e~l~------hp~f~~~~~~~ 344 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALL------HPFFAGLTPEE 344 (355)
T ss_dssp HTCSSTTTSCCHHHHTT------SGGGGGCCHHH
T ss_pred HhcCChhhCcCHHHHhc------ChhhcCCChhh
Confidence 99999999999999876 67777666554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.60 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=209.3
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCEE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKI 123 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~l 123 (632)
.|++.+.||+|+||.||+|.+..+.. ....||+|.+.........+...++..++..+ +|+||+.+++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCC
Confidence 46778999999999999999865442 23479999997654433333333444555555 799999999998766554
Q ss_pred -EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 124 -CIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 124 -~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+++|||+. |+|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999997 678777754 346789999999999999999999999999999999999999999999999999976533
Q ss_pred CCC-CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 202 RSL-SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 202 ~~~-~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
... .........||+.|+|||.+.+ ..++.++|+|||||++|+|++ +.+||...+..+....+. .......+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 252 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQT---YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEY 252 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTT---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTT
T ss_pred CcccccccCcCCCCCccccChhhhcc---CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCcc
Confidence 211 1122234567899999999974 368899999999999999999 555566666655555444 3445666788
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhccc
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVY 317 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~ 317 (632)
+++++.+++.+||+.||.+||++.++++.|+.+...+.
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999998876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=378.61 Aligned_cols=265 Identities=17% Similarity=0.316 Sum_probs=210.6
Q ss_pred CcCCCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.+..+++.+.+ .||+|+||.||+|.++..+ ....||||+++..... ..+.+.+ +..++..+ +|+||+.++++
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~-E~~il~~l-~hpniv~l~~~ 404 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQL-DNPYIVRLIGV 404 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHH-HHHHHTTC-CCTTBCCEEEE
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHH-HHHHHHhC-CCCCEeeEEEE
Confidence 46667888887 8999999999999886432 2357999999764332 3344444 44555555 79999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+.. +.+||||||+. |+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 405 ~~~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 405 CQA-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EES-SSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 865 56999999998 577777653 346799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++................+|+.|+|||++.. +.++.++|||||||+||||++ |..||.+.+..++...+. ...++
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~---~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~ 558 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRM 558 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCC
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 9765322111111122345789999999863 468999999999999999998 999999988887776665 34566
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
..|..+|+++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 77889999999999999999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=354.09 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=191.5
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
...+.++|++.+.||+|+||.||+|.++.++ +.||||++....... ..+. ++..++..+ +||||+.+++++
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~-~~~~-~E~~~l~~l-~hpniv~~~~~~ 85 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTK------ELVAVKYIERGAAID-ENVQ-REIINHRSL-RHPNIVRFKEVI 85 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTC------CEEEEEEEESSTTSC-HHHH-HHHHHHHHC-CCTTBCCEEEEE
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCC------cEEEEEEEecCcccc-HHHH-HHHHHHHhC-CCCCCCcEEEEE
Confidence 3445689999999999999999999998765 489999997543322 2222 333444444 699999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc--EEEEecC
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ--LVLGDFG 194 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~--vkL~DFG 194 (632)
..++.+||||||+. |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 86 LTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred eeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 99999999999997 5888877654 47999999999999999999999999999999999999987765 9999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCC-cccccchhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPIS-FETDTWGFGCSIMEMLTGIQPWFGKSV----EEIYHSVVI 269 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t-~ksDvwSlGvvL~EmltG~~PF~~~~~----~ei~~~i~~ 269 (632)
+++..... .......||+.|+|||++.+. .++ .++|||||||++|||++|..||.+... ......+..
T Consensus 164 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 236 (361)
T 3uc3_A 164 YSKSSVLH----SQPKSTVGTPAYIAPEVLLRQ---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236 (361)
T ss_dssp CC-------------------CTTSCHHHHHCS---SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT
T ss_pred cccccccc----CCCCCCcCCCCcCChhhhcCC---CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc
Confidence 98743221 222345799999999998743 343 459999999999999999999987543 334444443
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+.+..+++++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 22222233468999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=344.58 Aligned_cols=258 Identities=20% Similarity=0.368 Sum_probs=197.0
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
-.++|++.+.||+|+||+||+|.+. + +.||||++.... ...+..+.+.......+|+||+.+++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~------~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ--G------ENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET--T------EEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC--C------EEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 3578999999999999999999873 2 479999986532 233333332222223589999999988654
Q ss_pred ---CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeeeeeCCeEEEecCCc
Q 006772 120 ---NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH--------SIGLLVLNLKPSNLLLSEHDQ 187 (632)
Q Consensus 120 ---~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLH--------s~~IvHRDLKP~NILld~~g~ 187 (632)
...+|+||||++ |+|.+++. ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred cCCCceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 256899999998 58888773 357999999999999999999999 999999999999999999999
Q ss_pred EEEEecCCceeccCCCCC-CCccccccCCCccCCccccCCCCCC---CCCcccccchhHHHHHHHHhC----------CC
Q 006772 188 LVLGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRG---PISFETDTWGFGCSIMEMLTG----------IQ 253 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g---~~t~ksDvwSlGvvL~EmltG----------~~ 253 (632)
+||+|||+++........ ........||+.|+|||++.+.... .++.++|||||||++|||++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999865432211 1112334799999999999754211 345799999999999999999 88
Q ss_pred CCCCCC-----HHHHHHHHHhhccCCCCCC-----CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 254 PWFGKS-----VEEIYHSVVIKKEKPCIPS-----GLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 254 PF~~~~-----~~ei~~~i~~~~~~p~~p~-----~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
||.... .......+......+..|. .+++++.++|.+||+.||++|||+.++++.|+.+
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 986532 2333333333333444442 2557899999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.26 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=203.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|...+.||+|+||.||+|.+..++ +.||||++........+.+.++ ..++..+ +|+||+.+++++..++.
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g------~~vavK~~~~~~~~~~~~~~~E-~~~l~~l-~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSG------RQVAVKMMDLRKQQRRELLFNE-VVIMRDY-QHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCCSHHHHHHH-HHHHTTC-CCTTBCCEEEEEEETTE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCC------cEEEEEEEeccchhHHHHHHHH-HHHHHhC-CCCCcceEEEEEEECCE
Confidence 35888999999999999999987655 4899999976554444444443 3445555 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.++||||++| +|.+++. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp EEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 9999999985 6666553 34799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IPSG 279 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p~~ 279 (632)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+... ..+. .+..
T Consensus 194 ~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 266 (321)
T 2c30_A 194 DV---PKRKSLVGTPYWMAPEVISR---SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHK 266 (321)
T ss_dssp SS---CCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGG
T ss_pred Cc---cccccccCCccccCHhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCcccc
Confidence 21 12234579999999999974 46889999999999999999999999998877766655432 2222 2346
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++++.++|.+||+.||++||++.++++
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999999999886
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.80 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=201.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.+.||+|+||.||+|.+..++ +.||||++....... .++..++..+ +|+||+.+++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~------~~vAiK~~~~~~~~~-----~~E~~il~~l-~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESG------KRFALKKVLQDPRYK-----NRELDIMKVL-DHVNIIKLVDYFYT 71 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTC------CEEEEEEEECCTTSC-----CHHHHHHTTC-CCTTBCCEEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCC------CEEEEEEEecCcchH-----HHHHHHHHHc-CCCCccchhheeee
Confidence 34578999999999999999999988765 489999986543222 1233445554 79999999998844
Q ss_pred --------------------------------------CCEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHH
Q 006772 120 --------------------------------------NGKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLA 159 (632)
Q Consensus 120 --------------------------------------~~~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa 159 (632)
+..+++||||++|+|.+.+... .+..+++..++.++.||+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 3458999999999988877642 356899999999999999
Q ss_pred HHHHHHHhCCceeeeeeCCeEEEe-cCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCccccc
Q 006772 160 KGISDLHSIGLLVLNLKPSNLLLS-EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDT 238 (632)
Q Consensus 160 ~gL~yLHs~~IvHRDLKP~NILld-~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDv 238 (632)
.||+|||+++|+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. ..++.++||
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di 225 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGA--TEYTPSIDL 225 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----SCCCCCCCCSSCCCHHHHTTC--SSCCTHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----CCCcCcccCCCccCHHHhcCC--CCCCcchhh
Confidence 999999999999999999999998 6899999999999875332 222345789999999998743 248899999
Q ss_pred chhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---------------------------CCCCCCCHHHHHHHHHh
Q 006772 239 WGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP---------------------------CIPSGLPPAVENVIIGC 291 (632)
Q Consensus 239 wSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p---------------------------~~p~~lp~~l~~LI~~c 291 (632)
|||||++|||++|+.||.+.+..+....+......+ .+|..+|+++.+||.+|
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 999999999999999999988776665554321111 14566899999999999
Q ss_pred hhcCcCCCCCHHHHHH
Q 006772 292 FEYDLRNRPLMADILH 307 (632)
Q Consensus 292 L~~DP~~RPs~~ell~ 307 (632)
|+.||.+|||+.|+++
T Consensus 306 L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSSGGGSCCHHHHHT
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999886
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=344.52 Aligned_cols=264 Identities=18% Similarity=0.321 Sum_probs=204.6
Q ss_pred CCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee
Q 006772 32 TPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 32 ~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
.......+.+.++|++.+.||+|+||.||+|.+..++ +.||||++..... .. ..++..++..+.+|+||+
T Consensus 25 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~---~~-~~~E~~~l~~l~~~~~i~ 94 (330)
T 3nsz_A 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN------EKVVVKILKPVKK---KK-IKREIKILENLRGGPNII 94 (330)
T ss_dssp GGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECSCCH---HH-HHHHHHHHHHHTTSTTBC
T ss_pred hhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCC------cEEEEEEecccch---HH-HHHHHHHHHHcCCCCCEE
Confidence 3344455556789999999999999999999987765 4899999975443 22 334446667777899999
Q ss_pred EeeEEEEE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-c
Q 006772 112 WLHGISVI--NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-Q 187 (632)
Q Consensus 112 ~l~~~~~~--~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~ 187 (632)
.+++++.. ....++||||+.| +|.+++ + .+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .
T Consensus 95 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~ 169 (330)
T 3nsz_A 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-Q----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 169 (330)
T ss_dssp CEEEEEECTTTCCEEEEEECCCCCCHHHHG-G----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred EeeeeeccCCCCceEEEEeccCchhHHHHH-H----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCE
Confidence 99999987 6789999999995 555444 2 489999999999999999999999999999999999999777 8
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHS 266 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~ 266 (632)
+||+|||+++..... .......||+.|+|||++.+. ..++.++|||||||++|||++|..||... +..+....
T Consensus 170 ~kl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~ 243 (330)
T 3nsz_A 170 LRLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243 (330)
T ss_dssp EEECCCTTCEECCTT----CCCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred EEEEeCCCceEcCCC----CccccccccccccChhhhcCC--CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence 999999999865332 223345789999999998642 35889999999999999999999999653 23222221
Q ss_pred HHhh-----------cc------------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 267 VVIK-----------KE------------------------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 267 i~~~-----------~~------------------------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
+... .. ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~---- 319 (330)
T 3nsz_A 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME---- 319 (330)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT----
T ss_pred HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc----
Confidence 1100 00 01112237999999999999999999999999887
Q ss_pred hhhcccCCCCc
Q 006772 312 SQNAVYNDGEW 322 (632)
Q Consensus 312 ~~~~~~~~~~w 322 (632)
+++|.+..+
T Consensus 320 --hp~f~~~~~ 328 (330)
T 3nsz_A 320 --HPYFYTVVK 328 (330)
T ss_dssp --SGGGTTCC-
T ss_pred --CccHhhhcc
Confidence 677766544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.72 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=212.0
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|.+... ..||||.+...... ...+. ++..++..+ +|+||+.+++++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~vavK~~~~~~~~-~~~~~-~E~~~l~~l-~h~~i~~~~~~~ 77 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSMS-PDAFL-AEANLMKQL-QHQRLVRLYAVV 77 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSSC-HHHHH-HHHHHHHHC-CCTTBCCEEEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCC-------cEEEEEEecCCccc-HHHHH-HHHHHHHhC-CCcCcceEEEEE
Confidence 446678999999999999999999987532 47999999754322 23333 334555555 799999999987
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
. ++..++||||++ |+|.+++....+..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 5 556899999997 68888775443347999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
........ .......+|+.|+|||++.+ +.++.++|+|||||++|||++ |..||.+.+..+....+.. ...+.
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 230 (279)
T 1qpc_A 157 RLIEDNEY--TAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMV 230 (279)
T ss_dssp EECSSSCE--ECCTTCCCCTTTSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC
T ss_pred ccccCccc--ccccCCCCccCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccCCC
Confidence 87543211 11223456889999999863 367889999999999999999 9999999888777666543 34555
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
.+..+++++.+++.+||+.||++||++.++++.|+.+...
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 6788999999999999999999999999999999877643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.26 Aligned_cols=269 Identities=22% Similarity=0.325 Sum_probs=201.1
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+.++.++|++.+.||+|+||.||+|.+.. +.||||++..... ..+..+.+........|+||+.+++
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--------RPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEETT--------EEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEECC--------eEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhhee
Confidence 4566788999999999999999999997632 4899999964332 2333333333333468999999987
Q ss_pred EEEE-----CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeeeeeCCeE
Q 006772 116 ISVI-----NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI---------GLLVLNLKPSNL 180 (632)
Q Consensus 116 ~~~~-----~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~---------~IvHRDLKP~NI 180 (632)
.+.. ...+||||||++ |+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Ni 151 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGE
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceE
Confidence 6543 236789999997 5888887543 568999999999999999999999 999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCC-----CCccccccCCCccCCccccCCCCC----CCCCcccccchhHHHHHHHHhC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLS-----DSDMALRLGTPNYMAPEQWEPEVR----GPISFETDTWGFGCSIMEMLTG 251 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~-----~~~~~~~~GT~~YmAPE~~~~~~~----g~~t~ksDvwSlGvvL~EmltG 251 (632)
|++.++.+||+|||+++.+...... ........||+.|+|||++.+... ..++.++|||||||++|||++|
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 9999999999999999876432211 112234579999999999875211 2456789999999999999999
Q ss_pred CCCCCCC-C-----------------HHHHHHHHHhhccCCCCCCCC------CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 252 IQPWFGK-S-----------------VEEIYHSVVIKKEKPCIPSGL------PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 252 ~~PF~~~-~-----------------~~ei~~~i~~~~~~p~~p~~l------p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..||... + ..+....+.....++.+|..+ ++++.+||.+||+.||++|||+.|+++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 7775432 1 112222222334445555543 358999999999999999999999999
Q ss_pred HHHhhhhcccC
Q 006772 308 AFESSQNAVYN 318 (632)
Q Consensus 308 ~Le~~~~~~~~ 318 (632)
.|+.+.+.+..
T Consensus 312 ~L~~ll~~~~~ 322 (336)
T 3g2f_A 312 RMAELMMIWER 322 (336)
T ss_dssp HHHHHHHCCCC
T ss_pred HHHHHHHHHHh
Confidence 99998876653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=353.10 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=205.8
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++...... ....+.+ +..++..+ +|+||+.+++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTG------QKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNLIEICRT 87 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTC------CEEEEEECCCSSCSSSSCHHHHH-HHHHHHHC-CCTTBCCEEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCC------CEEEEEEEecccccccchHHHHH-HHHHHHhc-cCCCcccHhheeec
Confidence 368999999999999999999987665 48999998653321 1222333 33445555 69999999999877
Q ss_pred --------CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 120 --------NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 120 --------~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
++.+||||||++|++.+.+... ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp C--------CEEEEEEECCSEEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccCCceEEEEEeccCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 4579999999999998888654 3579999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCC-CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSL-SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~-~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+++....... .........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCC--CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999987643221 12233456789999999998643 35789999999999999999999999998877666555432
Q ss_pred ccCCC--CCCC----------------------------CCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 271 KEKPC--IPSG----------------------------LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 271 ~~~p~--~p~~----------------------------lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
...+. .... .++++.+||.+||+.||++||++.|+++ ++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~ 317 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFWS 317 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGGS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC------CCCcCC
Confidence 22211 1111 2678999999999999999999999887 566643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.00 Aligned_cols=276 Identities=24% Similarity=0.312 Sum_probs=214.0
Q ss_pred CCccccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHh
Q 006772 22 DPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELF 101 (632)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il 101 (632)
++....++++......... ..+|++.+.||+|+||.||+|.+..++ .||+|++....... .++..++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~-~~~Y~~~~~lG~G~~g~V~~a~~~~~~-------~~aikk~~~~~~~~-----~~E~~il 86 (394)
T 4e7w_A 20 DPNKVIKVLASDGKTGEQR-EIAYTNCKVIGNGSFGVVFQAKLVESD-------EVAIKKVLQDKRFK-----NRELQIM 86 (394)
T ss_dssp CCCCCEEEEEEESSSCCEE-EEEEEEEEEEEEETTEEEEEEEETTTE-------EEEEEEEECCTTSC-----CHHHHHH
T ss_pred CCCceEEEEecCCCCCCcc-cceEEEeEEEeeCCCeEEEEEEECCCC-------eEEEEEEecCcchH-----HHHHHHH
Confidence 3444555565555555443 367999999999999999999987644 58888886533221 1233444
Q ss_pred hhccCCCceeEeeEEEEECC------EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 006772 102 PKFRESQSVCWLHGISVING------KICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVL 173 (632)
Q Consensus 102 ~~l~~h~~I~~l~~~~~~~~------~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHR 173 (632)
..+ +|+||+.+++++...+ .+|+||||+++++.+.+... ....+++..++.++.||+.||+|||+++|+||
T Consensus 87 ~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 165 (394)
T 4e7w_A 87 RIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165 (394)
T ss_dssp HTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HhC-CCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 444 7999999999986543 38899999999887766532 24689999999999999999999999999999
Q ss_pred eeeCCeEEEe-cCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCC
Q 006772 174 NLKPSNLLLS-EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGI 252 (632)
Q Consensus 174 DLKP~NILld-~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~ 252 (632)
||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. ..++.++|||||||++|||++|+
T Consensus 166 Dlkp~Nill~~~~~~~kL~DFG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~ 239 (394)
T 4e7w_A 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAG----EPNVSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQ 239 (394)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTT----CCCCSSCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEEcCCCCcEEEeeCCCcccccCC----CCCcccccCcCccCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999 7999999999999875332 122345789999999998643 35889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhccCC---------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q 006772 253 QPWFGKSVEEIYHSVVIKKEKP---------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADI 305 (632)
Q Consensus 253 ~PF~~~~~~ei~~~i~~~~~~p---------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~el 305 (632)
.||.+.+..+....+......+ .++..+++++.+||.+||+.||.+||++.|+
T Consensus 240 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (394)
T 4e7w_A 240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319 (394)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence 9999988766555544321111 1234588999999999999999999999998
Q ss_pred HHHHHhhhhcccCCCCcc
Q 006772 306 LHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 306 l~~Le~~~~~~~~~~~w~ 323 (632)
++ +++|....|.
T Consensus 320 l~------hp~f~~~~~~ 331 (394)
T 4e7w_A 320 LC------HPFFDELRTG 331 (394)
T ss_dssp HT------SGGGSTTTSS
T ss_pred hc------Chhhhhhccc
Confidence 86 7777766554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.88 Aligned_cols=262 Identities=24% Similarity=0.268 Sum_probs=202.8
Q ss_pred ccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCC
Q 006772 28 TVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRES 107 (632)
Q Consensus 28 ~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h 107 (632)
+....+..........+|++.+.||+|+||.||+|.+..++ +.||||++...... ..++..++..+ +|
T Consensus 39 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~------~~vaiK~~~~~~~~-----~~~E~~il~~l-~h 106 (420)
T 1j1b_A 39 TVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG------ELVAIKKVLQDKRF-----KNRELQIMRKL-DH 106 (420)
T ss_dssp EEEEEESSSSCCCEEEEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEECCTTS-----CCHHHHHHHTC-CC
T ss_pred eeeccCCCCCCCcccceEEeeeEEeeCCCEEEEEEEECCCC------cEEEEEEecccchh-----HHHHHHHHHHc-CC
Confidence 33444333333334467999999999999999999997655 48999998654322 12233445554 79
Q ss_pred CceeEeeEEEEEC------CEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCe
Q 006772 108 QSVCWLHGISVIN------GKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSN 179 (632)
Q Consensus 108 ~~I~~l~~~~~~~------~~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~N 179 (632)
+||+.+++++... ..+++||||+++++.+.+... ....+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 107 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp TTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred CCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 9999999887542 247799999999888777542 34689999999999999999999999999999999999
Q ss_pred EEEecC-CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC
Q 006772 180 LLLSEH-DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258 (632)
Q Consensus 180 ILld~~-g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~ 258 (632)
||++.+ +.+||+|||+++..... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTT----CCCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeCCCCeEEeccchhhhhcccC----CCceeeeeCCCcCCHHHHcCC--CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999965 67899999999875332 122345789999999998643 25889999999999999999999999998
Q ss_pred CHHHHHHHHHhhccC---------------CC------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 259 SVEEIYHSVVIKKEK---------------PC------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~---------------p~------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+.+..+...... .. ++..+++++.+||.+||+.||.+||++.|+++
T Consensus 261 ~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 261 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 866555444321110 11 23467899999999999999999999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.13 Aligned_cols=266 Identities=20% Similarity=0.309 Sum_probs=207.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE-ECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV-ING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~-~~~ 121 (632)
.+|++.+.||+|+||.||+|.+...+. ....||+|.+.............++..++.++ +|+||+.+++++. .++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence 569999999999999999999765432 23469999997654433333333444555555 6999999999864 456
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..|+||||++| +|.+++.. ....+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred ceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 88999999985 88777754 34578999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCC-CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 201 GRSLS-DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 201 ~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
..... ........||+.|+|||++.+ ..++.++|+|||||++|||++ +.+||.+.+..+....+. .......|.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 255 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPE 255 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCT
T ss_pred ccchhccccccCCCCCccccChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCc
Confidence 32211 112234467889999999864 368899999999999999999 677777766655554444 344555678
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhccc
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVY 317 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~ 317 (632)
.+|+++.+++.+||+.||++||++.++++.|+.+...+.
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 899999999999999999999999999999998876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=349.01 Aligned_cols=263 Identities=18% Similarity=0.261 Sum_probs=202.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+..++|++.+.||+|+||.||+|.+..++ +.||||++.............++..++..+ .|+||+.+++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTG------DLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCC------cEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeec
Confidence 34578999999999999999999998765 489999997543222222233344555555 59999999999887
Q ss_pred CC--EEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE----ecCCcEEEE
Q 006772 120 NG--KICIAMKFYE-GSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL----SEHDQLVLG 191 (632)
Q Consensus 120 ~~--~l~LVmEy~~-GsL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl----d~~g~vkL~ 191 (632)
.+ ..||||||++ |+|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 54 7899999998 688887765432 349999999999999999999999999999999999999 777889999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCC-----CCCCCCcccccchhHHHHHHHHhCCCCCCCCC----HHH
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-----VRGPISFETDTWGFGCSIMEMLTGIQPWFGKS----VEE 262 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-----~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~----~~e 262 (632)
|||+++..... .......||+.|+|||++... ....++.++|||||||++|||++|..||.... ..+
T Consensus 159 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 159 DFGAARELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred cCCCceecCCC----CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 99999875432 222345799999999987521 12468899999999999999999999997532 234
Q ss_pred HHHHHHhhccCC-----------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 263 IYHSVVIKKEKP-----------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 263 i~~~i~~~~~~p-----------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+...+....... .++..+++.+.++|.+||+.||++||++.|+++...+..
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 444444322110 112234568899999999999999999999998765443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=370.21 Aligned_cols=278 Identities=20% Similarity=0.269 Sum_probs=218.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.++||+|+||.||+|.+..++ +.||||++....... . +..+..++..+.+++++..+..++...+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~~~~--~-~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKTKHP--Q-LLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTC------CEEEEEEEETTCSSC--C-HHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCC------cEEEEEEeccccccH--H-HHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 478999999999999999999987665 489999986543221 1 2334456677778889988888889999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFGlak~ 198 (632)
..||||||+.|+|.+++... .+.+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.
T Consensus 77 ~~~lvme~~g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEEECCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999999988999888653 4589999999999999999999999999999999999999 6889999999999987
Q ss_pred ccCCCCCC----CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhc
Q 006772 199 LLGRSLSD----SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---VEEIYHSVVIKK 271 (632)
Q Consensus 199 ~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~---~~ei~~~i~~~~ 271 (632)
+....... .......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.. ..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCC---CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 64432111 112356799999999999743 68899999999999999999999998754 333333333222
Q ss_pred cCC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh----cccCCCCccccccccccC
Q 006772 272 EKP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN----AVYNDGEWTGLGSRALTD 332 (632)
Q Consensus 272 ~~p---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~----~~~~~~~w~~~~~~~~~~ 332 (632)
... .++..+|+++.+||.+||+.||++||++.+|++.|+.+.. .++...+|+.+.......
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~ 300 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-----
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccc
Confidence 111 2236789999999999999999999999999998887754 345677888776554333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.08 Aligned_cols=245 Identities=16% Similarity=0.227 Sum_probs=199.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++..... .....+.+ +...+..+.+||||+.+++++..+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDG------CIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCCTTSHHHHHHHH-HHHHHHHSCSCTTBCCEEEEEEET
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCC------ceEEEEEecccccccHHHHHHHH-HHHHHHHhCCCCCeeeeeeeeecC
Confidence 67999999999999999999987655 4899999976422 22233333 334455666899999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC------------
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH------------ 185 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~------------ 185 (632)
+..++||||++| +|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999985 8888887543 2679999999999999999999999999999999999999854
Q ss_pred -------CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC
Q 006772 186 -------DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK 258 (632)
Q Consensus 186 -------g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~ 258 (632)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|||++|.+|+...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN--YTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC--CTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC--CCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999998865321 223589999999998743 24678999999999999999999887654
Q ss_pred CHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 259 SVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.. ...+ .....+.+|..+++++.++|.+||+.||++||++.++++
T Consensus 235 ~~---~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQ---WHEI-RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH---HHHH-HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH---HHHH-HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 32 2222 234556778899999999999999999999999999886
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=357.09 Aligned_cols=257 Identities=19% Similarity=0.252 Sum_probs=198.8
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc-------
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR------- 105 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~------- 105 (632)
+...+..+ .++|++.+.||+|+||.||+|++..++ +.||||++.... .....+.+ +..++..+.
T Consensus 28 ~~~~g~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~-E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 28 LVKIGDLF-NGRYHVIRKLGWGHFSTVWLSWDIQGK------KFVAMKVVKSAE-HYTETALD-EIRLLKSVRNSDPNDP 98 (397)
T ss_dssp SSCTTCEE-TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSCH-HHHHHHHH-HHHHHHHHHHSCTTCG
T ss_pred EEehhhhc-CCeEEEEEEeeecCCeeEEEEEecCCC------eEEEEEEEecCC-cchHHHHH-HHHHHHHHhhcCCCCC
Confidence 33334333 478999999999999999999987655 589999997542 22233333 334444443
Q ss_pred CCCceeEeeEEEE----ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeE
Q 006772 106 ESQSVCWLHGISV----INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNL 180 (632)
Q Consensus 106 ~h~~I~~l~~~~~----~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NI 180 (632)
.|+||+.+++++. .+..+||||||+.|++++.+.......+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI 178 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence 2788999999887 34689999999999999999876657899999999999999999999999 999999999999
Q ss_pred EEecCC-------------------------------------------------cEEEEecCCceeccCCCCCCCcccc
Q 006772 181 LLSEHD-------------------------------------------------QLVLGDFGIPYLLLGRSLSDSDMAL 211 (632)
Q Consensus 181 Lld~~g-------------------------------------------------~vkL~DFGlak~~~~~~~~~~~~~~ 211 (632)
|++.++ .+||+|||+++.... ....
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~ 252 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTE 252 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCS
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCcc
Confidence 999775 799999999986532 2234
Q ss_pred ccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhhccC------------
Q 006772 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV------EEIYHSVVIKKEK------------ 273 (632)
Q Consensus 212 ~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~------~ei~~~i~~~~~~------------ 273 (632)
..||+.|+|||++.+. .++.++|||||||+||||++|..||.+.+. ......+......
T Consensus 253 ~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 329 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGS---GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329 (397)
T ss_dssp CCSCGGGCCHHHHHTS---CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG
T ss_pred CCCCCcccCChhhcCC---CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc
Confidence 5789999999999743 588999999999999999999999986542 1222222110000
Q ss_pred ----------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ----------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ----------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+...++++.+||.+||+.||++||++.|+++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0122334567899999999999999999999886
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.67 Aligned_cols=261 Identities=21% Similarity=0.248 Sum_probs=202.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH----HHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA----KVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~----~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++........ .....++..++..+ +|+||+.+++++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 81 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTN------QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAF 81 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCC------SEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCC------cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEE
Confidence 478999999999999999999987655 4899999875322111 11122333445555 699999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++..++||||++|++.+.+.. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eeCCceEEEEEcCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999999999988877754 34578999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC-- 275 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~-- 275 (632)
..... .......+||+.|+|||++.+. ..++.++|+|||||++|||++|.+||.+.+..+.+..+......+.
T Consensus 161 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSP---NRAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSC---CCCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eccCC---cccCCcccccccccCchHhhCC--CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 65322 1223345789999999998642 2478899999999999999999999999887777666654322111
Q ss_pred -C-----------------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCC
Q 006772 276 -I-----------------------PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGE 321 (632)
Q Consensus 276 -~-----------------------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~ 321 (632)
. ...+++++.+||.+||+.||++|||+.|+++ ++++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------h~~f~~~~ 299 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK------MKYFSNRP 299 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT------SGGGTSSS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc------ChhhhcCC
Confidence 0 1456789999999999999999999999887 56665443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=360.02 Aligned_cols=267 Identities=19% Similarity=0.278 Sum_probs=201.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.++.++ +.||||++..... ...+.+. ++..++..+ +|+||+.+++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vAiK~~~~~~~~~~~~~~~~-~E~~~l~~l-~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTE------KNVAIKKVNRMFEDLIDCKRIL-REITILNRL-KSDYIIRLYDLIIP 96 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEECSTTTSHHHHHHHH-HHHHHHHHC-CCTTBCCEEEECCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCC------cEEEEEEeCchhcChHHHHHHH-HHHHHHHHc-CCCCcceEEEEEec
Confidence 478999999999999999999998765 4899999976422 2223333 334555555 69999999999876
Q ss_pred C-----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 120 N-----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 120 ~-----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
. +.+||||||++|+|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 5 57999999999999988854 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCC-------------------CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC----
Q 006772 195 IPYLLLGRSLS-------------------DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG---- 251 (632)
Q Consensus 195 lak~~~~~~~~-------------------~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG---- 251 (632)
+++........ .......+||+.|+|||++.. ...++.++|||||||++|||++|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL--QENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc--CCCCCcccccchHHHHHHHHHhccccc
Confidence 99876432111 012355689999999998743 23689999999999999999984
Q ss_pred -------CCCCCCCCH-----------------HHHHHHHHh------------------------hccCCCC-----CC
Q 006772 252 -------IQPWFGKSV-----------------EEIYHSVVI------------------------KKEKPCI-----PS 278 (632)
Q Consensus 252 -------~~PF~~~~~-----------------~ei~~~i~~------------------------~~~~p~~-----p~ 278 (632)
.++|.+.+. .+....+.. ....... .+
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 444444321 111111110 0001111 14
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccc
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLG 326 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~ 326 (632)
.+++++.+||.+||+.||++|||+.|+++ ++++....|....
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~------Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALD------HPYLKDVRKKKLE 374 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT------CGGGTTTCCTTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhc------ChhhhhccCcccC
Confidence 68999999999999999999999999886 7888877776544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=338.43 Aligned_cols=251 Identities=19% Similarity=0.301 Sum_probs=208.8
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+..++|++.+.||+|+||.||+|.+..++ ..||||++.+.... .....+.++..++..+ +|+||+.+++
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 81 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNK------FIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYN 81 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCC------cEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEE
Confidence 3456689999999999999999999987655 48999998643211 1122233344455555 6999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++..|+||||++| +|.+.+... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 82 YFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccc
Confidence 99999999999999985 888888654 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++...... ......||+.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+. ....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~ 229 (284)
T 2vgo_A 160 WSVHAPSL-----RRRTMCGTLDYLPPEMIEGK---THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDL 229 (284)
T ss_dssp TCEECSSS-----CBCCCCSCGGGCCHHHHTTC---CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCC
T ss_pred ccccCccc-----ccccccCCCCcCCHHHhccC---CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--cccc
Confidence 98764321 22345789999999998743 57889999999999999999999999988777766655 3455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+|..++.++.++|.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 678889999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=353.79 Aligned_cols=263 Identities=16% Similarity=0.210 Sum_probs=195.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHH--HHHH--------HHHHhhhccCCCc
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKV--FVNK--------FEELFPKFRESQS 109 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~--~~~~--------~~~il~~l~~h~~ 109 (632)
+..++|++.+.||+|+||.||+|.+...+ .....||||++.........+ +.++ +...+ ....|+|
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~-~~l~h~n 109 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKP---EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER-KQLDYLG 109 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSC---GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHH-HTCSCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCC---CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhh-ccccccC
Confidence 44578999999999999999999987632 233589999987653321111 1111 11112 3347999
Q ss_pred eeEeeEEEEE----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC
Q 006772 110 VCWLHGISVI----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185 (632)
Q Consensus 110 I~~l~~~~~~----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~ 185 (632)
|+.+++++.. +...||||||+.|+|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred cceeecccccccCCCcEEEEEEeccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 9999999988 7889999999977888877543 389999999999999999999999999999999999999988
Q ss_pred C--cEEEEecCCceeccCCCC----CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-
Q 006772 186 D--QLVLGDFGIPYLLLGRSL----SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK- 258 (632)
Q Consensus 186 g--~vkL~DFGlak~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~- 258 (632)
+ .+||+|||+++.+..... .........||+.|+|||++.+. .++.++|||||||++|||++|..||.+.
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV---ALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC---CCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC---CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 7 999999999987633211 11122445799999999998743 6899999999999999999999999653
Q ss_pred -CHHHHHHHHHhhccCCCCC---------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 259 -SVEEIYHSVVIKKEKPCIP---------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 259 -~~~ei~~~i~~~~~~p~~p---------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+......... .....+| ..+|+++.++|.+||+.||++||++.+|++.|+.+.
T Consensus 265 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPVAVQTAKT--NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHHHHHHHHH--HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccHHHHHHHH--hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 3322221111 1111122 278999999999999999999999999999887543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=352.83 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=200.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-----hhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-----EDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-----~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
++|++.+.||+|+||.||+|.+..++ ..||+|++.+.. ......+ .++..++..+ +||||+.+++++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~-~~E~~~l~~l-~hpniv~~~~~~ 97 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTR------AIRAIKIMNKNKIRQINPKDVERI-KTEVRLMKKL-HHPNIARLYEVY 97 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHC---CHHHHH-HHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCC------ceEEEeehhhhhhcccCHHHHHHH-HHHHHHHHhC-CCCCcceeehhh
Confidence 77999999999999999999987665 489999986431 1222333 3344555555 699999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------------------------------------CCCCCHHHHHHHHHHH
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR--------------------------------------GGKLPLPDILRYGIQL 158 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~--------------------------------------~~~l~~~~~~~ia~qI 158 (632)
..++..||||||++ |+|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999997 57777663110 1124677888999999
Q ss_pred HHHHHHHHhCCceeeeeeCCeEEEecCC--cEEEEecCCceeccCCCCC-CCccccccCCCccCCccccCCCCCCCCCcc
Q 006772 159 AKGISDLHSIGLLVLNLKPSNLLLSEHD--QLVLGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRGPISFE 235 (632)
Q Consensus 159 a~gL~yLHs~~IvHRDLKP~NILld~~g--~vkL~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g~~t~k 235 (632)
+.||+|||+++|+||||||+|||++.++ .+||+|||+++........ ........||+.|+|||++.+. ...++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-NESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-SSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-CCCCCcH
Confidence 9999999999999999999999998776 8999999999865332111 1123445799999999998643 3468899
Q ss_pred cccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 236 TDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 236 sDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+|||||||++|||++|..||.+.+..+....+.........+ ..+++++.+||.+||+.||.+||++.++++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999999988887777766544333322 348999999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.59 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=202.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.............++..++..+ +|+||+.+++++.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSG------LVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFY 101 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCC------cEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEE
Confidence 456689999999999999999999988665 489999997654333333344444555555 7999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.++..||||||++| +|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 99999999999985 888887654 4799999999999999999999996 9999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH-----------
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH----------- 265 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~----------- 265 (632)
+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...+..++..
T Consensus 180 ~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3eqc_A 180 GQLIDS-----MANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251 (360)
T ss_dssp HHHHHH-----C----CCCCTTCCHHHHTT---CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred cccccc-----cccCCCCCCCeECHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence 654221 2234578999999999974 368899999999999999999999998876544322
Q ss_pred -------------------------------HHHhhccCCCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 266 -------------------------------SVVIKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 266 -------------------------------~i~~~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+.. ...+..+ ..++.++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN-EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------------------CCCHHHHHHHHHH-SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCcccCCCcccccccCCCCcccchhhhhHHhc-cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111 1222222 457999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=342.23 Aligned_cols=260 Identities=22% Similarity=0.389 Sum_probs=199.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
...++|++.+.||+|+||.||+|.+..++ +.||||++...... .....+.++..++..+ +||||+.+++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~ 103 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRE------RIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFG 103 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTT------EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCC------eEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence 34579999999999999999999987655 48999998754322 1122233344455555 789999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..++..|+||||++| +|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence 999999999999985 888877654 47999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-CC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-PC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-p~ 275 (632)
........ .......||+.|+|||++.+ ..++.++|+||||+++|||++|..||.+.+...+...+...... ..
T Consensus 182 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 182 SATTDEKL--TQLGNTVGTLYYMAPERFSE---SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPST 256 (309)
T ss_dssp -----------------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGG
T ss_pred cccccccc--ccccccCCCcCccCHHHHcC---CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccc
Confidence 76533211 12234578999999999874 36788999999999999999999999987765444333321111 23
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCC-CHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRP-LMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RP-s~~ell~~Le~~~ 313 (632)
.+..+|+++.++|.+||+.||++|| ++.++++.|+...
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 4578999999999999999999999 9999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.34 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=205.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC-
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN- 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~- 120 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.............++..++..+ +|+||+.+++++..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTG------EIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCC------cEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccc
Confidence 378999999999999999999987655 489999997644333232233344555555 699999999987654
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 121 ----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 121 ----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
+..|+||||+.|+|.+.+.. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 83 FENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp STTCCCEEEEECCCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCccceEEEEEeccCccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67999999999998888765 47999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCC-------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006772 197 YLLLGRSLSD-------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 197 k~~~~~~~~~-------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~ 269 (632)
+......... .......||+.|+|||++.. ...++.++|+|||||++|||++|..||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT--SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHS--CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeecc--CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 8764321111 11233578999999998753 24688999999999999999999999999886654443332
Q ss_pred hccCC----------------------C--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 270 KKEKP----------------------C--------IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 270 ~~~~p----------------------~--------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
....+ . .+..+++++.+||.+||+.||++||++.++++ ++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~~ 311 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE------HPYLQT 311 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc------Cccccc
Confidence 11111 0 11468899999999999999999999999886 666655
Q ss_pred CCc
Q 006772 320 GEW 322 (632)
Q Consensus 320 ~~w 322 (632)
..+
T Consensus 312 ~~~ 314 (353)
T 2b9h_A 312 YHD 314 (353)
T ss_dssp TCC
T ss_pred cCC
Confidence 443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=347.65 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=191.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
++|++.+.||+|+||.||+|.++.++ +.||||++.............++..++..+ +||||+.+++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDD------CNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTC------CEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCC------cEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEecc
Confidence 57999999999999999999988665 489999997544433334444455566666 6999999999886543
Q ss_pred --------------------------------------------------------EEEEEEecCCC-CHHHHHHHhcC-
Q 006772 122 --------------------------------------------------------KICIAMKFYEG-SVGDRIAQQRG- 143 (632)
Q Consensus 122 --------------------------------------------------------~l~LVmEy~~G-sL~d~l~~~~~- 143 (632)
.+++||||++| +|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 38999999985 78887765422
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCC---------CCccccccC
Q 006772 144 GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLS---------DSDMALRLG 214 (632)
Q Consensus 144 ~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~---------~~~~~~~~G 214 (632)
...++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ ........|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 34566678999999999999999999999999999999999999999999999876433111 012234579
Q ss_pred CCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 006772 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEY 294 (632)
Q Consensus 215 T~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~ 294 (632)
|+.|+|||++.+. .++.++|+|||||++|||++|..|+.. ..+....+. ....+..+...++++.++|.+||+.
T Consensus 239 t~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 239 TKLYMSPEQIHGN---NYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp CGGGSCHHHHHCC---CCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred CcCccChHHhcCC---CCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh-ccCCCcccccCChhHHHHHHHHccC
Confidence 9999999999743 688999999999999999998776522 111222211 1122222245678899999999999
Q ss_pred CcCCCCCHHHHHH
Q 006772 295 DLRNRPLMADILH 307 (632)
Q Consensus 295 DP~~RPs~~ell~ 307 (632)
||++||++.++++
T Consensus 313 ~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 313 SPTERPEATDIIE 325 (332)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CCCcCCCHHHHhh
Confidence 9999999999887
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=335.32 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=205.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ ..||+|++.+........+.+ +..++..+ +|+||+.+++++..++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~-E~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTR------IRRAAKKIPKYFVEDVDRFKQ-EIEIMKSL-DHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCSCHHHHHH-HHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCC------cEEEEEeehhhccchHHHHHH-HHHHHHhC-CCCCEeeEEEEEecCCe
Confidence 57999999999999999999987665 489999987644333344444 33455555 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecCCcee
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFGlak~ 198 (632)
.|+||||++ |+|.+.+... +.+++.+++.++.|++.||+|||+++|+||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999998 4787877654 479999999999999999999999999999999999999 7889999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC-
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP- 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p- 277 (632)
.... .......||+.|+|||++.+ .++.++|+|||||++|||++|..||.+.+..+....+... ...+|
T Consensus 159 ~~~~----~~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 228 (277)
T 3f3z_A 159 FKPG----KMMRTKVGTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPE 228 (277)
T ss_dssp CCTT----SCBCCCCSCTTTCCHHHHTT----CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCH
T ss_pred ccCc----cchhccCCCCCccChHHhcc----cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCc
Confidence 5432 22234578999999999853 4788999999999999999999999998888777666533 33333
Q ss_pred ---CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 ---SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ---~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.++|.+||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 278999999999999999999999999885
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=338.79 Aligned_cols=262 Identities=19% Similarity=0.378 Sum_probs=197.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++.+.||+|+||.||+|.+..++ +.||||++.... .........++..++..+ +|+||+.+++++.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDG------VPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFI 102 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTC------CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCC------ceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE
Confidence 4568999999999999999999987655 489999997532 122222233333445555 6999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.++..++||||++| +|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 99999999999985 888877653 246799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhccC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--VEEIYHSVVIKKEK 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--~~ei~~~i~~~~~~ 273 (632)
++...... .......||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.. ..+....+......
T Consensus 183 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 183 GRFFSSKT---TAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256 (310)
T ss_dssp -------------------CCSSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred eeeecCCC---ccccccCCCeeEeChHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence 87653321 12234568999999999874 368899999999999999999999998753 33444444433333
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+..+..+++++.++|.+||+.||++||++.++++.|+.+...
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 333467899999999999999999999999999999887643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=367.15 Aligned_cols=247 Identities=21% Similarity=0.230 Sum_probs=194.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.+.. ......+.+ +..++..+ +|+||+.+++++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~-E~~~l~~l-~hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV-NHKNIISLLNVFTP 132 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTT------EEEEEEEEESGGGSHHHHHHHHH-HHHHHHHC-CCTTBCCCSEEECS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCC------CEEEEEEECccccChHHHHHHHH-HHHHHHhC-CCCCCCcEEEEEcc
Confidence 478999999999999999999988765 489999997542 222233333 33444554 79999999999865
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. ..+||||||++|++.+.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~~~~~~~lv~E~~~~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCccccCCeEEEEEeCCCCCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEE
Confidence 4 4689999999998887763 35899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 209 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 209 GLARTAGTS----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp CCC-----C----CCC----CCCTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeeeecCCC----cccCCCcccccccCHHHHcCC---CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999865321 223456899999999999753 6889999999999999999999999998877666655432211
Q ss_pred C--------------------CC---------CCC-----------CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 P--------------------CI---------PSG-----------LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p--------------------~~---------p~~-----------lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ .+ |.. .++++.+||.+||+.||++|||++|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 00 000 1567999999999999999999999886
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.83 Aligned_cols=278 Identities=22% Similarity=0.315 Sum_probs=214.2
Q ss_pred ccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc
Q 006772 30 VATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS 109 (632)
Q Consensus 30 ~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~ 109 (632)
.++....-..+..++|++.+.||+|+||.||+|.+..... ...++.||||++.............++..++..+ .|+|
T Consensus 17 ~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 94 (327)
T 2yfx_A 17 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 94 (327)
T ss_dssp EEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTT
T ss_pred CccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCC-CCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCC
Confidence 3334444456778999999999999999999998543211 1234689999997543332232233344555555 7999
Q ss_pred eeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 110 VCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG-----GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 110 I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~-----~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
|+.+++++..++..||||||++ |+|.+++..... ..+++.+++.++.||+.||.|||+++|+||||||+|||++
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~ 174 (327)
T 2yfx_A 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174 (327)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEe
Confidence 9999999999899999999996 588888876532 4589999999999999999999999999999999999999
Q ss_pred c---CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCC
Q 006772 184 E---HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259 (632)
Q Consensus 184 ~---~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~ 259 (632)
. +..+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+
T Consensus 175 ~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 175 CPGPGRVAKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CSSTTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCcceEEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 4 446999999998754332211 12233467999999999864 368899999999999999998 999999988
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+....+.. ...+..+..+++.+.++|.+||+.||.+||++.++++.|+.+..
T Consensus 251 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 251 NQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 8777666553 44556678899999999999999999999999999999887654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.85 Aligned_cols=256 Identities=19% Similarity=0.312 Sum_probs=203.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCC-----ceeEeeEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQ-----SVCWLHGI 116 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~-----~I~~l~~~ 116 (632)
.++|++.+.||+|+||+||+|.+..++ +.||||+++.... .... ...+..++..+.+|+ +++.+.++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~-~~~~-~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQ------EWVAIKIIKNKKA-FLNQ-AQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEECSSHH-HHHH-HHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCC------cEEEEEEEeccHH-HHHH-HHHHHHHHHHHHhcccccceeEEEeeee
Confidence 478999999999999999999987655 4899999975322 1222 223334445554555 48899999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCceeeeeeCCeEEEe--cCCcEEEEe
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS--IGLLVLNLKPSNLLLS--EHDQLVLGD 192 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs--~~IvHRDLKP~NILld--~~g~vkL~D 192 (632)
+...+.+||||||+.|+|.+++.....+.+++..++.++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|
T Consensus 125 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred eccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999999999999999987655679999999999999999999994 6899999999999995 478899999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 205 FG~a~~~~~------~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 205 FGSSCQLGQ------RIYQYIQSRFYRSPEVLLGM---PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CTTCEETTC------CCCSSCSCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccCceeccc------ccccccCCccccChHHHcCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999987532 22345789999999999743 688999999999999999999999999887776665553211
Q ss_pred CCC----------------CC------------------CC----------------------------CCHHHHHHHHH
Q 006772 273 KPC----------------IP------------------SG----------------------------LPPAVENVIIG 290 (632)
Q Consensus 273 ~p~----------------~p------------------~~----------------------------lp~~l~~LI~~ 290 (632)
.+. +| .. .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 110 00 00 01478999999
Q ss_pred hhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 291 CFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 291 cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
||+.||++|||+.|+++ ++++...
T Consensus 356 mL~~dP~~Rpta~e~L~------hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQ------HSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTT------SGGGCC-
T ss_pred hcCCChhhCCCHHHHhc------CcccccC
Confidence 99999999999999876 6666543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.92 Aligned_cols=259 Identities=19% Similarity=0.300 Sum_probs=211.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++...... ....+. ++..++..+ .||||+.++++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~-~E~~~l~~l-~h~~iv~~~~~ 83 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTG------LEYAAKFIKKRQSRASRRGVSREEIE-REVSILRQV-LHHNVITLHDV 83 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEBCSSSSCSSSBCHHHHH-HHHHHHHHC-CCTTBCCEEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCC------eEEEEEEEecccccccccchhHHHHH-HHHHHHHhC-CCCCcceEEEE
Confidence 67999999999999999999987655 48999999764321 123333 333455555 68999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC----cEEEE
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLG 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----~vkL~ 191 (632)
+..++..|+||||++ |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 999999999999997 588887754 35799999999999999999999999999999999999999888 79999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 162 Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 162 DFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp CCTTCEECCTT----CCCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred cCccceecCcc----ccccccCCCCCccCcccccC---CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 99999865432 12234578999999999874 368899999999999999999999999988877776665322
Q ss_pred cCC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccc
Q 006772 272 EKP--CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTG 324 (632)
Q Consensus 272 ~~p--~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~ 324 (632)
... .++..+++.+.++|.+||+.||++||++.++++ ++++...+|..
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~------hp~~~~~~~~~ 283 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR------HPWITPVDNQQ 283 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH------STTTSCSSHHH
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc------CccccCCCccc
Confidence 111 122578999999999999999999999999887 66676665543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.35 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=207.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++.+.||+|+||.||+|.+..++ +.||+|++.... .....+...++..++..+ .|+||+.+++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 85 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTK------EVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFE 85 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCC------ceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeec
Confidence 3468999999999999999999987665 489999986532 122223333344455555 7999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..++||||++ ++|.+++... +.+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 9999999999998 5777766543 479999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .......||+.|+|||++.+. .++.++|+||||+++|+|++|..||.+....+....+. .....+|
T Consensus 164 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~ 235 (294)
T 2rku_A 164 KVEYDG---ERKKVLCGTPNYIAPEVLSKK---GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIP 235 (294)
T ss_dssp ECCSTT---CCBCCCCSCCSSCCHHHHTTS---CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCC
T ss_pred ecccCc---cccccccCCCCcCCcchhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCc
Confidence 753221 122345789999999998743 57889999999999999999999999988777666554 3455678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.++|.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 899999999999999999999999999886
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=366.82 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=209.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..+..++|++.+.||+|+||.||+|.+..++ +.||||++.+.... .....+.++..++..+ +||||+.+++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~ 83 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTG------HKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQ 83 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTC------CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEE
Confidence 3455689999999999999999999988665 48999999653211 1112233333444444 6999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++...+.+||||||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 84 VISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999997 578887753 4579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... ......+||+.|+|||++.+.. ..+.++|||||||++|||++|..||.+.+..+++..+.. ...
T Consensus 162 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~ 233 (476)
T 2y94_A 162 LSNMMSDG----EFLRTSCGSPNYAAPEVISGRL--YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIF 233 (476)
T ss_dssp SCEECCTT----CCBCCCCSCSTTCCHHHHTTCC--BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--TCC
T ss_pred chhhcccc----ccccccCCCcCeEChhhccCCC--CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCc
Confidence 99875332 2234568999999999997541 236899999999999999999999999887777777653 345
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..|..+++++.+||.+||+.||.+||++.++++
T Consensus 234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 567889999999999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.74 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=180.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh--HHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC--AKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~--~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+..... ......++..++..+ +||||+.+++++..+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTG------LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDS 83 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECS
T ss_pred ccceeeeeecCCCceEEEEEEEccCC------ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccC
Confidence 58999999999999999999987655 489999986432111 112233333444554 689999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 121 GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 121 ~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
+..|+||||++| +|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999985 66666653 3467999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
.... .......||+.|+|||++.+. .++.++|+|||||++|||++|..||...+..+....+. ......|..
T Consensus 163 ~~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~ 234 (278)
T 3cok_A 163 KMPH---EKHYTLCGTPNYISPEIATRS---AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSF 234 (278)
T ss_dssp C----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTT
T ss_pred cCCC---CcceeccCCCCcCCcchhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccc
Confidence 3221 122345789999999998743 57889999999999999999999998876554443332 233456778
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++.++.++|.+||+.||++||++.++++
T Consensus 235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 235 LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 9999999999999999999999999886
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.09 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=207.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch----hhH---HHHHHHHHHHhhhccCCCceeEeeE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE----DCA---KVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~----~~~---~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
++|++.+.||+|+||.||+|.++.++ +.||||++..... ... ......+..++..+..||||+.+++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATG------HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCC------cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 46999999999999999999987655 4899999875431 111 2223344455666668999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++...+..|+||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999985 888877653 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCC---CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
++..+... ......+||+.|+|||++.+. ....++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 246 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 246 FSCHLEPG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp TCEECCTT----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cccccCCC----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 99875432 223446799999999998632 12357889999999999999999999999988777776665433
Q ss_pred cCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....| ..+++++.++|.+||+.||++||++.++++
T Consensus 322 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 332222 578899999999999999999999999887
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.71 Aligned_cols=268 Identities=20% Similarity=0.332 Sum_probs=205.5
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..++.++|++.+.||+|+||.||+|.+.... .....||+|+++... ......+.+ +..++..+ +||||+.+++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~-e~~~l~~l-~h~~iv~~~~ 103 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQED---GTSLKVAVKTMKLDNSSQREIEEFLS-EAACMKDF-SHPNVIRLLG 103 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTT---SCEEEEEEEEC---CCCHHHHHHHHH-HHHHHHTC-CCTTBCCCCE
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccC---CceeEEEEEEEeccccchhHHHHHHH-HHHHHhcC-CCCCeeeeeE
Confidence 3467789999999999999999999886543 234589999987543 222233333 33445555 6999999999
Q ss_pred EEEECC-----EEEEEEecCC-CCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC
Q 006772 116 ISVING-----KICIAMKFYE-GSVGDRIAQQ----RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185 (632)
Q Consensus 116 ~~~~~~-----~l~LVmEy~~-GsL~d~l~~~----~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~ 185 (632)
++...+ ..++||||++ |+|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC
Confidence 987654 3599999998 5888877543 23579999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHH
Q 006772 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIY 264 (632)
Q Consensus 186 g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~ 264 (632)
+.+||+|||+++........ .......+++.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..+..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp SCEEECSCSCC-----------------CCGGGSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CcEEEeecCcceeccccccc-CcccccCCCccccCchhhcC---CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 99999999999765332111 11223457889999999974 368899999999999999999 99999988877766
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 265 HSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 265 ~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
..+.. ...+..+..+++++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 260 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DYLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 65543 445667889999999999999999999999999999999887643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.12 Aligned_cols=246 Identities=20% Similarity=0.309 Sum_probs=189.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++..... .....++..++..+ .|+||+.+++++..++.
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQ------KPYALKVLKKTVD---KKIVRTEIGVLLRL-SHPNIIKLKEIFETPTE 122 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEC-------------CHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCC------cEEEEEEeccchh---HHHHHHHHHHHHhC-CCCCCcceeeeEecCCe
Confidence 56999999999999999999987655 4899999975432 22233333445555 68999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEecCCcee
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGDFGIPYL 198 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~DFGlak~ 198 (632)
.++||||++ |+|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 123 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999998 588887754 357999999999999999999999999999999999999975 88999999999876
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhhccCC--C
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE-IYHSVVIKKEKP--C 275 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e-i~~~i~~~~~~p--~ 275 (632)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+ ++..+....... .
T Consensus 201 ~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~ 273 (349)
T 2w4o_A 201 VEHQ----VLMKTVCGTPGYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP 273 (349)
T ss_dssp ----------------CGGGSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred cCcc----cccccccCCCCccCHHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence 5322 12234579999999999974 368899999999999999999999998766544 455554322221 2
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....++.++.+||.+||+.||++||++.++++
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23578999999999999999999999999887
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=342.17 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=197.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc-----CCCceeEeeEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR-----ESQSVCWLHGI 116 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~-----~h~~I~~l~~~ 116 (632)
.++|++.+.||+|+||.||+|.+.... ++.||||+++.... ....+ ..+..++..+. .+++++.++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~vavK~~~~~~~-~~~~~-~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAG-----GRHVAVKIVKNVDR-YCEAA-RSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEECSSHH-HHHHH-HHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCC-----CcEEEEEEEecCCc-hhHHH-HHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 478999999999999999999985422 25899999975432 22222 22333333332 34578999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec------------
Q 006772 117 SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE------------ 184 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~------------ 184 (632)
+..++..||||||+.|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 86 FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999999999999999998765567999999999999999999999999999999999999987
Q ss_pred -------CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC
Q 006772 185 -------HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257 (632)
Q Consensus 185 -------~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~ 257 (632)
++.+||+|||+++.... ......||+.|+|||++.+. .++.++|+|||||++|||++|..||.+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTTS---CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhCC---CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 66899999999976422 22345789999999999743 688999999999999999999999998
Q ss_pred CCHHHHHHHHHhhccCC------------------------------------------CCCCCCCHHHHHHHHHhhhcC
Q 006772 258 KSVEEIYHSVVIKKEKP------------------------------------------CIPSGLPPAVENVIIGCFEYD 295 (632)
Q Consensus 258 ~~~~ei~~~i~~~~~~p------------------------------------------~~p~~lp~~l~~LI~~cL~~D 295 (632)
.+..+....+....... ..+...++++.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 87665444332111100 011234578999999999999
Q ss_pred cCCCCCHHHHHH
Q 006772 296 LRNRPLMADILH 307 (632)
Q Consensus 296 P~~RPs~~ell~ 307 (632)
|.+||++.|+++
T Consensus 317 P~~Rpt~~ell~ 328 (339)
T 1z57_A 317 PAKRITLREALK 328 (339)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccccCHHHHhc
Confidence 999999999886
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.15 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=195.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE---
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV--- 118 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~--- 118 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++........+.+.++. .++..+ +|+||+.+++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~e~-~~l~~l-~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCD------KRVAIKKIVLTDPQSVKHALREI-KIIRRL-DHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTT------EEEEEEEEECCSHHHHHHHHHHH-HHHHTC-CCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCC------eEEEEEEEecCChHHHHHHHHHH-HHHHhc-CCCCeeEEEEeccccc
Confidence 478999999999999999999987655 48999999766544444444443 445555 7999999998863
Q ss_pred -----------ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-cCC
Q 006772 119 -----------INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-EHD 186 (632)
Q Consensus 119 -----------~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-~~g 186 (632)
..+..|+||||++|+|.+.+. .+.+++..++.++.||+.||+|||+++|+||||||+|||++ +++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYMETDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred cccccccccccccCceeEEeeccCCCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 347899999999999888774 35799999999999999999999999999999999999998 567
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~ 266 (632)
.+||+|||+++................||+.|+|||++... ..++.++|+|||||++|||++|+.||.+.+..+....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCc--ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999998654322222223445679999999988632 3688999999999999999999999999887666555
Q ss_pred HHhhccC-----------------------CC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 267 VVIKKEK-----------------------PC-----IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 267 i~~~~~~-----------------------p~-----~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+...... +. .+..+++++.++|.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 4422110 11 12468999999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.57 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=201.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+.+.|++.+.||+|+||.||+|.+..++ ..||+|.+..... ......+.++..++..+ .|+||+.+++++.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~------~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWE 95 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCc------eEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeec
Confidence 34567999999999999999999987665 4899999865321 22222233344555555 6999999999886
Q ss_pred E----CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEe-cCCcEEE
Q 006772 119 I----NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLS-EHDQLVL 190 (632)
Q Consensus 119 ~----~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld-~~g~vkL 190 (632)
. +..+|+||||++ |+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 5 466899999997 5888887654 47999999999999999999999999 99999999999998 7899999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~ 269 (632)
+|||++..... .......||+.|+|||++. +.++.++|+|||||++|+|++|..||.... .......+..
T Consensus 174 ~Dfg~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 174 GDLGLATLKRA-----SFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp CCTTGGGGCCT-----TSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred eeCCCcccccc-----cccccccCCcCcCCHHHHh----ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 99999864322 2223457899999999885 358899999999999999999999998854 4445544443
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
......++...++++.++|.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 33344456778899999999999999999999999886
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=347.94 Aligned_cols=268 Identities=21% Similarity=0.285 Sum_probs=205.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.+.||+|+||.||+|.+..++ +.||||++..........+.+ +..++..+ .|+||+.+++++
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~-E~~~l~~l-~h~~iv~~~~~~ 95 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDG------HFYALKRILCHEQQDREEAQR-EADMHRLF-NHPNILRLVAYC 95 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTC------CEEEEEEEEESSHHHHHHHHH-HHHHHHTC-CCTTBCCCCEEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCC------cEEEEEEEecCCHHHHHHHHH-HHHHHhhc-CCCCeeeEEEEE
Confidence 3467789999999999999999999987655 489999987654444444433 33445554 799999999988
Q ss_pred EE----CCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 118 VI----NGKICIAMKFYEG-SVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 118 ~~----~~~l~LVmEy~~G-sL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
.. .+..|+||||+.| +|.+++... .+..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 63 3478999999985 888888764 3467999999999999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCCCC------CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH--HH
Q 006772 191 GDFGIPYLLLGRSLSD------SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV--EE 262 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~------~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~--~e 262 (632)
+|||++.......... .......||+.|+|||++.+.....++.++|||||||++|||++|..||..... ..
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999987642211000 011234579999999998754333468899999999999999999999964211 11
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 263 i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
....+ ........+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 256 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 256 VALAV-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHH-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhHHh-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11112 2223334456789999999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=338.25 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=206.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|++.+.||+|+||.||+|.+..++ +.||||++...........+.++..++..+ .|+||+.+++++..++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQ------KVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCC------cEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCe
Confidence 67999999999999999999987655 489999997543222222233333455555 78999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++| +|.+++. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999986 7777663 35799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
.. .......||+.|+|||++.+ ..++.++|+|||||++|||++|..||......+....+. ....+.++..++
T Consensus 172 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (303)
T 3a7i_A 172 TQ---IKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYS 244 (303)
T ss_dssp TB---CCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCC
T ss_pred cc---cccCccCCCcCccCHHHHhc---CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccC
Confidence 21 12234578999999999974 367889999999999999999999999888776655543 345566778899
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.++.++|.+||+.||++||++.++++
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=351.19 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=198.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++..... ........++..++..+ +|+||+.+++++..+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTG------AKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC------CEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCC------CEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecC
Confidence 478999999999999999999987765 4899999865322 22222233334555555 599999999998765
Q ss_pred ------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 121 ------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 121 ------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
..+|+||||+.++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CccccCceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 34699999998888887754 479999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++.... ......||+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+.+..+......+
T Consensus 174 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 174 LARQADS------EMTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp TCEECCS------SCCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccc------ccCcCcCCCCcCCHHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9986432 23345789999999998742 368899999999999999999999999988766555544211111
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 275 -----------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 275 -----------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
.+...+++++.+||.+||+.||.+|||+.++++ ++++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~------hp~f~~~ 314 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA------HPYFESL 314 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGTTT
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc------ChHHHhh
Confidence 123567899999999999999999999999887 5666543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.72 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=205.4
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...++.++|++.+.||+|+||.||+|.+.. +.||||++.... ..+.+.+ +..++..+ +|+||+.++++
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~--~~~~~~~-E~~~l~~l-~h~~iv~~~~~ 82 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA--TAQAFLA-EASVMTQL-RHSNLVQLLGV 82 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETT--------EEEEEEECCCCC----HHHHH-THHHHTTC-CCTTBCCEEEE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcC--------CEEEEEEecchh--HHHHHHH-HHHHHHhC-CCCCEeeEEEE
Confidence 345778999999999999999999998742 479999987543 2233333 33445555 69999999998
Q ss_pred EEEC-CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 117 SVIN-GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 117 ~~~~-~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
+... +..|+||||++| +|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence 6544 578999999985 88888876543458999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++..... .....+|+.|+|||++.+ ..++.++|+||||+++|||++ |..||...+..+....+. ....
T Consensus 163 ~~~~~~~~------~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~ 232 (278)
T 1byg_A 163 LTKEASST------QDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYK 232 (278)
T ss_dssp C------------------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCC
T ss_pred cccccccc------ccCCCccccccCHHHhCC---CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCC
Confidence 98754321 123357889999999864 368899999999999999998 999999887766665554 3445
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+..+..+++++.++|.+||+.||++||++.++++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 667889999999999999999999999999999999887643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.18 Aligned_cols=265 Identities=20% Similarity=0.329 Sum_probs=200.8
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-CCE
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-NGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-~~~ 122 (632)
.|++.+.||+|+||.||+|.+...+. ....||+|.+...........+.++..++..+ +||||+.+++++.. ++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTT---EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCC---cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence 47889999999999999998764331 23479999987644333233333344455555 79999999998654 568
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++ |+|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred eEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 899999998 488877754 345789999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCC-CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCCCC
Q 006772 202 RSLSD-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279 (632)
Q Consensus 202 ~~~~~-~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p~~ 279 (632)
..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..++...+. ....+..|..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~ 320 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY 320 (373)
T ss_dssp -------------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTT
T ss_pred cccccccccCCCCCcccccChHHhcC---CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 22111 11233457889999999874 368899999999999999999 788888776555554444 3445566788
Q ss_pred CCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhccc
Q 006772 280 LPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVY 317 (632)
Q Consensus 280 lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~ 317 (632)
+|+++.++|.+||+.||++||++.++++.|+.+...+.
T Consensus 321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999999998876554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=345.79 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=207.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
..++|++.+.||+|+||.||+|.+..++ +.||+|++.... .....+.+.++..++..+ .|+||+.+++++.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 111 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTK------EVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFE 111 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence 3478999999999999999999987665 489999986532 122223333344445554 7999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++.+|+||||++ ++|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 9999999999998 5777776543 479999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .......||+.|+|||++.+. .++.++|+|||||++|||++|..||......+.+..+. .....+|
T Consensus 190 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~ 261 (335)
T 2owb_A 190 KVEYDG---ERKKVLCGTPNYIAPEVLSKK---GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIP 261 (335)
T ss_dssp ECCSTT---CCBCCCCSCCSSCCHHHHHTS---CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCC
T ss_pred ecccCc---ccccccCCCccccCHHHhccC---CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCC
Confidence 753221 222345789999999998743 57889999999999999999999999988777666554 3455678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+++++.+||.+||+.||++||++.++++
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 899999999999999999999999999886
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.00 Aligned_cols=258 Identities=18% Similarity=0.365 Sum_probs=198.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
++|++.+.||+|+||.||+|.+. + +.||||++.... ......+.+.......+|+||+.+++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~------~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--G------EKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--T------EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEEC--C------ceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 68999999999999999999875 2 489999986432 2233333333333345899999999999887
Q ss_pred --CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeeeeeCCeEEEecCCcEE
Q 006772 121 --GKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI--------GLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 121 --~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~--------~IvHRDLKP~NILld~~g~vk 189 (632)
+.+|+||||++| +|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 789999999985 88888754 3799999999999999999999999 999999999999999999999
Q ss_pred EEecCCceeccCCCCC-CCccccccCCCccCCccccCCCCCCCC---CcccccchhHHHHHHHHhC----------CCCC
Q 006772 190 LGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRGPI---SFETDTWGFGCSIMEMLTG----------IQPW 255 (632)
Q Consensus 190 L~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g~~---t~ksDvwSlGvvL~EmltG----------~~PF 255 (632)
|+|||+++........ ........||+.|+|||++.+...... +.++|||||||++|||++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999765332211 111234579999999999975421110 1249999999999999999 7787
Q ss_pred CCC-----CHHHHHHHHHhhccCCCCCC-----CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 256 FGK-----SVEEIYHSVVIKKEKPCIPS-----GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 256 ~~~-----~~~ei~~~i~~~~~~p~~p~-----~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
... ........+......+.+|. .+++++.++|.+||+.||++||++.++++.|+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 653 22333333333344455553 466789999999999999999999999999988764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.68 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=186.1
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEee
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
....++.++|++.+.||+|+||.||+|.+..++ +.||||++...... ....+..+... +.+..+|+||+.++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~~~~h~niv~~~ 87 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSG------QIMAVKRIRSTVDEKEQKQLLMDLDV-VMRSSDCPYIVQFY 87 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTT------EEEEEEEEECCCCHHHHHHHHHHHHH-HHSSCCCTTBCCEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCC------CEEEEEEeecccCchHHHHHHHHHHH-HHHcCCCCcEeeee
Confidence 334577899999999999999999999987655 48999999765332 22333333332 34455899999999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEE
Q 006772 115 GISVINGKICIAMKFYEGSVGDRIAQQ---RGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~GsL~d~l~~~---~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL 190 (632)
+++..++..+|||||+.|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 999999999999999999888877642 246899999999999999999999999 9999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCC-CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVV 268 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~ 268 (632)
+|||+++..... .......||+.|+|||++... ....++.++|+|||||++|||++|..||.+.... +....+.
T Consensus 168 ~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (327)
T 3aln_A 168 CDFGISGQLVDS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243 (327)
T ss_dssp CCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC
T ss_pred ccCCCceecccc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh
Confidence 999998765322 112234689999999998432 1345889999999999999999999999875432 2211111
Q ss_pred hhccCCCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 IKKEKPCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ~~~~~p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+.++ ..+++++.+||.+||+.||++||++.++++
T Consensus 244 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 -KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 12222222 468999999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.73 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=199.2
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.+.||+|+||.||+|.+.. +.||||.+.... ..+.+.++ ..++..+ +||||+.+++++
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~--~~~~~~~E-~~~l~~l-~hp~iv~~~~~~ 70 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRA--------KDVAIKQIESES--ERKAFIVE-LRQLSRV-NHPNIVKLYGAC 70 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETT--------EEEEEEECSSTT--HHHHHHHH-HHHHHHC-CCTTBCCEEEBC
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECC--------eeEEEEEecChh--HHHHHHHH-HHHHhcC-CCCCcCeEEEEE
Confidence 35778899999999999999999998752 479999986432 22333333 3445555 799999999876
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeeeeeCCeEEEecCCc-EEEE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHS---IGLLVLNLKPSNLLLSEHDQ-LVLG 191 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs---~~IvHRDLKP~NILld~~g~-vkL~ 191 (632)
. +..|+||||++ |+|.+++..... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++. +||+
T Consensus 71 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp T--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred c--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 5 45899999998 588888764322 247899999999999999999999 89999999999999998886 7999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS--VEEIYHSVVI 269 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~--~~ei~~~i~~ 269 (632)
|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+...+ .
T Consensus 149 Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~ 218 (307)
T 2eva_A 149 DFGTACDIQT------HMTNNKGSAAWMAPEVFEG---SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-H 218 (307)
T ss_dssp CCCC------------------CCTTSSCHHHHTC---CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-H
T ss_pred cccccccccc------ccccCCCCCceEChhhhCC---CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-h
Confidence 9999875422 1223468999999999974 368899999999999999999999998643 22333332 3
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 270 ~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
....+..+..+|+.+.++|.+||+.||++||++.++++.|+.+...+
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 34556677889999999999999999999999999999998876544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.61 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=180.3
Q ss_pred CCeEEE---eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLK---HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~---~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++. +.||+|+||.||+|.++.++ +.||||++.+... .. ..++..++..+.+||||+.+++++..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~---~~-~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSN------QAFAVKIISKRME---AN-TQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTC------CEEEEEEEEGGGH---HH-HHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCC------CEEEEEEEChhhh---hh-HHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 356665 78999999999999998765 4899999965322 22 23344556677779999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cEEEEecCC
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGI 195 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~vkL~DFGl 195 (632)
++..||||||++| +|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred CCEEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 9999999999985 88888765 35799999999999999999999999999999999999998766 899999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-------HHHHHHHH
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-------EEIYHSVV 268 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-------~ei~~~i~ 268 (632)
++..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+. .++...+.
T Consensus 156 a~~~~~~---~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~ 229 (325)
T 3kn6_A 156 ARLKPPD---NQPLKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229 (325)
T ss_dssp CEECCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT
T ss_pred ceecCCC---CCcccccCCCcCccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH
Confidence 9865332 122344578999999999874 3688999999999999999999999987432 34444443
Q ss_pred hhccCCCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 IKKEKPCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ~~~~~p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. ....++ ..+++++.+||.+||+.||.+||++.++++
T Consensus 230 ~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 230 K--GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp T--TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred c--CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2 222223 368999999999999999999999998775
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.56 Aligned_cols=247 Identities=21% Similarity=0.342 Sum_probs=203.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|++..........+ .++..++..+ +||||+.+++++..++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~-~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTG------KLFALKCIKKSPAFRDSSL-ENEIAVLKKI-KHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEECC------HH-HHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred ccceeeeeccCCCCceEEEEEECCCC------CEEEEEEEecccccchHHH-HHHHHHHHhC-CCCCeeehhhhcccCCE
Confidence 67999999999999999999987655 4899999976543333333 3333455555 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecCCcee
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFGlak~ 198 (632)
.|+||||++ |+|.+.+... +.+++..++.++.|++.||+|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999998 5888887654 479999999999999999999999999999999999999 7889999999999865
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--CCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK--PCI 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~--p~~ 276 (632)
... .......||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+....+...... ...
T Consensus 159 ~~~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 159 EQN-----GIMSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230 (304)
T ss_dssp CCC-----BTTHHHHSCCCBCCTTTBSS---CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred cCC-----CccccccCCCCccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 321 12234568999999999974 36889999999999999999999999998888777766644322 223
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+++++.++|.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4678999999999999999999999999886
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.15 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=189.0
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.+..++|++.+.||+|+||.||+|.+..++ +.||||++...... .......++..+ .+..+|+||+.+++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~-~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTG------HVIAVKQMRRSGNKEENKRILMDLDVV-LKSHDCPYIVQCFGTF 93 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTC------CEEEEEEEETTSCHHHHHHHHHHHHHH-HHTTTCTTBCCEEEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCC------eEEEEEEecccccchHHHHHHHHHHHH-HHhcCCCceeeEEEEE
Confidence 355689999999999999999999987655 48999999765432 223333333333 3455899999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..++.+|+||||+.+. .+.+.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~-~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 94 ITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp ECSSEEEEEECCCSEE-HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCcEEEEEeccCCc-HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 9999999999999544 4444444456899999999999999999999995 9999999999999999999999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhccC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVVIKKEK 273 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~i~~~~~~ 273 (632)
+..... .......||+.|+|||++... ....++.++|||||||++|||++|..||... ...+....+.. ...
T Consensus 173 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~ 247 (318)
T 2dyl_A 173 GRLVDD----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEP 247 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCC
T ss_pred hhccCC----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCC
Confidence 765322 112334689999999998532 1345788999999999999999999999874 34444444442 333
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+ ..+++++.++|.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 4344 468999999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=351.66 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=199.3
Q ss_pred CeEE--EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKL--KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l--~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.|++ .+.||+|+||.||+|.+..++ +.||+|+++.......+.+. ++..++..+ +|+||+.+++++...+
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g------~~vavK~~~~~~~~~~~~~~-~E~~~l~~l-~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATG------LKLAAKIIKTRGMKDKEEVK-NEISVMNQL-DHANLIQLYDAFESKN 159 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTC------CEEEEEEEECCSHHHHHHHH-HHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCC------cEEEEEEEcccccccHHHHH-HHHHHHHhC-CCCCCCeEEEEEEECC
Confidence 3444 678999999999999987665 48999999876544444444 344555555 7999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE--ecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL--SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl--d~~g~vkL~DFGlak~ 198 (632)
.+||||||++ |+|.+.+... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 9999999998 5777877653 3479999999999999999999999999999999999999 4667999999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--C
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--I 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~ 276 (632)
.... ......+||+.|+|||++.. ..++.++|||||||++|||++|..||.+.+..+....+........ .
T Consensus 239 ~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 239 YKPR----EKLKVNFGTPEFLAPEVVNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp CCTT----CBCCCCCSSCTTCCHHHHTT---CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred cCCc----cccccccCCCcEeChhhccC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 6432 12234579999999999864 3688999999999999999999999999988877777664432221 1
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+++++.+||.+||+.||.+||++.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2578999999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=373.27 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=214.3
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...|..++|++.++||+|+||.||+|.+... ..||||+++..... .+.+.+ +..++..+ +|+||+.++++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~~-~~~~~~-E~~~l~~l-~hpniv~~~~~ 330 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTMS-PEAFLQ-EAQVMKKL-RHEKLVQLYAV 330 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTT-------EEEEEEEECTTSSC-HHHHHH-HHHHHHHC-CCTTBCCEEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCC-------ceEEEEEeCCCCCC-HHHHHH-HHHHHHhC-CCCCEeeEEEE
Confidence 3447789999999999999999999998643 36999999764432 234444 34555555 69999999998
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+.. +.+||||||+. |+|.+++....+..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 765 67899999998 5899988765456799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++....... .......+|..|+|||++.. +.++.++|||||||+||||++ |..||.+....++...+. ...+.
T Consensus 410 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~ 483 (535)
T 2h8h_A 410 ARLIEDNEY--TARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRM 483 (535)
T ss_dssp TTTCCCHHH--HTTCSTTSCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCC
T ss_pred ceecCCCce--ecccCCcCcccccCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 976432110 11122356789999999863 468999999999999999999 999999998888777665 34455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..+..+++++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 667899999999999999999999999999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.20 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=199.9
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
..+..++|++.+.||+|+||.||+|.+..++ +.||||++..... .....+ .++..++..+ +|+||+.++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~-~~e~~~l~~l-~h~~i~~~~ 77 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG------HKVAVKILNRQKIRSLDVVGKI-KREIQNLKLF-RHPHIIKLY 77 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHH-HHHHHHHHTC-CCTTBCCEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCC------ceEEEEEeccccccchhHHHHH-HHHHHHHhcC-CCCCEeEEE
Confidence 3456689999999999999999999987655 4899999864321 111222 3333444444 699999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++..++..|+||||++ ++|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 78 QVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999998 5888888654 47999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|++...... .......||+.|+|||++.+. ...+.++|+||||+++|+|++|..||...+..+....+. ...
T Consensus 156 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~ 227 (276)
T 2h6d_A 156 GLSNMMSDG----EFLRTSCGSPNYAAPEVISGR--LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGV 227 (276)
T ss_dssp CGGGCCCC-----------------CCTGGGTTS--CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCC
T ss_pred ccccccCCC----cceecccCCccccCHHHHcCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCc
Confidence 998765322 112345689999999998743 123689999999999999999999999988777766654 344
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+|..++.++.++|.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 5567889999999999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=333.34 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=200.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.............++..++..+ +|+||+.+++++..++.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCC------cEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCE
Confidence 57999999999999999999987655 489999986543322233334444455554 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.|+||||++| +|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999985 77776643 35799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhccCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~~~p~~p~~l 280 (632)
... ........||+.|+|||++.+. ..++.++|+|||||++|||++|..||.+.+.. ..+...............+
T Consensus 158 ~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (276)
T 2yex_A 158 NNR-ERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234 (276)
T ss_dssp TTE-ECCBCCCCSCGGGCCGGGGTCS--SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred Ccc-hhcccCCccccCccChHHHhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhc
Confidence 211 1122345789999999998743 12477899999999999999999999876533 2233333222222223578
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++++.++|.+||+.||.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 235 DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 999999999999999999999999876
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.68 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=203.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------------hHHHHHHHHHHHhhhccCCCce
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------------CAKVFVNKFEELFPKFRESQSV 110 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------------~~~~~~~~~~~il~~l~~h~~I 110 (632)
++|++.++||+|+||.||+|.++.++ +.||||++.+.... ...+.+..+..++..+ +||||
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni 108 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGH------SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNI 108 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTC------CEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTB
T ss_pred cceEEEeEecccCCeEEEEEEECCCC------cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCC
Confidence 68999999999999999999998765 48999999764321 1112233334555555 69999
Q ss_pred eEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---
Q 006772 111 CWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD--- 186 (632)
Q Consensus 111 ~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g--- 186 (632)
+.+++++..++.+||||||++ |+|.+.+... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999998 5888888654 4799999999999999999999999999999999999999876
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~ 266 (632)
.+||+|||+++..... ......+||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+..++...
T Consensus 187 ~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258 (504)
T ss_dssp SEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cEEEEECCCCEEcCCC----CccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 6999999999875432 2234457999999999985 3588999999999999999999999999998888877
Q ss_pred HHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 267 VVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 267 i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.........+ ..+|+++.+||.+||+.||.+|||+.++++
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 76433222211 578999999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=339.72 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=204.0
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|++..........+.++. .++..+ +||||+.+++++..++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~e~-~~l~~l-~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETG------ALAAAKVIETKSEEELEDYIVEI-EILATC-DHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTC------CEEEEEEEC----CCHHHHHHHH-HHHHHC-CCTTBCCEEEEEECC-
T ss_pred ccceeecceeccCCCeEEEEEEEcCCC------cEEEEEEecCCCHHHHHHHHHHH-HHHhcC-CCCCEeeeeeeeeeCC
Confidence 378999999999999999999987655 48999998765444444444443 444554 7999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 122 KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 122 ~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
..++||||++| +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999986 55555544 34679999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-CCCC
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-PCIP 277 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-p~~p 277 (632)
.. ........||+.|+|||++... ....++.++|+|||||++|||++|..||...+..+....+...... ...+
T Consensus 169 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 169 KT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp HH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred cc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 11 0112234689999999998421 1346789999999999999999999999998877665555433222 2235
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
..++.++.++|.+||+.||++||++.++++ ++++....|
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~ 284 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE------HPFVSSITS 284 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT------STTTTTCCC
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc------ChHHhhhcc
Confidence 678999999999999999999999999876 556655444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=362.64 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=201.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.++.++ ..||||++.+.. ......+ .++..++..+ +||||+.+++++...
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~-~~E~~~l~~l-~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTH------VERAIKIIRKTSVSTSSNSKL-LEEVAVLKLL-DHPNIMKLYDFFEDK 108 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTC------CEEEEEEEEC-----CTTHHH-HHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCC------cEEEEEEEeccccCchHHHHH-HHHHHHHHhC-CCCCCCeEEEEEEeC
Confidence 46999999999999999999998765 489999997543 1222333 3333455554 799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC---CcEEEEecCCc
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH---DQLVLGDFGIP 196 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~---g~vkL~DFGla 196 (632)
+.+||||||+. |+|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+|||++.. +.+||+|||++
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999998 5888887654 479999999999999999999999999999999999999764 45999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
+..... ......+||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+..++...+.........
T Consensus 187 ~~~~~~----~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 187 AVFENQ----KKMKERLGTAYYIAPEVLR----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp EECBTT----BCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred eECCCC----ccccccCCCcCeeCHHHHc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 875432 2234467999999999985 35889999999999999999999999999988888777654433332
Q ss_pred C--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 P--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ ..+++++.+||.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2 478999999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=360.56 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=194.1
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-------hhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-------DCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-------~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.+... ......+.++..++.++ +||||+.++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~ 206 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTC------KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIK 206 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCC------cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEE
Confidence 478999999999999999999988765 4899999865321 01111123334455555 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC---cEEE
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD---QLVL 190 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g---~vkL 190 (632)
+++. .+..|+||||++ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence 9874 567899999998 577776643 45799999999999999999999999999999999999997544 5999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVI 269 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~ 269 (632)
+|||+++..... ......+||+.|+|||++.+.....++.++|+|||||++|||++|..||.+.... .....+..
T Consensus 284 ~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 284 TDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp CCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred eecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 999999765321 2234467999999999986533457889999999999999999999999875432 22233322
Q ss_pred hccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 270 KKEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 270 ~~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
..... ....+++++.+||.+||+.||++||++.++++ ++++.+.+|.
T Consensus 360 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~~~~ 409 (419)
T 3i6u_A 360 -GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR------HPWLQDEDMK 409 (419)
T ss_dssp -TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGCCHHHH
T ss_pred -CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC------CcccCChhHH
Confidence 22211 12578999999999999999999999999887 6666655443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=341.21 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=188.8
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.+.||+|+||.||+|.+..++ +.||||.+...........+.++..++..+ +||||+.+++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 82 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKK------EKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSF 82 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCC-CCTTBCCEEEEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCC------cEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEE
Confidence 4477899999999999999999999977554 489999986543222222222333344444 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQ------RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~------~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL 190 (632)
..++..++||||++ |+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 99999999999997 5888877642 2356999999999999999999999999999999999999999999999
Q ss_pred EecCCceeccCCCC--CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 006772 191 GDFGIPYLLLGRSL--SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV 268 (632)
Q Consensus 191 ~DFGlak~~~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~ 268 (632)
+|||++........ .........||+.|+|||++.+. ..++.++|+|||||++|||++|..||...+..+......
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 240 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHH--HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccc--cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence 99999876532211 11112345789999999998631 247889999999999999999999999877655444333
Q ss_pred hhccC--------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 IKKEK--------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ~~~~~--------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..... +.....+++++.++|.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 22111 1223567899999999999999999999999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=342.82 Aligned_cols=270 Identities=20% Similarity=0.351 Sum_probs=208.7
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..+..++|++.+.||+|+||.||+|.+..... ..++.||||++........+.+.++ ..++..+ +|+||+.+++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~ 111 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD--NTGEVVAVKKLQHSTEEHLRDFERE-IEILKSL-QHDNIVKYKGVC 111 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSS--SCCEEEEEEEESSCCSHHHHHHHHH-HHHHHTC-CCTTBCCEEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccC--CCceEEEEEEeccCCHHHHHHHHHH-HHHHHhC-CCCCeeeEEEEE
Confidence 44566889999999999999999998643211 2346899999987554444444443 3455555 699999999987
Q ss_pred EEC--CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 118 VIN--GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 118 ~~~--~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
... ..+++||||++ |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 654 37899999998 5888887654 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH------------H
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE------------E 262 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~------------e 262 (632)
+++................+|..|+|||++.+. .++.++|||||||++|||++|..||...... .
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES---KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCC---CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 998764322111112234578889999998743 5788999999999999999999998643111 0
Q ss_pred ---HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 263 ---IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 263 ---i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
...........+..+..+|+++.++|.+||+.||++||++.++++.|+.+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11122223345566788999999999999999999999999999999887643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.00 Aligned_cols=264 Identities=13% Similarity=0.146 Sum_probs=200.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCc--ccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCcee--------
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDF--DEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVC-------- 111 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~--~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~-------- 111 (632)
.++|++.+.||+|+||.||+|.+..+.... ..++.||||++..... + .++..++..+ .|+||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~-----~-~~E~~~l~~l-~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGR-----L-FNEQNFFQRA-AKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTST-----H-HHHHHHHHHH-CCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccch-----H-HHHHHHHHHh-cccchhhhhhhhcc
Confidence 479999999999999999999987642100 0235899999975421 1 1222333333 355544
Q ss_pred -------EeeEEEEE-CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 112 -------WLHGISVI-NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 112 -------~l~~~~~~-~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
.+++++.. ++..||||||+.|+|.+++.......+++.+++.++.||+.||+|||+++|+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 46777776 7899999999977999998765456899999999999999999999999999999999999999
Q ss_pred cCC--cEEEEecCCceeccCCCC----CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC
Q 006772 184 EHD--QLVLGDFGIPYLLLGRSL----SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257 (632)
Q Consensus 184 ~~g--~vkL~DFGlak~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~ 257 (632)
.++ .+||+|||+++....... .........||+.|+|||++.+. .++.++|||||||++|||++|..||.+
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC---GPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC---CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998 999999999976533211 11122345799999999999743 688999999999999999999999987
Q ss_pred CC--HHHHHHHHHh-hccCCCCC------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 258 KS--VEEIYHSVVI-KKEKPCIP------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 258 ~~--~~ei~~~i~~-~~~~p~~p------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
.. ...+...... ....+.++ ..+++++.++|.+||+.||++||++.++++.|+.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 53 3333322221 12222222 25699999999999999999999999999999887654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.93 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=201.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
|--.++|++.+.||+|+||.||+|.+..++ +.||||++...... .......++..++..+ +|+||+.+++++
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 110 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSG------EKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVF 110 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEE
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCC------CEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhhe
Confidence 333478999999999999999999988765 48999999754322 1122223333445555 699999999999
Q ss_pred EECCEE------EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 118 VINGKI------CIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 118 ~~~~~l------~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
...+.. |+||||+.|+|.+.+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQTDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCCEEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eccCCcccceeEEEEEccccccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEE
Confidence 876654 999999999887765 3469999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++.... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 187 Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 258 (371)
T 4exu_A 187 DFGLARHADA------EMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258 (371)
T ss_dssp STTCC--------------CTTCCCTTSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ecCccccccc------CcCCcccCccccCHHHhcCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999875422 22345789999999998742 368899999999999999999999999988766655554221
Q ss_pred cCC-----------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 272 EKP-----------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 272 ~~p-----------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
..+ ..+..+++++.+||.+||+.||++||++.++++ ++++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~ 330 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT------HPFFEPF 330 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTTT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc------CcccccC
Confidence 111 012467899999999999999999999999886 6666543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.62 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=196.3
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+..++|++.+.||+|+||.||+|.+.. ++.||||++...........+.++..++..+ .|+||+.+++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 97 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM 97 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSS-------SCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEEC
T ss_pred HHHhhccccceeEecCCCcEEEEEEecC-------CCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEe
Confidence 3556899999999999999999997432 2479999997643222111223333445554 6999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CceeeeeeCCeEEEecCCcEEEEe
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSI---GLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~---~IvHRDLKP~NILld~~g~vkL~D 192 (632)
.++..++||||+.| +|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999985 8888876543 23599999999999999999999999 999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-----VEEIYHSV 267 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-----~~ei~~~i 267 (632)
||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.... .......+
T Consensus 178 fg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 178 FGLAKLMDYKD--THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CSSCEECCSSS--SCEECCCCSCGGGCCHHHHHH---SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred CccccccCccc--ccccccccCCcCccCHHHhcc---CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99998753321 122234569999999999864 357899999999999999999999995211 00011111
Q ss_pred Hh---h---------ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 268 VI---K---------KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 268 ~~---~---------~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
.. . .....++...+.++.+++.+||+.||.+||++.++++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 0 00011122334789999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=364.49 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=207.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.++|++.+.||+|+||.||+|.++.++ +.||||++.+.. ......+. ++..++..+ +||||+.+++++.
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~-~E~~~l~~l-~hpniv~~~~~~~ 96 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITG------QECAVKVISKRQVKQKTDKESLL-REVQLLKQL-DHPNIMKLYEFFE 96 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCCBSSCHHHHH-HHHHHHTTC-CCTTBCCEEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCC------CEEEEEEEEhhhcccchHHHHHH-HHHHHHHhC-CCCCCCcEEEEEE
Confidence 468999999999999999999988765 489999986532 22233333 344555555 7999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE---ecCCcEEEEecC
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL---SEHDQLVLGDFG 194 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl---d~~g~vkL~DFG 194 (632)
..+.+|+||||+. |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 9999999999998 688887754 3579999999999999999999999999999999999999 567899999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.......
T Consensus 175 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 175 LSTHFEAS----KKMKDKIGTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp HHHHBCCC----CSHHHHTTGGGTCCHHHHHT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred eeEEcccc----cccccCCCCccccCceeecC----CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99765322 22344579999999999853 58899999999999999999999999999888888776544443
Q ss_pred CCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 CIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 ~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..| ..+|+++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 333 468999999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=363.20 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=204.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.++.++ +.||||++.+.. ......+. ++..++..+ +||||+.+++++...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~-~E~~~l~~l-~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQ------QEYAVKVINKASAKNKDTSTIL-REVELLKKL-DHPNIMKLFEILEDS 93 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTC------CEEEEEEEEHHHHBCSCHHHHH-HHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred cceEEeEEEeecCCEEEEEEEECCCC------CEEEEEEEecccccchHHHHHH-HHHHHHHhC-CCCCcCeEEEEEEcC
Confidence 78999999999999999999988665 489999986422 11223333 334555555 799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe---cCCcEEEEecCCc
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS---EHDQLVLGDFGIP 196 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld---~~g~vkL~DFGla 196 (632)
+.+|+||||+. |+|.+.+... +.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999998 5888888654 4799999999999999999999999999999999999995 4567999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
+..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........
T Consensus 172 ~~~~~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 172 TCFQQN----TKMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp TTBCCC--------CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred eECCCC----CccCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 754322 22344579999999999863 5889999999999999999999999999988888777654443333
Q ss_pred C--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 P--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
| ..+|+++.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3 468999999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=343.87 Aligned_cols=255 Identities=21% Similarity=0.322 Sum_probs=199.6
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
-..++|++.+.||+|+||.||+|.+..++ +.||||++...... .......++..++..+ +|+||+.+++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTG------RIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCK 94 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTC------CEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCC------ceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEee
Confidence 34589999999999999999999987655 48999998654332 2222333344455555 6999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++..|+||||++|++++.+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cCCEEEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 99999999999998777666443 35799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-----
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK----- 273 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~----- 273 (632)
..... .......||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......
T Consensus 174 ~~~~~---~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 174 LAAPG---EVYDDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ecCCc---cccCCCcCCccccCcccccCC--CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 53321 122345789999999998643 25788999999999999999999999998866654444321100
Q ss_pred ---------------CC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 ---------------PC---------IPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 ---------------p~---------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+. ..+.+++++.+||.+||+.||++||++.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 01357899999999999999999999999886
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.17 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=190.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.... ......+. ++..++..+ +||||+.+++++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~-~E~~~l~~l-~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILE------RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCV-NHKNIIGLLNVFTP 95 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEECTTSSHHHHHHHH-HHHHHHHHC-CCTTBCCEEEEECS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCC------ceEEEEEeccccCChHHHHHHH-HHHHHHHhc-CCCCccceEEeecc
Confidence 378999999999999999999987665 489999997532 22222333 333444554 79999999999876
Q ss_pred CC------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 NG------KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~~------~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
.+ .+||||||++|+|.+.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CCSTTTCCEEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccccccceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEe
Confidence 54 789999999999888874 36899999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 172 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 172 GLARTAGTS----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp CC--------------------CTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred ecccccccc----cccCCceecCCccCHHHhcCC---CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999764321 122345789999999999743 6889999999999999999999999998877666655432111
Q ss_pred C--------------------CC--------------CC------CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 P--------------------CI--------------PS------GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 p--------------------~~--------------p~------~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ .+ |. ..++++.+||.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 1 11 00 01568999999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=333.11 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=205.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||+|.+..... ......+.++..++..+ +|+||+.+++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDG------KILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCC------cEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecC
Confidence 368999999999999999999987655 4899999975432 22223333444555555 69999999998764
Q ss_pred -CCEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeeeeeCCeEEEecCCcEEE
Q 006772 120 -NGKICIAMKFYEG-SVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIG-----LLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 120 -~~~l~LVmEy~~G-sL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~-----IvHRDLKP~NILld~~g~vkL 190 (632)
++.+|+||||++| +|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 5789999999985 8888886542 345999999999999999999999999 999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||+++..... ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||...+..++...+..
T Consensus 158 ~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~- 230 (279)
T 2w5a_A 158 GDFGLARILNHD---TSFAKTFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE- 230 (279)
T ss_dssp CCCCHHHHC------CHHHHHHHSCCTTCCHHHHHCC----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-
T ss_pred ecCchheeeccc---cccccccCCCccccChHHhccC---CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-
Confidence 999998764321 1112234689999999998743 688999999999999999999999999887777666553
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHH
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHA 308 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~ 308 (632)
...+.+|..+++++.++|.+||+.||++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 34456788899999999999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=359.37 Aligned_cols=246 Identities=15% Similarity=0.157 Sum_probs=187.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC---chhhHHHHHHHHHHHhhhcc--CCCceeEee--
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL---KEDCAKVFVNKFEELFPKFR--ESQSVCWLH-- 114 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~---~~~~~~~~~~~~~~il~~l~--~h~~I~~l~-- 114 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.+. .....+.+ .++..++..+. +||||+.++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~-~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETG------ESFEVHVPYFTERPPSNAIKQM-KEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCC------CEEEEEEEEECC-CCTTHHHHH-HHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCC------cEEEEEEEeeccccchHHHHHH-HHHHHHHHhccccCCHHHHHHHhh
Confidence 478999999999999999999987654 48999999742 22222333 33333333333 799998887
Q ss_pred -----EEEEECC-----------------EEEEEEecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh
Q 006772 115 -----GISVING-----------------KICIAMKFYEGSVGDRIAQQRG-----GKLPLPDILRYGIQLAKGISDLHS 167 (632)
Q Consensus 115 -----~~~~~~~-----------------~l~LVmEy~~GsL~d~l~~~~~-----~~l~~~~~~~ia~qIa~gL~yLHs 167 (632)
+++...+ ..||||||+.|+|.+++..... ..+++..++.++.||+.||+|||+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 6665543 2899999999999999876421 122347888899999999999999
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCC--------CCCCCCcccccc
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--------VRGPISFETDTW 239 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~g~~t~ksDvw 239 (632)
++|+||||||+|||++.++.+||+|||+++... ......+| +.|+|||++.+. ....++.++|||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 999999999999999999999999999998532 12344578 999999998743 001588999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 240 GFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 240 SlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
||||++|||++|+.||.+.+..+....+. ..+..+|+++.+||.+||+.||++||++.++++
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999999998765433222211 224678999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=371.76 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=207.7
Q ss_pred CcCCCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 39 WIDPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 39 ~I~~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.++.+.+.+.. .||+|+||.||+|.+.... ..+.||||+++.... ...+.+. ++..++..+ +|+||+.+++
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~-~E~~il~~l-~hpnIv~l~~ 437 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELL-AEANVMQQL-DNPYIVRMIG 437 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSS----CEEEEEEEEECGGGGCGGGHHHHH-HHHHHHHHC-CCTTBCCEEE
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCC----cceEEEEEEeccccCCHHHHHHHH-HHHHHHHhC-CCCCEeeEEE
Confidence 35556677755 8999999999999765322 235899999975432 2233333 344555665 6999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++. ++..+|||||++ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 438 ~~~-~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 438 ICE-AESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEE-SSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EEe-cCCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 886 456889999998 578887754 3579999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+++.+..............||+.|+|||++.. ..++.++|||||||+||||++ |..||.+.+..++...+. ....
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~---~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~ 590 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGER 590 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred CccccccCccccccccCCCCceeeeChhhhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99865432211122233456889999999963 468999999999999999998 999999999888776665 3456
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+..|..+|+++.+||.+||+.||++||++.+|++.|+.+..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 66788999999999999999999999999999999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.97 Aligned_cols=257 Identities=18% Similarity=0.260 Sum_probs=196.8
Q ss_pred CCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc--------
Q 006772 34 TQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR-------- 105 (632)
Q Consensus 34 ~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~-------- 105 (632)
.-....+..++|++.+.||+|+||.||+|.+..++ +.||||++..... ....+ .++..++..+.
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~-~~~~~-~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 10 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNN------THVAMKIVRGDKV-YTEAA-EDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSCHH-HHHHH-HHHHHHHHHHHHTCCSHHH
T ss_pred eecCCcccCCeEEEEEeeeecCCeEEEEEEecCCC------cEEEEEEecCCcc-chhhh-hHHHHHHHHhhcccccchh
Confidence 33444566789999999999999999999987655 4899999975332 22222 22333333333
Q ss_pred --CCCceeEeeEEEEECC----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeeeeeCC
Q 006772 106 --ESQSVCWLHGISVING----KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI-GLLVLNLKPS 178 (632)
Q Consensus 106 --~h~~I~~l~~~~~~~~----~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~-~IvHRDLKP~ 178 (632)
.|+||+.+++++...+ .++++|||+.++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~ 161 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH
Confidence 3789999999887654 78999999988999999876666799999999999999999999998 9999999999
Q ss_pred eEEEecC------CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCC
Q 006772 179 NLLLSEH------DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGI 252 (632)
Q Consensus 179 NILld~~------g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~ 252 (632)
|||++.+ +.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTC---CCCTHHHHHHHHHHHHHHHHSS
T ss_pred HeEEeccCCCcCcceEEEcccccccccCC------CCCCCCCCccccCcHHHhCC---CCCchHhHHHHHHHHHHHHhCC
Confidence 9999543 3899999999986532 22335789999999999743 6889999999999999999999
Q ss_pred CCCCCCCH------HHHHHHHHhh----------------------------------------ccCCCCCCCCCHHHHH
Q 006772 253 QPWFGKSV------EEIYHSVVIK----------------------------------------KEKPCIPSGLPPAVEN 286 (632)
Q Consensus 253 ~PF~~~~~------~ei~~~i~~~----------------------------------------~~~p~~p~~lp~~l~~ 286 (632)
.||.+.+. .+....+... .....++..+++++.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 99986542 1112221110 0112234456778999
Q ss_pred HHHHhhhcCcCCCCCHHHHHH
Q 006772 287 VIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 287 LI~~cL~~DP~~RPs~~ell~ 307 (632)
||.+||+.||++||++.|+++
T Consensus 313 li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHhccCccccCCHHHHhh
Confidence 999999999999999999886
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.19 Aligned_cols=252 Identities=16% Similarity=0.148 Sum_probs=183.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhcc-CCCceeEee----
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFR-ESQSVCWLH---- 114 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~-~h~~I~~l~---- 114 (632)
..+|++.+.||+|+||.||+|.+..++ +.||||++..... ......+.++..++..+. .||||+.++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERL------EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCC------ceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 356999999999999999999987665 4899999987542 222233333333233333 699977644
Q ss_pred ---EEEEEC-----------------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhC
Q 006772 115 ---GISVIN-----------------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDI------LRYGIQLAKGISDLHSI 168 (632)
Q Consensus 115 ---~~~~~~-----------------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~------~~ia~qIa~gL~yLHs~ 168 (632)
+++... ..+||||||++|+|.+++.... ..++...+ +.++.||+.||+|||++
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 455443 3489999999999999997653 24455555 67779999999999999
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHH
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEM 248 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Em 248 (632)
+|+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+. ...++.++|||||||++|||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNAS-TATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCS-EEECCHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCC-CCCcCccccHHHHHHHHHHH
Confidence 999999999999999999999999999986522 11134567999999999642 23689999999999999999
Q ss_pred HhCCCCCCCCCHHHH--HHH---HHhhccCCCCC--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 249 LTGIQPWFGKSVEEI--YHS---VVIKKEKPCIP--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 249 ltG~~PF~~~~~~ei--~~~---i~~~~~~p~~p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
++|+.||.+...... +.. .........++ ..+++++.+||.+||+.||++||++.++++
T Consensus 287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999987643210 000 00011122222 578999999999999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.17 Aligned_cols=258 Identities=19% Similarity=0.292 Sum_probs=201.6
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccC-CCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRE-SQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~-h~~I~~l~ 114 (632)
..+..++|++.+.||+|+||.||+|.+.. + +.||||++.... ...... ..++..++..+.+ |+||+.++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~------~~vavK~~~~~~~~~~~~~~-~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK-K------QIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-C------CEEEEEEEECSSCCHHHHHH-HHHHHHHHHHHGGGCTTBCCEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCC-C------cEEEEEEeccccccccchHH-HHHHHHHHHhccccCCceEEEE
Confidence 44566889999999999999999998743 2 489999996532 222233 3334455666654 79999999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 115 GISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
+++..++.+|+|||+..|+|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||+++ +.+||+|||
T Consensus 95 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 95 DYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEEECSSEEEEEECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EEeecCCEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999999998888999988753 57999999999999999999999999999999999999964 899999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCC--------CCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHH
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE--------VRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYH 265 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~ 265 (632)
+++....... ........||+.|+|||++.+. ....++.++|||||||++|||++|..||.... ......
T Consensus 172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 172 IANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred ccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 9976533211 1112345789999999998642 12367889999999999999999999998754 333444
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+........++...+.++.++|.+||+.||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 444444556677888999999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.93 Aligned_cols=259 Identities=19% Similarity=0.241 Sum_probs=193.0
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
...++|++.+.||+|+||.||+|.+..++ +.||||++....... ....++. ..+..+ +|+||+.+++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~-~~~~~~~-~~l~~l-~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTG------MSVAIKKVIQDPRFR-NRELQIM-QDLAVL-HHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTC------CEEEEEEEECCTTCC-CHHHHHH-HHHHHH-CCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEecCcccc-HHHHHHH-HHHHhc-CCCCcccHHHhhhc
Confidence 44579999999999999999999987665 489999986543221 1122222 222233 79999999999876
Q ss_pred CCE-------EEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeeeeeCCeEEEec-CCc
Q 006772 120 NGK-------ICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLH--SIGLLVLNLKPSNLLLSE-HDQ 187 (632)
Q Consensus 120 ~~~-------l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLH--s~~IvHRDLKP~NILld~-~g~ 187 (632)
.+. +++||||++|++.+.+... ....+++..++.++.|++.||.||| +++|+||||||+|||++. ++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 433 8999999999888776542 3467899999999999999999999 999999999999999997 899
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
+||+|||+++..... .......||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+
T Consensus 171 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPS----EPNVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTT----SCCCSTTSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEeeCCCceecCCC----CCcccccCCcceeCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 999999999865332 122345789999999998643 34789999999999999999999999998877766655
Q ss_pred HhhccC------------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhccc
Q 006772 268 VIKKEK------------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVY 317 (632)
Q Consensus 268 ~~~~~~------------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~ 317 (632)
...... +..+...++++.+||.+||+.||.+||++.|+++ ++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~f 318 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC------HPYF 318 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT------SGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc------Cccc
Confidence 432111 1122336789999999999999999999999886 5666
Q ss_pred CC
Q 006772 318 ND 319 (632)
Q Consensus 318 ~~ 319 (632)
..
T Consensus 319 ~~ 320 (360)
T 3e3p_A 319 DE 320 (360)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=329.80 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=201.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------hHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------CAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|+++..... ..+.+ .++..++..+ +|+||+.++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~-~~E~~~l~~l-~h~~i~~~~~~ 76 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTG------KEYAAKFIKKRRLSSSRRGVSREEI-EREVNILREI-RHPNIITLHDI 76 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEBCSSTTCSSSBCHHHH-HHHHHHHHHC-CCTTBCCEEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCC------CeeehHHhhhccccccccchHHHHH-HHHHHHHHhC-CCCCeeehhhe
Confidence 57999999999999999999987655 48999998754221 12333 3334455555 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC----cEEEE
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLG 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----~vkL~ 191 (632)
+..++..++||||++ ++|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 77 FENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred ecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence 999999999999997 6888887653 4799999999999999999999999999999999999999877 89999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||++...... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+....+....
T Consensus 155 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (283)
T 3bhy_A 155 DFGIAHKIEAG----NEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227 (283)
T ss_dssp CCTTCEECC------------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred ecccceeccCC----CcccccCCCcCccCcceecC---CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence 99999865332 12234568999999999874 368899999999999999999999999988877766655322
Q ss_pred cCC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKP--CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p--~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
... ..+..+++.+.++|.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 211 122578999999999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.64 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=198.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
...++|++.+.||+|+||.||+|.+..++ +.||||.+..... ...+.++ ..++..+ +|+||+.+++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~--~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETG------QIVAIKQVPVESD--LQEIIKE-ISIMQQC-DSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTC------CEEEEEEEETTSC--CHHHHHH-HHHHHTC-CCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCC------CEEEEEecCchHH--HHHHHHH-HHHHHhC-CCCCCccEEEEEEe
Confidence 34578999999999999999999987655 4899999976432 2333333 3444454 79999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+|+||||++| +|.+++.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999986 77777653 346899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--CC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--CI 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--~~ 276 (632)
..... .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+.. ...+ ..
T Consensus 175 ~~~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 247 (314)
T 3com_A 175 LTDTM---AKRNTVIGTPFWMAPEVIQEI---GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPTFRK 247 (314)
T ss_dssp CBTTB---SCBCCCCSCGGGCCHHHHSSS---CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCSS
T ss_pred hhhhc---cccCccCCCCCccChhhcCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-CCCcccCC
Confidence 53321 122345789999999998743 678899999999999999999999998876655444332 2222 23
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..++.++.++|.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 4568999999999999999999999999886
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=349.22 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=201.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+.. + +.||||++........+.+.++ ..++..+ +||||+.+++++..++
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~------~~vavK~~~~~~~~~~~~~~~E-~~~l~~l-~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRD-G------AKVALKRRTPESSQGIEEFETE-IETLSFC-RHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTT-C------CEEEEEECCSCCSSHHHHHHHH-HHGGGSC-CCTTBCCEEEECCCTT
T ss_pred HhccCccceeecCCCeeEEEEEECC-C------CEEEEEEecccChHHHHHHHHH-HHHHHhC-CCCCEeeEEEEEcCCC
Confidence 3789999999999999999998642 2 4899999876654444444433 3445554 6999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 122 KICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~--~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..++||||++ |+|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999998 57777765432 23589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhhc-
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEI---YH---SVVIKK- 271 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei---~~---~i~~~~- 271 (632)
...... ........||+.|+|||++.+ +.++.++|||||||++|||++|+.||.+..+.+. .. ......
T Consensus 189 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 189 GTELDQ-THLSTVVKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp CSSSSC-CCCBCCCEEETTTCCHHHHHH---CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccc-cccccccCCCccccCHHHhcC---CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 432211 112234568999999999864 3688999999999999999999999986543221 00 000000
Q ss_pred ----cCC----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 272 ----EKP----CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 272 ----~~p----~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+ .++..++.++.+++.+||+.||++||++.++++.|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 011 1223345689999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.40 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=201.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE---
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI--- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--- 119 (632)
++|++.+.||+|+||.||+|.+..++ +.||+|.+....... .++..++..+ .|+||+.+++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~-----~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDG------KTYVIKRVKYNNEKA-----EREVKALAKL-DHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTC------CEEEEEEEECCSGGG-----HHHHHHHHHC-CCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCC------eEEEEEEeccccHHH-----HHHHHHHHhC-CCCCEEEEeeeEecccc
Confidence 57999999999999999999987655 489999997654321 2223444444 69999999988754
Q ss_pred -------------CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC
Q 006772 120 -------------NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185 (632)
Q Consensus 120 -------------~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~ 185 (632)
...+++||||++| +|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999995 89988876656789999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH
Q 006772 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH 265 (632)
Q Consensus 186 g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~ 265 (632)
+.+||+|||+++...... ......||+.|+|||++.+. .++.++|+|||||++|||++|..||... .....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQ---DYGKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp TEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCS---CCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred CCEEECcchhheeccccc----cccccCCcccccChhhhccC---CCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 999999999998754321 22345689999999998743 6789999999999999999999987532 12222
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+ ....++..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 230 ~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DL----RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HH----HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hh----hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 22 2334567899999999999999999999999999999887653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=371.45 Aligned_cols=265 Identities=21% Similarity=0.364 Sum_probs=213.2
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
...+..++|++.+.||+|+||.||+|.+...+. ....||||.+.........+...++..++..+ +||||+.++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSS---CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCC---ccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEE
Confidence 344667899999999999999999999876442 34589999987644333333333444455555 79999999998
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+. ++..|+||||++ |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence 74 567899999998 6888777543 45799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++....... .......||+.|||||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.. ...+
T Consensus 538 a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~ 611 (656)
T 2j0j_A 538 SRYMEDSTY--YKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERL 611 (656)
T ss_dssp CCSCCC------------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCC
T ss_pred CeecCCCcc--eeccCCCCCcceeCHHHhcC---CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 986533211 11223456889999999864 368899999999999999997 9999999888877766653 4556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+|..+|+++.++|.+||+.||++||++.++++.|+.+.
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 678899999999999999999999999999999988765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.19 Aligned_cols=241 Identities=18% Similarity=0.194 Sum_probs=197.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--------hHHHHHHHHHHHhhhccCCCceeEee
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--------CAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--------~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++.+.... ....+ ..+..++..+ +|+||+.++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~-~~E~~~l~~l-~h~~Iv~~~ 95 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKN------KEVVVKFIKKEKVLEDCWIEDPKLGKV-TLEIAILSRV-EHANIIKVL 95 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTT------EEEEEEEEESTTSCTTSEEEETTTEEE-EHHHHHHTTC-CCTTBCCEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCC------cEEEEEEEehhhcccccccchHHHHHH-HHHHHHHHhC-CCCCEeeEE
Confidence 57999999999999999999987765 48999999764311 11112 2233455555 799999999
Q ss_pred EEEEECCEEEEEEecCC-C-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 115 GISVINGKICIAMKFYE-G-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
+++..++..++||||+. | +|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999999996 5 77777654 35799999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+++..... ......+||+.|+|||++.+. ..++.++|||||||++|||++|..||..... ....
T Consensus 174 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~ 239 (335)
T 3dls_A 174 FGSAAYLERG----KLFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEA 239 (335)
T ss_dssp CTTCEECCTT----CCBCEECSCGGGCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTT
T ss_pred cccceECCCC----CceeccCCCccccChhhhcCC--CCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhh
Confidence 9999875332 223346799999999998743 1237899999999999999999999976321 1123
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....|..+++++.+||.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 33456779999999999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.87 Aligned_cols=264 Identities=18% Similarity=0.309 Sum_probs=204.3
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
..|+.++|++.+.||+|+||.||+|.+.. .||+|+++..... ..+.+ .++..++..+ +|+||+.+++
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~avk~~~~~~~~~~~~~~~-~~e~~~l~~l-~h~~iv~~~~ 96 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIERDNEDQLKAF-KREVMAYRQT-RHENVVLFMG 96 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---------SEEEEECCCCSCCCCCCCCC-CTTGGGGTTC-CCTTBCCCCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---------eEEEEEeecCCCCHHHHHHH-HHHHHHHhcC-CCCCEeEEEE
Confidence 44778999999999999999999998753 4999998653211 11111 2222334444 7999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++.+++||||++| +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred EEecCCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 99999999999999985 67666643 345799999999999999999999999999999999999998 6899999999
Q ss_pred CceeccCCC--CCCCccccccCCCccCCccccCCCC------CCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 006772 195 IPYLLLGRS--LSDSDMALRLGTPNYMAPEQWEPEV------RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266 (632)
Q Consensus 195 lak~~~~~~--~~~~~~~~~~GT~~YmAPE~~~~~~------~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~ 266 (632)
+++...... ..........||+.|+|||++.... ...++.++|||||||++|||++|..||.+.+..+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 987542211 1112223456899999999987421 23578899999999999999999999999888877766
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 267 VVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 267 i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
+.........+..++.++.++|.+||+.||++||++.++++.|+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 654433333345789999999999999999999999999999987653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.34 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=198.8
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|.....||+|+||.||+|.+..++ +.||||.+........+.+.+ +..++..+ +|+||+.+++++..++.
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~-e~~~l~~l-~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQ------VRIAIKEIPERDSRYSQPLHE-EIALHKHL-KHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTC------CEEEEEEEECCCC---HHHHH-HHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCC------eEEEEEEccCCchHHHHHHHH-HHHHHHhC-CCCCEeeEeeEEEeCCc
Confidence 44445568999999999999987655 489999997654433333333 33444444 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEecCCceec
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~DFGlak~~ 199 (632)
.++||||++ |+|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999997 577777765422 35678899999999999999999999999999999999997 899999999999865
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhccCCCCCC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~~~~~p~~p~ 278 (632)
.... .......||+.|+|||++.+. ...++.++|+|||||++|||++|..||.... ..............+.++.
T Consensus 174 ~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 174 AGIN---PCTETFTGTLQYMAPEIIDKG-PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp CC--------CCCCCCGGGCCHHHHHHG-GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred CCCC---CcccccCCCccccChhhhcCC-CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 3321 112345789999999998643 1237889999999999999999999997643 2222223333355667788
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+++++.++|.+||+.||++||++.++++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999999999886
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.31 Aligned_cols=260 Identities=14% Similarity=0.184 Sum_probs=198.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhc--cCCCceeEeeEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF--RESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l--~~h~~I~~l~~~~ 117 (632)
+..++|++.+.||+|+||.||+|.+.... +...++.||||++.+..... +..+ ..++..+ ..|++|+.+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~---~~~e-~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLN-DAKNKQKFVLKVQKPANPWE---FYIG-TQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCCHHH---HHHH-HHHHHHSCGGGGGGBCCEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCc-ccccCcEEEEEEeCCCChhH---HHHH-HHHHHHhhhhhhhhhhhhheee
Confidence 55688999999999999999999643321 11334689999997654332 2222 2222333 2378999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---------
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQ---RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE--------- 184 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~---~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~--------- 184 (632)
..++..||||||++ |+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 99999999999998 6888888653 2467999999999999999999999999999999999999998
Q ss_pred --CCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH
Q 006772 185 --HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE 262 (632)
Q Consensus 185 --~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e 262 (632)
++.+||+|||+|+.+.... ........+||+.|||||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNK---PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTC---CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCC---CCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 8999999999997653211 12233456899999999999754 58999999999999999999999996543211
Q ss_pred HHHHHHhhccCCCCC-CCCCHHHHHHHHHhhhcCcCCCC-CHHHHHHHHHhhhhc
Q 006772 263 IYHSVVIKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRP-LMADILHAFESSQNA 315 (632)
Q Consensus 263 i~~~i~~~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RP-s~~ell~~Le~~~~~ 315 (632)
......++ ...++.+.+++.+||+.+|.+|+ ++.++.+.|+.....
T Consensus 293 -------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 -------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111 23467899999999999999995 788888888776543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.36 Aligned_cols=257 Identities=18% Similarity=0.268 Sum_probs=196.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh----------hHHHHHHHHHHHhhhccCCCcee
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED----------CAKVFVNKFEELFPKFRESQSVC 111 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~----------~~~~~~~~~~~il~~l~~h~~I~ 111 (632)
.++|++.+.||+|+||.||+|.+.. + +.||||++...... .......++..++..+ +|+||+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 92 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-G------IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNIL 92 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-S------CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBC
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-C------CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCcc
Confidence 4789999999999999999998754 2 58999998542211 1112233333455555 699999
Q ss_pred EeeEEEEEC-----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 112 WLHGISVIN-----GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 112 ~l~~~~~~~-----~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
.+++++... ..+|+||||++|+|.+.+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN 171 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence 999998652 478999999999999988743 45799999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS 266 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~ 266 (632)
.+||+|||+++..... .......||+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+..+....
T Consensus 172 ~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 172 DITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQF--KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CEEECCTTC-------------------CGGGCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CEEEEecCcccccccc----cccceecccceecCcHHhcCC--CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999998754221 222345789999999998742 3588999999999999999999999999887766655
Q ss_pred HHhhccCCC------------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 267 VVIKKEKPC------------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 267 i~~~~~~p~------------------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
+......+. .+..+++.+.+||.+||+.||++|||+.++++ +++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~ 319 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR------HPY 319 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGG
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc------Cch
Confidence 543211111 12456889999999999999999999999886 556
Q ss_pred cCC
Q 006772 317 YND 319 (632)
Q Consensus 317 ~~~ 319 (632)
+..
T Consensus 320 f~~ 322 (362)
T 3pg1_A 320 FES 322 (362)
T ss_dssp GTT
T ss_pred hhh
Confidence 543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=341.54 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=197.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-------hHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-------CAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-------~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++...... .....+.++..++..+ +|+||+.+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~ 82 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTC------KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKN 82 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCC------cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEee
Confidence 67999999999999999999987665 48999998653210 1111123333455555 7999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc---EEEE
Q 006772 116 ISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLG 191 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~---vkL~ 191 (632)
++..++ .|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+
T Consensus 83 ~~~~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 83 FFDAED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEESSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred EEcCCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 986654 8999999985 78777753 358999999999999999999999999999999999999987664 9999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~ 270 (632)
|||+++..... .......||+.|+|||++.......++.++|+|||||++|+|++|..||...... .+...+..
T Consensus 160 Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~- 234 (322)
T 2ycf_A 160 DFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 234 (322)
T ss_dssp CCTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-
T ss_pred cCccceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-
Confidence 99999865321 1123457899999999975322446889999999999999999999999875432 22223322
Q ss_pred ccCCC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 271 KEKPC---IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 271 ~~~p~---~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
..... .+..+++++.++|.+||+.||++||++.++++ ++++.+.+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~------h~~~~~~~~ 283 (322)
T 2ycf_A 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR------HPWLQDEDM 283 (322)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGCCHHH
T ss_pred CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh------CcCcCCHHH
Confidence 21111 22578999999999999999999999999886 555554443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.67 Aligned_cols=264 Identities=18% Similarity=0.241 Sum_probs=186.7
Q ss_pred CCeEE-EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKL-KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l-~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
+.|++ .++||+|+||.||+|.++... .++.||||++...... ..+.+ +..++..+ +|+||+.+++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~----~~~~vaiK~~~~~~~~--~~~~~-E~~~l~~l-~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGK----DDKDYALKQIEGTGIS--MSACR-EIALLREL-KHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSS----CCCCEEEEECSSSSCC--HHHHH-HHHHHHHC-CCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCC----CCeEEEEEEECCCCCC--HHHHH-HHHHHHhc-CCCCeeeEeeEEecCC
Confidence 34666 458999999999999976432 2358999999754322 22333 33455555 69999999999965
Q ss_pred CCEEEEEEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE----ecCCcE
Q 006772 120 NGKICIAMKFYEGSVGDRIAQQR-------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL----SEHDQL 188 (632)
Q Consensus 120 ~~~l~LVmEy~~GsL~d~l~~~~-------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl----d~~g~v 188 (632)
+..+||||||++|+|.+.+.... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 67899999999999998886432 1259999999999999999999999999999999999999 678899
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-------
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE------- 261 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~------- 261 (632)
||+|||+++...............+||+.|+|||++.+. ..++.++|||||||++|||++|..||.+....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTC--CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCC--CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999998764322222233456899999999998742 34889999999999999999999999875532
Q ss_pred --HHHHHHHhhccCCC------------------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHH
Q 006772 262 --EIYHSVVIKKEKPC------------------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMA 303 (632)
Q Consensus 262 --ei~~~i~~~~~~p~------------------------------------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ 303 (632)
+....+......+. .....++++.+||.+||+.||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 22222221111111 0112367899999999999999999999
Q ss_pred HHHHHHHhhhhcccCCCCc
Q 006772 304 DILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 304 ell~~Le~~~~~~~~~~~w 322 (632)
|+++ +++|....+
T Consensus 330 e~L~------hp~f~~~~~ 342 (405)
T 3rgf_A 330 QAMQ------DPYFLEDPL 342 (405)
T ss_dssp HHHT------SGGGTSSSC
T ss_pred HHhc------ChhhccCCC
Confidence 9886 677765444
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=339.35 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++..... ........++..++..+ +|+||+.+++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSG------EKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPA 95 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCC------CEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecc
Confidence 478999999999999999999987665 4899999975332 22122223333445555 699999999998776
Q ss_pred CE------EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 121 GK------ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 121 ~~------l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
+. .|+||||+.|+|.+.+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred cccccceeEEEEeccccCCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 43 5999999999877665 2369999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc--
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-- 272 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-- 272 (632)
+++.... ......||+.|+|||++.+. ..++.++|+|||||++|||++|..||.+.+..+....+.....
T Consensus 172 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 172 LARHADA------EMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243 (353)
T ss_dssp CTTC--------------CCSBCCSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred cccCCCC------CccccccCcCcCCHHHHhCc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9875422 22345789999999998742 3578999999999999999999999999887665554432110
Q ss_pred ------------------------C---CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 273 ------------------------K---PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 273 ------------------------~---p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
. ...+..+++++.+||.+||+.||++||++.++++ ++++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~------hp~f~~ 311 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT------HPFFEP 311 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc------Ccchhh
Confidence 1 1223567999999999999999999999999886 566643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.72 Aligned_cols=257 Identities=20% Similarity=0.358 Sum_probs=201.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhh-ccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK-FRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~-l~~h~~I~~l~~~~~~~~ 121 (632)
++|++.+.||+|+||.||+|.+. + +.||||++.... ...+.++. +++.. ..+|+||+.+++++...+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~------~~vavK~~~~~~---~~~~~~e~-~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--G------EEVAVKIFSSRE---ERSWFREA-EIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--T------EEEEEEEECGGG---HHHHHHHH-HHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--C------ccEEEEEeCchh---HHHHHHHH-HHHHHhhcCCCcEEEEEeeecccC
Confidence 68999999999999999999874 2 489999986432 23333333 33333 258999999999988765
Q ss_pred ----EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeeeeeCCeEEEecCCcE
Q 006772 122 ----KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH--------SIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 122 ----~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLH--------s~~IvHRDLKP~NILld~~g~v 188 (632)
.+|+||||++| +|.+++.. ..+++.+++.++.|++.||+||| +++|+||||||+|||++.++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 89999999985 88888854 36999999999999999999999 8999999999999999999999
Q ss_pred EEEecCCceeccCCCCC-CCccccccCCCccCCccccCCCCCC---CCCcccccchhHHHHHHHHhC----------CCC
Q 006772 189 VLGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRG---PISFETDTWGFGCSIMEMLTG----------IQP 254 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g---~~t~ksDvwSlGvvL~EmltG----------~~P 254 (632)
||+|||+++........ ........||+.|+|||++.+.... .++.++|||||||++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876433211 0122345799999999998754211 234689999999999999999 789
Q ss_pred CCCC-----CHHHHHHHHHhhccCCCCCC-----CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 255 WFGK-----SVEEIYHSVVIKKEKPCIPS-----GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 255 F~~~-----~~~ei~~~i~~~~~~p~~p~-----~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
|... ....+...+......+.++. .++..+.+||.+||+.||++||++.++++.|+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 8764 23444444444444455543 344689999999999999999999999999988754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.58 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=186.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.... ......+. ++..++..+ +|+||+.+++++..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~-~E~~~l~~l-~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTG------LRVAVKKLSRPFQSIIHAKRTY-RELRLLKHM-KHENVIGLLDVFTP 99 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTT------EEEEEEECSSTTSSHHHHHHHH-HHHHHHHHC-CCTTBCCCSEEECS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCC------CEEEEEEeCccccCHHHHHHHH-HHHHHHHhC-CCCCCCcEEEEEec
Confidence 478999999999999999999987665 489999986532 22223333 333455555 59999999999865
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. ..+|++|||+.++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CSSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CCccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 4 56899999998888877753 47999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++.... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 177 G~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 177 GLARHTAD------EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp --------------------CCCTTCCHHHHTTC--CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred cccccccc------cCCCcCcCcCccChHHHcCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99876422 22345789999999998742 36889999999999999999999999998876655544321111
Q ss_pred C---------------------CC--------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 274 P---------------------CI--------PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 274 p---------------------~~--------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
+ .. ...+++++.+||.+||+.||.+|||+.++++ ++++..
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~------hp~~~~ 317 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA------HAYFAQ 317 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTT
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc------Chhhhh
Confidence 1 11 1356889999999999999999999999886 556543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.96 Aligned_cols=261 Identities=17% Similarity=0.236 Sum_probs=209.2
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-----------------HHHHHHHHHHHhh
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-----------------AKVFVNKFEELFP 102 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-----------------~~~~~~~~~~il~ 102 (632)
+..++|++.+.||+|+||.||+|.+ ++ +.||||++....... ...+ .++..++.
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~E~~~l~ 98 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DN------KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF-KNELQIIT 98 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TT------EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHH-HHHHHHHT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CC------ceEEEEEeecccccchhhhccccchhhhHHhHHHHH-HHHHHHHH
Confidence 3457999999999999999999998 33 589999986422111 0333 33445555
Q ss_pred hccCCCceeEeeEEEEECCEEEEEEecCCC-CHHHH------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeee
Q 006772 103 KFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDR------IAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLN 174 (632)
Q Consensus 103 ~l~~h~~I~~l~~~~~~~~~l~LVmEy~~G-sL~d~------l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRD 174 (632)
.+ +|+||+.+++++..++..|+||||++| +|.++ +.......+++..++.++.||+.||+|||+ ++|+|||
T Consensus 99 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 99 DI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp TC-CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred hC-CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 55 699999999999999999999999986 77776 443335789999999999999999999999 9999999
Q ss_pred eeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCc-ccccchhHHHHHHHHhCCC
Q 006772 175 LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISF-ETDTWGFGCSIMEMLTGIQ 253 (632)
Q Consensus 175 LKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~-ksDvwSlGvvL~EmltG~~ 253 (632)
|||+|||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|+|||||++|||++|..
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE--SSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC--CCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC--CCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999865332 23345789999999998743 14555 9999999999999999999
Q ss_pred CCCCCCH-HHHHHHHHhhccCCCCC-------------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 254 PWFGKSV-EEIYHSVVIKKEKPCIP-------------------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 254 PF~~~~~-~ei~~~i~~~~~~p~~p-------------------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
||...+. .+....+.. ....+| ..+++++.+||.+||+.||.+||++.++++
T Consensus 251 pf~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~------ 322 (348)
T 2pml_X 251 PFSLKISLVELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK------ 322 (348)
T ss_dssp SSCCSSCSHHHHHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT------
T ss_pred CCCCCCcHHHHHHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc------
Confidence 9998765 666655542 233344 678999999999999999999999999887
Q ss_pred hcccCCCCcccc
Q 006772 314 NAVYNDGEWTGL 325 (632)
Q Consensus 314 ~~~~~~~~w~~~ 325 (632)
++++.+..|..+
T Consensus 323 hp~f~~~~~~~~ 334 (348)
T 2pml_X 323 HEWLADTNIEDL 334 (348)
T ss_dssp SGGGTTCCHHHH
T ss_pred CccccCCCHHHH
Confidence 677777666543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.01 Aligned_cols=264 Identities=19% Similarity=0.263 Sum_probs=202.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
..++|++.+.||+|+||.||+|.+..++ +.||||++.............++..++..+ +|+||+.+++++...
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTG------DLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEET 79 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCC------cEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccC
Confidence 4578999999999999999999998765 489999997543222222233344555555 699999999998875
Q ss_pred C--EEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE----ecCCcEEEEe
Q 006772 121 G--KICIAMKFYE-GSVGDRIAQQRG-GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL----SEHDQLVLGD 192 (632)
Q Consensus 121 ~--~l~LVmEy~~-GsL~d~l~~~~~-~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl----d~~g~vkL~D 192 (632)
+ ..||||||++ |+|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 4 7899999998 577777754432 349999999999999999999999999999999999999 7778899999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCC-----CCCCCcccccchhHHHHHHHHhCCCCCCCC----CHHHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEV-----RGPISFETDTWGFGCSIMEMLTGIQPWFGK----SVEEI 263 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-----~g~~t~ksDvwSlGvvL~EmltG~~PF~~~----~~~ei 263 (632)
||+++..... .......||+.|+|||++.+.. ...++.++|||||||++|||++|..||... ...++
T Consensus 160 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 160 FGAARELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp GGGCEECCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred CCCceEccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 9999875332 2223457999999999985310 124678999999999999999999999742 23344
Q ss_pred HHHHHhhccCC-----------------C------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 264 YHSVVIKKEKP-----------------C------IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 264 ~~~i~~~~~~p-----------------~------~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
...+....... . ++..+++.+.++|.+||+.||++||++.++++.++.+.+.
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 44444322110 1 1123456889999999999999999999999988877653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=338.34 Aligned_cols=246 Identities=19% Similarity=0.268 Sum_probs=172.7
Q ss_pred CCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 42 PTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 42 ~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
.++|++.+ .||+|+||.||+|.++.++ +.||||++..... ..++... ......|+||+.+++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~-----~~~e~~~-~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTG------QKCALKLLYDSPK-----ARQEVDH-HWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEESSHH-----HHHHHHH-HHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCC------CEEEEEEecCcHH-----HHHHHHH-HHHhcCCCChHHHHHHHhhc
Confidence 37799965 6999999999999998765 4899999965321 1122222 2344589999999998876
Q ss_pred ---CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEe
Q 006772 120 ---NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGD 192 (632)
Q Consensus 120 ---~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~D 192 (632)
+..++|||||++| +|.+++.......+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 4568999999985 8888887655567999999999999999999999999999999999999986 45599999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH----HHH
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH----SVV 268 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~----~i~ 268 (632)
||+++.... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+........ .+.
T Consensus 175 fg~~~~~~~-----~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (336)
T 3fhr_A 175 FGFAKETTQ-----NALQTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246 (336)
T ss_dssp CTTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred cccceeccc-----cccccCCCCcCccChhhhCC---CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh
Confidence 999976532 12234578999999999863 367889999999999999999999998765443311 111
Q ss_pred hhcc--CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 269 IKKE--KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 269 ~~~~--~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.... .......+++++.+||.+||+.||++||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111 11222578999999999999999999999999997
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=329.56 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=202.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++..... .....+.++ ..++..+ +|+||+.+++++...
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~e-~~~l~~l-~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQ------QEYAVKVINKASAKNKDTSTILRE-VELLKKL-DHPNIMKLFEILEDS 93 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGBSSSCHHHHHHH-HHHHHTC-CCTTBCCEEEEEECS
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCC------cEEEEEEecccccchHHHHHHHHH-HHHHHhc-cCCCccEEEEEEeCC
Confidence 68999999999999999999987655 4899999865321 223333333 3445555 799999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC---CcEEEEecCCc
Q 006772 121 GKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH---DQLVLGDFGIP 196 (632)
Q Consensus 121 ~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~---g~vkL~DFGla 196 (632)
+..++||||+. ++|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999997 5787877654 479999999999999999999999999999999999999764 47999999998
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
...... .......||+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+..++...+.........
T Consensus 172 ~~~~~~----~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 172 TCFQQN----TKMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (287)
T ss_dssp GTBCCC----SSCSCHHHHHTTCCHHHHTT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred eeecCC----CccccccCcccccChHHhcC----CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 754322 12233468999999999863 4789999999999999999999999998888777766544333333
Q ss_pred C--CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 P--SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p--~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+ ..+++++.++|.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 3 578999999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.47 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=197.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
|...+.||+|+||.||+|.+. + +.||||++.... .......+.++..++..+ +||||+.+++++..++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~--~------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 103 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVN--N------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGD 103 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESS--S------CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred cccCCccccCCCeEEEEEEEC--C------ceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCC
Confidence 445689999999999999853 2 479999986532 122233333444555555 6999999999999989
Q ss_pred EEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 122 KICIAMKFYE-GSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
..++||||++ |+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183 (307)
T ss_dssp SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 9999999997 68888876443 357999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhh-----
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEE----IYHSVVIK----- 270 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~e----i~~~i~~~----- 270 (632)
.... .........||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+....+ +...+...
T Consensus 184 ~~~~-~~~~~~~~~g~~~y~aPE~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (307)
T 2nru_A 184 EKFA-QTVMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE 258 (307)
T ss_dssp CSCS-SCEECSSCCSCGGGCCHHHHTT----EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH
T ss_pred cccc-ccccccccCCCcCcCChHHhcC----CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh
Confidence 3321 1112234578999999999864 47889999999999999999999998754322 21111110
Q ss_pred ----ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 271 ----KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 271 ----~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
...+..+...+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111223345678999999999999999999999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.95 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=198.0
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-----HHHHHHHHHHHhhhcc-CCCceeEee
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-----AKVFVNKFEELFPKFR-ESQSVCWLH 114 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-----~~~~~~~~~~il~~l~-~h~~I~~l~ 114 (632)
-.++|++.+.||+|+||.||+|.+..++ +.||||++....... ....+..+..++..+. .|+||+.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDN------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTT------EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3578999999999999999999987655 589999986532110 0011122234455554 489999999
Q ss_pred EEEEECCEEEEEEecCC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-cCCcEEEE
Q 006772 115 GISVINGKICIAMKFYE--GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-EHDQLVLG 191 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~--GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-~~g~vkL~ 191 (632)
+++..++..++||||+. ++|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++ +++.+||+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999999997 6888888654 5799999999999999999999999999999999999999 78999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+++..... ......||+.|+|||++.+. ..++.++|+|||||++|||++|..||.... + +. .
T Consensus 193 Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~--~ 257 (320)
T 3a99_A 193 DFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----II--R 257 (320)
T ss_dssp CCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH--H
T ss_pred eCccccccccc-----cccCCCCCccCCChHHhccC--CCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hh--c
Confidence 99999875332 22345789999999998643 124688999999999999999999997632 1 11 2
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....++..+++++.++|.+||+.||++||++.++++
T Consensus 258 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 344567889999999999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=351.63 Aligned_cols=265 Identities=19% Similarity=0.231 Sum_probs=193.6
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+...+|++.+.||+|+||+||.... .+ ++.||||++.+..... ..++..++..+.+||||+.+++++.
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~-~~------~~~vAvK~~~~~~~~~----~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGM-FD------NRDVAVKRILPECFSF----ADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEE-SS------SSEEEEEEECTTTEEE----CHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEE-eC------CeEEEEEEECHHHHHH----HHHHHHHHHhccCCCCcCeEEEEEe
Confidence 34556799999999999999765432 22 2589999997643222 1233455666668999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---C--CcEEEEec
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---H--DQLVLGDF 193 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~--g~vkL~DF 193 (632)
.++..||||||+.|+|.+++.... ..++..+++.++.||+.||+|||+++|+||||||+|||++. + ..+||+||
T Consensus 89 ~~~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 89 DRQFQYIAIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp ETTEEEEEEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred cCCEEEEEEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 999999999999999999886543 35566677899999999999999999999999999999953 2 36889999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~ 272 (632)
|+++...............+||+.|+|||++.+.....++.++|||||||++|||++ |..||........... .....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~ 246 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-LGACS 246 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-TTCCC
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-hccCC
Confidence 999876432222223345679999999999975445567889999999999999999 9999976654443222 11111
Q ss_pred CCCC--CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCc
Q 006772 273 KPCI--PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEW 322 (632)
Q Consensus 273 ~p~~--p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w 322 (632)
.... +...+..+.+||.+||+.||.+||++.++++ +++|...+|
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~------hp~f~~~~~ 292 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK------HPFFWSLEK 292 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT------STTTCCHHH
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh------CccccChHH
Confidence 1111 1234567899999999999999999999886 555544433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.15 Aligned_cols=258 Identities=20% Similarity=0.266 Sum_probs=191.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE---
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI--- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~--- 119 (632)
++|++.+.||+|+||.||+|.+..++ +.||||++... ......+ .++..++..+ +||||+.+++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-~~~~~~~-~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDS------RYYAIKKIRHT-EEKLSTI-LSEVMLLASL-NHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEEE-HHHHHHH-HHHHHHHTTC-CCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCC------eEEEEEEEecc-HHHHHHH-HHHHHHHHhc-CchHHHHHHHHHHhhcc
Confidence 57999999999999999999987655 48999998642 2222333 3333455555 69999999988765
Q ss_pred ----------CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 120 ----------NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 120 ----------~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
.+..|+||||++ |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence 357899999998 5888887653 4568889999999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCC-----------CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCC
Q 006772 189 VLGDFGIPYLLLGRSL-----------SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG 257 (632)
Q Consensus 189 kL~DFGlak~~~~~~~-----------~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~ 257 (632)
||+|||+++....... .........||+.|+|||++.+. +.++.++|+|||||++|||++ ||..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSC--SCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--CCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 9999999876532110 01122345789999999998742 357899999999999999998 6654
Q ss_pred C-CHHHHHHHHHhh--ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCC
Q 006772 258 K-SVEEIYHSVVIK--KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGE 321 (632)
Q Consensus 258 ~-~~~ei~~~i~~~--~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~ 321 (632)
. +..+....+... ..++.++...++.+.++|.+||+.||.+||++.++++ ++++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~ 291 (303)
T 1zy4_A 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN------SGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH------SSCSCCCC
T ss_pred chhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC------CCCcCCCC
Confidence 2 223333333321 1223345667889999999999999999999999987 55554433
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.50 Aligned_cols=246 Identities=20% Similarity=0.238 Sum_probs=189.0
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH-----HHHHHHHHHHhhhcc---CCCce
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA-----KVFVNKFEELFPKFR---ESQSV 110 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~-----~~~~~~~~~il~~l~---~h~~I 110 (632)
..-.++|++.+.||+|+||.||+|.+..++ +.||||++........ ......+..++.++. .|+||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i 100 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDR------LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTC------CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCC------eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence 334578999999999999999999987655 4899999965432111 111112223333332 79999
Q ss_pred eEeeEEEEECCEEEEEEec-CC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe-cCCc
Q 006772 111 CWLHGISVINGKICIAMKF-YE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS-EHDQ 187 (632)
Q Consensus 111 ~~l~~~~~~~~~l~LVmEy-~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld-~~g~ 187 (632)
+.+++++..++..++|||| +. ++|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++ .++.
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 9999999988999999999 55 6888888654 4799999999999999999999999999999999999999 8899
Q ss_pred EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006772 188 LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267 (632)
Q Consensus 188 vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i 267 (632)
+||+|||+++..... ......||+.|+|||++.+. ...+.++|+|||||++|||++|+.||.... + +
T Consensus 179 ~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~ 245 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE-----PYTDFDGTRVYSPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPFERDQ--E----I 245 (312)
T ss_dssp EEECCCSSCEECCSS-----CBCCCCSCTTTSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H
T ss_pred EEEEEcchhhhcccC-----cccccCCcccccCceeeecC--CCCCccchHHHHHHHHHHHHHCCCCCCChH--H----H
Confidence 999999999875432 23345689999999998643 123568999999999999999999997632 1 1
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
. .....++..+++++.++|.+||+.||++||++.++++
T Consensus 246 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 L--EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H--HTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h--hhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 2345577889999999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.86 Aligned_cols=252 Identities=20% Similarity=0.262 Sum_probs=183.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|.+.+.||+|+||+||.+... + ++.||||++.... ... ..++..++..+.+||||+.+++++..++.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~-~------g~~vAvK~~~~~~---~~~-~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF-Q------GRPVAVKRMLIDF---CDI-ALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES-S------SSEEEEEEEEGGG---HHH-HHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred heeeccCeEeeCCCeEEEEEEEE-C------CeEEEEEEEcHHH---HHH-HHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 55677889999999999876432 2 2589999986532 122 23344555666689999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC------------
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGG-----KLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH------------ 185 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~-----~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~------------ 185 (632)
+||||||++|+|.+++...... ..++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 9999999999999988654211 11333467899999999999999999999999999999764
Q ss_pred -CcEEEEecCCceeccCCCCC-CCccccccCCCccCCccccCCC----CCCCCCcccccchhHHHHHHHHh-CCCCCCCC
Q 006772 186 -DQLVLGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPE----VRGPISFETDTWGFGCSIMEMLT-GIQPWFGK 258 (632)
Q Consensus 186 -g~vkL~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~----~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~ 258 (632)
+.+||+|||+++........ .......+||+.|+|||++.+. ....++.++|||||||++|||++ |..||.+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999876432111 1122345799999999999752 12468899999999999999999 99999876
Q ss_pred CHHHHHHHHHhhccC-CCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 259 SVEEIYHSVVIKKEK-PCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 259 ~~~ei~~~i~~~~~~-p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+. .+...... +..+ ..+++++.+||.+||+.||.+||++.++++
T Consensus 244 ~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 YSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 54332 22222111 1111 234588999999999999999999999885
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.67 Aligned_cols=225 Identities=20% Similarity=0.283 Sum_probs=178.2
Q ss_pred CCeEEE-eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKLK-HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l~-~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
++|.+. +.||+|+||.||+|.+..++ +.||||++.... .. .++..++.+...|+||+.+++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-----~~-~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQ------EKFALKMLQDCP-----KA-RREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECSH-----HH-HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCC------cEEEEEEecccH-----HH-HHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 578887 78999999999999988665 489999996422 12 2223344455689999999999877
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEec
Q 006772 120 --NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGDF 193 (632)
Q Consensus 120 --~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~DF 193 (632)
++.+||||||++ |+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999998 48988887765568999999999999999999999999999999999999998 789999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--c
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK--K 271 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~--~ 271 (632)
|++..... ..++.++|+|||||++|||++|..||.+.+........... .
T Consensus 165 g~a~~~~~----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 216 (299)
T 3m2w_A 165 GFAKETTG----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216 (299)
T ss_dssp TTCEECTT----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT
T ss_pred cccccccc----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh
Confidence 98864311 23678999999999999999999999876544322111111 1
Q ss_pred cCCCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 272 EKPCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 272 ~~p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....++ ..+++++.++|.+||+.||++||++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112223 568999999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.81 Aligned_cols=248 Identities=14% Similarity=0.128 Sum_probs=182.9
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhH--HHHHHHHHHHhhhccCCCce--------
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA--KVFVNKFEELFPKFRESQSV-------- 110 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~--~~~~~~~~~il~~l~~h~~I-------- 110 (632)
...+|++.+.||+|+||.||+|.+..++ +.||||++........ ...+.++..++..+.+.+++
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g------~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETG------ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCC------CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 3456999999999999999999988765 4899999874332221 12233333444554432211
Q ss_pred -------eE------eeEEEEE-----CCEEEEEEecCCCCHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 006772 111 -------CW------LHGISVI-----NGKICIAMKFYEGSVGDRIAQQ-----RGGKLPLPDILRYGIQLAKGISDLHS 167 (632)
Q Consensus 111 -------~~------l~~~~~~-----~~~l~LVmEy~~GsL~d~l~~~-----~~~~l~~~~~~~ia~qIa~gL~yLHs 167 (632)
+. +..++.. ...++++|+++.|+|.+++... .+..+++..++.++.||+.||+|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11 1111111 2347899999999999888532 23457888999999999999999999
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCC-------CCCCCCcccccch
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE-------VRGPISFETDTWG 240 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-------~~g~~t~ksDvwS 240 (632)
++|+||||||+|||++.++.+||+|||+++.... .....+| +.|||||++... ....++.++||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999999999876432 1344578 999999998311 1335788999999
Q ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 241 FGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 241 lGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|||++|||++|+.||.+.+..+....+. .....+|+++.+||.+||+.||++||++.++++
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999998866543322221 112468899999999999999999999988875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=309.13 Aligned_cols=229 Identities=16% Similarity=0.148 Sum_probs=179.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
+-.++|++.+.||+|+||.||+|.+..++ +.||||++..... .....+.++. ..+..+ .|+||+.++++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l-~hp~iv~~~~~ 99 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALD------RQVALTFVDPQGVLPDDVLQETLSRT-LRLSRI-DKPGVARVLDV 99 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTT------EEEEEEESCTTCCSCHHHHHHHHHHH-HHHHTC-CCTTBCCEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCC------ceEEEEEECcccccCHHHHHHHHHHH-HHHhcC-CCCCcceeeEE
Confidence 33467999999999999999999987655 5899999976432 2223344433 334444 79999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+..++..||||||++ ++|.+++.+ .....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 100 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 100 VHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp EEETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred EEECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-
Confidence 999999999999998 477777632 24666789999999999999999999999999999999999999998544
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH---HHHhhcc
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH---SVVIKKE 272 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~---~i~~~~~ 272 (632)
|++ +++.++|||||||++|||++|+.||.+.+..+... .......
T Consensus 175 ----------------------~~~----------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 222 (286)
T 3uqc_A 175 ----------------------TMP----------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222 (286)
T ss_dssp ----------------------CCT----------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB
T ss_pred ----------------------ccC----------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC
Confidence 232 36789999999999999999999998865432110 0000000
Q ss_pred CC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 273 KP--CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 273 ~p--~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+ ..+..+|+++.++|.+||+.||++| |+.|+++.|+.+..
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 1236789999999999999999999 99999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=339.72 Aligned_cols=241 Identities=21% Similarity=0.276 Sum_probs=186.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++.+.||+|+||.||+|.+.... ++.||||++..............+..++..+ +||||+.+++++...+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVN-----GRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGT-----TEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCC-----CcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecC
Confidence 478999999999999999999987522 2589999987544333333334444555555 6999999999998765
Q ss_pred E-----EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 122 K-----ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 122 ~-----l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
. .||||||++| +|.+.+. ..+++.+++.++.||+.||+|||+++|+||||||+|||++.+ .+||+|||+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 4 7999999986 5555432 379999999999999999999999999999999999999985 999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
++..... ....||+.|||||++.+ .++.++|||||||+||+|++|..||.+..... ....
T Consensus 228 a~~~~~~-------~~~~gt~~y~aPE~~~~----~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~~~ 287 (681)
T 2pzi_A 228 VSRINSF-------GYLYGTPGFQAPEIVRT----GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LPED 287 (681)
T ss_dssp CEETTCC-------SCCCCCTTTSCTTHHHH----CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CCTT
T ss_pred chhcccC-------CccCCCccccCHHHHcC----CCCCceehhhhHHHHHHHHhCCCCCccccccc---------cccc
Confidence 9865321 34579999999999864 34889999999999999999999987532110 0000
Q ss_pred C-CCCCCHHHHHHHHHhhhcCcCCCC-CHHHHHHHHHhhh
Q 006772 276 I-PSGLPPAVENVIIGCFEYDLRNRP-LMADILHAFESSQ 313 (632)
Q Consensus 276 ~-p~~lp~~l~~LI~~cL~~DP~~RP-s~~ell~~Le~~~ 313 (632)
. ....++.+.++|.+||+.||++|| +++++.+.|....
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 012457899999999999999999 5666777776554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.90 Aligned_cols=239 Identities=12% Similarity=0.142 Sum_probs=178.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--------hhHHHHHHHHHHHhhhcc-----
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--------DCAKVFVNKFEELFPKFR----- 105 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--------~~~~~~~~~~~~il~~l~----- 105 (632)
.+..++|++.+.||+|+||+||+|++. + +.||||++..... ...+.+.++ ..++..+.
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~--~------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E-~~~l~~l~~l~~~ 86 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIAD--H------TPVAIKIIAIEGPDLVNGSHQKTFEEILPE-IIISKELSLLSGE 86 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEET--T------EEEEEEEEEESCSSCBTTBCCBCHHHHHHH-HHHHHHHHHGGGC
T ss_pred hcccccchheeeecccCceEEEEEEeC--C------ceEEEEEEecCCccccccccchhHHHHHHH-HHHHHHHHHhhcc
Confidence 355688999999999999999999873 2 5899999975421 111233332 23334443
Q ss_pred ---CCCceeEeeEEEE------------------------------ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHH
Q 006772 106 ---ESQSVCWLHGISV------------------------------INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDI 151 (632)
Q Consensus 106 ---~h~~I~~l~~~~~------------------------------~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~ 151 (632)
.|+||+.+.+++. .++.+||||||++ |++++.+.+ +.+++..+
T Consensus 87 ~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~ 163 (336)
T 2vuw_A 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATA 163 (336)
T ss_dssp SSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHH
T ss_pred ccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHH
Confidence 5888888877654 2678999999997 456666632 57899999
Q ss_pred HHHHHHHHHHHHHHH-hCCceeeeeeCCeEEEecCC--------------------cEEEEecCCceeccCCCCCCCccc
Q 006772 152 LRYGIQLAKGISDLH-SIGLLVLNLKPSNLLLSEHD--------------------QLVLGDFGIPYLLLGRSLSDSDMA 210 (632)
Q Consensus 152 ~~ia~qIa~gL~yLH-s~~IvHRDLKP~NILld~~g--------------------~vkL~DFGlak~~~~~~~~~~~~~ 210 (632)
+.++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 164 ~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~ 235 (336)
T 2vuw_A 164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------G 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------T
T ss_pred HHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------C
Confidence 999999999999999 99999999999999999987 999999999987532 2
Q ss_pred cccCCCccCCccccCCCCCCCCCcccccchhHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhhccCC-C----CCCCCCHH
Q 006772 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCS-IMEMLTGIQPWFGKSV-EEIYHSVVIKKEKP-C----IPSGLPPA 283 (632)
Q Consensus 211 ~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvv-L~EmltG~~PF~~~~~-~ei~~~i~~~~~~p-~----~p~~lp~~ 283 (632)
..+||+.|||||++.+. .+.++|||||+++ .+++++|..||.+... ......+....... . .+..++++
T Consensus 236 ~~~gt~~y~aPE~~~g~----~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGD----GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp EEECCCCTTCSGGGCCC----SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cEEEeecccChhhhcCC----CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence 34799999999999754 3789999998777 7778889999854211 11222222111111 1 12347889
Q ss_pred HHHHHHHhhhcCcCCCCCHHHHH
Q 006772 284 VENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 284 l~~LI~~cL~~DP~~RPs~~ell 306 (632)
+.+||.+||++| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999987 888887
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=338.34 Aligned_cols=251 Identities=21% Similarity=0.241 Sum_probs=187.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
.++|++.+.||+|+||.||+|.+..++ +.||||++.............++..++..+ +||||+.+++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg------~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTG------EQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTT------CCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccc
Confidence 478999999999999999999887655 489999987643333333334444555665 79999999888654
Q ss_pred ----CCEEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc---EEE
Q 006772 120 ----NGKICIAMKFYE-GSVGDRIAQQR-GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ---LVL 190 (632)
Q Consensus 120 ----~~~l~LVmEy~~-GsL~d~l~~~~-~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~---vkL 190 (632)
++..|+||||++ |+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999997 58888776532 236899999999999999999999999999999999999997765 999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH-----
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH----- 265 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~----- 265 (632)
+|||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+......+.
T Consensus 166 ~DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 166 IDLGYAKELDQG----ELCTEFVGTLQYLAPELLEQ---KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp CSCCCCCBTTSC----CCCCCCCSCCTTCSSCSSCC---SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred cccccccccccc----cccccccCCcccCChHHhcc---CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 999999865332 12234578999999999874 468899999999999999999999997653221100
Q ss_pred ----HHHhh---cc------C----CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 006772 266 ----SVVIK---KE------K----PCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306 (632)
Q Consensus 266 ----~i~~~---~~------~----p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell 306 (632)
.+... .. . ..++..+++.+.++|.+||+.||++||++.+++
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000 00 0 012233678999999999999999999998755
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=280.08 Aligned_cols=188 Identities=11% Similarity=-0.018 Sum_probs=125.0
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc------h---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK------E---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~------~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
..++.|++|.+..++....+ ..||+|++.+.. . ....+.+.++.+++.++.+|+||+.+++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg------~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed 313 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFG------EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN 313 (569)
T ss_dssp CC-C--------CCEEEEEC------SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC
T ss_pred hccccCCccccccccccccc------ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE
Confidence 34556666666655544333 479999996531 1 11122244455778888899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+||||||++| +|.+++.+ +++++.. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 314 ~~~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 314 AQSGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp SSEEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred CCEEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCee
Confidence 9999999999996 78888754 3567654 4789999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P 254 (632)
.... .....+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 389 ~~~~---~~~~~t~vGTp~YmAPE~l~g----~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQD---CSWPTNLVQSFFVFVNELFAE----NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC------CCSHHHHHHHHHHHHHHC---------------------CCCCTTHHH
T ss_pred CCCC---CccccCceechhhccHHHhCC----CCCCcccccccccchhhhccccch
Confidence 5432 223455789999999999864 466789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=243.71 Aligned_cols=189 Identities=16% Similarity=0.122 Sum_probs=134.1
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhH-----HHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCA-----KVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~-----~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
...+.||+|+||.||+|.... +.+++|....... ... .+.+.++..++.++ +|+||+.+..++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~ 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLD--------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDV 409 (540)
T ss_dssp ---------CCEEEEEEECSS--------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECC--------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEE
Confidence 335789999999999995332 4789998754321 111 11123344555665 7899996666666
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++..||||||++ |+|.+++.. ++.++.|++.||+|||+++|+||||||+|||++. .+||+|||+++
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred eCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCE
Confidence 7888899999998 677776643 5689999999999999999999999999999999 99999999998
Q ss_pred eccCCCCCCC----ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCC
Q 006772 198 LLLGRSLSDS----DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256 (632)
Q Consensus 198 ~~~~~~~~~~----~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~ 256 (632)
.......... .....+||+.|||||++... ...|+..+|+||..+-..+...++.+|.
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~-~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF-LEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH-HHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHH-HHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 7633210000 11346899999999999752 1247788999999999888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=9.9e-21 Score=195.66 Aligned_cols=143 Identities=13% Similarity=0.059 Sum_probs=104.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-----------------hHHHHHHHHHHHhhhccCC
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-----------------CAKVFVNKFEELFPKFRES 107 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-----------------~~~~~~~~~~~il~~l~~h 107 (632)
|.+.+.||+|+||.||+|.+ .++ +.||||+++..... .......++..++..+. |
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g------~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~ 163 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G 163 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTT------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T
T ss_pred EEecCEeccCCCceEEEEEe-CCC------CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C
Confidence 33449999999999999998 443 48999999643211 01222334445566665 3
Q ss_pred CceeEeeEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC
Q 006772 108 QSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD 186 (632)
Q Consensus 108 ~~I~~l~~~~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g 186 (632)
.++ ..++.. +..|+||||++| +|.+ + .......++.|++.||+|||+++|+||||||+|||++ ++
T Consensus 164 ~~v---~~~~~~-~~~~lvmE~~~g~~L~~-l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAV---PKVYAW-EGNAVLMELIDAKELYR-V--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSS---CCEEEE-ETTEEEEECCCCEEGGG-C--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT
T ss_pred CCc---CeEEec-cceEEEEEecCCCcHHH-c--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC
Confidence 333 333333 456999999986 6655 3 1234557999999999999999999999999999999 99
Q ss_pred cEEEEecCCceeccCCCCCCCccccccCCCccCCccccC
Q 006772 187 QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE 225 (632)
Q Consensus 187 ~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 225 (632)
.+||+|||+|+. +..|+|||++.
T Consensus 230 ~vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE----------------CCCCCHHHHHH
Confidence 999999998863 44578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=175.55 Aligned_cols=138 Identities=17% Similarity=0.129 Sum_probs=96.1
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccE--EEEEEecCCchh-----------------------hHHHHHHHHHH
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHE--LAVKMLLPLKED-----------------------CAKVFVNKFEE 99 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~--VAIK~l~~~~~~-----------------------~~~~~~~~~~~ 99 (632)
|++.+.||+|+||.||+|.+..++ +. ||||+++..... ........+..
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 122 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDG------KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR 122 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETT------EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCC------cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence 789999999999999999985433 47 999997543211 01112233334
Q ss_pred HhhhccCCC-ceeEeeEEEEECCEEEEEEecCC--C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCce
Q 006772 100 LFPKFRESQ-SVCWLHGISVINGKICIAMKFYE--G----SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLH-SIGLL 171 (632)
Q Consensus 100 il~~l~~h~-~I~~l~~~~~~~~~l~LVmEy~~--G----sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLH-s~~Iv 171 (632)
++..+.++. +++.++.. +..+|||||+. | +|.+.... .++.++..++.|++.||.||| +.+|+
T Consensus 123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~giv 193 (258)
T 1zth_A 123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELV 193 (258)
T ss_dssp HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 444543221 12222221 24689999994 3 44443321 235578899999999999999 99999
Q ss_pred eeeeeCCeEEEecCCcEEEEecCCceec
Q 006772 172 VLNLKPSNLLLSEHDQLVLGDFGIPYLL 199 (632)
Q Consensus 172 HRDLKP~NILld~~g~vkL~DFGlak~~ 199 (632)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=163.24 Aligned_cols=136 Identities=15% Similarity=0.118 Sum_probs=89.8
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--------------hhHHH-------HHHHHHHHhhh
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--------------DCAKV-------FVNKFEELFPK 103 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--------------~~~~~-------~~~~~~~il~~ 103 (632)
|++.++||.|+||.||+|.+.. ++.||||+++.... ..... ...++...+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~-------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK-------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT-------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECCC-------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 8999999999999999998643 35899999754210 00000 01112223333
Q ss_pred ccCCCceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 104 l~~h~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
+. +.++....-+.... .+|||||++|..+..+ ...++...++.||+.+|.|||+.|||||||||.|||++
T Consensus 170 L~-~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 170 LY-EEGFPVPEPIAQSR--HTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp HH-HTTCSCCCEEEEET--TEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred HH-hcCCCCCeeeeccC--ceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 32 22222111122222 3799999998433221 12334567889999999999999999999999999999
Q ss_pred cCC----------cEEEEecCCce
Q 006772 184 EHD----------QLVLGDFGIPY 197 (632)
Q Consensus 184 ~~g----------~vkL~DFGlak 197 (632)
++| .+.|+||+-+-
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 877 48999999553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=2.4e-10 Score=115.03 Aligned_cols=140 Identities=13% Similarity=0.003 Sum_probs=100.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
..|++...++.|+++.||++... ++.+++|+........... +..+..++..+..+..++.+++++...+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--------~~~~vlK~~~~~~~~~~~~-~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYKGTTYD-VEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--------SCEEEEEEECGGGTTSTTC-HHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ccceeEeeccCCCCCeEEEEECC--------CCcEEEEeCCcccCCCHHH-HHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 36899999999999999999642 1479999986421111112 23333455555445667788888888899
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS----------------------------------- 167 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs----------------------------------- 167 (632)
.|+||||++|..+.... .+......++.+++.+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred eEEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999985443221 1223345788899999999998
Q ss_pred ------------------------CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 ------------------------IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ------------------------~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876566799999654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=2.3e-09 Score=106.68 Aligned_cols=135 Identities=10% Similarity=-0.026 Sum_probs=88.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc-eeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS-VCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~-I~~l~~~~~~~~ 121 (632)
..+.+....+.|..+.||++... ++ ..+++|+....... . ...+..++..+.++.. ++.++.+...++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~-~g------~~~vlK~~~~~~~~---~-~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ-GR------PVLFVKTDLSGALN---E-LQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT-TS------CCEEEEEECSCTTS---C-HHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCCceEecccCCCCceEEEEecC-CC------CeEEEEeCCcccch---h-hhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 35665544446667999998642 11 36999997653211 1 2223334444444433 556777777777
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG-------------------------------- 169 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~-------------------------------- 169 (632)
..++||||++|..++ .. ... ...++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~-~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL-SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp CEEEEEECCSSEETT-TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCEEEEEecCCcccC-cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 899999999984333 11 111 2356677777888888643
Q ss_pred --------------------------ceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 170 --------------------------LLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 170 --------------------------IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++|+|++|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=7.7e-09 Score=109.25 Aligned_cols=140 Identities=11% Similarity=0.120 Sum_probs=95.2
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEec--CCchhhHHHHHHHHHHHhhhccC-CCceeEeeEEEEEC---
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKFEELFPKFRE-SQSVCWLHGISVIN--- 120 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~--~~~~~~~~~~~~~~~~il~~l~~-h~~I~~l~~~~~~~--- 120 (632)
-.+.|+.|.++.||+..... ..+++|+.. +............+..++..+.. ...++.++.++...
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~--------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG--------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS--------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred eEEEcCCcccceEEEEEECC--------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 36779999999999987532 368888875 32211112223334444444443 23466677766655
Q ss_pred CEEEEEEecCCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 006772 121 GKICIAMKFYEGSVG-DRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-------------------------------- 167 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~-d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-------------------------------- 167 (632)
+..|+||||++|... +. .-..++..+...++.+++..|..||+
T Consensus 114 g~~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp SSCEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 458999999998432 21 11346788888999999999999997
Q ss_pred --------------------------CCceeeeeeCCeEEEecCCc--EEEEecCCcee
Q 006772 168 --------------------------IGLLVLNLKPSNLLLSEHDQ--LVLGDFGIPYL 198 (632)
Q Consensus 168 --------------------------~~IvHRDLKP~NILld~~g~--vkL~DFGlak~ 198 (632)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=1.1e-08 Score=105.58 Aligned_cols=186 Identities=13% Similarity=0.096 Sum_probs=110.4
Q ss_pred eEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc--eeEeeEEEEECC---EE
Q 006772 49 HRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS--VCWLHGISVING---KI 123 (632)
Q Consensus 49 ~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~--I~~l~~~~~~~~---~l 123 (632)
+.++.|.+..||+.. ..+++|+.... .. ......+..++..+..+.. ++.+......++ ..
T Consensus 26 ~~~~~G~~n~v~~v~-----------~~~vlR~~~~~--~~-~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----------RDFIFKFPKHS--RG-STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CEEEECSSEEEEEST-----------TSEEEEEESSH--HH-HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred EecCCCCcceEEEEC-----------CEEEEEecCCc--ch-HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 458999999999863 25899986432 11 2223334445544433322 233333322222 35
Q ss_pred EEEEecCCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 006772 124 CIAMKFYEGSVG-DRIAQQRGGKLPLPDILRYGIQLAKGISDLHS----------------------------------- 167 (632)
Q Consensus 124 ~LVmEy~~GsL~-d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs----------------------------------- 167 (632)
|+||++++|..+ +... ..++..+...++.+++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 889999998433 2222 256777888888888888888886
Q ss_pred -----------------------CCceeeeeeCCeEEEec--CCcEEEEecCCceeccCCCCCCCccccccCCCccCCcc
Q 006772 168 -----------------------IGLLVLNLKPSNLLLSE--HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222 (632)
Q Consensus 168 -----------------------~~IvHRDLKP~NILld~--~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE 222 (632)
..++|+|++|.|||++. .+.+.|+||+.+...... .+.........-..|+
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~----~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD----NDFISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT----HHHHTTCCTTTSCCHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH----HHHHHHHhhccccCHH
Confidence 13699999999999998 456789999988654211 0000000000001222
Q ss_pred ccCC--CCCC---------CCCcccccchhHHHHHHHHhCCCCCC
Q 006772 223 QWEP--EVRG---------PISFETDTWGFGCSIMEMLTGIQPWF 256 (632)
Q Consensus 223 ~~~~--~~~g---------~~t~ksDvwSlGvvL~EmltG~~PF~ 256 (632)
.... ..++ ......+.|+++.++|.+.+|..+|.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1110 0000 11223689999999999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.4e-05 Score=76.51 Aligned_cols=139 Identities=14% Similarity=-0.002 Sum_probs=84.9
Q ss_pred CeEEEeEEcccCce-EEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 44 SLKLKHRIGRGPFG-DVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 44 ~y~l~~~IG~G~FG-~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.|+.. .+..|..| .||+......+ +.+.+|+-.... ...+..+...+..+..+--+..++.++..++.
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~------~~~~lk~~~~~~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~ 94 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNA------PELFLKHGKGSV----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD 94 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTC------CCEEEEEEETHH----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCC------eEEEEEECCCCC----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCe
Confidence 34543 45556555 68987654332 468899865321 22233333444444333335667778888999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI---------------------------------- 168 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~---------------------------------- 168 (632)
.|+|||+++|......... .......+..+++..|.-||+.
T Consensus 95 ~~lvme~l~G~~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 95 AWLLTTAIPGKTAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEEEEECCCSEEHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEEEEeeCCccccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 9999999998433222111 1122233445555555555531
Q ss_pred ------------------------CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 169 ------------------------GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 169 ------------------------~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877778999997643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=7.7e-05 Score=77.05 Aligned_cols=134 Identities=18% Similarity=0.195 Sum_probs=81.7
Q ss_pred EeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCC-C-ceeEeeEEEE-ECCEEE
Q 006772 48 KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRES-Q-SVCWLHGISV-INGKIC 124 (632)
Q Consensus 48 ~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h-~-~I~~l~~~~~-~~~~l~ 124 (632)
.+.++.|....||+. + ..+++|+-.. .. .......+..++..+.++ + .++....++. ..+..|
T Consensus 24 v~~l~~G~~n~v~~v-----g------~~~VlR~~~~--~~-~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~ 89 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----N------GDWVFRFPKS--QQ-GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF 89 (306)
T ss_dssp EEEEEECSSEEEEEE-----T------TTEEEEEESS--HH-HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred eeecCCCcceeEEEE-----C------CEEEEEecCC--ch-HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence 345788888999987 1 2588887422 22 223344444555555443 2 2444444443 356678
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 006772 125 IAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSI------------------------------------ 168 (632)
Q Consensus 125 LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~------------------------------------ 168 (632)
++|||++|..+....- ..++..+...++.+++..|..||+.
T Consensus 90 ~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp EEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred EEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 9999999843332110 1234445555555555555555532
Q ss_pred ------------------------CceeeeeeCCeEEEec---CCc-EEEEecCCcee
Q 006772 169 ------------------------GLLVLNLKPSNLLLSE---HDQ-LVLGDFGIPYL 198 (632)
Q Consensus 169 ------------------------~IvHRDLKP~NILld~---~g~-vkL~DFGlak~ 198 (632)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999997 455 58999997654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00045 Score=71.11 Aligned_cols=30 Identities=23% Similarity=0.217 Sum_probs=27.2
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=6.3e-05 Score=80.24 Aligned_cols=30 Identities=20% Similarity=0.254 Sum_probs=25.6
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..++|+|+.|.|||++.+ .++|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 569999999999999875 489999987654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=9.3e-05 Score=77.50 Aligned_cols=30 Identities=17% Similarity=0.173 Sum_probs=25.3
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 468999999999999964457899999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0039 Score=61.52 Aligned_cols=138 Identities=11% Similarity=-0.013 Sum_probs=91.9
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCcccc
Q 006772 133 SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211 (632)
Q Consensus 133 sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~ 211 (632)
+|.+.+. ..+.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 34 SLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 5666665 456899999999999999999877621 1112333457999999999998864 2110
Q ss_pred ccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 006772 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGC 291 (632)
Q Consensus 212 ~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~c 291 (632)
.....+.+||... ...+.+.=|||||++||..+-= +.++..+..+|++|.+||..|
T Consensus 98 -~~~~~~~~pe~~~----~~~te~~~IysLG~tLY~ALDy-------------------gL~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 -AGEPPPVAGKLGY----SQCMETEVIESLGIIIYKALDY-------------------GLKENEERELSPPLEQLIDHM 153 (229)
T ss_dssp ----------CCSS----SSSCHHHHHHHHHHHHHHHHTT-------------------TCCTTEEECCCHHHHHHHHHH
T ss_pred -ccccCCCChhhcc----ccchHHHHHHHHHHHHHHHhhc-------------------CCCcccchhhCHHHHHHHHHH
Confidence 0123466888763 2356788899999999987742 222334568999999999999
Q ss_pred hhcC-------------------------cCCCCCHHHHHHHHH
Q 006772 292 FEYD-------------------------LRNRPLMADILHAFE 310 (632)
Q Consensus 292 L~~D-------------------------P~~RPs~~ell~~Le 310 (632)
.... +..|.+.++|++.-+
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 8662 356778888887543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.002 Score=69.36 Aligned_cols=81 Identities=9% Similarity=0.079 Sum_probs=47.4
Q ss_pred HhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccC--CCccCCccccCCCCCCCCCcccccchhHH
Q 006772 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG--TPNYMAPEQWEPEVRGPISFETDTWGFGC 243 (632)
Q Consensus 166 Hs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~G--T~~YmAPE~~~~~~~g~~t~ksDvwSlGv 243 (632)
+...++|+|++|.|||++.++ +.|+||+.+...... .+...... ...|++|+.........-....++.++..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~----~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG----FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH----HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH----HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 356799999999999999877 999999987653210 01111111 13456666543110101122344556777
Q ss_pred HHHHHHhC
Q 006772 244 SIMEMLTG 251 (632)
Q Consensus 244 vL~EmltG 251 (632)
.+|+.+++
T Consensus 305 ~~~~~y~~ 312 (420)
T 2pyw_A 305 QTWNLFNK 312 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 77777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.015 Score=60.37 Aligned_cols=75 Identities=16% Similarity=0.249 Sum_probs=49.3
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccC--CCceeEeeEEEEECCEE
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE--SQSVCWLHGISVINGKI 123 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~--h~~I~~l~~~~~~~~~l 123 (632)
.-.+.|+.|.+..+|+.... ...+++|+..... ......+...+..+.. ...++.++..+..++..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~--------~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE--------VQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS--------SCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeeEEeCCccceeeeEEEEC--------CCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 34678999999999998742 1368899875421 2223333344444432 24466677777777899
Q ss_pred EEEEecCCC
Q 006772 124 CIAMKFYEG 132 (632)
Q Consensus 124 ~LVmEy~~G 132 (632)
|+||||++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999987
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0053 Score=62.63 Aligned_cols=29 Identities=10% Similarity=0.093 Sum_probs=24.7
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++|+|+.|.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 6667889999997654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.39 E-value=0.044 Score=55.90 Aligned_cols=142 Identities=18% Similarity=0.204 Sum_probs=73.6
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCC-chhhHHHHHHHHHHHhhhcc----CCCceeEee-E--
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPL-KEDCAKVFVNKFEELFPKFR----ESQSVCWLH-G-- 115 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~-~~~~~~~~~~~~~~il~~l~----~h~~I~~l~-~-- 115 (632)
...-.+.|+.|....+|+..... ..+++|+..+. ....... +..++..+. ..|.++... +
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~--------g~~vlk~~~~~~~~~~l~~----e~~~l~~L~~~g~~vP~~~~~~~g~~ 90 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK--------DPLILTLYEKRVEKNDLPF----FLGLMQHLAAKGLSCPLPLPRKDGEL 90 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS--------CCEEEEEECC---CCHHHH----HHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred cceEeeccCCCcccceEEEEeCC--------ccEEEEEeCCCCCHHHHHH----HHHHHHHHHHCCCCCCcccCCCCCCE
Confidence 44456778889889999987532 15889988652 2122111 112222221 123322110 1
Q ss_pred EEEECCEEEEEEecCCCCH------------HHH---HHHhc-C--CC----CC---HHHHHH------------HHHHH
Q 006772 116 ISVINGKICIAMKFYEGSV------------GDR---IAQQR-G--GK----LP---LPDILR------------YGIQL 158 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~GsL------------~d~---l~~~~-~--~~----l~---~~~~~~------------ia~qI 158 (632)
+...++..+++|+|++|.. .+. ++... . .. .. +..... +...+
T Consensus 91 ~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l 170 (322)
T 2ppq_A 91 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 170 (322)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred EEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHH
Confidence 1234577899999998731 111 11111 0 00 11 111000 01124
Q ss_pred HHHHHHHHh-------CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 159 AKGISDLHS-------IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 159 a~gL~yLHs-------~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
...+++++. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 445566653 368999999999999987666899999664
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.032 Score=56.33 Aligned_cols=78 Identities=13% Similarity=-0.019 Sum_probs=44.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCc--eeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQS--VCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~--I~~l~~~~~~~ 120 (632)
....-.+.+|.|..+.||+.+... ++.|.+|+-....... ..+++.+...+..+..... ++.++. ..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~D-------G~~~~vK~~~~~~~~~-~~~~~~Ea~~L~~L~~~~~vpvP~v~~--~~~ 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELAD-------GTPLFVKALPDDAPAL-DGLFRAEALGLDWLGRSFGSPVPQVAG--WDD 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT-------SCEEEEEECCTTCCCC-TTHHHHHHHHHHHHTCSTTCCSCCEEE--EET
T ss_pred CCeEEEEecCCCCCeEEEEEEECC-------CCEEEEEEeCCCCcch-hhHHHHHHHHHHHHHhhCCCCcceEEe--ccC
Confidence 456668899999999999997542 3579999865432211 1223333333444432211 223333 233
Q ss_pred CEEEEEEecCCC
Q 006772 121 GKICIAMKFYEG 132 (632)
Q Consensus 121 ~~l~LVmEy~~G 132 (632)
-++||||+++
T Consensus 85 --~~lv~e~l~~ 94 (288)
T 3f7w_A 85 --RTLAMEWVDE 94 (288)
T ss_dssp --TEEEEECCCC
T ss_pred --ceEEEEeecc
Confidence 3689999974
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.27 E-value=0.071 Score=54.52 Aligned_cols=29 Identities=14% Similarity=0.022 Sum_probs=24.7
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999999 4 899999996643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.25 Score=53.85 Aligned_cols=78 Identities=9% Similarity=0.034 Sum_probs=41.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.+.+. .+.|+.|-...+|+...... .+.+++|+..+....... ...+..++..+..+...+.+++.+ .+
T Consensus 108 ~~~~~-i~~lsgG~tN~~y~v~~~~~------~~~~vLRi~g~~~~~~id--R~~E~~vl~~L~~~gl~P~ll~~~--~~ 176 (458)
T 2qg7_A 108 VDSLE-FQIINGGITNILIKVKDMSK------QAKYLIRLYGPKTDEIIN--REREKKISCILYNKNIAKKIYVFF--TN 176 (458)
T ss_dssp STTEE-EEEECC--CEEEEEEEETTT------TEEEEEEEECC-CCSCSC--HHHHHHHHHHHTTSSSBCCEEEEE--TT
T ss_pred ccCeE-EEEcCCCeEeEEEEEEECCC------CceEEEEECCCChhhhcC--HHHHHHHHHHHHhcCCCCCEEEEe--CC
Confidence 34555 45788888999999976431 146889987542211100 012223344444444445566655 33
Q ss_pred EEEEEEecCCC
Q 006772 122 KICIAMKFYEG 132 (632)
Q Consensus 122 ~l~LVmEy~~G 132 (632)
.+||||++|
T Consensus 177 --G~v~e~I~G 185 (458)
T 2qg7_A 177 --GRIEEFMDG 185 (458)
T ss_dssp --EEEEECCCS
T ss_pred --eEEEEeeCC
Confidence 259999987
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.96 E-value=0.14 Score=55.30 Aligned_cols=82 Identities=16% Similarity=0.154 Sum_probs=43.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCC-cccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADD-FDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~-~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
+.+. .+.|+.|-...||++........ ....+.+++|+...... ...+.. +..++..+..+...+.+++.+ .+
T Consensus 74 ~~~~-v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~-E~~~l~~L~~~g~~P~l~~~~--~~ 147 (429)
T 1nw1_A 74 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVA-ESVIFTLLSERHLGPKLYGIF--SG 147 (429)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHH-HHHHHHHHHHTTSSSCEEEEE--TT
T ss_pred cceE-EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHH-HHHHHHHHHhCCCCCcEEEEe--CC
Confidence 4444 56788888899999976431100 01135799998844211 022222 223333333333334555543 23
Q ss_pred EEEEEEecCCC
Q 006772 122 KICIAMKFYEG 132 (632)
Q Consensus 122 ~l~LVmEy~~G 132 (632)
.+||||++|
T Consensus 148 --g~v~e~l~G 156 (429)
T 1nw1_A 148 --GRLEEYIPS 156 (429)
T ss_dssp --EEEECCCCE
T ss_pred --CEEEEEeCC
Confidence 289999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.095 Score=53.89 Aligned_cols=32 Identities=19% Similarity=0.155 Sum_probs=27.5
Q ss_pred CCceeeeeeCCeEEEecC----CcEEEEecCCceec
Q 006772 168 IGLLVLNLKPSNLLLSEH----DQLVLGDFGIPYLL 199 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~----g~vkL~DFGlak~~ 199 (632)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999875 68999999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.71 E-value=0.062 Score=56.28 Aligned_cols=29 Identities=21% Similarity=0.193 Sum_probs=24.1
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++|+|+.+.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999998654 89999997653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.69 E-value=0.078 Score=56.47 Aligned_cols=150 Identities=17% Similarity=0.197 Sum_probs=76.5
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCC-CcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSAD-DFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~-~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
.+.+++ +.|..|-...+|+........ .....+.+++|+..+... ...... ++..++..+..+...+.+++.+ +
T Consensus 50 ~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-~~~~~~-rE~~vl~~L~~~gv~P~ll~~~--~ 124 (379)
T 3feg_A 50 PEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-GVDSLV-LESVMFAILAERSLGPQLYGVF--P 124 (379)
T ss_dssp GGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-CHHHHH-HHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred cCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-hHHHHH-HHHHHHHHHHhcCCCCeEEEEc--C
Confidence 455654 467778889999987642100 001235799998643211 122222 2333444443333334555444 3
Q ss_pred CEEEEEEecCCCCH---------------HHHHHHhcC------CCCC--HHHHHHHHHHHHH-----------------
Q 006772 121 GKICIAMKFYEGSV---------------GDRIAQQRG------GKLP--LPDILRYGIQLAK----------------- 160 (632)
Q Consensus 121 ~~l~LVmEy~~GsL---------------~d~l~~~~~------~~l~--~~~~~~ia~qIa~----------------- 160 (632)
+ .+||||++|.. .+.+.+... +... +.++.++..++..
T Consensus 125 ~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 125 E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 3 28999998711 111221111 1122 3455555544422
Q ss_pred --HHHHHHh--------CCceeeeeeCCeEEEecC----CcEEEEecCCcee
Q 006772 161 --GISDLHS--------IGLLVLNLKPSNLLLSEH----DQLVLGDFGIPYL 198 (632)
Q Consensus 161 --gL~yLHs--------~~IvHRDLKP~NILld~~----g~vkL~DFGlak~ 198 (632)
.++.|.. ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2333332 248999999999999976 7899999997643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.16 E-value=0.27 Score=51.09 Aligned_cols=31 Identities=19% Similarity=0.365 Sum_probs=27.3
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888999999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.40 E-value=0.55 Score=50.64 Aligned_cols=29 Identities=17% Similarity=0.289 Sum_probs=25.6
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++|+|+.+.||| +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 8888999999997653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.88 E-value=1.5 Score=46.41 Aligned_cols=29 Identities=31% Similarity=0.401 Sum_probs=24.6
Q ss_pred ceeeeeeCCeEEE------ecCCcEEEEecCCcee
Q 006772 170 LLVLNLKPSNLLL------SEHDQLVLGDFGIPYL 198 (632)
Q Consensus 170 IvHRDLKP~NILl------d~~g~vkL~DFGlak~ 198 (632)
++|.|+.+.|||+ ++++.+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4467899999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 632 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 9e-45
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 21/273 (7%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEEL-FPKF 104
++ +G+G FG+V+LA QS A+K+L + + A V E+
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQSKFIL------ALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 105 RESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
++ L+G ++ + +++ G+V + Q+ K Y +LA +S
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 120
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
HS ++ ++KP NLLL +L + DFG S GT +Y+ PE
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFG-----WSVHAPSSRRTTLCGTLDYLPPEM 175
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPA 283
E + D W G E L G P+ + +E Y I + + P +
Sbjct: 176 IE---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR--ISRVEFTFPDFVTEG 230
Query: 284 VENVIIGCFEYDLRNRPLMADIL-HAFESSQNA 315
++I +++ RP++ ++L H + ++ ++
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 2e-44
Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 19/273 (6%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP L IG G FG V+ A ++++ A+K + + + + + +E
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVV------AIKKMSYSGKQSNEKWQDIIKE 65
Query: 100 --LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
K R + G + + M++ GS D + + L +I
Sbjct: 66 VRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHG 123
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
+G++ LHS ++ ++K N+LLSE + LGDFG ++ ++ +GTP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANS--FVGTPY 176
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277
+MAPE G + D W G + +E+ P F + + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
N + C + ++RP +L H F
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-44
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 13/278 (4%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---LKEDCAKVFVNK 96
I L+L ++G G FG V + AVK L P + + F+ +
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV---AVKCLKPDVLSQPEAMDDFIRE 61
Query: 97 FEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGI 156
+ + +++ L+G+ V+ + + + ++ G L + RY +
Sbjct: 62 VNAM--HSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
Q+A+G+ L S + +L NLLL+ D + +GDFG+ L R
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275
+ APE + S +DTW FG ++ EM T G +PW G + +I H + + E+
Sbjct: 179 AWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313
P P + NV++ C+ + +RP + +Q
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 62/286 (21%), Positives = 118/286 (41%), Gaps = 32/286 (11%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W I + + RIG G FG V+ H ++AVKML + F
Sbjct: 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLN--VTAPTPQQLQAF 51
Query: 98 EELFPKFRESQSVCWLHGISVI-------NGKICIAMKFYE-GSVGDRIAQQRGGKLPLP 149
+ E + ++++ ++ I ++ E S+ + K +
Sbjct: 52 K------NEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHL-HIIETKFEMI 104
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
++ Q A+G+ LH+ ++ +LK +N+ L E + +GDFG+ + R
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK-SRWSGSHQF 163
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269
G+ +MAPE + + P SF++D + FG + E++TG P+ + + +V
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
Query: 270 KK----EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ + + S P A++ ++ C + RPL IL + E
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 7e-43
Identities = 52/275 (18%), Positives = 106/275 (38%), Gaps = 16/275 (5%)
Query: 40 IDPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE 98
++P ++ +G G FG V+ A + +++ A K++ E+ + ++ + +
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLA------AAKVIDTKSEEELEDYMVEID 61
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158
L + ++ L + I ++F G D + + L I Q
Sbjct: 62 IL--ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
++ LH ++ +LK N+L + + L DFG+ + +GTP +
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---TIQRRDSFIGTPYW 176
Query: 219 MAPEQWEPEV--RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV-IKKEKPC 275
MAPE E P ++ D W G +++EM P + + + +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
PS ++ + C E ++ R + +L H F
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-40
Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 24/279 (8%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W ++ LKL IG+G FGDV L + + ++AVK + + A+ F+ +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGN--------KVAVKCIK--NDATAQAFLAEA 51
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
+ + R S V L I G + I ++ GS+ D + + L +L++ +
Sbjct: 52 S-VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
+ + + L + +L N+L+SE + + DFG+ S
Sbjct: 111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPV 164
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275
+ APE S ++D W FG + E+ + G P+ ++++ V K K
Sbjct: 165 KWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMD 220
Query: 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314
P G PPAV V+ C+ D RP + E +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 28/293 (9%)
Query: 39 WIDPTSLKLKHR-IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
++D L L+ + +G G FG V + +AVK+L D
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVV----KTVAVKILKNEAND------PAL 51
Query: 98 EELFPKFRESQSVCWLHGISVIN-------GKICIAMKFYE-GSVGDRIAQQRGGKLPLP 149
++ E+ + L ++ + M+ E G + + Q+ +
Sbjct: 52 KDEL--LAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDK 107
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
+I+ Q++ G+ L + +L N+LL + DFG+ L
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVV 268
+ APE S ++D W FG + E + G +P+ G E+ ++
Sbjct: 168 THGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-ML 223
Query: 269 IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGE 321
K E+ P+G P + +++ C+ YD+ NRP A + + V N+G
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 47/272 (17%), Positives = 107/272 (39%), Gaps = 6/272 (2%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
I P+ + + IG G FG+V+ S + +A+K L + +V
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ +F + G+ + I ++ E D+ +++ G+ + ++ +A
Sbjct: 62 IMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
G+ L ++ + +L N+L++ + + DFG+ +L + + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSG 279
APE + +D W FG + E++T + + + + + P
Sbjct: 181 APEAIS---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P A+ +++ C++ + RP ADI+ +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-39
Identities = 59/281 (20%), Positives = 118/281 (41%), Gaps = 23/281 (8%)
Query: 37 RPW------IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCA 90
+PW + +LKL R+G G FG+VW+ ++ ++AVK L
Sbjct: 1 KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSL-KQGSMSP 52
Query: 91 KVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLP 149
F+ + + K + Q + L+ + V I I ++ E GS+ D + G KL +
Sbjct: 53 DAFLAEANLM--KQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
+L Q+A+G++ + + +L+ +N+L+S+ + DFG+ L+ + +
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269
A + APE G + ++D W FG + E++T + + +
Sbjct: 170 AK--FPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
+ + P P + ++ C++ +RP + E
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 46/269 (17%), Positives = 93/269 (34%), Gaps = 17/269 (6%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
IDP L +G G FG V +++A+KM+ F+ + +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSMS-EDEFIEEAKV 52
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ + + L+G+ I I ++ ++ + +L +
Sbjct: 53 M--MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
+ + L S L +L N L+++ + + DFG+ +L + S +
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG--SKFPVRWS 168
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
PE S ++D W FG + E+ + G P+ + E + + + P
Sbjct: 169 PPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPH 224
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307
V ++ C+ RP +L
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 55/290 (18%), Positives = 116/290 (40%), Gaps = 28/290 (9%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
+L+ +G G FG V AT + + ++AVKML + + + +
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI-QVAVKMLKEKADSSEREALMSELK 92
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG--------------- 143
+ + +++ L G ++G I + ++ G + + + +R
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 144 ------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197
L D+L + Q+AKG+ L + +L N+L++ + + DFG+
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWF 256
++ S R +MAPE G + ++D W +G + E+ + G+ P+
Sbjct: 213 DIMSDSNYVVRGNAR-LPVKWMAPESLF---EGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 257 GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL 306
G V+ ++ ++ K P + ++ C+ +D R RP ++
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 49/272 (18%), Positives = 106/272 (38%), Gaps = 19/272 (6%)
Query: 41 DPTSL-KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
DP +IG+G G V+ A + + A++ + ++ ++ +N+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEV------AIRQMNLQQQPKKELIINEILV 70
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ + ++ ++ ++ ++ + M++ G G + I +
Sbjct: 71 M--RENKNPNIVNYLDSYLVGDELWVVMEYLAG--GSLTDVVTETCMDEGQIAAVCRECL 126
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
+ + LHS ++ ++K N+LL + L DFG + + S + +GTP +M
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWM 183
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-KPCIPS 278
APE R + D W G +EM+ G P+ ++ + + + P
Sbjct: 184 APEVVT---RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
L + + C + D+ R ++L H F
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 3e-39
Identities = 55/273 (20%), Positives = 116/273 (42%), Gaps = 15/273 (5%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
++ T + +KH++G G +G+V+ + + +AVK L + + F+ +
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQL 158
+ K + ++ L G+ I +F G++ D + + ++ +L Q+
Sbjct: 67 M--KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
+ + L + +L N L+ E+ + + DFG+ L+ G + + A +
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK--FPIKW 182
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
APE S ++D W FG + E+ T + + ++ K + P
Sbjct: 183 TAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
G P V ++ C++++ +RP A+I AFE+
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 4e-39
Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 20/275 (7%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G FG V T + ++F A K ++ E + + + +
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNF------AAKFVMTPHESDKETVRKEIQTM--SVL 80
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
++ LH + ++ + +F G K+ + + Y Q+ KG+ +
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 166 HSIGLLVLNLKPSNLLLSEHD--QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
H + L+LKP N++ + +L L DFG+ L + GT + APE
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEV 196
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--CIPSGLP 281
E P+ + TD W G +L+G+ P+ G++ +E +V SG+
Sbjct: 197 AE---GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 282 PAVENVIIGCFEYDLRNRPLMADIL-HAFESSQNA 315
++ I D R + L H + + NA
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 1e-38
Identities = 53/279 (18%), Positives = 98/279 (35%), Gaps = 27/279 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFEELFP-- 102
+ K +GRG V H + ++ AVK++ + + V + E
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEY------AVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 103 -----KFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
K ++ L N + + G + D + L + +
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMR 117
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
L + I LH + ++ +LKP N+LL + + L DFG L + GTP
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTP 173
Query: 217 NYMAPEQWEPEV---RGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273
+Y+APE E + E D W G + +L G P++ + + ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 274 PCIP--SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P V++++ + R + L H F
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 17/268 (6%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFEELFPKF 104
L +G G +G+V LA + + + AVK++ + DC + + K
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAV------AVKIVDMKRAVDCPENIKKEICIN--KM 59
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
++V +G + +++ G + DRI + +P PD R+ QL G+
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 117
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
LH IG+ ++KP NLLL E D L + DFG+ + + + + GT Y+APE
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIKKEKPCIPSGLPP 282
+ R + D W G + ML G PW S + Y KK +
Sbjct: 177 LKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 283 AVENVIIGCFEYDLRNRPLMADIL-HAF 309
A ++ + R + DI +
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRW 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 51/289 (17%), Positives = 100/289 (34%), Gaps = 28/289 (9%)
Query: 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
P +D +K + IG G FG V A + + A+K +
Sbjct: 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGE 60
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRI--------------AQQR 142
E+ K ++ L G G + +A+++ G++ D + A
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 143 GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202
L +L + +A+G+ L + +L N+L+ E+ + DFG+
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVE 261
+MA E + +D W +G + E+++ + G +
Sbjct: 181 VKKTMGR----LPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233
Query: 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
E+Y + + + P V +++ C+ RP A IL +
Sbjct: 234 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 58/276 (21%), Positives = 99/276 (35%), Gaps = 29/276 (10%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELF 101
LK IGRG F V+ ++ E+A L K +F+ E+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQ--DRKLTKSERQRFKEEAEML 62
Query: 102 PKFRESQSV---CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158
+ V I + + +R + + + + Q+
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY-LKRFKVMKIKVLRSWCRQI 121
Query: 159 AKGISDLHSIGLLVL--NLKPSNLLLSEHD-QLVLGDFGIPYLLLGRSLSDSDMALRLGT 215
KG+ LH+ ++ +LK N+ ++ + +GD G L S +GT
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG-----LATLKRASFAKAVIGT 176
Query: 216 PNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVVIKKEKP 274
P +MAPE + D + FG ++EM T P+ + +IY V +
Sbjct: 177 PEFMAPEMY----EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P V+ +I GC + R + D+L HAF
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 4e-38
Identities = 49/274 (17%), Positives = 114/274 (41%), Gaps = 11/274 (4%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
ID + +K++ IG G FG+V +A+K L + +
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLK---LPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 79
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ +F +V L G+ + + I +F E D +Q G+ + ++ +A
Sbjct: 80 IMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSD--SDMALRLGTPN 217
G+ L + + +L N+L++ + + DFG+ L + +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276
+ APE + + +D W +G + E+++ G +P++ + +++ +++ + +
Sbjct: 199 WTAPEAIQ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPP 254
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
P P A+ +++ C++ D +RP I++ +
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 55/274 (20%), Positives = 116/274 (42%), Gaps = 16/274 (5%)
Query: 39 W-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W I SL+L+ ++G+G FG+VW+ T + + +A+K L P + F+ +
Sbjct: 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTMS-PEAFLQEA 63
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ + K + + L+ + + +GS+ D + + G L LP ++ Q
Sbjct: 64 QVM--KKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPN 217
+A G++ + + + +L+ +N+L+ E+ + DFG+ L+ +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG--AKFPIK 179
Query: 218 YMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277
+ APE G + ++D W FG + E+ T + + V V + + P
Sbjct: 180 WTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236
Query: 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P ++ +++ C+ + RP + E
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 63/308 (20%), Positives = 116/308 (37%), Gaps = 29/308 (9%)
Query: 22 DPDHLRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKM 81
DP L P + L +G G FG V AT + D +AVKM
Sbjct: 8 DPTQL------PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS-DAAMTVAVKM 60
Query: 82 LLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQ 140
L P + + ++ ++ L G I G + ++ G + + + +
Sbjct: 61 LKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR 120
Query: 141 QRG----------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE 184
+R L L D+L + Q+AKG++ L S + +L N+LL+
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180
Query: 185 HDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCS 244
+ DFG+ + S + +MAPE +FE+D W +G
Sbjct: 181 GRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIF 236
Query: 245 IMEMLTGIQPWF-GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMA 303
+ E+ + + G V+ ++ ++ + + P P + +++ C++ D RP
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 304 DILHAFES 311
I+ E
Sbjct: 297 QIVQLIEK 304
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 23/270 (8%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---LKEDCAKVFVNKFEELFP 102
L +G+G FG V+LA ++ F A+K L L +D + + + + +
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFF------AIKALKKDVVLMDDDVECTMVE-KRVLS 57
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
E + + + M++ G + I Q K L Y ++ G
Sbjct: 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG 115
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAP 221
+ LHS G++ +LK N+LL + + + DFG+ L D+ GTP+Y+AP
Sbjct: 116 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN---MLGDAKTNTFCGTPDYIAP 172
Query: 222 EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281
E + D W FG + EML G P+ G+ EE++H I+ + P P L
Sbjct: 173 EILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFYPRWLE 227
Query: 282 PAVENVIIGCFEYDLRNRPLMADIL--HAF 309
+++++ F + R + + H
Sbjct: 228 KEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (352), Expect = 3e-37
Identities = 54/270 (20%), Positives = 102/270 (37%), Gaps = 22/270 (8%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G FG V + F K + N+ +
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVF------VAKFINTPYPLDKYTVKNEISIM--NQL 83
Query: 106 ESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
+ LH ++ + ++F G + DRI K+ +++ Y Q +G+
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKH 142
Query: 165 LHSIGLLVLNLKPSNLLLSEHD--QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+H ++ L++KP N++ + + DFG+ L D + + T + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPE 198
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--CIPSGL 280
+ R P+ F TD W G +L+G+ P+ G+ E +V + S +
Sbjct: 199 IVD---REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 281 PPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P ++ I + + R R + D L H +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-37
Identities = 45/265 (16%), Positives = 100/265 (37%), Gaps = 17/265 (6%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFPKFRES 107
+G G FG V + + ++A+K+L K+ K + ++ + +
Sbjct: 17 LGCGNFGSVRQGVYRMR----KKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLD-N 68
Query: 108 QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS 167
+ L G+ + + M+ G + + ++P+ ++ Q++ G+ L
Sbjct: 69 PYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127
Query: 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE 227
+ +L N+LL + DFG+ L + + + APE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-- 185
Query: 228 VRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVEN 286
S +D W +G ++ E L+ G +P+ E+ + + ++ P PP +
Sbjct: 186 -FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYA 243
Query: 287 VIIGCFEYDLRNRPLMADILHAFES 311
++ C+ Y +RP + +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-37
Identities = 56/297 (18%), Positives = 109/297 (36%), Gaps = 23/297 (7%)
Query: 33 PTQTRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP-LKEDCA 90
P W LKL +GRG FG V A +AVKML
Sbjct: 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATC-RTVAVKMLKEGATHSEH 60
Query: 91 KVFVNKFEELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGK----- 145
+ +++ + L V L + G + + ++F + + + +
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 146 ----------LPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195
L L ++ Y Q+AKG+ L S + +L N+LLSE + + + DFG+
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPW 255
+ + +MAPE + ++D W FG + E+ +
Sbjct: 181 A-RDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASP 236
Query: 256 F-GKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ G ++E + + + + P P + ++ C+ + RP ++++ +
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-37
Identities = 54/289 (18%), Positives = 109/289 (37%), Gaps = 18/289 (6%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKF 97
P K +G G F V LA ++ ++ A+K+L + ++ +V +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREY------AIKILEKRHIIKENKVPYVTRE 58
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGI 156
++ + L+ + K+ + + + G + I ++ G Y
Sbjct: 59 RDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTA 115
Query: 157 QLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
++ + LH G++ +LKP N+LL+E + + DFG +L S + +GT
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGTA 174
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276
Y++PE +D W GC I +++ G+ P+ + I+ I K +
Sbjct: 175 QYVSPELLT---EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--IIKLEYDF 229
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGL 325
P P +++ D R ++ + + W L
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-36
Identities = 52/272 (19%), Positives = 105/272 (38%), Gaps = 17/272 (6%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
IDP+ L IG G FG V L ++A+K + + F+ + E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMS-EEDFIEEAEV 53
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ + L+G+ + IC+ +F E + + G +L + +
Sbjct: 54 M--MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
+G++ L ++ +L N L+ E+ + + DFG+ +L + S +
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG--TKFPVKWA 169
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
+PE + S ++D W FG + E+ + G P+ +S E+ + + P
Sbjct: 170 SPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPR 225
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
V ++ C++ +RP + +L
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 57/273 (20%), Positives = 108/273 (39%), Gaps = 12/273 (4%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
I ++L IG G FGDV + + +A+K D + +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYM---SPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+F + L G+ + + I M+ Q R L L ++ Y QL+
Sbjct: 61 TMRQFD-HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
++ L S + ++ N+L+S +D + LGDFG+ + + + +M
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK--LPIKWM 176
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
APE + +D W FG + E+L G++P+ G ++ + E+ +P
Sbjct: 177 APESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP 232
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
PP + +++ C+ YD RP ++ +
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 60/276 (21%), Positives = 106/276 (38%), Gaps = 26/276 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKFEELFPK 103
++ + IG G +G L K L + E ++ V++ L +
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDG------KILVWKELDYGSMTEAEKQMLVSEVNLLR-E 59
Query: 104 FRESQSVCWLH-GISVINGKICIAMKFYE-GSVGDRIAQQR--GGKLPLPDILRYGIQLA 159
+ V + I N + I M++ E G + I + L +LR QL
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 160 KGISDLHSIGLLVLN-----LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLG 214
+ + H LKP+N+ L + LGDFG+ +L + S +G
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKAFVG 176
Query: 215 TPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274
TP YM+PEQ R + ++D W GC + E+ + P+ S +E+ + + +
Sbjct: 177 TPYYMSPEQMN---RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFR 232
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
IP + +I +RP + +IL +
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-36
Identities = 53/273 (19%), Positives = 105/273 (38%), Gaps = 10/273 (3%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
+ T K +G G FG V+ + +A+K L A +
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI--PVAIKELREATSPKANKEILDEAY 63
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+ + VC L GI + + + + ++ + +L + +Q+A
Sbjct: 64 VMASVD-NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
KG++ L L+ +L N+L+ + + DFG+ LL + +M
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VPIKWM 180
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
A E + ++D W +G ++ E++T G +P+ G EI ++ K E+ P
Sbjct: 181 ALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPP 236
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
V +++ C+ D +RP +++ F
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 8e-36
Identities = 55/290 (18%), Positives = 105/290 (36%), Gaps = 31/290 (10%)
Query: 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKF 104
++ IG G FG V+ A ++ + +AVKML + + L +F
Sbjct: 15 IEYVRDIGEGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEG-----------------------SVGDRIAQQ 141
V G+ + +C+ ++ S R++
Sbjct: 74 DNPNIVKL-LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 142 RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201
L + L Q+A G++ L + +L N L+ E+ + + DFG+ +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSV 260
+D +M PE + E+D W +G + E+ + G+QP++G +
Sbjct: 193 ADYYKADGN-DAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 261 EEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
EE+ + V P P + N++ C+ +RP I +
Sbjct: 249 EEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 52/275 (18%), Positives = 104/275 (37%), Gaps = 9/275 (3%)
Query: 40 IDPTSLKL--KHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
I P+SL + IGRG FG V+ T D+ + AVK L + +
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLL---DNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ F + L G + + + + + + D++ +G+Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSL-SDSDMALRLGTP 216
+AKG+ L S + +L N +L E + + DFG+ + + S +
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCI 276
+MA E + + ++D W FG + E++T P + +++ +
Sbjct: 199 KWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
P P + V++ C+ RP ++++ +
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 48/282 (17%), Positives = 108/282 (38%), Gaps = 17/282 (6%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEE 99
+ + + +G+G FG V+ D E +A+K + ++
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEAS 75
Query: 100 LFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG--------GKLPLPD 150
+ +F V G+ + M+ G + + R L
Sbjct: 76 VMKEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
+++ ++A G++ L++ + +L N +++E + +GDFG+ +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVI 269
L +M+PE + G + +D W FG + E+ T + + G S E++ V+
Sbjct: 195 -GLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ P P + ++ C++Y+ + RP +I+ + +
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (333), Expect = 3e-35
Identities = 57/287 (19%), Positives = 110/287 (38%), Gaps = 26/287 (9%)
Query: 42 PTSL----KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML---LPLKEDCAKVFV 94
P+ L +L +G G +V LA + D AVK+L L F
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDV------AVKVLRADLARDPSFYLRFR 55
Query: 95 NKFEELFPKFRESQSVCWLHGI----SVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPD 150
+ + ++ ++ + I M++ +G I G +
Sbjct: 56 REAQNA--AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMTPKR 112
Query: 151 ILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMA 210
+ + ++ H G++ ++KP+N+++S + + + DFGI + S + A
Sbjct: 113 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 211 LRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270
+GT Y++PEQ + +D + GC + E+LTG P+ G S + + V +
Sbjct: 173 AVIGTAQYLSPEQAR---GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
Query: 271 KEKP--CIPSGLPPAVENVIIGCFEYDLRNRPL-MADILHAFESSQN 314
P GL ++ V++ + NR A++ N
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 60/260 (23%), Positives = 114/260 (43%), Gaps = 21/260 (8%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML-LPLKEDCAKVFVNKFEELFPKF 104
+ +G G G V+ +H S A K++ L +K + + + L
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVM------ARKLIHLEIKPAIRNQIIRELQVL--HE 60
Query: 105 RESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
S + +G +G+I I M+ +G D++ ++ G++P + + I + KG++
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 165 LHSI-GLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
L ++ ++KPSN+L++ ++ L DFG + L DS +GT +YM+PE+
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFG-----VSGQLIDSMANSFVGTRSYMSPER 174
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPA 283
+ S ++D W G S++EM G P +E+ ++ + + PP
Sbjct: 175 LQ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPR 229
Query: 284 VENVIIGCFEYDLRNRPLMA 303
Y + +RP MA
Sbjct: 230 PRTPGRPLSSYGMDSRPPMA 249
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-35
Identities = 54/288 (18%), Positives = 110/288 (38%), Gaps = 22/288 (7%)
Query: 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHEL-AVKMLLPLKEDCAKVFVNKFE 98
+ L L +G G FG V LA D AVKML + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 99 ELFPKFRESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRG-------------- 143
E+ + +++ L G +G + + +++ G++ + + +R
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 144 GKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203
+L D++ Q+A+G+ L S + +L N+L++E + + + DFG+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHI 188
Query: 204 LSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEE 262
+MAPE + ++D W FG + E+ T + G VEE
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFE 310
++ ++ + + PS + ++ C+ RP ++ +
Sbjct: 246 LFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 47/272 (17%), Positives = 83/272 (30%), Gaps = 29/272 (10%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE-----EL 100
++ +G G FG V+ A+K + + N L
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPV------AIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 101 FPKFRES-QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
K V L + ++ E G L + Q+
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
+ + H+ G+L ++K N+L+ + +L L DFG G L D+ GT Y
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVY 175
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
PE W G + +M+ G P+ I + +
Sbjct: 176 SPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVFFRQ 225
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ +++I C +RP +I H +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 54/278 (19%), Positives = 98/278 (35%), Gaps = 34/278 (12%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
+G G G V + ++ + F A+KML + + EL + +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKF------ALKMLQDCPK------ARREVELHWRASQ 63
Query: 107 SQSVCWLHGI----SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKG 161
+ + + + I M+ + G + RI + + + +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 162 ISDLHSIGLLVLNLKPSNLLLSEHDQ---LVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
I LHSI + ++KP NLL + L L DFG S + + TP Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET----TSHNSLTTPCYTPYY 179
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--IKKEKPCI 276
+APE PE D W G + +L G P++ I + I+ +
Sbjct: 180 VAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 277 P----SGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
P S + V+ +I + + R + + + H +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 1e-33
Identities = 57/271 (21%), Positives = 108/271 (39%), Gaps = 23/271 (8%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +G G F +V LA ++ A+K + + + + + K +
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLV------AIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 106 ESQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
++ L I G + + M+ G + DRI G D R Q+ +
Sbjct: 66 -HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKY 122
Query: 165 LHSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAP 221
LH +G++ +LKP NLL D ++++ DFG+ + S+ + GTP Y+AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST----ACGTPGYVAP 178
Query: 222 EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP--SG 279
E + P S D W G +L G P++ ++ +++ ++ + + P
Sbjct: 179 EVLA---QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 280 LPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ + ++ I E D R L H +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 53/273 (19%), Positives = 104/273 (38%), Gaps = 29/273 (10%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +GRG FG V S + K + D +V V K + R
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTY------MAKFVKVKGTD--QVLVKKEISILNIAR 59
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISD 164
+++ LH ++ + +F G + +RI +L +I+ Y Q+ + +
Sbjct: 60 -HRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQF 117
Query: 165 LHSIGLLVLNLKPSNLLLSEHD--QLVLGDFGIPYLLLGRSLSDSD-MALRLGTPNYMAP 221
LHS + +++P N++ + + +FG R L D L P Y AP
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG-----QARQLKPGDNFRLLFTAPEYYAP 172
Query: 222 EQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS--- 278
E + +S TD W G + +L+GI P+ ++ ++I + I +
Sbjct: 173 EVHQ---HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN--IMNAEYTFDEEAF 227
Query: 279 -GLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ + + + ++R ++ L H +
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 57/273 (20%), Positives = 105/273 (38%), Gaps = 26/273 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP---LKEDCAKVFVNKFEELFP 102
+G+G FG V L + + A+K+L + +D V + L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYY------AMKILRKEVIIAKDEVAHTVTESRVL-- 59
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
+ + L + ++C M++ G R YG ++ +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSAL 118
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
LHS ++ ++K NL+L + + + DFG+ + + M GTP Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATMKTFCGTPEYLAPE 175
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPP 282
E D WG G + EM+ G P++ + E ++ I E+ P L P
Sbjct: 176 VLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--ILMEEIRFPRTLSP 230
Query: 283 AVENVIIGCFEYDLRNRPLMA-----DIL-HAF 309
++++ G + D + R +++ H F
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (318), Expect = 2e-32
Identities = 51/276 (18%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEEL-F 101
+ IGRG FG+V+ + + A+K L + + + +N+ L
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMY------AMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 102 PKFRESQSVCWLHGISVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAK 160
+ + + K+ + G + + + G D+ Y ++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIIL 118
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMA 220
G+ +H+ ++ +LKP+N+LL EH + + D G L S +GT YMA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG-----LACDFSKKKPHASVGTHGYMA 173
Query: 221 PEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI-KKEKPCIPSG 279
PE + V D + GC + ++L G P+ ++ + + +P
Sbjct: 174 PEVLQKGV--AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 280 LPPAVENVIIGCFEYDLRNRP-----LMADIL-HAF 309
P + +++ G + D+ R ++ F
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (313), Expect = 2e-32
Identities = 47/299 (15%), Positives = 93/299 (31%), Gaps = 32/299 (10%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
K+ RIG G FG ++ T+ + A+K + A +++
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQV------AIKFEP--RRSDAPQLRDEYRTYK-LLA 58
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
+ ++ + + G + + G K + + Q+ + +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVI-DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 166 HSIGLLVLNLKPSNLLLSEHD-----QLVLGDFGIPYLL----LGRSLSDSDMALRLGTP 216
H L+ ++KP N L+ + + + DFG+ + + + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFG---KSVEEIYHSVVIKKEK 273
YM+ S D G M L G PW G + ++ Y + KK+
Sbjct: 178 RYMSINTHL---GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 274 PCI---PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES---SQNAVYNDG-EWTGL 325
+ +G P + P + F N ++ +W L
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (310), Expect = 1e-31
Identities = 67/308 (21%), Positives = 108/308 (35%), Gaps = 36/308 (11%)
Query: 32 TPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK 91
TP+Q +D +G G FG V L H +S + + A+K+L K K
Sbjct: 32 TPSQNTAQLD--QFDRIKTLGTGSFGRVMLVKHKESGNHY------AMKILDKQKVVKLK 83
Query: 92 VFVNKFEE--LFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLP 149
+ E + V + + G + + +R G+ P
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEP 141
Query: 150 DILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDM 209
Y Q+ LHS+ L+ +LKP NLL+ + + + DFG
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF------AKRVKGRT 195
Query: 210 ALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269
GTP +APE + D W G I EM G P+F +IY I
Sbjct: 196 WTLCGTPEALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KI 250
Query: 270 KKEKPCIPSGLPPAVENVIIGCFEYDLRNR-----PLMADIL-HAFESSQNAVYNDGEWT 323
K PS +++++ + DL R + DI H + ++ + W
Sbjct: 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD-------WI 303
Query: 324 GLGSRALT 331
+ R +
Sbjct: 304 AIYQRKVE 311
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 51/276 (18%), Positives = 98/276 (35%), Gaps = 27/276 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKFE---EL 100
+G G F V + + A K + K V E +
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQY------AAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 101 FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAK 160
+ + +V LH + + + ++ G L + + Q+
Sbjct: 67 LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILN 124
Query: 161 GISDLHSIGLLVLNLKPSNLLLSEHD----QLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
G+ LHS+ + +LKP N++L + + ++ + DFG+ + + ++ GTP
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTP 180
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK--P 274
++APE P+ E D W G +L+G P+ G + +E +V +
Sbjct: 181 EFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
S ++ I D + R + D L H +
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 3e-30
Identities = 60/272 (22%), Positives = 102/272 (37%), Gaps = 27/272 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF--EELFPK 103
++ +G G FG V L + + A+K+L K V E L
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYY------AMKVLKKEIVVRLK-QVEHTNDERLMLS 59
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
+ + G +I + M + EG + ++ + P P Y ++ +
Sbjct: 60 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALE 118
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
LHS ++ +LKP N+LL ++ + + DFG + GTP+Y+APE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEV 172
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLPPA 283
P + D W FG I EML G P++ + + Y I + P
Sbjct: 173 VS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--ILNAELRFPPFFNED 227
Query: 284 VENVIIGCFEYDLRNR-----PLMADIL-HAF 309
V++++ DL R D+ H +
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-30
Identities = 51/305 (16%), Positives = 102/305 (33%), Gaps = 51/305 (16%)
Query: 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPK 103
++ L+ IG+G FG+VW E+AVK+ + + + E
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRG--------EEVAVKIF---SSREERSWFREAEIYQTV 52
Query: 104 FRESQSVCWLHGISVING----KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQL 158
+++ + ++ + ++E GS+ D + + + +++ +
Sbjct: 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALST 109
Query: 159 AKGISDLHSIGLLVL--------NLKPSNLLLSEHDQLVLGDFGIPYLLL-GRSLSDSDM 209
A G++ LH + +LK N+L+ ++ + D G+ D
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 210 ALRLGTPNYMAPEQWEPEV---RGPISFETDTWGFGCSIMEMLTGIQPWFGK-------- 258
R+GT YMAPE + + D + G E+
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 259 -------SVEEIYHSVVIKKEKPCIPSGL-----PPAVENVIIGCFEYDLRNRPLMADIL 306
SVEE+ V +K +P IP+ + ++ C+ + R I
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 307 HAFES 311
Sbjct: 290 KTLSQ 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 6e-30
Identities = 47/279 (16%), Positives = 82/279 (29%), Gaps = 26/279 (9%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+L +IG G FGD++L T + E+A+K+ + + + K
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKH--PQLHIESKIY--KMM 59
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
+ G + + G + + K L +L Q+ I +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 166 HSIGLLVLNLKPSNLLLSEHD---QLVLGDFGIPYLLLGRSLSDSDMALRL----GTPNY 218
HS + ++KP N L+ + + DFG+ GT Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK----- 273
+ S D G +M G PW G EK
Sbjct: 180 ASINTHL---GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 274 -PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311
+ G P + C ++P + + F +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 58/294 (19%), Positives = 93/294 (31%), Gaps = 52/294 (17%)
Query: 51 IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE---- 106
+G G F V+ A + A+K + AK +N+ RE
Sbjct: 6 LGEGQFATVYKARDKNTNQIV------AIKKIKLGHRSEAKDGINRTAL-----REIKLL 54
Query: 107 ----SQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
++ L I + F E + + I + L I Y + +G+
Sbjct: 55 QELSHPNIIGLLDAFGHKSNISLVFDFMETDL-EVIIKDNSLVLTPSHIKAYMLMTLQGL 113
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
LH +L +LKP+NLLL E+ L L DFG+ + ++ T Y APE
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPE 170
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC------- 275
D W GC + E+L + G S + + P
Sbjct: 171 LLFG--ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 276 -------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
I S + ++I G F ++ R L +
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-29
Identities = 57/275 (20%), Positives = 101/275 (36%), Gaps = 18/275 (6%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFP 102
+L +G G +G V+L D Y A+K+L ++
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLY---AMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 103 KFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
R+S + LH K+ + + + G QR + ++ Y ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
LH +G++ ++K N+LL + +VL DFG+ + + GT YMAP+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPD 200
Query: 223 QWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--IKKEKPCIPSGL 280
G D W G + E+LTG P+ + + I K +P P +
Sbjct: 201 IVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 281 PPAVENVIIGCFEYDLRNRPLMA-----DIL-HAF 309
+++I D + R +I H F
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 54/299 (18%), Positives = 103/299 (34%), Gaps = 48/299 (16%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKFEEL-FP 102
+ IG G +G V+ A ++ F +A+K + +E + + L
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRF-----VALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 103 KFRESQSVCWLHGISVI-----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
+ E +V L + + K+ + + + + + + +P I Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRL-GTP 216
L +G+ LHS ++ +LKP N+L++ Q+ L DFG L R S + T
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG-----LARIYSFQMALTSVVVTL 179
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC- 275
Y APE + + D W GC EM + G S + ++ P
Sbjct: 180 WYRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 276 ------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ + +++++ C ++ R L H +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 4e-28
Identities = 66/313 (21%), Positives = 108/313 (34%), Gaps = 50/313 (15%)
Query: 38 PWIDPTS-LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNK 96
P+ D S + +IG+G FG+V+ A H ++ A+K +L E
Sbjct: 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKV------ALKKVLMENEKEGFPITAL 57
Query: 97 FEELFPKFRESQSVCWLHGI--------SVINGKICIAMKFYEGSVGDRIAQQRGGKLPL 148
E + + ++V L I + G I + F E + + K L
Sbjct: 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTL 116
Query: 149 PDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP-YLLLGRSLSDS 207
+I R L G+ +H +L ++K +N+L++ L L DFG+ L ++ +
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 208 DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV 267
R+ T Y PE E D WG GC + EM T G + + +
Sbjct: 177 RYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 268 V-------------------------IKKEKPCIPSGLPPAVE-----NVIIGCFEYDLR 297
+K +K + L V ++I D
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 298 NRPLMADIL-HAF 309
R D L H F
Sbjct: 295 QRIDSDDALNHDF 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 6e-27
Identities = 58/294 (19%), Positives = 97/294 (32%), Gaps = 43/294 (14%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKFEELFPK 103
+ +IG G +G V+ A + + + A+K + E + + L K
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVV------ALKKIRLDTETEGVPSTAIREISLL--K 56
Query: 104 FRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGIS 163
++ L + K+ + +F + + +PLP I Y QL +G++
Sbjct: 57 ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 164 DLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQ 223
HS +L +LKP NLL++ + L DFG+ + + T Y APE
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEI 173
Query: 224 WEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC-------- 275
S D W GC EM+T + G S + + P
Sbjct: 174 LLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 276 -------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ L +++ YD R L H F
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (270), Expect = 7e-27
Identities = 55/292 (18%), Positives = 97/292 (33%), Gaps = 41/292 (14%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+IG G +G V+ A ++ A+K + KED E K
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYG-------ETFALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
+ ++ L+ + ++ + + + + + GG L + +QL GI+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYC 116
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE 225
H +L +LKP NLL++ +L + DFG+ + + T Y AP+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 226 PEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC---------- 275
S D W GC EM+ G + G S + + P
Sbjct: 174 GS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 276 -----------------IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
GL + +++ + D R L HA+
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 9e-27
Identities = 48/301 (15%), Positives = 95/301 (31%), Gaps = 51/301 (16%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE---ELFP 102
IG G +G V A + + A+K + P + + + + ++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRV------AIKKISPFEH---QTYCQRTLREIKILL 61
Query: 103 KFRESQSV----CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQL 158
+FR + + + + + + L I + Q+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQI 118
Query: 159 AKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNY 218
+G+ +HS +L +LKPSNLLL+ L + DFG+ + + + T Y
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--- 275
APE + D W GC + EML+ + GK + + ++ P
Sbjct: 179 RAPEIMLNSK--GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 276 --------------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HA 308
+ +++ ++ R + L H
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296
Query: 309 F 309
+
Sbjct: 297 Y 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (253), Expect = 3e-24
Identities = 55/310 (17%), Positives = 109/310 (35%), Gaps = 56/310 (18%)
Query: 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKF 97
W + +L ++GRG + +V+ A + + + VK+L P+K+ K +
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV------VVKILKPVKKKKIKREIKIL 83
Query: 98 EELFPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQ 157
E L R ++ L I A+ F + D +Q L DI Y +
Sbjct: 84 ENL----RGGPNIITLADIVKDPVSRTPALVFEHVNNTD--FKQLYQTLTDYDIRFYMYE 137
Query: 158 LAKGISDLHSIGLLVLNLKPSNLLL-SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTP 216
+ K + HS+G++ ++KP N+++ EH +L L D+G+ + +R+ +
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY----HPGQEYNVRVASR 193
Query: 217 NYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVIKKEKPC 275
+ PE + D W GC + M+ +P+F G + +
Sbjct: 194 YFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 276 I-----------------------------------PSGLPPAVENVIIGCFEYDLRNRP 300
+ + P + + YD ++R
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
Query: 301 LMADIL-HAF 309
+ + H +
Sbjct: 312 TAREAMEHPY 321
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 6e-24
Identities = 60/300 (20%), Positives = 98/300 (32%), Gaps = 53/300 (17%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKFEEL--- 100
+ +G G +G V A ++ A+K L E AK + L
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKV------AIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 101 -FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
V + M F +G + + KL I Q+
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM---KHEKLGEDRIQFLVYQML 131
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYM 219
KG+ +H+ G++ +LKP NL ++E +L + DFG+ DS+M + T Y
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA------DSEMTGYVVTRWYR 185
Query: 220 APEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV----------- 268
APE + D W GC + EM+TG + G + ++
Sbjct: 186 APEVILN--WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 269 ------------------IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
KK+ I + P N++ D R + L H +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 2e-23
Identities = 52/293 (17%), Positives = 103/293 (35%), Gaps = 41/293 (13%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105
+ +IG G +G V+ A + ++ + +A+K + +D E K
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 106 ESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDL 165
+ +++ LH + + K+ + +F + + G P + + QL KG+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFC 117
Query: 166 HSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWE 225
HS +L +LKP NLL++ + +L L +FG+ + + + T Y P+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 226 PEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVIKKEKPC--------- 275
S D W GC E+ +P F G V++ + P
Sbjct: 175 G--AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 276 ------------------IPSGLPPAVENVIIGCFEYDLRNRPLMADIL-HAF 309
+ L +++ + + R + L H +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 2e-23
Identities = 68/323 (21%), Positives = 108/323 (33%), Gaps = 59/323 (18%)
Query: 26 LRTVVATPTQ--TRPW-IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKML 82
+ TVVATP Q RP + T K+ IG G FG V+ A S + A+K +
Sbjct: 3 VTTVVATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELV------AIKKV 53
Query: 83 LPLKEDCAKVFVNKFEELFPKFR-----ESQSVCWLHGISVINGKICIAMKFYEGSVGDR 137
L K F N+ ++ K + + G + + + + +V
Sbjct: 54 LQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 138 IAQ--QRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFG 194
+ LP+ + Y QL + ++ +HS G+ ++KP NLLL L L DFG
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP 254
L+ + + Y AP + D W GC + E+L G
Sbjct: 169 SAKQLV----RGEPNVSYICSRYYRAP--ELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
Query: 255 WFGKSVEEIYHSVVIKKEKPC---------------------------IPSGLPPAVENV 287
+ G S + ++ P PP +
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
Query: 288 IIGCFEYDLRNRPLMADIL-HAF 309
EY R + H+F
Sbjct: 283 CSRLLEYTPTARLTPLEACAHSF 305
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 8e-21
Identities = 57/308 (18%), Positives = 101/308 (32%), Gaps = 55/308 (17%)
Query: 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFE 98
W P + +G G +G V A ++ AVK L + + + +
Sbjct: 14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV------AVKKLS--RPFQSIIHAKRTY 65
Query: 99 ---ELFPKFRESQSV----CWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDI 151
L + + + S+ + G+ + I + KL +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHV 123
Query: 152 LRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMAL 211
Q+ +G+ +HS ++ +LKPSNL ++E +L + DFG+ D +M
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------DDEMTG 177
Query: 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV--- 268
+ T Y APE + D W GC + E+LTG + G + ++
Sbjct: 178 YVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 269 --------------------------IKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLM 302
K + G P +++ D R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 303 ADIL-HAF 309
A L HA+
Sbjct: 296 AQALAHAY 303
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (224), Expect = 2e-20
Identities = 58/294 (19%), Positives = 97/294 (32%), Gaps = 31/294 (10%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLP--LKEDCAKVFVNKFEEL--- 100
+ IG G G V A + A+K L + AK + +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNV------AIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 101 -FPKFRESQSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLA 159
+V + + M+ + ++ I + + Q+
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQML 129
Query: 160 KGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSD-MALRLGTPNY 218
GI LHS G++ +LKPSN+++ L + DFG L R+ S M + T Y
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFMMTPYVVTRYY 184
Query: 219 MAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278
APE D W GC + EM+ + G+ + ++ V+ + PC
Sbjct: 185 RAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC--- 238
Query: 279 GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALTD 332
P + + NRP A + + D E L + D
Sbjct: 239 ---PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 45/301 (14%), Positives = 96/301 (31%), Gaps = 24/301 (7%)
Query: 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLL--PLKEDCAKVFVNKFEELFPK 103
L ++G G F VWLA + A+K++ + + A+ + + +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHV------AMKIVRGDKVYTEAAEDEIKLLQRVNDA 69
Query: 104 FRESQSVCWLHGISVI----------NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILR 153
+ + I + + + + ++ I + +PL + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 154 YGIQLAKGISDLH-SIGLLVLNLKPSNLLLSEHDQ-LVLGDFGIPYLLLGRSLSDSDMAL 211
QL G+ +H G++ ++KP N+L+ D L I L +
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 212 RLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271
T Y +PE P D W C I E++TG +
Sbjct: 190 I-QTREYRSPEVLL---GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 272 EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSRALT 331
+ + LP + + L F ++ + +++ ++ ++
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 332 D 332
D
Sbjct: 306 D 306
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.9 bits (126), Expect = 1e-08
Identities = 28/212 (13%), Positives = 64/212 (30%), Gaps = 35/212 (16%)
Query: 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRE 106
+ +G G V+ + E VK KV +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKF-------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 107 SQSVCWLHGISVINGKICIAMKFYE----GSVGDRIAQQRGGKLPLPDILRYGIQLAKGI 162
+ ++ + K Y + + I + ++ + + + + +
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 163 SDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPE 222
+ + G++ +L N+L+SE + + DF ++ +G E
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFP--------------QSVEVGEEG--WRE 159
Query: 223 QWEPEVRGPISF-------ETDTWGFGCSIME 247
E +VR I++ E D I++
Sbjct: 160 ILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 632 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.29 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=442.63 Aligned_cols=274 Identities=20% Similarity=0.367 Sum_probs=233.1
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
|+.++|++++.||+|+||.||+|+++.++ +.||||++.+.. ......+.+ +..+++.+ +||||+.++++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~i~k~~~~~~~~~~~~~~-E~~il~~l-~hp~Iv~l~~~ 73 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNT-RHPFLTALKYA 73 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHH-HHHHHHSC-CCTTBCCEEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEchhhccCHHHHHHHHH-HHHHHHhC-CCCCEEEEEee
Confidence 67789999999999999999999998766 489999997532 122233333 34455555 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+.+++.+|+||||++ |+|.+++... +.+++..++.|+.||+.||+|||+++|+||||||+|||++.+|.+||+|||+
T Consensus 74 ~~~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 74 FQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eccccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999999999 5777776553 5899999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
|+..... .......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+++..+. ...+.
T Consensus 152 a~~~~~~---~~~~~~~~GT~~Y~aPE~~~~~---~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~ 223 (337)
T d1o6la_ 152 CKEGISD---GATMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIR 223 (337)
T ss_dssp CBCSCCT---TCCBCCCEECGGGCCGGGGSSS---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCC
T ss_pred ccccccC---CcccccceeCHHHhhhhhccCC---CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCC
Confidence 9865332 2233457899999999999754 68899999999999999999999999999988887766 45577
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
+|..+|+++.+||++||++||.+|++ +.|+++ |++|.+.+|..+..+.+.+|+.|.
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~------Hp~f~~i~~~~l~~~~~~~p~~P~ 284 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME------HRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc------CcccccCCHHHHHhCCCCCCCCCC
Confidence 89999999999999999999999995 667665 889999999999988888887654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=436.01 Aligned_cols=273 Identities=19% Similarity=0.342 Sum_probs=226.5
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.+++|++++.||+|+||+||+|.++.++ +.||||++.+... ......+.++..++.++ +||||+.+++++.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATS------REYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQ 78 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEE
Confidence 4578999999999999999999998766 4899999864321 11122233444555555 7999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
+++.+||||||++| +|.+++... +.+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccce
Confidence 99999999999984 787777654 589999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.+.... ........+||+.|||||++.+. .++.++|||||||+||||++|..||.+.+..+++..+. ...+.+|
T Consensus 157 ~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~---~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p 230 (288)
T d1uu3a_ 157 VLSPES-KQARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFP 230 (288)
T ss_dssp ECC-----------CCCCGGGCCHHHHHTC---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCC
T ss_pred ecccCC-cccccccccCCccccCceeeccC---CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCC
Confidence 764321 11223456899999999999754 68999999999999999999999999999888888776 3456788
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccc
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSR 328 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~ 328 (632)
..+++++.+||.+||+.||++|||++|++....-..++||.+.+|+.+..+
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 281 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC
Confidence 999999999999999999999999999876555556889999999988754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=419.70 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=211.6
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+.++|++.+.||+|+||+||+|+++.++ +.||||++.+... ........++..++..+ +||||+.+++++.
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~ 76 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSK------FILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFH 76 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCC------cEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEE
Confidence 4579999999999999999999998765 4899999865321 11122233334555555 7999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
+++.+||||||++ |+|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence 9999999999998 5888887654 479999999999999999999999999999999999999999999999999997
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.... ......+||+.|||||++.+. +++.++|||||||+||||++|+.||.+.+..+++..+. ...+.+|
T Consensus 155 ~~~~-----~~~~~~~Gt~~Y~APE~~~~~---~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p 224 (263)
T d2j4za1 155 HAPS-----SRRTTLCGTLDYLPPEMIEGR---MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFP 224 (263)
T ss_dssp CCCC-----CCCEETTEEGGGCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCC
T ss_pred ecCC-----CcccccCCCCcccCHHHHcCC---CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCC
Confidence 6432 223456899999999999854 68899999999999999999999999999888887765 4556788
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+|+++.+||.+||+.||++|||+.|+++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 999999999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=430.76 Aligned_cols=272 Identities=24% Similarity=0.408 Sum_probs=227.3
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++++.||+|+||+||+|.++.++ +.||||++++.. ....+.+..+ ..++....+||||+.+++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~------~~vAvK~i~k~~~~~~~~~~~~~~e-~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTN------QFFAIKALKKDVVLMDDDVECTMVE-KRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHHHHHH-HHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCC------CEEEEEEEchhhccChHHHHHHHHH-HHHHHHhCCCCcEEEEEEEEcc
Confidence 68999999999999999999998766 489999996532 1222333333 3444555689999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+||||||++ |+|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||+++++++||+|||+++.
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence 999999999998 5888877653 4799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPS 278 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~ 278 (632)
.... .......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+. ...+.+|.
T Consensus 153 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~ 224 (320)
T d1xjda_ 153 NMLG---DAKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPR 224 (320)
T ss_dssp CCCT---TCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCT
T ss_pred cccc---cccccccCCCCCcCCHHHHcC---CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCc
Confidence 5332 223344689999999999974 468899999999999999999999999999988888776 45677889
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHH-HHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMA-DILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~-ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.+|+++.+||++||++||++||++. ++++ ++++.+.+|+.+..+.+.+|+.|.
T Consensus 225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~------hpff~~~~~~~l~~~~~~pp~~p~ 278 (320)
T d1xjda_ 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ------HPLFREINWEELERKEIDPPFRPK 278 (320)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG------SGGGTTCCHHHHHTTCSCC-----
T ss_pred cCCHHHHHHHHHhcccCCCCCcCHHHHHHh------CchhccCCHHHHHhcCCCCCCCCC
Confidence 9999999999999999999999985 6654 789999999998888887776554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=432.13 Aligned_cols=269 Identities=20% Similarity=0.326 Sum_probs=220.1
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|++++|++.+.||+|+||+||+|++...++. .....||+|.+...........+.++..++.++.+||||+.+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKT-GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSS-SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcc-cceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 347889999999999999999999998765432 2334799999876443333333344456667777899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeeee
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRG---------------------GKLPLPDILRYGIQLAKGISDLHSIGLLVLNL 175 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~---------------------~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDL 175 (632)
.+++.+||||||++ |+|.+++..... ..+++..++.|+.||+.||+|||+++||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999998 688888865421 35899999999999999999999999999999
Q ss_pred eCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCC
Q 006772 176 KPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQP 254 (632)
Q Consensus 176 KP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~P 254 (632)
||+|||++.++++||+|||+|+....... ........||+.|||||++.+ +.++.++|||||||+||||+| |..|
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred chhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcC---CCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999999999999999986543221 112234568999999999874 478999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 255 WFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 255 F~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
|.+.+..+.+..++....++..|..+|+++.+||.+||+.||++|||++||++.|..
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 998776666666666677788899999999999999999999999999999998853
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-51 Score=426.53 Aligned_cols=271 Identities=22% Similarity=0.356 Sum_probs=227.7
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+.++|++++.||+|+||+||+|+++.++ +.||||++++... ....+...++..++..+ +||||+.+++++.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g------~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~ 74 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNG------RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQ 74 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCC------CEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEe
Confidence 4578999999999999999999998766 4899999964321 11122233344555554 7999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
+++.+|+||||++| ++..++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~ 152 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 152 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred eCCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccce
Confidence 99999999999996 44444433 4578999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
.... .....+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+++..+.. ....+|
T Consensus 153 ~~~~------~~~~~~Gt~~Y~APE~l~~~---~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p 221 (316)
T d1fota_ 153 YVPD------VTYTLCGTPDYIAPEVVSTK---PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFP 221 (316)
T ss_dssp ECSS------CBCCCCSCTTTCCHHHHTTC---CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCC
T ss_pred Eecc------ccccccCcccccCHHHHcCC---CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCC
Confidence 7532 23456899999999999754 688999999999999999999999999999888887763 456678
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
..+|+++.++|.+||++||.+|+ +++++++ ++++.+.+|+.+..+...+|+.++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~------Hp~f~~i~~~~l~~~~~~~p~~p~ 280 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN------HPWFKEVVWEKLLSRNIETPYEPP 280 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT------SGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc------CcccccCCHHHHHhCCCCcCCCCC
Confidence 89999999999999999999996 7888776 889999999999888887776553
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-51 Score=425.41 Aligned_cols=267 Identities=18% Similarity=0.327 Sum_probs=208.7
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.+.||+|+||+||+|+++.+++ ....||||.+.........+.+.++..++.++ +||||+.+++++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVV 96 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEE
Confidence 35778899999999999999999999876542 23469999987654433333233444556666 799999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
..++.+||||||++| +|.+++. ...+.+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~-~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHH-TTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeec-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 999999999999995 5655554 34567999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCC--ccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccC
Q 006772 197 YLLLGRSLSDS--DMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 197 k~~~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
+.......... ......||+.|||||++.. +.++.++|||||||+||||+| |+.||.+.+..++...+.. ..+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~ 251 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYR 251 (299)
T ss_dssp --------------------CGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhc---CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC
Confidence 87643221111 1122457999999999874 478999999999999999998 8999999998888777653 455
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
++.|..+|+++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 6678899999999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-51 Score=422.84 Aligned_cols=266 Identities=21% Similarity=0.383 Sum_probs=220.4
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeE
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~ 112 (632)
|.-....|+.++|++.++||+|+||+||+|.++.++ +.||||+++..... .+.+.++ ..++.++ +||||+.
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~-~~~~~~E-~~il~~l-~HpnIv~ 77 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTME-VEEFLKE-AAVMKEI-KHPNLVQ 77 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGT------EEEEEEECCTTCSC-HHHHHHH-HHHHHHC-CCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCC------eEEEEEEECCccch-HHHHHHH-HHHHHhC-CCCCEec
Confidence 333345588999999999999999999999998655 48999999764432 3444444 4556665 7999999
Q ss_pred eeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 113 LHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+++++.+++.+||||||++ |++.+++.......+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 9999999999999999998 688888877666789999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQP-WFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~P-F~~~~~~ei~~~i~~~ 270 (632)
|||+|+....... .......||+.|||||++.+ +.|+.++|||||||++|||++|..| |.+.+..+++..+ ..
T Consensus 158 DFG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~---~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~ 231 (287)
T d1opja_ 158 DFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EK 231 (287)
T ss_dssp CCCCTTTCCSSSS--EEETTEEECGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HT
T ss_pred cccceeecCCCCc--eeeccccccccccChHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hc
Confidence 9999986543211 12233458999999999874 4789999999999999999996555 5555666665544 45
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..++.+|..+|+++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 5677788999999999999999999999999999999887653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=415.73 Aligned_cols=269 Identities=19% Similarity=0.317 Sum_probs=209.2
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|+++.|++.+.||+|+||+||+|.++.++. .....||||++...........+.++..++.++ +||||+.+++++.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVIS 79 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEe
Confidence 5778999999999999999999999876543 233579999997654433333233444566665 6999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 119 INGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 119 ~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
..+..++||||+.+.++..+.......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999996444444444456899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...............||+.|||||++.+ +.++.++|||||||++|||+++ .+||.+.+..+++..+. ...++..|
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~ 235 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTP 235 (283)
T ss_dssp --------------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc---CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCc
Confidence 6443222222334568999999999874 4789999999999999999995 55566667777766554 45667788
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+|+++.+||.+||+.||++||++.||++.|+.+..
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999999987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=417.83 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=208.8
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc--hhhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK--EDCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~--~~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.|+.++|++.++||+|+||+||+|+++. .||||+++... ....+.+ .++..++.++ +||||+.++++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~~-~~E~~~l~~l-~HpnIv~~~~~ 72 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAF-KNEVGVLRKT-RHVNILLFMGY 72 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS---------EEEEEECCCSSCCTTHHHHH-HHHHHHHTTC-CCTTBCCEEEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC---------EEEEEEEEcccCCHHHHHHH-HHHHHHHHhC-CCCCEeeeeEE
Confidence 3889999999999999999999997532 59999997532 2333344 3444556665 79999999998
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+. ++.++|||||++ |+|.+++... +..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccc
Confidence 64 567899999999 6888877543 45799999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc-cCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK-EKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~-~~p 274 (632)
|+...... .........||+.|||||++.....++|+.++|||||||+||||+||+.||.+.+............ ..+
T Consensus 151 a~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 151 ATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229 (276)
T ss_dssp SCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred eeeccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 97653221 1223345679999999999976555678999999999999999999999999876554433333333 233
Q ss_pred ---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 ---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+..+|+++.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3457899999999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=414.95 Aligned_cols=263 Identities=17% Similarity=0.320 Sum_probs=215.8
Q ss_pred CcCCCCeEEEeE-EcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhh-HHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 39 WIDPTSLKLKHR-IGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDC-AKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 39 ~I~~~~y~l~~~-IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~-~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
.|..++|.+.+. ||+|+||+||+|.++.++. ...||||++++..... .+.+. ++..++.++ +||||+.++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~----~~~vAvK~l~~~~~~~~~~~~~-~E~~il~~l-~HpnIv~l~g~ 77 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKK----QIDVAIKVLKQGTEKADTEEMM-REAQIMHQL-DNPYIVRLIGV 77 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---C----CEEEEEEEECSSCCHHHHHHHH-HHHHHHHHC-CCTTBCCEEEE
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCC----cEEEEEEEEChhcCHHHHHHHH-HHHHHHHhC-CCCCEeeEeee
Confidence 467788999984 9999999999998865432 2479999997654333 34444 444566666 79999999998
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 117 SVINGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
+.. +.+||||||++| +|.+++.. .+..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 864 568999999995 77666543 346899999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
|+.+..............||+.|||||++.. +.++.++|||||||++|||+| |..||.+.+..++...+. ...++
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~ 231 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRM 231 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCC
T ss_pred hhcccccccccccccccccCccccChHHHhC---CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 9876543322233344578999999999874 468999999999999999998 999999988877776665 45667
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..|..+|+++.+||.+||+.||++||++.+|++.|+...
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 788999999999999999999999999999999887654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-50 Score=417.81 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=210.2
Q ss_pred CeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 44 SLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 44 ~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.|++.+.||+|+||+||+|+++.++ +.||||++...... .....+.++..++.++ +||||+.+++++.+++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNS------EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETT
T ss_pred hcEeeEEEecCCCeEEEEEEECCCC------cEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECC
Confidence 4999999999999999999998766 48999999764322 1122233344556665 6999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
.+|||||||.|++++.+... ++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999997766655443 46899999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
....+||+.|||||++.+...++|+.++|||||||++|||++|..||.+.+..+....+......+..+..+|
T Consensus 168 -------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp -------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred -------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 2345799999999999765456789999999999999999999999999888887777765554444566799
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 99999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=410.20 Aligned_cols=257 Identities=21% Similarity=0.400 Sum_probs=206.9
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|++++|++.+.||+|+||+||+|.++.. ..||||+++..... .+++.++. .++.++ +||||+.+++++..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~i~~~~~~-~~~~~~E~-~~l~~l-~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMS-EEDFIEEA-EVMMKL-SHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTT-------EEEEEEECCSSSSC-HHHHHHHH-HHHHHC-CCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCC-------CEEEEEEECCCcCc-HHHHHHHH-HHHHhc-CCCCcccccceecc
Confidence 7899999999999999999999997642 37999999764432 34454443 455555 69999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+||||||++ |+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+.
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred CCceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhee
Confidence 999999999998 6777776543 45789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .......||+.|||||++.+ ..++.++|||||||++|||+| |.+||...+..++...+. ...++..|
T Consensus 151 ~~~~~~--~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p 224 (263)
T d1sm2a_ 151 VLDDQY--TSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKP 224 (263)
T ss_dssp ----------------CTTSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCC
T ss_pred ccCCCc--eeecceecCcccCChHHhcC---CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCc
Confidence 643221 12233578999999999974 368999999999999999999 577777777777777665 35566778
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..+++++.+||.+||+.||++|||+++|++.|+++.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 899999999999999999999999999999998775
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=416.25 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=201.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||+||+|+++.++ +.||||++.........+...++..++.++ +||||+.+++++.+++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTE------EAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCce
Confidence 68999999999999999999998766 489999997644322222233444555555 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+||||||++| +|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+....
T Consensus 78 ~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999985 78777743 45899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhccCCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVE-EIYHSVVIKKEKPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~-ei~~~i~~~~~~p~~p~~l 280 (632)
.. ........+||+.|||||++.+.. .++.++|||||||++|||++|+.||.+.+.. ..+..+............+
T Consensus 156 ~~-~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T d1nvra_ 156 NN-RERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232 (271)
T ss_dssp TT-EECCBCCCCSCGGGSCTHHHHCSS--BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGS
T ss_pred CC-ccccccceeeCcCccCHhHhcCCC--CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccC
Confidence 21 112234568999999999987431 2467899999999999999999999876533 2333333222223333578
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|+++.+||.+||+.||++|||++|+++
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=419.18 Aligned_cols=269 Identities=21% Similarity=0.332 Sum_probs=211.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.++||+|+||+||+|++...+. ....+.||||+++.............+...+.++.+|+||+.+++++..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTS-SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCc-ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 788999999999999999999999876543 2344689999997644333333333344556677789999999888765
Q ss_pred -CCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe
Q 006772 120 -NGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS 183 (632)
Q Consensus 120 -~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld 183 (632)
++.+++|||||+ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+||||||+||||+
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 457899999998 68888876532 23589999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHH
Q 006772 184 EHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEE 262 (632)
Q Consensus 184 ~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~e 262 (632)
+++.+||+|||+|+...... .........||+.|||||++.+ +.++.++|||||||++|||+++ ..||.+.+..+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999998653322 1222344679999999999974 4689999999999999999986 56888876555
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 263 IYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 263 i~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.+..+......+..|..+++++.++|.+||+.||++|||+.|+++.|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 555555667778889999999999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=417.74 Aligned_cols=253 Identities=19% Similarity=0.308 Sum_probs=210.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|++++.||+|+||+||+|+++.++ +.||||++........+.+.++. .++..+ +||||+.+++++.+++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~E~-~il~~l-~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETS------VLAAAKVIDTKSEEELEDYMVEI-DILASC-DHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECSSSGGGGGTHHHH-HHHHHC-CCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCC------eEEEEEEECcCCHHHHHHHHHHH-HHHHhC-CCCCCCeEEEEEeeCCe
Confidence 56899999999999999999998766 48999999765544444544443 455555 69999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+||||||++| +|.+++.+. .+.+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999985 666665543 46799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCccccccCCCccCCccccCCC--CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-CCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPE--VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-KPCIPS 278 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~--~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-~p~~p~ 278 (632)
. .......+||+.|||||++... ....|+.++|||||||++|||++|+.||.+.+..+++..+..... ....|.
T Consensus 163 ~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (288)
T d2jfla1 163 T---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239 (288)
T ss_dssp H---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGG
T ss_pred C---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 1 1122346899999999998543 234688999999999999999999999999888777777664322 233457
Q ss_pred CCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 279 GLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 279 ~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.+|+++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 89999999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=422.69 Aligned_cols=279 Identities=24% Similarity=0.378 Sum_probs=233.3
Q ss_pred ccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccC
Q 006772 30 VATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRE 106 (632)
Q Consensus 30 ~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~ 106 (632)
...+......+ ++|++++.||+|+||+||+|+++.++ +.||||++.+... ...+.+.+ +..++..+ +
T Consensus 30 ~~~~~~~~~~l--d~y~i~~~lG~G~fg~Vy~a~~~~~g------~~~AvK~i~~~~~~~~~~~~~~~~-E~~il~~l-~ 99 (350)
T d1rdqe_ 30 WETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESG------NHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV-N 99 (350)
T ss_dssp HHSCCCCCCCG--GGEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHTTCHHHHHH-HHHHHTTC-C
T ss_pred ccccccCCCCc--cCeEEEEEeecCcCcEEEEEEECCCC------CEEEEEEEchHHccCHHHHHHHHH-HHHHHHHc-C
Confidence 33444444444 69999999999999999999998766 4899999864221 12223333 33455555 7
Q ss_pred CCceeEeeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC
Q 006772 107 SQSVCWLHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH 185 (632)
Q Consensus 107 h~~I~~l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~ 185 (632)
||||+.+++++...+.+++||||+. |++.+.+... +.+++..++.|+.||+.||.|||+++||||||||+|||++.+
T Consensus 100 hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~ 177 (350)
T d1rdqe_ 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177 (350)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCcEeecccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC
Confidence 9999999999999999999999998 5677777554 479999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHH
Q 006772 186 DQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYH 265 (632)
Q Consensus 186 g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~ 265 (632)
|++||+|||+|+.... .....+||+.|||||++.+. .++.++|||||||+||||++|..||.+.+..+++.
T Consensus 178 g~ikL~DFG~a~~~~~------~~~~~~Gt~~Y~APE~~~~~---~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 178 GYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILSK---GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp SCEEECCCTTCEECSS------CBCCCEECGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCEEeeeceeeeeccc------ccccccCccccCCHHHHcCC---CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 9999999999987632 22346899999999999754 68899999999999999999999999999888888
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 266 SVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRP-----LMADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 266 ~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RP-----s~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
.+. ...+.+|..+++++.+||.+||+.||.+|+ +++++++ |++|.+.+|..+..+.+.+|+.|.
T Consensus 249 ~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~------Hp~f~~~~~~~~~~~~~~~p~~p~ 317 (350)
T d1rdqe_ 249 KIV--SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN------HKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp HHH--HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT------SGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHh--cCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc------CccccCCCHHHHHhcCCCcCccCC
Confidence 776 345667889999999999999999999995 7888775 889999999999988888887664
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=416.16 Aligned_cols=248 Identities=19% Similarity=0.320 Sum_probs=207.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.++||+|+||+||+|.++.++ +.||||++........+.+.+ +..+++.+ +||||+.+++++.+++.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~------~~vAvK~~~~~~~~~~~~~~~-E~~il~~l-~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATG------QEVAIRQMNLQQQPKKELIIN-EILVMREN-KNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTC------CEEEEEEEEGGGCSCHHHHHH-HHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCC------CEEEEEEEecccChHHHHHHH-HHHHHHhC-CCCCEeeEeEEEEECCE
Confidence 57999999999999999999988766 489999997544433344433 44555555 79999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 123 ICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 123 l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
+||||||++| +|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 92 ~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999985 66665533 4799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc-CCCCCCCC
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE-KPCIPSGL 280 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~-~p~~p~~l 280 (632)
.. ......+||+.|||||++.+. +++.++|||||||++|||++|..||.+.+..+....+..... ....|..+
T Consensus 169 ~~---~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 169 EQ---SKRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHSSS---CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred cc---ccccccccCCCccChhhhcCC---CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccC
Confidence 21 223456899999999999753 688999999999999999999999999887776665554332 34456789
Q ss_pred CHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 281 PPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 281 p~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
|+++++||.+||+.||++|||+.|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-50 Score=427.05 Aligned_cols=277 Identities=17% Similarity=0.310 Sum_probs=222.8
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhh--hccCCCceeEeeE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFP--KFRESQSVCWLHG 115 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~--~l~~h~~I~~l~~ 115 (632)
++.++|++.+.||+|+||.||+|+++.++ +.||||++.+... ........++..++. +..+||||+.+++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~------~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCC------CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 46789999999999999999999998766 4899999864221 111111222222222 2346999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++..++.+||||||++ |+|.+++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++.+|.+||+|||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeec
Confidence 9999999999999998 6788877654 578999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhccC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSV-VIKKEK 273 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i-~~~~~~ 273 (632)
+|+.... ......+||+.|||||++... ..|+.++|||||||+||||++|+.||.+.+..+..... ......
T Consensus 153 la~~~~~-----~~~~~~~GT~~y~APE~~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~ 225 (364)
T d1omwa3 153 LACDFSK-----KKPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225 (364)
T ss_dssp TCEECSS-----SCCCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC
T ss_pred eeeecCC-----CcccccccccccchhHHhhcC--CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence 9986533 223456899999999998632 25789999999999999999999999876533222111 122445
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 274 PCIPSGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 274 p~~p~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
+.+|..+|+++.+||.+||++||++||+ ++|+++ +++|.+.+|..+..+...+|+.|.
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~------Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------SPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc------CccccCCCHHHHhcCCCCcCcCCC
Confidence 6677899999999999999999999998 577665 889999999999888887776553
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=411.51 Aligned_cols=259 Identities=22% Similarity=0.385 Sum_probs=212.5
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++.++||+|+||+||+|.++.. +.||||+++..... .+.+.++ ..++.++ +||||+.+++++
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~~~~~~~~-~~~~~~E-~~~l~~l-~HpnIv~~~g~~ 77 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSMS-PDAFLAE-ANLMKQL-QHQRLVRLYAVV 77 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSSC-HHHHHHH-HHHHHHC-CCTTBCCEEEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCC-------CEEEEEEEccCcCC-HHHHHHH-HHHHHhC-CCCCEeEEEeee
Confidence 348889999999999999999999997532 47999999764432 3444444 4556666 799999999987
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
. ++.+||||||++ |+|.+++......++++..++.++.||+.||.|||+++|+||||||+||||++++.+||+|||+|
T Consensus 78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 5 456799999998 67777665554457999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+....... .......||+.|||||++.. +.++.++|||||||+||||+|| .+||...+..++...+. ...++.
T Consensus 157 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~---~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~ 230 (272)
T d1qpca_ 157 RLIEDNEY--TAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMV 230 (272)
T ss_dssp EECSSSCE--ECCTTCCCCTTTSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred EEccCCcc--ccccccCCcccccChHHHhC---CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence 87643211 12234578999999999874 4688999999999999999995 55666667777766654 456677
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
.|..+|+++.+||.+||+.||++|||+.+|++.|+...
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 88999999999999999999999999999999887643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=410.28 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=199.9
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
.++|++.+.||+|+||+||+|+++.++ +.||||++..... ....+.+.++..++.++ +||||+.+++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~ 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDG------KILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC-
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCC------CEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeC
Confidence 368999999999999999999998766 4899999976432 22222333344555555 79999999998864
Q ss_pred -CCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeeeeeCCeEEEecCCcEEE
Q 006772 120 -NGKICIAMKFYE-GSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIG-----LLVLNLKPSNLLLSEHDQLVL 190 (632)
Q Consensus 120 -~~~l~LVmEy~~-GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~-----IvHRDLKP~NILld~~g~vkL 190 (632)
++.+||||||++ |+|.+++... .++.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 567899999998 5888887643 3468999999999999999999999976 999999999999999999999
Q ss_pred EecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 191 GDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 191 ~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
+|||+|+..... .......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..++...+..
T Consensus 156 ~DFG~a~~~~~~---~~~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~- 228 (269)
T d2java1 156 GDFGLARILNHD---TSFAKAFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE- 228 (269)
T ss_dssp CCHHHHHHC--------------CCCSCCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-
T ss_pred eeccceeecccC---CCccccCCCCcccCCHHHHcC---CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-
Confidence 999999875332 122345689999999999974 3689999999999999999999999999998888877754
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...+.+|..+|+++.+||.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 3445678899999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=408.09 Aligned_cols=263 Identities=21% Similarity=0.362 Sum_probs=207.9
Q ss_pred CcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 39 WIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 39 ~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
.|++++|++.+.||+|+||.||+|.+..++. ....||||.++..........+.++..++.++ +||||+.+++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCc---eeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 4778999999999999999999999876542 34579999987655444444344444556665 7999999999885
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++.+||||||++| ++.+++. .....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~-~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHH-HTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCeEEEEEEeccCCcHHhhhh-ccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 5678999999985 5665554 345689999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
....... .......||+.|||||++.. +.++.++|||||||++|||++ |.+||.+.+..+++..+.. ...+++
T Consensus 157 ~~~~~~~--~~~~~~~gt~~y~apE~l~~---~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~ 230 (273)
T d1mp8a_ 157 YMEDSTY--YKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPM 230 (273)
T ss_dssp ----------------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCC
T ss_pred eccCCcc--eeccceecCcccchhhHhcc---CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 6533211 12234568999999999973 478999999999999999998 8999999988888777654 456678
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
|..+|+++.+||.+||+.||++|||+.||++.|+.+.
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8999999999999999999999999999999888765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=414.12 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=196.0
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|++.+.||+|+||+||+|+++.++ +.||||++.+.........+.++..++..+ +||||+.+++++.+++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQ------KLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTC------CEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCC------CEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 56999999999999999999998766 489999997654333233333444555555 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe---cCCcEEEEecCCcee
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS---EHDQLVLGDFGIPYL 198 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld---~~g~vkL~DFGlak~ 198 (632)
+|||||||+ |+|.+++.. .+.+++.+++.++.||+.||+|||+++|+||||||+|||+. +++.+||+|||+|+.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999998 688888854 45899999999999999999999999999999999999995 578999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--C
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--I 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~ 276 (632)
.... ......+||+.|||||++.+. .|+.++|||||||++|||++|..||.+.+..++...+........ .
T Consensus 160 ~~~~----~~~~~~~GT~~y~APE~~~~~---~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (307)
T d1a06a_ 160 EDPG----SVLSTACGTPGYVAPEVLAQK---PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232 (307)
T ss_dssp -----------------CTTSCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT
T ss_pred ccCC----CeeeeeeeCccccCcHHHcCC---CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc
Confidence 5322 223456899999999999753 689999999999999999999999999998888888775443332 3
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+|+++.+||.+||++||++|||+.|+++
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 4679999999999999999999999999886
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=403.15 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=202.3
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc-hhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK-EDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~-~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+.+.|++.++||+|+||+||+|.++.++ ..||+|++.... .....+.+.++..+++++ +||||+++++++..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~------~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETT------VEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWES 79 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCC------eEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee
Confidence 3445689999999999999999998765 489999986543 122222334444566665 69999999999865
Q ss_pred ----CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeeeeeCCeEEEe-cCCcEEEE
Q 006772 120 ----NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIG--LLVLNLKPSNLLLS-EHDQLVLG 191 (632)
Q Consensus 120 ----~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~--IvHRDLKP~NILld-~~g~vkL~ 191 (632)
++.+||||||++ |+|.+++.+. +.+++.+++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 456899999998 5787877654 47999999999999999999999998 99999999999996 57899999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS-VEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~-~~ei~~~i~~~ 270 (632)
|||+|+.... ......+||+.|||||++.+ +++.++|||||||++|||++|+.||.+.. ..+++..+...
T Consensus 158 DFGla~~~~~-----~~~~~~~GT~~Y~aPE~~~~----~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 158 DLGLATLKRA-----SFAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228 (270)
T ss_dssp CTTGGGGCCT-----TSBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred ecCcceeccC-----CccCCcccCccccCHHHhCC----CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence 9999975322 22345689999999999853 58999999999999999999999998764 55555555544
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..++.++..+++++.+||.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 4444566788999999999999999999999999886
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=419.55 Aligned_cols=251 Identities=21% Similarity=0.366 Sum_probs=201.4
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|..++|++.++||+|+||+||+|+++.++ +.||||+++............++..++..+ +||||+.+++++.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSG------LVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS 75 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTT------EEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCC------cEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence 45689999999999999999999998765 489999997654333333334444556655 79999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 120 NGKICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 120 ~~~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++.+||||||++| +|.+++.+. +.+++..++.++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+|+
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred CCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 9999999999995 777777654 479999999999999999999997 499999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHS----------- 266 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~----------- 266 (632)
.... ....+.+||+.|||||++.+. +|+.++|||||||++|||++|+.||.+.+..+....
T Consensus 154 ~~~~-----~~~~~~~GT~~Y~APEvl~~~---~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 154 QLID-----SMANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp HHHH-----HTC---CCSSCCCCHHHHHCS---CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred ccCC-----CccccccCCccccCchHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 6532 223456899999999999854 689999999999999999999999987553221000
Q ss_pred ------------------------------HHhhccCCCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 267 ------------------------------VVIKKEKPCIP-SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 267 ------------------------------i~~~~~~p~~p-~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.......+..+ ..+++++.+||.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00111222233 246889999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=405.46 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=208.0
Q ss_pred cCCCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 40 IDPTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 40 I~~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
++.+.+.+.. +||+|+||+||+|.++... ..+.||||+++....+ ...+.+.++..++.++ +||||+.+++++
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~ 77 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC 77 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSS----SEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCC----cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEe
Confidence 4566677764 6999999999999875432 2368999999754322 2222233444556665 799999999998
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCc
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIP 196 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGla 196 (632)
.. +..||||||++ |+|.+++.+ ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 78 ~~-~~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 78 EA-ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp ES-SSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cc-CCEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhh
Confidence 64 56789999998 577777654 357999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCC
Q 006772 197 YLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPC 275 (632)
Q Consensus 197 k~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~ 275 (632)
+................||+.|||||++.+ +.++.++|||||||++|||++ |+.||.+.+..++...+. ...++.
T Consensus 155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~ 230 (277)
T d1xbba_ 155 KALRADENYYKAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMG 230 (277)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred hhccccccccccccccCCCceecCchhhcC---CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 876443222222334578999999999974 468999999999999999998 899999998888776655 456777
Q ss_pred CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 276 IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 276 ~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
.|..+|+++.+||.+||+.||++|||+++|++.|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 8899999999999999999999999999998877654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=403.22 Aligned_cols=255 Identities=18% Similarity=0.304 Sum_probs=215.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
||+++|++.++||+|+||+||+|+++. + +.||||++++.... .+.+.++. .++.++ +||||+++++++.+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~-~------~~vAvK~l~~~~~~-~~~~~~Ev-~~~~~l-~HpnIv~~~g~~~~ 70 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-Q------YDVAIKMIKEGSMS-EDEFIEEA-KVMMNL-SHEKLVQLYGVCTK 70 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETT-T------EEEEEEEEESSSSC-HHHHHHHH-HHHHTC-CCTTBCCEEEEECC
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECC-C------CEEEEEEECcCcCC-HHHHHHHH-HHHHhc-CCCceeeEEEEEee
Confidence 578999999999999999999999853 2 47999999865433 34454443 455555 79999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
++.+++||||+. |++.+++.. ....+++..+++++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred CCceEEEEEccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999998 566666544 345789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCCC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCIP 277 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~p 277 (632)
...... .......||+.|||||.+.. ..++.++|||||||++|||+| |+.||.+.+..++...+.. ..++..|
T Consensus 150 ~~~~~~--~~~~~~~~t~~y~aPE~~~~---~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p 223 (258)
T d1k2pa_ 150 VLDDEY--TSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRP 223 (258)
T ss_dssp CSSSSC--CCCCCSCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred ccCCCc--eeecccCCCCCcCCcHHhcC---CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCc
Confidence 543221 22334578999999999974 368999999999999999998 8999999998888877754 5567788
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHh
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFES 311 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~ 311 (632)
..+++++.+||.+||+.||++|||+.+|++.|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=405.48 Aligned_cols=263 Identities=19% Similarity=0.299 Sum_probs=212.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch------hhHHHHHHHHHHHhhhccCCCceeEeeEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE------DCAKVFVNKFEELFPKFRESQSVCWLHGI 116 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~------~~~~~~~~~~~~il~~l~~h~~I~~l~~~ 116 (632)
++|++++.||+|+||+||+|+++.++ +.||||++.+... ...+.+. ++..++.++ +||||+.++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~------~~~AvK~i~~~~~~~~~~~~~~~~~~-~E~~il~~l-~HpnIv~~~~~ 81 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTG------LQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI-QHPNVITLHEV 81 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTC------CEEEEEEEEBCSSTTCSSSBCHHHHH-HHHHHHHHC-CCTTBCCEEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCC------CEEEEEEEEhhhcchhhhhHHHHHHH-HHHHHHHhC-CCCCCCcEEEE
Confidence 57999999999999999999998766 4899999865321 1123333 344555665 69999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC----cEEEE
Q 006772 117 SVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD----QLVLG 191 (632)
Q Consensus 117 ~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g----~vkL~ 191 (632)
+.+++.+|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEec
Confidence 999999999999998 5888887654 4799999999999999999999999999999999999999877 59999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhc
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKK 271 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~ 271 (632)
|||+|+..... .......||+.|||||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 160 DfG~a~~~~~~----~~~~~~~~t~~y~APE~~~~~---~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 160 DFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp CCTTCEECTTS----CBCSCCCCCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred chhhhhhcCCC----ccccccCCCCcccCHHHHcCC---CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999876332 223446789999999999743 68899999999999999999999999999888887776443
Q ss_pred cCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCccccccc
Q 006772 272 EKPC--IPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWTGLGSR 328 (632)
Q Consensus 272 ~~p~--~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~~~~~~ 328 (632)
.... .+..+|+++.+||.+||+.||++|||++|+++ ++++...+|....++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~~~~~~~~l~~ 285 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIKPKDTQQALSS 285 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTCC---------
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCCCChhHhhcc
Confidence 3221 23679999999999999999999999999886 778877777654433
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=407.68 Aligned_cols=272 Identities=21% Similarity=0.321 Sum_probs=221.0
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCc-ccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDF-DEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~-~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
...|+.++|++++.||+|+||.||+|++..+++.. .....||||++++............+...+.++.+||||+.+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 44488999999999999999999999987654321 23458999999775543333333444455667778999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQR--------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~~--------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
++.+++.+++||||++ |++.+++.... ...+++.+++.++.||+.||+|||+++||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999998 68888876442 24689999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKS 259 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~ 259 (632)
|++.++.+||+|||+++....... ........||+.|||||.+.+ +.|+.++|||||||++|||++ |.+||.+.+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~---~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcC---CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999987643322 223344678999999999974 479999999999999999998 799999988
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..+++..+. ....+..|..+|+++.+||.+||+.||++|||+.||++.|+.+.
T Consensus 243 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 243 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 888776654 45677789999999999999999999999999999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=406.93 Aligned_cols=265 Identities=25% Similarity=0.427 Sum_probs=211.9
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEee
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWLH 114 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l~ 114 (632)
..|+.++|++.+.||+|+||+||+|++.... .....||||++.+.. ....+.+.++ ..++.++ +||||+.++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~~vAiK~l~~~~~~~~~~~~~~~~E-i~~l~~l-~H~nIv~~~ 77 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS---GKTVSVAVKCLKPDVLSQPEAMDDFIRE-VNAMHSL-DHRNLIRLY 77 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTT---SCEEEEEEEC--------CHHHHHHHHH-HHHHHHC-CCTTBCCEE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCC---CcEEEEEEEEEChhhcCCHHHHHHHHHH-HHHHHhC-CCCCEEEEE
Confidence 4688899999999999999999999876543 233579999987532 2223344444 3556666 799999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 115 GISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 115 ~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
+++.+ +..++||||++ |++.+.+... .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 78 g~~~~-~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 78 GVVLT-PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEee-cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 99965 56789999998 6777776654 357999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhcc
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~ 272 (632)
|+++................||..|||||++.+. .++.++|||||||++|||+| |..||.+.+..++...+.....
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCC---CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 9998764432222222344678899999999744 68899999999999999998 8999999999998888887777
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
+++.+..+|+++.+||.+||+.||++|||+.+|++.|+++
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 7888899999999999999999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-48 Score=413.35 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=216.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++++.||+|+||.||+|+++.++ +.||||++........+. +.++..++.++ +||||+.+++++.+++.
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g------~~vAvK~i~~~~~~~~~~-~~~E~~il~~l-~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATG------NNFAAKFVMTPHESDKET-VRKEIQTMSVL-RHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEECCCSHHHHHH-HHHHHHHHHHT-CCTTBCCEEEEEEETTE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEcccchhhHHH-HHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 68999999999999999999998765 489999997665544343 34444566666 69999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec--CCcEEEEecCCceec
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE--HDQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~--~g~vkL~DFGlak~~ 199 (632)
+|||||||+ |+|.+++... .+.+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999998 5787877543 457999999999999999999999999999999999999964 678999999999876
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p 277 (632)
... .......||+.|||||++.+. .++.++|||||||++|||++|..||.+.+..+++..+........ ..
T Consensus 177 ~~~----~~~~~~~gT~~Y~aPEv~~~~---~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 177 DPK----QSVKVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp CTT----SCEEEECSCTTTCCHHHHHTC---CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred ccc----cccceecCcccccCHHHHcCC---CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 432 223456899999999999754 688999999999999999999999999998888888765433322 22
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCCcc
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGEWT 323 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~w~ 323 (632)
..+|+++.+||.+||+.||++|||++|+++ ++++....|.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~~~~~~~~ 289 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTPGNAP 289 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH------STTTSCTTCC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCCCCCC
Confidence 568999999999999999999999999887 6777665554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=406.22 Aligned_cols=267 Identities=19% Similarity=0.287 Sum_probs=219.9
Q ss_pred CCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeE
Q 006772 36 TRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHG 115 (632)
Q Consensus 36 ~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~ 115 (632)
.-|+|+.++|++.+.||+|+||+||+|+++.++. ...||||.+.........+.+.++..++.++.+||||+++++
T Consensus 3 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTE----EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred CCCccCHHHcEEEEEEeeCCCcEEEEEEECCCCe----EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 4578999999999999999999999999876543 136889988654333223233444566777778999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeE
Q 006772 116 ISVINGKICIAMKFYE-GSVGDRIAQQ--------------RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNL 180 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~-GsL~d~l~~~--------------~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NI 180 (632)
++.+++.++|||||++ |+|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 158 (309)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence 9999999999999999 7888887543 236799999999999999999999999999999999999
Q ss_pred EEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCC
Q 006772 181 LLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKS 259 (632)
Q Consensus 181 Lld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~ 259 (632)
|++.++.+||+|||+|+..... .......||..|+|||.+.. +.++.++|||||||++|||++| .+||.+.+
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcCCCceEEcccccccccccc----ccccceecCCcccchHHhcc---CCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999754321 11233468999999999974 4789999999999999999996 56788888
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 260 VEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 260 ~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
..+++..+. ...++..|..+|+++.+||.+||+.||++|||+.||++.|+.+..
T Consensus 232 ~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 232 CAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 888877765 456777889999999999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.4e-48 Score=411.15 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=210.6
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++++.||+|+||.||+|.++.++ +.||||++.+........+. ++..++..+ +||||+.+++++..++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~-~Ei~il~~l-~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATG------RVFVAKFINTPYPLDKYTVK-NEISIMNQL-HHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSHHHHHHHH-HHHHHHTTC-CSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC------CEEEEEEECCcchhHHHHHH-HHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 367999999999999999999998766 48999999765544433333 344556665 7999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEe--cCCcEEEEecCCcee
Q 006772 122 KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLS--EHDQLVLGDFGIPYL 198 (632)
Q Consensus 122 ~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld--~~g~vkL~DFGlak~ 198 (632)
.+|||||||+ |+|.+.+.. .+.++++.+++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 9999999998 577776643 345799999999999999999999999999999999999998 678999999999987
Q ss_pred ccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC--CC
Q 006772 199 LLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--CI 276 (632)
Q Consensus 199 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--~~ 276 (632)
+... .......||+.|||||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+......+ ..
T Consensus 179 ~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 179 LNPD----EIVKVTTATAEFAAPEIVDRE---PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251 (352)
T ss_dssp CCTT----SCEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred cCCC----CceeeccCcccccCHHHHcCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 6432 223456799999999999754 68999999999999999999999999999888887776543322 23
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+..+|+++.+||.+||+.||.+|||+.|+++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4679999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=402.02 Aligned_cols=263 Identities=22% Similarity=0.390 Sum_probs=209.9
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeE
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCW 112 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~ 112 (632)
.....+.|+.++|++.+.||+|+||+||+|+++.+ ..||||+++..... .+.+.++. .++.++ +|+||+.
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-------~~vAiK~l~~~~~~-~~~~~~E~-~~l~~l-~h~nIv~ 76 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTMS-PEAFLQEA-QVMKKL-RHEKLVQ 76 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEECCTTSSC-HHHHHHHH-HHHHHC-CCTTBCC
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-------CEEEEEEECcccCC-HHHHHHHH-HHHHhc-ccCCEeE
Confidence 34445678899999999999999999999998654 36999999754432 34454443 445554 7899999
Q ss_pred eeEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 113 LHGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 113 l~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
+++++. ++.+++||||++ |++.+++.......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+
T Consensus 77 ~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~ 155 (285)
T d1fmka3 77 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 155 (285)
T ss_dssp EEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEc
Confidence 999884 566899999999 567777766555679999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+|+....... .......||+.|||||++. .+.++.++|||||||++|||++| .+||.+....++...+..
T Consensus 156 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~- 229 (285)
T d1fmka3 156 DFGLARLIEDNEY--TARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER- 229 (285)
T ss_dssp CCCTTC----------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-
T ss_pred ccchhhhccCCCc--eeeccccccccccChHHHh---CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-
Confidence 9999986533211 1223456899999999997 34789999999999999999995 555666677777766653
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhh
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESS 312 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~ 312 (632)
..++..+..+|+++.++|.+||+.||++||++.+|++.|+..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 456668899999999999999999999999999999888653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=404.16 Aligned_cols=269 Identities=23% Similarity=0.336 Sum_probs=223.3
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
|+.++|++.++||+|+||.||+|+++.... ....+.||||++++.........+.++..++.++.+||||+++++++..
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 788999999999999999999999864322 1455799999998755443343344445666777789999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEE
Q 006772 120 NGKICIAMKFYE-GSVGDRIAQQR----------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLL 182 (632)
Q Consensus 120 ~~~l~LVmEy~~-GsL~d~l~~~~----------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILl 182 (632)
++.++|||||++ |+|.+++.... ...+++.+++.++.||+.||+|||+++|+||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 999999999998 57777776532 2368999999999999999999999999999999999999
Q ss_pred ecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHH
Q 006772 183 SEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVE 261 (632)
Q Consensus 183 d~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ 261 (632)
+.++.+||+|||+++...... .........||+.|||||++. .+.++.++|||||||++|||+| |.+||.+.+..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhc---CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999998653321 112233457899999999997 3478999999999999999999 67777777766
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 262 EIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 262 ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
+.+..++....++..|..+|+++.+||.+||+.||++|||+.+|++.|++..
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 6666666777888888999999999999999999999999999999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-48 Score=394.83 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=202.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch---hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE---DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~---~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
++|++.+.||+|+||+||+|++..++ +.||||++++... .....+.+ +..++.. .+||||+.+++++..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~-E~~~l~~-~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLH------RDVAVKVLRADLARDPSFYLRFRR-EAQNAAA-LNHPAIVAVYDTGEA 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSTTTTCHHHHHHHHH-HHHHHHT-CCCTTBCCEEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCC------CEEEEEEEchhhccCHHHHHHHHH-HHHHHHh-cCCCCCCcccceeee
Confidence 67999999999999999999998766 4899999976432 22223333 3344444 589999999999876
Q ss_pred CC----EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecC
Q 006772 120 NG----KICIAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFG 194 (632)
Q Consensus 120 ~~----~l~LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFG 194 (632)
++ .+||||||++| +|.+.+... +.+++.+++.++.||+.||+|||+++|+||||||+|||++.++..+|+|||
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhh
Confidence 43 48999999995 666666543 589999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC
Q 006772 195 IPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 195 lak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
+++...............+||+.|||||++.+ ..++.++|||||||++|||+||..||.+.+..++...+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp TCEECC----------------TTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhccccccccccccccCcccccCHHHHcC---CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 98765443323333455689999999999974 368999999999999999999999999999888777766443332
Q ss_pred --CCCCCCCHHHHHHHHHhhhcCcCCCC-CHHHHHHHHHhhh
Q 006772 275 --CIPSGLPPAVENVIIGCFEYDLRNRP-LMADILHAFESSQ 313 (632)
Q Consensus 275 --~~p~~lp~~l~~LI~~cL~~DP~~RP-s~~ell~~Le~~~ 313 (632)
..+..+|+++.++|.+||++||.+|| +++++++.|..+.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 23467999999999999999999999 8999999887664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-47 Score=395.11 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=213.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--------hHHHHHHHHHHHhhhccCCCceeEe
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--------CAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--------~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
.++|++.+.||+|+||+||+|+++.++ +.||||++.+.... ...+...++..+++++..||||+.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~------~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 75 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTC------KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 75 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCC------CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 378999999999999999999987765 58999999764311 1122233455667788789999999
Q ss_pred eEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++.+++.+||||||++ |+|.+++... +.+++.+++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEcc
Confidence 999999999999999998 5888888654 4899999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCC---CCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPE---VRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI 269 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~ 269 (632)
||+++..... .......||+.|+|||.+.+. ....++.++||||+||++|||++|+.||.+.+..+....+..
T Consensus 154 FG~a~~~~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 154 FGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred chheeEccCC----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 9999876432 122446799999999998642 234578899999999999999999999999998888877775
Q ss_pred hccCCCC--CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 270 KKEKPCI--PSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 270 ~~~~p~~--p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
....+.. ...+|+++.+||.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 5443332 2479999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=403.67 Aligned_cols=264 Identities=21% Similarity=0.348 Sum_probs=208.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
+..++|++++.||+|+||+||+|.+..+++ .....||+|.++..... ..+.+.+ +..++.++ +||||+.+++++.
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~-E~~~l~~l-~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILD-EAYVMASV-DNPHVCRLLGICL 81 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHH-HHHHHHHC-CCTTBCCEEEEEE
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCC--EEEEEEEEEEeccccCHHHHHHHHH-HHHHHHhC-CCCCEeeEEEEEe
Confidence 456789999999999999999999887654 12246999998754332 3334444 44556665 7999999999987
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 119 INGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 119 ~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
+++ .+++|||+. |+|.+.+... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~-~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 82 TST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred cCC-eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 654 566667776 7888877654 5689999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCCCC
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKPCI 276 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p~~ 276 (632)
....... ........||+.|||||++.+ +.++.++|||||||+||||+| |..||.+.+..++...+. .+.++..
T Consensus 160 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~ 234 (317)
T d1xkka_ 160 LLGAEEK-EYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQ 234 (317)
T ss_dssp HTTTTCC---------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCC
T ss_pred ecccccc-cccccccccCccccChHHHhc---CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 7543221 112233468999999999974 478999999999999999998 899999888777765554 4566778
Q ss_pred CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 277 PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 277 p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
|..+|+++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999999998877653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-48 Score=402.99 Aligned_cols=269 Identities=19% Similarity=0.308 Sum_probs=219.7
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
.++..++|++.+.||+|+||+||+|+++... +...++.||||+++..........+.++..+++.+ +|+||+.+++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCc-cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeee
Confidence 3456789999999999999999999986432 12345689999997654443333334444556665 799999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeee
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR----------------------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLN 174 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~----------------------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRD 174 (632)
...+..+++|||++ |+|.+++.... ...+++..++.++.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999998 78888875431 13488999999999999999999999999999
Q ss_pred eeCCeEEEecCCcEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCC-C
Q 006772 175 LKPSNLLLSEHDQLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGI-Q 253 (632)
Q Consensus 175 LKP~NILld~~g~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~-~ 253 (632)
|||+|||+|.++.+||+|||+|+....... ........||+.|||||.+.+ ..++.++|||||||++|||++|. +
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHcc---CCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999986533221 122334678999999999974 47899999999999999999985 6
Q ss_pred CCCCCCHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 254 PWFGKSVEEIYHSVVIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 254 PF~~~~~~ei~~~i~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
||.+.+..++...+.. ...+..|..+|+++.+||.+||+.||++||||.||++.|+.+.
T Consensus 242 p~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 8988888888877654 4567788999999999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=393.23 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=209.4
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|+.++|++++.||+|+||.||+|.++. ..||||++++... .+.+.++ ..++.++ +||||+.+++++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~vAvK~i~~~~~--~~~~~~E-~~~l~~l-~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDAT--AQAFLAE-ASVMTQL-RHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT--------EEEEEEECCCCC----HHHHHT-HHHHTTC-CCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC--------eEEEEEEECcHHH--HHHHHHH-HHHHHhC-CCCCEeeEEEEE
Confidence 45888999999999999999999999742 3799999975432 2444444 4556666 799999999988
Q ss_pred EE-CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 118 VI-NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 118 ~~-~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
.. ++.+||||||++ |+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 64 466899999998 6888888665445689999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhccCC
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLT-GIQPWFGKSVEEIYHSVVIKKEKP 274 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~Emlt-G~~PF~~~~~~ei~~~i~~~~~~p 274 (632)
++.... ......+|+.|||||++.+ +.++.++|||||||++|||+| |+.||.+.+..++...+. ...++
T Consensus 150 s~~~~~------~~~~~~~~~~y~aPE~l~~---~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~ 219 (262)
T d1byga_ 150 TKEASS------TQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKM 219 (262)
T ss_dssp ------------------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCC
T ss_pred ceecCC------CCccccccccCCChHHHhC---CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 986432 1223467999999999874 478999999999999999998 799999988888777764 45677
Q ss_pred CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 275 CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 275 ~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+|..+++++.+||.+||+.||.+|||+.++++.|+.++.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=393.31 Aligned_cols=260 Identities=18% Similarity=0.288 Sum_probs=208.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhc--cCCCceeEeeEEEE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKF--RESQSVCWLHGISV 118 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l--~~h~~I~~l~~~~~ 118 (632)
++|+++++||+|+||+||+|++..++. +.||||+++.... .....+.++. .+++.+ .+||||+.+++++.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~-~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEEEEEBCTTSCBCTHHHHH-HHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCC-----EEEEEEEEehhhccchHHHHHHHHH-HHHHHHhhcCCCCcceeeeeec
Confidence 689999999999999999999876542 4799999864221 1111222332 333333 37999999999886
Q ss_pred E-----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 119 I-----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 119 ~-----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. +..++++|||+.|+++.+........+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence 3 35789999999998887776666678999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+++.... ........||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 161 g~~~~~~~----~~~~~~~~gT~~Y~APE~~~~---~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSF----QMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCG----GGGGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhhcc----cccCCCcccChhhcCcchhcC---CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99875432 123345689999999999974 47899999999999999999999999999887776665432111
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCC
Q 006772 274 -------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGE 321 (632)
Q Consensus 274 -------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~ 321 (632)
..++..+++++.+||.+||++||++|||+.|+++ ++|+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~------Hpff~~i~ 300 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQDLE 300 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGTTCC
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------ChhhcCch
Confidence 1134568899999999999999999999999876 67776554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=389.83 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=208.5
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|+++++||+|+||+||+|.++.++ +.||||+++..... ....+.+ +..+++++ +||||+.+++++.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~-Ei~il~~l-~Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTG------EVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKLLDVIHTE 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEC-------CCHHHHH-HHHHHTTC-CCTTBCCEEEEEEET
T ss_pred CCCEeccEEecCcCeEEEEEEECCCC------CEEEEEEEehhhcChHHHHHHHH-HHHHHHhC-CCCcEEEeccccccc
Confidence 68999999999999999999998766 48999999653321 1233333 34555554 799999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+.+||||||+.|++.+++.......+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence 99999999999988888877667789999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP------ 274 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p------ 274 (632)
.. ........||+.|+|||.+... ..++.++|+|||||++|+|++|+.||.+.+..+....+......+
T Consensus 154 ~~---~~~~~~~~gt~~y~apE~~~~~--~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 154 VP---VRTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp CC---SBCTTCCBCCCTTCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CC---cccceeecccceeeehhhhccc--cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 32 2233445799999999988643 245789999999999999999999999988776655544211111
Q ss_pred ----------CC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCC
Q 006772 275 ----------CI-----------PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYND 319 (632)
Q Consensus 275 ----------~~-----------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~ 319 (632)
.+ ...+++++.+||.+||+.||++|||+.|+++ ++|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~------H~ff~~ 288 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA------HPFFQD 288 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGTT
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC------CHhhcc
Confidence 01 1256789999999999999999999999886 566643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=400.40 Aligned_cols=287 Identities=18% Similarity=0.304 Sum_probs=228.7
Q ss_pred CCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCc---hhhHHHHHHHHHHHhhhccCCCceeEe
Q 006772 37 RPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLK---EDCAKVFVNKFEELFPKFRESQSVCWL 113 (632)
Q Consensus 37 ~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~---~~~~~~~~~~~~~il~~l~~h~~I~~l 113 (632)
...+..++|++++.||+|+||+||+|.+.... .+++.||||++++.. .....+...++..++.++.+||||+.+
T Consensus 18 ~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~ 94 (322)
T d1vzoa_ 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94 (322)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred CcccchhceEEEEEEecCCCeEEEEEEECccC---CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEe
Confidence 33456789999999999999999999986533 234689999986532 111122233444667788888999999
Q ss_pred eEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEe
Q 006772 114 HGISVINGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGD 192 (632)
Q Consensus 114 ~~~~~~~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~D 192 (632)
++++.+...++++|||+. |+|.+.+... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 95 HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred eeeeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence 999999999999999998 5777777554 4788999999999999999999999999999999999999999999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--h
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVI--K 270 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~--~ 270 (632)
||+++.+.... ........||+.|+|||.+.+. ...++.++|||||||+||||++|+.||.+.+..+....+.. .
T Consensus 173 FG~a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~-~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 173 FGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp SSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred ccchhhhcccc--cccccccccccccchhHHhhcC-CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 99998753321 2223456799999999999754 33578899999999999999999999987653332222221 2
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHHHHHhhhhcccCCCCccccccccccCCCcCC
Q 006772 271 KEKPCIPSGLPPAVENVIIGCFEYDLRNRPL-----MADILHAFESSQNAVYNDGEWTGLGSRALTDTSSVK 337 (632)
Q Consensus 271 ~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs-----~~ell~~Le~~~~~~~~~~~w~~~~~~~~~~~~~~~ 337 (632)
...+.+|..+++++.+||.+||++||.+||+ ++|+++ ++|+.+.+|..+..+.+.+|+.|.
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~------Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE------HLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc------CHhhcCCCHHHHHhCCCCcCCCCC
Confidence 3456678899999999999999999999995 677764 889999999999999988887663
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=394.56 Aligned_cols=272 Identities=18% Similarity=0.308 Sum_probs=222.5
Q ss_pred CCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEE
Q 006772 38 PWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGIS 117 (632)
Q Consensus 38 ~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~ 117 (632)
..|++++|++.++||+|+||+||+|.++..... .....||||++++.........+.++..++.++ +||||+.+++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~-~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETT-EEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccC-CCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEE
Confidence 348899999999999999999999998643221 223589999997654443333344444556665 689999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcE
Q 006772 118 VINGKICIAMKFYE-GSVGDRIAQQR--------GGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQL 188 (632)
Q Consensus 118 ~~~~~l~LVmEy~~-GsL~d~l~~~~--------~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~v 188 (632)
..++..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 99999999999998 78888776432 1357889999999999999999999999999999999999999999
Q ss_pred EEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 006772 189 VLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG-IQPWFGKSVEEIYHSV 267 (632)
Q Consensus 189 kL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG-~~PF~~~~~~ei~~~i 267 (632)
||+|||+|+....... ........||+.|||||.+.+ +.++.++|||||||++|||+|| .+||.+.+..+++..+
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~---~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc---CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999986543221 112233468999999999974 4688999999999999999997 5889898988888776
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcc
Q 006772 268 VIKKEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAV 316 (632)
Q Consensus 268 ~~~~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~ 316 (632)
.. ...+..|..+|+++.++|.+||+.||++|||+.+|++.|++...+.
T Consensus 249 ~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 249 ME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred Hh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 64 4566778999999999999999999999999999999998765443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=398.24 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=197.2
Q ss_pred CCCeEEEe-EEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 42 PTSLKLKH-RIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 42 ~~~y~l~~-~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
.++|++.. .||+|+||.||+|.+..++ +.||||+++... .. .++..++.++.+||||+.+++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~-----~~-~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQ------EKFALKMLQDCP-----KA-RREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTC------CEEEEEEEECSH-----HH-HHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCC------CEEEEEEECCcH-----HH-HHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 36899875 5999999999999998766 489999996532 22 2333445566789999999999875
Q ss_pred ---CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEe
Q 006772 120 ---NGKICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGD 192 (632)
Q Consensus 120 ---~~~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~D 192 (632)
+..+|||||||+ |+|.+++.......+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 467999999998 58998887654567999999999999999999999999999999999999985 56799999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK-- 270 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~-- 270 (632)
||+|+..... ......+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+..+....+...
T Consensus 158 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~ 230 (335)
T d2ozaa1 158 FGFAKETTSH----NSLTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230 (335)
T ss_dssp CTTCEECCCC----CCCCCCSCCCSSCCCCCCCGG---GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC
T ss_pred cceeeeccCC----CccccccCCcccCCcHHHcCC---CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh
Confidence 9999875432 223456899999999999754 6889999999999999999999999887644433333211
Q ss_pred ccCCCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 271 KEKPCIP----SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 271 ~~~p~~p----~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+| ..+|+++.+||.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1222333 358999999999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=392.58 Aligned_cols=248 Identities=19% Similarity=0.309 Sum_probs=207.4
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++++.||+|+||+||+|.++.++ +.||||+++....+ .....++..++..+ +||||+.+++++.+++.
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~------~~~AiK~i~~~~~~--~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSK------KTYMAKFVKVKGTD--QVLVKKEISILNIA-RHRNILHLHESFESMEE 75 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCCTHH--HHHHHHHHHHHHHS-CCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCC------cEEEEEEEcCCccc--HHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence 68999999999999999999998766 48999999765433 22333444555555 69999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecC--CcEEEEecCCceec
Q 006772 123 ICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEH--DQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~--g~vkL~DFGlak~~ 199 (632)
+|||||||+ |+|.+++.. .+..+++.+++.|+.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++..
T Consensus 76 ~~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999 478877754 33579999999999999999999999999999999999999854 48999999999865
Q ss_pred cCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC--CC
Q 006772 200 LGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC--IP 277 (632)
Q Consensus 200 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~--~p 277 (632)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||.+.+..+++..+........ .+
T Consensus 155 ~~~----~~~~~~~~t~~y~ape~~~~~---~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 155 KPG----DNFRLLFTAPEYYAPEVHQHD---VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp CTT----CEEEEEESCGGGSCHHHHTTC---EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ccC----CcccccccccccccchhccCC---CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc
Confidence 321 223445789999999998743 688999999999999999999999999999888888774432221 11
Q ss_pred CCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 278 SGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 278 ~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..+|+++.+||.+||+.||.+|||+.|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 478999999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=387.31 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=199.1
Q ss_pred EEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHH----HHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 47 LKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAK----VFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 47 l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~----~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
.++.||+|+||+||+|+++.++ +.||||+++........ ....++..++..+ +||||+.+++++..++.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~ 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTN------QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCC------SEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC
T ss_pred cceEeccCcCeEEEEEEECCCC------cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCc
Confidence 4678999999999999988765 48999998654322111 1122333455555 79999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCC
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGR 202 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~ 202 (632)
+||||||+.|++...+.. .+..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 75 ~~ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CEEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eeehhhhhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 999999999877766643 3468999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCCC-------
Q 006772 203 SLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKPC------- 275 (632)
Q Consensus 203 ~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p~------- 275 (632)
.......+||+.|||||++... ..|+.++|||||||++|||++|..||.+.+..+....+......+.
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ---cccccceecChhhccHHHHccC--CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 1223345799999999998632 3578999999999999999999999999888777666553211110
Q ss_pred --------------C-----CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccC
Q 006772 276 --------------I-----PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318 (632)
Q Consensus 276 --------------~-----p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~ 318 (632)
. ...+++++.+||.+||+.||++|||++|+++ ++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~------Hp~f~ 284 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK------MKYFS 284 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT------SGGGT
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC------CHhhC
Confidence 0 1356889999999999999999999999876 66664
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=387.98 Aligned_cols=263 Identities=19% Similarity=0.310 Sum_probs=206.1
Q ss_pred EEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-CCEEE
Q 006772 46 KLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI-NGKIC 124 (632)
Q Consensus 46 ~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-~~~l~ 124 (632)
.+.++||+|+||+||+|++..++. ....||||.+++.........+.++..++.++ +||||+.+++++.. ++..+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceE
Confidence 447899999999999999876542 22369999997644433333334444566666 69999999999876 57899
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccCCC
Q 006772 125 IAMKFYEG-SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLGRS 203 (632)
Q Consensus 125 LVmEy~~G-sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~~~ 203 (632)
+|||||+| ++.+++ ......+++..++.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++......
T Consensus 106 lv~E~~~~g~l~~~~-~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEECCTTCBHHHHH-HCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEeecCchhhhh-ccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999995 555554 4445678899999999999999999999999999999999999999999999999998764432
Q ss_pred CCC-CccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhccCCCCCCCCC
Q 006772 204 LSD-SDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGK-SVEEIYHSVVIKKEKPCIPSGLP 281 (632)
Q Consensus 204 ~~~-~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~-~~~ei~~~i~~~~~~p~~p~~lp 281 (632)
... .......||+.|+|||.+.. +.++.++||||||+++|||++|..||... +..++...+. .+.++..|..++
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~ 260 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP 260 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCC
T ss_pred cccceecccccccccccChHHHhc---CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCc
Confidence 222 22234578999999999873 47899999999999999999977776654 3444444444 456777889999
Q ss_pred HHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhccc
Q 006772 282 PAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVY 317 (632)
Q Consensus 282 ~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~ 317 (632)
+++.+||.+||+.||++||++.||++.|+.+...+.
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=386.72 Aligned_cols=241 Identities=19% Similarity=0.232 Sum_probs=196.2
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh------hHHHHHHHHHHHhhhcc-CCCceeEeeE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED------CAKVFVNKFEELFPKFR-ESQSVCWLHG 115 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~------~~~~~~~~~~~il~~l~-~h~~I~~l~~ 115 (632)
++|++.+.||+|+||.||+|+++.++ +.||||++.+.... ....+. .+..++.++. .||||+.+++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~~~-~E~~il~~l~~~h~nIv~~~~ 76 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDN------LPVAIKHVEKDRISDWGELPNGTRVP-MEVVLLKKVSSGFSGVIRLLD 76 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEEGGGCCCEEECTTCCEEE-HHHHHHHHHCSSSCSBCCEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCC------CEEEEEEEehHHccchhhhhHHHHHH-HHHHHHHHhccCCCCccEEEE
Confidence 57999999999999999999998765 48999998643211 011112 2334455554 5899999999
Q ss_pred EEEECCEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-CCcEEEEe
Q 006772 116 ISVINGKICIAMKFYEG--SVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-HDQLVLGD 192 (632)
Q Consensus 116 ~~~~~~~l~LVmEy~~G--sL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-~g~vkL~D 192 (632)
++.+++..|+||||+.| ++.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence 99999999999999974 566666543 58999999999999999999999999999999999999995 47999999
Q ss_pred cCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhcc
Q 006772 193 FGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKE 272 (632)
Q Consensus 193 FGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~ 272 (632)
||+|+.... .......||+.|||||++.+. ..++.++|||||||++|||++|+.||.+.+ .+. ..
T Consensus 155 FG~a~~~~~-----~~~~~~~GT~~y~aPE~~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~--~~ 219 (273)
T d1xwsa_ 155 FGSGALLKD-----TVYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII--RG 219 (273)
T ss_dssp CTTCEECCS-----SCBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH--HC
T ss_pred cccceeccc-----ccccccccCCCcCCHHHHcCC--CCCCcccccccceeeehhHhhCCCCCCCch------HHh--hc
Confidence 999986532 223456899999999998743 124678999999999999999999997632 122 23
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 273 KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 273 ~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
...++..+|+++.+||.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 45678899999999999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=381.58 Aligned_cols=258 Identities=18% Similarity=0.245 Sum_probs=204.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
++|++.+.||+|+||.||+|++..++ +.||||++...... .+ +..+.+++..+.+|++|+.+..++..++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~~~--~~-~~~E~~i~~~l~~~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKH--PQ-LHIESKIYKMMQGGVGIPTIRWCGAEGDY 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT------EEEEEEEEESCTTS--CC-HHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCC------CEEEEEEEchhccC--HH-HHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence 57999999999999999999988765 48999998754332 12 23445667778888889998898899999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec---CCcEEEEecCCceec
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE---HDQLVLGDFGIPYLL 199 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~---~g~vkL~DFGlak~~ 199 (632)
.++||||+.|++.+.+.. ..+.+++..++.++.|++.||+|||+++|+||||||+|||++. +..+||+|||+|+.+
T Consensus 78 ~~ivme~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEcCCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999999988877654 3468999999999999999999999999999999999999864 457999999999876
Q ss_pred cCCCCC----CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhc-
Q 006772 200 LGRSLS----DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVV---IKK- 271 (632)
Q Consensus 200 ~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~---~~~- 271 (632)
...... ........||+.|||||++.+. +++.++|||||||++|||++|..||.+.........+. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB---CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCC---CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 432211 1223456899999999999754 68999999999999999999999998865443322211 111
Q ss_pred --cCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhh
Q 006772 272 --EKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQ 313 (632)
Q Consensus 272 --~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~ 313 (632)
..+..+..+|+++.++|.+||+.||++||++.++.+.|+.+.
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112234689999999999999999999999999888777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.8e-45 Score=375.18 Aligned_cols=260 Identities=17% Similarity=0.229 Sum_probs=209.2
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
.++|++++.||+|+||+||+|++..++ +.||||++...... ..+ .++.+++..+.+++|++.+++++..++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~~~--~~~-~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNN------QQVAIKFEPRRSDA--PQL-RDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTT------EEEEEEEEECCTTS--CCH-HHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEccccCc--HHH-HHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 468999999999999999999998765 48999998654322 122 233355667778899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEec-----CCcEEEEecCCc
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSE-----HDQLVLGDFGIP 196 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~-----~g~vkL~DFGla 196 (632)
..|+||||+.|+|.+.+.. .+..+++.+++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 75 ~~~~vme~~~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEecCCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 9999999999999888754 3468999999999999999999999999999999999999974 578999999999
Q ss_pred eeccCCCC----CCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q 006772 197 YLLLGRSL----SDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKS---VEEIYHSVVI 269 (632)
Q Consensus 197 k~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~---~~ei~~~i~~ 269 (632)
+....... ........+||+.|||||++.+. .++.++|+|||||++|||++|..||.+.+ ..+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~---~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCC---CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 87643211 11223456899999999999743 68999999999999999999999998653 3333333332
Q ss_pred hccCC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 270 KKEKP---CIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 270 ~~~~p---~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
....+ ..+..+|+++.+++..|+..+|++||+++.+.+.|+++..
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 22221 2346789999999999999999999999998887777643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-45 Score=375.65 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=201.6
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh--hHHHHHHHHHHHhhhccCCCceeEeeEEEEEC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED--CAKVFVNKFEELFPKFRESQSVCWLHGISVIN 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~--~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~ 120 (632)
++|++.++||+|+||+||+|+++. + +.||||++...... ....+. ++..+++++ +||||+.+++++..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-~------~~vAvK~i~~~~~~~~~~~~~~-~E~~il~~l-~hpnIv~~~~~~~~~ 72 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNY-G------ETFALKKIRLEKEDEGIPSTTI-REISILKEL-KHSNIVKLYDVIHTK 72 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT-S------CEEEEEEECCSSGGGCCCHHHH-HHHHGGGGC-CCTTBCCEEEEEECS
T ss_pred CCceeccEEecCCCcEEEEEEeCC-C------CEEEEEEEehhhcChHHHHHHH-HHHHHHHhC-CCCcEEeeeeecccC
Confidence 689999999999999999999853 2 48999999764322 123333 344556665 699999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceecc
Q 006772 121 GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLL 200 (632)
Q Consensus 121 ~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~ 200 (632)
+..+++|||+.|+++..+... .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|....
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred CceeEEEEeehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 999999999999888777653 4689999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC-------
Q 006772 201 GRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK------- 273 (632)
Q Consensus 201 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~------- 273 (632)
... .......||+.|+|||.+.+. ..++.++|+|||||++|||++|+.||.+.+..+...++......
T Consensus 152 ~~~---~~~~~~~~~~~y~~pE~~~~~--~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 152 IPV---RKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp C------------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cCc---cccceecccchhhhHHHHhCC--CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhcc
Confidence 321 122344689999999998743 35789999999999999999999999998877666554421111
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 274 --------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 274 --------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
..++..+++++.+||.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123567899999999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=383.84 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=207.6
Q ss_pred ccccccCCCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc
Q 006772 26 LRTVVATPTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR 105 (632)
Q Consensus 26 ~~~~~~~~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~ 105 (632)
..++.++|.........-+|+..+.||+|+||+||+|+++.++ +.||||++.+..... .++..++.++
T Consensus 3 ~~~~~~~~~~~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~-----~~Ei~il~~l- 70 (350)
T d1q5ka_ 3 VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG------ELVAIKKVLQDKRFK-----NRELQIMRKL- 70 (350)
T ss_dssp CEEEEEEESSSSCCCEEEEEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEECCSSSC-----CHHHHHHHHC-
T ss_pred CcccccCCCCCCCCcccCCcEeeeEEeeCcCeEEEEEEECCCC------CEEEEEEECccchHH-----HHHHHHHHhc-
Confidence 3455666655444444457999999999999999999998766 489999997654322 2233455555
Q ss_pred CCCceeEeeEEEEEC------CEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeC
Q 006772 106 ESQSVCWLHGISVIN------GKICIAMKFYEGSVGDRIAQQ--RGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKP 177 (632)
Q Consensus 106 ~h~~I~~l~~~~~~~------~~l~LVmEy~~GsL~d~l~~~--~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP 177 (632)
+|+||+.+++++... .++||||||++|++.+.+... ....+++.+++.++.||+.||+|||++||+||||||
T Consensus 71 ~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp 150 (350)
T d1q5ka_ 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150 (350)
T ss_dssp CCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred CCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCc
Confidence 799999999988643 358999999998877666542 346799999999999999999999999999999999
Q ss_pred CeEEEecCC-cEEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCC
Q 006772 178 SNLLLSEHD-QLVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF 256 (632)
Q Consensus 178 ~NILld~~g-~vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~ 256 (632)
+|||++.++ .+||+|||+++..... ......+||+.|+|||.+.+. ..++.++|||||||++|||++|+.||.
T Consensus 151 ~NILl~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 151 QNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp GGEEECTTTCCEEECCCTTCEECCTT----SCCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ceEEEecCCCceeEecccchhhccCC----cccccccccccccChHHhhcc--cCCCcceeecccceEEEehhhCCCCCC
Confidence 999999775 8999999999876432 223446799999999988643 358899999999999999999999999
Q ss_pred CCCHHHHHHHHHhhcc---------------CC------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 257 GKSVEEIYHSVVIKKE---------------KP------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 257 ~~~~~ei~~~i~~~~~---------------~p------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
+.+..+.+..+..... .. .....+++++.+||.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8887665555432100 00 112457899999999999999999999999886
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=375.78 Aligned_cols=258 Identities=20% Similarity=0.305 Sum_probs=198.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC-
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVING- 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~- 121 (632)
++|.+.++||+|+||.||+|++.. +.||||++.... ...+..+.+.......+||||+.+++++..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g--------~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRG--------EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT--------EEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC--------EEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 579999999999999999998632 489999986432 23333333233333457999999999998654
Q ss_pred ---EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeeeeeCCeEEEecCCcEE
Q 006772 122 ---KICIAMKFYE-GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS--------IGLLVLNLKPSNLLLSEHDQLV 189 (632)
Q Consensus 122 ---~l~LVmEy~~-GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs--------~~IvHRDLKP~NILld~~g~vk 189 (632)
.+||||||++ |+|.+++.+ ..+++..++.++.|++.||+|||+ ++|+||||||+||||+.++.+|
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 6899999998 688888754 369999999999999999999996 5999999999999999999999
Q ss_pred EEecCCceeccCCCCC-CCccccccCCCccCCccccCCCCC---CCCCcccccchhHHHHHHHHhCCCCCCC--------
Q 006772 190 LGDFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVR---GPISFETDTWGFGCSIMEMLTGIQPWFG-------- 257 (632)
Q Consensus 190 L~DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~---g~~t~ksDvwSlGvvL~EmltG~~PF~~-------- 257 (632)
|+|||+++........ ........||+.|||||++.+... ..++.++|||||||+||||+||..||..
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999999876443211 223345689999999999875421 1357889999999999999999887642
Q ss_pred -------CCHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhh
Q 006772 258 -------KSVEEIYHSVVIKKEKPCIPSGL-----PPAVENVIIGCFEYDLRNRPLMADILHAFESSQN 314 (632)
Q Consensus 258 -------~~~~ei~~~i~~~~~~p~~p~~l-----p~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~ 314 (632)
.+...+...+.....+|.+|... +..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12334444444444555555432 3469999999999999999999999999987763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=378.95 Aligned_cols=253 Identities=19% Similarity=0.246 Sum_probs=199.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEEC--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVIN-- 120 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~-- 120 (632)
++|++++.||+|+||+||+|.++.++ +.||||++.+...........++..++..+ +||||+.+++++..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNK------VRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTC------SEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCC------cEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccc
Confidence 56999999999999999999988766 489999997654333333333444556665 789999999998654
Q ss_pred ---CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 121 ---GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 121 ---~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
...||+|+++.|+|.+++.. +.+++.+++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34778877777899988854 379999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccCC---
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEKP--- 274 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~p--- 274 (632)
...............+||+.|+|||++... ..++.++|+||+||++|||++|+.||.+.+..+...........+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTB--CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccCCCccceeeccccccceechHHHhhcC--CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 764433333334556899999999998643 357889999999999999999999999887655444332111110
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHH
Q 006772 275 --------------------------CIPSGLPPAVENVIIGCFEYDLRNRPLMADILH 307 (632)
Q Consensus 275 --------------------------~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~ 307 (632)
.....+++++.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012467889999999999999999999999886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.1e-44 Score=373.90 Aligned_cols=257 Identities=17% Similarity=0.299 Sum_probs=201.8
Q ss_pred CCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEE-
Q 006772 41 DPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVI- 119 (632)
Q Consensus 41 ~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~- 119 (632)
+.++|+++++||+|+||+||+|+++.++ +.||||++++... +.+ .++..++..+.+||||+.+++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~------~~vAiK~i~~~~~---~~~-~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNN------EKVVVKILKPVKK---KKI-KREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSSCH---HHH-HHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCC------CEEEEEEECHHHH---HHH-HHHHHHHHhccCCCCCcEEEEEEEec
Confidence 3478999999999999999999998766 4899999976442 333 3344567777789999999999874
Q ss_pred -CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCC-cEEEEecCCce
Q 006772 120 -NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHD-QLVLGDFGIPY 197 (632)
Q Consensus 120 -~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g-~vkL~DFGlak 197 (632)
...+++||||+.++.+..+ .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred CCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 4569999999996443222 24799999999999999999999999999999999999999655 68999999998
Q ss_pred eccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhh------
Q 006772 198 LLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSV-EEIYHSVVIK------ 270 (632)
Q Consensus 198 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~-~ei~~~i~~~------ 270 (632)
..... ......+||+.|+|||.+.+. ..++.++|+||+||++|||++|..||..... .+....+...
T Consensus 179 ~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 179 FYHPG----QEYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp ECCTT----CCCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eccCC----CcccccccCccccCcccccCC--CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 75432 223456789999999998753 3478999999999999999999999976542 2221111100
Q ss_pred -----------------------------ccCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCCC
Q 006772 271 -----------------------------KEKPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDGE 321 (632)
Q Consensus 271 -----------------------------~~~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~~ 321 (632)
.........+++++.+||++||+.||++|||++|+|+ +++|.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~------Hp~F~~v~ 326 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME------HPYFYTVV 326 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTTSC
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCCCC
Confidence 0000111347899999999999999999999999876 88888887
Q ss_pred cc
Q 006772 322 WT 323 (632)
Q Consensus 322 w~ 323 (632)
|+
T Consensus 327 ~~ 328 (328)
T d3bqca1 327 KD 328 (328)
T ss_dssp CC
T ss_pred CC
Confidence 74
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=375.37 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=197.7
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|++++.||+|+||+||+|.++.++ +.||||++++... ...+.+. ++..++..+ +||||+.+++++..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~-~Ei~il~~l-~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTG------AKVAIKKLYRPFQSELFAKRAY-RELRLLKHM-RHENVIGLLDVFTP 88 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC------CEEEEEECSSTTSSHHHHHHHH-HHHHHHHHC-CBTTBCCCSEEECS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCC------CEEEEEEEchhhcChHHHHHHH-HHHHHHHhc-CCCCeeEEEEEecc
Confidence 478999999999999999999998766 4899999975322 2222333 334555555 79999999999876
Q ss_pred CC------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 NG------KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~~------~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
.+ .+||||||+.+++.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred CccccccceEEEEEecccccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccc
Confidence 54 5799999997666665533 47999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|+|+.... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 166 g~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 166 GLARQADS------EMTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp TTCEECCS------SCCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceeccCC------ccccccccccccCHHHHcCC--CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 99987532 23456799999999998643 35688999999999999999999999988766554433221111
Q ss_pred -----------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 274 -----------------------------PCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 274 -----------------------------p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
......+++++.+||.+||..||.+|||+.|+++ ++++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~------Hp~f~~~ 307 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA------HPYFESL 307 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGTTT
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc------ChhhCcC
Confidence 1123567899999999999999999999999987 6666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=369.13 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=200.3
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
.++|+++++||+|+||+||+|+++.++ +.||||++..... .....+.++ ..+++++ +|+|++.+++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E-~~il~~l-~h~nii~~~~~~~~ 80 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTG------QKVALKKVLMENEKEGFPITALRE-IKILQLL-KHENVVNLIEICRT 80 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEC----CTTSSCHHHHHH-HHHHHHC-CCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCC------CEEEEEEEehhhcchHHHHHHHHH-HHHHHHh-cCCCccceEeeeec
Confidence 479999999999999999999998765 4899999864322 222333333 4556666 68999999888754
Q ss_pred --------CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEE
Q 006772 120 --------NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLG 191 (632)
Q Consensus 120 --------~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~ 191 (632)
++.+|++|||+.++++..+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred ccccccccCceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence 356899999999877766543 34689999999999999999999999999999999999999999999999
Q ss_pred ecCCceeccCCCCC-CCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 006772 192 DFGIPYLLLGRSLS-DSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIK 270 (632)
Q Consensus 192 DFGlak~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~ 270 (632)
|||+++........ .......+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCC--CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999765432211 2223445799999999998743 35789999999999999999999999998877665554432
Q ss_pred ccCCC--CCC----------------------------CCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccC
Q 006772 271 KEKPC--IPS----------------------------GLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318 (632)
Q Consensus 271 ~~~p~--~p~----------------------------~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~ 318 (632)
...+. ... ..++++.+||.+||+.||++|||++|+++ ++||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~------Hpff~ 309 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFW 309 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc------Chhhc
Confidence 21111 000 12667889999999999999999999887 66664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=357.17 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=202.9
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch-hhHHHHHHHHHHHhhhccCCCceeEeeEEEEECC
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE-DCAKVFVNKFEELFPKFRESQSVCWLHGISVING 121 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~-~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~ 121 (632)
++|+++++||+|+||+||+|+++.++ +.||||+++.... ........++..+++.+ +|+||+.+++++...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETH------EIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC------CEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCC------cEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccccc
Confidence 68999999999999999999998766 4899999965432 22222333344555554 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCCceeccC
Q 006772 122 KICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGIPYLLLG 201 (632)
Q Consensus 122 ~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGlak~~~~ 201 (632)
..+++|+++.|.++..+.. ..+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999999876666554 356899999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhcc--------
Q 006772 202 RSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWF-GKSVEEIYHSVVIKKE-------- 272 (632)
Q Consensus 202 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~-~~~~~ei~~~i~~~~~-------- 272 (632)
.. .......+++.|+|||.+... ..++.++|||||||++|||++|..||. +.+..+....+.....
T Consensus 154 ~~---~~~~~~~~~~~~~~pe~~~~~--~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 154 PV---RCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CC---SCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred CC---ccceeeccccchhhhhHhccC--CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 21 122334578899999998743 246889999999999999999999865 4455555444432111
Q ss_pred -------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccC
Q 006772 273 -------------------KPCIPSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318 (632)
Q Consensus 273 -------------------~p~~p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~ 318 (632)
....+..+++++.+||.+||+.||.+|||++|+++ +++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~------Hp~f~ 287 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ------HPYFS 287 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc------Chhhc
Confidence 11233467889999999999999999999999876 56664
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=366.26 Aligned_cols=252 Identities=20% Similarity=0.219 Sum_probs=191.7
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-hHHHHHHHHHHHhhhccCCCceeEeeEEEEE--
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-CAKVFVNKFEELFPKFRESQSVCWLHGISVI-- 119 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~-- 119 (632)
++|++++.||+|+||+||+|.++.++ +.||||++.+.... .......++..+++.+ +||||+.+++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQK 89 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTT------EEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCC------CEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccc
Confidence 67999999999999999999998766 48999999754322 2222233444555565 79999999999864
Q ss_pred ----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEecCC
Q 006772 120 ----NGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDFGI 195 (632)
Q Consensus 120 ----~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DFGl 195 (632)
...+|+||||+.|++++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+
T Consensus 90 ~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp STTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence 36899999999998887663 4789999999999999999999999999999999999999999999999999
Q ss_pred ceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC--
Q 006772 196 PYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK-- 273 (632)
Q Consensus 196 ak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~-- 273 (632)
++..... ......+||+.|+|||++.+. .++.++|+||+||++|||++|+.||.+.+.......+......
T Consensus 166 ~~~~~~~----~~~~~~~~t~~y~aPE~l~~~---~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 166 ARTAGTS----FMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp -------------------CCTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred hhccccc----cccccccccccccChhhhcCC---CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence 8754321 223445789999999999753 6889999999999999999999999988766655444321111
Q ss_pred ------------------CCC--------------C------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhc
Q 006772 274 ------------------PCI--------------P------SGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNA 315 (632)
Q Consensus 274 ------------------p~~--------------p------~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~ 315 (632)
+.. + ...++++.+||++||+.||++|||++|+|+ ++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~------Hp 312 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ------HP 312 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT------ST
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------Cc
Confidence 000 0 113567899999999999999999999986 56
Q ss_pred ccC
Q 006772 316 VYN 318 (632)
Q Consensus 316 ~~~ 318 (632)
++.
T Consensus 313 w~~ 315 (355)
T d2b1pa1 313 YIN 315 (355)
T ss_dssp TTG
T ss_pred ccC
Confidence 664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-42 Score=361.75 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=195.4
Q ss_pred CCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCch--hhHHHHHHHHHHHhhhccCCCceeEeeEEEEE
Q 006772 42 PTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKE--DCAKVFVNKFEELFPKFRESQSVCWLHGISVI 119 (632)
Q Consensus 42 ~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~--~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~ 119 (632)
+++|+++++||+|+||+||+|+++.++ +.||||++.+... ...+.+. ++..++..+ +|+|++.+++++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~-~Ei~il~~l-~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTG------LRVAVKKLSRPFQSIIHAKRTY-RELRLLKHM-KHENVIGLLDVFTP 88 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTT------EEEEEEECSCTTSSHHHHHHHH-HHHHHHHHC-CCTTBCCCSEEECS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCC------CEEEEEEECchhcChHHHHHHH-HHHHHHHhc-CCCCeeeEEEEEee
Confidence 478999999999999999999998766 4899999975432 2223333 344555665 69999999998864
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCcEEEEec
Q 006772 120 N------GKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQLVLGDF 193 (632)
Q Consensus 120 ~------~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~vkL~DF 193 (632)
. +..+++|++..|+|.+++. .+++++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++||
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccccccCceEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccccc
Confidence 2 3355555555578877763 347999999999999999999999999999999999999999999999999
Q ss_pred CCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhccC
Q 006772 194 GIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTGIQPWFGKSVEEIYHSVVIKKEK 273 (632)
Q Consensus 194 Glak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG~~PF~~~~~~ei~~~i~~~~~~ 273 (632)
|++.... .......||+.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+.......+......
T Consensus 166 g~a~~~~------~~~~~~~g~~~y~apE~~~~~--~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 166 GLARHTD------DEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp ----CCT------GGGSSSCHHHHTSCHHHHTTC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhcccC------cccccccccccccCchhhcCC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9986542 223446789999999987643 34688999999999999999999999998877666555432211
Q ss_pred C---------------------CC--------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccC
Q 006772 274 P---------------------CI--------PSGLPPAVENVIIGCFEYDLRNRPLMADILHAFESSQNAVYN 318 (632)
Q Consensus 274 p---------------------~~--------p~~lp~~l~~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~ 318 (632)
+ .. ...+++++.+||.+||+.||++|||++|+++ ++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~------Hp~f~ 305 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA------HAYFA 305 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc------CHhhC
Confidence 1 11 1357899999999999999999999999886 56654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-38 Score=333.30 Aligned_cols=265 Identities=18% Similarity=0.265 Sum_probs=191.6
Q ss_pred CCCCCCCcCCCCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhcc-------
Q 006772 33 PTQTRPWIDPTSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFR------- 105 (632)
Q Consensus 33 ~~~~~~~I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~------- 105 (632)
|..++..+...+|+++++||+|+||+||+|+++.++ +.||||++++.... .....+ +..++..+.
T Consensus 3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g------~~vAvKvi~~~~~~-~~~~~~-Ei~~l~~l~~~~~~~~ 74 (362)
T d1q8ya_ 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNN------THVAMKIVRGDKVY-TEAAED-EIKLLQRVNDADNTKE 74 (362)
T ss_dssp CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSCHHH-HHHHHH-HHHHHHHHHHTCCSHH
T ss_pred CCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCC------CEEEEEEEeccccc-hHHHHH-HHHHHHHhcchhhhhh
Confidence 455565566667999999999999999999998766 48999999764322 122222 222333322
Q ss_pred ---CCCceeEeeEEEEE--CCEEEEEEecCC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeeeeeC
Q 006772 106 ---ESQSVCWLHGISVI--NGKICIAMKFYE--GSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS-IGLLVLNLKP 177 (632)
Q Consensus 106 ---~h~~I~~l~~~~~~--~~~l~LVmEy~~--GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs-~~IvHRDLKP 177 (632)
.|+||+.+++++.. ....+++|+++. ++............+++..++.++.||+.||+|||+ +||+||||||
T Consensus 75 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp 154 (362)
T d1q8ya_ 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 154 (362)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred hhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh
Confidence 46889998887754 456677777765 344444444455789999999999999999999998 8999999999
Q ss_pred CeEEEecCCc------EEEEecCCceeccCCCCCCCccccccCCCccCCccccCCCCCCCCCcccccchhHHHHHHHHhC
Q 006772 178 SNLLLSEHDQ------LVLGDFGIPYLLLGRSLSDSDMALRLGTPNYMAPEQWEPEVRGPISFETDTWGFGCSIMEMLTG 251 (632)
Q Consensus 178 ~NILld~~g~------vkL~DFGlak~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~g~~t~ksDvwSlGvvL~EmltG 251 (632)
+|||++.++. ++++|||.|..... .....+||+.|+|||++.. ..++.++|+||+||+++||++|
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g 225 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITG 225 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHS
T ss_pred hHeeeeccCcccccceeeEeeccccccccc------ccccccccccccChhhccc---cCCCccccccchHHHHHHHHHC
Confidence 9999987663 99999999876432 2244679999999999874 4688999999999999999999
Q ss_pred CCCCCCCCHH------HHHHHHH-hhc---------------------------------------cCCCCCCCCCHHHH
Q 006772 252 IQPWFGKSVE------EIYHSVV-IKK---------------------------------------EKPCIPSGLPPAVE 285 (632)
Q Consensus 252 ~~PF~~~~~~------ei~~~i~-~~~---------------------------------------~~p~~p~~lp~~l~ 285 (632)
+.||...+.. +...... ..+ ....++...++++.
T Consensus 226 ~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (362)
T d1q8ya_ 226 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305 (362)
T ss_dssp SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred CCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHH
Confidence 9999754321 1111110 000 01111223457899
Q ss_pred HHHHHhhhcCcCCCCCHHHHHHHHHhhhhcccCCC
Q 006772 286 NVIIGCFEYDLRNRPLMADILHAFESSQNAVYNDG 320 (632)
Q Consensus 286 ~LI~~cL~~DP~~RPs~~ell~~Le~~~~~~~~~~ 320 (632)
+||.+||+.||.+|||++|+|+ +++|.+.
T Consensus 306 dll~~mL~~dP~~Rpta~e~L~------Hp~f~~~ 334 (362)
T d1q8ya_ 306 DFLSPMLQLDPRKRADAGGLVN------HPWLKDT 334 (362)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHT------CGGGTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhc------CcccCCC
Confidence 9999999999999999999875 6777533
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=188.52 Aligned_cols=134 Identities=13% Similarity=0.056 Sum_probs=94.6
Q ss_pred eEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchh-----------------hHHHHHHHHHHHhhhccCC
Q 006772 45 LKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKED-----------------CAKVFVNKFEELFPKFRES 107 (632)
Q Consensus 45 y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~-----------------~~~~~~~~~~~il~~l~~h 107 (632)
+.++++||+|+||+||+|.+.. + +.||||+++..... ........+...+..+ .+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g------~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~ 73 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-F------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QG 73 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-T------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TT
T ss_pred chhCCEeeeCcceEEEEEECCC-C------CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cC
Confidence 4688999999999999998743 2 48999987542110 0001111122233344 45
Q ss_pred CceeEeeEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeeeeeCCeEEEecCCc
Q 006772 108 QSVCWLHGISVINGKICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHSIGLLVLNLKPSNLLLSEHDQ 187 (632)
Q Consensus 108 ~~I~~l~~~~~~~~~l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs~~IvHRDLKP~NILld~~g~ 187 (632)
.+++..++. .. .+++|||+++... ..++...+..++.|++.+|+|||++||+||||||+|||++++ .
T Consensus 74 ~~v~~~~~~--~~--~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 74 LAVPKVYAW--EG--NAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp SSSCCEEEE--ET--TEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-E
T ss_pred CCcceEEEe--cC--CEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-C
Confidence 666665543 22 2789999997432 135566678899999999999999999999999999999965 5
Q ss_pred EEEEecCCceec
Q 006772 188 LVLGDFGIPYLL 199 (632)
Q Consensus 188 vkL~DFGlak~~ 199 (632)
++|+|||+|...
T Consensus 141 ~~liDFG~a~~~ 152 (191)
T d1zara2 141 IWIIDFPQSVEV 152 (191)
T ss_dssp EEECCCTTCEET
T ss_pred EEEEECCCcccC
Confidence 899999998764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.01 E-value=1.4e-05 Score=77.41 Aligned_cols=140 Identities=12% Similarity=-0.005 Sum_probs=81.1
Q ss_pred CCeEEEeEEcccCceEEEEEEEcCCCCCcccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEEECCE
Q 006772 43 TSLKLKHRIGRGPFGDVWLATHHQSADDFDEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISVINGK 122 (632)
Q Consensus 43 ~~y~l~~~IG~G~FG~VylA~~~~~~~~~~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~~~~~ 122 (632)
+.|++.+..+.++.+.||+.... + ..+.+|+...........+ ..+...+..+..+--++.+..+...++.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~--~------~~~vlk~~~~~~~~~~~~~-~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGE--N------ENLYLKMTDSRYKGTTYDV-EREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECS--S------CEEEEEEECGGGTTSTTCH-HHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hceEEEEcCCCCCCCcEEEEEeC--C------CeEEEEEcCCCcccchhhH-HHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 46777776555556799987522 1 3578888754322111111 2222333333333334566677778899
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 006772 123 ICIAMKFYEGSVGDRIAQQRGGKLPLPDILRYGIQLAKGISDLHS----------------------------------- 167 (632)
Q Consensus 123 l~LVmEy~~GsL~d~l~~~~~~~l~~~~~~~ia~qIa~gL~yLHs----------------------------------- 167 (632)
.++||++++|........ +......++.+++..|..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred eEEEEEeccccccccccc------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999843321110 011111223333333333332
Q ss_pred ------------------C------CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 ------------------I------GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ------------------~------~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26899999999999987667799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.10 E-value=0.0012 Score=62.86 Aligned_cols=28 Identities=11% Similarity=-0.089 Sum_probs=24.6
Q ss_pred ceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 170 LLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 170 IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987777899999654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.96 E-value=0.00095 Score=68.92 Aligned_cols=29 Identities=21% Similarity=0.305 Sum_probs=25.0
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCcee
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPYL 198 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak~ 198 (632)
.++|+|+.|.|||+++++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998765 89999987654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.39 E-value=0.014 Score=59.64 Aligned_cols=85 Identities=14% Similarity=0.173 Sum_probs=49.7
Q ss_pred cCCCCeEEEeEEcccCceEEEEEEEcCCCCCc-ccccEEEEEEecCCchhhHHHHHHHHHHHhhhccCCCceeEeeEEEE
Q 006772 40 IDPTSLKLKHRIGRGPFGDVWLATHHQSADDF-DEYHELAVKMLLPLKEDCAKVFVNKFEELFPKFRESQSVCWLHGISV 118 (632)
Q Consensus 40 I~~~~y~l~~~IG~G~FG~VylA~~~~~~~~~-~~~~~VAIK~l~~~~~~~~~~~~~~~~~il~~l~~h~~I~~l~~~~~ 118 (632)
++.+++++ +.|+.|--=.+|++......... ...+.|.+++.-..... .. ...+..+++.+..+...+.+++++
T Consensus 40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~--id-r~~E~~i~~~ls~~gl~Pkll~~~- 114 (395)
T d1nw1a_ 40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE--SH-LVAESVIFTLLSERHLGPKLYGIF- 114 (395)
T ss_dssp CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH--HH-HHHHHHHHHHHHHTTSSSCEEEEE-
T ss_pred CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh--hH-HHHHHHHHHHHHhCCCCCeEEEEc-
Confidence 45667776 46888888999999876433211 22346777776532221 11 223334444454455455666655
Q ss_pred ECCEEEEEEecCCC
Q 006772 119 INGKICIAMKFYEG 132 (632)
Q Consensus 119 ~~~~l~LVmEy~~G 132 (632)
++ .+||||++|
T Consensus 115 -~~--g~I~efi~g 125 (395)
T d1nw1a_ 115 -SG--GRLEEYIPS 125 (395)
T ss_dssp -TT--EEEECCCCE
T ss_pred -CC--ceEEEEecc
Confidence 23 579999986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.04 E-value=0.15 Score=50.01 Aligned_cols=27 Identities=15% Similarity=0.064 Sum_probs=22.2
Q ss_pred CceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 169 GLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 169 ~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
++||+|+.|.|||+++ + ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 5899999999999974 3 4589999654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.29 E-value=0.44 Score=45.92 Aligned_cols=30 Identities=20% Similarity=0.237 Sum_probs=26.6
Q ss_pred CCceeeeeeCCeEEEecCCcEEEEecCCce
Q 006772 168 IGLLVLNLKPSNLLLSEHDQLVLGDFGIPY 197 (632)
Q Consensus 168 ~~IvHRDLKP~NILld~~g~vkL~DFGlak 197 (632)
.++||+|+.+.|||++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 469999999999999988877899999764
|